data_1h92_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1h92 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.493 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 5.8 mp . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.221 0.534 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 31' ' ' LEU . 18.2 m -147.67 168.9 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.2 -0.938 . . . . 0.0 110.309 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 81.8 mt -112.24 145.3 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.388 -0.82 . . . . 0.0 109.671 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.48 ' HB2' ' N ' ' A' ' 29' ' ' GLU . . . -77.56 114.94 16.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.077 -1.014 . . . . 0.0 110.367 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.483 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 37.6 tp -71.4 -26.9 62.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.104 -0.997 . . . . 0.0 109.386 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.483 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 25.8 m80 -158.22 149.41 20.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.469 -0.769 . . . . 0.0 109.7 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 44.2 p -61.97 141.44 58.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.026 -1.046 . . . . 0.0 110.092 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.583 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 77.1 t80 -102.76 165.05 11.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.079 -1.013 . . . . 0.0 110.408 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.579 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 35.8 mt-10 -113.52 129.64 24.46 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 110.228 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.464 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 49.9 Cg_endo -85.21 88.67 0.88 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.983 1.518 . . . . 0.0 110.509 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.0 m -79.59 -6.99 58.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.925 . . . . 0.0 110.084 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 -128.23 -155.35 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 110.007 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -112.36 -4.63 14.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 110.27 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.68 5.53 16.59 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -92.21 159.32 15.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -1.187 . . . . 0.0 110.232 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.499 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 35.5 tp -116.78 122.28 43.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.248 -0.908 . . . . 0.0 110.119 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.469 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -99.33 47.83 1.32 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.583 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 35.9 p90 -45.57 171.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -1.189 . . . . 0.0 110.834 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -98.71 176.85 5.49 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.415 -0.803 . . . . 0.0 110.446 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -71.8 122.95 21.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.262 -0.899 . . . . 0.0 110.239 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 92.96 -8.85 76.05 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.48 ' N ' ' HB2' ' A' ' 11' ' ' ALA . 27.3 tt0 -61.3 137.27 58.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.137 -1.214 . . . . 0.0 110.112 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.414 ' O ' HD13 ' A' ' 31' ' ' LEU . 87.8 mt-30 -79.63 126.85 31.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 0.0 109.965 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.502 HD23 ' CG ' ' A' ' 25' ' ' PHE . 10.3 mp -126.36 145.45 50.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.919 . . . . 0.0 110.468 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.482 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 25.3 ttt180 -103.23 139.71 38.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.828 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.445 HD13 HG12 ' A' ' 9' ' ' VAL . 11.8 mt -87.45 130.14 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.14 -0.975 . . . . 0.0 110.263 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.42 HD22 ' HG2' ' A' ' 32' ' ' ARG . 60.6 mt -117.43 -30.44 5.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 110.193 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.448 ' HB3' ' HB3' ' A' ' 42' ' ' LYS . 83.0 tt0 -139.15 149.65 44.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -0.907 . . . . 0.0 110.232 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.541 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 96.9 mt-30 -139.54 58.79 1.61 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 110.212 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.5 t -123.93 130.31 52.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 0.0 110.246 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.86 -162.8 33.0 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -82.79 -32.33 27.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -1.136 . . . . 0.0 110.075 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.562 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 92.1 m95 -98.03 146.08 25.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.922 . . . . 0.0 110.134 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.541 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 49.3 m0 -120.9 154.95 35.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.297 -0.877 . . . . 0.0 110.302 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 35' ' ' GLU . 79.1 tttt -93.48 143.56 26.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.919 . . . . 0.0 109.798 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.488 ' CB ' HG12 ' A' ' 54' ' ' ILE . . . -152.14 175.17 12.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.135 -0.978 . . . . 0.0 110.632 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 50' ' ' GLN . 39.4 tt0 -139.22 147.49 41.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.43 -0.794 . . . . 0.0 109.884 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.46 ' HB2' ' OG1' ' A' ' 48' ' ' THR . 21.6 m -79.79 145.79 32.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.088 -1.007 . . . . 0.0 110.222 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.501 ' N ' HD13 ' A' ' 46' ' ' LEU . 5.9 mp -94.73 -11.89 28.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.311 -0.868 . . . . 0.0 109.855 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.2 p -105.43 -30.09 9.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.405 -0.809 . . . . 0.0 110.435 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.46 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 17.6 p -99.84 -17.82 17.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.1 -1.0 . . . . 0.0 110.451 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.88 48.79 63.26 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.466 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 38.3 mt-30 -132.76 157.34 45.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.358 -1.084 . . . . 0.0 110.115 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.447 ' HG2' ' HG3' ' A' ' 44' ' ' GLN . 94.3 mt-10 -119.6 141.69 49.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.925 . . . . 0.0 110.097 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.499 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -166.29 159.16 32.38 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -70.24 142.73 52.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.243 -1.151 . . . . 0.0 110.045 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.488 HG12 ' CB ' ' A' ' 43' ' ' ALA . 1.8 pp -137.65 131.1 17.03 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 110.158 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.583 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 46.0 Cg_endo -55.94 160.9 9.26 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.03 1.542 . . . . 0.0 110.07 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -88.45 -2.36 58.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 110.911 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 -100.09 -25.83 14.16 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.987 -1.071 . . . . 0.0 111.054 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.548 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 26.5 m-85 -80.24 -11.93 59.68 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.017 -1.052 . . . . 0.0 110.446 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.452 ' CG2' ' CD1' ' A' ' 54' ' ' ILE . 26.9 m -132.22 145.55 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.95 . . . . 0.0 110.24 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 110.286 179.997 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.418 ' C ' HG11 ' A' ' 9' ' ' VAL . 21.1 tp . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.182 0.515 . . . . 0.0 109.957 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.418 HG11 ' C ' ' A' ' 8' ' ' LEU . 31.2 m -145.63 167.84 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 110.378 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 86.1 mt -112.6 148.99 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.395 -0.816 . . . . 0.0 109.702 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.479 ' HB2' ' CD2' ' A' ' 25' ' ' PHE . . . -80.17 113.39 18.31 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.128 -0.983 . . . . 0.0 110.443 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.516 HD11 ' CD2' ' A' ' 13' ' ' HIS . 0.2 OUTLIER -70.74 -25.31 62.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.115 -0.991 . . . . 0.0 109.091 179.202 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.516 ' CD2' HD11 ' A' ' 12' ' ' LEU . 23.9 m-70 -159.13 151.05 20.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.703 -0.623 . . . . 0.0 109.481 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 41.6 p -63.38 140.83 58.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.907 -1.121 . . . . 0.0 109.883 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.581 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 65.5 t80 -100.89 162.81 12.64 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.063 -1.023 . . . . 0.0 110.255 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.571 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 29.8 tt0 -118.12 128.31 26.06 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.24 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.451 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 46.9 Cg_endo -82.17 84.6 1.82 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.111 1.585 . . . . 0.0 110.55 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.46 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 86.1 p -79.78 -3.94 49.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.932 . . . . 0.0 109.974 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.46 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 90.3 m-70 -139.85 151.21 45.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 0.0 110.136 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -65.35 125.47 25.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 110.117 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.59 11.43 28.88 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.45 ' OD2' ' HB2' ' A' ' 19' ' ' HIS . 11.4 m-20 -105.94 160.08 15.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.151 -1.205 . . . . 0.0 110.308 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.508 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 20.5 tp -116.4 122.99 46.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.338 -0.851 . . . . 0.0 110.18 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.478 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -104.39 51.28 0.81 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 33.0 p90 -45.32 172.19 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.197 -1.178 . . . . 0.0 110.9 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -99.26 176.0 5.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.405 -0.809 . . . . 0.0 110.554 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.9 tttm -71.18 124.88 25.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.364 -0.835 . . . . 0.0 110.28 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 90.39 -8.62 79.5 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.465 ' N ' ' HB1' ' A' ' 11' ' ' ALA . 27.0 tt0 -62.39 132.45 52.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.103 -1.234 . . . . 0.0 110.365 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -79.87 130.59 35.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 109.842 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.572 HD12 ' CG ' ' A' ' 25' ' ' PHE . 17.6 mt -130.67 150.43 51.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.934 . . . . 0.0 110.501 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 40.3 ttt180 -100.82 135.77 41.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.434 -0.791 . . . . 0.0 109.75 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.2 mt -83.37 127.87 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 110.317 -179.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.478 ' CD1' ' HB2' ' A' ' 44' ' ' GLN . 75.1 mt -107.13 -30.98 8.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.284 -0.885 . . . . 0.0 110.215 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -143.39 153.42 42.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 0.0 110.197 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.445 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 93.0 mt-30 -138.58 54.21 1.77 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 110.242 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 75.3 m -121.81 134.48 54.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.908 . . . . 0.0 110.101 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.68 -172.11 47.98 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -74.45 -34.26 63.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -1.144 . . . . 0.0 110.178 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.403 ' HZ3' ' CE1' ' A' ' 15' ' ' TYR . 72.6 m95 -97.17 145.78 25.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -0.921 . . . . 0.0 110.08 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.46 ' O ' HG13 ' A' ' 54' ' ' ILE . 52.1 m0 -120.69 153.81 36.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.256 -0.903 . . . . 0.0 110.056 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -90.07 144.5 25.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -0.953 . . . . 0.0 109.749 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 32' ' ' ARG . . . -148.54 170.41 18.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.086 -1.009 . . . . 0.0 110.611 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.478 ' HB2' ' CD1' ' A' ' 34' ' ' LEU . 51.9 tt0 -137.89 146.11 42.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.371 -0.831 . . . . 0.0 109.827 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.7 m -76.77 142.08 40.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.097 -1.002 . . . . 0.0 110.376 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 36.3 mt -88.66 -18.48 27.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.35 -0.844 . . . . 0.0 109.848 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.5 p -106.41 -30.06 9.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -0.862 . . . . 0.0 110.37 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.0 m -92.07 -24.31 19.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.064 -1.022 . . . . 0.0 110.421 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.78 46.29 54.17 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 59.1 mt-30 -134.28 158.75 42.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -1.121 . . . . 0.0 110.204 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.437 ' HG2' ' HB2' ' A' ' 44' ' ' GLN . 92.4 mt-10 -121.02 143.71 48.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.35 -0.844 . . . . 0.0 110.148 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.508 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -163.65 157.27 29.43 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -69.4 141.92 54.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -1.156 . . . . 0.0 109.926 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.504 ' CD1' HG22 ' A' ' 59' ' ' VAL . 1.3 pt -135.84 145.71 53.98 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 110.066 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.581 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 45.5 Cg_endo -72.45 162.62 40.94 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.987 1.519 . . . . 0.0 110.065 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.445 ' CE2' ' OD1' ' A' ' 57' ' ' ASN . 31.7 p90 -88.07 -3.98 58.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.959 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.445 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 60.3 m-20 -98.5 -26.57 14.39 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.899 -1.126 . . . . 0.0 111.062 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.577 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 34.2 m-85 -81.52 -10.85 59.38 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.939 -1.1 . . . . 0.0 110.326 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.504 HG22 ' CD1' ' A' ' 54' ' ' ILE . 25.3 m -131.05 142.66 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 110.273 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.193 -0.942 . . . . 0.0 110.122 179.995 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 91.7 mt . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.187 0.518 . . . . 0.0 109.98 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 60' ' ' ALA . 22.9 m -145.82 167.6 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.127 -0.983 . . . . 0.0 110.539 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.5 mt -111.05 149.45 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.377 -0.827 . . . . 0.0 109.621 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.436 ' CB ' ' CD2' ' A' ' 25' ' ' PHE . . . -80.14 112.83 17.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.031 -1.043 . . . . 0.0 110.339 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.455 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 82.9 mt -69.58 -25.96 64.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.102 -0.999 . . . . 0.0 109.191 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.455 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 72.2 m80 -155.37 152.39 29.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.576 -0.702 . . . . 0.0 109.501 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 26.9 p -64.28 142.15 58.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.898 -1.126 . . . . 0.0 109.92 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.573 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 73.9 t80 -102.67 165.05 11.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.012 -1.055 . . . . 0.0 110.167 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.57 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 1.9 tp10 -119.5 132.84 23.86 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.285 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.469 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 49.2 Cg_endo -84.48 84.0 1.56 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.961 1.506 . . . . 0.0 110.299 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.404 ' OG ' ' ND1' ' A' ' 19' ' ' HIS . 83.3 p -79.59 -3.18 45.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.939 . . . . 0.0 110.051 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.455 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 51.5 m80 -144.86 165.95 26.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 110.039 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -76.87 126.21 30.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.911 . . . . 0.0 110.156 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.17 -1.9 35.19 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.455 ' OD2' ' HB2' ' A' ' 19' ' ' HIS . 17.2 m-20 -93.96 157.64 16.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.27 -1.135 . . . . 0.0 110.259 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.455 HD13 ' NE2' ' A' ' 50' ' ' GLN . 25.5 tp -115.6 120.91 40.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.296 -0.877 . . . . 0.0 109.988 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.469 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -100.62 51.47 0.99 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.565 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 40.7 p90 -48.46 172.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.192 -1.181 . . . . 0.0 110.995 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -100.82 174.99 5.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.507 -0.745 . . . . 0.0 110.189 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.4 pttm -71.39 131.62 43.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.137 -0.977 . . . . 0.0 110.102 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.48 -10.16 72.78 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.428 ' CD ' ' HB2' ' A' ' 25' ' ' PHE . 33.0 tt0 -64.5 132.88 51.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -1.168 . . . . 0.0 110.245 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -79.68 131.47 35.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.784 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.428 HD11 ' N ' ' A' ' 31' ' ' LEU . 9.4 mp -129.84 148.58 51.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.92 . . . . 0.0 110.562 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.523 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 24.7 ttt180 -103.13 134.72 46.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.448 -0.782 . . . . 0.0 109.534 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.9 mm -83.82 131.53 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.143 -0.973 . . . . 0.0 110.194 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.1 mt -115.57 -32.9 5.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.331 -0.855 . . . . 0.0 110.178 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 87.1 mt-10 -132.06 153.95 49.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 110.21 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.573 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 97.9 mt-30 -139.97 55.61 1.64 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.86 . . . . 0.0 110.204 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 99.1 p -125.24 126.8 45.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 110.287 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.61 174.8 49.43 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -63.34 -28.91 70.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -1.197 . . . . 0.0 110.208 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.573 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 97.3 m95 -97.54 145.26 26.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 110.226 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.573 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 35.9 m0 -124.7 157.0 36.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.289 -0.882 . . . . 0.0 110.1 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 35' ' ' GLU . 34.0 tttt -96.26 145.33 25.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.689 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -158.24 -177.71 6.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 110.56 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -145.52 153.85 41.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.424 -0.798 . . . . 0.0 109.982 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.8 t -98.89 126.02 44.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.115 -0.991 . . . . 0.0 110.17 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.1 mt -80.7 9.27 6.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.904 . . . . 0.0 110.312 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.8 m -92.79 -35.59 13.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.175 -0.953 . . . . 0.0 110.194 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 49.2 p -132.69 -0.98 3.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.389 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.32 30.85 56.26 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.455 ' NE2' HD13 ' A' ' 23' ' ' LEU . 54.7 tt0 -91.27 131.79 36.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -1.116 . . . . 0.0 110.135 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.456 ' OE2' ' NZ ' ' A' ' 42' ' ' LYS . 85.6 tt0 -117.22 136.24 53.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 0.0 110.082 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.444 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -171.88 166.18 39.06 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -70.44 146.41 50.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -1.131 . . . . 0.0 110.113 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.468 ' CD1' HG22 ' A' ' 59' ' ' VAL . 2.2 pp -139.23 131.59 15.37 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.235 -0.916 . . . . 0.0 110.147 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.573 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 47.3 Cg_endo -55.68 158.49 13.3 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.972 1.511 . . . . 0.0 110.102 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.572 ' CE2' ' OD1' ' A' ' 57' ' ' ASN . 18.8 p90 -87.41 -0.42 56.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 0.0 110.771 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.572 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 89.9 m-20 -99.65 -26.42 14.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.958 -1.089 . . . . 0.0 110.855 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.469 ' HB2' ' HG2' ' A' ' 55' ' ' PRO . 10.8 m-85 -83.47 -3.0 57.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.004 -1.06 . . . . 0.0 110.391 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.468 HG22 ' CD1' ' A' ' 54' ' ' ILE . 26.9 m -130.6 143.52 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 0.0 110.328 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.451 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 110.149 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.442 ' CD1' HD13 ' A' ' 46' ' ' LEU . 19.7 tp . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.133 0.492 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 60' ' ' ALA . 33.0 m -145.84 167.98 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.129 -0.982 . . . . 0.0 110.415 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.3 mt -113.44 149.9 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.366 -0.834 . . . . 0.0 109.596 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.574 ' HB2' ' CD2' ' A' ' 25' ' ' PHE . . . -80.38 114.52 19.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.169 -0.957 . . . . 0.0 110.679 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.458 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 16.8 tp -78.95 -19.74 50.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 109.256 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.458 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 39.8 m-70 -159.98 142.05 13.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.566 -0.709 . . . . 0.0 109.511 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.0 p -60.56 139.73 57.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.818 -1.176 . . . . 0.0 110.101 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.584 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 81.6 t80 -99.93 161.97 13.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.124 -0.985 . . . . 0.0 110.296 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.46 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 2.1 mp0 -117.46 129.03 25.62 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.322 -0.861 . . . . 0.0 110.12 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.448 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 48.2 Cg_endo -83.06 83.77 1.87 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.081 1.569 . . . . 0.0 110.381 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.563 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 56.8 p -79.8 -3.88 49.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 110.121 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.563 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 89.4 m-70 -141.61 168.49 19.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 0.0 110.264 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -82.01 125.12 30.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.27 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.15 18.36 11.4 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -114.97 161.03 18.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.259 -1.142 . . . . 0.0 110.127 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.495 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 17.6 tp -115.76 120.77 40.39 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 110.28 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.479 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -101.72 54.63 0.77 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.584 ' CE1' ' HB2' ' A' ' 15' ' ' TYR . 44.0 p90 -50.26 171.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.31 -1.112 . . . . 0.0 110.908 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.42 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 91.5 mt-10 -100.39 178.33 4.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 110.488 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -71.86 123.07 21.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -0.88 . . . . 0.0 110.246 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 91.76 -10.09 75.38 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.536 ' N ' ' HB1' ' A' ' 11' ' ' ALA . 16.6 tt0 -61.65 131.93 51.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -1.17 . . . . 0.0 110.135 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.463 ' O ' HD21 ' A' ' 31' ' ' LEU . 96.3 mt-30 -79.98 130.81 35.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.305 -0.872 . . . . 0.0 110.192 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.574 HD13 ' CG ' ' A' ' 25' ' ' PHE . 32.3 mt -126.76 145.65 50.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -0.954 . . . . 0.0 110.459 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.486 ' HB2' ' CD2' ' A' ' 46' ' ' LEU . 5.4 tpt180 -93.72 137.74 32.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.366 -0.834 . . . . 0.0 109.531 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.436 HG22 HD11 ' A' ' 33' ' ' ILE . 18.7 mm -90.99 129.13 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.131 -0.981 . . . . 0.0 110.287 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.466 ' CD1' ' HB2' ' A' ' 44' ' ' GLN . 49.9 mt -112.94 -26.4 8.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.902 . . . . 0.0 110.068 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 75.3 mt-10 -150.45 156.33 41.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 110.147 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.56 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 97.6 mt-30 -142.09 58.6 1.47 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 110.238 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -119.0 140.36 50.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.254 -0.904 . . . . 0.0 110.156 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.8 -168.3 53.47 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -76.37 -34.43 58.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -1.162 . . . . 0.0 110.128 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.573 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 96.8 m95 -96.25 143.75 27.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 110.251 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.56 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.9 m0 -116.53 152.29 34.39 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -0.897 . . . . 0.0 110.261 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 35' ' ' GLU . 18.1 tttt -89.95 141.43 28.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.254 -0.904 . . . . 0.0 109.987 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.529 ' CB ' HG12 ' A' ' 54' ' ' ILE . . . -147.87 170.22 18.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.16 -0.963 . . . . 0.0 110.428 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 59.2 tt0 -130.48 136.31 48.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 110.037 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.1 m -68.45 138.02 54.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.127 -0.983 . . . . 0.0 110.242 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.486 ' CD2' ' HB2' ' A' ' 32' ' ' ARG . 54.2 mt -87.65 -12.52 45.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.094 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.9 p -101.34 -28.42 12.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.863 . . . . 0.0 110.285 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 46.2 p -113.37 -3.6 13.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.169 -0.957 . . . . 0.0 110.366 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 58.67 14.15 20.75 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -86.93 157.19 19.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.122 -1.222 . . . . 0.0 110.39 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 94.9 mt-10 -117.4 138.68 51.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.355 -0.84 . . . . 0.0 109.972 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.495 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -161.07 156.7 28.14 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -68.68 144.5 54.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.247 -1.149 . . . . 0.0 109.899 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.529 HG12 ' CB ' ' A' ' 43' ' ' ALA . 1.1 pt -137.37 123.43 13.18 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.142 -0.974 . . . . 0.0 110.38 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.593 ' CG ' ' CD2' ' A' ' 58' ' ' PHE . 43.5 Cg_endo -47.16 159.35 0.39 Allowed 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.963 1.507 . . . . 0.0 110.068 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -96.48 0.78 50.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 110.736 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -100.18 -26.73 13.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.027 -1.046 . . . . 0.0 110.694 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.593 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 7.9 m-30 -89.19 -8.18 54.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.143 -0.973 . . . . 0.0 110.494 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.437 HG12 HD11 ' A' ' 54' ' ' ILE . 26.9 m -125.02 143.42 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.087 -1.008 . . . . 0.0 110.187 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.453 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.224 -0.922 . . . . 0.0 110.211 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.522 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 5.2 mp . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.178 0.513 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.486 ' CG1' ' O ' ' A' ' 8' ' ' LEU . 9.4 m -157.62 174.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.286 -0.884 . . . . 0.0 110.328 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 80.0 mt -115.75 141.88 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.392 -0.818 . . . . 0.0 109.721 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.554 ' CB ' ' CD2' ' A' ' 25' ' ' PHE . . . -80.17 116.69 20.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 0.0 110.427 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.47 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 10.1 tp -70.06 -23.13 63.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.113 -0.992 . . . . 0.0 109.284 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.47 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 30.0 m80 -158.28 147.73 19.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.537 -0.727 . . . . 0.0 109.568 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 55.9 p -60.87 144.34 53.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.943 -1.098 . . . . 0.0 109.919 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.578 ' CD1' ' HD3' ' A' ' 55' ' ' PRO . 89.4 t80 -101.45 163.39 12.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.001 -1.062 . . . . 0.0 110.579 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.411 ' N ' ' CG ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -110.62 113.58 55.57 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.317 -0.864 . . . . 0.0 109.891 179.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.482 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 51.0 Cg_endo -74.36 96.85 0.99 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.066 1.561 . . . . 0.0 110.514 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.3 p -79.65 -1.54 38.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 110.103 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -133.49 -178.91 5.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 110.118 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -93.23 -2.26 55.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.285 -0.884 . . . . 0.0 110.194 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.474 ' O ' ' CD2' ' A' ' 53' ' ' PHE . . . -115.11 5.98 21.78 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 4.1 m-20 -98.77 167.81 10.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.241 -1.152 . . . . 0.0 110.346 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.496 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 31.0 tp -123.44 127.45 48.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.281 -0.887 . . . . 0.0 110.15 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.482 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . -104.22 54.87 0.63 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.572 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 40.3 p90 -44.78 169.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -1.124 . . . . 0.0 110.922 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.407 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 95.6 mt-10 -98.6 176.92 5.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.448 -0.783 . . . . 0.0 110.225 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -70.84 127.09 31.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.167 -0.958 . . . . 0.0 110.225 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.98 -7.66 81.65 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.417 ' CD ' ' HB2' ' A' ' 25' ' ' PHE . 19.0 tt0 -66.12 131.93 47.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.132 -1.216 . . . . 0.0 110.238 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.465 ' O ' HD13 ' A' ' 31' ' ' LEU . 98.1 mt-30 -79.54 133.42 36.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.259 -0.901 . . . . 0.0 109.903 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 30' ' ' GLN . 8.4 mp -132.19 152.17 51.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.254 -0.904 . . . . 0.0 110.483 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 26.1 ttm-85 -102.21 134.01 46.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.431 -0.793 . . . . 0.0 109.837 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.427 HD12 HG22 ' A' ' 33' ' ' ILE . 12.3 mt -88.46 137.18 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.921 . . . . 0.0 110.101 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.468 ' CD1' ' HA ' ' A' ' 43' ' ' ALA . 1.3 mt -122.6 -29.25 4.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 110.095 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 73.9 mm-40 -135.3 147.67 49.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.182 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.56 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 95.3 mt-30 -137.95 56.63 1.74 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.898 . . . . 0.0 110.198 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.8 p -120.73 130.3 54.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 110.237 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.81 -164.8 41.39 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -81.16 -31.32 34.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.241 -1.152 . . . . 0.0 110.197 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.574 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 98.5 m95 -96.07 144.41 26.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 110.223 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.571 ' CZ3' ' HB2' ' A' ' 56' ' ' PHE . 48.8 m0 -123.21 156.52 34.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 110.335 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 35' ' ' GLU . 36.1 tttt -95.16 143.04 26.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 109.735 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -157.61 -178.77 7.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.942 . . . . 0.0 110.444 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 17.3 pt20 -151.46 159.68 44.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.399 -0.813 . . . . 0.0 110.104 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.1 t -97.37 115.61 28.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.206 -0.934 . . . . 0.0 110.14 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.6 mt -73.26 -1.2 16.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.271 -0.893 . . . . 0.0 110.356 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.5 m -92.81 -28.57 16.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 110.059 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.8 p -116.86 -10.3 11.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.898 . . . . 0.0 110.088 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.02 41.86 53.45 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.404 ' O ' ' HB2' ' A' ' 44' ' ' GLN . 37.8 mt-30 -124.07 151.83 43.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -1.167 . . . . 0.0 110.231 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 43.7 mt-10 -122.92 147.09 46.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 110.067 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.496 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -162.39 -146.27 4.62 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.474 ' CD2' ' O ' ' A' ' 21' ' ' GLY . 81.0 m-85 -128.44 142.62 51.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -1.092 . . . . 0.0 110.129 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.502 ' CD1' HG23 ' A' ' 59' ' ' VAL . 2.0 pp -138.23 145.06 45.71 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.266 -0.897 . . . . 0.0 110.251 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.578 ' HD3' ' CD1' ' A' ' 15' ' ' TYR . 45.4 Cg_endo -70.37 156.35 61.93 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.953 1.502 . . . . 0.0 110.037 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.571 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 27.4 p90 -78.51 -3.21 42.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.271 -0.893 . . . . 0.0 111.01 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -99.92 -25.74 14.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.985 -1.072 . . . . 0.0 111.197 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.563 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 9.8 m-85 -82.17 -5.16 58.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.954 -1.091 . . . . 0.0 110.467 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.502 HG23 ' CD1' ' A' ' 54' ' ' ILE . 27.6 m -134.47 145.54 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.123 -0.986 . . . . 0.0 110.187 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.237 179.974 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.503 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 6.7 mp . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.221 0.534 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.472 ' CG1' ' O ' ' A' ' 8' ' ' LEU . 34.4 m -155.03 172.55 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.319 -0.863 . . . . 0.0 110.157 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.442 HG22 HD11 ' A' ' 10' ' ' ILE . 19.0 mm -114.36 154.66 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.915 . . . . 0.0 109.778 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.459 ' HB1' ' N ' ' A' ' 29' ' ' GLU . . . -79.72 109.86 14.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.1 -1.0 . . . . 0.0 110.226 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.551 ' HG ' ' CE1' ' A' ' 13' ' ' HIS . 20.2 tp -70.61 -20.85 62.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.003 -1.061 . . . . 0.0 109.339 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.551 ' CE1' ' HG ' ' A' ' 12' ' ' LEU . 71.3 m80 -150.88 -164.08 1.93 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.525 -0.734 . . . . 0.0 109.863 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.7 t -111.6 138.94 47.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.155 -0.966 . . . . 0.0 110.077 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.578 ' CD2' ' HD3' ' A' ' 55' ' ' PRO . 53.2 t80 -103.19 164.16 11.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.064 -1.022 . . . . 0.0 110.128 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.565 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 74.7 mm-40 -120.69 125.37 27.15 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.226 -0.921 . . . . 0.0 110.209 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.467 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 48.9 Cg_endo -74.91 81.94 2.09 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.985 1.519 . . . . 0.0 110.33 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.554 ' OG ' ' CE1' ' A' ' 19' ' ' HIS . 83.4 p -79.62 -1.8 39.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.141 -0.975 . . . . 0.0 110.187 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.554 ' CE1' ' OG ' ' A' ' 18' ' ' SER . 36.5 m80 -147.62 143.97 28.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 110.167 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -54.83 128.49 33.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.176 -0.952 . . . . 0.0 110.335 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.94 -13.28 49.55 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -82.95 158.21 22.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -1.139 . . . . 0.0 110.328 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.543 ' O ' ' CD1' ' A' ' 15' ' ' TYR . 15.8 tp -119.82 125.99 49.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.353 -0.842 . . . . 0.0 110.073 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.474 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -105.21 55.89 0.55 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.512 ' CG ' HD12 ' A' ' 31' ' ' LEU . 40.4 p90 -50.14 173.53 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.088 -1.242 . . . . 0.0 110.942 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -111.78 -177.44 3.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.475 -0.765 . . . . 0.0 110.027 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -67.96 129.57 40.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.15 -0.969 . . . . 0.0 110.328 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.1 -17.93 57.24 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.459 ' N ' ' HB1' ' A' ' 11' ' ' ALA . 8.6 tt0 -55.43 122.71 11.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.179 -1.189 . . . . 0.0 110.382 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.404 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 29.5 tt0 -79.97 131.42 35.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 109.901 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.512 HD12 ' CG ' ' A' ' 25' ' ' PHE . 38.7 mt -137.19 158.72 43.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.953 . . . . 0.0 110.316 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.517 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 17.8 ttt180 -108.14 135.75 48.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 0.0 109.867 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.4 mt -91.75 92.03 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.175 -0.953 . . . . 0.0 110.325 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.44 HD22 ' HG2' ' A' ' 32' ' ' ARG . 81.1 mt -78.91 -27.79 43.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.267 -0.896 . . . . 0.0 110.554 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.534 ' HB2' ' CB ' ' A' ' 42' ' ' LYS . 95.7 mt-10 -131.33 136.11 47.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.145 -0.972 . . . . 0.0 110.16 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.576 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 19.0 pt20 -133.79 55.41 1.9 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 110.185 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.0 t -117.13 142.78 46.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.181 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.09 -165.61 54.77 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -79.61 -33.53 41.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -1.113 . . . . 0.0 110.086 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.401 ' HZ3' ' CE2' ' A' ' 15' ' ' TYR . 52.1 m95 -95.71 144.12 26.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.305 -0.872 . . . . 0.0 110.113 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.576 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 47.4 m0 -124.5 155.62 38.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 110.419 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 22.9 tttt -98.99 146.31 26.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.331 -0.856 . . . . 0.0 109.317 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.517 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -148.79 175.27 11.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.988 -1.07 . . . . 0.0 110.821 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 46.9 tt0 -138.81 147.51 42.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.416 -0.802 . . . . 0.0 109.837 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.5 m -95.97 117.23 30.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.115 -0.991 . . . . 0.0 110.075 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 76.6 mt -75.22 1.61 13.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 0.0 110.315 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 65.9 p -99.57 -33.2 10.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.925 . . . . 0.0 109.977 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.7 p -110.32 -15.23 14.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.891 . . . . 0.0 110.063 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.13 40.6 50.09 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -127.51 154.39 45.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -1.164 . . . . 0.0 110.335 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 64.6 tt0 -120.2 143.89 48.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.266 -0.896 . . . . 0.0 109.919 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.505 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -153.41 -153.94 6.56 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -119.98 132.45 55.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.492 -1.005 . . . . 0.0 109.915 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 54' ' ' ILE . 11.3 pt -125.77 145.25 51.03 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.167 -0.958 . . . . 0.0 110.439 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.58 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 45.8 Cg_endo -78.97 151.51 24.13 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.987 1.52 . . . . 0.0 109.833 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.57 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 33.3 p90 -71.05 -4.8 26.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.235 -0.916 . . . . 0.0 111.034 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.49 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 65.8 m-20 -98.1 -25.99 14.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.88 -1.138 . . . . 0.0 111.274 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.58 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 8.5 m-85 -85.16 -4.03 59.01 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.859 -1.151 . . . . 0.0 110.36 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.411 HG23 HD13 ' A' ' 54' ' ' ILE . 36.0 m -132.21 139.74 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -0.937 . . . . 0.0 110.106 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 110.384 -179.888 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.8 tp . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.189 0.518 . . . . 0.0 110.115 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.544 ' CG2' ' CG1' ' A' ' 59' ' ' VAL . 4.5 m -151.8 170.9 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.869 . . . . 0.0 110.329 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.3 mt -113.64 142.33 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.852 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 58' ' ' PHE . . . -80.3 114.34 19.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.147 -0.971 . . . . 0.0 110.192 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.52 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 75.3 mt -68.84 -22.6 64.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.068 -1.02 . . . . 0.0 109.471 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 82.2 m-70 -157.98 152.43 24.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.548 -0.72 . . . . 0.0 109.762 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 54.2 p -65.26 144.76 56.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.989 -1.07 . . . . 0.0 110.075 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 36.2 t80 -97.37 157.11 16.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.086 -1.009 . . . . 0.0 110.502 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -111.2 85.34 5.34 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.263 -0.898 . . . . 0.0 110.116 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.527 ' HD3' ' CA ' ' A' ' 24' ' ' GLY . 47.1 Cg_endo -55.86 120.61 8.55 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.101 1.579 . . . . 0.0 110.502 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.459 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 98.7 p -92.1 10.53 28.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 110.119 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.459 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 98.6 m-70 -141.02 -158.25 0.84 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 110.214 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 56.7 p30 -112.03 4.8 18.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -0.867 . . . . 0.0 110.135 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -118.15 4.37 16.03 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.511 ' HB2' ' CB ' ' A' ' 17' ' ' PRO . 42.6 m-20 -95.07 165.18 12.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.181 -1.188 . . . . 0.0 110.272 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.501 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 16.0 tp -113.5 116.21 29.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.273 -0.892 . . . . 0.0 110.003 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.527 ' CA ' ' HD3' ' A' ' 17' ' ' PRO . . . -96.33 51.85 1.6 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 25.4 p90 -49.91 171.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -1.152 . . . . 0.0 110.882 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.403 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 95.7 mt-10 -103.16 178.38 4.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.465 -0.772 . . . . 0.0 110.004 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -68.88 132.78 47.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.209 -0.932 . . . . 0.0 110.284 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.56 -9.65 74.98 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.481 ' OE2' ' CB ' ' A' ' 25' ' ' PHE . 21.8 tt0 -65.27 125.94 26.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.124 -1.221 . . . . 0.0 110.202 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.458 ' O ' HD22 ' A' ' 31' ' ' LEU . 85.9 mt-30 -79.72 137.94 37.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 110.04 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.458 HD22 ' O ' ' A' ' 30' ' ' GLN . 29.2 mt -141.58 163.78 32.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.194 -0.941 . . . . 0.0 110.358 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 5.8 ttt180 -107.18 134.21 50.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.376 -0.828 . . . . 0.0 109.485 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.523 HG23 ' CG ' ' A' ' 36' ' ' GLN . 25.5 mm -96.11 93.38 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.133 -0.979 . . . . 0.0 110.515 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.506 ' CD1' ' HA ' ' A' ' 43' ' ' ALA . 1.5 mp -79.49 -25.75 41.76 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.305 -0.872 . . . . 0.0 110.654 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 41' ' ' TRP . 11.0 mt-10 -136.38 139.65 42.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.057 -1.027 . . . . 0.0 110.39 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.577 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 96.2 mt-30 -134.21 54.47 1.94 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.368 -0.832 . . . . 0.0 110.044 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -112.69 146.91 37.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.403 -0.811 . . . . 0.0 110.224 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.18 -167.38 31.65 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -77.5 -34.13 54.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.319 -1.107 . . . . 0.0 110.154 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.544 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 99.3 m95 -92.96 137.98 31.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.191 -0.943 . . . . 0.0 110.326 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.577 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 50.6 m0 -120.42 156.08 32.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.32 -0.863 . . . . 0.0 110.023 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 35' ' ' GLU . 20.3 mttp -98.25 139.55 33.87 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 109.275 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -148.57 174.24 12.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.015 -1.053 . . . . 0.0 110.694 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 50' ' ' GLN . 47.3 tt0 -140.68 149.27 42.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.409 -0.807 . . . . 0.0 109.9 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 t -96.08 110.64 22.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.924 . . . . 0.0 110.161 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 70.2 mt -71.55 -2.35 16.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.298 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 91.5 m -85.84 -28.23 24.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 0.0 109.948 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.1 p -127.89 -4.61 5.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 110.172 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.77 39.69 65.61 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.466 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 32.6 mt-30 -114.97 148.11 39.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.171 -1.193 . . . . 0.0 110.242 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 37.3 tt0 -120.94 144.47 48.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 0.0 109.887 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.501 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -162.19 -152.54 6.77 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -124.56 140.16 53.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.419 -1.048 . . . . 0.0 109.946 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.519 HD12 ' CG2' ' A' ' 59' ' ' VAL . 1.6 pp -136.09 137.73 25.64 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.18 -0.95 . . . . 0.0 110.491 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.585 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 45.1 Cg_endo -64.75 152.4 82.18 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.006 1.53 . . . . 0.0 109.964 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.57 ' HB2' ' CH2' ' A' ' 41' ' ' TRP . 30.1 p90 -72.36 -8.04 52.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.253 -0.904 . . . . 0.0 111.267 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -94.11 -26.12 16.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.817 -1.177 . . . . 0.0 110.993 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.585 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 6.5 m-85 -81.81 0.15 40.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.048 -1.033 . . . . 0.0 110.146 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.544 ' CG1' ' CG2' ' A' ' 9' ' ' VAL . 27.9 t -144.79 170.2 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.328 -0.858 . . . . 0.0 109.956 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.521 ' O ' ' CG1' ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.204 -0.935 . . . . 0.0 110.305 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.443 ' O ' HG11 ' A' ' 9' ' ' VAL . 21.8 mt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.196 0.522 . . . . 0.0 110.183 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.514 ' CB ' ' O ' ' A' ' 60' ' ' ALA . 15.0 m -147.08 168.15 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 110.271 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.1 mm -111.83 139.26 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 0.0 109.936 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.506 ' CB ' ' CD2' ' A' ' 25' ' ' PHE . . . -80.42 115.61 20.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 110.448 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.444 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 61.4 mt -74.74 -19.81 60.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.991 -1.068 . . . . 0.0 109.436 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.444 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 51.9 m-70 -157.33 143.66 17.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.538 -0.726 . . . . 0.0 109.668 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 52.0 p -58.92 145.21 42.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.006 -1.059 . . . . 0.0 110.01 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.576 ' CE2' ' O ' ' A' ' 16' ' ' GLU . 85.2 t80 -105.6 167.33 9.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.152 -0.968 . . . . 0.0 110.292 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.576 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 25.1 mt-10 -114.9 127.54 26.73 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 110.018 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.466 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 50.9 Cg_endo -79.79 89.63 1.32 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.917 1.483 . . . . 0.0 110.393 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.4 p -79.18 -10.09 59.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.867 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.439 ' CD2' ' OD2' ' A' ' 22' ' ' ASP . 44.7 m-70 -126.96 -179.51 4.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.858 . . . . 0.0 110.073 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -86.92 1.91 51.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 110.267 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . 0.465 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -123.29 -15.78 3.66 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.439 ' OD2' ' CD2' ' A' ' 19' ' ' HIS . 87.5 m-20 -67.84 156.38 37.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.126 -1.22 . . . . 0.0 110.35 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.466 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 21.9 tp -116.51 120.31 38.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 109.829 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.473 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -97.53 53.16 1.31 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.578 ' CG ' HD12 ' A' ' 31' ' ' LEU . 42.7 p90 -48.28 168.72 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.211 -1.17 . . . . 0.0 110.948 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -96.9 176.98 5.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.475 -0.766 . . . . 0.0 110.349 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -71.33 127.03 31.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 110.161 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.61 -6.08 83.32 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.429 ' CD ' ' HB2' ' A' ' 25' ' ' PHE . 20.5 tt0 -65.99 130.04 41.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.114 -1.227 . . . . 0.0 110.054 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.424 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 50.8 tt0 -79.54 136.46 36.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.826 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.578 HD12 ' CG ' ' A' ' 25' ' ' PHE . 54.2 mt -139.65 162.36 35.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 0.0 110.528 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 11.3 ttt180 -111.83 138.77 47.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.394 -0.816 . . . . 0.0 109.558 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.526 HD11 HG22 ' A' ' 33' ' ' ILE . 57.9 mt -98.68 92.35 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.121 -0.987 . . . . 0.0 110.392 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 73.4 mt -79.49 -21.79 44.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 0.0 110.908 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.505 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 75.9 tt0 -138.12 131.54 30.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.993 -1.067 . . . . 0.0 110.234 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.582 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 95.4 mt-30 -126.25 56.75 1.43 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 110.25 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.7 t -115.84 150.26 37.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.296 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.58 -168.88 34.58 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -75.71 -32.72 60.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.306 -1.114 . . . . 0.0 110.088 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.567 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 95.4 m95 -97.9 144.71 27.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -0.901 . . . . 0.0 110.008 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.582 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 50.0 m0 -119.72 154.62 33.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.336 -0.852 . . . . 0.0 110.094 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.505 ' CB ' ' HB3' ' A' ' 35' ' ' GLU . 18.4 tttp -92.96 140.43 29.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.324 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -148.92 171.66 15.96 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.046 -1.034 . . . . 0.0 110.932 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 4.8 tt0 -139.57 147.78 41.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.56 -0.713 . . . . 0.0 109.622 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.0 t -94.22 109.81 21.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.15 -0.969 . . . . 0.0 110.144 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 46' ' ' LEU . 16.5 tp -71.93 -1.58 14.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.437 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 98.0 m -90.87 -31.11 16.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -0.909 . . . . 0.0 110.142 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.0 p -120.73 -8.94 9.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.284 -0.885 . . . . 0.0 110.201 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.65 36.86 47.32 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -112.43 144.47 41.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -1.127 . . . . 0.0 110.268 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 83.8 tt0 -120.69 141.69 50.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.23 -0.919 . . . . 0.0 110.168 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -172.95 163.93 35.82 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -74.37 147.31 42.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -1.15 . . . . 0.0 109.832 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.514 ' CD1' HG23 ' A' ' 59' ' ' VAL . 1.7 pp -142.67 137.86 15.64 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.281 -0.887 . . . . 0.0 110.285 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.571 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 45.4 Cg_endo -57.89 156.81 26.7 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.112 1.585 . . . . 0.0 110.169 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.577 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 20.8 p90 -92.78 -0.9 57.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.375 -0.828 . . . . 0.0 111.243 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 58' ' ' PHE . 49.1 p-10 -98.32 -26.63 14.44 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.824 -1.172 . . . . 0.0 111.051 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.522 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 16.8 m-30 -88.65 2.3 53.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.938 -1.102 . . . . 0.0 110.502 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.514 HG23 ' CD1' ' A' ' 54' ' ' ILE . 33.2 m -132.19 146.64 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.111 -0.993 . . . . 0.0 110.208 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.316 -0.865 . . . . 0.0 110.181 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.2 tp . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.259 0.552 . . . . 0.0 110.155 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.418 HG13 HD12 ' A' ' 33' ' ' ILE . 24.5 m -149.48 168.78 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 110.269 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.2 mt -111.15 141.44 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.93 . . . . 0.0 109.886 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.423 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -80.12 109.86 14.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.167 -0.958 . . . . 0.0 110.316 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.414 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 71.6 mt -69.93 -24.52 63.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.02 -1.05 . . . . 0.0 109.247 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.414 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 74.2 m80 -152.84 148.23 26.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.561 -0.712 . . . . 0.0 109.632 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.501 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 51.4 p -63.75 144.76 56.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.037 -1.039 . . . . 0.0 109.987 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.552 ' CD1' ' HG3' ' A' ' 55' ' ' PRO . 39.5 t80 -97.68 157.38 16.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.026 -1.046 . . . . 0.0 110.357 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -110.32 99.82 41.91 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.372 -0.83 . . . . 0.0 109.998 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.464 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 48.3 Cg_endo -59.96 91.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.069 1.563 . . . . 0.0 110.461 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.9 m -83.28 1.33 41.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 110.102 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.467 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 77.3 m80 -146.67 152.35 38.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -0.887 . . . . 0.0 110.135 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -65.04 130.01 41.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -0.917 . . . . 0.0 110.189 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.07 13.58 24.78 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.467 ' OD2' ' HB2' ' A' ' 19' ' ' HIS . 13.8 m-20 -108.29 158.24 17.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.29 -1.123 . . . . 0.0 110.448 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.504 ' CD1' ' HG2' ' A' ' 50' ' ' GLN . 13.5 tp -109.3 111.89 23.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 109.834 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.464 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . -93.24 49.87 2.43 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 31.7 p90 -53.36 174.42 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -1.127 . . . . 0.0 110.89 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.501 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 91.6 mt-10 -109.33 178.74 4.35 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.471 -0.768 . . . . 0.0 109.918 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -68.29 140.57 55.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.081 -1.012 . . . . 0.0 110.287 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.07 -14.31 50.02 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 3.6 mt-10 -65.8 126.59 28.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.175 -1.191 . . . . 0.0 110.37 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.481 ' C ' ' CD1' ' A' ' 31' ' ' LEU . 19.4 pt20 -79.76 136.33 36.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 109.958 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.481 ' CD1' ' C ' ' A' ' 30' ' ' GLN . 7.7 mp -137.95 158.88 43.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -0.96 . . . . 0.0 110.536 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 5.8 tpt180 -106.29 132.33 52.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.406 -0.809 . . . . 0.0 109.332 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.454 ' N ' ' HD2' ' A' ' 32' ' ' ARG . 23.3 mt -90.79 93.73 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.083 -1.01 . . . . 0.0 110.544 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.413 ' CD2' ' HG3' ' A' ' 32' ' ' ARG . 67.1 mt -79.58 -29.94 41.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.367 -0.833 . . . . 0.0 110.844 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.426 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 85.3 tt0 -130.91 140.48 50.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.947 -1.096 . . . . 0.0 110.406 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.577 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 76.5 mt-30 -134.52 54.88 1.92 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 110.111 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 51.4 m -119.65 148.18 43.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -0.876 . . . . 0.0 110.167 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.11 -177.87 27.52 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -69.18 -29.85 67.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -1.205 . . . . 0.0 110.333 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.461 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 99.2 m95 -98.61 144.15 28.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 110.378 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.577 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 43.5 m0 -121.02 155.87 33.41 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.349 -0.844 . . . . 0.0 110.176 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 53' ' ' PHE . 77.9 tttt -101.1 143.54 31.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 109.331 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -153.98 -179.9 8.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.014 -1.054 . . . . 0.0 110.85 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 48.3 tt0 -141.24 149.94 41.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.379 -0.825 . . . . 0.0 109.691 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.0 t -100.49 123.95 45.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.05 -1.031 . . . . 0.0 110.3 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.6 mt -80.85 6.21 13.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 110.051 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 87.0 m -91.07 -35.62 14.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 110.071 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.7 p -127.27 -3.55 6.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 110.093 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.2 35.24 57.25 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.504 ' HG2' ' CD1' ' A' ' 23' ' ' LEU . 63.1 tt0 -104.87 140.76 37.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -1.13 . . . . 0.0 110.283 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 86.3 tt0 -119.51 139.09 52.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.892 . . . . 0.0 110.18 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -170.81 163.17 36.25 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 94.4 m-85 -69.36 141.85 54.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.308 -1.113 . . . . 0.0 110.0 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.468 HG12 ' HB1' ' A' ' 43' ' ' ALA . 1.6 pt -131.57 142.37 45.06 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.194 -0.941 . . . . 0.0 110.38 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.557 ' CG ' ' CD2' ' A' ' 58' ' ' PHE . 44.8 Cg_endo -68.49 140.89 49.11 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.066 1.561 . . . . 0.0 110.08 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.548 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 25.1 p90 -75.54 -7.03 53.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 0.0 111.144 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -90.34 -26.48 19.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.899 -1.126 . . . . 0.0 110.725 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.557 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 17.8 m-30 -92.71 4.16 54.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.091 -1.006 . . . . 0.0 110.22 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 55' ' ' PRO . 35.6 m -136.04 143.49 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.263 -0.898 . . . . 0.0 110.103 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.956 . . . . 0.0 110.343 -179.956 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.516 ' CD1' ' N ' ' A' ' 9' ' ' VAL . 2.9 tm? . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.165 0.507 . . . . 0.0 110.111 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.516 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 30.1 m -150.41 170.02 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.178 -0.951 . . . . 0.0 110.319 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.0 mt -115.16 145.05 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.377 -0.827 . . . . 0.0 109.954 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.576 ' HB2' ' CD2' ' A' ' 25' ' ' PHE . . . -80.33 109.15 14.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.124 -0.985 . . . . 0.0 110.337 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.469 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 57.6 mt -67.05 -24.3 65.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.985 -1.072 . . . . 0.0 109.353 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.469 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 58.1 m80 -157.09 155.16 30.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.611 -0.681 . . . . 0.0 109.487 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 47.7 t -66.49 139.15 57.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.972 -1.08 . . . . 0.0 109.98 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.584 ' CE2' ' O ' ' A' ' 16' ' ' GLU . 73.5 t80 -95.96 155.27 16.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.084 -1.01 . . . . 0.0 110.375 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.584 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 1.2 mp0 -105.66 128.71 25.95 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.361 -0.837 . . . . 0.0 110.11 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.409 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 48.5 Cg_endo -87.31 81.28 1.28 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.875 1.461 . . . . 0.0 110.448 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 97.1 p -79.88 -2.33 43.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.385 -0.822 . . . . 0.0 109.942 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.41 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 63.8 m80 -138.95 149.81 45.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.888 . . . . 0.0 110.18 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -69.21 129.1 38.9 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.287 -0.883 . . . . 0.0 110.227 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.83 -4.41 39.26 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.41 ' OD2' ' HB2' ' A' ' 19' ' ' HIS . 34.9 m-20 -92.25 165.99 12.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.225 -1.162 . . . . 0.0 110.464 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.499 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 18.0 tp -117.85 124.33 48.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.272 -0.893 . . . . 0.0 110.011 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.473 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -105.68 52.7 0.69 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.576 ' CD2' ' HB2' ' A' ' 11' ' ' ALA . 41.3 p90 -48.74 175.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -1.18 . . . . 0.0 110.841 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 73.5 mm-40 -109.76 179.34 4.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.445 -0.784 . . . . 0.0 110.157 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -69.41 133.48 47.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.008 -1.058 . . . . 0.0 110.478 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.28 -15.53 55.95 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 3.3 mt-10 -64.25 122.56 16.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.034 -1.274 . . . . 0.0 110.454 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -79.4 137.15 37.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -0.879 . . . . 0.0 109.651 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.439 ' O ' HG21 ' A' ' 9' ' ' VAL . 15.7 mt -133.77 154.35 51.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.174 -0.954 . . . . 0.0 110.488 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 14.9 ttm180 -98.79 130.89 45.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.397 -0.815 . . . . 0.0 109.931 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 69.2 mt -73.72 113.95 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.186 -0.946 . . . . 0.0 110.109 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 43' ' ' ALA . 35.7 mt -86.49 -38.83 16.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.87 . . . . 0.0 110.201 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' A' ' 41' ' ' TRP . 94.4 mt-10 -139.25 161.45 37.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.343 -0.848 . . . . 0.0 109.946 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.574 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 45.7 tt0 -143.78 61.2 1.37 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 0.0 110.141 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.9 t -131.81 122.48 25.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 110.196 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.35 176.69 41.84 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.75 -34.39 75.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.365 -1.079 . . . . 0.0 110.249 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.434 ' O ' ' CD1' ' A' ' 41' ' ' TRP . 73.4 m95 -100.08 150.16 22.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.89 . . . . 0.0 110.242 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.574 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 40.1 m0 -130.84 160.03 35.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.29 -0.881 . . . . 0.0 110.381 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 34' ' ' LEU . 80.0 tttt -88.89 146.6 24.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.914 . . . . 0.0 109.605 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.521 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . . . -147.14 167.82 23.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.029 -1.045 . . . . 0.0 110.759 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.519 ' CG ' ' HG2' ' A' ' 51' ' ' GLU . 43.4 tt0 -145.69 154.22 41.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.433 -0.792 . . . . 0.0 110.025 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.5 t -83.09 145.4 29.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.065 -1.022 . . . . 0.0 110.196 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.448 HD11 ' NH1' ' A' ' 32' ' ' ARG . 48.3 tp -91.38 -21.14 21.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 110.132 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.7 t -105.45 -26.49 11.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 0.0 110.429 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.3 m -100.35 -29.22 12.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.122 -0.986 . . . . 0.0 110.108 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.06 22.04 64.2 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.49 ' NE2' HD13 ' A' ' 23' ' ' LEU . 62.0 tt0 -92.75 134.48 35.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.442 -1.034 . . . . 0.0 110.259 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.519 ' HG2' ' CG ' ' A' ' 44' ' ' GLN . 79.9 mt-10 -114.96 133.09 56.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.282 -0.887 . . . . 0.0 109.934 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.499 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -161.26 157.03 28.58 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -67.07 142.19 57.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.349 -1.089 . . . . 0.0 110.159 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.521 ' CG2' ' HB2' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -133.63 162.13 59.52 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 110.137 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.582 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 47.8 Cg_endo -90.26 162.88 4.63 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.993 1.523 . . . . 0.0 110.09 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -87.34 -2.23 58.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -0.924 . . . . 0.0 110.819 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -100.1 -25.74 14.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.036 -1.04 . . . . 0.0 110.987 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.559 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 22.4 m-85 -84.26 -9.26 58.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.924 -1.11 . . . . 0.0 110.53 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.447 HG23 ' CD1' ' A' ' 54' ' ' ILE . 22.4 m -131.16 143.24 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 110.301 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.185 179.942 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.462 ' O ' HG11 ' A' ' 9' ' ' VAL . 12.4 tp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.155 0.502 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.524 ' CG1' ' O ' ' A' ' 60' ' ' ALA . 4.2 m -153.18 173.39 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 0.0 110.532 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 62.1 mt -120.63 142.6 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.376 -0.828 . . . . 0.0 109.527 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.523 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . . . -77.54 115.77 17.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.116 -0.99 . . . . 0.0 110.342 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.5 tp -73.55 -20.3 60.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.14 -0.975 . . . . 0.0 109.086 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -149.35 -158.95 0.97 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.586 -0.696 . . . . 0.0 109.693 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 93.8 p -118.07 140.51 49.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.164 -0.96 . . . . 0.0 110.151 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.579 ' CD2' ' HD3' ' A' ' 55' ' ' PRO . 60.2 t80 -103.53 162.6 12.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.067 -1.021 . . . . 0.0 110.223 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.567 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 47.0 tt0 -119.91 130.32 24.91 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 110.273 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.441 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 48.1 Cg_endo -81.22 84.46 1.97 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.02 1.537 . . . . 0.0 110.403 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 77.0 p -79.83 -1.19 37.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.925 . . . . 0.0 110.093 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.444 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 82.2 m-70 -150.28 158.16 43.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 110.02 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -66.09 127.47 32.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 110.217 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.12 -10.91 40.34 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.444 ' OD2' ' HB2' ' A' ' 19' ' ' HIS . 41.5 m-20 -83.18 152.45 25.23 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.231 -1.158 . . . . 0.0 110.316 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.546 ' O ' ' CD1' ' A' ' 15' ' ' TYR . 14.2 tp -114.22 120.01 39.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.308 -0.87 . . . . 0.0 110.036 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.472 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -102.86 56.71 0.61 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 36.2 p90 -50.8 171.6 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.185 -1.185 . . . . 0.0 110.874 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -103.62 178.59 4.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.545 -0.722 . . . . 0.0 109.981 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.9 mttp -69.69 124.56 24.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 110.328 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 92.45 -12.26 70.15 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.447 ' HG2' HD22 ' A' ' 31' ' ' LEU . 41.4 tt0 -59.74 127.68 33.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.129 -1.218 . . . . 0.0 110.395 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -79.83 131.93 36.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.929 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.447 HD22 ' HG2' ' A' ' 29' ' ' GLU . 18.9 mt -131.58 151.31 51.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -0.938 . . . . 0.0 110.408 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.496 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 20.2 mtp85 -98.54 133.66 42.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.341 -0.849 . . . . 0.0 109.523 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.3 mt -77.1 118.12 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.978 . . . . 0.0 110.067 179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.451 ' HG ' ' HA ' ' A' ' 43' ' ' ALA . 86.3 mt -95.68 -36.74 11.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 0.0 110.273 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.433 ' OE1' ' HA ' ' A' ' 35' ' ' GLU . 67.3 mm-40 -139.96 153.17 46.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 110.213 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.526 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 96.1 mt-30 -135.48 55.14 1.89 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.304 -0.873 . . . . 0.0 110.215 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.3 m -120.03 135.72 54.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.272 -0.892 . . . . 0.0 110.148 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.44 178.42 42.75 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.97 -33.19 75.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.359 -1.083 . . . . 0.0 110.355 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.578 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 98.7 m95 -91.89 140.81 29.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.174 -0.954 . . . . 0.0 110.153 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.526 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 40.7 m0 -122.01 152.99 39.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.9 . . . . 0.0 110.212 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.5 tttm -91.85 148.23 22.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 0.0 109.589 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.519 ' HB1' ' CG2' ' A' ' 54' ' ' ILE . . . -155.49 178.11 10.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.0 -1.062 . . . . 0.0 110.622 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.535 ' CG ' ' HG2' ' A' ' 51' ' ' GLU . 28.4 tt0 -150.9 159.67 44.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.296 -0.878 . . . . 0.0 109.724 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.416 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 6.4 t -82.27 147.56 28.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.072 -1.018 . . . . 0.0 109.933 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.496 HD11 ' CZ ' ' A' ' 32' ' ' ARG . 30.3 tp -91.68 -21.31 20.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.927 . . . . 0.0 109.945 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.4 p -107.77 -28.14 9.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.354 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.3 m -94.43 -31.16 14.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.124 -0.985 . . . . 0.0 110.233 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.55 24.02 59.36 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 65.2 tp60 -97.55 136.66 37.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.358 -1.084 . . . . 0.0 110.022 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.535 ' HG2' ' CG ' ' A' ' 44' ' ' GLN . 31.2 mt-10 -117.52 136.73 53.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.094 -1.004 . . . . 0.0 110.244 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.497 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -167.79 162.52 36.31 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -66.37 141.94 57.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.297 -1.119 . . . . 0.0 110.217 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.519 ' CG2' ' HB1' ' A' ' 43' ' ' ALA . 1.3 pp -133.4 144.35 51.92 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.255 -0.903 . . . . 0.0 110.171 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.579 ' HD3' ' CD2' ' A' ' 15' ' ' TYR . 44.6 Cg_endo -71.23 152.57 61.71 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.023 1.538 . . . . 0.0 110.373 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.566 ' CE2' ' OD1' ' A' ' 57' ' ' ASN . 20.1 p90 -89.89 -1.08 57.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.335 -0.853 . . . . 0.0 110.68 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.566 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 92.3 m-20 -95.64 -27.14 15.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.089 -1.007 . . . . 0.0 110.668 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.565 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 12.8 m-30 -90.46 4.39 51.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.096 -1.002 . . . . 0.0 110.465 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.472 ' CG1' ' HB ' ' A' ' 9' ' ' VAL . 10.7 t -140.93 163.84 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 110.206 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.524 ' O ' ' CG1' ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.346 -0.846 . . . . 0.0 110.193 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.487 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 6.7 mp . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.158 0.504 . . . . 0.0 110.048 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.434 ' HB ' ' O ' ' A' ' 60' ' ' ALA . 27.3 m -143.5 166.99 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.228 -0.92 . . . . 0.0 110.404 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.44 ' O ' HD13 ' A' ' 12' ' ' LEU . 21.3 mm -110.73 146.23 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.86 . . . . 0.0 109.754 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.15 113.51 18.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.116 -0.99 . . . . 0.0 110.381 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.513 ' O ' ' ND1' ' A' ' 13' ' ' HIS . 8.2 mp -74.57 -19.98 60.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 0.0 109.371 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.513 ' ND1' ' O ' ' A' ' 12' ' ' LEU . 71.9 m80 -155.61 145.17 21.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.497 -0.752 . . . . 0.0 109.611 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.53 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 33.1 p -64.03 145.98 54.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.94 -1.1 . . . . 0.0 110.129 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 82.9 t80 -104.35 166.7 10.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.101 -0.999 . . . . 0.0 110.211 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.24 120.08 29.26 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.912 . . . . 0.0 110.125 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.463 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 49.5 Cg_endo -70.19 84.35 0.73 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.949 1.5 . . . . 0.0 110.219 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.514 ' OG ' ' ND1' ' A' ' 19' ' ' HIS . 73.8 p -79.9 -3.84 49.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -0.881 . . . . 0.0 110.082 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.514 ' ND1' ' OG ' ' A' ' 18' ' ' SER . 50.9 m80 -145.94 140.5 26.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 110.195 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -53.45 124.48 14.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 110.279 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.76 16.02 12.35 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -114.69 159.85 20.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -1.184 . . . . 0.0 110.303 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.484 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 15.4 tp -115.23 118.41 33.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.329 -0.857 . . . . 0.0 110.081 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.463 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . -95.9 47.59 1.84 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 40.2 p90 -47.36 171.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.269 -1.136 . . . . 0.0 111.042 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.53 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 92.4 mt-10 -105.95 178.82 4.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.412 -0.805 . . . . 0.0 110.069 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.6 tttt -69.32 138.0 53.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.083 -1.011 . . . . 0.0 110.136 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.09 -12.31 60.48 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.458 ' O ' HD11 ' A' ' 31' ' ' LEU . 8.4 tt0 -63.57 128.17 34.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.174 -1.191 . . . . 0.0 110.118 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.483 ' C ' ' CD1' ' A' ' 31' ' ' LEU . 92.6 mt-30 -79.55 134.53 36.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 109.992 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.483 ' CD1' ' C ' ' A' ' 30' ' ' GLN . 8.5 mp -136.11 156.87 48.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.919 . . . . 0.0 110.736 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.535 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 22.8 ttt180 -107.76 135.81 48.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.442 -0.786 . . . . 0.0 109.138 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.529 HG22 HD11 ' A' ' 33' ' ' ILE . 54.4 mt -91.39 92.35 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.042 -1.036 . . . . 0.0 110.879 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.5 HD22 ' NE ' ' A' ' 32' ' ' ARG . 11.0 mt -79.08 -29.84 43.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.581 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.52 ' CB ' ' HB3' ' A' ' 42' ' ' LYS . 45.7 tt0 -134.6 132.86 39.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.961 -1.087 . . . . 0.0 110.234 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.579 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 53.3 tt0 -129.08 59.31 1.58 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.286 -0.884 . . . . 0.0 110.119 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 89.5 p -121.53 146.12 47.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 110.237 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.02 -170.26 47.57 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -74.6 -33.1 62.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -1.138 . . . . 0.0 110.072 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.51 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 99.0 m95 -96.44 142.8 28.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.212 -0.93 . . . . 0.0 110.16 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.579 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 43.1 m0 -119.94 154.97 33.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.22 -0.925 . . . . 0.0 110.192 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.52 ' HB3' ' CB ' ' A' ' 35' ' ' GLU . 34.3 tttp -97.63 141.17 31.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.343 -0.848 . . . . 0.0 109.132 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -152.52 177.77 10.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.94 -1.1 . . . . 0.0 110.803 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 58.6 tt0 -142.65 150.62 40.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.438 -0.789 . . . . 0.0 109.912 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.1 t -97.16 114.75 26.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.989 . . . . 0.0 110.229 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.7 mt -74.63 0.18 15.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -0.944 . . . . 0.0 110.118 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 54.9 m -86.16 -33.26 20.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 110.045 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.8 p -128.39 -3.58 5.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.159 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.2 33.77 56.23 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.428 ' HB3' HD12 ' A' ' 23' ' ' LEU . 17.2 mt-30 -101.86 139.96 36.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.289 -1.124 . . . . 0.0 110.148 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 78.6 tt0 -120.77 140.77 51.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 0.0 110.163 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.484 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -174.12 164.53 35.81 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.406 ' C ' HG21 ' A' ' 54' ' ' ILE . 81.7 m-85 -74.06 146.37 43.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.174 -1.192 . . . . 0.0 109.758 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.506 ' CD1' HG12 ' A' ' 59' ' ' VAL . 1.8 pp -140.71 143.16 31.16 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.183 -0.948 . . . . 0.0 110.501 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.622 ' CG ' ' CD2' ' A' ' 58' ' ' PHE . 44.6 Cg_endo -63.1 148.39 93.35 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.157 1.609 . . . . 0.0 110.109 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.572 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 20.4 p90 -84.67 -1.42 56.08 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.294 -0.879 . . . . 0.0 110.895 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.539 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 87.8 m-20 -94.6 -26.24 16.45 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.984 -1.073 . . . . 0.0 110.634 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.622 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 13.1 m-30 -90.87 6.84 42.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.087 -1.008 . . . . 0.0 110.391 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.506 HG12 ' CD1' ' A' ' 54' ' ' ILE . 31.0 m -132.53 142.18 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 0.0 110.053 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.434 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.914 . . . . 0.0 110.247 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.4 mp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.217 0.532 . . . . 0.0 110.094 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 21.5 m -138.33 163.78 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.144 -0.973 . . . . 0.0 110.44 -179.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 90.7 mt -112.77 143.39 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.367 -0.833 . . . . 0.0 109.802 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.574 ' CB ' ' CD2' ' A' ' 25' ' ' PHE . . . -80.57 110.62 16.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.159 -0.963 . . . . 0.0 110.505 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.497 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 6.3 mp -68.56 -22.99 64.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.985 -1.072 . . . . 0.0 109.031 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.497 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 75.3 m-70 -158.29 149.26 20.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.593 -0.692 . . . . 0.0 109.342 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 54.3 p -61.65 142.75 56.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.928 -1.108 . . . . 0.0 109.982 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.583 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 80.1 t80 -98.66 159.97 14.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.084 -1.01 . . . . 0.0 110.443 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -105.63 112.32 64.62 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 109.999 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.451 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 49.3 Cg_endo -72.66 89.76 0.84 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.965 1.508 . . . . 0.0 110.513 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.6 p -79.68 -4.07 50.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.929 . . . . 0.0 110.183 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -130.47 -176.01 3.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.216 -0.927 . . . . 0.0 110.213 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -92.38 -10.85 36.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 0.0 110.247 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.32 32.69 5.95 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -117.8 159.33 23.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -1.131 . . . . 0.0 110.385 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.506 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 14.5 tp -114.18 118.43 33.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.357 -0.84 . . . . 0.0 109.763 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.451 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . -96.23 50.36 1.67 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.574 ' CD2' ' CB ' ' A' ' 11' ' ' ALA . 41.5 p90 -48.1 170.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -1.171 . . . . 0.0 110.823 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.406 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 77.2 mm-40 -101.39 178.49 4.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.421 -0.8 . . . . 0.0 110.237 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 12' ' ' LEU . 50.0 tttm -70.55 124.07 23.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.171 -0.956 . . . . 0.0 110.379 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.86 -8.19 73.61 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.426 ' CD ' ' HB2' ' A' ' 25' ' ' PHE . 45.7 tt0 -67.25 125.54 26.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.116 -1.226 . . . . 0.0 110.374 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.437 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 96.4 mt-30 -79.72 138.29 37.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.21 -0.931 . . . . 0.0 109.859 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.437 ' HG ' ' C ' ' A' ' 30' ' ' GLN . 21.1 mt -137.32 159.0 43.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 110.398 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 9.4 ttt180 -101.62 132.32 47.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.401 -0.812 . . . . 0.0 109.526 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.8 mt -72.92 115.04 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.172 -0.955 . . . . 0.0 110.39 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.484 HD13 ' HB2' ' A' ' 44' ' ' GLN . 38.3 mt -83.32 -38.05 22.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.929 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.423 ' C ' ' HG3' ' A' ' 36' ' ' GLN . 87.3 mt-10 -148.62 170.63 17.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.309 -0.869 . . . . 0.0 110.26 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.47 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 98.5 mt-30 -147.33 60.46 1.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 110.201 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.1 p -130.34 136.47 49.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 110.222 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.95 -170.97 44.17 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -75.88 -31.89 59.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.191 -1.182 . . . . 0.0 110.31 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.568 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 85.8 m95 -100.45 149.43 23.68 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.228 -0.92 . . . . 0.0 110.089 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.47 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 38.2 m0 -119.95 153.28 36.16 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.222 -0.924 . . . . 0.0 110.425 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 34' ' ' LEU . 41.9 tttp -89.4 142.98 27.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.349 -0.844 . . . . 0.0 109.662 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.526 ' CB ' HG12 ' A' ' 54' ' ' ILE . . . -137.22 158.04 45.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.138 -0.976 . . . . 0.0 110.805 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.484 ' HB2' HD13 ' A' ' 34' ' ' LEU . 56.3 tt0 -129.04 138.35 51.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.484 -0.76 . . . . 0.0 109.962 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.456 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 6.5 t -79.14 140.0 37.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.115 -0.991 . . . . 0.0 110.011 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 61.9 mt -92.94 -13.04 29.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.885 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.7 m -99.4 -25.73 14.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.426 -0.796 . . . . 0.0 110.349 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.456 ' OG1' ' HB3' ' A' ' 45' ' ' SER . 40.6 p -114.59 -13.42 12.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.063 -1.023 . . . . 0.0 110.398 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 64.88 45.83 91.31 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 20.2 mt-30 -120.76 152.03 38.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.368 -1.078 . . . . 0.0 110.17 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.455 ' HG2' HD13 ' A' ' 34' ' ' LEU . 96.7 mt-10 -116.81 134.52 54.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -0.871 . . . . 0.0 110.173 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.506 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -155.58 151.83 23.36 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -70.56 143.52 51.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -1.182 . . . . 0.0 110.094 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.541 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 1.9 pp -138.46 134.73 17.62 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.9 . . . . 0.0 110.117 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.583 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 46.0 Cg_endo -59.1 158.92 23.73 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.94 1.495 . . . . 0.0 110.286 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.476 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 23.5 p90 -84.14 -5.07 59.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 110.885 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -96.28 -25.13 15.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.048 -1.032 . . . . 0.0 110.931 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.561 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 19.2 m-85 -83.92 -8.63 59.13 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.022 -1.049 . . . . 0.0 110.306 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.541 ' CG2' ' CD1' ' A' ' 54' ' ' ILE . 33.6 m -136.22 146.0 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.138 -0.977 . . . . 0.0 110.359 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.271 -0.893 . . . . 0.0 110.22 -180.0 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.55 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 5.5 mp . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.185 0.517 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.8 m -148.32 168.87 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.197 -0.94 . . . . 0.0 110.389 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.1 mm -112.57 146.44 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.376 -0.827 . . . . 0.0 109.842 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.18 112.29 17.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.14 -0.975 . . . . 0.0 110.388 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 27.0 tp -75.27 -22.45 57.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.108 -0.995 . . . . 0.0 109.621 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.455 ' HA ' ' HG2' ' A' ' 27' ' ' LYS . 94.7 m-70 -151.97 149.75 29.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.492 -0.755 . . . . 0.0 109.762 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.47 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 15.9 t -68.35 141.88 55.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.011 -1.056 . . . . 0.0 109.941 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.59 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 85.8 t80 -98.83 160.08 14.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.938 . . . . 0.0 110.246 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.503 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 2.1 tm-20 -112.38 128.54 25.38 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 0.0 110.169 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.454 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 47.3 Cg_endo -83.39 82.28 2.11 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.028 1.541 . . . . 0.0 110.532 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.513 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 88.9 p -80.8 -0.97 41.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 110.137 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.513 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 84.2 m-70 -145.68 179.59 7.33 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.906 . . . . 0.0 110.167 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -90.39 127.92 36.33 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 110.106 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.76 -3.13 41.89 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -89.97 154.66 19.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -1.138 . . . . 0.0 110.278 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.499 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 22.5 tp -109.63 114.6 28.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.171 -0.956 . . . . 0.0 110.067 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.464 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -96.17 47.41 1.8 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' A' ' 15' ' ' TYR . 46.4 p90 -50.43 174.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.149 -1.206 . . . . 0.0 111.164 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.47 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 83.2 mt-10 -110.59 177.9 4.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.464 -0.772 . . . . 0.0 110.216 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.468 ' HG2' ' N ' ' A' ' 14' ' ' SER . 5.4 mtmm -69.16 139.39 54.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.036 -1.04 . . . . 0.0 110.231 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.15 -16.24 49.16 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 39.0 mm-40 -66.4 125.61 26.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.051 -1.264 . . . . 0.0 110.012 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.4 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 22.5 tt0 -79.48 137.77 37.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.875 . . . . 0.0 110.168 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.528 HD12 ' CG ' ' A' ' 25' ' ' PHE . 41.4 mt -137.84 159.87 40.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.316 -0.865 . . . . 0.0 110.211 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.515 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 37.0 ttp180 -108.48 135.78 49.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.623 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.521 HG23 ' CG ' ' A' ' 36' ' ' GLN . 36.9 mm -96.18 92.63 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.166 -0.959 . . . . 0.0 110.435 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.467 ' HG ' ' HG2' ' A' ' 32' ' ' ARG . 17.2 mt -79.45 -24.91 42.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.214 -0.929 . . . . 0.0 110.777 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.458 ' O ' ' HB3' ' A' ' 41' ' ' TRP . 45.1 tp10 -136.2 134.67 38.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.954 -1.091 . . . . 0.0 110.388 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.578 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 75.3 mt-30 -129.41 54.87 1.79 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.347 -0.846 . . . . 0.0 110.153 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.4 m -114.86 154.01 29.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 110.183 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.26 -173.27 8.53 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -72.2 -31.91 66.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -1.136 . . . . 0.0 110.181 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.446 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 92.5 m95 -97.77 143.06 28.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.258 -0.902 . . . . 0.0 110.34 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.578 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 51.2 m0 -120.15 155.41 33.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.367 -0.833 . . . . 0.0 110.115 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.491 ' NZ ' ' OE2' ' A' ' 51' ' ' GLU . 48.8 tttt -96.55 141.34 29.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.882 . . . . 0.0 109.365 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -149.97 174.58 12.54 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.078 -1.014 . . . . 0.0 110.815 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 61.3 tt0 -141.12 149.53 41.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.451 -0.781 . . . . 0.0 109.765 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.0 t -95.48 111.88 23.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.197 -0.94 . . . . 0.0 110.161 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 46' ' ' LEU . 18.5 tp -71.85 -1.85 15.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -0.896 . . . . 0.0 110.415 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.1 m -88.57 -29.1 20.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.237 -0.915 . . . . 0.0 110.098 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.7 p -126.67 -6.15 6.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 110.163 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.21 36.63 59.95 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -109.63 144.98 37.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -1.159 . . . . 0.0 110.228 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.491 ' OE2' ' NZ ' ' A' ' 42' ' ' LYS . 83.5 tt0 -118.52 138.92 52.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.898 . . . . 0.0 110.033 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.499 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -166.88 158.17 31.01 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.409 ' C ' HG21 ' A' ' 54' ' ' ILE . 90.0 m-85 -72.55 143.81 48.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -1.132 . . . . 0.0 110.18 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.451 HG12 ' HB1' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -137.47 145.47 49.47 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 110.213 -179.866 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.59 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 47.3 Cg_endo -69.51 149.14 68.11 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.98 1.516 . . . . 0.0 110.156 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.575 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 36.3 p90 -74.99 -4.78 40.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.969 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -96.17 -25.33 15.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.875 -1.141 . . . . 0.0 110.954 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.582 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 9.0 m-85 -83.14 -2.16 54.73 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.055 -1.028 . . . . 0.0 110.284 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.423 HG22 ' CD1' ' A' ' 54' ' ' ILE . 33.1 m -136.32 144.08 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 110.071 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.138 -0.977 . . . . 0.0 110.242 -179.981 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.473 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 6.5 mp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.207 0.527 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.529 ' CG2' ' CG1' ' A' ' 59' ' ' VAL . 11.8 m -144.65 167.04 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.181 -0.949 . . . . 0.0 110.334 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.8 mt -111.41 145.51 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.0 109.707 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.477 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . . . -79.2 112.9 16.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.97 . . . . 0.0 110.303 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.505 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 55.2 mt -71.55 -21.35 61.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.105 -0.997 . . . . 0.0 109.487 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.505 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 62.7 m-70 -157.61 148.86 21.58 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.574 -0.704 . . . . 0.0 109.628 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 58.6 p -63.06 143.31 57.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.981 -1.075 . . . . 0.0 109.919 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.579 ' CD1' ' HG3' ' A' ' 55' ' ' PRO . 24.4 t80 -96.65 155.05 16.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.055 -1.028 . . . . 0.0 110.269 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.11 75.28 0.88 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.854 . . . . 0.0 110.17 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.526 ' HD3' ' CA ' ' A' ' 24' ' ' GLY . 46.8 Cg_endo -46.96 122.5 6.26 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.047 1.551 . . . . 0.0 110.372 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.499 ' O ' ' CD2' ' A' ' 19' ' ' HIS . 58.4 m -91.89 10.69 27.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.366 -0.834 . . . . 0.0 110.128 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.499 ' CD2' ' O ' ' A' ' 18' ' ' SER . 33.8 m170 -140.55 -158.26 0.84 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.303 -0.873 . . . . 0.0 110.192 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.4 p30 -112.67 3.92 16.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.193 -0.942 . . . . 0.0 110.187 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.43 -9.36 17.49 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.476 ' HB2' ' CB ' ' A' ' 17' ' ' PRO . 84.2 m-20 -81.65 165.7 20.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.214 -1.168 . . . . 0.0 110.4 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.479 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 14.7 tp -113.39 115.19 27.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 0.0 109.779 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.526 ' CA ' ' HD3' ' A' ' 17' ' ' PRO . . . -96.18 55.46 1.53 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.494 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 17.9 p90 -54.2 172.71 0.08 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.367 -1.078 . . . . 0.0 110.97 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -103.53 178.39 4.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.514 -0.741 . . . . 0.0 110.145 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -69.97 132.78 46.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.966 . . . . 0.0 110.101 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.13 -10.64 72.25 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.483 ' OE2' ' CB ' ' A' ' 25' ' ' PHE . 22.2 tt0 -64.09 126.58 28.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -1.222 . . . . 0.0 110.032 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.469 ' O ' HD13 ' A' ' 31' ' ' LEU . 38.1 tt0 -79.47 136.79 37.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.178 -0.952 . . . . 0.0 109.857 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.469 HD13 ' O ' ' A' ' 30' ' ' GLN . 7.1 mp -139.8 161.87 36.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 110.593 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 2.7 tpt180 -109.28 135.9 49.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.406 -0.809 . . . . 0.0 109.257 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.519 ' CG2' ' HG2' ' A' ' 36' ' ' GLN . 33.7 mm -91.21 92.42 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.102 -0.998 . . . . 0.0 110.567 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.422 ' CD1' ' HB2' ' A' ' 44' ' ' GLN . 1.5 mt -79.54 -30.01 41.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 110.789 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.494 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 77.5 tt0 -133.6 137.12 45.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.017 -1.052 . . . . 0.0 110.45 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.563 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 75.6 mt-30 -133.65 54.78 1.93 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 110.092 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -120.75 143.25 48.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.917 . . . . 0.0 110.221 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.83 -168.62 54.82 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -77.49 -33.83 54.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -1.141 . . . . 0.0 110.151 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.557 ' CZ3' ' OH ' ' A' ' 15' ' ' TYR . 98.6 m95 -96.79 141.77 29.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 110.251 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.569 ' CZ3' ' HB2' ' A' ' 56' ' ' PHE . 40.6 m0 -116.83 153.65 32.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.902 . . . . 0.0 110.199 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.494 ' CB ' ' HB3' ' A' ' 35' ' ' GLU . 12.0 tttt -99.9 140.5 34.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.372 -0.83 . . . . 0.0 109.409 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -150.36 176.48 10.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.069 -1.02 . . . . 0.0 110.662 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 50' ' ' GLN . 62.0 tt0 -139.01 147.57 42.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.368 -0.832 . . . . 0.0 109.96 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.5 t -97.21 117.03 30.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.95 . . . . 0.0 110.303 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.5 mt -76.6 2.59 13.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.168 -0.958 . . . . 0.0 110.118 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.9 m -91.58 -35.58 14.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 110.163 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 70.8 p -118.62 -6.02 10.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -0.884 . . . . 0.0 110.237 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.93 43.73 64.5 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.441 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 7.0 mt-30 -121.17 149.61 42.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -1.177 . . . . 0.0 110.234 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.438 ' OE2' ' HE2' ' A' ' 42' ' ' LYS . 82.3 tt0 -122.83 145.47 48.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 110.132 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -174.36 163.71 34.51 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 90.4 m-85 -75.24 146.08 41.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.322 -1.105 . . . . 0.0 109.847 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 54' ' ' ILE . 1.5 pp -140.02 140.46 24.06 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.135 -0.978 . . . . 0.0 110.544 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.635 ' CG ' ' CD2' ' A' ' 58' ' ' PHE . 44.6 Cg_endo -60.22 145.17 99.11 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.164 1.613 . . . . 0.0 110.062 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.569 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 21.9 p90 -82.7 -5.12 58.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 110.927 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -91.59 -27.48 18.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.928 -1.108 . . . . 0.0 110.648 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.635 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 18.2 m-30 -85.86 6.82 26.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.106 -0.997 . . . . 0.0 110.105 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.529 ' CG1' ' CG2' ' A' ' 9' ' ' VAL . 26.4 t -141.85 169.46 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.882 . . . . 0.0 109.769 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.517 ' O ' ' CG1' ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.089 -1.007 . . . . 0.0 110.267 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.457 ' O ' HG11 ' A' ' 9' ' ' VAL . 9.5 tp . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.203 0.525 . . . . 0.0 110.065 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.499 ' CG1' ' O ' ' A' ' 60' ' ' ALA . 4.1 m -152.32 172.96 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.129 -0.982 . . . . 0.0 110.464 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.6 mt -120.14 140.46 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.406 -0.809 . . . . 0.0 109.511 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.449 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . . . -74.22 114.69 12.86 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.176 -0.952 . . . . 0.0 110.33 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.418 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 23.9 tp -71.18 -21.58 62.14 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 109.264 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.418 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 65.5 m-70 -154.94 -163.63 1.61 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.607 -0.683 . . . . 0.0 109.733 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.407 ' O ' ' OE2' ' A' ' 16' ' ' GLU . 30.1 t -106.91 135.76 47.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.085 -1.009 . . . . 0.0 109.756 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.584 ' CD1' ' HD3' ' A' ' 55' ' ' PRO . 81.5 t80 -97.15 151.79 19.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.993 -1.067 . . . . 0.0 110.4 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.407 ' OE2' ' O ' ' A' ' 14' ' ' SER . 1.9 mp0 -117.09 102.71 52.59 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.337 -0.852 . . . . 0.0 110.209 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.448 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 46.9 Cg_endo -62.99 98.91 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.013 1.533 . . . . 0.0 110.366 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.566 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 97.8 p -81.25 7.43 11.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.144 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.566 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 97.8 m-70 -154.27 -177.59 6.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 110.143 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -88.49 130.69 35.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.11 -0.994 . . . . 0.0 110.239 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.76 13.45 25.69 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -109.3 159.18 17.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.165 -1.197 . . . . 0.0 110.403 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.509 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 15.7 tp -115.26 120.07 38.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 110.177 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.493 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -101.54 58.41 0.64 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.582 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 34.9 p90 -52.94 171.35 0.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.14 -1.212 . . . . 0.0 111.326 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.447 ' N ' ' OE1' ' A' ' 29' ' ' GLU . 94.4 mt-10 -105.06 178.35 4.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.565 -0.71 . . . . 0.0 109.949 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -69.84 129.46 39.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.117 -0.989 . . . . 0.0 110.3 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.45 -15.04 56.36 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.447 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 24.4 tt0 -59.02 124.4 19.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.134 -1.215 . . . . 0.0 110.063 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.433 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 88.9 mt-30 -79.9 134.18 36.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.139 -0.976 . . . . 0.0 109.991 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.433 ' HG ' ' C ' ' A' ' 30' ' ' GLN . 10.8 mt -133.07 154.04 50.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.204 -0.935 . . . . 0.0 110.313 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 14.5 ttt180 -97.33 132.69 42.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.853 . . . . 0.0 109.686 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.444 ' CD1' HG22 ' A' ' 9' ' ' VAL . 23.4 mm -77.85 118.92 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.179 -0.951 . . . . 0.0 110.396 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.5 ' CD1' ' O ' ' A' ' 43' ' ' ALA . 45.7 mt -87.78 -34.55 18.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 109.94 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -172.72 125.49 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.448 -0.782 . . . . 0.0 109.956 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.573 ' HA ' ' CG ' ' A' ' 41' ' ' TRP . 95.1 mt-30 -101.87 62.88 0.91 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.931 . . . . 0.0 110.304 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.5 m -108.54 136.18 48.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.347 -0.846 . . . . 0.0 110.129 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.56 -175.04 53.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -65.47 -36.88 85.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -1.125 . . . . 0.0 110.181 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.58 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 91.8 m95 -95.12 140.32 30.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.9 . . . . 0.0 110.32 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.573 ' CG ' ' HA ' ' A' ' 36' ' ' GLN . 52.3 m0 -113.63 148.89 35.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.303 -0.873 . . . . 0.0 110.257 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.487 ' CB ' ' HB2' ' A' ' 34' ' ' LEU . 24.5 mttm -86.25 141.8 29.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.261 -0.9 . . . . 0.0 109.703 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.522 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . . . -146.28 167.03 24.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.127 -0.983 . . . . 0.0 110.485 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.48 ' CG ' ' HG2' ' A' ' 51' ' ' GLU . 58.7 tt0 -137.63 145.48 42.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.339 -0.85 . . . . 0.0 110.148 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.6 t -90.56 113.31 25.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.113 -0.992 . . . . 0.0 109.892 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 78.5 mt -74.82 3.49 8.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -0.963 . . . . 0.0 110.541 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.0 m -96.54 -33.33 11.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.107 -0.996 . . . . 0.0 110.032 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.6 m -119.17 -7.63 10.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 110.24 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.05 42.45 51.59 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -119.52 148.02 43.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -1.143 . . . . 0.0 110.073 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.48 ' HG2' ' CG ' ' A' ' 44' ' ' GLN . 90.9 mt-10 -118.07 138.27 52.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.948 . . . . 0.0 110.325 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.509 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -159.27 154.91 25.99 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -68.56 146.22 53.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.121 -1.223 . . . . 0.0 110.198 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.522 ' CG2' ' HB2' ' A' ' 43' ' ' ALA . 1.3 pt -136.41 147.9 61.9 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.868 . . . . 0.0 110.215 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.584 ' HD3' ' CD1' ' A' ' 15' ' ' TYR . 43.7 Cg_endo -72.76 145.46 41.07 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 124.046 1.551 . . . . 0.0 110.327 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.517 ' HB2' ' CH2' ' A' ' 41' ' ' TRP . 21.0 p90 -81.56 -0.02 40.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.518 -0.739 . . . . 0.0 110.592 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.491 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 85.5 m-20 -98.74 -27.56 13.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.051 -1.031 . . . . 0.0 110.942 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.54 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 18.2 m-30 -90.88 5.86 46.84 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.93 -1.106 . . . . 0.0 110.482 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.44 ' CG1' ' HB ' ' A' ' 9' ' ' VAL . 8.4 t -145.06 164.2 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 0.0 110.137 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.499 ' O ' ' CG1' ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.0 110.295 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.5 mt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.168 0.509 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.454 ' O ' HD11 ' A' ' 10' ' ' ILE . 12.6 m -150.95 170.63 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.342 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 19.6 mm -114.35 143.34 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.87 . . . . 0.0 110.076 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.54 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -79.63 110.82 15.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.119 -0.988 . . . . 0.0 110.134 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.439 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 15.9 tp -63.68 -24.67 67.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.05 -1.032 . . . . 0.0 109.529 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.439 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 37.0 m-70 -156.57 158.55 37.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.481 -0.762 . . . . 0.0 109.818 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.523 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 28.3 p -67.32 142.11 56.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.118 -0.989 . . . . 0.0 110.161 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.577 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 81.8 t80 -97.67 158.34 15.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 0.0 110.339 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.491 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -110.11 126.92 27.97 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 110.055 179.925 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.453 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 48.1 Cg_endo -82.91 81.16 2.47 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.976 1.514 . . . . 0.0 110.382 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 55.8 p -79.76 -1.08 37.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 110.078 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -142.69 169.46 17.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.155 -0.966 . . . . 0.0 110.136 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -83.87 130.6 34.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 110.216 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.26 4.01 53.68 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -98.88 161.15 13.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.171 -1.194 . . . . 0.0 110.238 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.525 ' CD1' ' HG3' ' A' ' 50' ' ' GLN . 31.9 tp -114.71 120.11 38.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.875 . . . . 0.0 110.141 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.467 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -100.92 50.52 1.02 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.569 ' CE2' ' HB2' ' A' ' 15' ' ' TYR . 48.0 p90 -50.76 176.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.122 -1.222 . . . . 0.0 111.12 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.523 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 83.4 mt-10 -107.63 174.11 6.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.52 -0.738 . . . . 0.0 110.253 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -68.37 139.76 55.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.122 -0.986 . . . . 0.0 110.405 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.26 -13.27 55.72 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 38.0 mm-40 -67.92 125.59 26.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.015 -1.285 . . . . 0.0 110.262 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.493 ' C ' ' CD1' ' A' ' 31' ' ' LEU . 80.4 mt-30 -79.53 138.69 37.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 109.663 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.493 ' CD1' ' C ' ' A' ' 30' ' ' GLN . 8.3 mp -136.56 156.78 48.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.046 -1.034 . . . . 0.0 110.633 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 15.9 mtm180 -103.92 131.32 51.26 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.387 -0.821 . . . . 0.0 109.394 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 99.4 mt -88.71 93.5 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.087 -1.008 . . . . 0.0 110.669 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.507 ' CD1' ' HA ' ' A' ' 43' ' ' ALA . 1.6 mp -79.25 -31.55 43.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.342 -0.849 . . . . 0.0 110.85 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.524 ' HB2' ' CB ' ' A' ' 42' ' ' LYS . 79.5 mt-10 -127.62 140.03 52.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.848 -1.158 . . . . 0.0 110.191 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.582 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 49.7 tt0 -135.06 59.7 1.72 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 110.263 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.8 t -125.2 130.98 53.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.897 . . . . 0.0 110.219 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.35 177.29 51.82 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.27 -30.89 71.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.236 -1.155 . . . . 0.0 110.281 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -98.33 144.45 27.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.0 110.263 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.586 ' CZ3' ' HB2' ' A' ' 56' ' ' PHE . 43.6 m0 -126.08 157.88 36.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.37 -0.831 . . . . 0.0 110.166 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.524 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 28.7 tttt -100.03 146.78 26.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.886 . . . . 0.0 109.327 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -157.94 -175.97 5.66 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.916 -1.115 . . . . 0.0 110.834 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -146.03 154.31 41.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.416 -0.803 . . . . 0.0 109.622 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.3 t -101.71 125.68 48.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 110.392 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 46' ' ' LEU . 44.0 tp -81.39 6.12 15.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.387 -0.821 . . . . 0.0 110.135 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.9 m -93.29 -37.96 11.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 110.226 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.8 p -125.39 -7.52 6.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.231 -0.918 . . . . 0.0 110.188 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.91 27.28 56.82 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.525 ' HG3' ' CD1' ' A' ' 23' ' ' LEU . 70.3 tp60 -90.79 131.71 36.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.318 -1.107 . . . . 0.0 110.3 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 51' ' ' GLU . 22.7 pt-20 -115.97 134.33 55.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.322 -0.861 . . . . 0.0 110.057 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.451 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -172.49 166.21 38.88 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.484 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 59.4 m-85 -69.05 142.31 54.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -1.142 . . . . 0.0 110.288 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.506 ' CD1' HG23 ' A' ' 59' ' ' VAL . 1.6 pp -136.19 138.51 27.47 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 110.107 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.577 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 47.3 Cg_endo -64.61 154.94 69.55 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.916 1.482 . . . . 0.0 110.289 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.586 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 22.3 p90 -83.97 -1.46 54.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.318 -0.864 . . . . 0.0 110.643 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.567 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 87.3 m-20 -98.39 -26.1 14.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.043 -1.036 . . . . 0.0 110.965 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.473 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 14.9 m-85 -83.16 -0.61 50.05 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.925 -1.109 . . . . 0.0 110.285 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.506 HG23 ' CD1' ' A' ' 54' ' ' ILE . 27.8 m -135.16 147.21 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.092 -1.005 . . . . 0.0 110.304 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.429 ' O ' ' CG1' ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.931 . . . . 0.0 110.223 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.491 HD22 ' CD2' ' A' ' 46' ' ' LEU . 7.0 mp . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.287 0.565 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.552 ' CG2' ' CG1' ' A' ' 59' ' ' VAL . 13.2 m -152.3 171.32 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.889 . . . . 0.0 110.306 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.3 mt -112.88 144.12 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -0.844 . . . . 0.0 109.923 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.549 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . . . -80.25 111.0 16.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 110.268 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.521 ' CD2' ' N ' ' A' ' 12' ' ' LEU . 4.1 mm? -64.6 -26.2 68.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.17 -0.956 . . . . 0.0 109.448 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.47 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 52.5 m80 -156.9 154.56 29.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.54 -0.725 . . . . 0.0 109.661 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.52 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 53.8 p -64.69 143.4 57.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.985 -1.072 . . . . 0.0 110.056 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.585 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 89.1 t80 -100.57 164.1 12.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.036 -1.04 . . . . 0.0 110.26 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.459 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -117.94 125.32 28.07 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.367 -0.833 . . . . 0.0 110.098 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.454 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 48.3 Cg_endo -78.39 82.25 2.52 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.016 1.535 . . . . 0.0 110.369 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 72.6 m -79.74 -2.53 43.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.88 . . . . 0.0 109.966 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.437 ' CG ' ' N ' ' A' ' 20' ' ' ASP . 86.4 t60 -145.09 172.2 13.42 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.369 -0.832 . . . . 0.0 110.095 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . 0.437 ' N ' ' CG ' ' A' ' 19' ' ' HIS . 21.8 t70 -80.32 129.51 34.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.175 -0.953 . . . . 0.0 110.223 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.46 18.01 29.56 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -106.9 150.02 26.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -1.118 . . . . 0.0 110.284 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.466 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 15.3 tp -105.75 112.08 25.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 110.042 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.459 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -95.28 45.23 2.08 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.58 ' CG ' HD12 ' A' ' 31' ' ' LEU . 40.6 p90 -46.64 171.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -1.175 . . . . 0.0 110.865 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.52 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 88.0 mt-10 -101.74 177.29 4.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.464 -0.773 . . . . 0.0 110.259 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -69.69 126.65 30.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.266 -0.896 . . . . 0.0 110.272 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.71 -8.66 74.01 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.43 ' CD ' ' HB2' ' A' ' 25' ' ' PHE . 20.9 tt0 -67.27 126.03 27.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -1.18 . . . . 0.0 110.317 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.435 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 89.4 mt-30 -79.49 138.22 37.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 109.929 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.58 HD12 ' CG ' ' A' ' 25' ' ' PHE . 14.4 mt -140.44 162.74 34.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.909 . . . . 0.0 110.38 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 25.2 ttp180 -106.01 133.33 50.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 0.0 109.682 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.526 ' CG1' HG23 ' A' ' 9' ' ' VAL . 15.5 mt -97.82 94.67 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.104 -0.997 . . . . 0.0 110.623 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 50.0 mt -79.46 -22.48 44.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.932 . . . . 0.0 110.777 -179.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.531 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 83.2 tt0 -136.39 129.69 31.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.961 -1.087 . . . . 0.0 110.33 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.572 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 97.0 mt-30 -126.32 54.19 1.58 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.842 . . . . 0.0 110.122 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.5 p -119.47 157.91 27.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.913 . . . . 0.0 110.278 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.23 -172.1 26.97 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -72.54 -34.66 67.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -1.166 . . . . 0.0 110.28 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.409 ' HZ3' ' CE1' ' A' ' 15' ' ' TYR . 69.1 m95 -101.81 150.07 23.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.228 -0.92 . . . . 0.0 110.441 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.572 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 50.8 m0 -120.75 154.69 35.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.357 -0.84 . . . . 0.0 110.264 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.531 ' CB ' ' HB3' ' A' ' 35' ' ' GLU . 67.3 tttt -95.53 143.49 26.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.569 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -153.27 176.89 11.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.933 -1.104 . . . . 0.0 111.085 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 48.7 tt0 -143.67 152.01 40.8 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.591 -0.693 . . . . 0.0 109.722 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.413 ' CB ' ' OG1' ' A' ' 48' ' ' THR . 17.3 m -85.1 149.35 25.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.164 -0.96 . . . . 0.0 110.298 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.491 ' CD2' HD22 ' A' ' 8' ' ' LEU . 6.6 mp -98.39 -13.2 20.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.325 -0.859 . . . . 0.0 109.964 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.8 p -101.04 -27.49 13.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.84 . . . . 0.0 110.234 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.413 ' OG1' ' CB ' ' A' ' 45' ' ' SER . 81.4 p -107.62 -18.57 13.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 110.316 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.99 41.82 80.28 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.464 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 7.2 mt-30 -119.21 150.21 40.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -1.118 . . . . 0.0 110.281 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 81.9 tt0 -116.43 134.08 55.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.93 . . . . 0.0 110.181 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -160.03 154.88 25.96 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -69.26 142.56 54.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -1.134 . . . . 0.0 109.984 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 54' ' ' ILE . 1.7 pt -131.97 132.35 23.1 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.949 . . . . 0.0 110.437 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.585 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 47.9 Cg_endo -61.1 156.11 46.77 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.981 1.517 . . . . 0.0 109.884 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.551 ' CE1' ' OD1' ' A' ' 57' ' ' ASN . 41.7 p90 -80.12 -8.14 59.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 111.326 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.551 ' OD1' ' CE1' ' A' ' 56' ' ' PHE . 58.7 m-20 -92.49 -26.59 17.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.766 -1.209 . . . . 0.0 110.98 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.564 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 21.8 m-85 -82.94 -6.38 59.45 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.999 -1.063 . . . . 0.0 110.048 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.552 ' CG1' ' CG2' ' A' ' 9' ' ' VAL . 58.1 t -132.38 174.71 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.845 . . . . 0.0 109.723 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.44 ' N ' HG13 ' A' ' 59' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 0.0 110.244 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.464 ' O ' HG11 ' A' ' 9' ' ' VAL . 41.4 tp . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.292 0.567 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.489 ' HB ' ' CG1' ' A' ' 59' ' ' VAL . 3.7 m -155.36 173.33 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -0.915 . . . . 0.0 110.271 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.1 mt -117.38 142.09 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.857 . . . . 0.0 109.807 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.602 ' CB ' ' CD2' ' A' ' 25' ' ' PHE . . . -78.58 113.76 16.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.972 . . . . 0.0 110.257 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.2 mp -66.71 -26.83 67.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.071 -1.018 . . . . 0.0 109.542 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -149.95 155.4 39.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.459 -0.775 . . . . 0.0 109.764 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.515 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 53.0 p -68.59 143.04 54.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.089 -1.007 . . . . 0.0 110.05 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.58 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 81.2 t80 -101.69 164.53 11.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.014 -1.054 . . . . 0.0 110.354 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.563 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 28.2 mm-40 -118.01 129.67 25.21 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 110.126 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.466 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 49.2 Cg_endo -81.56 81.91 2.51 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.926 1.487 . . . . 0.0 110.535 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.477 ' OG ' ' ND1' ' A' ' 19' ' ' HIS . 81.0 p -79.72 -1.97 40.88 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.172 -0.955 . . . . 0.0 110.06 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.477 ' ND1' ' OG ' ' A' ' 18' ' ' SER . 74.7 m80 -144.06 -176.8 5.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.941 . . . . 0.0 110.135 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -92.69 131.61 37.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.0 110.072 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.36 -5.33 57.27 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.07 157.38 18.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.14 -1.212 . . . . 0.0 110.294 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.482 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 32.1 tp -115.3 120.06 38.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 110.079 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.471 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -97.74 47.85 1.52 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.602 ' CD2' ' CB ' ' A' ' 11' ' ' ALA . 46.6 p90 -49.29 174.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -1.153 . . . . 0.0 111.305 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.515 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 95.8 mt-10 -107.63 173.68 6.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.523 -0.736 . . . . 0.0 109.943 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -68.39 139.45 55.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.098 -1.001 . . . . 0.0 110.355 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.16 -15.41 49.41 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.516 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 22.8 tt0 -62.28 124.4 20.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.116 -1.226 . . . . 0.0 110.016 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.493 ' C ' ' CD1' ' A' ' 31' ' ' LEU . 91.9 mt-30 -79.9 136.87 36.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -0.887 . . . . 0.0 109.902 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.516 ' CD1' ' O ' ' A' ' 29' ' ' GLU . 6.6 mp -141.65 163.61 32.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.126 -0.984 . . . . 0.0 110.533 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.518 ' CZ ' HD22 ' A' ' 34' ' ' LEU . 10.5 ptt180 -112.72 136.85 51.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.351 -0.843 . . . . 0.0 109.575 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.444 HG22 HD11 ' A' ' 33' ' ' ILE . 61.8 mt -90.74 95.28 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.175 -0.953 . . . . 0.0 110.655 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.518 HD22 ' CZ ' ' A' ' 32' ' ' ARG . 1.2 mt -79.46 -30.49 42.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 110.778 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.527 ' CG ' ' HB3' ' A' ' 42' ' ' LYS . 39.8 mm-40 -135.07 139.76 45.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.885 -1.135 . . . . 0.0 110.438 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.564 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 86.7 mt-30 -130.9 54.67 1.89 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.282 -0.886 . . . . 0.0 110.158 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.0 m -116.87 145.7 43.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.237 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.28 172.15 10.6 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.3 -28.01 66.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.181 -1.188 . . . . 0.0 110.16 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.569 ' CZ3' ' OH ' ' A' ' 15' ' ' TYR . 94.8 m95 -99.53 144.67 28.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 110.282 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.576 ' CZ3' ' HB2' ' A' ' 56' ' ' PHE . 45.6 m0 -120.79 156.36 32.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.864 . . . . 0.0 110.149 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.527 ' HB3' ' CG ' ' A' ' 35' ' ' GLU . 24.6 tttp -98.32 140.25 32.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.372 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 32' ' ' ARG . . . -156.25 -178.41 7.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.061 -1.024 . . . . 0.0 110.618 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.51 ' HG3' ' CA ' ' A' ' 51' ' ' GLU . 48.4 tt0 -151.09 158.81 44.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.479 -0.763 . . . . 0.0 109.72 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -108.01 140.04 41.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.155 -0.966 . . . . 0.0 110.357 -179.8 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 46' ' ' LEU . 22.7 tp -90.85 11.2 23.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -0.86 . . . . 0.0 110.07 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.4 m -97.03 -38.6 9.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.0 110.241 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.1 p -119.35 -8.84 10.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.217 -0.927 . . . . 0.0 110.207 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.47 36.21 49.99 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.453 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 3.1 mt-30 -108.75 141.76 40.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -1.109 . . . . 0.0 110.14 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.51 ' CA ' ' HG3' ' A' ' 44' ' ' GLN . 83.4 tt0 -121.61 143.08 49.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.216 -0.928 . . . . 0.0 110.124 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.482 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -173.47 165.63 37.7 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -71.77 145.45 48.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.401 -1.058 . . . . 0.0 110.075 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 54' ' ' ILE . 1.3 pt -136.97 137.66 23.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.182 -0.949 . . . . 0.0 110.198 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.58 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 46.6 Cg_endo -62.06 145.16 96.68 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.944 1.497 . . . . 0.0 110.049 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.576 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 31.1 p90 -73.27 -3.96 30.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.365 -0.835 . . . . 0.0 110.902 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -96.09 -26.23 15.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.912 -1.117 . . . . 0.0 111.066 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.569 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 15.3 m-85 -83.43 3.07 33.58 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.96 -1.087 . . . . 0.0 110.242 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.489 ' CG1' ' HB ' ' A' ' 9' ' ' VAL . 16.0 t -146.41 168.19 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 109.907 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.45 ' O ' HG13 ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 110.26 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.7 mp . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.239 0.543 . . . . 0.0 110.14 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 31' ' ' LEU . 13.6 m -150.25 169.83 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.185 -0.947 . . . . 0.0 110.387 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 57.0 mt -116.79 141.86 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.311 -0.868 . . . . 0.0 109.559 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.623 ' CB ' ' CD2' ' A' ' 25' ' ' PHE . . . -80.26 113.74 18.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.122 -0.986 . . . . 0.0 110.515 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.458 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 82.5 mt -67.07 -24.28 65.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.061 -1.024 . . . . 0.0 109.121 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.458 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 42.8 m80 -157.31 150.83 24.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.602 -0.686 . . . . 0.0 109.547 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 36.8 p -62.31 142.17 57.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.93 -1.106 . . . . 0.0 110.069 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.583 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 82.1 t80 -100.82 162.64 12.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.078 -1.014 . . . . 0.0 110.472 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -119.71 121.59 29.75 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.334 -0.854 . . . . 0.0 109.911 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.467 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 47.6 Cg_endo -79.42 94.36 1.06 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.037 1.546 . . . . 0.0 110.521 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.6 p -79.89 0.97 28.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 110.005 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -145.08 165.71 27.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.893 . . . . 0.0 109.888 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -77.46 131.74 38.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.133 -0.979 . . . . 0.0 110.185 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.27 -7.13 40.04 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 4.3 m-20 -91.58 165.35 13.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.231 -1.158 . . . . 0.0 110.201 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.513 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 20.1 tp -122.81 128.5 50.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 109.978 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.476 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -106.77 55.34 0.53 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.623 ' CD2' ' CB ' ' A' ' 11' ' ' ALA . 37.3 p90 -45.31 171.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -1.14 . . . . 0.0 110.882 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.474 ' N ' ' OE1' ' A' ' 29' ' ' GLU . 94.9 mt-10 -97.66 174.48 6.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.412 -0.805 . . . . 0.0 110.239 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -70.66 122.68 20.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.873 . . . . 0.0 110.349 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.01 -7.1 76.64 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.474 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 39.1 tt0 -70.34 129.57 39.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.001 -1.293 . . . . 0.0 110.06 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -79.46 138.35 37.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.885 . . . . 0.0 109.981 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.448 HD12 ' CG ' ' A' ' 25' ' ' PHE . 16.9 mt -135.56 156.41 48.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.149 -0.969 . . . . 0.0 110.47 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 31.3 ttm180 -98.37 130.99 45.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.379 -0.826 . . . . 0.0 109.918 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.41 ' CD1' HG12 ' A' ' 9' ' ' VAL . 34.5 mt -76.03 119.7 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 110.164 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 42' ' ' LYS . 96.9 mt -87.75 -35.19 18.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.334 -0.854 . . . . 0.0 110.179 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -150.56 175.08 12.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -0.921 . . . . 0.0 110.314 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.571 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 88.9 mt-30 -151.09 57.8 0.9 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.281 -0.887 . . . . 0.0 110.192 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.3 t -125.2 130.36 51.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 110.152 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.88 -170.79 42.14 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -75.65 -34.24 60.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.194 -1.18 . . . . 0.0 110.178 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.572 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 94.8 m95 -97.84 146.4 25.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -0.89 . . . . 0.0 110.155 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.571 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.2 m0 -124.42 155.76 38.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.289 -0.882 . . . . 0.0 110.18 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 34' ' ' LEU . 19.7 mttt -91.12 146.3 23.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 109.663 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.519 ' CB ' HG12 ' A' ' 54' ' ' ILE . . . -144.05 165.92 26.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.221 -0.924 . . . . 0.0 110.635 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 50' ' ' GLN . 59.5 tt0 -134.59 142.89 47.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.415 -0.803 . . . . 0.0 109.957 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.9 m -76.99 140.06 40.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 110.14 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 14.2 tp -88.31 -19.69 26.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.913 . . . . 0.0 109.968 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.0 p -102.92 -28.13 12.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.828 . . . . 0.0 110.404 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m -96.3 -20.94 18.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.081 -1.012 . . . . 0.0 110.107 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.71 47.49 67.59 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.471 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 61.2 mt-30 -133.86 158.59 43.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.325 -1.103 . . . . 0.0 110.191 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 92.5 mt-10 -119.77 143.67 47.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.083 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.513 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -154.63 -152.05 6.01 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -122.16 134.33 54.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.368 -1.078 . . . . 0.0 110.056 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.519 HG12 ' CB ' ' A' ' 43' ' ' ALA . 1.8 pt -129.11 140.48 38.74 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.965 . . . . 0.0 110.183 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.583 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 47.3 Cg_endo -73.0 157.34 51.25 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.958 1.504 . . . . 0.0 110.12 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -78.84 -5.01 52.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -0.858 . . . . 0.0 111.009 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -98.44 -26.51 14.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.897 -1.127 . . . . 0.0 111.215 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.567 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 13.1 m-85 -83.63 -9.18 59.07 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.929 -1.107 . . . . 0.0 110.469 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.0 m -133.98 145.0 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.166 -0.959 . . . . 0.0 110.383 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.836 . . . . 0.0 110.119 179.905 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.434 ' O ' ' CG1' ' A' ' 9' ' ' VAL . 23.6 tp . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.263 0.554 . . . . 0.0 110.115 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.434 ' CG1' ' O ' ' A' ' 8' ' ' LEU . 31.7 m -153.7 172.03 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.192 -0.943 . . . . 0.0 110.37 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.447 HG22 HD11 ' A' ' 10' ' ' ILE . 54.8 mt -113.9 146.11 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.319 -0.863 . . . . 0.0 109.712 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.581 ' CB ' ' CD2' ' A' ' 25' ' ' PHE . . . -80.13 110.12 15.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.13 -0.982 . . . . 0.0 110.287 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.519 ' O ' ' CD1' ' A' ' 12' ' ' LEU . 2.0 tm? -65.61 -25.07 67.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.065 -1.022 . . . . 0.0 109.405 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.474 ' ND1' HD11 ' A' ' 12' ' ' LEU . 11.5 m170 -155.69 158.95 39.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.51 -0.744 . . . . 0.0 109.744 179.669 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.525 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 47.3 p -68.41 139.89 55.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.999 -1.063 . . . . 0.0 110.105 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.579 ' CD1' ' HD3' ' A' ' 55' ' ' PRO . 87.9 t80 -95.72 156.42 16.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.046 -1.034 . . . . 0.0 110.33 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.563 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -99.4 127.13 35.3 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.322 -0.861 . . . . 0.0 110.062 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.468 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 48.0 Cg_endo -89.5 86.78 0.43 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.033 1.544 . . . . 0.0 110.397 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.9 p -79.98 1.3 28.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -0.943 . . . . 0.0 110.111 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -134.7 -168.31 2.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.078 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.7 p30 -105.79 -6.19 19.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.187 -0.945 . . . . 0.0 110.196 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.48 -0.53 23.39 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -88.13 163.17 16.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.127 -1.22 . . . . 0.0 110.243 -179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.482 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 22.2 tp -114.53 120.49 40.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.298 -0.876 . . . . 0.0 110.086 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.468 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . -103.7 54.81 0.65 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.581 ' CD2' ' CB ' ' A' ' 11' ' ' ALA . 50.6 p90 -53.39 176.57 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -1.155 . . . . 0.0 111.022 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.525 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 92.5 mt-10 -110.39 178.27 4.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.442 -0.786 . . . . 0.0 110.026 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 12' ' ' LEU . 27.9 tttt -67.38 136.45 54.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.124 -0.985 . . . . 0.0 110.421 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.47 -16.13 50.91 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.449 ' HG2' HD22 ' A' ' 31' ' ' LEU . 10.3 tt0 -60.83 123.21 16.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.131 -1.217 . . . . 0.0 110.41 -179.666 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.422 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 94.0 mt-30 -79.75 134.52 36.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.35 -0.844 . . . . 0.0 109.79 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.564 HD12 ' CG ' ' A' ' 25' ' ' PHE . 15.5 mt -137.99 159.38 42.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.949 . . . . 0.0 110.319 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.532 ' CD ' ' HB3' ' A' ' 44' ' ' GLN . 3.7 ptt180 -109.25 134.98 51.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.278 -0.889 . . . . 0.0 109.614 179.357 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.51 HG22 HD11 ' A' ' 33' ' ' ILE . 61.1 mt -91.39 95.17 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.094 -1.004 . . . . 0.0 110.758 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.438 HD22 ' NE ' ' A' ' 32' ' ' ARG . 1.6 mt -78.86 -29.45 44.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 110.622 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.472 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 74.1 tt0 -128.6 140.76 51.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.002 -1.062 . . . . 0.0 110.274 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.568 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 47.7 tt0 -138.42 68.4 1.39 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 110.222 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.4 p -131.81 132.83 44.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.0 110.207 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.84 -162.56 41.15 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -80.96 -31.17 34.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -1.163 . . . . 0.0 110.208 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.574 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 91.4 m95 -98.87 146.51 25.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.269 -0.894 . . . . 0.0 110.352 -179.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.574 ' CZ3' ' HB2' ' A' ' 56' ' ' PHE . 47.3 m0 -125.35 156.46 38.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 110.21 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.472 ' CB ' ' HB3' ' A' ' 35' ' ' GLU . 25.7 tttp -97.6 145.32 26.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.14 179.217 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -160.35 -173.57 4.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.908 -1.12 . . . . 0.0 110.947 -179.638 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.532 ' HB3' ' CD ' ' A' ' 32' ' ' ARG . 39.2 tt0 -155.15 162.18 41.05 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.576 -0.702 . . . . 0.0 109.475 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.523 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 1.7 m -103.22 128.42 50.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.068 -1.02 . . . . 0.0 110.276 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 46' ' ' LEU . 25.4 tp -82.44 1.89 35.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.337 -0.852 . . . . 0.0 110.154 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.0 m -96.96 -34.48 11.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 110.205 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.0 p -115.99 -16.31 11.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.935 . . . . 0.0 110.183 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.8 25.68 55.55 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.425 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 56.9 tt0 -97.18 135.65 38.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -1.154 . . . . 0.0 110.243 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 82.1 tt0 -120.02 141.13 50.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.253 -0.905 . . . . 0.0 109.939 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.482 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -167.32 -137.84 2.32 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -125.91 138.42 53.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.416 -1.049 . . . . 0.0 109.947 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.463 HG12 ' HB2' ' A' ' 43' ' ' ALA . 16.9 pt -128.23 148.78 69.16 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 110.255 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.579 ' HD3' ' CD1' ' A' ' 15' ' ' TYR . 45.3 Cg_endo -80.42 148.31 18.45 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.017 1.535 . . . . 0.0 109.728 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.574 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 35.8 p90 -69.87 -4.61 21.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 111.021 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -98.21 -26.44 14.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.831 -1.168 . . . . 0.0 111.396 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.573 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 8.1 m-85 -84.41 -2.84 57.81 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.938 -1.101 . . . . 0.0 110.395 -179.666 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.4 m -131.32 141.71 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.131 -0.981 . . . . 0.0 110.1 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.114 -0.991 . . . . 0.0 110.38 -179.977 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.487 ' C ' ' CD1' ' A' ' 8' ' ' LEU . 3.2 tm? . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.127 0.489 . . . . 0.0 110.192 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.513 HG23 ' CD1' ' A' ' 33' ' ' ILE . 27.1 m -146.6 167.66 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.312 -0.867 . . . . 0.0 110.345 180.0 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.6 mm -112.54 141.34 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.705 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.43 ' CB ' ' CD1' ' A' ' 25' ' ' PHE . . . -79.03 109.64 13.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.057 -1.027 . . . . 0.0 110.268 -179.817 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.434 ' HG ' ' CE1' ' A' ' 13' ' ' HIS . 16.6 tp -67.39 -24.96 65.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.09 -1.006 . . . . 0.0 109.255 179.39 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.434 ' CE1' ' HG ' ' A' ' 12' ' ' LEU . 66.1 m80 -153.51 151.4 29.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.551 -0.718 . . . . 0.0 109.622 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.521 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 52.7 p -65.4 143.66 57.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 109.996 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.58 ' CD1' ' HG3' ' A' ' 55' ' ' PRO . 22.3 t80 -92.77 150.31 20.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.106 -0.996 . . . . 0.0 110.287 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -106.9 79.48 0.67 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.895 . . . . 0.0 110.268 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -47.45 109.62 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.08 1.568 . . . . 0.0 110.396 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 91.6 p -90.35 12.1 19.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.213 -0.93 . . . . 0.0 110.217 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -147.54 -178.97 6.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.207 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -98.7 116.59 31.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.247 -0.908 . . . . 0.0 110.203 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.4 7.54 6.89 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -105.8 171.85 7.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.16 -1.2 . . . . 0.0 110.152 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.491 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 18.7 tp -113.32 115.59 28.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.303 -0.873 . . . . 0.0 109.876 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.12 55.21 0.97 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 14' ' ' SER . 37.0 p90 -54.76 175.99 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -1.118 . . . . 0.0 111.208 -179.498 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.521 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 96.0 mt-10 -110.25 177.97 4.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.546 -0.721 . . . . 0.0 110.056 179.797 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.7 tttt -67.22 139.23 57.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.11 -0.994 . . . . 0.0 110.505 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.63 -14.72 54.89 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.853 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 3.1 mt-10 -65.05 125.59 25.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.06 -1.259 . . . . 0.0 110.293 -179.698 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.487 ' C ' ' CD1' ' A' ' 31' ' ' LEU . 52.1 tt0 -79.62 136.16 36.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 109.916 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.487 ' CD1' ' C ' ' A' ' 30' ' ' GLN . 7.6 mp -138.94 160.02 40.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 110.467 -179.698 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.533 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 46.7 ttt180 -105.82 131.7 52.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.414 -0.804 . . . . 0.0 109.427 179.4 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.513 ' CD1' HG23 ' A' ' 9' ' ' VAL . 35.0 mm -92.35 94.39 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.093 -1.004 . . . . 0.0 110.623 -179.551 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.489 HD22 ' CZ ' ' A' ' 32' ' ' ARG . 11.8 mt -79.84 -29.91 40.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.278 -0.889 . . . . 0.0 110.751 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.449 ' HB3' ' HB3' ' A' ' 42' ' ' LYS . 41.5 tp10 -131.03 142.96 50.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.908 -1.12 . . . . 0.0 110.383 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.589 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 78.3 mt-30 -138.01 54.88 1.78 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.88 . . . . 0.0 110.017 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.1 m -120.38 137.47 54.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.935 . . . . 0.0 110.237 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.26 -171.66 55.15 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -74.83 -33.67 62.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -1.17 . . . . 0.0 110.212 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.457 ' CZ3' ' OH ' ' A' ' 15' ' ' TYR . 95.6 m95 -93.77 139.83 30.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 110.212 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.589 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 32.2 m0 -118.17 154.97 31.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.041 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 35' ' ' GLU . 16.3 tttm -100.95 138.78 37.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.312 -0.868 . . . . 0.0 109.145 179.235 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -150.74 177.57 9.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.998 -1.064 . . . . 0.0 110.965 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.459 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 47.2 tt0 -138.27 146.77 42.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.48 -0.763 . . . . 0.0 109.788 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.52 116.12 28.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.13 -0.981 . . . . 0.0 110.255 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.6 mt -75.71 1.65 14.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.888 . . . . 0.0 110.307 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 47.9 p -89.92 -32.33 16.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.124 -0.985 . . . . 0.0 110.144 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.5 p -120.56 -3.8 9.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 110.082 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.24 48.16 60.25 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.448 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 10.8 mt-30 -130.17 155.65 45.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -1.142 . . . . 0.0 110.349 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.459 ' HG2' ' HB2' ' A' ' 44' ' ' GLN . 97.9 mt-10 -121.41 147.86 45.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.325 -0.859 . . . . 0.0 109.944 179.785 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.491 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -164.75 -153.6 7.55 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -119.67 135.08 54.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.505 -0.997 . . . . 0.0 109.719 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.528 HD11 ' CG1' ' A' ' 59' ' ' VAL . 1.0 OUTLIER -126.7 149.42 68.33 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.126 -0.984 . . . . 0.0 110.568 -179.668 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.58 ' HG3' ' CD1' ' A' ' 15' ' ' TYR . 46.3 Cg_endo -77.78 132.6 12.04 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.057 1.556 . . . . 0.0 109.965 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.566 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 15.0 p90 -66.46 -9.68 36.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 111.017 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -87.28 -26.41 23.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.883 -1.136 . . . . 0.0 110.841 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.568 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 16.8 m-30 -96.28 7.18 47.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.045 -1.034 . . . . 0.0 110.259 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.528 ' CG1' HD11 ' A' ' 54' ' ' ILE . 35.2 m -135.55 142.26 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 0.0 110.091 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.232 -0.917 . . . . 0.0 110.219 -179.948 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.7 tp . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.197 0.523 . . . . 0.0 110.105 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.2 m -150.02 169.87 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.159 -0.963 . . . . 0.0 110.367 -179.952 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 85.9 mt -112.27 144.91 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 109.728 179.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . -77.83 114.89 17.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.13 -0.981 . . . . 0.0 110.349 -179.712 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.575 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 73.1 mt -73.7 -24.93 60.0 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.071 -1.018 . . . . 0.0 109.316 179.409 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 77.0 m-70 -161.38 146.47 13.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.612 -0.68 . . . . 0.0 109.543 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 53.5 p -60.59 142.07 55.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.919 -1.113 . . . . 0.0 109.904 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 45.8 t80 -99.0 159.12 15.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.015 -1.053 . . . . 0.0 110.587 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -109.4 82.08 1.98 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.411 -0.806 . . . . 0.0 110.067 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.53 ' HD3' ' CA ' ' A' ' 24' ' ' GLY . 47.4 Cg_endo -48.55 104.55 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.034 1.544 . . . . 0.0 110.44 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.522 ' OG ' ' CE1' ' A' ' 19' ' ' HIS . 64.5 p -80.67 0.1 35.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.201 -0.937 . . . . 0.0 110.169 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.522 ' CE1' ' OG ' ' A' ' 18' ' ' SER . 64.5 m80 -134.85 176.73 8.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.143 -0.973 . . . . 0.0 110.147 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -82.38 -11.86 58.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 110.461 -179.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -105.66 25.05 25.5 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.525 ' HB2' ' CB ' ' A' ' 17' ' ' PRO . 52.4 m-20 -111.92 161.83 15.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.157 -1.202 . . . . 0.0 110.364 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.496 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 23.7 tp -116.18 120.46 39.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.773 179.713 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.53 ' CA ' ' HD3' ' A' ' 17' ' ' PRO . . . -98.02 51.06 1.31 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.866 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.559 ' CG ' HD12 ' A' ' 31' ' ' LEU . 22.2 p90 -47.34 170.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -1.155 . . . . 0.0 110.568 -179.649 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -100.01 179.05 4.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.391 -0.818 . . . . 0.0 110.282 -179.649 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.57 ' HE3' ' CE1' ' A' ' 13' ' ' HIS . 20.6 tttt -71.96 120.47 17.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.326 -0.859 . . . . 0.0 110.033 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 96.63 -9.18 66.47 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.513 ' OE2' ' CB ' ' A' ' 25' ' ' PHE . 31.4 tt0 -60.7 133.21 55.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.168 -1.195 . . . . 0.0 110.27 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.41 ' O ' HD22 ' A' ' 31' ' ' LEU . 17.5 mt-30 -79.93 129.06 34.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.0 109.888 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.559 HD12 ' CG ' ' A' ' 25' ' ' PHE . 27.0 mt -130.11 150.7 51.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.168 -0.958 . . . . 0.0 110.437 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.488 ' O ' ' CA ' ' A' ' 43' ' ' ALA . 30.5 ttp180 -106.01 140.64 38.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.349 -0.845 . . . . 0.0 109.824 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 55.8 mt -91.51 136.09 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 110.173 -179.903 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.431 ' CD1' ' HB2' ' A' ' 44' ' ' GLN . 91.6 mt -129.94 -30.89 1.98 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.371 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.456 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 78.6 tt0 -128.25 146.64 50.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 110.307 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.552 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 52.6 tt0 -142.25 58.1 1.46 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.254 -0.904 . . . . 0.0 110.144 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.4 t -118.22 114.38 22.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.269 -0.894 . . . . 0.0 110.229 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.3 -160.93 20.62 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -84.18 -29.59 26.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.189 -1.183 . . . . 0.0 110.251 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.567 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 91.3 m95 -96.06 145.05 25.79 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.288 -0.883 . . . . 0.0 110.169 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.552 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 48.8 m0 -119.17 153.1 35.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.226 -0.922 . . . . 0.0 110.281 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.458 ' HE2' ' OE2' ' A' ' 51' ' ' GLU . 9.9 tttp -99.43 110.58 23.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 110.043 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.488 ' CA ' ' O ' ' A' ' 32' ' ' ARG . . . -112.37 175.46 5.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.229 -0.919 . . . . 0.0 110.708 -179.588 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.49 ' CG ' ' O ' ' A' ' 50' ' ' GLN . 44.4 tt0 -138.18 146.59 42.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.338 -0.851 . . . . 0.0 109.951 -179.799 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.434 ' O ' ' HA3' ' A' ' 49' ' ' GLY . 6.9 t -79.01 137.78 37.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.109 -0.994 . . . . 0.0 110.174 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.2 tp -80.7 -21.06 41.58 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.596 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 95.9 m -83.35 -50.68 8.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.447 -0.783 . . . . 0.0 110.241 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 50' ' ' GLN . 18.0 p -100.22 1.69 42.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.079 -1.013 . . . . 0.0 110.32 -179.694 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 45' ' ' SER . . . 54.03 18.92 9.79 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.49 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 37.2 mt-30 -78.7 153.67 30.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -1.148 . . . . 0.0 110.281 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.458 ' OE2' ' HE2' ' A' ' 42' ' ' LYS . 86.6 tt0 -120.36 142.82 48.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 110.13 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.496 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -165.83 156.81 28.98 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -71.55 141.0 50.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -1.175 . . . . 0.0 109.961 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.461 ' O ' ' CG1' ' A' ' 54' ' ' ILE . 1.9 pp -141.21 124.8 10.05 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.302 -0.874 . . . . 0.0 110.146 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.57 ' CG ' ' CD1' ' A' ' 58' ' ' PHE . 46.2 Cg_endo -46.37 167.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.931 1.49 . . . . 0.0 110.098 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -95.69 -1.84 49.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 110.539 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -99.18 -24.58 14.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.141 -0.974 . . . . 0.0 110.724 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.57 ' CD1' ' CG ' ' A' ' 55' ' ' PRO . 27.4 m-85 -79.64 -12.87 59.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.988 -1.07 . . . . 0.0 110.515 -179.66 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.458 ' CG2' ' CD1' ' A' ' 54' ' ' ILE . 30.6 m -131.25 143.32 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.106 -0.996 . . . . 0.0 110.187 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.301 -0.874 . . . . 0.0 110.172 -179.916 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.44 ' O ' ' CG1' ' A' ' 9' ' ' VAL . 6.6 tp . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.244 0.545 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.44 ' CG1' ' O ' ' A' ' 8' ' ' LEU . 28.7 m -154.84 172.73 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 0.0 110.287 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 62.8 mt -112.49 145.43 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 109.806 179.618 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.525 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . -80.11 111.69 16.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.046 -1.034 . . . . 0.0 110.273 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 58' ' ' PHE . 6.1 mp -64.87 -28.46 69.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.068 -1.02 . . . . 0.0 109.356 179.451 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.444 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 30.7 m80 -155.39 157.66 37.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.564 -0.71 . . . . 0.0 109.794 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.527 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 10.3 t -64.92 140.61 58.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.099 -1.0 . . . . 0.0 109.939 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.581 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 86.3 t80 -94.5 151.69 19.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.02 -1.05 . . . . 0.0 110.474 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -114.02 91.89 24.2 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.409 -0.807 . . . . 0.0 110.076 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.472 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 46.8 Cg_endo -59.26 114.12 1.89 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.055 1.555 . . . . 0.0 110.476 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.459 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 74.2 p -89.54 11.33 19.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.275 -0.891 . . . . 0.0 109.996 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.459 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 98.6 m-70 -145.95 -177.11 5.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 0.0 110.15 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -100.33 118.89 37.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 110.139 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.95 -14.33 7.51 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -85.24 174.13 9.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -1.121 . . . . 0.0 110.339 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.505 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 20.2 tp -118.42 122.43 42.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 110.011 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.472 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . -102.17 57.08 0.64 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 15' ' ' TYR . 48.6 p90 -53.67 174.13 0.05 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.167 -1.196 . . . . 0.0 110.86 -179.805 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.527 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 73.6 mm-40 -108.0 -179.48 3.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.463 -0.773 . . . . 0.0 110.137 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -68.37 134.52 50.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.928 . . . . 0.0 110.365 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.17 -13.19 62.23 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.46 ' HG3' HD22 ' A' ' 31' ' ' LEU . 26.1 tp10 -62.08 122.99 16.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -1.16 . . . . 0.0 110.409 -179.712 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.431 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 97.0 mt-30 -79.91 136.42 36.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.33 -0.856 . . . . 0.0 109.879 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.518 HD12 ' CG ' ' A' ' 25' ' ' PHE . 17.4 mt -139.04 160.87 38.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.418 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.524 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 4.1 tpt180 -106.4 134.03 50.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.381 -0.825 . . . . 0.0 109.498 179.533 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.509 ' CG2' ' HG2' ' A' ' 36' ' ' GLN . 35.4 mt -95.77 92.84 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.139 -0.976 . . . . 0.0 110.485 -179.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mt -79.2 -24.97 42.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.274 -0.891 . . . . 0.0 110.631 -179.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 41' ' ' TRP . 70.7 tt0 -135.82 136.3 40.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.026 -1.046 . . . . 0.0 110.253 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.587 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 79.7 mt-30 -132.23 53.86 1.98 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.879 . . . . 0.0 110.188 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.0 m -115.9 138.4 51.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -0.882 . . . . 0.0 110.099 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.95 -172.89 55.2 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -72.73 -34.43 67.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.188 -1.184 . . . . 0.0 110.234 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.574 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 99.5 m95 -96.73 143.62 27.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 110.139 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.587 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 51.2 m0 -121.78 155.64 34.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.317 -0.865 . . . . 0.0 110.096 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 35' ' ' GLU . 46.7 tttm -96.32 141.98 29.0 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.277 -0.89 . . . . 0.0 109.237 179.282 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -150.03 174.13 13.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.927 -1.108 . . . . 0.0 111.023 -179.456 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 58.7 tt0 -137.82 146.06 43.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.613 -0.679 . . . . 0.0 109.771 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 t -92.92 107.3 19.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 110.136 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 44.7 mt -70.01 -3.04 14.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.24 -0.913 . . . . 0.0 110.429 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.1 p -89.07 -30.16 18.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.124 -0.985 . . . . 0.0 109.799 179.656 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 49.2 p -120.81 -7.32 9.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.28 -0.887 . . . . 0.0 110.068 179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.26 44.07 60.98 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.446 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 23.2 mt-30 -123.47 151.55 42.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -1.154 . . . . 0.0 110.301 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 97.1 mt-10 -119.3 141.56 48.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.322 -0.861 . . . . 0.0 109.998 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.505 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -159.1 -151.92 6.28 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.425 ' C ' HG21 ' A' ' 54' ' ' ILE . 95.7 m-85 -124.27 138.28 54.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.398 -1.06 . . . . 0.0 109.818 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.458 HG12 ' HB1' ' A' ' 43' ' ' ALA . 2.9 pt -133.53 144.37 51.86 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.157 -0.964 . . . . 0.0 110.343 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.581 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 47.0 Cg_endo -72.64 151.86 52.85 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.06 1.558 . . . . 0.0 109.985 179.736 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.579 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 31.6 p90 -73.99 -4.26 34.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 111.134 -179.375 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -98.6 -26.14 14.49 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.895 -1.128 . . . . 0.0 111.341 -179.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.567 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 8.5 m-85 -82.65 -2.53 54.25 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.803 -1.186 . . . . 0.0 110.346 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 30.9 m -133.74 143.21 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.161 -0.962 . . . . 0.0 110.117 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.404 ' CB ' HD12 ' A' ' 12' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 110.246 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.469 ' O ' HG11 ' A' ' 9' ' ' VAL . 5.4 mp . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.254 0.55 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.469 HG11 ' O ' ' A' ' 8' ' ' LEU . 4.2 m -145.95 167.72 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.267 -0.895 . . . . 0.0 110.288 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . 0.463 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 61.8 mt -113.43 140.11 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.865 . . . . 0.0 109.781 179.661 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.576 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . . . -80.66 110.22 15.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.137 -0.977 . . . . 0.0 110.555 -179.631 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.439 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 52.4 mt -67.52 -22.94 65.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.08 -1.013 . . . . 0.0 109.162 179.164 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.439 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 21.8 m80 -157.37 146.72 20.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.641 -0.662 . . . . 0.0 109.408 179.704 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 81.9 p -61.5 146.38 48.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.998 -1.064 . . . . 0.0 110.14 -179.831 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.579 ' OH ' ' CZ3' ' A' ' 40' ' ' TRP . 25.1 t80 -95.76 156.93 16.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.978 -1.076 . . . . 0.0 110.348 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 17' ' ' PRO . 46.1 mt-10 -114.07 73.87 2.58 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.326 -0.859 . . . . 0.0 110.121 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.461 ' HB3' ' HB2' ' A' ' 22' ' ' ASP . 47.7 Cg_endo -40.6 110.35 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.043 1.549 . . . . 0.0 110.429 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.469 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 59.6 p -87.25 8.21 25.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.348 -0.845 . . . . 0.0 110.168 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.469 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 96.2 m-70 -145.48 170.54 16.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.09 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -87.25 126.89 35.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.266 -0.896 . . . . 0.0 110.294 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.27 -14.0 13.66 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 2.4 m-20 -86.68 174.66 8.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -1.152 . . . . 0.0 110.262 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.493 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 19.2 tp -120.63 124.66 45.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.868 . . . . 0.0 110.062 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.468 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -104.13 57.52 0.53 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.576 ' CD1' ' HB3' ' A' ' 11' ' ' ALA . 28.6 p90 -47.07 169.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.259 -1.142 . . . . 0.0 110.878 -179.532 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.477 ' N ' ' OE1' ' A' ' 29' ' ' GLU . 90.7 mt-10 -98.84 177.48 5.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.495 -0.753 . . . . 0.0 110.14 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -71.55 119.89 16.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.184 -0.947 . . . . 0.0 110.348 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.9 -6.75 58.68 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.503 ' OE1' ' CA ' ' A' ' 25' ' ' PHE . 71.6 tt0 -73.71 127.43 32.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.008 -1.289 . . . . 0.0 110.172 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.424 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 58.2 mt-30 -79.25 142.67 36.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 110.004 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.553 HD12 ' CG ' ' A' ' 25' ' ' PHE . 73.0 mt -141.36 163.83 31.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.243 -0.91 . . . . 0.0 110.348 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.554 ' NE ' ' CD2' ' A' ' 34' ' ' LEU . 19.0 ttt180 -105.85 133.25 50.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.885 . . . . 0.0 109.63 179.553 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.422 HD13 HG22 ' A' ' 9' ' ' VAL . 31.0 mm -96.53 93.78 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.12 -0.987 . . . . 0.0 110.417 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.554 ' CD2' ' NE ' ' A' ' 32' ' ' ARG . 41.8 mt -79.83 -24.52 41.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.258 -0.901 . . . . 0.0 110.859 -179.543 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.49 ' CB ' ' HB3' ' A' ' 42' ' ' LYS . 17.9 tt0 -136.18 140.87 43.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.992 -1.067 . . . . 0.0 110.345 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.57 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 84.3 mt-30 -135.29 55.18 1.89 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.158 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -119.27 142.13 48.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.178 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.0 -171.16 54.62 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -74.16 -34.77 63.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -1.166 . . . . 0.0 110.132 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.579 ' CZ3' ' OH ' ' A' ' 15' ' ' TYR . 95.3 m95 -96.28 144.5 26.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.302 -0.874 . . . . 0.0 110.272 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.57 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.9 m0 -118.85 156.09 30.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 110.217 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.49 ' HB3' ' CB ' ' A' ' 35' ' ' GLU . 29.0 tttt -96.18 137.57 35.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.358 -0.839 . . . . 0.0 109.408 179.412 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -152.77 176.65 11.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.01 . . . . 0.0 110.666 -179.554 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.478 ' CB ' ' HG2' ' A' ' 51' ' ' GLU . 14.5 pt20 -148.18 156.67 42.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.455 -0.778 . . . . 0.0 109.819 179.719 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.8 t -98.55 116.91 31.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.122 -0.987 . . . . 0.0 110.275 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.3 mt -74.51 -0.78 18.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 110.094 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 70.7 p -94.63 -27.22 16.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.36 -0.838 . . . . 0.0 110.166 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 47.4 p -114.25 -13.02 12.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 110.157 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.42 39.46 50.7 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -128.16 155.51 44.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -1.154 . . . . 0.0 110.276 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.478 ' HG2' ' CB ' ' A' ' 44' ' ' GLN . 73.6 mt-10 -123.8 152.56 42.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.905 . . . . 0.0 110.031 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.493 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -165.94 -149.89 6.09 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.441 ' O ' HG21 ' A' ' 54' ' ' ILE . 92.6 m-85 -127.74 143.63 51.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.46 -1.024 . . . . 0.0 109.683 179.61 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.459 HG23 ' CE2' ' A' ' 25' ' ' PHE . 1.7 pp -141.01 139.2 18.94 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.132 -0.98 . . . . 0.0 110.696 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.579 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 44.8 Cg_endo -59.39 156.97 33.09 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.093 1.575 . . . . 0.0 109.907 179.465 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.577 ' CZ ' ' OD1' ' A' ' 57' ' ' ASN . 20.8 p90 -84.56 -2.28 57.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.097 -1.002 . . . . 0.0 110.766 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.577 ' OD1' ' CZ ' ' A' ' 56' ' ' PHE . 8.6 m120 -103.65 13.22 33.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.984 -1.073 . . . . 0.0 110.696 -179.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.579 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 6.1 m-85 -111.32 -6.41 14.52 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.097 -1.002 . . . . 0.0 110.028 179.694 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.47 HG11 ' HA ' ' A' ' 11' ' ' ALA . 7.8 m -138.46 145.47 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.334 -0.854 . . . . 0.0 110.032 179.801 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.165 -0.959 . . . . 0.0 110.398 -179.863 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.516 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 6.2 mp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.235 0.54 . . . . 0.0 110.231 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 30.9 m -150.9 170.21 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 110.289 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.9 mt -112.27 148.7 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -0.83 . . . . 0.0 109.887 179.729 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.557 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . -80.12 112.01 17.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.131 -0.981 . . . . 0.0 110.422 -179.779 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.513 ' CD2' ' N ' ' A' ' 12' ' ' LEU . 3.9 mm? -71.71 -22.41 61.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.192 -0.942 . . . . 0.0 109.442 179.442 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.422 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 86.0 m-70 -153.62 151.13 29.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.464 -0.772 . . . . 0.0 109.75 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.52 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 54.2 p -67.25 142.83 56.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.059 -1.026 . . . . 0.0 109.97 179.861 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.591 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 88.5 t80 -99.08 160.17 14.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.072 -1.017 . . . . 0.0 110.414 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.551 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 2.4 mm-40 -104.69 124.4 37.06 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.356 -0.84 . . . . 0.0 110.063 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.456 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 49.6 Cg_endo -81.06 82.84 2.34 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.945 1.497 . . . . 0.0 110.429 -179.843 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 59.6 p -79.99 -2.73 45.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 110.213 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -129.13 -159.34 0.95 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.933 . . . . 0.0 110.266 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -107.72 -19.1 13.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.191 -0.943 . . . . 0.0 110.235 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.23 10.48 31.28 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -89.95 155.94 18.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -1.184 . . . . 0.0 110.157 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.448 ' O ' ' CD2' ' A' ' 15' ' ' TYR . 14.5 tp -111.65 116.31 30.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.301 -0.874 . . . . 0.0 110.169 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.47 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -97.06 47.59 1.63 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.569 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 43.7 p90 -48.43 173.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -1.159 . . . . 0.0 111.006 -179.828 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.52 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 95.5 mt-10 -109.36 179.05 4.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.458 -0.776 . . . . 0.0 110.191 179.903 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -68.42 136.46 53.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 110.439 -179.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.35 -14.39 57.87 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 3.2 mt-10 -62.98 124.08 20.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -1.2 . . . . 0.0 110.393 -179.746 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.431 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 86.8 mt-30 -79.75 136.64 36.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.24 -0.913 . . . . 0.0 109.832 179.768 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 15.1 mt -137.74 158.51 44.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.069 -1.019 . . . . 0.0 110.653 -179.723 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.538 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 25.4 mtp180 -108.05 134.37 51.03 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.436 -0.79 . . . . 0.0 109.142 179.295 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.4 mm -90.82 93.97 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.047 -1.033 . . . . 0.0 110.737 -179.502 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.9 mt -79.38 -29.79 42.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 110.842 -179.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.504 ' HB2' ' CB ' ' A' ' 42' ' ' LYS . 74.0 mt-10 -129.54 143.93 51.04 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.923 -1.111 . . . . 0.0 110.366 -179.957 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.576 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 15.1 pt20 -138.04 55.87 1.76 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.363 -0.836 . . . . 0.0 110.241 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.6 t -120.66 142.06 49.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.171 -0.956 . . . . 0.0 110.204 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.35 -176.01 50.55 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -70.57 -28.28 64.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -1.1 . . . . 0.0 110.211 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.521 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 95.4 m95 -100.27 147.59 25.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 110.345 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.576 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 47.1 m0 -124.27 156.17 37.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.192 -179.985 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.504 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 13.5 tttp -98.94 145.23 27.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.413 179.421 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -158.21 -177.33 6.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.011 -1.056 . . . . 0.0 111.002 -179.596 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.472 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 58.4 tt0 -144.45 152.87 41.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.454 -0.779 . . . . 0.0 109.365 179.584 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.424 ' HB2' ' CD2' ' A' ' 31' ' ' LEU . 10.5 t -102.76 128.12 49.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.026 -1.046 . . . . 0.0 110.515 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.513 ' CD2' ' HD2' ' A' ' 32' ' ' ARG . 37.8 mt -83.17 8.31 13.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.886 . . . . 0.0 109.917 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.4 p -98.48 -42.07 7.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.348 -0.845 . . . . 0.0 110.11 -179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 58.2 p -113.05 -10.78 13.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 110.101 -179.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.11 38.93 46.43 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -112.61 142.52 45.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -1.138 . . . . 0.0 110.197 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -117.9 136.67 53.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 110.092 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.446 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -171.44 165.15 38.11 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 97.0 m-85 -71.09 145.3 49.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -1.078 . . . . 0.0 110.145 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 54' ' ' ILE . 1.2 pp -136.68 140.07 31.0 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 110.216 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.591 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 47.7 Cg_endo -65.14 149.73 88.59 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.021 1.537 . . . . 0.0 110.073 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.569 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 39.6 p90 -75.61 -5.45 45.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 110.931 -179.449 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -95.44 -25.74 16.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.955 -1.091 . . . . 0.0 111.039 -179.363 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.567 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 9.3 m-85 -82.22 0.26 42.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.905 -1.122 . . . . 0.0 110.453 -179.741 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.451 HG23 ' CD1' ' A' ' 54' ' ' ILE . 23.3 m -141.95 154.11 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 0.0 110.097 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.241 -0.912 . . . . 0.0 110.227 -179.97 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.2 tp . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.13 0.49 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.445 ' HB ' ' O ' ' A' ' 60' ' ' ALA . 27.8 m -141.78 165.74 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.129 -0.982 . . . . 0.0 110.465 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 72.4 mt -112.5 148.01 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.337 -0.852 . . . . 0.0 109.684 179.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.446 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . . . -78.56 111.18 14.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.063 -1.023 . . . . 0.0 110.347 -179.71 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.442 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 49.9 mt -70.05 -25.68 63.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.088 -1.008 . . . . 0.0 109.16 179.322 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.442 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 80.7 m-70 -155.62 151.92 28.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.692 -0.63 . . . . 0.0 109.506 179.703 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.2 p -64.91 140.0 58.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.951 -1.093 . . . . 0.0 109.774 179.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.583 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 85.6 t80 -97.59 157.13 16.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.014 -1.054 . . . . 0.0 110.332 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -111.44 124.61 32.21 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.909 . . . . 0.0 110.188 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.453 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 48.4 Cg_endo -80.21 81.67 2.69 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.02 1.537 . . . . 0.0 110.47 -179.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.486 ' OG ' ' ND1' ' A' ' 19' ' ' HIS . 92.2 p -79.81 -1.96 41.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.135 -0.978 . . . . 0.0 110.013 179.904 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.486 ' ND1' ' OG ' ' A' ' 18' ' ' SER . 72.4 m80 -140.34 172.86 12.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 110.076 -179.997 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -90.07 125.3 35.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.238 -0.913 . . . . 0.0 110.248 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.09 6.99 31.51 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -104.16 164.37 11.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -1.164 . . . . 0.0 110.28 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.483 ' CD1' ' CD ' ' A' ' 50' ' ' GLN . 22.8 tp -114.82 119.63 37.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.174 -179.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.472 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -99.91 54.21 0.94 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.866 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.583 ' CE1' ' HB2' ' A' ' 15' ' ' TYR . 45.9 p90 -53.12 173.73 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.235 -1.156 . . . . 0.0 111.131 -179.482 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 96.0 mt-10 -105.61 176.57 5.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.553 -0.717 . . . . 0.0 110.288 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.7 tttm -70.97 135.67 48.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.058 -1.026 . . . . 0.0 110.322 179.772 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.0 -13.67 53.07 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 30.6 mm-40 -63.91 136.18 57.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.035 -1.274 . . . . 0.0 109.99 -179.764 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -79.6 128.1 32.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.895 . . . . 0.0 110.075 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.499 HD23 ' CG ' ' A' ' 25' ' ' PHE . 10.4 mp -124.31 141.63 51.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 110.393 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 15.7 ttt85 -100.95 134.58 43.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.336 -0.852 . . . . 0.0 109.588 179.633 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 27.0 mt -85.78 132.58 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.163 -0.96 . . . . 0.0 110.307 -179.925 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.0 mt -118.71 -31.75 4.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.363 -0.835 . . . . 0.0 110.112 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.514 ' HB2' ' CB ' ' A' ' 42' ' ' LYS . 85.7 mt-10 -135.58 149.87 49.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.19 -0.944 . . . . 0.0 110.198 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.568 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 93.2 mt-30 -135.84 59.01 1.73 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.268 -0.895 . . . . 0.0 110.15 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.7 t -124.24 135.59 53.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.235 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.7 176.65 45.76 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.9 -27.44 69.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.204 -1.174 . . . . 0.0 110.236 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.571 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 98.3 m95 -98.96 146.28 26.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.22 -0.925 . . . . 0.0 110.241 -179.897 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.573 ' CZ3' ' HB2' ' A' ' 56' ' ' PHE . 40.9 m0 -122.88 156.48 34.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.901 . . . . 0.0 110.14 179.795 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.514 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 20.7 tttt -93.75 142.3 27.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.956 . . . . 0.0 109.776 179.581 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.512 ' CB ' HG12 ' A' ' 54' ' ' ILE . . . -155.9 178.83 9.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.115 -0.991 . . . . 0.0 110.771 -179.803 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.415 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 46.3 tt0 -141.82 150.14 41.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.394 -0.816 . . . . 0.0 109.909 179.697 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 t -95.3 119.63 34.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 110.276 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 32' ' ' ARG . 4.9 mp -78.13 6.28 8.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -0.9 . . . . 0.0 110.412 -179.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 65.5 p -96.57 -37.29 10.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 110.019 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.1 p -120.13 -6.09 9.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 110.098 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.67 40.6 52.96 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.483 ' CD ' ' CD1' ' A' ' 23' ' ' LEU . 62.1 tt0 -110.29 141.15 43.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -1.14 . . . . 0.0 110.288 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.415 ' HG2' ' HB2' ' A' ' 44' ' ' GLN . 92.6 mt-10 -117.15 136.57 52.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.341 -0.849 . . . . 0.0 109.938 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.446 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -170.14 164.7 38.05 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -69.1 144.59 53.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -1.13 . . . . 0.0 110.029 179.894 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.512 HG12 ' CB ' ' A' ' 43' ' ' ALA . 1.1 pt -136.0 139.53 30.59 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 110.257 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.575 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 45.4 Cg_endo -63.94 150.45 88.37 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.911 1.479 . . . . 0.0 110.188 179.739 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.573 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 16.2 p90 -85.41 1.3 49.23 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.348 -0.845 . . . . 0.0 111.18 -179.402 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.538 ' OD1' ' N ' ' A' ' 58' ' ' PHE . 48.9 p30 -100.41 -24.03 14.6 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.955 -1.091 . . . . 0.0 111.178 -179.365 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.544 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 14.1 m-30 -94.18 1.34 56.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.87 -1.144 . . . . 0.0 110.591 -179.812 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.507 HG22 ' CD1' ' A' ' 54' ' ' ILE . 33.9 m -130.69 146.22 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.178 -0.951 . . . . 0.0 110.198 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.445 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.318 -0.864 . . . . 0.0 110.271 -179.945 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.524 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 5.3 mp . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.203 0.525 . . . . 0.0 110.101 . . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.5 HG12 ' CD1' ' A' ' 33' ' ' ILE . 15.5 m -151.86 171.95 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.172 -0.955 . . . . 0.0 110.448 179.911 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 52.7 mt -118.02 143.32 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.418 -0.801 . . . . 0.0 109.927 179.754 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.493 ' CB ' ' O ' ' A' ' 26' ' ' GLU . . . -76.9 112.61 13.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.179 -0.95 . . . . 0.0 110.514 -179.659 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.481 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 52.5 mt -72.99 -22.32 60.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.089 -1.007 . . . . 0.0 109.314 179.262 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.481 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 77.8 m-70 -156.83 151.68 25.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.651 -0.656 . . . . 0.0 109.521 179.881 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 34.9 p -65.26 136.83 57.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.899 -1.126 . . . . 0.0 109.895 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.572 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 67.0 t80 -97.78 157.08 16.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.085 -1.009 . . . . 0.0 110.119 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.558 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 3.0 mt-10 -111.74 136.07 21.14 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.852 . . . . 0.0 110.295 -179.82 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.436 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 46.8 Cg_endo -94.32 87.17 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.065 1.561 . . . . 0.0 110.272 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 90.1 p -80.51 0.86 31.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 110.242 -179.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -142.12 -177.92 5.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 110.278 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -97.72 126.11 42.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 110.169 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.33 -9.87 26.55 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 1.1 m-20 -92.12 171.05 9.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -1.171 . . . . 0.0 110.129 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.493 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 15.5 tp -127.12 132.31 50.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 110.052 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.487 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -109.2 60.29 0.33 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.653 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.567 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 39.6 p90 -52.61 175.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.156 -1.202 . . . . 0.0 110.92 -179.684 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 96.3 mt-10 -109.75 -179.5 3.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.401 -0.812 . . . . 0.0 110.323 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.0 tttt -70.87 130.34 41.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.093 -1.005 . . . . 0.0 110.187 179.674 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.9 -18.47 47.31 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 -179.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 22.3 mm-40 -61.45 123.91 19.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.081 -1.246 . . . . 0.0 110.086 -179.667 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -79.46 134.47 36.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.335 -0.853 . . . . 0.0 110.28 -179.76 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.541 HD12 ' CD2' ' A' ' 25' ' ' PHE . 41.8 mt -129.85 150.03 51.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -0.854 . . . . 0.0 110.176 -179.895 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 19.4 ttt180 -94.59 133.35 38.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.329 -0.857 . . . . 0.0 110.065 179.809 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.5 ' CD1' HG12 ' A' ' 9' ' ' VAL . 34.8 mt -80.89 121.48 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.202 -0.936 . . . . 0.0 110.031 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.432 HD11 ' OE2' ' A' ' 51' ' ' GLU . 4.6 mt -99.49 -33.15 10.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.272 -0.892 . . . . 0.0 110.317 -179.777 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.523 ' OE1' ' CE ' ' A' ' 42' ' ' LYS . 79.6 tt0 -150.98 146.97 26.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.176 -0.953 . . . . 0.0 110.194 -179.924 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.565 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 98.2 mt-30 -128.82 55.17 1.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.895 . . . . 0.0 110.195 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.1 t -111.23 125.99 54.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 110.249 -179.89 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.74 -175.05 53.25 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -67.91 -37.08 81.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -1.104 . . . . 0.0 110.203 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.417 ' HZ3' ' CE1' ' A' ' 15' ' ' TYR . 85.7 m95 -91.47 141.31 28.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 0.0 110.149 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.565 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 50.9 m0 -122.28 153.75 38.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 0.0 110.391 -179.97 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.523 ' CE ' ' OE1' ' A' ' 35' ' ' GLU . 50.2 mttt -89.13 146.42 24.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.302 -0.874 . . . . 0.0 109.558 179.472 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.506 ' CB ' HG12 ' A' ' 54' ' ' ILE . . . -148.71 170.08 18.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.085 -1.01 . . . . 0.0 110.653 -179.61 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 42.8 tt0 -137.51 145.25 42.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.383 -0.823 . . . . 0.0 109.878 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 53.4 m -74.2 139.34 44.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 110.256 -179.936 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.8 tp -82.34 -26.14 33.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.183 -0.948 . . . . 0.0 110.224 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.3 p -98.96 -28.23 13.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 110.158 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.14 -18.94 18.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.241 -0.912 . . . . 0.0 110.091 179.836 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.95 6.04 35.72 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.634 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -83.13 155.18 23.94 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.04 -1.271 . . . . 0.0 110.485 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 69.1 tt0 -114.99 134.81 54.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.326 -0.859 . . . . 0.0 109.951 179.813 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.493 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -145.6 -152.14 5.57 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.68 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -122.9 134.25 54.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.481 -1.011 . . . . 0.0 109.614 179.638 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.506 HG12 ' CB ' ' A' ' 43' ' ' ALA . 1.2 pp -127.46 133.73 25.4 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.116 -0.99 . . . . 0.0 110.631 -179.617 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.572 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 43.0 Cg_endo -66.08 157.42 59.66 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.149 1.605 . . . . 0.0 110.187 179.611 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.453 ' HB2' ' CH2' ' A' ' 41' ' ' TRP . 18.9 p90 -88.19 -1.63 58.13 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.274 -0.891 . . . . 0.0 111.36 -179.06 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 58' ' ' PHE . 42.3 p30 -99.43 -25.83 14.33 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.82 -1.175 . . . . 0.0 111.066 -179.451 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.569 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 11.7 m-30 -92.43 -3.97 54.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.89 -1.131 . . . . 0.0 110.54 -179.78 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.459 HG23 ' CD1' ' A' ' 54' ' ' ILE . 21.8 m -126.91 144.32 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.1 -1.0 . . . . 0.0 110.095 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.914 . . . . 0.0 110.362 -179.856 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 44.0 mt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.159 0.504 . . . . 0.0 110.215 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.576 ' CG2' ' CG1' ' A' ' 59' ' ' VAL . 4.2 m -154.48 172.68 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.862 . . . . 0.0 110.333 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 60.0 mt -113.69 141.51 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.342 -0.849 . . . . 0.0 109.943 179.783 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.483 ' HB3' ' CE1' ' A' ' 25' ' ' PHE . . . -80.46 111.89 17.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.143 -0.973 . . . . 0.0 110.119 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.416 ' O ' ' ND1' ' A' ' 13' ' ' HIS . 24.2 tp -66.43 -27.86 68.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.099 -1.0 . . . . 0.0 109.543 179.529 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.416 ' ND1' ' O ' ' A' ' 12' ' ' LEU . 89.5 m-70 -150.8 155.73 39.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.472 -0.767 . . . . 0.0 109.836 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.517 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 52.5 p -68.15 144.28 55.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.14 -0.975 . . . . 0.0 110.019 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.578 ' OH ' ' CZ3' ' A' ' 40' ' ' TRP . 27.4 t80 -94.44 153.71 17.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.042 -1.036 . . . . 0.0 110.323 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 17' ' ' PRO . 19.0 tp10 -110.45 77.83 1.34 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 110.216 -179.911 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.466 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 48.1 Cg_endo -41.52 98.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.127 1.593 . . . . 0.0 110.422 179.895 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.489 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 87.5 p -82.31 9.27 9.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 110.25 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.489 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 87.3 m-70 -148.3 164.23 34.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 110.192 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -80.93 118.94 22.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 110.304 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.08 14.8 6.4 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.465 ' HB2' ' HB3' ' A' ' 17' ' ' PRO . 13.0 m-20 -111.32 168.47 9.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.174 -1.192 . . . . 0.0 110.284 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.502 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 17.1 tp -110.22 113.38 26.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 109.998 179.872 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.466 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . -96.43 53.25 1.54 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.901 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.554 ' CD2' HD23 ' A' ' 31' ' ' LEU . 35.8 p90 -54.13 174.5 0.06 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.248 -1.148 . . . . 0.0 111.123 -179.557 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.517 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 94.3 mt-10 -109.43 177.23 4.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.499 -0.751 . . . . 0.0 109.964 179.78 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -66.95 139.59 57.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -0.955 . . . . 0.0 110.378 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.96 -14.02 57.98 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 3.7 mt-10 -66.6 126.16 28.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -1.215 . . . . 0.0 110.308 -179.865 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.483 ' C ' ' CD1' ' A' ' 31' ' ' LEU . 44.7 tt0 -79.7 137.33 37.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.814 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.554 HD23 ' CD2' ' A' ' 25' ' ' PHE . 8.3 mp -136.89 156.99 47.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -0.909 . . . . 0.0 110.627 -179.553 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 38.5 ttt180 -106.26 131.65 53.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.412 -0.805 . . . . 0.0 109.24 179.247 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 87.6 mt -90.8 94.35 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.109 -0.994 . . . . 0.0 110.713 -179.318 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -79.85 -32.69 40.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 110.379 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.472 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 67.3 tt0 -130.58 135.46 47.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.119 -0.988 . . . . 0.0 110.253 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.571 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 58.8 tt0 -131.41 55.7 1.84 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 110.174 179.984 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.2 m -120.65 145.42 47.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.281 -0.887 . . . . 0.0 110.231 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.89 -174.66 48.61 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -71.8 -30.68 65.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.236 -1.155 . . . . 0.0 110.128 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.578 ' CZ3' ' OH ' ' A' ' 15' ' ' TYR . 99.3 m95 -99.38 145.71 27.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 110.23 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.571 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.6 m0 -121.2 157.04 31.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 110.207 179.896 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.472 ' CB ' ' HB3' ' A' ' 35' ' ' GLU . 43.8 tttp -101.37 138.69 38.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 109.012 179.065 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -149.93 177.38 9.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.838 -1.164 . . . . 0.0 110.998 -179.419 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . 0.528 ' HG3' ' CG ' ' A' ' 51' ' ' GLU . 39.4 tt0 -140.14 148.42 41.62 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.53 -0.731 . . . . 0.0 109.886 179.81 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.0 t -96.4 111.32 23.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.121 -0.987 . . . . 0.0 110.283 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 66.3 mt -71.19 -2.89 17.45 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 110.34 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.3 p -85.53 -32.38 22.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.219 -0.926 . . . . 0.0 110.005 179.866 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.6 p -120.82 -3.74 9.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 0.0 110.134 179.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.05 48.07 61.87 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.84 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.456 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 49.6 mt-30 -129.41 155.67 45.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -1.18 . . . . 0.0 110.428 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.528 ' CG ' ' HG3' ' A' ' 44' ' ' GLN . 95.4 mt-10 -119.56 160.77 21.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.337 -0.852 . . . . 0.0 109.844 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.502 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -178.32 -157.69 19.52 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -120.79 136.09 54.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.457 -1.025 . . . . 0.0 109.973 179.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.513 HG23 ' CE2' ' A' ' 25' ' ' PHE . 5.2 pt -130.91 149.71 74.49 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 110.417 -179.773 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.58 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 44.8 Cg_endo -78.13 143.2 19.98 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 124.023 1.538 . . . . 0.0 109.848 179.702 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.543 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 35.2 p90 -66.86 -8.95 32.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.241 -0.912 . . . . 0.0 110.962 -179.311 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -90.81 -26.13 19.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.911 -1.118 . . . . 0.0 110.939 -179.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.58 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 7.2 m-85 -84.18 6.67 21.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.005 -1.059 . . . . 0.0 110.215 -179.761 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.576 ' CG1' ' CG2' ' A' ' 9' ' ' VAL . 15.2 t -147.3 169.11 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.918 . . . . 0.0 110.136 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.487 ' O ' ' CG1' ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 110.374 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' LEU . . . . . 0.502 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 6.1 mp . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.175 0.512 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.461 HG22 HD13 ' A' ' 33' ' ' ILE . 25.3 m -140.69 164.34 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.265 -0.897 . . . . 0.0 110.29 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.5 mm -109.39 140.71 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.361 -0.837 . . . . 0.0 109.75 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' ALA . . . . . 0.483 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -80.0 107.25 12.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.178 -0.951 . . . . 0.0 110.311 -179.828 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.417 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 7.6 mp -67.63 -23.19 65.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.097 -1.002 . . . . 0.0 109.173 179.366 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' HIS . . . . . 0.417 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 90.8 m-70 -153.33 146.45 24.64 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.621 -0.674 . . . . 0.0 109.576 179.75 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 55.4 p -63.01 147.28 51.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.044 -1.035 . . . . 0.0 109.8 179.917 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.571 ' CD1' ' HG3' ' A' ' 55' ' ' PRO . 38.6 t80 -99.08 161.32 13.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.141 -0.974 . . . . 0.0 110.398 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' GLU . . . . . 0.455 ' O ' ' CG ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -118.96 85.17 28.23 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 0.0 110.148 179.92 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.52 ' CB ' ' HB2' ' A' ' 22' ' ' ASP . 47.4 Cg_endo -44.36 96.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.02 1.537 . . . . 0.0 110.546 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 16' ' ' GLU . 25.2 p -83.24 3.9 29.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.905 . . . . 0.0 109.955 179.783 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' HIS . . . . . 0.438 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 84.9 t60 -148.2 166.9 26.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.342 -0.849 . . . . 0.0 110.116 -179.92 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -75.81 130.72 39.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.201 -0.937 . . . . 0.0 110.139 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.45 15.36 21.35 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.52 ' HB2' ' CB ' ' A' ' 17' ' ' PRO . 27.8 m-20 -111.74 161.04 16.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -1.159 . . . . 0.0 110.439 -179.862 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.457 HD22 ' OG ' ' A' ' 45' ' ' SER . 13.6 tp -116.2 120.03 37.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.283 -0.886 . . . . 0.0 109.801 179.927 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.47 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . -97.78 50.51 1.38 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.792 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.564 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 30.2 p90 -48.71 172.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.227 -1.161 . . . . 0.0 111.19 -179.847 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -102.78 173.46 6.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.565 -0.71 . . . . 0.0 110.078 179.635 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 pttm -70.11 136.8 50.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.134 -0.979 . . . . 0.0 110.159 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.77 -10.23 73.16 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' GLU . . . . . 0.459 ' HG2' HD22 ' A' ' 31' ' ' LEU . 67.2 tt0 -73.43 128.31 35.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.05 -1.264 . . . . 0.0 110.124 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' GLN . . . . . 0.46 ' O ' ' CD2' ' A' ' 31' ' ' LEU . 46.4 tt0 -79.61 141.46 36.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.93 . . . . 0.0 109.82 179.906 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . 0.504 HD12 ' CG ' ' A' ' 25' ' ' PHE . 17.4 mt -140.64 161.97 36.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.924 . . . . 0.0 110.515 -179.693 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.534 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 7.2 tpt180 -103.67 129.91 51.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.414 -0.804 . . . . 0.0 109.617 179.487 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.512 HG23 ' CG ' ' A' ' 36' ' ' GLN . 25.3 mm -93.67 94.26 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.179 -0.951 . . . . 0.0 110.458 -179.744 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . 0.458 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 1.2 mt -79.92 -28.08 39.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -0.888 . . . . 0.0 110.775 -179.675 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.464 ' HB2' ' CB ' ' A' ' 42' ' ' LYS . 62.1 mt-10 -131.19 138.38 49.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.965 -1.084 . . . . 0.0 110.489 -179.83 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' GLN . . . . . 0.573 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 98.8 mt-30 -135.03 54.28 1.95 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 110.043 179.892 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.6 t -120.49 142.52 49.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 110.205 179.972 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.63 -169.88 54.96 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -76.6 -33.96 58.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -1.12 . . . . 0.0 110.146 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' TRP . . . . . 0.571 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 98.7 m95 -96.93 143.37 27.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 110.42 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' TRP . . . . . 0.573 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.5 m0 -120.1 156.19 31.5 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.284 -0.885 . . . . 0.0 110.238 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 53' ' ' PHE . 12.6 tttp -100.28 141.78 32.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.329 -0.857 . . . . 0.0 109.368 179.372 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -153.69 179.44 8.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.053 -1.029 . . . . 0.0 110.94 -179.612 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -142.01 150.61 41.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 109.876 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.457 ' OG ' HD22 ' A' ' 23' ' ' LEU . 13.3 m -99.02 121.97 41.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.118 -0.989 . . . . 0.0 110.356 -179.952 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 71.6 mt -79.2 5.04 13.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 110.179 179.888 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.52 -42.07 4.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.283 -0.885 . . . . 0.0 110.159 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.2 p -90.65 -27.41 19.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -0.898 . . . . 0.0 110.135 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.8 33.42 24.44 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -128.34 153.02 47.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.268 -1.136 . . . . 0.0 110.306 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.408 ' OE2' ' HE2' ' A' ' 42' ' ' LYS . 84.8 tt0 -120.43 142.57 49.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 110.231 179.85 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' GLY . . . . . 0.442 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -168.55 161.62 35.35 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.856 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 95.4 m-85 -71.72 146.92 47.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -1.101 . . . . 0.0 109.854 179.591 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' ILE . . . . . 0.474 HD12 ' CD1' ' A' ' 33' ' ' ILE . 1.1 pt -136.87 136.47 21.4 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.195 -0.941 . . . . 0.0 110.357 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.571 ' HG3' ' CD1' ' A' ' 15' ' ' TYR . 45.0 Cg_endo -58.7 147.66 86.68 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.048 1.551 . . . . 0.0 110.045 179.651 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.567 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 19.1 p90 -82.89 -5.64 59.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 110.999 -179.419 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' ASN . . . . . 0.56 ' OD1' ' CZ ' ' A' ' 56' ' ' PHE . 83.6 m-20 -89.54 -25.58 21.3 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.927 -1.108 . . . . 0.0 110.632 -179.642 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . 0.542 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 17.3 m-30 -93.55 2.22 56.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.064 -1.023 . . . . 0.0 110.268 179.968 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.462 HG23 HD13 ' A' ' 54' ' ' ILE . 34.1 m -137.2 143.38 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.215 -0.928 . . . . 0.0 110.12 179.763 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' ALA . . . . . 0.461 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.215 -0.928 . . . . 0.0 110.411 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.1 134.34 22.2 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.246 -1.15 . . . . 0.0 110.16 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -56.94 -19.72 33.36 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.008 1.531 . . . . 0.0 110.352 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.473 ' C ' ' CD1' ' A' ' 4' ' ' LEU . 3.0 tm? -95.09 129.06 42.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.892 . . . . 0.0 110.228 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.442 ' N ' HD12 ' A' ' 4' ' ' LEU . 63.5 tt0 -107.02 119.18 38.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 110.216 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 48.0 p30 -100.54 13.55 34.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.906 . . . . 0.0 110.227 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.457 ' O ' HG13 ' A' ' 33' ' ' ILE . 19.4 m120 -84.19 9.58 12.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 110.252 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.493 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 5.8 mp -92.33 150.07 21.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.194 -0.941 . . . . 0.0 110.198 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 31' ' ' LEU . 18.2 m -147.67 168.9 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.2 -0.938 . . . . 0.0 110.309 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 81.8 mt -112.24 145.3 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.388 -0.82 . . . . 0.0 109.671 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.48 ' HB2' ' N ' ' A' ' 29' ' ' GLU . . . -77.56 114.94 16.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.077 -1.014 . . . . 0.0 110.367 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.483 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 37.6 tp -71.4 -26.9 62.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.104 -0.997 . . . . 0.0 109.386 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.483 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 25.8 m80 -158.22 149.41 20.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.469 -0.769 . . . . 0.0 109.7 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 44.2 p -61.97 141.44 58.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.026 -1.046 . . . . 0.0 110.092 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.583 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 77.1 t80 -102.76 165.05 11.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.079 -1.013 . . . . 0.0 110.408 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.579 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 35.8 mt-10 -113.52 129.64 24.46 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 110.228 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.464 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 49.9 Cg_endo -85.21 88.67 0.88 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.983 1.518 . . . . 0.0 110.509 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.0 m -79.59 -6.99 58.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.925 . . . . 0.0 110.084 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 -128.23 -155.35 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 110.007 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -112.36 -4.63 14.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 110.27 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.68 5.53 16.59 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -92.21 159.32 15.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -1.187 . . . . 0.0 110.232 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.499 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 35.5 tp -116.78 122.28 43.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.248 -0.908 . . . . 0.0 110.119 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.469 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -99.33 47.83 1.32 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.583 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 35.9 p90 -45.57 171.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -1.189 . . . . 0.0 110.834 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -98.71 176.85 5.49 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.415 -0.803 . . . . 0.0 110.446 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -71.8 122.95 21.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.262 -0.899 . . . . 0.0 110.239 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 92.96 -8.85 76.05 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.48 ' N ' ' HB2' ' A' ' 11' ' ' ALA . 27.3 tt0 -61.3 137.27 58.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.137 -1.214 . . . . 0.0 110.112 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.414 ' O ' HD13 ' A' ' 31' ' ' LEU . 87.8 mt-30 -79.63 126.85 31.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 0.0 109.965 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.502 HD23 ' CG ' ' A' ' 25' ' ' PHE . 10.3 mp -126.36 145.45 50.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.919 . . . . 0.0 110.468 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.482 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 25.3 ttt180 -103.23 139.71 38.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.828 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.457 HG13 ' O ' ' A' ' 7' ' ' ASN . 11.8 mt -87.45 130.14 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.14 -0.975 . . . . 0.0 110.263 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.42 HD22 ' HG2' ' A' ' 32' ' ' ARG . 60.6 mt -117.43 -30.44 5.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 110.193 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.448 ' HB3' ' HB3' ' A' ' 42' ' ' LYS . 83.0 tt0 -139.15 149.65 44.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -0.907 . . . . 0.0 110.232 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.541 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 96.9 mt-30 -139.54 58.79 1.61 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 110.212 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.5 t -123.93 130.31 52.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 0.0 110.246 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.86 -162.8 33.0 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -82.79 -32.33 27.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -1.136 . . . . 0.0 110.075 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.562 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 92.1 m95 -98.03 146.08 25.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.922 . . . . 0.0 110.134 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.541 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 49.3 m0 -120.9 154.95 35.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.297 -0.877 . . . . 0.0 110.302 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.448 ' HB3' ' HB3' ' A' ' 35' ' ' GLU . 79.1 tttt -93.48 143.56 26.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.919 . . . . 0.0 109.798 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.488 ' CB ' HG12 ' A' ' 54' ' ' ILE . . . -152.14 175.17 12.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.135 -0.978 . . . . 0.0 110.632 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 50' ' ' GLN . 39.4 tt0 -139.22 147.49 41.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.43 -0.794 . . . . 0.0 109.884 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.46 ' HB2' ' OG1' ' A' ' 48' ' ' THR . 21.6 m -79.79 145.79 32.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.088 -1.007 . . . . 0.0 110.222 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.501 ' N ' HD13 ' A' ' 46' ' ' LEU . 5.9 mp -94.73 -11.89 28.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.311 -0.868 . . . . 0.0 109.855 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.2 p -105.43 -30.09 9.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.405 -0.809 . . . . 0.0 110.435 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.46 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 17.6 p -99.84 -17.82 17.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.1 -1.0 . . . . 0.0 110.451 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.88 48.79 63.26 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.466 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 38.3 mt-30 -132.76 157.34 45.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.358 -1.084 . . . . 0.0 110.115 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.447 ' HG2' ' HG3' ' A' ' 44' ' ' GLN . 94.3 mt-10 -119.6 141.69 49.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.925 . . . . 0.0 110.097 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.499 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -166.29 159.16 32.38 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -70.24 142.73 52.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.243 -1.151 . . . . 0.0 110.045 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.488 HG12 ' CB ' ' A' ' 43' ' ' ALA . 1.8 pp -137.65 131.1 17.03 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 110.158 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.583 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 46.0 Cg_endo -55.94 160.9 9.26 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.03 1.542 . . . . 0.0 110.07 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -88.45 -2.36 58.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 110.911 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 -100.09 -25.83 14.16 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.987 -1.071 . . . . 0.0 111.054 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.548 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 26.5 m-85 -80.24 -11.93 59.68 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.017 -1.052 . . . . 0.0 110.446 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.452 ' CG2' ' CD1' ' A' ' 54' ' ' ILE . 26.9 m -132.22 145.55 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.95 . . . . 0.0 110.24 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.38 161.07 33.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 110.286 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -69.26 132.0 45.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 110.214 179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.79 150.61 32.06 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 110.235 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.191 -179.979 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.6 t -124.84 69.82 57.55 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.227 -1.161 . . . . 0.0 110.146 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -58.77 138.14 84.01 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.011 1.532 . . . . 0.0 110.33 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 45.0 tp -56.85 -32.04 65.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.266 -0.896 . . . . 0.0 110.084 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -102.23 105.3 15.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 110.19 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -146.73 84.29 1.61 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.279 -0.888 . . . . 0.0 110.151 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.512 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 85.3 m-20 -100.0 105.0 16.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.308 -0.87 . . . . 0.0 110.377 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.418 ' C ' HG11 ' A' ' 9' ' ' VAL . 21.1 tp -113.98 143.58 44.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.886 . . . . 0.0 109.957 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.451 HG13 ' HA ' ' A' ' 61' ' ' LYS . 31.2 m -145.63 167.84 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 110.378 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 86.1 mt -112.6 148.99 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.395 -0.816 . . . . 0.0 109.702 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.479 ' HB2' ' CD2' ' A' ' 25' ' ' PHE . . . -80.17 113.39 18.31 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.128 -0.983 . . . . 0.0 110.443 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.516 HD11 ' CD2' ' A' ' 13' ' ' HIS . 0.2 OUTLIER -70.74 -25.31 62.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.115 -0.991 . . . . 0.0 109.091 179.202 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.516 ' CD2' HD11 ' A' ' 12' ' ' LEU . 23.9 m-70 -159.13 151.05 20.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.703 -0.623 . . . . 0.0 109.481 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.436 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 41.6 p -63.38 140.83 58.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.907 -1.121 . . . . 0.0 109.883 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.581 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 65.5 t80 -100.89 162.81 12.64 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.063 -1.023 . . . . 0.0 110.255 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.571 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 29.8 tt0 -118.12 128.31 26.06 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.24 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.451 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 46.9 Cg_endo -82.17 84.6 1.82 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.111 1.585 . . . . 0.0 110.55 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.46 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 86.1 p -79.78 -3.94 49.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.932 . . . . 0.0 109.974 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.46 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 90.3 m-70 -139.85 151.21 45.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 0.0 110.136 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -65.35 125.47 25.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 110.117 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.59 11.43 28.88 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.45 ' OD2' ' HB2' ' A' ' 19' ' ' HIS . 11.4 m-20 -105.94 160.08 15.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.151 -1.205 . . . . 0.0 110.308 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.508 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 20.5 tp -116.4 122.99 46.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.338 -0.851 . . . . 0.0 110.18 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.478 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -104.39 51.28 0.81 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.581 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 33.0 p90 -45.32 172.19 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.197 -1.178 . . . . 0.0 110.9 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -99.26 176.0 5.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.405 -0.809 . . . . 0.0 110.554 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.9 tttm -71.18 124.88 25.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.364 -0.835 . . . . 0.0 110.28 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 90.39 -8.62 79.5 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.465 ' N ' ' HB1' ' A' ' 11' ' ' ALA . 27.0 tt0 -62.39 132.45 52.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.103 -1.234 . . . . 0.0 110.365 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 90.6 mt-30 -79.87 130.59 35.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 109.842 179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.572 HD12 ' CG ' ' A' ' 25' ' ' PHE . 17.6 mt -130.67 150.43 51.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.934 . . . . 0.0 110.501 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 40.3 ttt180 -100.82 135.77 41.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.434 -0.791 . . . . 0.0 109.75 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.512 ' HB ' ' CB ' ' A' ' 7' ' ' ASN . 11.2 mt -83.37 127.87 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 110.317 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.478 ' CD1' ' HB2' ' A' ' 44' ' ' GLN . 75.1 mt -107.13 -30.98 8.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.284 -0.885 . . . . 0.0 110.215 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -143.39 153.42 42.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 0.0 110.197 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.445 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 93.0 mt-30 -138.58 54.21 1.77 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 110.242 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 75.3 m -121.81 134.48 54.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.908 . . . . 0.0 110.101 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.68 -172.11 47.98 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -74.45 -34.26 63.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -1.144 . . . . 0.0 110.178 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.403 ' HZ3' ' CE1' ' A' ' 15' ' ' TYR . 72.6 m95 -97.17 145.78 25.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -0.921 . . . . 0.0 110.08 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.46 ' O ' HG13 ' A' ' 54' ' ' ILE . 52.1 m0 -120.69 153.81 36.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.256 -0.903 . . . . 0.0 110.056 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -90.07 144.5 25.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -0.953 . . . . 0.0 109.749 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 32' ' ' ARG . . . -148.54 170.41 18.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.086 -1.009 . . . . 0.0 110.611 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.478 ' HB2' ' CD1' ' A' ' 34' ' ' LEU . 51.9 tt0 -137.89 146.11 42.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.371 -0.831 . . . . 0.0 109.827 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.7 m -76.77 142.08 40.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.097 -1.002 . . . . 0.0 110.376 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 36.3 mt -88.66 -18.48 27.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.35 -0.844 . . . . 0.0 109.848 179.774 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.5 p -106.41 -30.06 9.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -0.862 . . . . 0.0 110.37 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.0 m -92.07 -24.31 19.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.064 -1.022 . . . . 0.0 110.421 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.78 46.29 54.17 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.463 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 59.1 mt-30 -134.28 158.75 42.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -1.121 . . . . 0.0 110.204 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.437 ' HG2' ' HB2' ' A' ' 44' ' ' GLN . 92.4 mt-10 -121.02 143.71 48.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.35 -0.844 . . . . 0.0 110.148 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.508 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -163.65 157.27 29.43 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -69.4 141.92 54.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -1.156 . . . . 0.0 109.926 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.504 ' CD1' HG22 ' A' ' 59' ' ' VAL . 1.3 pt -135.84 145.71 53.98 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 110.066 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.581 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 45.5 Cg_endo -72.45 162.62 40.94 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.987 1.519 . . . . 0.0 110.065 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.445 ' CE2' ' OD1' ' A' ' 57' ' ' ASN . 31.7 p90 -88.07 -3.98 58.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.959 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.445 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 60.3 m-20 -98.5 -26.57 14.39 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.899 -1.126 . . . . 0.0 111.062 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.577 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 34.2 m-85 -81.52 -10.85 59.38 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.939 -1.1 . . . . 0.0 110.326 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.504 HG22 ' CD1' ' A' ' 54' ' ' ILE . 25.3 m -131.05 142.66 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 110.273 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.51 161.59 32.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.193 -0.942 . . . . 0.0 110.122 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.451 ' HA ' HG13 ' A' ' 9' ' ' VAL . 42.2 mttp -76.95 127.44 32.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.901 . . . . 0.0 110.249 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.85 -36.42 84.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.303 -0.873 . . . . 0.0 110.146 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.407 ' OD1' ' C ' ' A' ' 63' ' ' ASN . 41.8 p-10 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.17 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.2 m -65.06 145.31 99.12 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.197 -1.178 . . . . 0.0 110.236 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -58.41 -16.78 30.59 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.981 1.516 . . . . 0.0 110.387 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.452 ' O ' ' OD1' ' A' ' 7' ' ' ASN . 2.6 mp -70.05 -34.59 73.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 110.255 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.475 ' HA ' ' CD1' ' A' ' 8' ' ' LEU . 97.1 mt-30 -65.24 -11.29 39.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 110.374 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -71.92 -30.14 65.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.251 -0.906 . . . . 0.0 110.21 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.517 ' O ' ' CG1' ' A' ' 33' ' ' ILE . 19.3 p-10 -79.81 7.11 9.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.248 -0.907 . . . . 0.0 110.35 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.475 ' CD1' ' HA ' ' A' ' 5' ' ' GLN . 91.7 mt -81.84 142.66 32.34 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.212 -0.93 . . . . 0.0 109.98 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.451 ' HB ' ' O ' ' A' ' 60' ' ' ALA . 22.9 m -145.82 167.6 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.127 -0.983 . . . . 0.0 110.539 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.5 mt -111.05 149.45 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.377 -0.827 . . . . 0.0 109.621 179.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.436 ' CB ' ' CD2' ' A' ' 25' ' ' PHE . . . -80.14 112.83 17.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.031 -1.043 . . . . 0.0 110.339 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.455 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 82.9 mt -69.58 -25.96 64.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.102 -0.999 . . . . 0.0 109.191 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.455 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 72.2 m80 -155.37 152.39 29.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.576 -0.702 . . . . 0.0 109.501 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.411 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 26.9 p -64.28 142.15 58.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.898 -1.126 . . . . 0.0 109.92 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.573 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 73.9 t80 -102.67 165.05 11.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.012 -1.055 . . . . 0.0 110.167 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.57 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 1.9 tp10 -119.5 132.84 23.86 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.285 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.469 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 49.2 Cg_endo -84.48 84.0 1.56 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.961 1.506 . . . . 0.0 110.299 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.404 ' OG ' ' ND1' ' A' ' 19' ' ' HIS . 83.3 p -79.59 -3.18 45.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.939 . . . . 0.0 110.051 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.455 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 51.5 m80 -144.86 165.95 26.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 110.039 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -76.87 126.21 30.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.911 . . . . 0.0 110.156 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.17 -1.9 35.19 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.455 ' OD2' ' HB2' ' A' ' 19' ' ' HIS . 17.2 m-20 -93.96 157.64 16.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.27 -1.135 . . . . 0.0 110.259 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.455 HD13 ' NE2' ' A' ' 50' ' ' GLN . 25.5 tp -115.6 120.91 40.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.296 -0.877 . . . . 0.0 109.988 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.469 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -100.62 51.47 0.99 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.565 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 40.7 p90 -48.46 172.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.192 -1.181 . . . . 0.0 110.995 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 68.8 mm-40 -100.82 174.99 5.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.507 -0.745 . . . . 0.0 110.189 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.4 pttm -71.39 131.62 43.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.137 -0.977 . . . . 0.0 110.102 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.48 -10.16 72.78 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.428 ' CD ' ' HB2' ' A' ' 25' ' ' PHE . 33.0 tt0 -64.5 132.88 51.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -1.168 . . . . 0.0 110.245 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -79.68 131.47 35.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.784 179.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.428 HD11 ' N ' ' A' ' 31' ' ' LEU . 9.4 mp -129.84 148.58 51.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.92 . . . . 0.0 110.562 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.523 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 24.7 ttt180 -103.13 134.72 46.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.448 -0.782 . . . . 0.0 109.534 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.517 ' CG1' ' O ' ' A' ' 7' ' ' ASN . 21.9 mm -83.82 131.53 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.143 -0.973 . . . . 0.0 110.194 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.1 mt -115.57 -32.9 5.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.331 -0.855 . . . . 0.0 110.178 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.458 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 87.1 mt-10 -132.06 153.95 49.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 110.21 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.573 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 97.9 mt-30 -139.97 55.61 1.64 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.86 . . . . 0.0 110.204 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 99.1 p -125.24 126.8 45.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 110.287 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.61 174.8 49.43 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -63.34 -28.91 70.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -1.197 . . . . 0.0 110.208 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.573 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 97.3 m95 -97.54 145.26 26.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 110.226 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.573 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 35.9 m0 -124.7 157.0 36.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.289 -0.882 . . . . 0.0 110.1 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.458 ' HB3' ' HB2' ' A' ' 35' ' ' GLU . 34.0 tttt -96.26 145.33 25.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.689 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.523 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -158.24 -177.71 6.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 110.56 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -145.52 153.85 41.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.424 -0.798 . . . . 0.0 109.982 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.8 t -98.89 126.02 44.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.115 -0.991 . . . . 0.0 110.17 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.1 mt -80.7 9.27 6.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.904 . . . . 0.0 110.312 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.8 m -92.79 -35.59 13.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.175 -0.953 . . . . 0.0 110.194 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 49.2 p -132.69 -0.98 3.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.389 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.32 30.85 56.26 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.455 ' NE2' HD13 ' A' ' 23' ' ' LEU . 54.7 tt0 -91.27 131.79 36.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -1.116 . . . . 0.0 110.135 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.456 ' OE2' ' NZ ' ' A' ' 42' ' ' LYS . 85.6 tt0 -117.22 136.24 53.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 0.0 110.082 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.444 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -171.88 166.18 39.06 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -70.44 146.41 50.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -1.131 . . . . 0.0 110.113 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.468 ' CD1' HG22 ' A' ' 59' ' ' VAL . 2.2 pp -139.23 131.59 15.37 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.235 -0.916 . . . . 0.0 110.147 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.573 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 47.3 Cg_endo -55.68 158.49 13.3 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.972 1.511 . . . . 0.0 110.102 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.572 ' CE2' ' OD1' ' A' ' 57' ' ' ASN . 18.8 p90 -87.41 -0.42 56.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 0.0 110.771 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.572 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 89.9 m-20 -99.65 -26.42 14.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.958 -1.089 . . . . 0.0 110.855 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.469 ' HB2' ' HG2' ' A' ' 55' ' ' PRO . 10.8 m-85 -83.47 -3.0 57.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.004 -1.06 . . . . 0.0 110.391 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.468 HG22 ' CD1' ' A' ' 54' ' ' ILE . 26.9 m -130.6 143.52 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 0.0 110.328 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.451 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . -127.8 156.41 42.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 110.149 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.445 ' HA ' HG11 ' A' ' 9' ' ' VAL . 17.6 mttp -76.24 132.89 40.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 110.23 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.437 ' O ' ' OD1' ' A' ' 63' ' ' ASN . . . -58.98 154.09 16.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.23 -0.919 . . . . 0.0 110.183 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 62' ' ' ALA . 78.3 m-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.262 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.39 154.61 69.24 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.218 -1.166 . . . . 0.0 110.216 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -46.06 144.79 5.86 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.996 1.524 . . . . 0.0 110.33 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 46.9 tp -104.87 125.45 50.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.915 . . . . 0.0 110.303 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.454 ' O ' ' NE ' ' A' ' 32' ' ' ARG . 94.7 mm-40 -111.54 155.86 22.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.18 -0.95 . . . . 0.0 110.115 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -112.42 23.37 13.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 0.0 110.273 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.456 ' CB ' ' HB ' ' A' ' 33' ' ' ILE . 73.0 m-20 -86.06 112.62 21.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.917 . . . . 0.0 110.367 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.442 ' CD1' HD13 ' A' ' 46' ' ' LEU . 19.7 tp -110.67 148.9 31.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 110.041 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.457 HG11 ' HA ' ' A' ' 61' ' ' LYS . 33.0 m -145.84 167.98 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.129 -0.982 . . . . 0.0 110.415 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.3 mt -113.44 149.9 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.366 -0.834 . . . . 0.0 109.596 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.574 ' HB2' ' CD2' ' A' ' 25' ' ' PHE . . . -80.38 114.52 19.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.169 -0.957 . . . . 0.0 110.679 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.458 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 16.8 tp -78.95 -19.74 50.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 109.256 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.458 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 39.8 m-70 -159.98 142.05 13.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.566 -0.709 . . . . 0.0 109.511 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.0 p -60.56 139.73 57.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.818 -1.176 . . . . 0.0 110.101 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.584 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 81.6 t80 -99.93 161.97 13.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.124 -0.985 . . . . 0.0 110.296 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.46 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 2.1 mp0 -117.46 129.03 25.62 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.322 -0.861 . . . . 0.0 110.12 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.448 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 48.2 Cg_endo -83.06 83.77 1.87 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.081 1.569 . . . . 0.0 110.381 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.563 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 56.8 p -79.8 -3.88 49.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 110.121 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.563 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 89.4 m-70 -141.61 168.49 19.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 0.0 110.264 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -82.01 125.12 30.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.27 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.15 18.36 11.4 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -114.97 161.03 18.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.259 -1.142 . . . . 0.0 110.127 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.495 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 17.6 tp -115.76 120.77 40.39 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 110.28 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.479 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -101.72 54.63 0.77 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.584 ' CE1' ' HB2' ' A' ' 15' ' ' TYR . 44.0 p90 -50.26 171.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.31 -1.112 . . . . 0.0 110.908 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.42 ' O ' ' HB3' ' A' ' 11' ' ' ALA . 91.5 mt-10 -100.39 178.33 4.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 110.488 -179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -71.86 123.07 21.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -0.88 . . . . 0.0 110.246 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 91.76 -10.09 75.38 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.536 ' N ' ' HB1' ' A' ' 11' ' ' ALA . 16.6 tt0 -61.65 131.93 51.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -1.17 . . . . 0.0 110.135 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.463 ' O ' HD21 ' A' ' 31' ' ' LEU . 96.3 mt-30 -79.98 130.81 35.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.305 -0.872 . . . . 0.0 110.192 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.574 HD13 ' CG ' ' A' ' 25' ' ' PHE . 32.3 mt -126.76 145.65 50.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -0.954 . . . . 0.0 110.459 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.486 ' HB2' ' CD2' ' A' ' 46' ' ' LEU . 5.4 tpt180 -93.72 137.74 32.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.366 -0.834 . . . . 0.0 109.531 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.456 ' HB ' ' CB ' ' A' ' 7' ' ' ASN . 18.7 mm -90.99 129.13 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.131 -0.981 . . . . 0.0 110.287 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.466 ' CD1' ' HB2' ' A' ' 44' ' ' GLN . 49.9 mt -112.94 -26.4 8.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.902 . . . . 0.0 110.068 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.453 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 75.3 mt-10 -150.45 156.33 41.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 110.147 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.56 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 97.6 mt-30 -142.09 58.6 1.47 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 110.238 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -119.0 140.36 50.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.254 -0.904 . . . . 0.0 110.156 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.8 -168.3 53.47 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -76.37 -34.43 58.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -1.162 . . . . 0.0 110.128 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.573 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 96.8 m95 -96.25 143.75 27.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 110.251 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.56 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.9 m0 -116.53 152.29 34.39 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -0.897 . . . . 0.0 110.261 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.453 ' HB3' ' HB2' ' A' ' 35' ' ' GLU . 18.1 tttt -89.95 141.43 28.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.254 -0.904 . . . . 0.0 109.987 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.529 ' CB ' HG12 ' A' ' 54' ' ' ILE . . . -147.87 170.22 18.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.16 -0.963 . . . . 0.0 110.428 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.467 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 59.2 tt0 -130.48 136.31 48.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 110.037 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 66.1 m -68.45 138.02 54.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.127 -0.983 . . . . 0.0 110.242 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.486 ' CD2' ' HB2' ' A' ' 32' ' ' ARG . 54.2 mt -87.65 -12.52 45.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.094 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.9 p -101.34 -28.42 12.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.863 . . . . 0.0 110.285 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 46.2 p -113.37 -3.6 13.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.169 -0.957 . . . . 0.0 110.366 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 58.67 14.15 20.75 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -86.93 157.19 19.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.122 -1.222 . . . . 0.0 110.39 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 94.9 mt-10 -117.4 138.68 51.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.355 -0.84 . . . . 0.0 109.972 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.495 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -161.07 156.7 28.14 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -68.68 144.5 54.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.247 -1.149 . . . . 0.0 109.899 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.529 HG12 ' CB ' ' A' ' 43' ' ' ALA . 1.1 pt -137.37 123.43 13.18 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.142 -0.974 . . . . 0.0 110.38 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.593 ' CG ' ' CD2' ' A' ' 58' ' ' PHE . 43.5 Cg_endo -47.16 159.35 0.39 Allowed 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.963 1.507 . . . . 0.0 110.068 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -96.48 0.78 50.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 110.736 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -100.18 -26.73 13.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.027 -1.046 . . . . 0.0 110.694 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.593 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 7.9 m-30 -89.19 -8.18 54.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.143 -0.973 . . . . 0.0 110.494 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.437 HG12 HD11 ' A' ' 54' ' ' ILE . 26.9 m -125.02 143.42 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.087 -1.008 . . . . 0.0 110.187 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.453 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . -134.48 164.74 26.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.224 -0.922 . . . . 0.0 110.211 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.457 ' HA ' HG11 ' A' ' 9' ' ' VAL . 17.2 tptm -76.38 136.39 39.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.273 -0.892 . . . . 0.0 110.188 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.46 147.58 47.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.328 -0.857 . . . . 0.0 110.155 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 40.5 p-10 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.176 -179.98 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 m -124.67 75.89 64.24 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.25 -1.147 . . . . 0.0 110.168 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -57.65 -28.87 83.33 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.977 1.514 . . . . 0.0 110.321 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 39.9 mt -97.97 140.33 32.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.277 -0.89 . . . . 0.0 110.251 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.419 ' O ' HD11 ' A' ' 8' ' ' LEU . 90.0 mt-30 -117.78 156.32 28.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.349 -0.844 . . . . 0.0 110.191 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -100.68 14.35 31.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.206 -0.934 . . . . 0.0 110.197 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.458 ' O ' HG13 ' A' ' 33' ' ' ILE . 22.5 m120 -88.03 7.33 31.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 110.28 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.522 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 5.2 mp -94.1 150.63 20.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.897 . . . . 0.0 110.147 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.486 ' CG1' ' O ' ' A' ' 8' ' ' LEU . 9.4 m -157.62 174.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.286 -0.884 . . . . 0.0 110.328 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 80.0 mt -115.75 141.88 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.392 -0.818 . . . . 0.0 109.721 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.554 ' CB ' ' CD2' ' A' ' 25' ' ' PHE . . . -80.17 116.69 20.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 0.0 110.427 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.47 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 10.1 tp -70.06 -23.13 63.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.113 -0.992 . . . . 0.0 109.284 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.47 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 30.0 m80 -158.28 147.73 19.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.537 -0.727 . . . . 0.0 109.568 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 55.9 p -60.87 144.34 53.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.943 -1.098 . . . . 0.0 109.919 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.578 ' CD1' ' HD3' ' A' ' 55' ' ' PRO . 89.4 t80 -101.45 163.39 12.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.001 -1.062 . . . . 0.0 110.579 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.411 ' N ' ' CG ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -110.62 113.58 55.57 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.317 -0.864 . . . . 0.0 109.891 179.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.482 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 51.0 Cg_endo -74.36 96.85 0.99 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.066 1.561 . . . . 0.0 110.514 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.3 p -79.65 -1.54 38.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 110.103 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -133.49 -178.91 5.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 110.118 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -93.23 -2.26 55.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.285 -0.884 . . . . 0.0 110.194 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.474 ' O ' ' CD2' ' A' ' 53' ' ' PHE . . . -115.11 5.98 21.78 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 4.1 m-20 -98.77 167.81 10.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.241 -1.152 . . . . 0.0 110.346 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.496 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 31.0 tp -123.44 127.45 48.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.281 -0.887 . . . . 0.0 110.15 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.482 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . -104.22 54.87 0.63 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.572 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 40.3 p90 -44.78 169.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -1.124 . . . . 0.0 110.922 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.407 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 95.6 mt-10 -98.6 176.92 5.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.448 -0.783 . . . . 0.0 110.225 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -70.84 127.09 31.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.167 -0.958 . . . . 0.0 110.225 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.98 -7.66 81.65 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.417 ' CD ' ' HB2' ' A' ' 25' ' ' PHE . 19.0 tt0 -66.12 131.93 47.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.132 -1.216 . . . . 0.0 110.238 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.465 ' O ' HD13 ' A' ' 31' ' ' LEU . 98.1 mt-30 -79.54 133.42 36.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.259 -0.901 . . . . 0.0 109.903 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.465 HD13 ' O ' ' A' ' 30' ' ' GLN . 8.4 mp -132.19 152.17 51.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.254 -0.904 . . . . 0.0 110.483 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 26.1 ttm-85 -102.21 134.01 46.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.431 -0.793 . . . . 0.0 109.837 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 7' ' ' ASN . 12.3 mt -88.46 137.18 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.921 . . . . 0.0 110.101 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.468 ' CD1' ' HA ' ' A' ' 43' ' ' ALA . 1.3 mt -122.6 -29.25 4.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 110.095 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.463 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 73.9 mm-40 -135.3 147.67 49.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.182 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.56 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 95.3 mt-30 -137.95 56.63 1.74 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.898 . . . . 0.0 110.198 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.8 p -120.73 130.3 54.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 110.237 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.81 -164.8 41.39 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -81.16 -31.32 34.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.241 -1.152 . . . . 0.0 110.197 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.574 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 98.5 m95 -96.07 144.41 26.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 110.223 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.571 ' CZ3' ' HB2' ' A' ' 56' ' ' PHE . 48.8 m0 -123.21 156.52 34.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 110.335 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 35' ' ' GLU . 36.1 tttt -95.16 143.04 26.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 109.735 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -157.61 -178.77 7.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.942 . . . . 0.0 110.444 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 17.3 pt20 -151.46 159.68 44.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.399 -0.813 . . . . 0.0 110.104 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.1 t -97.37 115.61 28.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.206 -0.934 . . . . 0.0 110.14 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.6 mt -73.26 -1.2 16.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.271 -0.893 . . . . 0.0 110.356 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.5 m -92.81 -28.57 16.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 110.059 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.8 p -116.86 -10.3 11.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.898 . . . . 0.0 110.088 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.02 41.86 53.45 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.404 ' O ' ' HB2' ' A' ' 44' ' ' GLN . 37.8 mt-30 -124.07 151.83 43.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -1.167 . . . . 0.0 110.231 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 43.7 mt-10 -122.92 147.09 46.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 110.067 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.496 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -162.39 -146.27 4.62 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.474 ' CD2' ' O ' ' A' ' 21' ' ' GLY . 81.0 m-85 -128.44 142.62 51.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -1.092 . . . . 0.0 110.129 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.502 ' CD1' HG23 ' A' ' 59' ' ' VAL . 2.0 pp -138.23 145.06 45.71 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.266 -0.897 . . . . 0.0 110.251 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.578 ' HD3' ' CD1' ' A' ' 15' ' ' TYR . 45.4 Cg_endo -70.37 156.35 61.93 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.953 1.502 . . . . 0.0 110.037 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.571 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 27.4 p90 -78.51 -3.21 42.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.271 -0.893 . . . . 0.0 111.01 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -99.92 -25.74 14.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.985 -1.072 . . . . 0.0 111.197 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.563 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 9.8 m-85 -82.17 -5.16 58.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.954 -1.091 . . . . 0.0 110.467 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.502 HG23 ' CD1' ' A' ' 54' ' ' ILE . 27.6 m -134.47 145.54 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.123 -0.986 . . . . 0.0 110.187 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -125.51 148.09 49.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.237 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 66.8 mttm -67.18 121.57 15.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 110.223 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.38 138.34 13.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.871 . . . . 0.0 110.232 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.213 179.934 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 m -124.74 81.68 60.88 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.274 -1.133 . . . . 0.0 110.214 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -56.77 144.62 86.56 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.0 1.526 . . . . 0.0 110.343 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 63.9 mt -101.4 142.25 33.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.296 -0.878 . . . . 0.0 110.22 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -67.32 -16.53 64.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.932 . . . . 0.0 110.226 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 47.41 44.92 16.9 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.913 . . . . 0.0 110.165 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -81.19 0.66 35.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.289 -0.882 . . . . 0.0 110.151 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.503 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 6.7 mp -79.67 142.3 35.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 110.239 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.472 ' CG1' ' O ' ' A' ' 8' ' ' LEU . 34.4 m -155.03 172.55 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.319 -0.863 . . . . 0.0 110.157 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.442 HG22 HD11 ' A' ' 10' ' ' ILE . 19.0 mm -114.36 154.66 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.915 . . . . 0.0 109.778 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.459 ' HB1' ' N ' ' A' ' 29' ' ' GLU . . . -79.72 109.86 14.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.1 -1.0 . . . . 0.0 110.226 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.551 ' HG ' ' CE1' ' A' ' 13' ' ' HIS . 20.2 tp -70.61 -20.85 62.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.003 -1.061 . . . . 0.0 109.339 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.551 ' CE1' ' HG ' ' A' ' 12' ' ' LEU . 71.3 m80 -150.88 -164.08 1.93 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.525 -0.734 . . . . 0.0 109.863 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 20.7 t -111.6 138.94 47.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.155 -0.966 . . . . 0.0 110.077 179.851 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.578 ' CD2' ' HD3' ' A' ' 55' ' ' PRO . 53.2 t80 -103.19 164.16 11.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.064 -1.022 . . . . 0.0 110.128 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.565 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 74.7 mm-40 -120.69 125.37 27.15 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.226 -0.921 . . . . 0.0 110.209 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.467 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 48.9 Cg_endo -74.91 81.94 2.09 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.985 1.519 . . . . 0.0 110.33 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.554 ' OG ' ' CE1' ' A' ' 19' ' ' HIS . 83.4 p -79.62 -1.8 39.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.141 -0.975 . . . . 0.0 110.187 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.554 ' CE1' ' OG ' ' A' ' 18' ' ' SER . 36.5 m80 -147.62 143.97 28.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 110.167 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -54.83 128.49 33.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.176 -0.952 . . . . 0.0 110.335 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.94 -13.28 49.55 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -82.95 158.21 22.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -1.139 . . . . 0.0 110.328 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.543 ' O ' ' CD1' ' A' ' 15' ' ' TYR . 15.8 tp -119.82 125.99 49.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.353 -0.842 . . . . 0.0 110.073 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.474 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -105.21 55.89 0.55 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.512 ' CG ' HD12 ' A' ' 31' ' ' LEU . 40.4 p90 -50.14 173.53 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.088 -1.242 . . . . 0.0 110.942 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -111.78 -177.44 3.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.475 -0.765 . . . . 0.0 110.027 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -67.96 129.57 40.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.15 -0.969 . . . . 0.0 110.328 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.1 -17.93 57.24 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.459 ' N ' ' HB1' ' A' ' 11' ' ' ALA . 8.6 tt0 -55.43 122.71 11.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.179 -1.189 . . . . 0.0 110.382 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.404 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 29.5 tt0 -79.97 131.42 35.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 109.901 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.512 HD12 ' CG ' ' A' ' 25' ' ' PHE . 38.7 mt -137.19 158.72 43.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.953 . . . . 0.0 110.316 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.517 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 17.8 ttt180 -108.14 135.75 48.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 0.0 109.867 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.4 mt -91.75 92.03 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.175 -0.953 . . . . 0.0 110.325 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.44 HD22 ' HG2' ' A' ' 32' ' ' ARG . 81.1 mt -78.91 -27.79 43.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.267 -0.896 . . . . 0.0 110.554 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.534 ' HB2' ' CB ' ' A' ' 42' ' ' LYS . 95.7 mt-10 -131.33 136.11 47.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.145 -0.972 . . . . 0.0 110.16 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.576 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 19.0 pt20 -133.79 55.41 1.9 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 110.185 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.0 t -117.13 142.78 46.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.181 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.09 -165.61 54.77 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -79.61 -33.53 41.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -1.113 . . . . 0.0 110.086 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.401 ' HZ3' ' CE2' ' A' ' 15' ' ' TYR . 52.1 m95 -95.71 144.12 26.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.305 -0.872 . . . . 0.0 110.113 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.576 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 47.4 m0 -124.5 155.62 38.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 110.419 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 22.9 tttt -98.99 146.31 26.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.331 -0.856 . . . . 0.0 109.317 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.517 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -148.79 175.27 11.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.988 -1.07 . . . . 0.0 110.821 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.477 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 46.9 tt0 -138.81 147.51 42.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.416 -0.802 . . . . 0.0 109.837 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 42.5 m -95.97 117.23 30.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.115 -0.991 . . . . 0.0 110.075 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 76.6 mt -75.22 1.61 13.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 0.0 110.315 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 65.9 p -99.57 -33.2 10.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.925 . . . . 0.0 109.977 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.7 p -110.32 -15.23 14.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.891 . . . . 0.0 110.063 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.13 40.6 50.09 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -127.51 154.39 45.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -1.164 . . . . 0.0 110.335 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.477 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 64.6 tt0 -120.2 143.89 48.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.266 -0.896 . . . . 0.0 109.919 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.505 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -153.41 -153.94 6.56 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -119.98 132.45 55.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.492 -1.005 . . . . 0.0 109.915 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.462 HG13 ' O ' ' A' ' 54' ' ' ILE . 11.3 pt -125.77 145.25 51.03 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.167 -0.958 . . . . 0.0 110.439 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.58 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 45.8 Cg_endo -78.97 151.51 24.13 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.987 1.52 . . . . 0.0 109.833 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.57 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 33.3 p90 -71.05 -4.8 26.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.235 -0.916 . . . . 0.0 111.034 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.49 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 65.8 m-20 -98.1 -25.99 14.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.88 -1.138 . . . . 0.0 111.274 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.58 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 8.5 m-85 -85.16 -4.03 59.01 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.859 -1.151 . . . . 0.0 110.36 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.411 HG23 HD13 ' A' ' 54' ' ' ILE . 36.0 m -132.21 139.74 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -0.937 . . . . 0.0 110.106 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -130.44 148.22 52.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 110.384 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -52.28 128.6 25.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.307 -0.871 . . . . 0.0 110.166 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.1 139.86 58.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 0.0 110.222 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.212 179.993 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.26 163.47 45.93 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.226 -1.161 . . . . 0.0 110.187 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -58.9 142.15 98.84 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.969 1.51 . . . . 0.0 110.359 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 58.7 mt -90.99 148.45 22.4 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.25 -0.907 . . . . 0.0 110.273 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -64.18 -39.36 93.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -0.93 . . . . 0.0 110.197 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -77.23 52.55 0.92 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 110.241 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 55.2 m-20 -86.96 90.27 8.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.314 -0.866 . . . . 0.0 110.214 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 13.8 tp -96.22 148.37 22.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.898 . . . . 0.0 110.115 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.544 ' CG2' ' CG1' ' A' ' 59' ' ' VAL . 4.5 m -151.8 170.9 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.869 . . . . 0.0 110.329 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.3 mt -113.64 142.33 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.852 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.449 ' HA ' ' O ' ' A' ' 58' ' ' PHE . . . -80.3 114.34 19.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.147 -0.971 . . . . 0.0 110.192 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.52 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 75.3 mt -68.84 -22.6 64.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.068 -1.02 . . . . 0.0 109.471 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 82.2 m-70 -157.98 152.43 24.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.548 -0.72 . . . . 0.0 109.762 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.485 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 54.2 p -65.26 144.76 56.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.989 -1.07 . . . . 0.0 110.075 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.557 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 36.2 t80 -97.37 157.11 16.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.086 -1.009 . . . . 0.0 110.502 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -111.2 85.34 5.34 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.263 -0.898 . . . . 0.0 110.116 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.527 ' HD3' ' CA ' ' A' ' 24' ' ' GLY . 47.1 Cg_endo -55.86 120.61 8.55 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.101 1.579 . . . . 0.0 110.502 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.459 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 98.7 p -92.1 10.53 28.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 110.119 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.459 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 98.6 m-70 -141.02 -158.25 0.84 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 110.214 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 56.7 p30 -112.03 4.8 18.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -0.867 . . . . 0.0 110.135 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -118.15 4.37 16.03 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.511 ' HB2' ' CB ' ' A' ' 17' ' ' PRO . 42.6 m-20 -95.07 165.18 12.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.181 -1.188 . . . . 0.0 110.272 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.501 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 16.0 tp -113.5 116.21 29.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.273 -0.892 . . . . 0.0 110.003 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.527 ' CA ' ' HD3' ' A' ' 17' ' ' PRO . . . -96.33 51.85 1.6 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.557 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 25.4 p90 -49.91 171.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -1.152 . . . . 0.0 110.882 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.403 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 95.7 mt-10 -103.16 178.38 4.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.465 -0.772 . . . . 0.0 110.004 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -68.88 132.78 47.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.209 -0.932 . . . . 0.0 110.284 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.56 -9.65 74.98 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.481 ' OE2' ' CB ' ' A' ' 25' ' ' PHE . 21.8 tt0 -65.27 125.94 26.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.124 -1.221 . . . . 0.0 110.202 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.458 ' O ' HD22 ' A' ' 31' ' ' LEU . 85.9 mt-30 -79.72 137.94 37.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 110.04 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.458 HD22 ' O ' ' A' ' 30' ' ' GLN . 29.2 mt -141.58 163.78 32.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.194 -0.941 . . . . 0.0 110.358 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 5.8 ttt180 -107.18 134.21 50.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.376 -0.828 . . . . 0.0 109.485 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.523 HG23 ' CG ' ' A' ' 36' ' ' GLN . 25.5 mm -96.11 93.38 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.133 -0.979 . . . . 0.0 110.515 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.506 ' CD1' ' HA ' ' A' ' 43' ' ' ALA . 1.5 mp -79.49 -25.75 41.76 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.305 -0.872 . . . . 0.0 110.654 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.465 ' O ' ' HB3' ' A' ' 41' ' ' TRP . 11.0 mt-10 -136.38 139.65 42.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.057 -1.027 . . . . 0.0 110.39 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.577 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 96.2 mt-30 -134.21 54.47 1.94 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.368 -0.832 . . . . 0.0 110.044 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -112.69 146.91 37.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.403 -0.811 . . . . 0.0 110.224 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.18 -167.38 31.65 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -77.5 -34.13 54.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.319 -1.107 . . . . 0.0 110.154 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.544 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 99.3 m95 -92.96 137.98 31.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.191 -0.943 . . . . 0.0 110.326 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.577 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 50.6 m0 -120.42 156.08 32.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.32 -0.863 . . . . 0.0 110.023 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.459 ' HB2' ' HB2' ' A' ' 35' ' ' GLU . 20.3 mttp -98.25 139.55 33.87 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 109.275 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -148.57 174.24 12.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.015 -1.053 . . . . 0.0 110.694 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.466 ' HG3' ' O ' ' A' ' 50' ' ' GLN . 47.3 tt0 -140.68 149.27 42.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.409 -0.807 . . . . 0.0 109.9 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 t -96.08 110.64 22.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.924 . . . . 0.0 110.161 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 70.2 mt -71.55 -2.35 16.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.298 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 91.5 m -85.84 -28.23 24.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 0.0 109.948 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.1 p -127.89 -4.61 5.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 110.172 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.77 39.69 65.61 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.466 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 32.6 mt-30 -114.97 148.11 39.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.171 -1.193 . . . . 0.0 110.242 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.445 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 37.3 tt0 -120.94 144.47 48.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 0.0 109.887 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.501 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -162.19 -152.54 6.77 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -124.56 140.16 53.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.419 -1.048 . . . . 0.0 109.946 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.519 HD12 ' CG2' ' A' ' 59' ' ' VAL . 1.6 pp -136.09 137.73 25.64 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.18 -0.95 . . . . 0.0 110.491 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.585 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 45.1 Cg_endo -64.75 152.4 82.18 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.006 1.53 . . . . 0.0 109.964 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.57 ' HB2' ' CH2' ' A' ' 41' ' ' TRP . 30.1 p90 -72.36 -8.04 52.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.253 -0.904 . . . . 0.0 111.267 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -94.11 -26.12 16.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.817 -1.177 . . . . 0.0 110.993 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.585 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 6.5 m-85 -81.81 0.15 40.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.048 -1.033 . . . . 0.0 110.146 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.544 ' CG1' ' CG2' ' A' ' 9' ' ' VAL . 27.9 t -144.79 170.2 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.328 -0.858 . . . . 0.0 109.956 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.521 ' O ' ' CG1' ' A' ' 9' ' ' VAL . . . -157.36 151.39 24.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.204 -0.935 . . . . 0.0 110.305 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -65.18 122.86 18.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 110.218 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.52 -35.5 70.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 0.0 110.241 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 51.7 t30 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.195 179.983 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 m -76.58 153.66 83.57 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.224 -1.162 . . . . 0.0 110.155 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -53.69 147.73 38.98 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.039 1.547 . . . . 0.0 110.41 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.522 ' N ' ' CD1' ' A' ' 4' ' ' LEU . 5.6 mp -99.24 139.03 35.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.283 -0.885 . . . . 0.0 110.143 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -118.18 143.52 46.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.913 . . . . 0.0 110.234 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -97.3 -2.3 42.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.243 -0.911 . . . . 0.0 110.238 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 33' ' ' ILE . 10.3 t-20 -80.03 2.86 22.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 0.0 110.246 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.443 ' O ' HG11 ' A' ' 9' ' ' VAL . 21.8 mt -86.62 155.04 20.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -0.911 . . . . 0.0 110.183 179.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.514 ' CB ' ' O ' ' A' ' 60' ' ' ALA . 15.0 m -147.08 168.15 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 110.271 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.442 HG12 ' HB3' ' A' ' 62' ' ' ALA . 29.1 mm -111.83 139.26 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 0.0 109.936 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.506 ' CB ' ' CD2' ' A' ' 25' ' ' PHE . . . -80.42 115.61 20.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 110.448 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.444 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 61.4 mt -74.74 -19.81 60.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.991 -1.068 . . . . 0.0 109.436 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.444 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 51.9 m-70 -157.33 143.66 17.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.538 -0.726 . . . . 0.0 109.668 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.458 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 52.0 p -58.92 145.21 42.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.006 -1.059 . . . . 0.0 110.01 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.576 ' CE2' ' O ' ' A' ' 16' ' ' GLU . 85.2 t80 -105.6 167.33 9.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.152 -0.968 . . . . 0.0 110.292 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.576 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 25.1 mt-10 -114.9 127.54 26.73 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 110.018 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.466 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 50.9 Cg_endo -79.79 89.63 1.32 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.917 1.483 . . . . 0.0 110.393 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.4 p -79.18 -10.09 59.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.867 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.439 ' CD2' ' OD2' ' A' ' 22' ' ' ASP . 44.7 m-70 -126.96 -179.51 4.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.858 . . . . 0.0 110.073 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -86.92 1.91 51.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 110.267 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . 0.465 ' O ' ' HA3' ' A' ' 52' ' ' GLY . . . -123.29 -15.78 3.66 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.439 ' OD2' ' CD2' ' A' ' 19' ' ' HIS . 87.5 m-20 -67.84 156.38 37.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.126 -1.22 . . . . 0.0 110.35 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.466 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 21.9 tp -116.51 120.31 38.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 109.829 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.473 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -97.53 53.16 1.31 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.578 ' CG ' HD12 ' A' ' 31' ' ' LEU . 42.7 p90 -48.28 168.72 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.211 -1.17 . . . . 0.0 110.948 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -96.9 176.98 5.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.475 -0.766 . . . . 0.0 110.349 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -71.33 127.03 31.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 110.161 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.61 -6.08 83.32 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.429 ' CD ' ' HB2' ' A' ' 25' ' ' PHE . 20.5 tt0 -65.99 130.04 41.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.114 -1.227 . . . . 0.0 110.054 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.424 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 50.8 tt0 -79.54 136.46 36.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.826 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.578 HD12 ' CG ' ' A' ' 25' ' ' PHE . 54.2 mt -139.65 162.36 35.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 0.0 110.528 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.519 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 11.3 ttt180 -111.83 138.77 47.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.394 -0.816 . . . . 0.0 109.558 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.526 HD11 HG22 ' A' ' 33' ' ' ILE . 57.9 mt -98.68 92.35 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.121 -0.987 . . . . 0.0 110.392 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 73.4 mt -79.49 -21.79 44.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 0.0 110.908 -179.404 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.505 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 75.9 tt0 -138.12 131.54 30.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.993 -1.067 . . . . 0.0 110.234 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.582 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 95.4 mt-30 -126.25 56.75 1.43 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 110.25 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.7 t -115.84 150.26 37.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.296 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.58 -168.88 34.58 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -75.71 -32.72 60.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.306 -1.114 . . . . 0.0 110.088 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.567 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 95.4 m95 -97.9 144.71 27.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -0.901 . . . . 0.0 110.008 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.582 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 50.0 m0 -119.72 154.62 33.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.336 -0.852 . . . . 0.0 110.094 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.505 ' CB ' ' HB3' ' A' ' 35' ' ' GLU . 18.4 tttp -92.96 140.43 29.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.324 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.519 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -148.92 171.66 15.96 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.046 -1.034 . . . . 0.0 110.932 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.454 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 4.8 tt0 -139.57 147.78 41.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.56 -0.713 . . . . 0.0 109.622 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.0 t -94.22 109.81 21.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.15 -0.969 . . . . 0.0 110.144 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.429 ' HG ' ' O ' ' A' ' 46' ' ' LEU . 16.5 tp -71.93 -1.58 14.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.437 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 98.0 m -90.87 -31.11 16.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -0.909 . . . . 0.0 110.142 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.0 p -120.73 -8.94 9.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.284 -0.885 . . . . 0.0 110.201 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.65 36.86 47.32 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -112.43 144.47 41.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -1.127 . . . . 0.0 110.268 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 83.8 tt0 -120.69 141.69 50.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.23 -0.919 . . . . 0.0 110.168 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -172.95 163.93 35.82 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -74.37 147.31 42.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -1.15 . . . . 0.0 109.832 179.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.514 ' CD1' HG23 ' A' ' 59' ' ' VAL . 1.7 pp -142.67 137.86 15.64 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.281 -0.887 . . . . 0.0 110.285 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.571 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 45.4 Cg_endo -57.89 156.81 26.7 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.112 1.585 . . . . 0.0 110.169 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.577 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 20.8 p90 -92.78 -0.9 57.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.375 -0.828 . . . . 0.0 111.243 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 58' ' ' PHE . 49.1 p-10 -98.32 -26.63 14.44 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.824 -1.172 . . . . 0.0 111.051 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.522 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 16.8 m-30 -88.65 2.3 53.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.938 -1.102 . . . . 0.0 110.502 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.514 HG23 ' CD1' ' A' ' 54' ' ' ILE . 33.2 m -132.19 146.64 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.111 -0.993 . . . . 0.0 110.208 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' A' ' 9' ' ' VAL . . . -135.67 168.26 19.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.316 -0.865 . . . . 0.0 110.181 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.447 ' HA ' HG11 ' A' ' 9' ' ' VAL . 85.7 mttt -78.21 131.41 37.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 110.281 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.442 ' HB3' HG12 ' A' ' 10' ' ' ILE . . . -96.39 154.39 17.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.0 110.176 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.238 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.2 79.08 59.81 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.26 -1.141 . . . . 0.0 110.18 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -58.98 146.29 94.53 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.933 1.491 . . . . 0.0 110.395 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.447 ' HB3' ' OD1' ' A' ' 6' ' ' ASP . 13.4 tp -105.29 123.93 48.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 0.0 110.227 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -55.94 -25.65 44.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.15 -0.969 . . . . 0.0 110.163 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.447 ' OD1' ' HB3' ' A' ' 4' ' ' LEU . 46.8 m-20 55.02 57.02 5.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.307 -0.87 . . . . 0.0 110.277 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.428 ' O ' HG13 ' A' ' 33' ' ' ILE . 24.7 m120 -80.96 -10.0 59.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.243 -0.91 . . . . 0.0 110.263 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 15.2 tp -70.31 142.83 52.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -0.926 . . . . 0.0 110.155 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.444 HG11 ' HA ' ' A' ' 61' ' ' LYS . 24.5 m -149.48 168.78 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 110.269 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.2 mt -111.15 141.44 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.93 . . . . 0.0 109.886 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.423 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -80.12 109.86 14.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.167 -0.958 . . . . 0.0 110.316 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.414 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 71.6 mt -69.93 -24.52 63.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.02 -1.05 . . . . 0.0 109.247 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.414 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 74.2 m80 -152.84 148.23 26.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.561 -0.712 . . . . 0.0 109.632 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.501 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 51.4 p -63.75 144.76 56.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.037 -1.039 . . . . 0.0 109.987 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.552 ' CD1' ' HG3' ' A' ' 55' ' ' PRO . 39.5 t80 -97.68 157.38 16.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.026 -1.046 . . . . 0.0 110.357 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -110.32 99.82 41.91 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.372 -0.83 . . . . 0.0 109.998 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.464 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 48.3 Cg_endo -59.96 91.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.069 1.563 . . . . 0.0 110.461 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.9 m -83.28 1.33 41.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 110.102 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.467 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 77.3 m80 -146.67 152.35 38.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -0.887 . . . . 0.0 110.135 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -65.04 130.01 41.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -0.917 . . . . 0.0 110.189 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.07 13.58 24.78 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.467 ' OD2' ' HB2' ' A' ' 19' ' ' HIS . 13.8 m-20 -108.29 158.24 17.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.29 -1.123 . . . . 0.0 110.448 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.504 ' CD1' ' HG2' ' A' ' 50' ' ' GLN . 13.5 tp -109.3 111.89 23.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 109.834 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.464 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . -93.24 49.87 2.43 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.529 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 31.7 p90 -53.36 174.42 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -1.127 . . . . 0.0 110.89 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.501 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 91.6 mt-10 -109.33 178.74 4.35 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.471 -0.768 . . . . 0.0 109.918 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -68.29 140.57 55.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.081 -1.012 . . . . 0.0 110.287 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.07 -14.31 50.02 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 3.6 mt-10 -65.8 126.59 28.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.175 -1.191 . . . . 0.0 110.37 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.481 ' C ' ' CD1' ' A' ' 31' ' ' LEU . 19.4 pt20 -79.76 136.33 36.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 109.958 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.481 ' CD1' ' C ' ' A' ' 30' ' ' GLN . 7.7 mp -137.95 158.88 43.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -0.96 . . . . 0.0 110.536 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.537 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 5.8 tpt180 -106.29 132.33 52.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.406 -0.809 . . . . 0.0 109.332 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.454 ' N ' ' HD2' ' A' ' 32' ' ' ARG . 23.3 mt -90.79 93.73 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.083 -1.01 . . . . 0.0 110.544 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.413 ' CD2' ' HG3' ' A' ' 32' ' ' ARG . 67.1 mt -79.58 -29.94 41.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.367 -0.833 . . . . 0.0 110.844 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.426 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 85.3 tt0 -130.91 140.48 50.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.947 -1.096 . . . . 0.0 110.406 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.577 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 76.5 mt-30 -134.52 54.88 1.92 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 110.111 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 51.4 m -119.65 148.18 43.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -0.876 . . . . 0.0 110.167 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.11 -177.87 27.52 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -69.18 -29.85 67.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -1.205 . . . . 0.0 110.333 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.461 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 99.2 m95 -98.61 144.15 28.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 110.378 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.577 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 43.5 m0 -121.02 155.87 33.41 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.349 -0.844 . . . . 0.0 110.176 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.45 ' HA ' ' HA ' ' A' ' 53' ' ' PHE . 77.9 tttt -101.1 143.54 31.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 109.331 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -153.98 -179.9 8.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.014 -1.054 . . . . 0.0 110.85 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.442 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 48.3 tt0 -141.24 149.94 41.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.379 -0.825 . . . . 0.0 109.691 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 18.0 t -100.49 123.95 45.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.05 -1.031 . . . . 0.0 110.3 -179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.6 mt -80.85 6.21 13.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 110.051 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 87.0 m -91.07 -35.62 14.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 110.071 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.7 p -127.27 -3.55 6.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 110.093 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.2 35.24 57.25 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.504 ' HG2' ' CD1' ' A' ' 23' ' ' LEU . 63.1 tt0 -104.87 140.76 37.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -1.13 . . . . 0.0 110.283 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 86.3 tt0 -119.51 139.09 52.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.892 . . . . 0.0 110.18 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.41 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -170.81 163.17 36.25 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.45 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 94.4 m-85 -69.36 141.85 54.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.308 -1.113 . . . . 0.0 110.0 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.468 HG12 ' HB1' ' A' ' 43' ' ' ALA . 1.6 pt -131.57 142.37 45.06 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.194 -0.941 . . . . 0.0 110.38 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.557 ' CG ' ' CD2' ' A' ' 58' ' ' PHE . 44.8 Cg_endo -68.49 140.89 49.11 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.066 1.561 . . . . 0.0 110.08 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.548 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 25.1 p90 -75.54 -7.03 53.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 0.0 111.144 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -90.34 -26.48 19.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.899 -1.126 . . . . 0.0 110.725 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.557 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 17.8 m-30 -92.71 4.16 54.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.091 -1.006 . . . . 0.0 110.22 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 55' ' ' PRO . 35.6 m -136.04 143.49 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.263 -0.898 . . . . 0.0 110.103 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -136.82 160.15 39.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.956 . . . . 0.0 110.343 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.444 ' HA ' HG11 ' A' ' 9' ' ' VAL . 11.1 mtmt -69.07 140.06 54.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.286 -0.884 . . . . 0.0 110.232 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.68 148.44 49.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.262 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.28 179.922 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.429 ' O ' ' HB2' ' A' ' 4' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.507 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 0.4 OUTLIER -44.64 -57.57 6.55 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.166 -1.196 . . . . 0.0 110.186 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.507 ' HD2' ' N ' ' A' ' 2' ' ' SER . 47.3 Cg_endo -66.12 -30.48 46.78 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.957 1.504 . . . . 0.0 110.241 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 1' ' ' GLY . 43.1 mt -62.12 -34.07 75.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -0.87 . . . . 0.0 110.211 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -57.67 -39.73 77.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 110.105 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -51.3 -35.35 37.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 110.118 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.465 ' O ' HG13 ' A' ' 33' ' ' ILE . 20.9 m120 -85.77 12.12 9.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.246 -0.909 . . . . 0.0 110.142 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.516 ' CD1' ' N ' ' A' ' 9' ' ' VAL . 2.9 tm? -94.79 145.84 24.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.859 . . . . 0.0 110.111 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.516 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 30.1 m -150.41 170.02 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.178 -0.951 . . . . 0.0 110.319 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.0 mt -115.16 145.05 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.377 -0.827 . . . . 0.0 109.954 179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.576 ' HB2' ' CD2' ' A' ' 25' ' ' PHE . . . -80.33 109.15 14.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.124 -0.985 . . . . 0.0 110.337 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.469 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 57.6 mt -67.05 -24.3 65.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.985 -1.072 . . . . 0.0 109.353 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.469 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 58.1 m80 -157.09 155.16 30.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.611 -0.681 . . . . 0.0 109.487 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.481 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 47.7 t -66.49 139.15 57.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.972 -1.08 . . . . 0.0 109.98 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.584 ' CE2' ' O ' ' A' ' 16' ' ' GLU . 73.5 t80 -95.96 155.27 16.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.084 -1.01 . . . . 0.0 110.375 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.584 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 1.2 mp0 -105.66 128.71 25.95 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.361 -0.837 . . . . 0.0 110.11 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.409 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 48.5 Cg_endo -87.31 81.28 1.28 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.875 1.461 . . . . 0.0 110.448 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 97.1 p -79.88 -2.33 43.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.385 -0.822 . . . . 0.0 109.942 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.41 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 63.8 m80 -138.95 149.81 45.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.888 . . . . 0.0 110.18 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -69.21 129.1 38.9 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.287 -0.883 . . . . 0.0 110.227 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.83 -4.41 39.26 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.41 ' OD2' ' HB2' ' A' ' 19' ' ' HIS . 34.9 m-20 -92.25 165.99 12.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.225 -1.162 . . . . 0.0 110.464 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.499 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 18.0 tp -117.85 124.33 48.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.272 -0.893 . . . . 0.0 110.011 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.473 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -105.68 52.7 0.69 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.576 ' CD2' ' HB2' ' A' ' 11' ' ' ALA . 41.3 p90 -48.74 175.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -1.18 . . . . 0.0 110.841 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.487 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 73.5 mm-40 -109.76 179.34 4.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.445 -0.784 . . . . 0.0 110.157 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -69.41 133.48 47.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.008 -1.058 . . . . 0.0 110.478 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.28 -15.53 55.95 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.487 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 3.3 mt-10 -64.25 122.56 16.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.034 -1.274 . . . . 0.0 110.454 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 99.0 mt-30 -79.4 137.15 37.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -0.879 . . . . 0.0 109.651 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.439 ' O ' HG21 ' A' ' 9' ' ' VAL . 15.7 mt -133.77 154.35 51.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.174 -0.954 . . . . 0.0 110.488 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.474 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 14.9 ttm180 -98.79 130.89 45.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.397 -0.815 . . . . 0.0 109.931 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.465 HG13 ' O ' ' A' ' 7' ' ' ASN . 69.2 mt -73.72 113.95 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.186 -0.946 . . . . 0.0 110.109 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.454 HD13 ' O ' ' A' ' 43' ' ' ALA . 35.7 mt -86.49 -38.83 16.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.87 . . . . 0.0 110.201 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.461 ' O ' ' HB3' ' A' ' 41' ' ' TRP . 94.4 mt-10 -139.25 161.45 37.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.343 -0.848 . . . . 0.0 109.946 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.574 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 45.7 tt0 -143.78 61.2 1.37 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 0.0 110.141 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.9 t -131.81 122.48 25.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 110.196 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.35 176.69 41.84 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.75 -34.39 75.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.365 -1.079 . . . . 0.0 110.249 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.434 ' O ' ' CD1' ' A' ' 41' ' ' TRP . 73.4 m95 -100.08 150.16 22.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.89 . . . . 0.0 110.242 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.574 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 40.1 m0 -130.84 160.03 35.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.29 -0.881 . . . . 0.0 110.381 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.417 ' O ' ' N ' ' A' ' 34' ' ' LEU . 80.0 tttt -88.89 146.6 24.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.914 . . . . 0.0 109.605 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.521 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . . . -147.14 167.82 23.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.029 -1.045 . . . . 0.0 110.759 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.519 ' CG ' ' HG2' ' A' ' 51' ' ' GLU . 43.4 tt0 -145.69 154.22 41.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.433 -0.792 . . . . 0.0 110.025 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.5 t -83.09 145.4 29.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.065 -1.022 . . . . 0.0 110.196 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.448 HD11 ' NH1' ' A' ' 32' ' ' ARG . 48.3 tp -91.38 -21.14 21.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 110.132 179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.7 t -105.45 -26.49 11.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 0.0 110.429 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.3 m -100.35 -29.22 12.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.122 -0.986 . . . . 0.0 110.108 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.06 22.04 64.2 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.49 ' NE2' HD13 ' A' ' 23' ' ' LEU . 62.0 tt0 -92.75 134.48 35.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.442 -1.034 . . . . 0.0 110.259 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.519 ' HG2' ' CG ' ' A' ' 44' ' ' GLN . 79.9 mt-10 -114.96 133.09 56.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.282 -0.887 . . . . 0.0 109.934 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.499 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -161.26 157.03 28.58 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -67.07 142.19 57.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.349 -1.089 . . . . 0.0 110.159 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.521 ' CG2' ' HB2' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -133.63 162.13 59.52 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 110.137 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.582 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 47.8 Cg_endo -90.26 162.88 4.63 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.993 1.523 . . . . 0.0 110.09 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -87.34 -2.23 58.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -0.924 . . . . 0.0 110.819 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -100.1 -25.74 14.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.036 -1.04 . . . . 0.0 110.987 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.559 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 22.4 m-85 -84.26 -9.26 58.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.924 -1.11 . . . . 0.0 110.53 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.447 HG23 ' CD1' ' A' ' 54' ' ' ILE . 22.4 m -131.16 143.24 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 110.301 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -130.33 156.72 44.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.185 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 93.1 mttt -68.53 133.52 48.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.32 -0.863 . . . . 0.0 110.177 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.9 -31.78 68.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.931 . . . . 0.0 110.148 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.208 -179.984 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 m -125.87 76.09 71.02 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.222 -1.164 . . . . 0.0 110.171 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -56.56 -17.21 21.31 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.086 1.571 . . . . 0.0 110.263 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.7 tp -91.91 132.72 36.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.295 -0.878 . . . . 0.0 110.212 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -84.55 119.76 25.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.159 -0.963 . . . . 0.0 110.183 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.426 ' C ' ' OD1' ' A' ' 6' ' ' ASP . 55.9 p30 -92.44 10.19 31.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.322 -0.861 . . . . 0.0 110.308 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.444 ' O ' HG13 ' A' ' 33' ' ' ILE . 29.0 m120 -86.89 4.58 40.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.165 -0.959 . . . . 0.0 110.364 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.462 ' O ' HG11 ' A' ' 9' ' ' VAL . 12.4 tp -91.85 151.83 20.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.216 -0.928 . . . . 0.0 110.204 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.524 ' CG1' ' O ' ' A' ' 60' ' ' ALA . 4.2 m -153.18 173.39 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 0.0 110.532 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 62.1 mt -120.63 142.6 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.376 -0.828 . . . . 0.0 109.527 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.523 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . . . -77.54 115.77 17.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.116 -0.99 . . . . 0.0 110.342 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 15.5 tp -73.55 -20.3 60.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.14 -0.975 . . . . 0.0 109.086 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -149.35 -158.95 0.97 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.586 -0.696 . . . . 0.0 109.693 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 93.8 p -118.07 140.51 49.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.164 -0.96 . . . . 0.0 110.151 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.579 ' CD2' ' HD3' ' A' ' 55' ' ' PRO . 60.2 t80 -103.53 162.6 12.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.067 -1.021 . . . . 0.0 110.223 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.567 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 47.0 tt0 -119.91 130.32 24.91 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 110.273 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.441 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 48.1 Cg_endo -81.22 84.46 1.97 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.02 1.537 . . . . 0.0 110.403 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 77.0 p -79.83 -1.19 37.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.925 . . . . 0.0 110.093 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.444 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 82.2 m-70 -150.28 158.16 43.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 110.02 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -66.09 127.47 32.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 110.217 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.12 -10.91 40.34 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.444 ' OD2' ' HB2' ' A' ' 19' ' ' HIS . 41.5 m-20 -83.18 152.45 25.23 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.231 -1.158 . . . . 0.0 110.316 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.546 ' O ' ' CD1' ' A' ' 15' ' ' TYR . 14.2 tp -114.22 120.01 39.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.308 -0.87 . . . . 0.0 110.036 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.472 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -102.86 56.71 0.61 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.542 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 36.2 p90 -50.8 171.6 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.185 -1.185 . . . . 0.0 110.874 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -103.62 178.59 4.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.545 -0.722 . . . . 0.0 109.981 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.9 mttp -69.69 124.56 24.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 110.328 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.443 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 92.45 -12.26 70.15 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.674 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.447 ' HG2' HD22 ' A' ' 31' ' ' LEU . 41.4 tt0 -59.74 127.68 33.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.129 -1.218 . . . . 0.0 110.395 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -79.83 131.93 36.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.929 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.447 HD22 ' HG2' ' A' ' 29' ' ' GLU . 18.9 mt -131.58 151.31 51.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -0.938 . . . . 0.0 110.408 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.496 ' CZ ' HD11 ' A' ' 46' ' ' LEU . 20.2 mtp85 -98.54 133.66 42.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.341 -0.849 . . . . 0.0 109.523 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.444 HG13 ' O ' ' A' ' 7' ' ' ASN . 27.3 mt -77.1 118.12 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.978 . . . . 0.0 110.067 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.451 ' HG ' ' HA ' ' A' ' 43' ' ' ALA . 86.3 mt -95.68 -36.74 11.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 0.0 110.273 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.433 ' OE1' ' HA ' ' A' ' 35' ' ' GLU . 67.3 mm-40 -139.96 153.17 46.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 110.213 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.526 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 96.1 mt-30 -135.48 55.14 1.89 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.304 -0.873 . . . . 0.0 110.215 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.3 m -120.03 135.72 54.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.272 -0.892 . . . . 0.0 110.148 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.44 178.42 42.75 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.97 -33.19 75.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.359 -1.083 . . . . 0.0 110.355 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.578 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 98.7 m95 -91.89 140.81 29.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.174 -0.954 . . . . 0.0 110.153 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.526 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 40.7 m0 -122.01 152.99 39.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.9 . . . . 0.0 110.212 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.5 tttm -91.85 148.23 22.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 0.0 109.589 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.519 ' HB1' ' CG2' ' A' ' 54' ' ' ILE . . . -155.49 178.11 10.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.0 -1.062 . . . . 0.0 110.622 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.535 ' CG ' ' HG2' ' A' ' 51' ' ' GLU . 28.4 tt0 -150.9 159.67 44.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.296 -0.878 . . . . 0.0 109.724 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.416 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 6.4 t -82.27 147.56 28.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.072 -1.018 . . . . 0.0 109.933 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.496 HD11 ' CZ ' ' A' ' 32' ' ' ARG . 30.3 tp -91.68 -21.31 20.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.927 . . . . 0.0 109.945 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.4 p -107.77 -28.14 9.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.354 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.3 m -94.43 -31.16 14.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.124 -0.985 . . . . 0.0 110.233 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.55 24.02 59.36 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.46 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 65.2 tp60 -97.55 136.66 37.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.358 -1.084 . . . . 0.0 110.022 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.535 ' HG2' ' CG ' ' A' ' 44' ' ' GLN . 31.2 mt-10 -117.52 136.73 53.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.094 -1.004 . . . . 0.0 110.244 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.497 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -167.79 162.52 36.31 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -66.37 141.94 57.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.297 -1.119 . . . . 0.0 110.217 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.519 ' CG2' ' HB1' ' A' ' 43' ' ' ALA . 1.3 pp -133.4 144.35 51.92 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.255 -0.903 . . . . 0.0 110.171 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.579 ' HD3' ' CD2' ' A' ' 15' ' ' TYR . 44.6 Cg_endo -71.23 152.57 61.71 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.023 1.538 . . . . 0.0 110.373 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.566 ' CE2' ' OD1' ' A' ' 57' ' ' ASN . 20.1 p90 -89.89 -1.08 57.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.335 -0.853 . . . . 0.0 110.68 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.566 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 92.3 m-20 -95.64 -27.14 15.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.089 -1.007 . . . . 0.0 110.668 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.565 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 12.8 m-30 -90.46 4.39 51.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.096 -1.002 . . . . 0.0 110.465 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.472 ' CG1' ' HB ' ' A' ' 9' ' ' VAL . 10.7 t -140.93 163.84 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 110.206 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.524 ' O ' ' CG1' ' A' ' 9' ' ' VAL . . . -152.7 173.86 14.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -0.846 . . . . 0.0 110.193 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -68.51 132.14 46.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.173 -0.955 . . . . 0.0 110.164 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.3 148.08 51.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.223 -0.923 . . . . 0.0 110.185 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.232 -179.988 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 m -92.17 132.99 30.94 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.294 -1.121 . . . . 0.0 110.155 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -63.38 -12.02 28.56 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.086 1.572 . . . . 0.0 110.323 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 25.9 tp -62.93 -26.8 68.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 110.275 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -129.21 146.4 51.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 110.185 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.495 ' OD1' ' CD1' ' A' ' 8' ' ' LEU . 43.3 t0 -136.72 78.13 1.68 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.151 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 43.9 t-20 -87.01 108.73 18.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 110.34 -179.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.495 ' CD1' ' OD1' ' A' ' 6' ' ' ASP . 6.7 mp -109.57 142.41 40.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.238 -0.914 . . . . 0.0 110.048 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.448 HG11 ' HA ' ' A' ' 61' ' ' LYS . 27.3 m -143.5 166.99 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.228 -0.92 . . . . 0.0 110.404 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.44 ' O ' HD13 ' A' ' 12' ' ' LEU . 21.3 mm -110.73 146.23 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.86 . . . . 0.0 109.754 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.15 113.51 18.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.116 -0.99 . . . . 0.0 110.381 -179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.513 ' O ' ' ND1' ' A' ' 13' ' ' HIS . 8.2 mp -74.57 -19.98 60.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 0.0 109.371 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.513 ' ND1' ' O ' ' A' ' 12' ' ' LEU . 71.9 m80 -155.61 145.17 21.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.497 -0.752 . . . . 0.0 109.611 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.53 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 33.1 p -64.03 145.98 54.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.94 -1.1 . . . . 0.0 110.129 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.585 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 82.9 t80 -104.35 166.7 10.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.101 -0.999 . . . . 0.0 110.211 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.24 120.08 29.26 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.912 . . . . 0.0 110.125 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.463 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 49.5 Cg_endo -70.19 84.35 0.73 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.949 1.5 . . . . 0.0 110.219 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.514 ' OG ' ' ND1' ' A' ' 19' ' ' HIS . 73.8 p -79.9 -3.84 49.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -0.881 . . . . 0.0 110.082 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.514 ' ND1' ' OG ' ' A' ' 18' ' ' SER . 50.9 m80 -145.94 140.5 26.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 110.195 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -53.45 124.48 14.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 110.279 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.76 16.02 12.35 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -114.69 159.85 20.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -1.184 . . . . 0.0 110.303 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.484 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 15.4 tp -115.23 118.41 33.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.329 -0.857 . . . . 0.0 110.081 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.463 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . -95.9 47.59 1.84 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.585 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 40.2 p90 -47.36 171.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.269 -1.136 . . . . 0.0 111.042 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.53 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 92.4 mt-10 -105.95 178.82 4.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.412 -0.805 . . . . 0.0 110.069 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.6 tttt -69.32 138.0 53.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.083 -1.011 . . . . 0.0 110.136 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.09 -12.31 60.48 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.458 ' O ' HD11 ' A' ' 31' ' ' LEU . 8.4 tt0 -63.57 128.17 34.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.174 -1.191 . . . . 0.0 110.118 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.483 ' C ' ' CD1' ' A' ' 31' ' ' LEU . 92.6 mt-30 -79.55 134.53 36.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 109.992 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.483 ' CD1' ' C ' ' A' ' 30' ' ' GLN . 8.5 mp -136.11 156.87 48.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.919 . . . . 0.0 110.736 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.535 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 22.8 ttt180 -107.76 135.81 48.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.442 -0.786 . . . . 0.0 109.138 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.529 HG22 HD11 ' A' ' 33' ' ' ILE . 54.4 mt -91.39 92.35 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.042 -1.036 . . . . 0.0 110.879 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.5 HD22 ' NE ' ' A' ' 32' ' ' ARG . 11.0 mt -79.08 -29.84 43.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.581 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.52 ' CB ' ' HB3' ' A' ' 42' ' ' LYS . 45.7 tt0 -134.6 132.86 39.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.961 -1.087 . . . . 0.0 110.234 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.579 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 53.3 tt0 -129.08 59.31 1.58 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.286 -0.884 . . . . 0.0 110.119 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 89.5 p -121.53 146.12 47.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 110.237 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.02 -170.26 47.57 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -74.6 -33.1 62.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -1.138 . . . . 0.0 110.072 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.51 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 99.0 m95 -96.44 142.8 28.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.212 -0.93 . . . . 0.0 110.16 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.579 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 43.1 m0 -119.94 154.97 33.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.22 -0.925 . . . . 0.0 110.192 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.52 ' HB3' ' CB ' ' A' ' 35' ' ' GLU . 34.3 tttp -97.63 141.17 31.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.343 -0.848 . . . . 0.0 109.132 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.535 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -152.52 177.77 10.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.94 -1.1 . . . . 0.0 110.803 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.449 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 58.6 tt0 -142.65 150.62 40.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.438 -0.789 . . . . 0.0 109.912 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.1 t -97.16 114.75 26.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.989 . . . . 0.0 110.229 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.7 mt -74.63 0.18 15.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -0.944 . . . . 0.0 110.118 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 54.9 m -86.16 -33.26 20.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 110.045 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.8 p -128.39 -3.58 5.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.159 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.2 33.77 56.23 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.428 ' HB3' HD12 ' A' ' 23' ' ' LEU . 17.2 mt-30 -101.86 139.96 36.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.289 -1.124 . . . . 0.0 110.148 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.449 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 78.6 tt0 -120.77 140.77 51.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 0.0 110.163 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.484 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -174.12 164.53 35.81 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.406 ' C ' HG21 ' A' ' 54' ' ' ILE . 81.7 m-85 -74.06 146.37 43.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.174 -1.192 . . . . 0.0 109.758 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.506 ' CD1' HG12 ' A' ' 59' ' ' VAL . 1.8 pp -140.71 143.16 31.16 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.183 -0.948 . . . . 0.0 110.501 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.622 ' CG ' ' CD2' ' A' ' 58' ' ' PHE . 44.6 Cg_endo -63.1 148.39 93.35 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.157 1.609 . . . . 0.0 110.109 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.572 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 20.4 p90 -84.67 -1.42 56.08 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.294 -0.879 . . . . 0.0 110.895 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.539 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 87.8 m-20 -94.6 -26.24 16.45 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.984 -1.073 . . . . 0.0 110.634 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.622 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 13.1 m-30 -90.87 6.84 42.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.087 -1.008 . . . . 0.0 110.391 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.506 HG12 ' CD1' ' A' ' 54' ' ' ILE . 31.0 m -132.53 142.18 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 0.0 110.053 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.434 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . -131.38 158.92 39.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.914 . . . . 0.0 110.247 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.448 ' HA ' HG11 ' A' ' 9' ' ' VAL . 74.9 mttt -75.28 125.23 28.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 110.259 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.96 150.39 44.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.924 . . . . 0.0 110.245 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.166 -179.965 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 4' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.516 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 0.5 OUTLIER -44.48 -52.61 16.82 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.273 -1.133 . . . . 0.0 110.285 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.516 ' HD2' ' N ' ' A' ' 2' ' ' SER . 47.0 Cg_endo -72.2 -15.87 28.51 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.892 1.469 . . . . 0.0 110.327 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 1' ' ' GLY . 19.6 tp -102.29 136.88 41.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 110.237 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -107.77 127.85 54.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.235 -0.916 . . . . 0.0 110.181 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.467 ' OD1' ' CD1' ' A' ' 8' ' ' LEU . 50.1 t0 -143.39 83.07 1.76 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.268 -0.895 . . . . 0.0 110.213 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -90.63 112.38 24.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.267 -0.896 . . . . 0.0 110.268 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.467 ' CD1' ' OD1' ' A' ' 6' ' ' ASP . 5.4 mp -114.71 139.97 49.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 110.094 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.451 HG13 ' HA ' ' A' ' 61' ' ' LYS . 21.5 m -138.33 163.78 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.144 -0.973 . . . . 0.0 110.44 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.434 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 90.7 mt -112.77 143.39 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.367 -0.833 . . . . 0.0 109.802 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.574 ' CB ' ' CD2' ' A' ' 25' ' ' PHE . . . -80.57 110.62 16.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.159 -0.963 . . . . 0.0 110.505 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.497 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 6.3 mp -68.56 -22.99 64.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.985 -1.072 . . . . 0.0 109.031 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.497 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 75.3 m-70 -158.29 149.26 20.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.593 -0.692 . . . . 0.0 109.342 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.48 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 54.3 p -61.65 142.75 56.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.928 -1.108 . . . . 0.0 109.982 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.583 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 80.1 t80 -98.66 159.97 14.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.084 -1.01 . . . . 0.0 110.443 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -105.63 112.32 64.62 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 109.999 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.451 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 49.3 Cg_endo -72.66 89.76 0.84 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.965 1.508 . . . . 0.0 110.513 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.6 p -79.68 -4.07 50.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.929 . . . . 0.0 110.183 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -130.47 -176.01 3.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.216 -0.927 . . . . 0.0 110.213 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -92.38 -10.85 36.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 0.0 110.247 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.32 32.69 5.95 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -117.8 159.33 23.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -1.131 . . . . 0.0 110.385 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.506 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 14.5 tp -114.18 118.43 33.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.357 -0.84 . . . . 0.0 109.763 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.451 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . -96.23 50.36 1.67 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.574 ' CD2' ' CB ' ' A' ' 11' ' ' ALA . 41.5 p90 -48.1 170.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -1.171 . . . . 0.0 110.823 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.406 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 77.2 mm-40 -101.39 178.49 4.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.421 -0.8 . . . . 0.0 110.237 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.42 ' HG3' ' O ' ' A' ' 12' ' ' LEU . 50.0 tttm -70.55 124.07 23.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.171 -0.956 . . . . 0.0 110.379 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.86 -8.19 73.61 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.426 ' CD ' ' HB2' ' A' ' 25' ' ' PHE . 45.7 tt0 -67.25 125.54 26.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.116 -1.226 . . . . 0.0 110.374 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.437 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 96.4 mt-30 -79.72 138.29 37.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.21 -0.931 . . . . 0.0 109.859 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.437 ' HG ' ' C ' ' A' ' 30' ' ' GLN . 21.1 mt -137.32 159.0 43.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 110.398 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.482 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 9.4 ttt180 -101.62 132.32 47.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.401 -0.812 . . . . 0.0 109.526 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.8 mt -72.92 115.04 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.172 -0.955 . . . . 0.0 110.39 -179.689 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.484 HD13 ' HB2' ' A' ' 44' ' ' GLN . 38.3 mt -83.32 -38.05 22.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.929 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.423 ' C ' ' HG3' ' A' ' 36' ' ' GLN . 87.3 mt-10 -148.62 170.63 17.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.309 -0.869 . . . . 0.0 110.26 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.47 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 98.5 mt-30 -147.33 60.46 1.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 110.201 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.1 p -130.34 136.47 49.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 110.222 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.95 -170.97 44.17 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -75.88 -31.89 59.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.191 -1.182 . . . . 0.0 110.31 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.568 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 85.8 m95 -100.45 149.43 23.68 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.228 -0.92 . . . . 0.0 110.089 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.47 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 38.2 m0 -119.95 153.28 36.16 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.222 -0.924 . . . . 0.0 110.425 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 34' ' ' LEU . 41.9 tttp -89.4 142.98 27.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.349 -0.844 . . . . 0.0 109.662 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.526 ' CB ' HG12 ' A' ' 54' ' ' ILE . . . -137.22 158.04 45.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.138 -0.976 . . . . 0.0 110.805 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.484 ' HB2' HD13 ' A' ' 34' ' ' LEU . 56.3 tt0 -129.04 138.35 51.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.484 -0.76 . . . . 0.0 109.962 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.456 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 6.5 t -79.14 140.0 37.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.115 -0.991 . . . . 0.0 110.011 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 61.9 mt -92.94 -13.04 29.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.885 179.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.7 m -99.4 -25.73 14.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.426 -0.796 . . . . 0.0 110.349 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.456 ' OG1' ' HB3' ' A' ' 45' ' ' SER . 40.6 p -114.59 -13.42 12.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.063 -1.023 . . . . 0.0 110.398 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 64.88 45.83 91.31 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.45 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 20.2 mt-30 -120.76 152.03 38.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.368 -1.078 . . . . 0.0 110.17 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.455 ' HG2' HD13 ' A' ' 34' ' ' LEU . 96.7 mt-10 -116.81 134.52 54.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -0.871 . . . . 0.0 110.173 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.506 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -155.58 151.83 23.36 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -70.56 143.52 51.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -1.182 . . . . 0.0 110.094 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.541 ' CD1' ' CG2' ' A' ' 59' ' ' VAL . 1.9 pp -138.46 134.73 17.62 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.9 . . . . 0.0 110.117 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.583 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 46.0 Cg_endo -59.1 158.92 23.73 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.94 1.495 . . . . 0.0 110.286 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.476 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 23.5 p90 -84.14 -5.07 59.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 110.885 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -96.28 -25.13 15.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.048 -1.032 . . . . 0.0 110.931 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.561 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 19.2 m-85 -83.92 -8.63 59.13 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.022 -1.049 . . . . 0.0 110.306 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.541 ' CG2' ' CD1' ' A' ' 54' ' ' ILE . 33.6 m -136.22 146.0 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.138 -0.977 . . . . 0.0 110.359 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -132.56 154.72 49.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.271 -0.893 . . . . 0.0 110.22 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.451 ' HA ' HG13 ' A' ' 9' ' ' VAL . 41.0 mttp -68.55 125.07 25.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 110.243 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.71 -37.95 71.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 110.208 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.175 -179.96 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m -65.57 153.98 89.27 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.287 -1.125 . . . . 0.0 110.287 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.427 ' O ' ' OD1' ' A' ' 6' ' ' ASP . 46.4 Cg_endo -59.99 142.09 97.75 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.022 1.538 . . . . 0.0 110.303 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.49 ' C ' ' CD1' ' A' ' 4' ' ' LEU . 3.1 tm? -62.52 -37.72 87.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 110.21 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.405 ' O ' ' HB2' ' A' ' 6' ' ' ASP . 96.4 mt-30 -58.24 -30.49 66.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.0 110.25 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 3' ' ' PRO . 94.8 m-20 54.04 44.31 29.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.216 -0.927 . . . . 0.0 110.182 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -82.53 5.19 21.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.204 -0.935 . . . . 0.0 110.309 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.55 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 5.5 mp -89.99 154.94 19.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.907 . . . . 0.0 110.197 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 27.8 m -148.32 168.87 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.197 -0.94 . . . . 0.0 110.389 -179.868 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 26.1 mm -112.57 146.44 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.376 -0.827 . . . . 0.0 109.842 179.694 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . . . . . . . . . . . -80.18 112.29 17.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.14 -0.975 . . . . 0.0 110.388 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 27.0 tp -75.27 -22.45 57.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.108 -0.995 . . . . 0.0 109.621 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.455 ' HA ' ' HG2' ' A' ' 27' ' ' LYS . 94.7 m-70 -151.97 149.75 29.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.492 -0.755 . . . . 0.0 109.762 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.47 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 15.9 t -68.35 141.88 55.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.011 -1.056 . . . . 0.0 109.941 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.59 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 85.8 t80 -98.83 160.08 14.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.938 . . . . 0.0 110.246 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.503 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 2.1 tm-20 -112.38 128.54 25.38 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 0.0 110.169 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.454 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 47.3 Cg_endo -83.39 82.28 2.11 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.028 1.541 . . . . 0.0 110.532 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.513 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 88.9 p -80.8 -0.97 41.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 110.137 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.513 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 84.2 m-70 -145.68 179.59 7.33 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.906 . . . . 0.0 110.167 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -90.39 127.92 36.33 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 110.106 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.76 -3.13 41.89 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -89.97 154.66 19.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -1.138 . . . . 0.0 110.278 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.499 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 22.5 tp -109.63 114.6 28.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.171 -0.956 . . . . 0.0 110.067 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.464 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -96.17 47.41 1.8 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.564 ' CE1' ' HB2' ' A' ' 15' ' ' TYR . 46.4 p90 -50.43 174.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.149 -1.206 . . . . 0.0 111.164 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.47 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 83.2 mt-10 -110.59 177.9 4.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.464 -0.772 . . . . 0.0 110.216 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.468 ' HG2' ' N ' ' A' ' 14' ' ' SER . 5.4 mtmm -69.16 139.39 54.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.036 -1.04 . . . . 0.0 110.231 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.15 -16.24 49.16 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 39.0 mm-40 -66.4 125.61 26.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.051 -1.264 . . . . 0.0 110.012 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.4 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 22.5 tt0 -79.48 137.77 37.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.875 . . . . 0.0 110.168 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.528 HD12 ' CG ' ' A' ' 25' ' ' PHE . 41.4 mt -137.84 159.87 40.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.316 -0.865 . . . . 0.0 110.211 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.515 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 37.0 ttp180 -108.48 135.78 49.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.623 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.521 HG23 ' CG ' ' A' ' 36' ' ' GLN . 36.9 mm -96.18 92.63 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.166 -0.959 . . . . 0.0 110.435 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.467 ' HG ' ' HG2' ' A' ' 32' ' ' ARG . 17.2 mt -79.45 -24.91 42.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.214 -0.929 . . . . 0.0 110.777 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.458 ' O ' ' HB3' ' A' ' 41' ' ' TRP . 45.1 tp10 -136.2 134.67 38.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.954 -1.091 . . . . 0.0 110.388 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.578 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 75.3 mt-30 -129.41 54.87 1.79 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.347 -0.846 . . . . 0.0 110.153 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.4 m -114.86 154.01 29.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 110.183 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.26 -173.27 8.53 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -72.2 -31.91 66.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -1.136 . . . . 0.0 110.181 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.446 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 92.5 m95 -97.77 143.06 28.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.258 -0.902 . . . . 0.0 110.34 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.578 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 51.2 m0 -120.15 155.41 33.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.367 -0.833 . . . . 0.0 110.115 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.491 ' NZ ' ' OE2' ' A' ' 51' ' ' GLU . 48.8 tttt -96.55 141.34 29.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.882 . . . . 0.0 109.365 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -149.97 174.58 12.54 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.078 -1.014 . . . . 0.0 110.815 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.438 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 61.3 tt0 -141.12 149.53 41.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.451 -0.781 . . . . 0.0 109.765 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.0 t -95.48 111.88 23.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.197 -0.94 . . . . 0.0 110.161 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.426 ' HG ' ' O ' ' A' ' 46' ' ' LEU . 18.5 tp -71.85 -1.85 15.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -0.896 . . . . 0.0 110.415 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.1 m -88.57 -29.1 20.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.237 -0.915 . . . . 0.0 110.098 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.7 p -126.67 -6.15 6.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 110.163 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.21 36.63 59.95 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.8 mt-30 -109.63 144.98 37.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -1.159 . . . . 0.0 110.228 -179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.491 ' OE2' ' NZ ' ' A' ' 42' ' ' LYS . 83.5 tt0 -118.52 138.92 52.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.898 . . . . 0.0 110.033 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.499 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -166.88 158.17 31.01 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.409 ' C ' HG21 ' A' ' 54' ' ' ILE . 90.0 m-85 -72.55 143.81 48.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -1.132 . . . . 0.0 110.18 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.451 HG12 ' HB1' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -137.47 145.47 49.47 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 110.213 -179.866 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.59 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 47.3 Cg_endo -69.51 149.14 68.11 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.98 1.516 . . . . 0.0 110.156 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.575 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 36.3 p90 -74.99 -4.78 40.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.969 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -96.17 -25.33 15.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.875 -1.141 . . . . 0.0 110.954 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.582 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 9.0 m-85 -83.14 -2.16 54.73 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.055 -1.028 . . . . 0.0 110.284 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.423 HG22 ' CD1' ' A' ' 54' ' ' ILE . 33.1 m -136.32 144.08 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 110.071 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -135.23 151.5 50.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.138 -0.977 . . . . 0.0 110.242 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -62.74 128.03 34.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 0.0 110.242 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.4 -31.49 72.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 110.149 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.5 m120 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.233 179.973 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p -64.13 150.17 92.73 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.195 -1.179 . . . . 0.0 110.226 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.516 ' CG ' ' NH1' ' A' ' 32' ' ' ARG . 46.6 Cg_endo -55.81 139.87 84.36 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.04 1.547 . . . . 0.0 110.336 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 49.9 mt -71.71 -8.19 52.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 0.0 110.211 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 6' ' ' ASP . 46.1 tt0 -81.43 -34.02 31.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.216 -0.927 . . . . 0.0 110.233 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.521 ' O ' ' CD1' ' A' ' 8' ' ' LEU . 57.0 m-20 42.99 51.11 5.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.299 -0.876 . . . . 0.0 110.209 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -84.91 102.33 13.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 110.339 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.521 ' CD1' ' O ' ' A' ' 6' ' ' ASP . 6.5 mp -99.92 146.03 27.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.894 . . . . 0.0 110.206 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.529 ' CG2' ' CG1' ' A' ' 59' ' ' VAL . 11.8 m -144.65 167.04 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.181 -0.949 . . . . 0.0 110.334 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.8 mt -111.41 145.51 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.0 109.707 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.477 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . . . -79.2 112.9 16.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.97 . . . . 0.0 110.303 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.505 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 55.2 mt -71.55 -21.35 61.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.105 -0.997 . . . . 0.0 109.487 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.505 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 62.7 m-70 -157.61 148.86 21.58 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.574 -0.704 . . . . 0.0 109.628 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 58.6 p -63.06 143.31 57.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.981 -1.075 . . . . 0.0 109.919 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.579 ' CD1' ' HG3' ' A' ' 55' ' ' PRO . 24.4 t80 -96.65 155.05 16.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.055 -1.028 . . . . 0.0 110.269 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -110.11 75.28 0.88 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.854 . . . . 0.0 110.17 179.989 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.526 ' HD3' ' CA ' ' A' ' 24' ' ' GLY . 46.8 Cg_endo -46.96 122.5 6.26 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.047 1.551 . . . . 0.0 110.372 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.499 ' O ' ' CD2' ' A' ' 19' ' ' HIS . 58.4 m -91.89 10.69 27.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.366 -0.834 . . . . 0.0 110.128 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.499 ' CD2' ' O ' ' A' ' 18' ' ' SER . 33.8 m170 -140.55 -158.26 0.84 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.303 -0.873 . . . . 0.0 110.192 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.4 p30 -112.67 3.92 16.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.193 -0.942 . . . . 0.0 110.187 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.43 -9.36 17.49 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.476 ' HB2' ' CB ' ' A' ' 17' ' ' PRO . 84.2 m-20 -81.65 165.7 20.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.214 -1.168 . . . . 0.0 110.4 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.479 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 14.7 tp -113.39 115.19 27.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 0.0 109.779 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.526 ' CA ' ' HD3' ' A' ' 17' ' ' PRO . . . -96.18 55.46 1.53 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.494 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 17.9 p90 -54.2 172.71 0.08 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.367 -1.078 . . . . 0.0 110.97 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -103.53 178.39 4.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.514 -0.741 . . . . 0.0 110.145 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -69.97 132.78 46.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.966 . . . . 0.0 110.101 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.13 -10.64 72.25 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.483 ' OE2' ' CB ' ' A' ' 25' ' ' PHE . 22.2 tt0 -64.09 126.58 28.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -1.222 . . . . 0.0 110.032 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.469 ' O ' HD13 ' A' ' 31' ' ' LEU . 38.1 tt0 -79.47 136.79 37.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.178 -0.952 . . . . 0.0 109.857 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.469 HD13 ' O ' ' A' ' 30' ' ' GLN . 7.1 mp -139.8 161.87 36.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 110.593 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.531 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 2.7 tpt180 -109.28 135.9 49.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.406 -0.809 . . . . 0.0 109.257 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.519 ' CG2' ' HG2' ' A' ' 36' ' ' GLN . 33.7 mm -91.21 92.42 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.102 -0.998 . . . . 0.0 110.567 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.422 ' CD1' ' HB2' ' A' ' 44' ' ' GLN . 1.5 mt -79.54 -30.01 41.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 110.789 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.494 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 77.5 tt0 -133.6 137.12 45.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.017 -1.052 . . . . 0.0 110.45 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.563 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 75.6 mt-30 -133.65 54.78 1.93 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 110.092 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -120.75 143.25 48.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.917 . . . . 0.0 110.221 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.83 -168.62 54.82 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -77.49 -33.83 54.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -1.141 . . . . 0.0 110.151 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.557 ' CZ3' ' OH ' ' A' ' 15' ' ' TYR . 98.6 m95 -96.79 141.77 29.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 110.251 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.569 ' CZ3' ' HB2' ' A' ' 56' ' ' PHE . 40.6 m0 -116.83 153.65 32.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.902 . . . . 0.0 110.199 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.494 ' CB ' ' HB3' ' A' ' 35' ' ' GLU . 12.0 tttt -99.9 140.5 34.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.372 -0.83 . . . . 0.0 109.409 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.531 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -150.36 176.48 10.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.069 -1.02 . . . . 0.0 110.662 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.441 ' HG3' ' O ' ' A' ' 50' ' ' GLN . 62.0 tt0 -139.01 147.57 42.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.368 -0.832 . . . . 0.0 109.96 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.5 t -97.21 117.03 30.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.95 . . . . 0.0 110.303 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.5 mt -76.6 2.59 13.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.168 -0.958 . . . . 0.0 110.118 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.9 m -91.58 -35.58 14.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 110.163 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 70.8 p -118.62 -6.02 10.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -0.884 . . . . 0.0 110.237 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.93 43.73 64.5 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.441 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 7.0 mt-30 -121.17 149.61 42.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -1.177 . . . . 0.0 110.234 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.438 ' OE2' ' HE2' ' A' ' 42' ' ' LYS . 82.3 tt0 -122.83 145.47 48.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 110.132 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.479 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -174.36 163.71 34.51 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.431 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 90.4 m-85 -75.24 146.08 41.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.322 -1.105 . . . . 0.0 109.847 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 54' ' ' ILE . 1.5 pp -140.02 140.46 24.06 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.135 -0.978 . . . . 0.0 110.544 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.635 ' CG ' ' CD2' ' A' ' 58' ' ' PHE . 44.6 Cg_endo -60.22 145.17 99.11 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.164 1.613 . . . . 0.0 110.062 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.569 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 21.9 p90 -82.7 -5.12 58.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 110.927 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -91.59 -27.48 18.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.928 -1.108 . . . . 0.0 110.648 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.635 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 18.2 m-30 -85.86 6.82 26.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.106 -0.997 . . . . 0.0 110.105 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.529 ' CG1' ' CG2' ' A' ' 9' ' ' VAL . 26.4 t -141.85 169.46 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.882 . . . . 0.0 109.769 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.517 ' O ' ' CG1' ' A' ' 9' ' ' VAL . . . -159.91 156.3 27.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.089 -1.007 . . . . 0.0 110.267 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 48.5 tttm -56.74 129.5 41.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.206 -0.934 . . . . 0.0 110.3 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.06 148.83 48.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 110.236 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.309 179.927 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.506 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 0.3 OUTLIER -45.17 -58.39 5.78 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.221 -1.164 . . . . 0.0 110.162 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.506 ' HD2' ' N ' ' A' ' 2' ' ' SER . 47.4 Cg_endo -66.64 147.9 82.39 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.033 1.544 . . . . 0.0 110.337 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 20.0 tp -104.2 132.44 50.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 110.256 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -121.48 161.73 21.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 0.0 110.214 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -147.1 81.18 1.54 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 0.0 110.182 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 70.4 m-20 -98.56 101.75 13.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 110.358 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.457 ' O ' HG11 ' A' ' 9' ' ' VAL . 9.5 tp -110.8 153.09 25.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -0.869 . . . . 0.0 110.065 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.499 ' CG1' ' O ' ' A' ' 60' ' ' ALA . 4.1 m -152.32 172.96 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.129 -0.982 . . . . 0.0 110.464 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.6 mt -120.14 140.46 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.406 -0.809 . . . . 0.0 109.511 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.449 ' HB2' ' CD1' ' A' ' 25' ' ' PHE . . . -74.22 114.69 12.86 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.176 -0.952 . . . . 0.0 110.33 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.418 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 23.9 tp -71.18 -21.58 62.14 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 109.264 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.418 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 65.5 m-70 -154.94 -163.63 1.61 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.607 -0.683 . . . . 0.0 109.733 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.407 ' O ' ' OE2' ' A' ' 16' ' ' GLU . 30.1 t -106.91 135.76 47.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.085 -1.009 . . . . 0.0 109.756 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.584 ' CD1' ' HD3' ' A' ' 55' ' ' PRO . 81.5 t80 -97.15 151.79 19.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.993 -1.067 . . . . 0.0 110.4 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.407 ' OE2' ' O ' ' A' ' 14' ' ' SER . 1.9 mp0 -117.09 102.71 52.59 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.337 -0.852 . . . . 0.0 110.209 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.448 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 46.9 Cg_endo -62.99 98.91 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.013 1.533 . . . . 0.0 110.366 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.566 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 97.8 p -81.25 7.43 11.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.144 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.566 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 97.8 m-70 -154.27 -177.59 6.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 110.143 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -88.49 130.69 35.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.11 -0.994 . . . . 0.0 110.239 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.76 13.45 25.69 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -109.3 159.18 17.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.165 -1.197 . . . . 0.0 110.403 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.509 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 15.7 tp -115.26 120.07 38.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 110.177 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.493 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -101.54 58.41 0.64 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.582 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 34.9 p90 -52.94 171.35 0.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.14 -1.212 . . . . 0.0 111.326 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.447 ' N ' ' OE1' ' A' ' 29' ' ' GLU . 94.4 mt-10 -105.06 178.35 4.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.565 -0.71 . . . . 0.0 109.949 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -69.84 129.46 39.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.117 -0.989 . . . . 0.0 110.3 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.45 -15.04 56.36 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.447 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 24.4 tt0 -59.02 124.4 19.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.134 -1.215 . . . . 0.0 110.063 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.433 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 88.9 mt-30 -79.9 134.18 36.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.139 -0.976 . . . . 0.0 109.991 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.433 ' HG ' ' C ' ' A' ' 30' ' ' GLN . 10.8 mt -133.07 154.04 50.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.204 -0.935 . . . . 0.0 110.313 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.481 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 14.5 ttt180 -97.33 132.69 42.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.853 . . . . 0.0 109.686 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.444 ' CD1' HG22 ' A' ' 9' ' ' VAL . 23.4 mm -77.85 118.92 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.179 -0.951 . . . . 0.0 110.396 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.5 ' CD1' ' O ' ' A' ' 43' ' ' ALA . 45.7 mt -87.78 -34.55 18.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 109.94 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -172.72 125.49 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.448 -0.782 . . . . 0.0 109.956 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.573 ' HA ' ' CG ' ' A' ' 41' ' ' TRP . 95.1 mt-30 -101.87 62.88 0.91 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.931 . . . . 0.0 110.304 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.5 m -108.54 136.18 48.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.347 -0.846 . . . . 0.0 110.129 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.56 -175.04 53.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -65.47 -36.88 85.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -1.125 . . . . 0.0 110.181 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.58 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 91.8 m95 -95.12 140.32 30.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.9 . . . . 0.0 110.32 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.573 ' CG ' ' HA ' ' A' ' 36' ' ' GLN . 52.3 m0 -113.63 148.89 35.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.303 -0.873 . . . . 0.0 110.257 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.487 ' CB ' ' HB2' ' A' ' 34' ' ' LEU . 24.5 mttm -86.25 141.8 29.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.261 -0.9 . . . . 0.0 109.703 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.522 ' HB2' ' CG2' ' A' ' 54' ' ' ILE . . . -146.28 167.03 24.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.127 -0.983 . . . . 0.0 110.485 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.48 ' CG ' ' HG2' ' A' ' 51' ' ' GLU . 58.7 tt0 -137.63 145.48 42.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.339 -0.85 . . . . 0.0 110.148 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.6 t -90.56 113.31 25.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.113 -0.992 . . . . 0.0 109.892 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 78.5 mt -74.82 3.49 8.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -0.963 . . . . 0.0 110.541 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.0 m -96.54 -33.33 11.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.107 -0.996 . . . . 0.0 110.032 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.6 m -119.17 -7.63 10.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 110.24 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.05 42.45 51.59 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -119.52 148.02 43.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -1.143 . . . . 0.0 110.073 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.48 ' HG2' ' CG ' ' A' ' 44' ' ' GLN . 90.9 mt-10 -118.07 138.27 52.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.948 . . . . 0.0 110.325 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.509 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -159.27 154.91 25.99 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 99.0 m-85 -68.56 146.22 53.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.121 -1.223 . . . . 0.0 110.198 -179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.522 ' CG2' ' HB2' ' A' ' 43' ' ' ALA . 1.3 pt -136.41 147.9 61.9 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.868 . . . . 0.0 110.215 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.584 ' HD3' ' CD1' ' A' ' 15' ' ' TYR . 43.7 Cg_endo -72.76 145.46 41.07 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 124.046 1.551 . . . . 0.0 110.327 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.517 ' HB2' ' CH2' ' A' ' 41' ' ' TRP . 21.0 p90 -81.56 -0.02 40.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.518 -0.739 . . . . 0.0 110.592 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.491 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 85.5 m-20 -98.74 -27.56 13.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.051 -1.031 . . . . 0.0 110.942 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.54 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 18.2 m-30 -90.88 5.86 46.84 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.93 -1.106 . . . . 0.0 110.482 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.44 ' CG1' ' HB ' ' A' ' 9' ' ' VAL . 8.4 t -145.06 164.2 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 0.0 110.137 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.499 ' O ' ' CG1' ' A' ' 9' ' ' VAL . . . -154.97 167.6 29.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.0 110.295 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 64.6 tttt -70.97 132.67 45.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.286 -0.884 . . . . 0.0 110.165 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.83 147.2 28.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.934 . . . . 0.0 110.195 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.167 179.971 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.428 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.6 OUTLIER -128.45 68.94 78.37 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.308 -1.113 . . . . 0.0 110.1 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 5' ' ' GLN . 47.1 Cg_endo -48.01 -45.95 23.54 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.044 1.549 . . . . 0.0 110.379 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.462 ' HB2' ' O ' ' A' ' 3' ' ' PRO . 35.0 mt 55.86 -85.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -0.906 . . . . 0.0 110.257 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 3' ' ' PRO . 98.2 mt-30 -109.41 140.73 42.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 110.315 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 35.1 p-10 -92.17 7.62 41.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.218 -0.926 . . . . 0.0 110.157 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -86.71 2.47 48.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 110.23 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 36.5 mt -83.64 140.68 32.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.193 -0.942 . . . . 0.0 110.189 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.464 HG11 ' HA ' ' A' ' 61' ' ' LYS . 12.6 m -150.95 170.63 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.342 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 19.6 mm -114.35 143.34 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.87 . . . . 0.0 110.076 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.54 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -79.63 110.82 15.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.119 -0.988 . . . . 0.0 110.134 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.439 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 15.9 tp -63.68 -24.67 67.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.05 -1.032 . . . . 0.0 109.529 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.439 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 37.0 m-70 -156.57 158.55 37.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.481 -0.762 . . . . 0.0 109.818 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.523 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 28.3 p -67.32 142.11 56.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.118 -0.989 . . . . 0.0 110.161 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.577 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 81.8 t80 -97.67 158.34 15.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 0.0 110.339 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.491 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -110.11 126.92 27.97 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 110.055 179.925 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.453 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 48.1 Cg_endo -82.91 81.16 2.47 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.976 1.514 . . . . 0.0 110.382 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 55.8 p -79.76 -1.08 37.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 110.078 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -142.69 169.46 17.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.155 -0.966 . . . . 0.0 110.136 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -83.87 130.6 34.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 110.216 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.26 4.01 53.68 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -98.88 161.15 13.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.171 -1.194 . . . . 0.0 110.238 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.525 ' CD1' ' HG3' ' A' ' 50' ' ' GLN . 31.9 tp -114.71 120.11 38.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.875 . . . . 0.0 110.141 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.467 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -100.92 50.52 1.02 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.569 ' CE2' ' HB2' ' A' ' 15' ' ' TYR . 48.0 p90 -50.76 176.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.122 -1.222 . . . . 0.0 111.12 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.523 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 83.4 mt-10 -107.63 174.11 6.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.52 -0.738 . . . . 0.0 110.253 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -68.37 139.76 55.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.122 -0.986 . . . . 0.0 110.405 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.26 -13.27 55.72 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 38.0 mm-40 -67.92 125.59 26.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.015 -1.285 . . . . 0.0 110.262 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.493 ' C ' ' CD1' ' A' ' 31' ' ' LEU . 80.4 mt-30 -79.53 138.69 37.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 109.663 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.493 ' CD1' ' C ' ' A' ' 30' ' ' GLN . 8.3 mp -136.56 156.78 48.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.046 -1.034 . . . . 0.0 110.633 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.53 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 15.9 mtm180 -103.92 131.32 51.26 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.387 -0.821 . . . . 0.0 109.394 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 99.4 mt -88.71 93.5 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.087 -1.008 . . . . 0.0 110.669 -179.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.507 ' CD1' ' HA ' ' A' ' 43' ' ' ALA . 1.6 mp -79.25 -31.55 43.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.342 -0.849 . . . . 0.0 110.85 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.524 ' HB2' ' CB ' ' A' ' 42' ' ' LYS . 79.5 mt-10 -127.62 140.03 52.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.848 -1.158 . . . . 0.0 110.191 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.582 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 49.7 tt0 -135.06 59.7 1.72 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 110.263 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.8 t -125.2 130.98 53.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.897 . . . . 0.0 110.219 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.35 177.29 51.82 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.27 -30.89 71.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.236 -1.155 . . . . 0.0 110.281 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -98.33 144.45 27.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.0 110.263 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.586 ' CZ3' ' HB2' ' A' ' 56' ' ' PHE . 43.6 m0 -126.08 157.88 36.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.37 -0.831 . . . . 0.0 110.166 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.524 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 28.7 tttt -100.03 146.78 26.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.886 . . . . 0.0 109.327 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.53 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -157.94 -175.97 5.66 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.916 -1.115 . . . . 0.0 110.834 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -146.03 154.31 41.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.416 -0.803 . . . . 0.0 109.622 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.3 t -101.71 125.68 48.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 110.392 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.456 ' HG ' ' O ' ' A' ' 46' ' ' LEU . 44.0 tp -81.39 6.12 15.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.387 -0.821 . . . . 0.0 110.135 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.9 m -93.29 -37.96 11.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 110.226 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.8 p -125.39 -7.52 6.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.231 -0.918 . . . . 0.0 110.188 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.91 27.28 56.82 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.525 ' HG3' ' CD1' ' A' ' 23' ' ' LEU . 70.3 tp60 -90.79 131.71 36.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.318 -1.107 . . . . 0.0 110.3 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.444 ' O ' ' HG3' ' A' ' 51' ' ' GLU . 22.7 pt-20 -115.97 134.33 55.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.322 -0.861 . . . . 0.0 110.057 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.451 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -172.49 166.21 38.88 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.484 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 59.4 m-85 -69.05 142.31 54.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -1.142 . . . . 0.0 110.288 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.506 ' CD1' HG23 ' A' ' 59' ' ' VAL . 1.6 pp -136.19 138.51 27.47 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 110.107 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.577 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 47.3 Cg_endo -64.61 154.94 69.55 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.916 1.482 . . . . 0.0 110.289 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.586 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 22.3 p90 -83.97 -1.46 54.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.318 -0.864 . . . . 0.0 110.643 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.567 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 87.3 m-20 -98.39 -26.1 14.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.043 -1.036 . . . . 0.0 110.965 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.473 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 14.9 m-85 -83.16 -0.61 50.05 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.925 -1.109 . . . . 0.0 110.285 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.506 HG23 ' CD1' ' A' ' 54' ' ' ILE . 27.8 m -135.16 147.21 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.092 -1.005 . . . . 0.0 110.304 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.429 ' O ' ' CG1' ' A' ' 9' ' ' VAL . . . -125.0 162.33 24.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.931 . . . . 0.0 110.223 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.464 ' HA ' HG11 ' A' ' 9' ' ' VAL . 39.6 mttp -77.36 130.82 37.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.873 . . . . 0.0 110.21 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.6 144.9 5.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 110.248 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 27.2 t30 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.159 179.994 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.27 144.61 98.23 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.262 -1.14 . . . . 0.0 110.23 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -56.7 153.65 35.27 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.047 1.551 . . . . 0.0 110.349 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 33.9 mt -61.21 -29.5 69.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 110.197 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.474 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 93.6 mt-30 -60.56 -33.47 72.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 0.0 110.233 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.468 ' O ' ' CD1' ' A' ' 8' ' ' LEU . 81.3 m-20 -88.04 6.8 34.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.27 -0.894 . . . . 0.0 110.236 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 4.8 t30 -84.31 109.91 18.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.293 -0.88 . . . . 0.0 110.212 179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.491 HD22 ' CD2' ' A' ' 46' ' ' LEU . 7.0 mp -110.47 156.05 21.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.197 -0.939 . . . . 0.0 110.217 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.552 ' CG2' ' CG1' ' A' ' 59' ' ' VAL . 13.2 m -152.3 171.32 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.889 . . . . 0.0 110.306 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.3 mt -112.88 144.12 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -0.844 . . . . 0.0 109.923 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.549 ' HB3' ' CE2' ' A' ' 25' ' ' PHE . . . -80.25 111.0 16.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 110.268 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.521 ' CD2' ' N ' ' A' ' 12' ' ' LEU . 4.1 mm? -64.6 -26.2 68.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.17 -0.956 . . . . 0.0 109.448 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.47 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 52.5 m80 -156.9 154.56 29.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.54 -0.725 . . . . 0.0 109.661 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.52 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 53.8 p -64.69 143.4 57.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.985 -1.072 . . . . 0.0 110.056 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.585 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 89.1 t80 -100.57 164.1 12.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.036 -1.04 . . . . 0.0 110.26 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.459 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -117.94 125.32 28.07 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.367 -0.833 . . . . 0.0 110.098 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.454 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 48.3 Cg_endo -78.39 82.25 2.52 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.016 1.535 . . . . 0.0 110.369 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 72.6 m -79.74 -2.53 43.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.88 . . . . 0.0 109.966 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.437 ' CG ' ' N ' ' A' ' 20' ' ' ASP . 86.4 t60 -145.09 172.2 13.42 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.369 -0.832 . . . . 0.0 110.095 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . 0.437 ' N ' ' CG ' ' A' ' 19' ' ' HIS . 21.8 t70 -80.32 129.51 34.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.175 -0.953 . . . . 0.0 110.223 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.46 18.01 29.56 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -106.9 150.02 26.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -1.118 . . . . 0.0 110.284 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.466 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 15.3 tp -105.75 112.08 25.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 110.042 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.459 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -95.28 45.23 2.08 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.58 ' CG ' HD12 ' A' ' 31' ' ' LEU . 40.6 p90 -46.64 171.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -1.175 . . . . 0.0 110.865 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.52 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 88.0 mt-10 -101.74 177.29 4.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.464 -0.773 . . . . 0.0 110.259 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -69.69 126.65 30.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.266 -0.896 . . . . 0.0 110.272 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.71 -8.66 74.01 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.43 ' CD ' ' HB2' ' A' ' 25' ' ' PHE . 20.9 tt0 -67.27 126.03 27.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -1.18 . . . . 0.0 110.317 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.435 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 89.4 mt-30 -79.49 138.22 37.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 109.929 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.58 HD12 ' CG ' ' A' ' 25' ' ' PHE . 14.4 mt -140.44 162.74 34.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.909 . . . . 0.0 110.38 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 25.2 ttp180 -106.01 133.33 50.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 0.0 109.682 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.526 ' CG1' HG23 ' A' ' 9' ' ' VAL . 15.5 mt -97.82 94.67 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.104 -0.997 . . . . 0.0 110.623 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.474 ' CD2' ' HA ' ' A' ' 5' ' ' GLN . 50.0 mt -79.46 -22.48 44.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.932 . . . . 0.0 110.777 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.531 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 83.2 tt0 -136.39 129.69 31.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.961 -1.087 . . . . 0.0 110.33 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.572 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 97.0 mt-30 -126.32 54.19 1.58 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.842 . . . . 0.0 110.122 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.5 p -119.47 157.91 27.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.913 . . . . 0.0 110.278 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.23 -172.1 26.97 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -72.54 -34.66 67.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -1.166 . . . . 0.0 110.28 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.409 ' HZ3' ' CE1' ' A' ' 15' ' ' TYR . 69.1 m95 -101.81 150.07 23.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.228 -0.92 . . . . 0.0 110.441 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.572 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 50.8 m0 -120.75 154.69 35.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.357 -0.84 . . . . 0.0 110.264 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.531 ' CB ' ' HB3' ' A' ' 35' ' ' GLU . 67.3 tttt -95.53 143.49 26.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.569 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -153.27 176.89 11.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.933 -1.104 . . . . 0.0 111.085 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.475 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 48.7 tt0 -143.67 152.01 40.8 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.591 -0.693 . . . . 0.0 109.722 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.413 ' CB ' ' OG1' ' A' ' 48' ' ' THR . 17.3 m -85.1 149.35 25.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.164 -0.96 . . . . 0.0 110.298 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.491 ' CD2' HD22 ' A' ' 8' ' ' LEU . 6.6 mp -98.39 -13.2 20.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.325 -0.859 . . . . 0.0 109.964 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.8 p -101.04 -27.49 13.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.84 . . . . 0.0 110.234 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.413 ' OG1' ' CB ' ' A' ' 45' ' ' SER . 81.4 p -107.62 -18.57 13.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 110.316 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.99 41.82 80.28 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.464 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 7.2 mt-30 -119.21 150.21 40.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -1.118 . . . . 0.0 110.281 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 81.9 tt0 -116.43 134.08 55.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.93 . . . . 0.0 110.181 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.466 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -160.03 154.88 25.96 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -69.26 142.56 54.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -1.134 . . . . 0.0 109.984 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.458 HG13 ' O ' ' A' ' 54' ' ' ILE . 1.7 pt -131.97 132.35 23.1 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.949 . . . . 0.0 110.437 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.585 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 47.9 Cg_endo -61.1 156.11 46.77 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.981 1.517 . . . . 0.0 109.884 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.551 ' CE1' ' OD1' ' A' ' 57' ' ' ASN . 41.7 p90 -80.12 -8.14 59.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 111.326 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.551 ' OD1' ' CE1' ' A' ' 56' ' ' PHE . 58.7 m-20 -92.49 -26.59 17.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.766 -1.209 . . . . 0.0 110.98 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.564 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 21.8 m-85 -82.94 -6.38 59.45 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.999 -1.063 . . . . 0.0 110.048 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.552 ' CG1' ' CG2' ' A' ' 9' ' ' VAL . 58.1 t -132.38 174.71 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.845 . . . . 0.0 109.723 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.44 ' N ' HG13 ' A' ' 59' ' ' VAL . . . -159.98 149.97 18.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 0.0 110.244 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 62' ' ' ALA . 66.2 mttm -68.51 113.86 6.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.89 . . . . 0.0 110.289 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 61' ' ' LYS . . . -42.94 141.3 1.15 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 0.0 110.269 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 28.1 m120 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.247 -179.972 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.7 t -132.99 76.61 69.95 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.17 -1.194 . . . . 0.0 110.23 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -43.25 146.74 1.0 Allowed 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.039 1.547 . . . . 0.0 110.328 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.8 tp -108.67 121.28 44.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.903 . . . . 0.0 110.275 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -120.1 161.69 20.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.259 -0.901 . . . . 0.0 110.199 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -67.64 -30.33 69.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 110.19 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -88.18 -12.74 43.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.138 -0.976 . . . . 0.0 110.264 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.464 ' O ' HG11 ' A' ' 9' ' ' VAL . 41.4 tp -71.47 143.81 49.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 0.0 110.177 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.489 ' HB ' ' CG1' ' A' ' 59' ' ' VAL . 3.7 m -155.36 173.33 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -0.915 . . . . 0.0 110.271 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.1 mt -117.38 142.09 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.857 . . . . 0.0 109.807 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.602 ' CB ' ' CD2' ' A' ' 25' ' ' PHE . . . -78.58 113.76 16.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.972 . . . . 0.0 110.257 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 7.2 mp -66.71 -26.83 67.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.071 -1.018 . . . . 0.0 109.542 179.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -149.95 155.4 39.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.459 -0.775 . . . . 0.0 109.764 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.515 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 53.0 p -68.59 143.04 54.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.089 -1.007 . . . . 0.0 110.05 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.58 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 81.2 t80 -101.69 164.53 11.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.014 -1.054 . . . . 0.0 110.354 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.563 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 28.2 mm-40 -118.01 129.67 25.21 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 110.126 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.466 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 49.2 Cg_endo -81.56 81.91 2.51 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.926 1.487 . . . . 0.0 110.535 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.477 ' OG ' ' ND1' ' A' ' 19' ' ' HIS . 81.0 p -79.72 -1.97 40.88 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.172 -0.955 . . . . 0.0 110.06 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.477 ' ND1' ' OG ' ' A' ' 18' ' ' SER . 74.7 m80 -144.06 -176.8 5.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.941 . . . . 0.0 110.135 179.887 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -92.69 131.61 37.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.0 110.072 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.36 -5.33 57.27 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.07 157.38 18.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.14 -1.212 . . . . 0.0 110.294 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.482 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 32.1 tp -115.3 120.06 38.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 110.079 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.471 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -97.74 47.85 1.52 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.602 ' CD2' ' CB ' ' A' ' 11' ' ' ALA . 46.6 p90 -49.29 174.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -1.153 . . . . 0.0 111.305 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.515 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 95.8 mt-10 -107.63 173.68 6.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.523 -0.736 . . . . 0.0 109.943 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -68.39 139.45 55.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.098 -1.001 . . . . 0.0 110.355 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.16 -15.41 49.41 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.516 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 22.8 tt0 -62.28 124.4 20.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.116 -1.226 . . . . 0.0 110.016 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.493 ' C ' ' CD1' ' A' ' 31' ' ' LEU . 91.9 mt-30 -79.9 136.87 36.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -0.887 . . . . 0.0 109.902 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.516 ' CD1' ' O ' ' A' ' 29' ' ' GLU . 6.6 mp -141.65 163.61 32.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.126 -0.984 . . . . 0.0 110.533 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.518 ' CZ ' HD22 ' A' ' 34' ' ' LEU . 10.5 ptt180 -112.72 136.85 51.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.351 -0.843 . . . . 0.0 109.575 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.444 HG22 HD11 ' A' ' 33' ' ' ILE . 61.8 mt -90.74 95.28 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.175 -0.953 . . . . 0.0 110.655 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.518 HD22 ' CZ ' ' A' ' 32' ' ' ARG . 1.2 mt -79.46 -30.49 42.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 110.778 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.527 ' CG ' ' HB3' ' A' ' 42' ' ' LYS . 39.8 mm-40 -135.07 139.76 45.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.885 -1.135 . . . . 0.0 110.438 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.564 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 86.7 mt-30 -130.9 54.67 1.89 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.282 -0.886 . . . . 0.0 110.158 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.0 m -116.87 145.7 43.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.237 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.28 172.15 10.6 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.3 -28.01 66.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.181 -1.188 . . . . 0.0 110.16 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.569 ' CZ3' ' OH ' ' A' ' 15' ' ' TYR . 94.8 m95 -99.53 144.67 28.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 110.282 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.576 ' CZ3' ' HB2' ' A' ' 56' ' ' PHE . 45.6 m0 -120.79 156.36 32.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.864 . . . . 0.0 110.149 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.527 ' HB3' ' CG ' ' A' ' 35' ' ' GLU . 24.6 tttp -98.32 140.25 32.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.372 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 32' ' ' ARG . . . -156.25 -178.41 7.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.061 -1.024 . . . . 0.0 110.618 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.51 ' HG3' ' CA ' ' A' ' 51' ' ' GLU . 48.4 tt0 -151.09 158.81 44.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.479 -0.763 . . . . 0.0 109.72 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.434 ' HA ' ' HA ' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -108.01 140.04 41.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.155 -0.966 . . . . 0.0 110.357 -179.8 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 46' ' ' LEU . 22.7 tp -90.85 11.2 23.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -0.86 . . . . 0.0 110.07 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.4 m -97.03 -38.6 9.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.0 110.241 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.1 p -119.35 -8.84 10.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.217 -0.927 . . . . 0.0 110.207 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.47 36.21 49.99 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.453 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 3.1 mt-30 -108.75 141.76 40.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -1.109 . . . . 0.0 110.14 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.51 ' CA ' ' HG3' ' A' ' 44' ' ' GLN . 83.4 tt0 -121.61 143.08 49.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.216 -0.928 . . . . 0.0 110.124 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.482 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -173.47 165.63 37.7 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -71.77 145.45 48.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.401 -1.058 . . . . 0.0 110.075 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.47 HG13 ' O ' ' A' ' 54' ' ' ILE . 1.3 pt -136.97 137.66 23.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.182 -0.949 . . . . 0.0 110.198 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.58 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 46.6 Cg_endo -62.06 145.16 96.68 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.944 1.497 . . . . 0.0 110.049 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.576 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 31.1 p90 -73.27 -3.96 30.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.365 -0.835 . . . . 0.0 110.902 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -96.09 -26.23 15.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.912 -1.117 . . . . 0.0 111.066 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.569 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 15.3 m-85 -83.43 3.07 33.58 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.96 -1.087 . . . . 0.0 110.242 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.489 ' CG1' ' HB ' ' A' ' 9' ' ' VAL . 16.0 t -146.41 168.19 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 109.907 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.45 ' O ' HG13 ' A' ' 9' ' ' VAL . . . -158.96 160.83 36.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 110.26 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 62' ' ' ALA . 92.2 mttt -69.28 121.92 17.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -0.904 . . . . 0.0 110.169 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 61' ' ' LYS . . . -43.45 154.97 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 110.187 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.8 t30 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.176 -179.979 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p -124.82 80.17 63.07 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.295 -1.121 . . . . 0.0 110.171 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -51.27 146.35 24.24 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.973 1.512 . . . . 0.0 110.4 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 48.9 mt -58.34 -37.95 76.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.236 -0.915 . . . . 0.0 110.181 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.41 ' O ' ' HB2' ' A' ' 6' ' ' ASP . 87.6 mt-30 -51.53 -29.66 17.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.162 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.41 ' HB2' ' O ' ' A' ' 5' ' ' GLN . 92.0 m-20 54.09 51.13 15.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 110.197 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.456 ' O ' HG13 ' A' ' 33' ' ' ILE . 23.9 m120 -87.51 11.09 15.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.898 . . . . 0.0 110.266 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 5.7 mp -96.48 149.34 21.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.945 . . . . 0.0 110.14 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 31' ' ' LEU . 13.6 m -150.25 169.83 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.185 -0.947 . . . . 0.0 110.387 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 57.0 mt -116.79 141.86 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.311 -0.868 . . . . 0.0 109.559 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.623 ' CB ' ' CD2' ' A' ' 25' ' ' PHE . . . -80.26 113.74 18.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.122 -0.986 . . . . 0.0 110.515 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.458 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 82.5 mt -67.07 -24.28 65.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.061 -1.024 . . . . 0.0 109.121 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.458 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 42.8 m80 -157.31 150.83 24.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.602 -0.686 . . . . 0.0 109.547 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.44 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 36.8 p -62.31 142.17 57.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.93 -1.106 . . . . 0.0 110.069 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.583 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 82.1 t80 -100.82 162.64 12.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.078 -1.014 . . . . 0.0 110.472 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -119.71 121.59 29.75 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.334 -0.854 . . . . 0.0 109.911 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.467 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 47.6 Cg_endo -79.42 94.36 1.06 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.037 1.546 . . . . 0.0 110.521 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 50.6 p -79.89 0.97 28.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 110.005 179.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 48.4 m80 -145.08 165.71 27.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.893 . . . . 0.0 109.888 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -77.46 131.74 38.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.133 -0.979 . . . . 0.0 110.185 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.27 -7.13 40.04 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 4.3 m-20 -91.58 165.35 13.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.231 -1.158 . . . . 0.0 110.201 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.513 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 20.1 tp -122.81 128.5 50.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 109.978 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.476 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -106.77 55.34 0.53 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.623 ' CD2' ' CB ' ' A' ' 11' ' ' ALA . 37.3 p90 -45.31 171.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -1.14 . . . . 0.0 110.882 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.474 ' N ' ' OE1' ' A' ' 29' ' ' GLU . 94.9 mt-10 -97.66 174.48 6.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.412 -0.805 . . . . 0.0 110.239 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.471 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -70.66 122.68 20.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.873 . . . . 0.0 110.349 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.01 -7.1 76.64 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.474 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 39.1 tt0 -70.34 129.57 39.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.001 -1.293 . . . . 0.0 110.06 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -79.46 138.35 37.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.885 . . . . 0.0 109.981 -179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.448 HD12 ' CG ' ' A' ' 25' ' ' PHE . 16.9 mt -135.56 156.41 48.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.149 -0.969 . . . . 0.0 110.47 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.462 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 31.3 ttm180 -98.37 130.99 45.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.379 -0.826 . . . . 0.0 109.918 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.456 HG13 ' O ' ' A' ' 7' ' ' ASN . 34.5 mt -76.03 119.7 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 110.164 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.466 ' N ' ' O ' ' A' ' 42' ' ' LYS . 96.9 mt -87.75 -35.19 18.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.334 -0.854 . . . . 0.0 110.179 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -150.56 175.08 12.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -0.921 . . . . 0.0 110.314 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.571 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 88.9 mt-30 -151.09 57.8 0.9 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.281 -0.887 . . . . 0.0 110.192 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.3 t -125.2 130.36 51.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 110.152 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.88 -170.79 42.14 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -75.65 -34.24 60.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.194 -1.18 . . . . 0.0 110.178 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.572 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 94.8 m95 -97.84 146.4 25.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -0.89 . . . . 0.0 110.155 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.571 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.2 m0 -124.42 155.76 38.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.289 -0.882 . . . . 0.0 110.18 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.466 ' O ' ' N ' ' A' ' 34' ' ' LEU . 19.7 mttt -91.12 146.3 23.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 109.663 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.519 ' CB ' HG12 ' A' ' 54' ' ' ILE . . . -144.05 165.92 26.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.221 -0.924 . . . . 0.0 110.635 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.471 ' HG3' ' O ' ' A' ' 50' ' ' GLN . 59.5 tt0 -134.59 142.89 47.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.415 -0.803 . . . . 0.0 109.957 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.9 m -76.99 140.06 40.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 110.14 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 14.2 tp -88.31 -19.69 26.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.913 . . . . 0.0 109.968 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.0 p -102.92 -28.13 12.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.828 . . . . 0.0 110.404 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m -96.3 -20.94 18.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.081 -1.012 . . . . 0.0 110.107 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.71 47.49 67.59 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.471 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 61.2 mt-30 -133.86 158.59 43.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.325 -1.103 . . . . 0.0 110.191 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.457 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 92.5 mt-10 -119.77 143.67 47.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.083 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.513 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -154.63 -152.05 6.01 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -122.16 134.33 54.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.368 -1.078 . . . . 0.0 110.056 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.519 HG12 ' CB ' ' A' ' 43' ' ' ALA . 1.8 pt -129.11 140.48 38.74 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.965 . . . . 0.0 110.183 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.583 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 47.3 Cg_endo -73.0 157.34 51.25 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.958 1.504 . . . . 0.0 110.12 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -78.84 -5.01 52.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -0.858 . . . . 0.0 111.009 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -98.44 -26.51 14.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.897 -1.127 . . . . 0.0 111.215 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.567 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 13.1 m-85 -83.63 -9.18 59.07 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.929 -1.107 . . . . 0.0 110.469 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 31.0 m -133.98 145.0 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.166 -0.959 . . . . 0.0 110.383 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -129.12 159.21 36.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.836 . . . . 0.0 110.119 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 89.9 mttt -76.22 118.7 19.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -0.959 . . . . 0.0 110.177 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.79 144.45 8.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 110.204 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 30.6 m120 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.234 -179.952 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.62 78.44 68.66 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.227 -1.161 . . . . 0.0 110.251 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -51.18 146.01 24.63 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.948 1.499 . . . . 0.0 110.347 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 43.2 tp -65.2 -29.39 70.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.235 -0.916 . . . . 0.0 110.232 179.972 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.457 ' HB3' ' OD1' ' A' ' 7' ' ' ASN . 98.7 mt-30 -59.64 -27.01 65.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.889 . . . . 0.0 110.22 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 50.57 44.93 27.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 110.185 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.457 ' OD1' ' HB3' ' A' ' 5' ' ' GLN . 22.8 m120 -79.74 -1.13 37.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.145 -0.972 . . . . 0.0 110.251 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.434 ' O ' ' CG1' ' A' ' 9' ' ' VAL . 23.6 tp -80.06 148.59 30.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.115 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.434 ' CG1' ' O ' ' A' ' 8' ' ' LEU . 31.7 m -153.7 172.03 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.192 -0.943 . . . . 0.0 110.37 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.447 HG22 HD11 ' A' ' 10' ' ' ILE . 54.8 mt -113.9 146.11 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.319 -0.863 . . . . 0.0 109.712 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.581 ' CB ' ' CD2' ' A' ' 25' ' ' PHE . . . -80.13 110.12 15.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.13 -0.982 . . . . 0.0 110.287 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.519 ' O ' ' CD1' ' A' ' 12' ' ' LEU . 2.0 tm? -65.61 -25.07 67.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.065 -1.022 . . . . 0.0 109.405 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.474 ' ND1' HD11 ' A' ' 12' ' ' LEU . 11.5 m170 -155.69 158.95 39.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.51 -0.744 . . . . 0.0 109.744 179.669 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.525 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 47.3 p -68.41 139.89 55.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.999 -1.063 . . . . 0.0 110.105 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.579 ' CD1' ' HD3' ' A' ' 55' ' ' PRO . 87.9 t80 -95.72 156.42 16.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.046 -1.034 . . . . 0.0 110.33 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.563 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -99.4 127.13 35.3 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.322 -0.861 . . . . 0.0 110.062 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.468 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 48.0 Cg_endo -89.5 86.78 0.43 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.033 1.544 . . . . 0.0 110.397 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.9 p -79.98 1.3 28.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -0.943 . . . . 0.0 110.111 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 38.8 m80 -134.7 -168.31 2.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.078 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.7 p30 -105.79 -6.19 19.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.187 -0.945 . . . . 0.0 110.196 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.48 -0.53 23.39 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 61.3 m-20 -88.13 163.17 16.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.127 -1.22 . . . . 0.0 110.243 -179.905 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.482 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 22.2 tp -114.53 120.49 40.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.298 -0.876 . . . . 0.0 110.086 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.468 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . -103.7 54.81 0.65 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.581 ' CD2' ' CB ' ' A' ' 11' ' ' ALA . 50.6 p90 -53.39 176.57 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -1.155 . . . . 0.0 111.022 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.525 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 92.5 mt-10 -110.39 178.27 4.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.442 -0.786 . . . . 0.0 110.026 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.414 ' HG3' ' O ' ' A' ' 12' ' ' LEU . 27.9 tttt -67.38 136.45 54.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.124 -0.985 . . . . 0.0 110.421 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.47 -16.13 50.91 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.449 ' HG2' HD22 ' A' ' 31' ' ' LEU . 10.3 tt0 -60.83 123.21 16.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.131 -1.217 . . . . 0.0 110.41 -179.666 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.422 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 94.0 mt-30 -79.75 134.52 36.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.35 -0.844 . . . . 0.0 109.79 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.564 HD12 ' CG ' ' A' ' 25' ' ' PHE . 15.5 mt -137.99 159.38 42.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.949 . . . . 0.0 110.319 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.532 ' CD ' ' HB3' ' A' ' 44' ' ' GLN . 3.7 ptt180 -109.25 134.98 51.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.278 -0.889 . . . . 0.0 109.614 179.357 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.51 HG22 HD11 ' A' ' 33' ' ' ILE . 61.1 mt -91.39 95.17 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.094 -1.004 . . . . 0.0 110.758 -179.281 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.438 HD22 ' NE ' ' A' ' 32' ' ' ARG . 1.6 mt -78.86 -29.45 44.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 110.622 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.472 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 74.1 tt0 -128.6 140.76 51.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.002 -1.062 . . . . 0.0 110.274 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.568 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 47.7 tt0 -138.42 68.4 1.39 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 110.222 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.4 p -131.81 132.83 44.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.0 110.207 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.84 -162.56 41.15 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -80.96 -31.17 34.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -1.163 . . . . 0.0 110.208 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.574 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 91.4 m95 -98.87 146.51 25.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.269 -0.894 . . . . 0.0 110.352 -179.79 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.574 ' CZ3' ' HB2' ' A' ' 56' ' ' PHE . 47.3 m0 -125.35 156.46 38.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 110.21 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.472 ' CB ' ' HB3' ' A' ' 35' ' ' GLU . 25.7 tttp -97.6 145.32 26.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.14 179.217 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.525 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -160.35 -173.57 4.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.908 -1.12 . . . . 0.0 110.947 -179.638 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.532 ' HB3' ' CD ' ' A' ' 32' ' ' ARG . 39.2 tt0 -155.15 162.18 41.05 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.576 -0.702 . . . . 0.0 109.475 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.523 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 1.7 m -103.22 128.42 50.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.068 -1.02 . . . . 0.0 110.276 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.448 ' HG ' ' O ' ' A' ' 46' ' ' LEU . 25.4 tp -82.44 1.89 35.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.337 -0.852 . . . . 0.0 110.154 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.0 m -96.96 -34.48 11.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 110.205 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.0 p -115.99 -16.31 11.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.935 . . . . 0.0 110.183 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.8 25.68 55.55 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.425 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 56.9 tt0 -97.18 135.65 38.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -1.154 . . . . 0.0 110.243 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.461 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 82.1 tt0 -120.02 141.13 50.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.253 -0.905 . . . . 0.0 109.939 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.482 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -167.32 -137.84 2.32 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -125.91 138.42 53.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.416 -1.049 . . . . 0.0 109.947 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.463 HG12 ' HB2' ' A' ' 43' ' ' ALA . 16.9 pt -128.23 148.78 69.16 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 110.255 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.579 ' HD3' ' CD1' ' A' ' 15' ' ' TYR . 45.3 Cg_endo -80.42 148.31 18.45 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.017 1.535 . . . . 0.0 109.728 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.574 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 35.8 p90 -69.87 -4.61 21.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 111.021 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -98.21 -26.44 14.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.831 -1.168 . . . . 0.0 111.396 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.573 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 8.1 m-85 -84.41 -2.84 57.81 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.938 -1.101 . . . . 0.0 110.395 -179.666 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 33.4 m -131.32 141.71 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.131 -0.981 . . . . 0.0 110.1 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.65 157.66 31.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.114 -0.991 . . . . 0.0 110.38 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -65.65 128.12 34.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 0.0 110.169 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.82 145.67 19.16 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.311 -0.868 . . . . 0.0 110.154 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 42.6 t30 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.204 -179.983 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 m -65.95 145.57 99.01 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.265 -1.138 . . . . 0.0 110.202 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -57.51 142.37 95.37 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.085 1.571 . . . . 0.0 110.315 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 62.1 mt -59.1 -36.17 74.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 110.183 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.426 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . 98.0 mt-30 -123.02 137.63 54.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.313 -0.867 . . . . 0.0 110.21 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -60.49 -29.92 69.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.909 . . . . 0.0 110.191 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -83.43 3.86 30.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.314 -0.866 . . . . 0.0 110.207 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.487 ' C ' ' CD1' ' A' ' 8' ' ' LEU . 3.2 tm? -82.19 137.43 34.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.33 -0.856 . . . . 0.0 110.192 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.513 HG23 ' CD1' ' A' ' 33' ' ' ILE . 27.1 m -146.6 167.66 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.312 -0.867 . . . . 0.0 110.345 180.0 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.6 mm -112.54 141.34 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.705 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.43 ' CB ' ' CD1' ' A' ' 25' ' ' PHE . . . -79.03 109.64 13.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.057 -1.027 . . . . 0.0 110.268 -179.817 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.434 ' HG ' ' CE1' ' A' ' 13' ' ' HIS . 16.6 tp -67.39 -24.96 65.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.09 -1.006 . . . . 0.0 109.255 179.39 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.434 ' CE1' ' HG ' ' A' ' 12' ' ' LEU . 66.1 m80 -153.51 151.4 29.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.551 -0.718 . . . . 0.0 109.622 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.521 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 52.7 p -65.4 143.66 57.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 109.996 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.58 ' CD1' ' HG3' ' A' ' 55' ' ' PRO . 22.3 t80 -92.77 150.31 20.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.106 -0.996 . . . . 0.0 110.287 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -106.9 79.48 0.67 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.895 . . . . 0.0 110.268 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -47.45 109.62 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.08 1.568 . . . . 0.0 110.396 179.954 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 91.6 p -90.35 12.1 19.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.213 -0.93 . . . . 0.0 110.217 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -147.54 -178.97 6.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.207 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -98.7 116.59 31.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.247 -0.908 . . . . 0.0 110.203 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.4 7.54 6.89 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -105.8 171.85 7.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.16 -1.2 . . . . 0.0 110.152 -179.927 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.491 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 18.7 tp -113.32 115.59 28.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.303 -0.873 . . . . 0.0 109.876 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.12 55.21 0.97 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.963 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.47 ' O ' ' HA ' ' A' ' 14' ' ' SER . 37.0 p90 -54.76 175.99 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -1.118 . . . . 0.0 111.208 -179.498 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.521 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 96.0 mt-10 -110.25 177.97 4.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.546 -0.721 . . . . 0.0 110.056 179.797 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.7 tttt -67.22 139.23 57.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.11 -0.994 . . . . 0.0 110.505 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.63 -14.72 54.89 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.853 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.467 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 3.1 mt-10 -65.05 125.59 25.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.06 -1.259 . . . . 0.0 110.293 -179.698 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.487 ' C ' ' CD1' ' A' ' 31' ' ' LEU . 52.1 tt0 -79.62 136.16 36.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 109.916 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.487 ' CD1' ' C ' ' A' ' 30' ' ' GLN . 7.6 mp -138.94 160.02 40.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 110.467 -179.698 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.533 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 46.7 ttt180 -105.82 131.7 52.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.414 -0.804 . . . . 0.0 109.427 179.4 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.513 ' CD1' HG23 ' A' ' 9' ' ' VAL . 35.0 mm -92.35 94.39 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.093 -1.004 . . . . 0.0 110.623 -179.551 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.489 HD22 ' CZ ' ' A' ' 32' ' ' ARG . 11.8 mt -79.84 -29.91 40.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.278 -0.889 . . . . 0.0 110.751 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.449 ' HB3' ' HB3' ' A' ' 42' ' ' LYS . 41.5 tp10 -131.03 142.96 50.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.908 -1.12 . . . . 0.0 110.383 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.589 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 78.3 mt-30 -138.01 54.88 1.78 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.88 . . . . 0.0 110.017 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.1 m -120.38 137.47 54.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.935 . . . . 0.0 110.237 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.26 -171.66 55.15 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -74.83 -33.67 62.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -1.17 . . . . 0.0 110.212 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.457 ' CZ3' ' OH ' ' A' ' 15' ' ' TYR . 95.6 m95 -93.77 139.83 30.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 110.212 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.589 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 32.2 m0 -118.17 154.97 31.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.041 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.449 ' HB3' ' HB3' ' A' ' 35' ' ' GLU . 16.3 tttm -100.95 138.78 37.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.312 -0.868 . . . . 0.0 109.145 179.235 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.533 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -150.74 177.57 9.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.998 -1.064 . . . . 0.0 110.965 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.459 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 47.2 tt0 -138.27 146.77 42.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.48 -0.763 . . . . 0.0 109.788 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -96.52 116.12 28.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.13 -0.981 . . . . 0.0 110.255 -179.884 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.6 mt -75.71 1.65 14.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.888 . . . . 0.0 110.307 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 47.9 p -89.92 -32.33 16.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.124 -0.985 . . . . 0.0 110.144 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.5 p -120.56 -3.8 9.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 110.082 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.24 48.16 60.25 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.448 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 10.8 mt-30 -130.17 155.65 45.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -1.142 . . . . 0.0 110.349 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.459 ' HG2' ' HB2' ' A' ' 44' ' ' GLN . 97.9 mt-10 -121.41 147.86 45.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.325 -0.859 . . . . 0.0 109.944 179.785 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.491 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -164.75 -153.6 7.55 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -119.67 135.08 54.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.505 -0.997 . . . . 0.0 109.719 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.528 HD11 ' CG1' ' A' ' 59' ' ' VAL . 1.0 OUTLIER -126.7 149.42 68.33 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.126 -0.984 . . . . 0.0 110.568 -179.668 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.58 ' HG3' ' CD1' ' A' ' 15' ' ' TYR . 46.3 Cg_endo -77.78 132.6 12.04 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.057 1.556 . . . . 0.0 109.965 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.566 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 15.0 p90 -66.46 -9.68 36.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 111.017 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -87.28 -26.41 23.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.883 -1.136 . . . . 0.0 110.841 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.568 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 16.8 m-30 -96.28 7.18 47.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.045 -1.034 . . . . 0.0 110.259 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.528 ' CG1' HD11 ' A' ' 54' ' ' ILE . 35.2 m -135.55 142.26 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 0.0 110.091 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -145.34 154.96 42.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.232 -0.917 . . . . 0.0 110.219 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.447 ' HA ' HG11 ' A' ' 9' ' ' VAL . 79.3 tttt -65.64 128.12 34.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 110.204 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.405 ' O ' ' ND2' ' A' ' 63' ' ' ASN . . . -64.51 142.75 58.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.904 . . . . 0.0 110.184 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . 0.405 ' ND2' ' O ' ' A' ' 62' ' ' ALA . 15.6 m120 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.209 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 p -79.06 152.91 77.18 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.209 -1.171 . . . . 0.0 110.185 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -57.79 145.69 89.22 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.001 1.527 . . . . 0.0 110.327 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 56.8 tp -91.36 132.53 36.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.243 -0.91 . . . . 0.0 110.268 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.481 ' NE2' ' HB2' ' A' ' 7' ' ' ASN . 14.2 pt20 -144.01 156.14 44.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 110.267 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.407 ' C ' ' OD1' ' A' ' 6' ' ' ASP . 58.1 p30 -82.27 4.68 22.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.894 . . . . 0.0 110.176 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.481 ' HB2' ' NE2' ' A' ' 5' ' ' GLN . 24.3 m120 -84.65 1.44 46.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.903 . . . . 0.0 110.269 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.7 tp -81.72 146.23 30.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.275 -0.89 . . . . 0.0 110.105 179.884 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.459 HG11 ' HA ' ' A' ' 61' ' ' LYS . 30.2 m -150.02 169.87 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.159 -0.963 . . . . 0.0 110.367 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 85.9 mt -112.27 144.91 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 109.728 179.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . -77.83 114.89 17.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.13 -0.981 . . . . 0.0 110.349 -179.712 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.575 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 73.1 mt -73.7 -24.93 60.0 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.071 -1.018 . . . . 0.0 109.316 179.409 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 77.0 m-70 -161.38 146.47 13.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.612 -0.68 . . . . 0.0 109.543 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.482 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 53.5 p -60.59 142.07 55.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.919 -1.113 . . . . 0.0 109.904 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.516 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 45.8 t80 -99.0 159.12 15.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.015 -1.053 . . . . 0.0 110.587 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -109.4 82.08 1.98 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.411 -0.806 . . . . 0.0 110.067 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.53 ' HD3' ' CA ' ' A' ' 24' ' ' GLY . 47.4 Cg_endo -48.55 104.55 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.034 1.544 . . . . 0.0 110.44 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.522 ' OG ' ' CE1' ' A' ' 19' ' ' HIS . 64.5 p -80.67 0.1 35.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.201 -0.937 . . . . 0.0 110.169 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.522 ' CE1' ' OG ' ' A' ' 18' ' ' SER . 64.5 m80 -134.85 176.73 8.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.143 -0.973 . . . . 0.0 110.147 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -82.38 -11.86 58.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 110.461 -179.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -105.66 25.05 25.5 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.525 ' HB2' ' CB ' ' A' ' 17' ' ' PRO . 52.4 m-20 -111.92 161.83 15.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.157 -1.202 . . . . 0.0 110.364 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.496 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 23.7 tp -116.18 120.46 39.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.773 179.713 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.53 ' CA ' ' HD3' ' A' ' 17' ' ' PRO . . . -98.02 51.06 1.31 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.866 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.559 ' CG ' HD12 ' A' ' 31' ' ' LEU . 22.2 p90 -47.34 170.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -1.155 . . . . 0.0 110.568 -179.649 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -100.01 179.05 4.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.391 -0.818 . . . . 0.0 110.282 -179.649 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.57 ' HE3' ' CE1' ' A' ' 13' ' ' HIS . 20.6 tttt -71.96 120.47 17.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.326 -0.859 . . . . 0.0 110.033 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 96.63 -9.18 66.47 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.513 ' OE2' ' CB ' ' A' ' 25' ' ' PHE . 31.4 tt0 -60.7 133.21 55.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.168 -1.195 . . . . 0.0 110.27 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.41 ' O ' HD22 ' A' ' 31' ' ' LEU . 17.5 mt-30 -79.93 129.06 34.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.0 109.888 179.867 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.559 HD12 ' CG ' ' A' ' 25' ' ' PHE . 27.0 mt -130.11 150.7 51.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.168 -0.958 . . . . 0.0 110.437 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.488 ' O ' ' CA ' ' A' ' 43' ' ' ALA . 30.5 ttp180 -106.01 140.64 38.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.349 -0.845 . . . . 0.0 109.824 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.453 HG13 ' O ' ' A' ' 7' ' ' ASN . 55.8 mt -91.51 136.09 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 110.173 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.431 ' CD1' ' HB2' ' A' ' 44' ' ' GLN . 91.6 mt -129.94 -30.89 1.98 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.371 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.456 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 78.6 tt0 -128.25 146.64 50.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 110.307 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.552 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 52.6 tt0 -142.25 58.1 1.46 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.254 -0.904 . . . . 0.0 110.144 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.4 t -118.22 114.38 22.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.269 -0.894 . . . . 0.0 110.229 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.3 -160.93 20.62 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -84.18 -29.59 26.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.189 -1.183 . . . . 0.0 110.251 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.567 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 91.3 m95 -96.06 145.05 25.79 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.288 -0.883 . . . . 0.0 110.169 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.552 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 48.8 m0 -119.17 153.1 35.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.226 -0.922 . . . . 0.0 110.281 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.458 ' HE2' ' OE2' ' A' ' 51' ' ' GLU . 9.9 tttp -99.43 110.58 23.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 110.043 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.488 ' CA ' ' O ' ' A' ' 32' ' ' ARG . . . -112.37 175.46 5.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.229 -0.919 . . . . 0.0 110.708 -179.588 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.49 ' CG ' ' O ' ' A' ' 50' ' ' GLN . 44.4 tt0 -138.18 146.59 42.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.338 -0.851 . . . . 0.0 109.951 -179.799 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.434 ' O ' ' HA3' ' A' ' 49' ' ' GLY . 6.9 t -79.01 137.78 37.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.109 -0.994 . . . . 0.0 110.174 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 21.2 tp -80.7 -21.06 41.58 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.596 179.593 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 95.9 m -83.35 -50.68 8.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.447 -0.783 . . . . 0.0 110.241 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' THR . . . . . 0.464 ' OG1' ' HB2' ' A' ' 50' ' ' GLN . 18.0 p -100.22 1.69 42.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.079 -1.013 . . . . 0.0 110.32 -179.694 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.434 ' HA3' ' O ' ' A' ' 45' ' ' SER . . . 54.03 18.92 9.79 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.49 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 37.2 mt-30 -78.7 153.67 30.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -1.148 . . . . 0.0 110.281 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.458 ' OE2' ' HE2' ' A' ' 42' ' ' LYS . 86.6 tt0 -120.36 142.82 48.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 110.13 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.496 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -165.83 156.81 28.98 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -71.55 141.0 50.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -1.175 . . . . 0.0 109.961 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.461 ' O ' ' CG1' ' A' ' 54' ' ' ILE . 1.9 pp -141.21 124.8 10.05 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.302 -0.874 . . . . 0.0 110.146 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.57 ' CG ' ' CD1' ' A' ' 58' ' ' PHE . 46.2 Cg_endo -46.37 167.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.931 1.49 . . . . 0.0 110.098 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -95.69 -1.84 49.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 110.539 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -99.18 -24.58 14.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.141 -0.974 . . . . 0.0 110.724 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.57 ' CD1' ' CG ' ' A' ' 55' ' ' PRO . 27.4 m-85 -79.64 -12.87 59.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.988 -1.07 . . . . 0.0 110.515 -179.66 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.458 ' CG2' ' CD1' ' A' ' 54' ' ' ILE . 30.6 m -131.25 143.32 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.106 -0.996 . . . . 0.0 110.187 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -129.57 151.27 50.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.301 -0.874 . . . . 0.0 110.172 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.459 ' HA ' HG11 ' A' ' 9' ' ' VAL . 78.7 tttt -67.83 115.38 7.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.287 -0.883 . . . . 0.0 110.269 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 49.62 -145.73 0.41 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -0.888 . . . . 0.0 110.219 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.155 -179.958 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.92 137.07 97.03 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.212 -1.169 . . . . 0.0 110.179 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -53.05 142.91 52.61 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.083 1.57 . . . . 0.0 110.425 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.4 mt -70.53 -31.51 68.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 110.224 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.433 ' HB3' ' CB ' ' A' ' 8' ' ' LEU . 96.3 mt-30 51.04 48.55 22.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 110.238 179.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -63.46 -34.39 77.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.333 -0.854 . . . . 0.0 110.186 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.463 ' O ' HG13 ' A' ' 33' ' ' ILE . 77.7 m-20 -84.0 -5.42 59.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 110.287 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.44 ' O ' ' CG1' ' A' ' 9' ' ' VAL . 6.6 tp -75.89 141.42 42.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -0.952 . . . . 0.0 110.142 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.44 ' CG1' ' O ' ' A' ' 8' ' ' LEU . 28.7 m -154.84 172.73 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 0.0 110.287 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.427 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 62.8 mt -112.49 145.43 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 109.806 179.618 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.525 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . -80.11 111.69 16.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.046 -1.034 . . . . 0.0 110.273 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 58' ' ' PHE . 6.1 mp -64.87 -28.46 69.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.068 -1.02 . . . . 0.0 109.356 179.451 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.444 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 30.7 m80 -155.39 157.66 37.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.564 -0.71 . . . . 0.0 109.794 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.527 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 10.3 t -64.92 140.61 58.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.099 -1.0 . . . . 0.0 109.939 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.581 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 86.3 t80 -94.5 151.69 19.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.02 -1.05 . . . . 0.0 110.474 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -114.02 91.89 24.2 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.409 -0.807 . . . . 0.0 110.076 179.932 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.472 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 46.8 Cg_endo -59.26 114.12 1.89 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.055 1.555 . . . . 0.0 110.476 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.459 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 74.2 p -89.54 11.33 19.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.275 -0.891 . . . . 0.0 109.996 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.459 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 98.6 m-70 -145.95 -177.11 5.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 0.0 110.15 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -100.33 118.89 37.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 110.139 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.95 -14.33 7.51 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -85.24 174.13 9.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -1.121 . . . . 0.0 110.339 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.505 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 20.2 tp -118.42 122.43 42.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 110.011 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.472 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . -102.17 57.08 0.64 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.579 ' CE1' ' HB2' ' A' ' 15' ' ' TYR . 48.6 p90 -53.67 174.13 0.05 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.167 -1.196 . . . . 0.0 110.86 -179.805 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.527 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 73.6 mm-40 -108.0 -179.48 3.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.463 -0.773 . . . . 0.0 110.137 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -68.37 134.52 50.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.928 . . . . 0.0 110.365 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.17 -13.19 62.23 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.46 ' HG3' HD22 ' A' ' 31' ' ' LEU . 26.1 tp10 -62.08 122.99 16.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -1.16 . . . . 0.0 110.409 -179.712 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.431 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 97.0 mt-30 -79.91 136.42 36.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.33 -0.856 . . . . 0.0 109.879 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.518 HD12 ' CG ' ' A' ' 25' ' ' PHE . 17.4 mt -139.04 160.87 38.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.418 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.524 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 4.1 tpt180 -106.4 134.03 50.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.381 -0.825 . . . . 0.0 109.498 179.533 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.509 ' CG2' ' HG2' ' A' ' 36' ' ' GLN . 35.4 mt -95.77 92.84 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.139 -0.976 . . . . 0.0 110.485 -179.669 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mt -79.2 -24.97 42.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.274 -0.891 . . . . 0.0 110.631 -179.406 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.449 ' O ' ' HB3' ' A' ' 41' ' ' TRP . 70.7 tt0 -135.82 136.3 40.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.026 -1.046 . . . . 0.0 110.253 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.587 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 79.7 mt-30 -132.23 53.86 1.98 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.879 . . . . 0.0 110.188 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.0 m -115.9 138.4 51.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -0.882 . . . . 0.0 110.099 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.95 -172.89 55.2 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -72.73 -34.43 67.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.188 -1.184 . . . . 0.0 110.234 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.574 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 99.5 m95 -96.73 143.62 27.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 110.139 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.587 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 51.2 m0 -121.78 155.64 34.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.317 -0.865 . . . . 0.0 110.096 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.434 ' HB3' ' HB3' ' A' ' 35' ' ' GLU . 46.7 tttm -96.32 141.98 29.0 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.277 -0.89 . . . . 0.0 109.237 179.282 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -150.03 174.13 13.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.927 -1.108 . . . . 0.0 111.023 -179.456 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.451 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 58.7 tt0 -137.82 146.06 43.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.613 -0.679 . . . . 0.0 109.771 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 t -92.92 107.3 19.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 110.136 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 44.7 mt -70.01 -3.04 14.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.24 -0.913 . . . . 0.0 110.429 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 30.1 p -89.07 -30.16 18.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.124 -0.985 . . . . 0.0 109.799 179.656 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 49.2 p -120.81 -7.32 9.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.28 -0.887 . . . . 0.0 110.068 179.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.26 44.07 60.98 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.446 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 23.2 mt-30 -123.47 151.55 42.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -1.154 . . . . 0.0 110.301 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.451 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 97.1 mt-10 -119.3 141.56 48.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.322 -0.861 . . . . 0.0 109.998 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.505 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -159.1 -151.92 6.28 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.425 ' C ' HG21 ' A' ' 54' ' ' ILE . 95.7 m-85 -124.27 138.28 54.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.398 -1.06 . . . . 0.0 109.818 179.829 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.458 HG12 ' HB1' ' A' ' 43' ' ' ALA . 2.9 pt -133.53 144.37 51.86 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.157 -0.964 . . . . 0.0 110.343 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.581 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 47.0 Cg_endo -72.64 151.86 52.85 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.06 1.558 . . . . 0.0 109.985 179.736 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.579 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 31.6 p90 -73.99 -4.26 34.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 111.134 -179.375 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -98.6 -26.14 14.49 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.895 -1.128 . . . . 0.0 111.341 -179.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.567 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 8.5 m-85 -82.65 -2.53 54.25 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.803 -1.186 . . . . 0.0 110.346 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.427 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 30.9 m -133.74 143.21 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.161 -0.962 . . . . 0.0 110.117 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.404 ' CB ' HD12 ' A' ' 12' ' ' LEU . . . -127.25 155.97 42.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 110.246 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 60.8 mttp -71.66 134.64 46.46 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.284 -0.885 . . . . 0.0 110.162 179.996 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.98 -34.82 76.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 0.0 110.241 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.959 -1.019 . . . . 0.0 110.212 -179.971 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.28 71.33 64.04 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.258 -1.142 . . . . 0.0 110.228 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -59.95 140.51 93.22 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.927 1.488 . . . . 0.0 110.369 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.8 tp -65.52 -34.43 78.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 110.218 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.71 -37.86 83.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.875 . . . . 0.0 110.257 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . 0.411 ' OD1' ' CD1' ' A' ' 8' ' ' LEU . 48.2 t0 -141.92 75.51 1.5 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.302 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -86.14 113.06 21.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.217 -0.927 . . . . 0.0 110.227 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.469 ' O ' HG11 ' A' ' 9' ' ' VAL . 5.4 mp -112.91 150.86 31.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.297 -0.877 . . . . 0.0 110.31 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.516 ' CG1' ' HA ' ' A' ' 62' ' ' ALA . 4.2 m -145.95 167.72 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.267 -0.895 . . . . 0.0 110.288 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . 0.503 ' CD1' ' HD2' ' A' ' 61' ' ' LYS . 61.8 mt -113.43 140.11 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.865 . . . . 0.0 109.781 179.661 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.576 ' HB3' ' CD1' ' A' ' 25' ' ' PHE . . . -80.66 110.22 15.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.137 -0.977 . . . . 0.0 110.555 -179.631 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.439 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 52.4 mt -67.52 -22.94 65.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.08 -1.013 . . . . 0.0 109.162 179.164 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.439 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 21.8 m80 -157.37 146.72 20.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.641 -0.662 . . . . 0.0 109.408 179.704 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.486 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 81.9 p -61.5 146.38 48.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.998 -1.064 . . . . 0.0 110.14 -179.831 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.579 ' OH ' ' CZ3' ' A' ' 40' ' ' TRP . 25.1 t80 -95.76 156.93 16.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.978 -1.076 . . . . 0.0 110.348 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 17' ' ' PRO . 46.1 mt-10 -114.07 73.87 2.58 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.326 -0.859 . . . . 0.0 110.121 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.461 ' HB3' ' HB2' ' A' ' 22' ' ' ASP . 47.7 Cg_endo -40.6 110.35 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.043 1.549 . . . . 0.0 110.429 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.469 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 59.6 p -87.25 8.21 25.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.348 -0.845 . . . . 0.0 110.168 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.469 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 96.2 m-70 -145.48 170.54 16.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.09 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -87.25 126.89 35.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.266 -0.896 . . . . 0.0 110.294 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.27 -14.0 13.66 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.507 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 2.4 m-20 -86.68 174.66 8.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -1.152 . . . . 0.0 110.262 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.493 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 19.2 tp -120.63 124.66 45.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.868 . . . . 0.0 110.062 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.468 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -104.13 57.52 0.53 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.576 ' CD1' ' HB3' ' A' ' 11' ' ' ALA . 28.6 p90 -47.07 169.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.259 -1.142 . . . . 0.0 110.878 -179.532 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.477 ' N ' ' OE1' ' A' ' 29' ' ' GLU . 90.7 mt-10 -98.84 177.48 5.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.495 -0.753 . . . . 0.0 110.14 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -71.55 119.89 16.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.184 -0.947 . . . . 0.0 110.348 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.9 -6.75 58.68 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.503 ' OE1' ' CA ' ' A' ' 25' ' ' PHE . 71.6 tt0 -73.71 127.43 32.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.008 -1.289 . . . . 0.0 110.172 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.424 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 58.2 mt-30 -79.25 142.67 36.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 110.004 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.553 HD12 ' CG ' ' A' ' 25' ' ' PHE . 73.0 mt -141.36 163.83 31.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.243 -0.91 . . . . 0.0 110.348 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.554 ' NE ' ' CD2' ' A' ' 34' ' ' LEU . 19.0 ttt180 -105.85 133.25 50.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.885 . . . . 0.0 109.63 179.553 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.422 HD13 HG22 ' A' ' 9' ' ' VAL . 31.0 mm -96.53 93.78 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.12 -0.987 . . . . 0.0 110.417 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.554 ' CD2' ' NE ' ' A' ' 32' ' ' ARG . 41.8 mt -79.83 -24.52 41.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.258 -0.901 . . . . 0.0 110.859 -179.543 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.49 ' CB ' ' HB3' ' A' ' 42' ' ' LYS . 17.9 tt0 -136.18 140.87 43.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.992 -1.067 . . . . 0.0 110.345 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.57 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 84.3 mt-30 -135.29 55.18 1.89 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.158 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -119.27 142.13 48.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.178 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.0 -171.16 54.62 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -74.16 -34.77 63.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -1.166 . . . . 0.0 110.132 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.579 ' CZ3' ' OH ' ' A' ' 15' ' ' TYR . 95.3 m95 -96.28 144.5 26.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.302 -0.874 . . . . 0.0 110.272 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.57 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.9 m0 -118.85 156.09 30.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 110.217 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.49 ' HB3' ' CB ' ' A' ' 35' ' ' GLU . 29.0 tttt -96.18 137.57 35.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.358 -0.839 . . . . 0.0 109.408 179.412 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.524 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -152.77 176.65 11.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.01 . . . . 0.0 110.666 -179.554 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.478 ' CB ' ' HG2' ' A' ' 51' ' ' GLU . 14.5 pt20 -148.18 156.67 42.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.455 -0.778 . . . . 0.0 109.819 179.719 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.8 t -98.55 116.91 31.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.122 -0.987 . . . . 0.0 110.275 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 60.3 mt -74.51 -0.78 18.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 110.094 179.96 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 70.7 p -94.63 -27.22 16.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.36 -0.838 . . . . 0.0 110.166 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 47.4 p -114.25 -13.02 12.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 110.157 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.42 39.46 50.7 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -128.16 155.51 44.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -1.154 . . . . 0.0 110.276 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.478 ' HG2' ' CB ' ' A' ' 44' ' ' GLN . 73.6 mt-10 -123.8 152.56 42.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.905 . . . . 0.0 110.031 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.493 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -165.94 -149.89 6.09 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.441 ' O ' HG21 ' A' ' 54' ' ' ILE . 92.6 m-85 -127.74 143.63 51.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.46 -1.024 . . . . 0.0 109.683 179.61 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.459 HG23 ' CE2' ' A' ' 25' ' ' PHE . 1.7 pp -141.01 139.2 18.94 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.132 -0.98 . . . . 0.0 110.696 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.579 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 44.8 Cg_endo -59.39 156.97 33.09 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.093 1.575 . . . . 0.0 109.907 179.465 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.577 ' CZ ' ' OD1' ' A' ' 57' ' ' ASN . 20.8 p90 -84.56 -2.28 57.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.097 -1.002 . . . . 0.0 110.766 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.577 ' OD1' ' CZ ' ' A' ' 56' ' ' PHE . 8.6 m120 -103.65 13.22 33.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.984 -1.073 . . . . 0.0 110.696 -179.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.579 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 6.1 m-85 -111.32 -6.41 14.52 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.097 -1.002 . . . . 0.0 110.028 179.694 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.47 HG11 ' HA ' ' A' ' 11' ' ' ALA . 7.8 m -138.46 145.47 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.334 -0.854 . . . . 0.0 110.032 179.801 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 61' ' ' LYS . . . -160.26 -41.28 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.165 -0.959 . . . . 0.0 110.398 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.503 ' HD2' ' CD1' ' A' ' 10' ' ' ILE . 91.2 mttt -41.93 -29.18 0.2 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.87 . . . . 0.0 110.319 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.516 ' HA ' ' CG1' ' A' ' 9' ' ' VAL . . . 49.18 25.13 1.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.328 -0.857 . . . . 0.0 110.23 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.2 t30 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.268 -179.939 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.13 146.27 92.32 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.279 -1.13 . . . . 0.0 110.234 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -53.34 -29.13 46.49 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.012 1.532 . . . . 0.0 110.446 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 39.3 mt -88.91 146.65 24.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.153 -0.967 . . . . 0.0 110.21 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.405 ' O ' HD11 ' A' ' 8' ' ' LEU . 89.0 mt-30 -116.68 138.76 51.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.178 -0.952 . . . . 0.0 110.184 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -102.14 13.7 33.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.357 -0.84 . . . . 0.0 110.175 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -80.31 6.84 10.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.24 -0.913 . . . . 0.0 110.207 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.516 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 6.2 mp -84.23 140.92 31.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.208 -0.932 . . . . 0.0 110.231 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.429 HG11 ' HA ' ' A' ' 61' ' ' LYS . 30.9 m -150.9 170.21 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 110.289 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.9 mt -112.27 148.7 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -0.83 . . . . 0.0 109.887 179.729 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.557 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . -80.12 112.01 17.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.131 -0.981 . . . . 0.0 110.422 -179.779 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.513 ' CD2' ' N ' ' A' ' 12' ' ' LEU . 3.9 mm? -71.71 -22.41 61.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.192 -0.942 . . . . 0.0 109.442 179.442 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.422 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 86.0 m-70 -153.62 151.13 29.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.464 -0.772 . . . . 0.0 109.75 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.52 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 54.2 p -67.25 142.83 56.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.059 -1.026 . . . . 0.0 109.97 179.861 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.591 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 88.5 t80 -99.08 160.17 14.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.072 -1.017 . . . . 0.0 110.414 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.551 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 2.4 mm-40 -104.69 124.4 37.06 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.356 -0.84 . . . . 0.0 110.063 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.456 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 49.6 Cg_endo -81.06 82.84 2.34 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.945 1.497 . . . . 0.0 110.429 -179.843 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 59.6 p -79.99 -2.73 45.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 110.213 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -129.13 -159.34 0.95 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.933 . . . . 0.0 110.266 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -107.72 -19.1 13.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.191 -0.943 . . . . 0.0 110.235 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.23 10.48 31.28 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -89.95 155.94 18.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -1.184 . . . . 0.0 110.157 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.448 ' O ' ' CD2' ' A' ' 15' ' ' TYR . 14.5 tp -111.65 116.31 30.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.301 -0.874 . . . . 0.0 110.169 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.47 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -97.06 47.59 1.63 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.569 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 43.7 p90 -48.43 173.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -1.159 . . . . 0.0 111.006 -179.828 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.52 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 95.5 mt-10 -109.36 179.05 4.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.458 -0.776 . . . . 0.0 110.191 179.903 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -68.42 136.46 53.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 110.439 -179.914 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.35 -14.39 57.87 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.789 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 3.2 mt-10 -62.98 124.08 20.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -1.2 . . . . 0.0 110.393 -179.746 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.431 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 86.8 mt-30 -79.75 136.64 36.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.24 -0.913 . . . . 0.0 109.832 179.768 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.472 ' HA ' ' O ' ' A' ' 44' ' ' GLN . 15.1 mt -137.74 158.51 44.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.069 -1.019 . . . . 0.0 110.653 -179.723 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.538 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 25.4 mtp180 -108.05 134.37 51.03 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.436 -0.79 . . . . 0.0 109.142 179.295 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.4 mm -90.82 93.97 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.047 -1.033 . . . . 0.0 110.737 -179.502 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.9 mt -79.38 -29.79 42.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 110.842 -179.507 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.504 ' HB2' ' CB ' ' A' ' 42' ' ' LYS . 74.0 mt-10 -129.54 143.93 51.04 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.923 -1.111 . . . . 0.0 110.366 -179.957 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.576 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 15.1 pt20 -138.04 55.87 1.76 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.363 -0.836 . . . . 0.0 110.241 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.6 t -120.66 142.06 49.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.171 -0.956 . . . . 0.0 110.204 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.35 -176.01 50.55 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -70.57 -28.28 64.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -1.1 . . . . 0.0 110.211 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.521 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 95.4 m95 -100.27 147.59 25.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 110.345 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.576 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 47.1 m0 -124.27 156.17 37.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.192 -179.985 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.504 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 13.5 tttp -98.94 145.23 27.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.413 179.421 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -158.21 -177.33 6.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.011 -1.056 . . . . 0.0 111.002 -179.596 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.472 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 58.4 tt0 -144.45 152.87 41.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.454 -0.779 . . . . 0.0 109.365 179.584 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.424 ' HB2' ' CD2' ' A' ' 31' ' ' LEU . 10.5 t -102.76 128.12 49.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.026 -1.046 . . . . 0.0 110.515 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.513 ' CD2' ' HD2' ' A' ' 32' ' ' ARG . 37.8 mt -83.17 8.31 13.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.886 . . . . 0.0 109.917 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 20.4 p -98.48 -42.07 7.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.348 -0.845 . . . . 0.0 110.11 -179.993 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 58.2 p -113.05 -10.78 13.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 110.101 -179.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.11 38.93 46.43 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.852 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -112.61 142.52 45.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -1.138 . . . . 0.0 110.197 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -117.9 136.67 53.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 110.092 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.446 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -171.44 165.15 38.11 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.438 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 97.0 m-85 -71.09 145.3 49.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -1.078 . . . . 0.0 110.145 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.463 HG13 ' O ' ' A' ' 54' ' ' ILE . 1.2 pp -136.68 140.07 31.0 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 110.216 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.591 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 47.7 Cg_endo -65.14 149.73 88.59 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.021 1.537 . . . . 0.0 110.073 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.569 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 39.6 p90 -75.61 -5.45 45.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 110.931 -179.449 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -95.44 -25.74 16.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.955 -1.091 . . . . 0.0 111.039 -179.363 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.567 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 9.3 m-85 -82.22 0.26 42.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.905 -1.122 . . . . 0.0 110.453 -179.741 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.451 HG23 ' CD1' ' A' ' 54' ' ' ILE . 23.3 m -141.95 154.11 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 0.0 110.097 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -148.73 157.51 43.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.241 -0.912 . . . . 0.0 110.227 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.429 ' HA ' HG11 ' A' ' 9' ' ' VAL . 31.1 mttt -67.93 123.26 20.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.264 -0.898 . . . . 0.0 110.257 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.79 -29.51 69.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.167 -0.958 . . . . 0.0 110.175 -179.952 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.5 t30 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.187 -179.93 . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.434 ' O ' ' HB3' ' A' ' 4' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.503 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.3 OUTLIER -47.32 -66.3 0.56 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.222 -1.164 . . . . 0.0 110.165 179.959 . . . . . . . . 3 3 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . 0.503 ' CD ' ' CB ' ' A' ' 2' ' ' SER . 46.5 Cg_endo -58.42 -31.17 93.48 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.05 1.553 . . . . 0.0 110.29 -179.945 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . 0.504 ' CD1' ' O ' ' A' ' 4' ' ' LEU . 2.9 tm? -56.51 -26.15 53.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.282 -0.886 . . . . 0.0 110.179 179.963 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -73.31 -19.83 60.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.282 -0.886 . . . . 0.0 110.256 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 45.81 43.9 10.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.17 -0.956 . . . . 0.0 110.027 -179.932 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . 0.521 ' ND2' HD11 ' A' ' 33' ' ' ILE . 44.9 t-20 -92.37 99.94 12.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 110.393 -179.844 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.2 tp -103.78 143.24 33.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.262 -0.899 . . . . 0.0 109.973 179.885 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.453 HG11 ' HA ' ' A' ' 61' ' ' LYS . 27.8 m -141.78 165.74 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.129 -0.982 . . . . 0.0 110.465 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 72.4 mt -112.5 148.01 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.337 -0.852 . . . . 0.0 109.684 179.561 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.446 ' HB3' ' CD2' ' A' ' 25' ' ' PHE . . . -78.56 111.18 14.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.063 -1.023 . . . . 0.0 110.347 -179.71 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.442 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 49.9 mt -70.05 -25.68 63.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.088 -1.008 . . . . 0.0 109.16 179.322 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.442 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 80.7 m-70 -155.62 151.92 28.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.692 -0.63 . . . . 0.0 109.506 179.703 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.2 p -64.91 140.0 58.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.951 -1.093 . . . . 0.0 109.774 179.75 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.583 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 85.6 t80 -97.59 157.13 16.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.014 -1.054 . . . . 0.0 110.332 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -111.44 124.61 32.21 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.909 . . . . 0.0 110.188 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.453 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 48.4 Cg_endo -80.21 81.67 2.69 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.02 1.537 . . . . 0.0 110.47 -179.884 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.486 ' OG ' ' ND1' ' A' ' 19' ' ' HIS . 92.2 p -79.81 -1.96 41.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.135 -0.978 . . . . 0.0 110.013 179.904 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.486 ' ND1' ' OG ' ' A' ' 18' ' ' SER . 72.4 m80 -140.34 172.86 12.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 110.076 -179.997 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -90.07 125.3 35.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.238 -0.913 . . . . 0.0 110.248 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.09 6.99 31.51 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.997 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -104.16 164.37 11.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -1.164 . . . . 0.0 110.28 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.483 ' CD1' ' CD ' ' A' ' 50' ' ' GLN . 22.8 tp -114.82 119.63 37.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.174 -179.961 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.472 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -99.91 54.21 0.94 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.866 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.583 ' CE1' ' HB2' ' A' ' 15' ' ' TYR . 45.9 p90 -53.12 173.73 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.235 -1.156 . . . . 0.0 111.131 -179.482 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.459 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 96.0 mt-10 -105.61 176.57 5.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.553 -0.717 . . . . 0.0 110.288 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.7 tttm -70.97 135.67 48.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.058 -1.026 . . . . 0.0 110.322 179.772 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.0 -13.67 53.07 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 30.6 mm-40 -63.91 136.18 57.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.035 -1.274 . . . . 0.0 109.99 -179.764 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 88.3 mt-30 -79.6 128.1 32.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.895 . . . . 0.0 110.075 -179.873 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.499 HD23 ' CG ' ' A' ' 25' ' ' PHE . 10.4 mp -124.31 141.63 51.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 110.393 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.472 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 15.7 ttt85 -100.95 134.58 43.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.336 -0.852 . . . . 0.0 109.588 179.633 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.521 HD11 ' ND2' ' A' ' 7' ' ' ASN . 27.0 mt -85.78 132.58 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.163 -0.96 . . . . 0.0 110.307 -179.925 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.426 HD21 ' OG ' ' A' ' 2' ' ' SER . 7.0 mt -118.71 -31.75 4.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.363 -0.835 . . . . 0.0 110.112 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.514 ' HB2' ' CB ' ' A' ' 42' ' ' LYS . 85.7 mt-10 -135.58 149.87 49.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.19 -0.944 . . . . 0.0 110.198 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.568 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 93.2 mt-30 -135.84 59.01 1.73 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.268 -0.895 . . . . 0.0 110.15 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.7 t -124.24 135.59 53.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.235 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.7 176.65 45.76 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.97 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.9 -27.44 69.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.204 -1.174 . . . . 0.0 110.236 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.571 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 98.3 m95 -98.96 146.28 26.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.22 -0.925 . . . . 0.0 110.241 -179.897 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.573 ' CZ3' ' HB2' ' A' ' 56' ' ' PHE . 40.9 m0 -122.88 156.48 34.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.901 . . . . 0.0 110.14 179.795 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.514 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 20.7 tttt -93.75 142.3 27.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.956 . . . . 0.0 109.776 179.581 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.512 ' CB ' HG12 ' A' ' 54' ' ' ILE . . . -155.9 178.83 9.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.115 -0.991 . . . . 0.0 110.771 -179.803 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.415 ' HB2' ' HG2' ' A' ' 51' ' ' GLU . 46.3 tt0 -141.82 150.14 41.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.394 -0.816 . . . . 0.0 109.909 179.697 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 t -95.3 119.63 34.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 110.276 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 32' ' ' ARG . 4.9 mp -78.13 6.28 8.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -0.9 . . . . 0.0 110.412 -179.98 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 65.5 p -96.57 -37.29 10.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 110.019 179.853 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.1 p -120.13 -6.09 9.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 110.098 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.67 40.6 52.96 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.483 ' CD ' ' CD1' ' A' ' 23' ' ' LEU . 62.1 tt0 -110.29 141.15 43.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -1.14 . . . . 0.0 110.288 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.415 ' HG2' ' HB2' ' A' ' 44' ' ' GLN . 92.6 mt-10 -117.15 136.57 52.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.341 -0.849 . . . . 0.0 109.938 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.446 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -170.14 164.7 38.05 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -69.1 144.59 53.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -1.13 . . . . 0.0 110.029 179.894 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.512 HG12 ' CB ' ' A' ' 43' ' ' ALA . 1.1 pt -136.0 139.53 30.59 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 110.257 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.575 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 45.4 Cg_endo -63.94 150.45 88.37 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.911 1.479 . . . . 0.0 110.188 179.739 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.573 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 16.2 p90 -85.41 1.3 49.23 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.348 -0.845 . . . . 0.0 111.18 -179.402 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.538 ' OD1' ' N ' ' A' ' 58' ' ' PHE . 48.9 p30 -100.41 -24.03 14.6 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.955 -1.091 . . . . 0.0 111.178 -179.365 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.544 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 14.1 m-30 -94.18 1.34 56.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.87 -1.144 . . . . 0.0 110.591 -179.812 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.507 HG22 ' CD1' ' A' ' 54' ' ' ILE . 33.9 m -130.69 146.22 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.178 -0.951 . . . . 0.0 110.198 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.445 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . -140.41 160.59 39.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.318 -0.864 . . . . 0.0 110.271 -179.945 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.453 ' HA ' HG11 ' A' ' 9' ' ' VAL . 22.4 mttm -74.8 134.68 41.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.953 . . . . 0.0 110.23 -179.988 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.97 -34.72 72.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.881 . . . . 0.0 110.179 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.207 179.983 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 m -67.31 138.27 94.22 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.282 -1.128 . . . . 0.0 110.177 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -57.52 145.21 89.81 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.054 1.555 . . . . 0.0 110.376 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 57.3 mt -62.15 -38.31 88.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.217 -0.927 . . . . 0.0 110.107 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -123.72 151.16 43.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.892 . . . . 0.0 110.199 179.96 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -104.28 16.61 25.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 110.133 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -87.82 15.8 6.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.93 . . . . 0.0 110.283 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.524 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 5.3 mp -102.67 151.82 21.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.204 -0.935 . . . . 0.0 110.101 179.917 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.5 HG12 ' CD1' ' A' ' 33' ' ' ILE . 15.5 m -151.86 171.95 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.172 -0.955 . . . . 0.0 110.448 179.911 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 52.7 mt -118.02 143.32 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.418 -0.801 . . . . 0.0 109.927 179.754 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.493 ' CB ' ' O ' ' A' ' 26' ' ' GLU . . . -76.9 112.61 13.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.179 -0.95 . . . . 0.0 110.514 -179.659 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.481 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 52.5 mt -72.99 -22.32 60.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.089 -1.007 . . . . 0.0 109.314 179.262 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.481 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 77.8 m-70 -156.83 151.68 25.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.651 -0.656 . . . . 0.0 109.521 179.881 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.453 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 34.9 p -65.26 136.83 57.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.899 -1.126 . . . . 0.0 109.895 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.572 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 67.0 t80 -97.78 157.08 16.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.085 -1.009 . . . . 0.0 110.119 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.558 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 3.0 mt-10 -111.74 136.07 21.14 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.852 . . . . 0.0 110.295 -179.82 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.436 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 46.8 Cg_endo -94.32 87.17 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.065 1.561 . . . . 0.0 110.272 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 90.1 p -80.51 0.86 31.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 110.242 -179.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -142.12 -177.92 5.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 110.278 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -97.72 126.11 42.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 110.169 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.33 -9.87 26.55 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.984 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 1.1 m-20 -92.12 171.05 9.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -1.171 . . . . 0.0 110.129 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.493 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 15.5 tp -127.12 132.31 50.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 110.052 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.487 ' HA3' ' HB3' ' A' ' 15' ' ' TYR . . . -109.2 60.29 0.33 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.653 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.567 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 39.6 p90 -52.61 175.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.156 -1.202 . . . . 0.0 110.92 -179.684 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 96.3 mt-10 -109.75 -179.5 3.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.401 -0.812 . . . . 0.0 110.323 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.0 tttt -70.87 130.34 41.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.093 -1.005 . . . . 0.0 110.187 179.674 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.9 -18.47 47.31 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 -179.991 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 22.3 mm-40 -61.45 123.91 19.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.081 -1.246 . . . . 0.0 110.086 -179.667 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 48.9 tt0 -79.46 134.47 36.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.335 -0.853 . . . . 0.0 110.28 -179.76 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.541 HD12 ' CD2' ' A' ' 25' ' ' PHE . 41.8 mt -129.85 150.03 51.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -0.854 . . . . 0.0 110.176 -179.895 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.458 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 19.4 ttt180 -94.59 133.35 38.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.329 -0.857 . . . . 0.0 110.065 179.809 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.5 ' CD1' HG12 ' A' ' 9' ' ' VAL . 34.8 mt -80.89 121.48 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.202 -0.936 . . . . 0.0 110.031 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.432 HD11 ' OE2' ' A' ' 51' ' ' GLU . 4.6 mt -99.49 -33.15 10.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.272 -0.892 . . . . 0.0 110.317 -179.777 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.523 ' OE1' ' CE ' ' A' ' 42' ' ' LYS . 79.6 tt0 -150.98 146.97 26.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.176 -0.953 . . . . 0.0 110.194 -179.924 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.565 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 98.2 mt-30 -128.82 55.17 1.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.895 . . . . 0.0 110.195 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.1 t -111.23 125.99 54.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 110.249 -179.89 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.74 -175.05 53.25 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -67.91 -37.08 81.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -1.104 . . . . 0.0 110.203 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.417 ' HZ3' ' CE1' ' A' ' 15' ' ' TYR . 85.7 m95 -91.47 141.31 28.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 0.0 110.149 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.565 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 50.9 m0 -122.28 153.75 38.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 0.0 110.391 -179.97 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.523 ' CE ' ' OE1' ' A' ' 35' ' ' GLU . 50.2 mttt -89.13 146.42 24.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.302 -0.874 . . . . 0.0 109.558 179.472 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.506 ' CB ' HG12 ' A' ' 54' ' ' ILE . . . -148.71 170.08 18.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.085 -1.01 . . . . 0.0 110.653 -179.61 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.46 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 42.8 tt0 -137.51 145.25 42.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.383 -0.823 . . . . 0.0 109.878 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 53.4 m -74.2 139.34 44.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 110.256 -179.936 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.8 tp -82.34 -26.14 33.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.183 -0.948 . . . . 0.0 110.224 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.3 p -98.96 -28.23 13.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 110.158 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.14 -18.94 18.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.241 -0.912 . . . . 0.0 110.091 179.836 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.95 6.04 35.72 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.634 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -83.13 155.18 23.94 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.04 -1.271 . . . . 0.0 110.485 -179.803 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.46 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 69.1 tt0 -114.99 134.81 54.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.326 -0.859 . . . . 0.0 109.951 179.813 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.493 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -145.6 -152.14 5.57 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.68 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -122.9 134.25 54.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.481 -1.011 . . . . 0.0 109.614 179.638 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.506 HG12 ' CB ' ' A' ' 43' ' ' ALA . 1.2 pp -127.46 133.73 25.4 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.116 -0.99 . . . . 0.0 110.631 -179.617 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.572 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 43.0 Cg_endo -66.08 157.42 59.66 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.149 1.605 . . . . 0.0 110.187 179.611 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.453 ' HB2' ' CH2' ' A' ' 41' ' ' TRP . 18.9 p90 -88.19 -1.63 58.13 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.274 -0.891 . . . . 0.0 111.36 -179.06 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 58' ' ' PHE . 42.3 p30 -99.43 -25.83 14.33 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.82 -1.175 . . . . 0.0 111.066 -179.451 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.569 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 11.7 m-30 -92.43 -3.97 54.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.89 -1.131 . . . . 0.0 110.54 -179.78 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.459 HG23 ' CD1' ' A' ' 54' ' ' ILE . 21.8 m -126.91 144.32 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.1 -1.0 . . . . 0.0 110.095 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -137.22 167.19 22.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.914 . . . . 0.0 110.362 -179.856 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -66.49 133.34 50.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.336 -0.852 . . . . 0.0 110.194 179.98 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.18 146.77 49.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 110.208 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.187 179.993 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.4 m -123.22 80.07 52.41 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.262 -1.14 . . . . 0.0 110.173 -179.964 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -59.51 -18.93 49.49 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.014 1.534 . . . . 0.0 110.336 -179.991 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.9 tp -56.02 -38.35 70.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.912 . . . . 0.0 110.256 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.524 ' HA ' ' CD1' ' A' ' 8' ' ' LEU . 99.0 mt-30 -62.24 -32.73 73.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 110.27 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -61.7 -26.05 67.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.893 . . . . 0.0 110.315 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -86.94 -6.04 58.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.162 -0.961 . . . . 0.0 110.256 -179.989 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.524 ' CD1' ' HA ' ' A' ' 5' ' ' GLN . 44.0 mt -79.07 146.97 32.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.273 -0.892 . . . . 0.0 110.215 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.576 ' CG2' ' CG1' ' A' ' 59' ' ' VAL . 4.2 m -154.48 172.68 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.862 . . . . 0.0 110.333 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 60.0 mt -113.69 141.51 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.342 -0.849 . . . . 0.0 109.943 179.783 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.483 ' HB3' ' CE1' ' A' ' 25' ' ' PHE . . . -80.46 111.89 17.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.143 -0.973 . . . . 0.0 110.119 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.416 ' O ' ' ND1' ' A' ' 13' ' ' HIS . 24.2 tp -66.43 -27.86 68.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.099 -1.0 . . . . 0.0 109.543 179.529 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.416 ' ND1' ' O ' ' A' ' 12' ' ' LEU . 89.5 m-70 -150.8 155.73 39.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.472 -0.767 . . . . 0.0 109.836 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.517 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 52.5 p -68.15 144.28 55.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.14 -0.975 . . . . 0.0 110.019 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.578 ' OH ' ' CZ3' ' A' ' 40' ' ' TRP . 27.4 t80 -94.44 153.71 17.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.042 -1.036 . . . . 0.0 110.323 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.411 ' O ' ' C ' ' A' ' 17' ' ' PRO . 19.0 tp10 -110.45 77.83 1.34 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 110.216 -179.911 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.466 ' HD3' ' HA2' ' A' ' 24' ' ' GLY . 48.1 Cg_endo -41.52 98.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.127 1.593 . . . . 0.0 110.422 179.895 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.489 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 87.5 p -82.31 9.27 9.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 110.25 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.489 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 87.3 m-70 -148.3 164.23 34.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 110.192 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -80.93 118.94 22.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 110.304 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.08 14.8 6.4 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.465 ' HB2' ' HB3' ' A' ' 17' ' ' PRO . 13.0 m-20 -111.32 168.47 9.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.174 -1.192 . . . . 0.0 110.284 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.502 ' HB2' ' HA2' ' A' ' 52' ' ' GLY . 17.1 tp -110.22 113.38 26.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 109.998 179.872 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.466 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . -96.43 53.25 1.54 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.901 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.554 ' CD2' HD23 ' A' ' 31' ' ' LEU . 35.8 p90 -54.13 174.5 0.06 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.248 -1.148 . . . . 0.0 111.123 -179.557 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.517 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 94.3 mt-10 -109.43 177.23 4.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.499 -0.751 . . . . 0.0 109.964 179.78 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -66.95 139.59 57.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -0.955 . . . . 0.0 110.378 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.96 -14.02 57.98 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.459 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 3.7 mt-10 -66.6 126.16 28.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -1.215 . . . . 0.0 110.308 -179.865 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.483 ' C ' ' CD1' ' A' ' 31' ' ' LEU . 44.7 tt0 -79.7 137.33 37.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.814 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.554 HD23 ' CD2' ' A' ' 25' ' ' PHE . 8.3 mp -136.89 156.99 47.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -0.909 . . . . 0.0 110.627 -179.553 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.527 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 38.5 ttt180 -106.26 131.65 53.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.412 -0.805 . . . . 0.0 109.24 179.247 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 87.6 mt -90.8 94.35 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.109 -0.994 . . . . 0.0 110.713 -179.318 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 mp -79.85 -32.69 40.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 110.379 179.993 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.472 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 67.3 tt0 -130.58 135.46 47.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.119 -0.988 . . . . 0.0 110.253 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.571 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 58.8 tt0 -131.41 55.7 1.84 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 110.174 179.984 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.2 m -120.65 145.42 47.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.281 -0.887 . . . . 0.0 110.231 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.89 -174.66 48.61 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -71.8 -30.68 65.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.236 -1.155 . . . . 0.0 110.128 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.578 ' CZ3' ' OH ' ' A' ' 15' ' ' TYR . 99.3 m95 -99.38 145.71 27.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 110.23 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.571 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.6 m0 -121.2 157.04 31.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 110.207 179.896 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.472 ' CB ' ' HB3' ' A' ' 35' ' ' GLU . 43.8 tttp -101.37 138.69 38.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 109.012 179.065 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.527 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -149.93 177.38 9.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.838 -1.164 . . . . 0.0 110.998 -179.419 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . 0.528 ' HG3' ' CG ' ' A' ' 51' ' ' GLU . 39.4 tt0 -140.14 148.42 41.62 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.53 -0.731 . . . . 0.0 109.886 179.81 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.0 t -96.4 111.32 23.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.121 -0.987 . . . . 0.0 110.283 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 66.3 mt -71.19 -2.89 17.45 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 110.34 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 31.3 p -85.53 -32.38 22.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.219 -0.926 . . . . 0.0 110.005 179.866 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 23.6 p -120.82 -3.74 9.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 0.0 110.134 179.88 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.05 48.07 61.87 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.84 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.456 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 49.6 mt-30 -129.41 155.67 45.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -1.18 . . . . 0.0 110.428 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.528 ' CG ' ' HG3' ' A' ' 44' ' ' GLN . 95.4 mt-10 -119.56 160.77 21.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.337 -0.852 . . . . 0.0 109.844 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.502 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -178.32 -157.69 19.52 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -120.79 136.09 54.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.457 -1.025 . . . . 0.0 109.973 179.833 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.513 HG23 ' CE2' ' A' ' 25' ' ' PHE . 5.2 pt -130.91 149.71 74.49 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 110.417 -179.773 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.58 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 44.8 Cg_endo -78.13 143.2 19.98 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 124.023 1.538 . . . . 0.0 109.848 179.702 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.543 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 35.2 p90 -66.86 -8.95 32.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.241 -0.912 . . . . 0.0 110.962 -179.311 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -90.81 -26.13 19.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.911 -1.118 . . . . 0.0 110.939 -179.355 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.58 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 7.2 m-85 -84.18 6.67 21.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.005 -1.059 . . . . 0.0 110.215 -179.761 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.576 ' CG1' ' CG2' ' A' ' 9' ' ' VAL . 15.2 t -147.3 169.11 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.918 . . . . 0.0 110.136 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.487 ' O ' ' CG1' ' A' ' 9' ' ' VAL . . . -159.02 166.03 32.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 110.374 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -76.51 121.37 23.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.263 -0.898 . . . . 0.0 110.2 179.935 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.31 -34.36 23.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 0.0 110.194 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.193 -179.961 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.7 m -124.7 152.03 68.7 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.273 -1.133 . . . . 0.0 110.159 179.93 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -55.79 -20.88 30.32 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.032 1.543 . . . . 0.0 110.44 -179.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.7 mp -94.6 136.87 34.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.935 . . . . 0.0 110.206 -179.963 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . 0.439 ' HB2' HD12 ' A' ' 8' ' ' LEU . 93.2 mt-30 -105.55 148.5 27.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.261 -0.899 . . . . 0.0 110.08 179.995 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -104.47 11.13 34.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.299 -0.876 . . . . 0.0 110.077 179.863 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -86.71 4.85 38.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.874 . . . . 0.0 110.175 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' LEU . . . . . 0.502 ' N ' ' CD1' ' A' ' 8' ' ' LEU . 6.1 mp -83.63 136.46 34.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 0.0 110.267 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.461 HG22 HD13 ' A' ' 33' ' ' ILE . 25.3 m -140.69 164.34 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.265 -0.897 . . . . 0.0 110.29 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.5 mm -109.39 140.71 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.361 -0.837 . . . . 0.0 109.75 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' ALA . . . . . 0.483 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -80.0 107.25 12.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.178 -0.951 . . . . 0.0 110.311 -179.828 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.417 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 7.6 mp -67.63 -23.19 65.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.097 -1.002 . . . . 0.0 109.173 179.366 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' HIS . . . . . 0.417 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 90.8 m-70 -153.33 146.45 24.64 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.621 -0.674 . . . . 0.0 109.576 179.75 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 55.4 p -63.01 147.28 51.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.044 -1.035 . . . . 0.0 109.8 179.917 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.571 ' CD1' ' HG3' ' A' ' 55' ' ' PRO . 38.6 t80 -99.08 161.32 13.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.141 -0.974 . . . . 0.0 110.398 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.455 ' O ' ' CG ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -118.96 85.17 28.23 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 0.0 110.148 179.92 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.52 ' CB ' ' HB2' ' A' ' 22' ' ' ASP . 47.4 Cg_endo -44.36 96.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.02 1.537 . . . . 0.0 110.546 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 16' ' ' GLU . 25.2 p -83.24 3.9 29.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.905 . . . . 0.0 109.955 179.783 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' HIS . . . . . 0.438 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 84.9 t60 -148.2 166.9 26.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.342 -0.849 . . . . 0.0 110.116 -179.92 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -75.81 130.72 39.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.201 -0.937 . . . . 0.0 110.139 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.45 15.36 21.35 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.52 ' HB2' ' CB ' ' A' ' 17' ' ' PRO . 27.8 m-20 -111.74 161.04 16.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -1.159 . . . . 0.0 110.439 -179.862 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.457 HD22 ' OG ' ' A' ' 45' ' ' SER . 13.6 tp -116.2 120.03 37.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.283 -0.886 . . . . 0.0 109.801 179.927 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.47 ' HA2' ' HD3' ' A' ' 17' ' ' PRO . . . -97.78 50.51 1.38 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.792 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.564 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 30.2 p90 -48.71 172.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.227 -1.161 . . . . 0.0 111.19 -179.847 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 81.0 mt-10 -102.78 173.46 6.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.565 -0.71 . . . . 0.0 110.078 179.635 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 pttm -70.11 136.8 50.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.134 -0.979 . . . . 0.0 110.159 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.77 -10.23 73.16 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' GLU . . . . . 0.459 ' HG2' HD22 ' A' ' 31' ' ' LEU . 67.2 tt0 -73.43 128.31 35.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.05 -1.264 . . . . 0.0 110.124 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' GLN . . . . . 0.46 ' O ' ' CD2' ' A' ' 31' ' ' LEU . 46.4 tt0 -79.61 141.46 36.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.93 . . . . 0.0 109.82 179.906 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.504 HD12 ' CG ' ' A' ' 25' ' ' PHE . 17.4 mt -140.64 161.97 36.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.924 . . . . 0.0 110.515 -179.693 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.534 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 7.2 tpt180 -103.67 129.91 51.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.414 -0.804 . . . . 0.0 109.617 179.487 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.512 HG23 ' CG ' ' A' ' 36' ' ' GLN . 25.3 mm -93.67 94.26 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.179 -0.951 . . . . 0.0 110.458 -179.744 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.458 ' HG ' ' HG3' ' A' ' 32' ' ' ARG . 1.2 mt -79.92 -28.08 39.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -0.888 . . . . 0.0 110.775 -179.675 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.464 ' HB2' ' CB ' ' A' ' 42' ' ' LYS . 62.1 mt-10 -131.19 138.38 49.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.965 -1.084 . . . . 0.0 110.489 -179.83 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.573 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 98.8 mt-30 -135.03 54.28 1.95 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 110.043 179.892 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.6 t -120.49 142.52 49.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 110.205 179.972 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.63 -169.88 54.96 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.889 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -76.6 -33.96 58.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -1.12 . . . . 0.0 110.146 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' TRP . . . . . 0.571 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 98.7 m95 -96.93 143.37 27.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 110.42 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' TRP . . . . . 0.573 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.5 m0 -120.1 156.19 31.5 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.284 -0.885 . . . . 0.0 110.238 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' LYS . . . . . 0.472 ' HA ' ' HA ' ' A' ' 53' ' ' PHE . 12.6 tttp -100.28 141.78 32.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.329 -0.857 . . . . 0.0 109.368 179.372 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.534 ' CB ' ' O ' ' A' ' 32' ' ' ARG . . . -153.69 179.44 8.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.053 -1.029 . . . . 0.0 110.94 -179.612 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -142.01 150.61 41.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 109.876 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.457 ' OG ' HD22 ' A' ' 23' ' ' LEU . 13.3 m -99.02 121.97 41.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.118 -0.989 . . . . 0.0 110.356 -179.952 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 71.6 mt -79.2 5.04 13.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 110.179 179.888 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.52 -42.07 4.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.283 -0.885 . . . . 0.0 110.159 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.2 p -90.65 -27.41 19.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -0.898 . . . . 0.0 110.135 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.8 33.42 24.44 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -128.34 153.02 47.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.268 -1.136 . . . . 0.0 110.306 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.408 ' OE2' ' HE2' ' A' ' 42' ' ' LYS . 84.8 tt0 -120.43 142.57 49.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 110.231 179.85 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' GLY . . . . . 0.442 ' HA2' ' HB2' ' A' ' 23' ' ' LEU . . . -168.55 161.62 35.35 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.856 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' PHE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 95.4 m-85 -71.72 146.92 47.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -1.101 . . . . 0.0 109.854 179.591 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' ILE . . . . . 0.474 HD12 ' CD1' ' A' ' 33' ' ' ILE . 1.1 pt -136.87 136.47 21.4 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.195 -0.941 . . . . 0.0 110.357 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.571 ' HG3' ' CD1' ' A' ' 15' ' ' TYR . 45.0 Cg_endo -58.7 147.66 86.68 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.048 1.551 . . . . 0.0 110.045 179.651 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.567 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 19.1 p90 -82.89 -5.64 59.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 110.999 -179.419 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' ASN . . . . . 0.56 ' OD1' ' CZ ' ' A' ' 56' ' ' PHE . 83.6 m-20 -89.54 -25.58 21.3 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.927 -1.108 . . . . 0.0 110.632 -179.642 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . 0.542 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 17.3 m-30 -93.55 2.22 56.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.064 -1.023 . . . . 0.0 110.268 179.968 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.462 HG23 HD13 ' A' ' 54' ' ' ILE . 34.1 m -137.2 143.38 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.215 -0.928 . . . . 0.0 110.12 179.763 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' ALA . . . . . 0.461 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . -135.09 161.55 34.99 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.215 -0.928 . . . . 0.0 110.411 -179.875 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' LYS . . . . . 0.456 ' HA ' HG11 ' A' ' 9' ' ' VAL . 54.6 mttp -71.45 136.52 47.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 0.0 110.161 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.25 -35.61 80.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.291 -0.881 . . . . 0.0 110.254 179.925 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.228 -179.973 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.738 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.8 mp . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.221 0.534 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.684 HG11 HD11 ' A' ' 33' ' ' ILE . 18.2 m -147.67 168.9 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.2 -0.938 . . . . 0.0 110.309 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 81.8 mt -112.24 145.3 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.388 -0.82 . . . . 0.0 109.671 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . -77.56 114.94 16.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.077 -1.014 . . . . 0.0 110.367 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.483 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 37.6 tp -71.4 -26.9 62.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.104 -0.997 . . . . 0.0 109.386 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.483 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 25.8 m80 -158.22 149.41 20.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.469 -0.769 . . . . 0.0 109.7 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 44.2 p -61.97 141.44 58.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.026 -1.046 . . . . 0.0 110.092 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 77.1 t80 -102.76 165.05 11.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.079 -1.013 . . . . 0.0 110.408 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.579 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 35.8 mt-10 -113.52 129.64 24.46 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 110.228 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.485 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 49.9 Cg_endo -85.21 88.67 0.88 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.983 1.518 . . . . 0.0 110.509 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.0 m -79.59 -6.99 58.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.925 . . . . 0.0 110.084 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 -128.23 -155.35 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 110.007 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -112.36 -4.63 14.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 110.27 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.68 5.53 16.59 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -92.21 159.32 15.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -1.187 . . . . 0.0 110.232 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.492 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 35.5 tp -116.78 122.28 43.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.248 -0.908 . . . . 0.0 110.119 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.485 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -99.33 47.83 1.32 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.658 ' CD1' HD21 ' A' ' 31' ' ' LEU . 35.9 p90 -45.57 171.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -1.189 . . . . 0.0 110.834 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -98.71 176.85 5.49 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.415 -0.803 . . . . 0.0 110.446 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -71.8 122.95 21.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.262 -0.899 . . . . 0.0 110.239 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 92.96 -8.85 76.05 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.453 ' N ' ' HB3' ' A' ' 11' ' ' ALA . 27.3 tt0 -61.3 137.27 58.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.137 -1.214 . . . . 0.0 110.112 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.798 ' C ' HD12 ' A' ' 31' ' ' LEU . 87.8 mt-30 -79.63 126.85 31.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 0.0 109.965 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.798 HD12 ' C ' ' A' ' 30' ' ' GLN . 10.3 mp -126.36 145.45 50.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.919 . . . . 0.0 110.468 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.557 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 25.3 ttt180 -103.23 139.71 38.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.828 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.684 HD11 HG11 ' A' ' 9' ' ' VAL . 11.8 mt -87.45 130.14 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.14 -0.975 . . . . 0.0 110.263 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.58 HD11 ' HB2' ' A' ' 44' ' ' GLN . 60.6 mt -117.43 -30.44 5.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 110.193 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 42' ' ' LYS . 83.0 tt0 -139.15 149.65 44.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -0.907 . . . . 0.0 110.232 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.588 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 96.9 mt-30 -139.54 58.79 1.61 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 110.212 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.5 t -123.93 130.31 52.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 0.0 110.246 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.86 -162.8 33.0 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -82.79 -32.33 27.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -1.136 . . . . 0.0 110.075 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.549 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 92.1 m95 -98.03 146.08 25.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.922 . . . . 0.0 110.134 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.588 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 49.3 m0 -120.9 154.95 35.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.297 -0.877 . . . . 0.0 110.302 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 35' ' ' GLU . 79.1 tttt -93.48 143.56 26.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.919 . . . . 0.0 109.798 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.557 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -152.14 175.17 12.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.135 -0.978 . . . . 0.0 110.632 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.58 ' HB2' HD11 ' A' ' 34' ' ' LEU . 39.4 tt0 -139.22 147.49 41.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.43 -0.794 . . . . 0.0 109.884 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.481 ' HB2' ' OG1' ' A' ' 48' ' ' THR . 21.6 m -79.79 145.79 32.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.088 -1.007 . . . . 0.0 110.222 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.635 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.9 mp -94.73 -11.89 28.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.311 -0.868 . . . . 0.0 109.855 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.2 p -105.43 -30.09 9.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.405 -0.809 . . . . 0.0 110.435 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.481 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 17.6 p -99.84 -17.82 17.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.1 -1.0 . . . . 0.0 110.451 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.88 48.79 63.26 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.487 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 38.3 mt-30 -132.76 157.34 45.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.358 -1.084 . . . . 0.0 110.115 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.457 ' HG2' ' HG3' ' A' ' 44' ' ' GLN . 94.3 mt-10 -119.6 141.69 49.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.925 . . . . 0.0 110.097 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.492 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -166.29 159.16 32.38 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -70.24 142.73 52.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.243 -1.151 . . . . 0.0 110.045 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.872 ' CD1' HG21 ' A' ' 59' ' ' VAL . 1.8 pp -137.65 131.1 17.03 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 110.158 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.586 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 46.0 Cg_endo -55.94 160.9 9.26 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.03 1.542 . . . . 0.0 110.07 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -88.45 -2.36 58.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 110.911 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 -100.09 -25.83 14.16 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.987 -1.071 . . . . 0.0 111.054 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.569 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 26.5 m-85 -80.24 -11.93 59.68 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.017 -1.052 . . . . 0.0 110.446 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.872 HG21 ' CD1' ' A' ' 54' ' ' ILE . 26.9 m -132.22 145.55 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.95 . . . . 0.0 110.24 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 110.286 179.997 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.685 ' CD1' HD11 ' A' ' 46' ' ' LEU . 21.1 tp . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.182 0.515 . . . . 0.0 109.957 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.839 HG11 HD11 ' A' ' 33' ' ' ILE . 31.2 m -145.63 167.84 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 110.378 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 86.1 mt -112.6 148.99 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.395 -0.816 . . . . 0.0 109.702 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . -80.17 113.39 18.31 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.128 -0.983 . . . . 0.0 110.443 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.642 HD13 ' O ' ' A' ' 12' ' ' LEU . 0.2 OUTLIER -70.74 -25.31 62.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.115 -0.991 . . . . 0.0 109.091 179.202 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.51 ' CD2' ' O ' ' A' ' 12' ' ' LEU . 14.0 m170 -159.13 151.05 20.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.703 -0.623 . . . . 0.0 109.481 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 41.6 p -63.38 140.83 58.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.907 -1.121 . . . . 0.0 109.883 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 65.5 t80 -100.89 162.81 12.64 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.063 -1.023 . . . . 0.0 110.255 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.571 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 29.8 tt0 -118.12 128.31 26.06 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.24 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.477 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 46.9 Cg_endo -82.17 84.6 1.82 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.111 1.585 . . . . 0.0 110.55 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.1 p -79.78 -3.94 49.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.932 . . . . 0.0 109.974 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.451 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 37.7 m80 -139.85 151.21 45.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 0.0 110.136 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -65.35 125.47 25.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 110.117 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.59 11.43 28.88 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.451 ' OD2' ' HB2' ' A' ' 19' ' ' HIS . 11.4 m-20 -105.94 160.08 15.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.151 -1.205 . . . . 0.0 110.308 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.507 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 20.5 tp -116.4 122.99 46.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.338 -0.851 . . . . 0.0 110.18 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.477 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -104.39 51.28 0.81 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 33.0 p90 -45.32 172.19 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.197 -1.178 . . . . 0.0 110.9 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -99.26 176.0 5.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.405 -0.809 . . . . 0.0 110.554 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.9 tttm -71.18 124.88 25.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.364 -0.835 . . . . 0.0 110.28 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 90.39 -8.62 79.5 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.491 ' OE2' HD21 ' A' ' 31' ' ' LEU . 27.0 tt0 -62.39 132.45 52.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.103 -1.234 . . . . 0.0 110.365 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.524 ' O ' HD23 ' A' ' 31' ' ' LEU . 90.6 mt-30 -79.87 130.59 35.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 109.842 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.524 HD23 ' O ' ' A' ' 30' ' ' GLN . 17.6 mt -130.67 150.43 51.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.934 . . . . 0.0 110.501 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.865 ' HB2' HD21 ' A' ' 46' ' ' LEU . 40.3 ttt180 -100.82 135.77 41.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.434 -0.791 . . . . 0.0 109.75 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.839 HD11 HG11 ' A' ' 9' ' ' VAL . 11.2 mt -83.37 127.87 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 110.317 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.035 HD11 ' HB2' ' A' ' 44' ' ' GLN . 75.1 mt -107.13 -30.98 8.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.284 -0.885 . . . . 0.0 110.215 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -143.39 153.42 42.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 0.0 110.197 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.493 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 20.9 mt-30 -138.58 54.21 1.77 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 110.242 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 75.3 m -121.81 134.48 54.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.908 . . . . 0.0 110.101 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.68 -172.11 47.98 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -74.45 -34.26 63.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -1.144 . . . . 0.0 110.178 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.402 ' HZ3' ' CE1' ' A' ' 15' ' ' TYR . 72.6 m95 -97.17 145.78 25.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -0.921 . . . . 0.0 110.08 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.493 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 52.1 m0 -120.69 153.81 36.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.256 -0.903 . . . . 0.0 110.056 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -90.07 144.5 25.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -0.953 . . . . 0.0 109.749 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 32' ' ' ARG . . . -148.54 170.41 18.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.086 -1.009 . . . . 0.0 110.611 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 1.035 ' HB2' HD11 ' A' ' 34' ' ' LEU . 51.9 tt0 -137.89 146.11 42.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.371 -0.831 . . . . 0.0 109.827 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.7 m -76.77 142.08 40.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.097 -1.002 . . . . 0.0 110.376 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.865 HD21 ' HB2' ' A' ' 32' ' ' ARG . 36.3 mt -88.66 -18.48 27.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.35 -0.844 . . . . 0.0 109.848 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.5 p -106.41 -30.06 9.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -0.862 . . . . 0.0 110.37 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.0 m -92.07 -24.31 19.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.064 -1.022 . . . . 0.0 110.421 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.78 46.29 54.17 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 59.1 mt-30 -134.28 158.75 42.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -1.121 . . . . 0.0 110.204 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.431 ' HG2' ' HB2' ' A' ' 44' ' ' GLN . 92.4 mt-10 -121.02 143.71 48.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.35 -0.844 . . . . 0.0 110.148 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -163.65 157.27 29.43 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -69.4 141.92 54.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -1.156 . . . . 0.0 109.926 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.577 HD12 HG21 ' A' ' 59' ' ' VAL . 1.3 pt -135.84 145.71 53.98 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 110.066 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.602 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 45.5 Cg_endo -72.45 162.62 40.94 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.987 1.519 . . . . 0.0 110.065 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.445 ' CE2' ' OD1' ' A' ' 57' ' ' ASN . 31.7 p90 -88.07 -3.98 58.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.959 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.445 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 60.3 m-20 -98.5 -26.57 14.39 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.899 -1.126 . . . . 0.0 111.062 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.602 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 34.2 m-85 -81.52 -10.85 59.38 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.939 -1.1 . . . . 0.0 110.326 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.577 HG21 HD12 ' A' ' 54' ' ' ILE . 25.3 m -131.05 142.66 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 110.273 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.193 -0.942 . . . . 0.0 110.122 179.995 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.414 ' C ' HG13 ' A' ' 9' ' ' VAL . 91.7 mt . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.187 0.518 . . . . 0.0 109.98 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 60' ' ' ALA . 22.9 m -145.82 167.6 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.127 -0.983 . . . . 0.0 110.539 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 64.5 mt -111.05 149.45 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.377 -0.827 . . . . 0.0 109.621 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.542 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . -80.14 112.83 17.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.031 -1.043 . . . . 0.0 110.339 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.455 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 82.9 mt -69.58 -25.96 64.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.102 -0.999 . . . . 0.0 109.191 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.455 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 72.2 m80 -155.37 152.39 29.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.576 -0.702 . . . . 0.0 109.501 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 26.9 p -64.28 142.15 58.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.898 -1.126 . . . . 0.0 109.92 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 73.9 t80 -102.67 165.05 11.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.012 -1.055 . . . . 0.0 110.167 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.57 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 1.9 tp10 -119.5 132.84 23.86 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.285 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.484 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 49.2 Cg_endo -84.48 84.0 1.56 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.961 1.506 . . . . 0.0 110.299 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 83.3 p -79.59 -3.18 45.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.939 . . . . 0.0 110.051 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.457 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 51.5 m80 -144.86 165.95 26.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 110.039 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -76.87 126.21 30.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.911 . . . . 0.0 110.156 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.17 -1.9 35.19 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.457 ' OD2' ' HB2' ' A' ' 19' ' ' HIS . 17.2 m-20 -93.96 157.64 16.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.27 -1.135 . . . . 0.0 110.259 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.502 HD13 ' HG2' ' A' ' 50' ' ' GLN . 25.5 tp -115.6 120.91 40.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.296 -0.877 . . . . 0.0 109.988 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.484 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -100.62 51.47 0.99 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.586 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 40.7 p90 -48.46 172.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.192 -1.181 . . . . 0.0 110.995 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.4 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 68.8 mm-40 -100.82 174.99 5.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.507 -0.745 . . . . 0.0 110.189 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.4 pttm -71.39 131.62 43.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.137 -0.977 . . . . 0.0 110.102 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.48 -10.16 72.78 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.442 ' CD ' ' HB2' ' A' ' 25' ' ' PHE . 33.0 tt0 -64.5 132.88 51.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -1.168 . . . . 0.0 110.245 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.875 ' C ' HD12 ' A' ' 31' ' ' LEU . 95.1 mt-30 -79.68 131.47 35.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.784 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.875 HD12 ' C ' ' A' ' 30' ' ' GLN . 9.4 mp -129.84 148.58 51.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.92 . . . . 0.0 110.562 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.617 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 24.7 ttt180 -103.13 134.72 46.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.448 -0.782 . . . . 0.0 109.534 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.9 mm -83.82 131.53 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.143 -0.973 . . . . 0.0 110.194 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.1 mt -115.57 -32.9 5.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.331 -0.855 . . . . 0.0 110.178 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 87.1 mt-10 -132.06 153.95 49.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 110.21 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.627 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 97.9 mt-30 -139.97 55.61 1.64 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.86 . . . . 0.0 110.204 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 99.1 p -125.24 126.8 45.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 110.287 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.61 174.8 49.43 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -63.34 -28.91 70.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -1.197 . . . . 0.0 110.208 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.555 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 97.3 m95 -97.54 145.26 26.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 110.226 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.627 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 35.9 m0 -124.7 157.0 36.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.289 -0.882 . . . . 0.0 110.1 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 35' ' ' GLU . 34.0 tttt -96.26 145.33 25.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.689 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.617 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -158.24 -177.71 6.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 110.56 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -145.52 153.85 41.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.424 -0.798 . . . . 0.0 109.982 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.8 t -98.89 126.02 44.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.115 -0.991 . . . . 0.0 110.17 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.1 mt -80.7 9.27 6.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.904 . . . . 0.0 110.312 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.504 HG22 HG23 ' A' ' 48' ' ' THR . 31.8 m -92.79 -35.59 13.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.175 -0.953 . . . . 0.0 110.194 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.504 HG23 HG22 ' A' ' 47' ' ' THR . 49.2 p -132.69 -0.98 3.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.389 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.32 30.85 56.26 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.502 ' HG2' HD13 ' A' ' 23' ' ' LEU . 54.7 tt0 -91.27 131.79 36.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -1.116 . . . . 0.0 110.135 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -117.22 136.24 53.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 0.0 110.082 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -171.88 166.18 39.06 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 91.5 m-85 -70.44 146.41 50.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -1.131 . . . . 0.0 110.113 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.682 HD13 HG11 ' A' ' 59' ' ' VAL . 2.2 pp -139.23 131.59 15.37 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.235 -0.916 . . . . 0.0 110.147 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.653 ' O ' HD12 ' A' ' 54' ' ' ILE . 47.3 Cg_endo -55.68 158.49 13.3 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.972 1.511 . . . . 0.0 110.102 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.572 ' CE2' ' OD1' ' A' ' 57' ' ' ASN . 18.8 p90 -87.41 -0.42 56.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 0.0 110.771 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.572 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 89.9 m-20 -99.65 -26.42 14.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.958 -1.089 . . . . 0.0 110.855 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.479 ' HB2' ' HG2' ' A' ' 55' ' ' PRO . 10.8 m-85 -83.47 -3.0 57.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.004 -1.06 . . . . 0.0 110.391 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.682 HG11 HD13 ' A' ' 54' ' ' ILE . 26.9 m -130.6 143.52 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 0.0 110.328 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.457 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 110.149 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.617 ' CD1' HD11 ' A' ' 46' ' ' LEU . 19.7 tp . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.133 0.492 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.836 HG21 HD11 ' A' ' 33' ' ' ILE . 33.0 m -145.84 167.98 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.129 -0.982 . . . . 0.0 110.415 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.3 mt -113.44 149.9 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.366 -0.834 . . . . 0.0 109.596 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.487 ' HB3' ' N ' ' A' ' 29' ' ' GLU . . . -80.38 114.52 19.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.169 -0.957 . . . . 0.0 110.679 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.458 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 16.8 tp -78.95 -19.74 50.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 109.256 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.458 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 39.8 m-70 -159.98 142.05 13.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.566 -0.709 . . . . 0.0 109.511 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.0 p -60.56 139.73 57.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.818 -1.176 . . . . 0.0 110.101 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.612 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 81.6 t80 -99.93 161.97 13.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.124 -0.985 . . . . 0.0 110.296 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.46 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 2.1 mp0 -117.46 129.03 25.62 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.322 -0.861 . . . . 0.0 110.12 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.468 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.2 Cg_endo -83.06 83.77 1.87 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.081 1.569 . . . . 0.0 110.381 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.563 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 56.8 p -79.8 -3.88 49.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 110.121 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.563 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 89.4 m-70 -141.61 168.49 19.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 0.0 110.264 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -82.01 125.12 30.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.27 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.15 18.36 11.4 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -114.97 161.03 18.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.259 -1.142 . . . . 0.0 110.127 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.498 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 17.6 tp -115.76 120.77 40.39 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 110.28 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.468 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -101.72 54.63 0.77 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.629 ' CG ' HD11 ' A' ' 31' ' ' LEU . 44.0 p90 -50.26 171.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.31 -1.112 . . . . 0.0 110.908 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -100.39 178.33 4.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 110.488 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -71.86 123.07 21.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -0.88 . . . . 0.0 110.246 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 91.76 -10.09 75.38 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.488 ' OE1' ' HA ' ' A' ' 25' ' ' PHE . 16.6 tt0 -61.65 131.93 51.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -1.17 . . . . 0.0 110.135 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.557 ' O ' HD23 ' A' ' 31' ' ' LEU . 96.3 mt-30 -79.98 130.81 35.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.305 -0.872 . . . . 0.0 110.192 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.629 HD11 ' CG ' ' A' ' 25' ' ' PHE . 32.3 mt -126.76 145.65 50.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -0.954 . . . . 0.0 110.459 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.928 ' HB2' HD21 ' A' ' 46' ' ' LEU . 5.4 tpt180 -93.72 137.74 32.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.366 -0.834 . . . . 0.0 109.531 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.836 HD11 HG21 ' A' ' 9' ' ' VAL . 18.7 mm -90.99 129.13 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.131 -0.981 . . . . 0.0 110.287 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.992 HD11 ' HB2' ' A' ' 44' ' ' GLN . 49.9 mt -112.94 -26.4 8.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.902 . . . . 0.0 110.068 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 75.3 mt-10 -150.45 156.33 41.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 110.147 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.612 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 26.6 mt-30 -142.09 58.6 1.47 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 110.238 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -119.0 140.36 50.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.254 -0.904 . . . . 0.0 110.156 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.8 -168.3 53.47 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -76.37 -34.43 58.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -1.162 . . . . 0.0 110.128 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.554 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 96.8 m95 -96.25 143.75 27.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 110.251 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.612 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.9 m0 -116.53 152.29 34.39 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -0.897 . . . . 0.0 110.261 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 35' ' ' GLU . 18.1 tttt -89.95 141.43 28.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.254 -0.904 . . . . 0.0 109.987 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.531 ' CB ' HG12 ' A' ' 54' ' ' ILE . . . -147.87 170.22 18.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.16 -0.963 . . . . 0.0 110.428 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.992 ' HB2' HD11 ' A' ' 34' ' ' LEU . 59.2 tt0 -130.48 136.31 48.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 110.037 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.447 ' OG ' HD21 ' A' ' 23' ' ' LEU . 66.1 m -68.45 138.02 54.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.127 -0.983 . . . . 0.0 110.242 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.928 HD21 ' HB2' ' A' ' 32' ' ' ARG . 54.2 mt -87.65 -12.52 45.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.094 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.9 p -101.34 -28.42 12.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.863 . . . . 0.0 110.285 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 46.2 p -113.37 -3.6 13.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.169 -0.957 . . . . 0.0 110.366 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 58.67 14.15 20.75 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -86.93 157.19 19.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.122 -1.222 . . . . 0.0 110.39 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 94.9 mt-10 -117.4 138.68 51.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.355 -0.84 . . . . 0.0 109.972 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.498 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -161.07 156.7 28.14 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -68.68 144.5 54.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.247 -1.149 . . . . 0.0 109.899 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.73 HD12 HG21 ' A' ' 59' ' ' VAL . 1.1 pt -137.37 123.43 13.18 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.142 -0.974 . . . . 0.0 110.38 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.608 ' HG3' ' CD2' ' A' ' 58' ' ' PHE . 43.5 Cg_endo -47.16 159.35 0.39 Allowed 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.963 1.507 . . . . 0.0 110.068 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -96.48 0.78 50.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 110.736 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -100.18 -26.73 13.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.027 -1.046 . . . . 0.0 110.694 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.608 ' CD2' ' HG3' ' A' ' 55' ' ' PRO . 7.9 m-30 -89.19 -8.18 54.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.143 -0.973 . . . . 0.0 110.494 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.73 HG21 HD12 ' A' ' 54' ' ' ILE . 26.9 m -125.02 143.42 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.087 -1.008 . . . . 0.0 110.187 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.458 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.224 -0.922 . . . . 0.0 110.211 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.77 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.2 mp . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.178 0.513 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 8' ' ' LEU . 9.4 m -157.62 174.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.286 -0.884 . . . . 0.0 110.328 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 80.0 mt -115.75 141.88 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.392 -0.818 . . . . 0.0 109.721 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.713 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -80.17 116.69 20.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 0.0 110.427 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.47 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 10.1 tp -70.06 -23.13 63.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.113 -0.992 . . . . 0.0 109.284 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.47 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 30.0 m80 -158.28 147.73 19.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.537 -0.727 . . . . 0.0 109.568 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 55.9 p -60.87 144.34 53.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.943 -1.098 . . . . 0.0 109.919 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 89.4 t80 -101.45 163.39 12.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.001 -1.062 . . . . 0.0 110.579 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.411 ' N ' ' CG ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -110.62 113.58 55.57 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.317 -0.864 . . . . 0.0 109.891 179.678 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.492 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 51.0 Cg_endo -74.36 96.85 0.99 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.066 1.561 . . . . 0.0 110.514 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.3 p -79.65 -1.54 38.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 110.103 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -133.49 -178.91 5.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 110.118 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -93.23 -2.26 55.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.285 -0.884 . . . . 0.0 110.194 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.474 ' O ' ' CD2' ' A' ' 53' ' ' PHE . . . -115.11 5.98 21.78 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 4.1 m-20 -98.77 167.81 10.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.241 -1.152 . . . . 0.0 110.346 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.507 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 31.0 tp -123.44 127.45 48.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.281 -0.887 . . . . 0.0 110.15 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.492 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -104.22 54.87 0.63 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.713 ' CE2' ' HB1' ' A' ' 11' ' ' ALA . 40.3 p90 -44.78 169.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -1.124 . . . . 0.0 110.922 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.451 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 95.6 mt-10 -98.6 176.92 5.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.448 -0.783 . . . . 0.0 110.225 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -70.84 127.09 31.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.167 -0.958 . . . . 0.0 110.225 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.98 -7.66 81.65 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.559 ' OE2' HD11 ' A' ' 31' ' ' LEU . 19.0 tt0 -66.12 131.93 47.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.132 -1.216 . . . . 0.0 110.238 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.854 ' O ' HD12 ' A' ' 31' ' ' LEU . 98.1 mt-30 -79.54 133.42 36.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.259 -0.901 . . . . 0.0 109.903 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.854 HD12 ' O ' ' A' ' 30' ' ' GLN . 8.4 mp -132.19 152.17 51.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.254 -0.904 . . . . 0.0 110.483 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.655 HH22 HD11 ' A' ' 8' ' ' LEU . 26.1 ttm-85 -102.21 134.01 46.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.431 -0.793 . . . . 0.0 109.837 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.497 HD11 HG11 ' A' ' 9' ' ' VAL . 12.3 mt -88.46 137.18 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.921 . . . . 0.0 110.101 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.969 HD12 ' HA ' ' A' ' 43' ' ' ALA . 1.3 mt -122.6 -29.25 4.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 110.095 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.47 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 73.9 mm-40 -135.3 147.67 49.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.182 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.615 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 95.3 mt-30 -137.95 56.63 1.74 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.898 . . . . 0.0 110.198 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.8 p -120.73 130.3 54.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 110.237 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.81 -164.8 41.39 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -81.16 -31.32 34.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.241 -1.152 . . . . 0.0 110.197 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.561 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 98.5 m95 -96.07 144.41 26.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 110.223 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.615 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 48.8 m0 -123.21 156.52 34.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 110.335 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 35' ' ' GLU . 36.1 tttt -95.16 143.04 26.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 109.735 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.969 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -157.61 -178.77 7.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.942 . . . . 0.0 110.444 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.684 ' OE1' HD21 ' A' ' 34' ' ' LEU . 17.3 pt20 -151.46 159.68 44.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.399 -0.813 . . . . 0.0 110.104 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.1 t -97.37 115.61 28.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.206 -0.934 . . . . 0.0 110.14 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.6 mt -73.26 -1.2 16.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.271 -0.893 . . . . 0.0 110.356 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.5 m -92.81 -28.57 16.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 110.059 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.8 p -116.86 -10.3 11.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.898 . . . . 0.0 110.088 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.02 41.86 53.45 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 44' ' ' GLN . 37.8 mt-30 -124.07 151.83 43.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -1.167 . . . . 0.0 110.231 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 43.7 mt-10 -122.92 147.09 46.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 110.067 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -162.39 -146.27 4.62 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.474 ' CD2' ' O ' ' A' ' 21' ' ' GLY . 81.0 m-85 -128.44 142.62 51.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -1.092 . . . . 0.0 110.129 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.771 ' CD1' HG21 ' A' ' 59' ' ' VAL . 2.0 pp -138.23 145.06 45.71 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.266 -0.897 . . . . 0.0 110.251 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.596 ' HD3' ' CD1' ' A' ' 15' ' ' TYR . 45.4 Cg_endo -70.37 156.35 61.93 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.953 1.502 . . . . 0.0 110.037 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.591 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 27.4 p90 -78.51 -3.21 42.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.271 -0.893 . . . . 0.0 111.01 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -99.92 -25.74 14.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.985 -1.072 . . . . 0.0 111.197 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.593 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 9.8 m-85 -82.17 -5.16 58.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.954 -1.091 . . . . 0.0 110.467 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.771 HG21 ' CD1' ' A' ' 54' ' ' ILE . 27.6 m -134.47 145.54 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.123 -0.986 . . . . 0.0 110.187 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.237 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.735 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.7 mp . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.221 0.534 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.569 HG13 ' C ' ' A' ' 8' ' ' LEU . 34.4 m -155.03 172.55 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.319 -0.863 . . . . 0.0 110.157 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.452 HD13 ' O ' ' A' ' 9' ' ' VAL . 19.0 mm -114.36 154.66 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.915 . . . . 0.0 109.778 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.528 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -79.72 109.86 14.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.1 -1.0 . . . . 0.0 110.226 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.2 tp -70.61 -20.85 62.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.003 -1.061 . . . . 0.0 109.339 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -150.88 -164.08 1.93 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.525 -0.734 . . . . 0.0 109.863 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 20.7 t -111.6 138.94 47.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.155 -0.966 . . . . 0.0 110.077 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.604 ' CD2' ' HD3' ' A' ' 55' ' ' PRO . 53.2 t80 -103.19 164.16 11.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.064 -1.022 . . . . 0.0 110.128 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.565 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 74.7 mm-40 -120.69 125.37 27.15 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.226 -0.921 . . . . 0.0 110.209 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.483 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.9 Cg_endo -74.91 81.94 2.09 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.985 1.519 . . . . 0.0 110.33 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.643 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 83.4 p -79.62 -1.8 39.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.141 -0.975 . . . . 0.0 110.187 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.643 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 90.1 m-70 -147.62 143.97 28.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 110.167 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -54.83 128.49 33.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.176 -0.952 . . . . 0.0 110.335 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.401 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . 104.94 -13.28 49.55 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -82.95 158.21 22.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -1.139 . . . . 0.0 110.328 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.543 ' O ' ' CD1' ' A' ' 15' ' ' TYR . 15.8 tp -119.82 125.99 49.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.353 -0.842 . . . . 0.0 110.073 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.483 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -105.21 55.89 0.55 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.528 ' CD1' ' HB1' ' A' ' 11' ' ' ALA . 40.4 p90 -50.14 173.53 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.088 -1.242 . . . . 0.0 110.942 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -111.78 -177.44 3.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.475 -0.765 . . . . 0.0 110.027 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -67.96 129.57 40.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.15 -0.969 . . . . 0.0 110.328 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.1 -17.93 57.24 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.457 ' HG2' HD21 ' A' ' 31' ' ' LEU . 8.6 tt0 -55.43 122.71 11.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.179 -1.189 . . . . 0.0 110.382 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.411 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 29.5 tt0 -79.97 131.42 35.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 109.901 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.519 HD11 ' CG ' ' A' ' 25' ' ' PHE . 38.7 mt -137.19 158.72 43.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.953 . . . . 0.0 110.316 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.696 ' HD3' HD21 ' A' ' 34' ' ' LEU . 17.8 ttt180 -108.14 135.75 48.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 0.0 109.867 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.4 mt -91.75 92.03 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.175 -0.953 . . . . 0.0 110.325 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.696 HD21 ' HD3' ' A' ' 32' ' ' ARG . 81.1 mt -78.91 -27.79 43.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.267 -0.896 . . . . 0.0 110.554 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.54 ' HB2' ' CB ' ' A' ' 42' ' ' LYS . 95.7 mt-10 -131.33 136.11 47.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.145 -0.972 . . . . 0.0 110.16 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.629 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 19.0 pt20 -133.79 55.41 1.9 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 110.185 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.0 t -117.13 142.78 46.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.181 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.09 -165.61 54.77 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -79.61 -33.53 41.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -1.113 . . . . 0.0 110.086 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 52.1 m95 -95.71 144.12 26.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.305 -0.872 . . . . 0.0 110.113 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.629 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 47.4 m0 -124.5 155.62 38.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 110.419 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.54 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 22.9 tttt -98.99 146.31 26.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.331 -0.856 . . . . 0.0 109.317 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -148.79 175.27 11.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.988 -1.07 . . . . 0.0 110.821 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 46.9 tt0 -138.81 147.51 42.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.416 -0.802 . . . . 0.0 109.837 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.47 ' OG ' HD21 ' A' ' 23' ' ' LEU . 42.5 m -95.97 117.23 30.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.115 -0.991 . . . . 0.0 110.075 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 76.6 mt -75.22 1.61 13.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 0.0 110.315 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 65.9 p -99.57 -33.2 10.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.925 . . . . 0.0 109.977 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.7 p -110.32 -15.23 14.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.891 . . . . 0.0 110.063 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.13 40.6 50.09 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -127.51 154.39 45.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -1.164 . . . . 0.0 110.335 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 64.6 tt0 -120.2 143.89 48.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.266 -0.896 . . . . 0.0 109.919 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.522 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -153.41 -153.94 6.56 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -119.98 132.45 55.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.492 -1.005 . . . . 0.0 109.915 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.499 HD12 HG21 ' A' ' 59' ' ' VAL . 11.3 pt -125.77 145.25 51.03 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.167 -0.958 . . . . 0.0 110.439 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.609 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 45.8 Cg_endo -78.97 151.51 24.13 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.987 1.52 . . . . 0.0 109.833 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.589 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 33.3 p90 -71.05 -4.8 26.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.235 -0.916 . . . . 0.0 111.034 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.49 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 65.8 m-20 -98.1 -25.99 14.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.88 -1.138 . . . . 0.0 111.274 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.609 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 8.5 m-85 -85.16 -4.03 59.01 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.859 -1.151 . . . . 0.0 110.36 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.499 HG21 HD12 ' A' ' 54' ' ' ILE . 36.0 m -132.21 139.74 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -0.937 . . . . 0.0 110.106 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 110.384 -179.888 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.428 ' O ' HG13 ' A' ' 9' ' ' VAL . 13.8 tp . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.189 0.518 . . . . 0.0 110.115 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.705 HG12 ' O ' ' A' ' 60' ' ' ALA . 4.5 m -151.8 170.9 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.869 . . . . 0.0 110.329 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.3 mt -113.64 142.33 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.852 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 58' ' ' PHE . . . -80.3 114.34 19.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.147 -0.971 . . . . 0.0 110.192 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.52 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 75.3 mt -68.84 -22.6 64.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.068 -1.02 . . . . 0.0 109.471 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 82.2 m-70 -157.98 152.43 24.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.548 -0.72 . . . . 0.0 109.762 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 54.2 p -65.26 144.76 56.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.989 -1.07 . . . . 0.0 110.075 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 36.2 t80 -97.37 157.11 16.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.086 -1.009 . . . . 0.0 110.502 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -111.2 85.34 5.34 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.263 -0.898 . . . . 0.0 110.116 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.535 ' HD3' ' CA ' ' A' ' 24' ' ' GLY . 47.1 Cg_endo -55.86 120.61 8.55 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.101 1.579 . . . . 0.0 110.502 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 98.7 p -92.1 10.53 28.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 110.119 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -141.02 -158.25 0.84 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 110.214 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 56.7 p30 -112.03 4.8 18.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -0.867 . . . . 0.0 110.135 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -118.15 4.37 16.03 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.534 ' HB2' ' CB ' ' A' ' 17' ' ' PRO . 42.6 m-20 -95.07 165.18 12.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.181 -1.188 . . . . 0.0 110.272 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.512 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 16.0 tp -113.5 116.21 29.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.273 -0.892 . . . . 0.0 110.003 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.535 ' CA ' ' HD3' ' A' ' 17' ' ' PRO . . . -96.33 51.85 1.6 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.58 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 25.4 p90 -49.91 171.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -1.152 . . . . 0.0 110.882 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.433 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 95.7 mt-10 -103.16 178.38 4.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.465 -0.772 . . . . 0.0 110.004 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -68.88 132.78 47.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.209 -0.932 . . . . 0.0 110.284 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.56 -9.65 74.98 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.481 ' OE2' ' CB ' ' A' ' 25' ' ' PHE . 21.8 tt0 -65.27 125.94 26.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.124 -1.221 . . . . 0.0 110.202 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.801 ' O ' HD23 ' A' ' 31' ' ' LEU . 85.9 mt-30 -79.72 137.94 37.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 110.04 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.801 HD23 ' O ' ' A' ' 30' ' ' GLN . 29.2 mt -141.58 163.78 32.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.194 -0.941 . . . . 0.0 110.358 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.588 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 5.8 ttt180 -107.18 134.21 50.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.376 -0.828 . . . . 0.0 109.485 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.464 ' CG2' ' CG ' ' A' ' 36' ' ' GLN . 25.5 mm -96.11 93.38 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.133 -0.979 . . . . 0.0 110.515 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.002 HD12 ' HA ' ' A' ' 43' ' ' ALA . 1.5 mp -79.49 -25.75 41.76 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.305 -0.872 . . . . 0.0 110.654 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.457 ' O ' ' HB3' ' A' ' 41' ' ' TRP . 11.0 mt-10 -136.38 139.65 42.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.057 -1.027 . . . . 0.0 110.39 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.633 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 20.8 mt-30 -134.21 54.47 1.94 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.368 -0.832 . . . . 0.0 110.044 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -112.69 146.91 37.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.403 -0.811 . . . . 0.0 110.224 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.18 -167.38 31.65 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -77.5 -34.13 54.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.319 -1.107 . . . . 0.0 110.154 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.53 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 99.3 m95 -92.96 137.98 31.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.191 -0.943 . . . . 0.0 110.326 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.633 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 50.6 m0 -120.42 156.08 32.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.32 -0.863 . . . . 0.0 110.023 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.438 ' HB2' ' HB2' ' A' ' 35' ' ' GLU . 20.3 mttp -98.25 139.55 33.87 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 109.275 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 1.002 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -148.57 174.24 12.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.015 -1.053 . . . . 0.0 110.694 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 50' ' ' GLN . 47.3 tt0 -140.68 149.27 42.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.409 -0.807 . . . . 0.0 109.9 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 t -96.08 110.64 22.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.924 . . . . 0.0 110.161 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 70.2 mt -71.55 -2.35 16.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.298 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 91.5 m -85.84 -28.23 24.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 0.0 109.948 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.1 p -127.89 -4.61 5.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 110.172 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.77 39.69 65.61 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.487 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 32.6 mt-30 -114.97 148.11 39.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.171 -1.193 . . . . 0.0 110.242 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 37.3 tt0 -120.94 144.47 48.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 0.0 109.887 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.512 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -162.19 -152.54 6.77 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -124.56 140.16 53.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.419 -1.048 . . . . 0.0 109.946 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.943 HD13 HG21 ' A' ' 59' ' ' VAL . 1.6 pp -136.09 137.73 25.64 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.18 -0.95 . . . . 0.0 110.491 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.612 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 45.1 Cg_endo -64.75 152.4 82.18 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.006 1.53 . . . . 0.0 109.964 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.593 ' HB2' ' CH2' ' A' ' 41' ' ' TRP . 30.1 p90 -72.36 -8.04 52.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.253 -0.904 . . . . 0.0 111.267 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -94.11 -26.12 16.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.817 -1.177 . . . . 0.0 110.993 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.612 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 6.5 m-85 -81.81 0.15 40.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.048 -1.033 . . . . 0.0 110.146 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.943 HG21 HD13 ' A' ' 54' ' ' ILE . 27.9 t -144.79 170.2 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.328 -0.858 . . . . 0.0 109.956 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.705 ' O ' HG12 ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.204 -0.935 . . . . 0.0 110.305 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.8 mt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.196 0.522 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.672 HG11 ' CD1' ' A' ' 33' ' ' ILE . 15.0 m -147.08 168.15 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 110.271 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.1 mm -111.83 139.26 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 0.0 109.936 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.655 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -80.42 115.61 20.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 110.448 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.444 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 61.4 mt -74.74 -19.81 60.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.991 -1.068 . . . . 0.0 109.436 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.444 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 51.9 m-70 -157.33 143.66 17.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.538 -0.726 . . . . 0.0 109.668 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 52.0 p -58.92 145.21 42.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.006 -1.059 . . . . 0.0 110.01 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.597 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 85.2 t80 -105.6 167.33 9.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.152 -0.968 . . . . 0.0 110.292 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.576 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 25.1 mt-10 -114.9 127.54 26.73 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 110.018 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.479 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 50.9 Cg_endo -79.79 89.63 1.32 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.917 1.483 . . . . 0.0 110.393 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.4 p -79.18 -10.09 59.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.867 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -126.96 -179.51 4.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.858 . . . . 0.0 110.073 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -86.92 1.91 51.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 110.267 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.487 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -123.29 -15.78 3.66 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -67.84 156.38 37.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.126 -1.22 . . . . 0.0 110.35 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.46 ' HA ' HD12 ' A' ' 23' ' ' LEU . 21.9 tp -116.51 120.31 38.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 109.829 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.479 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -97.53 53.16 1.31 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.655 ' CE2' ' HB1' ' A' ' 11' ' ' ALA . 42.7 p90 -48.28 168.72 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.211 -1.17 . . . . 0.0 110.948 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -96.9 176.98 5.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.475 -0.766 . . . . 0.0 110.349 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -71.33 127.03 31.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 110.161 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.61 -6.08 83.32 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.444 ' CD ' ' HB2' ' A' ' 25' ' ' PHE . 20.5 tt0 -65.99 130.04 41.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.114 -1.227 . . . . 0.0 110.054 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.432 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 50.8 tt0 -79.54 136.46 36.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.826 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.626 HD11 ' CG ' ' A' ' 25' ' ' PHE . 54.2 mt -139.65 162.36 35.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 0.0 110.528 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.582 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 11.3 ttt180 -111.83 138.77 47.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.394 -0.816 . . . . 0.0 109.558 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.672 ' CD1' HG11 ' A' ' 9' ' ' VAL . 57.9 mt -98.68 92.35 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.121 -0.987 . . . . 0.0 110.392 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.533 HD21 ' CD ' ' A' ' 32' ' ' ARG . 73.4 mt -79.49 -21.79 44.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 0.0 110.908 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.527 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 75.9 tt0 -138.12 131.54 30.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.993 -1.067 . . . . 0.0 110.234 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.635 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 21.1 mt-30 -126.25 56.75 1.43 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 110.25 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.7 t -115.84 150.26 37.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.296 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.58 -168.88 34.58 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -75.71 -32.72 60.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.306 -1.114 . . . . 0.0 110.088 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.553 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 95.4 m95 -97.9 144.71 27.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -0.901 . . . . 0.0 110.008 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.635 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 50.0 m0 -119.72 154.62 33.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.336 -0.852 . . . . 0.0 110.094 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.527 ' CB ' ' HB3' ' A' ' 35' ' ' GLU . 18.4 tttp -92.96 140.43 29.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.324 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.582 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -148.92 171.66 15.96 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.046 -1.034 . . . . 0.0 110.932 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 4.8 tt0 -139.57 147.78 41.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.56 -0.713 . . . . 0.0 109.622 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.0 t -94.22 109.81 21.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.15 -0.969 . . . . 0.0 110.144 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.435 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 16.5 tp -71.93 -1.58 14.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.437 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 98.0 m -90.87 -31.11 16.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -0.909 . . . . 0.0 110.142 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.0 p -120.73 -8.94 9.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.284 -0.885 . . . . 0.0 110.201 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.65 36.86 47.32 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -112.43 144.47 41.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -1.127 . . . . 0.0 110.268 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 83.8 tt0 -120.69 141.69 50.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.23 -0.919 . . . . 0.0 110.168 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 21' ' ' GLY . . . -172.95 163.93 35.82 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 91.7 m-85 -74.37 147.31 42.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -1.15 . . . . 0.0 109.832 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.815 HD12 ' O ' ' A' ' 55' ' ' PRO . 1.7 pp -142.67 137.86 15.64 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.281 -0.887 . . . . 0.0 110.285 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.815 ' O ' HD12 ' A' ' 54' ' ' ILE . 45.4 Cg_endo -57.89 156.81 26.7 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.112 1.585 . . . . 0.0 110.169 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.596 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 20.8 p90 -92.78 -0.9 57.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.375 -0.828 . . . . 0.0 111.243 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 58' ' ' PHE . 49.1 p-10 -98.32 -26.63 14.44 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.824 -1.172 . . . . 0.0 111.051 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.522 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 16.8 m-30 -88.65 2.3 53.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.938 -1.102 . . . . 0.0 110.502 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.799 HG11 HD13 ' A' ' 54' ' ' ILE . 33.2 m -132.19 146.64 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.111 -0.993 . . . . 0.0 110.208 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.316 -0.865 . . . . 0.0 110.181 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.437 ' C ' HG13 ' A' ' 9' ' ' VAL . 15.2 tp . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.259 0.552 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.917 HG11 HD11 ' A' ' 33' ' ' ILE . 24.5 m -149.48 168.78 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 110.269 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.2 mt -111.15 141.44 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.93 . . . . 0.0 109.886 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.433 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -80.12 109.86 14.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.167 -0.958 . . . . 0.0 110.316 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.414 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 71.6 mt -69.93 -24.52 63.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.02 -1.05 . . . . 0.0 109.247 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.414 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 74.2 m80 -152.84 148.23 26.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.561 -0.712 . . . . 0.0 109.632 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.527 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 51.4 p -63.75 144.76 56.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.037 -1.039 . . . . 0.0 109.987 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 39.5 t80 -97.68 157.38 16.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.026 -1.046 . . . . 0.0 110.357 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -110.32 99.82 41.91 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.372 -0.83 . . . . 0.0 109.998 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.494 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.3 Cg_endo -59.96 91.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.069 1.563 . . . . 0.0 110.461 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.9 m -83.28 1.33 41.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 110.102 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.462 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 77.3 m80 -146.67 152.35 38.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -0.887 . . . . 0.0 110.135 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -65.04 130.01 41.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -0.917 . . . . 0.0 110.189 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.07 13.58 24.78 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.462 ' OD2' ' HB2' ' A' ' 19' ' ' HIS . 13.8 m-20 -108.29 158.24 17.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.29 -1.123 . . . . 0.0 110.448 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.665 HD13 ' HG2' ' A' ' 50' ' ' GLN . 13.5 tp -109.3 111.89 23.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 109.834 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.494 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -93.24 49.87 2.43 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 31.7 p90 -53.36 174.42 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -1.127 . . . . 0.0 110.89 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.527 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 91.6 mt-10 -109.33 178.74 4.35 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.471 -0.768 . . . . 0.0 109.918 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -68.29 140.57 55.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.081 -1.012 . . . . 0.0 110.287 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.07 -14.31 50.02 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.465 ' HG3' ' HB2' ' A' ' 26' ' ' GLU . 3.6 mt-10 -65.8 126.59 28.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.175 -1.191 . . . . 0.0 110.37 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.975 ' C ' HD12 ' A' ' 31' ' ' LEU . 10.0 pt20 -79.76 136.33 36.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 109.958 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.975 HD12 ' C ' ' A' ' 30' ' ' GLN . 7.7 mp -137.95 158.88 43.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -0.96 . . . . 0.0 110.536 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.594 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 5.8 tpt180 -106.29 132.33 52.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.406 -0.809 . . . . 0.0 109.332 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.917 HD11 HG11 ' A' ' 9' ' ' VAL . 23.3 mt -90.79 93.73 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.083 -1.01 . . . . 0.0 110.544 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.438 ' CD2' ' HG3' ' A' ' 32' ' ' ARG . 67.1 mt -79.58 -29.94 41.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.367 -0.833 . . . . 0.0 110.844 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 42' ' ' LYS . 85.3 tt0 -130.91 140.48 50.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.947 -1.096 . . . . 0.0 110.406 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.627 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 76.5 mt-30 -134.52 54.88 1.92 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 110.111 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 51.4 m -119.65 148.18 43.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -0.876 . . . . 0.0 110.167 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.11 -177.87 27.52 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -69.18 -29.85 67.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -1.205 . . . . 0.0 110.333 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.459 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 99.2 m95 -98.61 144.15 28.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 110.378 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.627 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 43.5 m0 -121.02 155.87 33.41 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.349 -0.844 . . . . 0.0 110.176 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 35' ' ' GLU . 77.9 tttt -101.1 143.54 31.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 109.331 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.594 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -153.98 -179.9 8.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.014 -1.054 . . . . 0.0 110.85 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 48.3 tt0 -141.24 149.94 41.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.379 -0.825 . . . . 0.0 109.691 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.469 ' HB2' HD21 ' A' ' 23' ' ' LEU . 18.0 t -100.49 123.95 45.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.05 -1.031 . . . . 0.0 110.3 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.6 mt -80.85 6.21 13.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 110.051 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 87.0 m -91.07 -35.62 14.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 110.071 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.7 p -127.27 -3.55 6.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 110.093 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.2 35.24 57.25 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.665 ' HG2' HD13 ' A' ' 23' ' ' LEU . 63.1 tt0 -104.87 140.76 37.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -1.13 . . . . 0.0 110.283 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 86.3 tt0 -119.51 139.09 52.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.892 . . . . 0.0 110.18 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -170.81 163.17 36.25 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 94.4 m-85 -69.36 141.85 54.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.308 -1.113 . . . . 0.0 110.0 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.689 HD12 HG21 ' A' ' 59' ' ' VAL . 1.6 pt -131.57 142.37 45.06 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.194 -0.941 . . . . 0.0 110.38 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.579 ' O ' HG22 ' A' ' 59' ' ' VAL . 44.8 Cg_endo -68.49 140.89 49.11 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.066 1.561 . . . . 0.0 110.08 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.57 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 25.1 p90 -75.54 -7.03 53.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 0.0 111.144 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -90.34 -26.48 19.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.899 -1.126 . . . . 0.0 110.725 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.557 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 17.8 m-30 -92.71 4.16 54.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.091 -1.006 . . . . 0.0 110.22 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.689 HG21 HD12 ' A' ' 54' ' ' ILE . 35.6 m -136.04 143.49 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.263 -0.898 . . . . 0.0 110.103 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.956 . . . . 0.0 110.343 -179.956 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 1.011 HD13 ' N ' ' A' ' 9' ' ' VAL . 2.9 tm? . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.165 0.507 . . . . 0.0 110.111 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.011 ' N ' HD13 ' A' ' 8' ' ' LEU . 30.1 m -150.41 170.02 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.178 -0.951 . . . . 0.0 110.319 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 58.0 mt -115.16 145.05 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.377 -0.827 . . . . 0.0 109.954 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.608 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . -80.33 109.15 14.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.124 -0.985 . . . . 0.0 110.337 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.469 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 57.6 mt -67.05 -24.3 65.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.985 -1.072 . . . . 0.0 109.353 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.469 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 58.1 m80 -157.09 155.16 30.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.611 -0.681 . . . . 0.0 109.487 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 47.7 t -66.49 139.15 57.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.972 -1.08 . . . . 0.0 109.98 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.59 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 73.5 t80 -95.96 155.27 16.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.084 -1.01 . . . . 0.0 110.375 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.584 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 1.2 mp0 -105.66 128.71 25.95 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.361 -0.837 . . . . 0.0 110.11 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.426 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.5 Cg_endo -87.31 81.28 1.28 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.875 1.461 . . . . 0.0 110.448 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 97.1 p -79.88 -2.33 43.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.385 -0.822 . . . . 0.0 109.942 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.416 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 63.8 m80 -138.95 149.81 45.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.888 . . . . 0.0 110.18 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -69.21 129.1 38.9 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.287 -0.883 . . . . 0.0 110.227 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.83 -4.41 39.26 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.416 ' OD2' ' HB2' ' A' ' 19' ' ' HIS . 34.9 m-20 -92.25 165.99 12.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.225 -1.162 . . . . 0.0 110.464 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.489 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 18.0 tp -117.85 124.33 48.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.272 -0.893 . . . . 0.0 110.011 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 15' ' ' TYR . . . -105.68 52.7 0.69 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.608 ' CD2' ' HB1' ' A' ' 11' ' ' ALA . 41.3 p90 -48.74 175.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -1.18 . . . . 0.0 110.841 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.496 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 73.5 mm-40 -109.76 179.34 4.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.445 -0.784 . . . . 0.0 110.157 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -69.41 133.48 47.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.008 -1.058 . . . . 0.0 110.478 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.28 -15.53 55.95 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 3.3 mt-10 -64.25 122.56 16.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.034 -1.274 . . . . 0.0 110.454 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.43 ' O ' HD23 ' A' ' 31' ' ' LEU . 99.0 mt-30 -79.4 137.15 37.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -0.879 . . . . 0.0 109.651 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.525 HD11 ' CG ' ' A' ' 25' ' ' PHE . 15.7 mt -133.77 154.35 51.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.174 -0.954 . . . . 0.0 110.488 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 14.9 ttm180 -98.79 130.89 45.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.397 -0.815 . . . . 0.0 109.931 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.562 HD11 ' CG1' ' A' ' 9' ' ' VAL . 69.2 mt -73.72 113.95 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.186 -0.946 . . . . 0.0 110.109 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.914 HD11 ' HB2' ' A' ' 44' ' ' GLN . 35.7 mt -86.49 -38.83 16.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.87 . . . . 0.0 110.201 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.457 ' O ' ' HB3' ' A' ' 41' ' ' TRP . 94.4 mt-10 -139.25 161.45 37.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.343 -0.848 . . . . 0.0 109.946 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.631 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 45.7 tt0 -143.78 61.2 1.37 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 0.0 110.141 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.9 t -131.81 122.48 25.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 110.196 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.35 176.69 41.84 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.75 -34.39 75.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.365 -1.079 . . . . 0.0 110.249 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.434 ' O ' ' CD1' ' A' ' 41' ' ' TRP . 73.4 m95 -100.08 150.16 22.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.89 . . . . 0.0 110.242 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.631 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 40.1 m0 -130.84 160.03 35.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.29 -0.881 . . . . 0.0 110.381 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.421 ' HD3' ' HB3' ' A' ' 34' ' ' LEU . 80.0 tttt -88.89 146.6 24.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.914 . . . . 0.0 109.605 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.664 ' HB2' HG12 ' A' ' 54' ' ' ILE . . . -147.14 167.82 23.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.029 -1.045 . . . . 0.0 110.759 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.914 ' HB2' HD11 ' A' ' 34' ' ' LEU . 43.4 tt0 -145.69 154.22 41.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.433 -0.792 . . . . 0.0 110.025 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.5 t -83.09 145.4 29.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.065 -1.022 . . . . 0.0 110.196 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.3 tp -91.38 -21.14 21.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 110.132 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.7 t -105.45 -26.49 11.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 0.0 110.429 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.3 m -100.35 -29.22 12.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.122 -0.986 . . . . 0.0 110.108 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.06 22.04 64.2 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 62.0 tt0 -92.75 134.48 35.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.442 -1.034 . . . . 0.0 110.259 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.54 ' HG2' ' CG ' ' A' ' 44' ' ' GLN . 79.9 mt-10 -114.96 133.09 56.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.282 -0.887 . . . . 0.0 109.934 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -161.26 157.03 28.58 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -67.07 142.19 57.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.349 -1.089 . . . . 0.0 110.159 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.664 HG12 ' HB2' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -133.63 162.13 59.52 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 110.137 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.59 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 47.8 Cg_endo -90.26 162.88 4.63 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.993 1.523 . . . . 0.0 110.09 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -87.34 -2.23 58.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -0.924 . . . . 0.0 110.819 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -100.1 -25.74 14.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.036 -1.04 . . . . 0.0 110.987 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.586 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 22.4 m-85 -84.26 -9.26 58.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.924 -1.11 . . . . 0.0 110.53 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 22.4 m -131.16 143.24 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 110.301 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.185 179.942 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.461 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.4 tp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.155 0.502 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.786 HG12 ' O ' ' A' ' 60' ' ' ALA . 4.2 m -153.18 173.39 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 0.0 110.532 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 62.1 mt -120.63 142.6 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.376 -0.828 . . . . 0.0 109.527 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.443 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -77.54 115.77 17.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.116 -0.99 . . . . 0.0 110.342 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 12' ' ' LEU . 15.5 tp -73.55 -20.3 60.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.14 -0.975 . . . . 0.0 109.086 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -149.35 -158.95 0.97 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.586 -0.696 . . . . 0.0 109.693 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 93.8 p -118.07 140.51 49.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.164 -0.96 . . . . 0.0 110.151 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.593 ' CD2' ' HD3' ' A' ' 55' ' ' PRO . 60.2 t80 -103.53 162.6 12.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.067 -1.021 . . . . 0.0 110.223 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.567 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 47.0 tt0 -119.91 130.32 24.91 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 110.273 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.458 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.1 Cg_endo -81.22 84.46 1.97 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.02 1.537 . . . . 0.0 110.403 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.587 ' O ' ' CD2' ' A' ' 19' ' ' HIS . 77.0 p -79.83 -1.19 37.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.925 . . . . 0.0 110.093 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.587 ' CD2' ' O ' ' A' ' 18' ' ' SER . 37.2 m80 -150.28 158.16 43.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 110.02 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -66.09 127.47 32.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 110.217 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.415 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . 107.12 -10.91 40.34 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.445 ' OD2' ' HB2' ' A' ' 19' ' ' HIS . 41.5 m-20 -83.18 152.45 25.23 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.231 -1.158 . . . . 0.0 110.316 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.546 ' O ' ' CD1' ' A' ' 15' ' ' TYR . 14.2 tp -114.22 120.01 39.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.308 -0.87 . . . . 0.0 110.036 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.458 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -102.86 56.71 0.61 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.563 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 36.2 p90 -50.8 171.6 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.185 -1.185 . . . . 0.0 110.874 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -103.62 178.59 4.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.545 -0.722 . . . . 0.0 109.981 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.9 mttp -69.69 124.56 24.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 110.328 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.45 -12.26 70.15 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.439 ' CD ' ' HB2' ' A' ' 25' ' ' PHE . 41.4 tt0 -59.74 127.68 33.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.129 -1.218 . . . . 0.0 110.395 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -79.83 131.93 36.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.929 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.475 HD11 ' CG ' ' A' ' 25' ' ' PHE . 18.9 mt -131.58 151.31 51.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -0.938 . . . . 0.0 110.408 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.65 ' NH1' HD13 ' A' ' 46' ' ' LEU . 20.2 mtp85 -98.54 133.66 42.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.341 -0.849 . . . . 0.0 109.523 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.517 HD11 HG11 ' A' ' 9' ' ' VAL . 27.3 mt -77.1 118.12 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.978 . . . . 0.0 110.067 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.699 HD11 ' HB2' ' A' ' 44' ' ' GLN . 86.3 mt -95.68 -36.74 11.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 0.0 110.273 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.406 ' HA ' ' OE1' ' A' ' 35' ' ' GLU . 67.3 mm-40 -139.96 153.17 46.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 110.213 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.581 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 20.8 mt-30 -135.48 55.14 1.89 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.304 -0.873 . . . . 0.0 110.215 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.3 m -120.03 135.72 54.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.272 -0.892 . . . . 0.0 110.148 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.44 178.42 42.75 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.97 -33.19 75.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.359 -1.083 . . . . 0.0 110.355 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.565 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 98.7 m95 -91.89 140.81 29.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.174 -0.954 . . . . 0.0 110.153 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.581 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 40.7 m0 -122.01 152.99 39.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.9 . . . . 0.0 110.212 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.5 tttm -91.85 148.23 22.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 0.0 109.589 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.695 ' HB3' HG21 ' A' ' 54' ' ' ILE . . . -155.49 178.11 10.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.0 -1.062 . . . . 0.0 110.622 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.699 ' HB2' HD11 ' A' ' 34' ' ' LEU . 28.4 tt0 -150.9 159.67 44.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.296 -0.878 . . . . 0.0 109.724 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 6.4 t -82.27 147.56 28.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.072 -1.018 . . . . 0.0 109.933 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.65 HD13 ' NH1' ' A' ' 32' ' ' ARG . 30.3 tp -91.68 -21.31 20.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.927 . . . . 0.0 109.945 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.4 p -107.77 -28.14 9.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.354 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.3 m -94.43 -31.16 14.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.124 -0.985 . . . . 0.0 110.233 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.55 24.02 59.36 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.496 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 65.2 tp60 -97.55 136.66 37.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.358 -1.084 . . . . 0.0 110.022 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.55 ' HG2' ' CG ' ' A' ' 44' ' ' GLN . 31.2 mt-10 -117.52 136.73 53.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.094 -1.004 . . . . 0.0 110.244 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.49 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -167.79 162.52 36.31 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -66.37 141.94 57.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.297 -1.119 . . . . 0.0 110.217 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.695 HG21 ' HB3' ' A' ' 43' ' ' ALA . 1.3 pp -133.4 144.35 51.92 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.255 -0.903 . . . . 0.0 110.171 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.593 ' HD3' ' CD2' ' A' ' 15' ' ' TYR . 44.6 Cg_endo -71.23 152.57 61.71 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.023 1.538 . . . . 0.0 110.373 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.566 ' CE2' ' OD1' ' A' ' 57' ' ' ASN . 20.1 p90 -89.89 -1.08 57.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.335 -0.853 . . . . 0.0 110.68 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.566 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 92.3 m-20 -95.64 -27.14 15.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.089 -1.007 . . . . 0.0 110.668 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.565 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 12.8 m-30 -90.46 4.39 51.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.096 -1.002 . . . . 0.0 110.465 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.508 HG12 ' HB ' ' A' ' 9' ' ' VAL . 10.7 t -140.93 163.84 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 110.206 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.786 ' O ' HG12 ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.346 -0.846 . . . . 0.0 110.193 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.713 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.7 mp . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.158 0.504 . . . . 0.0 110.048 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.859 HG11 HD11 ' A' ' 33' ' ' ILE . 27.3 m -143.5 166.99 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.228 -0.92 . . . . 0.0 110.404 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.432 ' O ' HD12 ' A' ' 12' ' ' LEU . 21.3 mm -110.73 146.23 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.86 . . . . 0.0 109.754 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.48 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -80.15 113.51 18.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.116 -0.99 . . . . 0.0 110.381 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.697 HD12 ' N ' ' A' ' 12' ' ' LEU . 8.2 mp -74.57 -19.98 60.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 0.0 109.371 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.513 ' ND1' ' O ' ' A' ' 12' ' ' LEU . 71.9 m80 -155.61 145.17 21.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.497 -0.752 . . . . 0.0 109.611 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.556 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 33.1 p -64.03 145.98 54.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.94 -1.1 . . . . 0.0 110.129 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 82.9 t80 -104.35 166.7 10.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.101 -0.999 . . . . 0.0 110.211 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.24 120.08 29.26 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.912 . . . . 0.0 110.125 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.487 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 49.5 Cg_endo -70.19 84.35 0.73 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.949 1.5 . . . . 0.0 110.219 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.501 ' OG ' ' ND1' ' A' ' 19' ' ' HIS . 73.8 p -79.9 -3.84 49.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -0.881 . . . . 0.0 110.082 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.501 ' ND1' ' OG ' ' A' ' 18' ' ' SER . 50.9 m80 -145.94 140.5 26.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 110.195 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -53.45 124.48 14.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 110.279 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.76 16.02 12.35 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -114.69 159.85 20.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -1.184 . . . . 0.0 110.303 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.501 ' HA ' HD12 ' A' ' 23' ' ' LEU . 15.4 tp -115.23 118.41 33.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.329 -0.857 . . . . 0.0 110.081 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.487 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -95.9 47.59 1.84 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 40.2 p90 -47.36 171.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.269 -1.136 . . . . 0.0 111.042 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.556 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 92.4 mt-10 -105.95 178.82 4.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.412 -0.805 . . . . 0.0 110.069 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.6 tttt -69.32 138.0 53.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.083 -1.011 . . . . 0.0 110.136 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.09 -12.31 60.48 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.581 ' HG2' HD11 ' A' ' 31' ' ' LEU . 8.4 tt0 -63.57 128.17 34.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.174 -1.191 . . . . 0.0 110.118 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.97 ' C ' HD12 ' A' ' 31' ' ' LEU . 92.6 mt-30 -79.55 134.53 36.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 109.992 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.97 HD12 ' C ' ' A' ' 30' ' ' GLN . 8.5 mp -136.11 156.87 48.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.919 . . . . 0.0 110.736 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.586 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 22.8 ttt180 -107.76 135.81 48.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.442 -0.786 . . . . 0.0 109.138 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.859 HD11 HG11 ' A' ' 9' ' ' VAL . 54.4 mt -91.39 92.35 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.042 -1.036 . . . . 0.0 110.879 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 44' ' ' GLN . 11.0 mt -79.08 -29.84 43.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.581 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.546 ' CB ' ' HB3' ' A' ' 42' ' ' LYS . 45.7 tt0 -134.6 132.86 39.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.961 -1.087 . . . . 0.0 110.234 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.633 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 53.3 tt0 -129.08 59.31 1.58 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.286 -0.884 . . . . 0.0 110.119 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 89.5 p -121.53 146.12 47.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 110.237 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.02 -170.26 47.57 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -74.6 -33.1 62.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -1.138 . . . . 0.0 110.072 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.494 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 99.0 m95 -96.44 142.8 28.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.212 -0.93 . . . . 0.0 110.16 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.633 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 43.1 m0 -119.94 154.97 33.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.22 -0.925 . . . . 0.0 110.192 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.546 ' HB3' ' CB ' ' A' ' 35' ' ' GLU . 34.3 tttp -97.63 141.17 31.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.343 -0.848 . . . . 0.0 109.132 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.586 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -152.52 177.77 10.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.94 -1.1 . . . . 0.0 110.803 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.485 ' HB2' HD11 ' A' ' 34' ' ' LEU . 58.6 tt0 -142.65 150.62 40.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.438 -0.789 . . . . 0.0 109.912 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.1 t -97.16 114.75 26.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.989 . . . . 0.0 110.229 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.7 mt -74.63 0.18 15.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -0.944 . . . . 0.0 110.118 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 54.9 m -86.16 -33.26 20.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 110.045 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.8 p -128.39 -3.58 5.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.159 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.2 33.77 56.23 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -101.86 139.96 36.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.289 -1.124 . . . . 0.0 110.148 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.448 ' OE2' ' HE3' ' A' ' 42' ' ' LYS . 78.6 tt0 -120.77 140.77 51.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 0.0 110.163 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -174.12 164.53 35.81 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 81.7 m-85 -74.06 146.37 43.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.174 -1.192 . . . . 0.0 109.758 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.986 HD13 HG11 ' A' ' 59' ' ' VAL . 1.8 pp -140.71 143.16 31.16 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.183 -0.948 . . . . 0.0 110.501 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.762 ' O ' HD12 ' A' ' 54' ' ' ILE . 44.6 Cg_endo -63.1 148.39 93.35 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.157 1.609 . . . . 0.0 110.109 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.695 ' CE2' ' ND2' ' A' ' 57' ' ' ASN . 20.4 p90 -84.67 -1.42 56.08 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.294 -0.879 . . . . 0.0 110.895 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.695 ' ND2' ' CE2' ' A' ' 56' ' ' PHE . 22.5 m120 -94.6 -26.24 16.45 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.984 -1.073 . . . . 0.0 110.634 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.622 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 13.1 m-30 -90.87 6.84 42.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.087 -1.008 . . . . 0.0 110.391 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.986 HG11 HD13 ' A' ' 54' ' ' ILE . 31.0 m -132.53 142.18 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 0.0 110.053 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.437 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.914 . . . . 0.0 110.247 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.477 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.4 mp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.217 0.532 . . . . 0.0 110.094 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.696 ' CG1' HD11 ' A' ' 33' ' ' ILE . 21.5 m -138.33 163.78 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.144 -0.973 . . . . 0.0 110.44 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 90.7 mt -112.77 143.39 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.367 -0.833 . . . . 0.0 109.802 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.65 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . -80.57 110.62 16.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.159 -0.963 . . . . 0.0 110.505 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.525 HD12 ' N ' ' A' ' 12' ' ' LEU . 6.3 mp -68.56 -22.99 64.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.985 -1.072 . . . . 0.0 109.031 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.497 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 75.3 m-70 -158.29 149.26 20.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.593 -0.692 . . . . 0.0 109.342 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 54.3 p -61.65 142.75 56.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.928 -1.108 . . . . 0.0 109.982 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 80.1 t80 -98.66 159.97 14.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.084 -1.01 . . . . 0.0 110.443 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -105.63 112.32 64.62 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 109.999 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.474 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 49.3 Cg_endo -72.66 89.76 0.84 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.965 1.508 . . . . 0.0 110.513 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.6 p -79.68 -4.07 50.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.929 . . . . 0.0 110.183 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -130.47 -176.01 3.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.216 -0.927 . . . . 0.0 110.213 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -92.38 -10.85 36.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 0.0 110.247 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.32 32.69 5.95 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -117.8 159.33 23.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -1.131 . . . . 0.0 110.385 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.503 ' HA ' HD12 ' A' ' 23' ' ' LEU . 14.5 tp -114.18 118.43 33.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.357 -0.84 . . . . 0.0 109.763 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.474 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -96.23 50.36 1.67 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.65 ' CD2' ' HB1' ' A' ' 11' ' ' ALA . 41.5 p90 -48.1 170.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -1.171 . . . . 0.0 110.823 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.442 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 77.2 mm-40 -101.39 178.49 4.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.421 -0.8 . . . . 0.0 110.237 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 12' ' ' LEU . 50.0 tttm -70.55 124.07 23.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.171 -0.956 . . . . 0.0 110.379 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.86 -8.19 73.61 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.438 ' CD ' ' HB2' ' A' ' 25' ' ' PHE . 45.7 tt0 -67.25 125.54 26.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.116 -1.226 . . . . 0.0 110.374 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.441 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 96.4 mt-30 -79.72 138.29 37.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.21 -0.931 . . . . 0.0 109.859 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.577 HD11 ' CG ' ' A' ' 25' ' ' PHE . 21.1 mt -137.32 159.0 43.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 110.398 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 9.4 ttt180 -101.62 132.32 47.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.401 -0.812 . . . . 0.0 109.526 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.696 HD11 ' CG1' ' A' ' 9' ' ' VAL . 6.8 mt -72.92 115.04 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.172 -0.955 . . . . 0.0 110.39 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.578 HD11 ' HG2' ' A' ' 51' ' ' GLU . 38.3 mt -83.32 -38.05 22.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.929 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.432 ' C ' ' HG3' ' A' ' 36' ' ' GLN . 87.3 mt-10 -148.62 170.63 17.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.309 -0.869 . . . . 0.0 110.26 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.517 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 27.1 mt-30 -147.33 60.46 1.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 110.201 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.1 p -130.34 136.47 49.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 110.222 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.95 -170.97 44.17 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -75.88 -31.89 59.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.191 -1.182 . . . . 0.0 110.31 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.556 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 85.8 m95 -100.45 149.43 23.68 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.228 -0.92 . . . . 0.0 110.089 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.517 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 38.2 m0 -119.95 153.28 36.16 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.222 -0.924 . . . . 0.0 110.425 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 34' ' ' LEU . 41.9 tttp -89.4 142.98 27.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.349 -0.844 . . . . 0.0 109.662 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.842 ' HB2' HG12 ' A' ' 54' ' ' ILE . . . -137.22 158.04 45.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.138 -0.976 . . . . 0.0 110.805 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 56.3 tt0 -129.04 138.35 51.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.484 -0.76 . . . . 0.0 109.962 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.465 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 6.5 t -79.14 140.0 37.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.115 -0.991 . . . . 0.0 110.011 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.444 HD21 ' HB2' ' A' ' 32' ' ' ARG . 61.9 mt -92.94 -13.04 29.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.885 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.7 m -99.4 -25.73 14.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.426 -0.796 . . . . 0.0 110.349 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.465 ' OG1' ' HB3' ' A' ' 45' ' ' SER . 40.6 p -114.59 -13.42 12.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.063 -1.023 . . . . 0.0 110.398 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 64.88 45.83 91.31 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 20.2 mt-30 -120.76 152.03 38.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.368 -1.078 . . . . 0.0 110.17 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.578 ' HG2' HD11 ' A' ' 34' ' ' LEU . 96.7 mt-10 -116.81 134.52 54.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -0.871 . . . . 0.0 110.173 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -155.58 151.83 23.36 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -70.56 143.52 51.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -1.182 . . . . 0.0 110.094 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.985 ' CD1' HG21 ' A' ' 59' ' ' VAL . 1.9 pp -138.46 134.73 17.62 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.9 . . . . 0.0 110.117 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.59 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 46.0 Cg_endo -59.1 158.92 23.73 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.94 1.495 . . . . 0.0 110.286 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.476 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 23.5 p90 -84.14 -5.07 59.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 110.885 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -96.28 -25.13 15.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.048 -1.032 . . . . 0.0 110.931 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.59 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 19.2 m-85 -83.92 -8.63 59.13 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.022 -1.049 . . . . 0.0 110.306 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.985 HG21 ' CD1' ' A' ' 54' ' ' ILE . 33.6 m -136.22 146.0 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.138 -0.977 . . . . 0.0 110.359 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.271 -0.893 . . . . 0.0 110.22 -180.0 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.795 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.5 mp . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.185 0.517 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 31' ' ' LEU . 27.8 m -148.32 168.87 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.197 -0.94 . . . . 0.0 110.389 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.413 HD13 ' O ' ' A' ' 9' ' ' VAL . 26.1 mm -112.57 146.44 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.376 -0.827 . . . . 0.0 109.842 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.504 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . -80.18 112.29 17.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.14 -0.975 . . . . 0.0 110.388 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 27.0 tp -75.27 -22.45 57.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.108 -0.995 . . . . 0.0 109.621 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.501 ' HA ' ' HG2' ' A' ' 27' ' ' LYS . 94.7 m-70 -151.97 149.75 29.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.492 -0.755 . . . . 0.0 109.762 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.5 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 15.9 t -68.35 141.88 55.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.011 -1.056 . . . . 0.0 109.941 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.593 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 85.8 t80 -98.83 160.08 14.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.938 . . . . 0.0 110.246 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.503 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 2.1 tm-20 -112.38 128.54 25.38 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 0.0 110.169 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.478 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 47.3 Cg_endo -83.39 82.28 2.11 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.028 1.541 . . . . 0.0 110.532 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.588 ' O ' ' CD2' ' A' ' 19' ' ' HIS . 88.9 p -80.8 -0.97 41.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 110.137 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.588 ' CD2' ' O ' ' A' ' 18' ' ' SER . 33.8 m80 -145.68 179.59 7.33 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.906 . . . . 0.0 110.167 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -90.39 127.92 36.33 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 110.106 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.76 -3.13 41.89 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -89.97 154.66 19.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -1.138 . . . . 0.0 110.278 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.5 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 22.5 tp -109.63 114.6 28.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.171 -0.956 . . . . 0.0 110.067 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.478 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -96.17 47.41 1.8 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.589 ' CE1' ' HB2' ' A' ' 15' ' ' TYR . 46.4 p90 -50.43 174.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.149 -1.206 . . . . 0.0 111.164 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.5 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 83.2 mt-10 -110.59 177.9 4.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.464 -0.772 . . . . 0.0 110.216 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.501 ' HG2' ' HA ' ' A' ' 13' ' ' HIS . 5.4 mtmm -69.16 139.39 54.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.036 -1.04 . . . . 0.0 110.231 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.15 -16.24 49.16 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 39.0 mm-40 -66.4 125.61 26.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.051 -1.264 . . . . 0.0 110.012 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.406 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 22.5 tt0 -79.48 137.77 37.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.875 . . . . 0.0 110.168 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.574 ' O ' HG22 ' A' ' 9' ' ' VAL . 41.4 mt -137.84 159.87 40.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.316 -0.865 . . . . 0.0 110.211 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.579 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 37.0 ttp180 -108.48 135.78 49.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.623 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.522 HD11 HG21 ' A' ' 9' ' ' VAL . 36.9 mm -96.18 92.63 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.166 -0.959 . . . . 0.0 110.435 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.494 HD21 ' NE ' ' A' ' 32' ' ' ARG . 17.2 mt -79.45 -24.91 42.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.214 -0.929 . . . . 0.0 110.777 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.456 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 45.1 tp10 -136.2 134.67 38.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.954 -1.091 . . . . 0.0 110.388 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.636 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 75.3 mt-30 -129.41 54.87 1.79 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.347 -0.846 . . . . 0.0 110.153 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.4 m -114.86 154.01 29.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 110.183 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.26 -173.27 8.53 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -72.2 -31.91 66.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -1.136 . . . . 0.0 110.181 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.425 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 92.5 m95 -97.77 143.06 28.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.258 -0.902 . . . . 0.0 110.34 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.636 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 51.2 m0 -120.15 155.41 33.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.367 -0.833 . . . . 0.0 110.115 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.491 ' NZ ' ' OE2' ' A' ' 51' ' ' GLU . 48.8 tttt -96.55 141.34 29.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.882 . . . . 0.0 109.365 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.579 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -149.97 174.58 12.54 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.078 -1.014 . . . . 0.0 110.815 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 61.3 tt0 -141.12 149.53 41.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.451 -0.781 . . . . 0.0 109.765 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.0 t -95.48 111.88 23.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.197 -0.94 . . . . 0.0 110.161 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.433 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 18.5 tp -71.85 -1.85 15.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -0.896 . . . . 0.0 110.415 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.1 m -88.57 -29.1 20.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.237 -0.915 . . . . 0.0 110.098 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.7 p -126.67 -6.15 6.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 110.163 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.21 36.63 59.95 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.414 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 30.8 mt-30 -109.63 144.98 37.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -1.159 . . . . 0.0 110.228 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.491 ' OE2' ' NZ ' ' A' ' 42' ' ' LYS . 83.5 tt0 -118.52 138.92 52.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.898 . . . . 0.0 110.033 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -166.88 158.17 31.01 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -72.55 143.81 48.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -1.132 . . . . 0.0 110.18 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.713 HD13 HG11 ' A' ' 59' ' ' VAL . 1.0 OUTLIER -137.47 145.47 49.47 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 110.213 -179.866 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.607 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 47.3 Cg_endo -69.51 149.14 68.11 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.98 1.516 . . . . 0.0 110.156 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.593 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 36.3 p90 -74.99 -4.78 40.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.969 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -96.17 -25.33 15.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.875 -1.141 . . . . 0.0 110.954 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.607 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 9.0 m-85 -83.14 -2.16 54.73 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.055 -1.028 . . . . 0.0 110.284 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.713 HG11 HD13 ' A' ' 54' ' ' ILE . 33.1 m -136.32 144.08 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 110.071 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.138 -0.977 . . . . 0.0 110.242 -179.981 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.708 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.5 mp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.207 0.527 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 60' ' ' ALA . 11.8 m -144.65 167.04 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.181 -0.949 . . . . 0.0 110.334 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.8 mt -111.41 145.51 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.0 109.707 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.401 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -79.2 112.9 16.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.97 . . . . 0.0 110.303 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.505 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 55.2 mt -71.55 -21.35 61.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.105 -0.997 . . . . 0.0 109.487 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.505 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 62.7 m-70 -157.61 148.86 21.58 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.574 -0.704 . . . . 0.0 109.628 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 58.6 p -63.06 143.31 57.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.981 -1.075 . . . . 0.0 109.919 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.578 ' CD1' ' HG3' ' A' ' 55' ' ' PRO . 24.4 t80 -96.65 155.05 16.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.055 -1.028 . . . . 0.0 110.269 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.419 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -110.11 75.28 0.88 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.854 . . . . 0.0 110.17 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.537 ' HD3' ' CA ' ' A' ' 24' ' ' GLY . 46.8 Cg_endo -46.96 122.5 6.26 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.047 1.551 . . . . 0.0 110.372 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.4 m -91.89 10.69 27.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.366 -0.834 . . . . 0.0 110.128 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 49.9 m-70 -140.55 -158.26 0.84 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.303 -0.873 . . . . 0.0 110.192 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.4 p30 -112.67 3.92 16.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.193 -0.942 . . . . 0.0 110.187 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.43 -9.36 17.49 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.5 ' HB2' ' CB ' ' A' ' 17' ' ' PRO . 84.2 m-20 -81.65 165.7 20.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.214 -1.168 . . . . 0.0 110.4 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.503 ' HA ' HD12 ' A' ' 23' ' ' LEU . 14.7 tp -113.39 115.19 27.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 0.0 109.779 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.537 ' CA ' ' HD3' ' A' ' 17' ' ' PRO . . . -96.18 55.46 1.53 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 17.9 p90 -54.2 172.71 0.08 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.367 -1.078 . . . . 0.0 110.97 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -103.53 178.39 4.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.514 -0.741 . . . . 0.0 110.145 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -69.97 132.78 46.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.966 . . . . 0.0 110.101 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.13 -10.64 72.25 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.483 ' OE2' ' CB ' ' A' ' 25' ' ' PHE . 22.2 tt0 -64.09 126.58 28.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -1.222 . . . . 0.0 110.032 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.947 ' C ' HD12 ' A' ' 31' ' ' LEU . 38.1 tt0 -79.47 136.79 37.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.178 -0.952 . . . . 0.0 109.857 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.947 HD12 ' C ' ' A' ' 30' ' ' GLN . 7.1 mp -139.8 161.87 36.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 110.593 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.587 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 2.7 tpt180 -109.28 135.9 49.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.406 -0.809 . . . . 0.0 109.257 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.62 HD11 HG21 ' A' ' 9' ' ' VAL . 33.7 mm -91.21 92.42 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.102 -0.998 . . . . 0.0 110.567 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.637 HD11 ' HB2' ' A' ' 44' ' ' GLN . 1.5 mt -79.54 -30.01 41.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 110.789 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.515 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 77.5 tt0 -133.6 137.12 45.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.017 -1.052 . . . . 0.0 110.45 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.611 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 75.6 mt-30 -133.65 54.78 1.93 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 110.092 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -120.75 143.25 48.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.917 . . . . 0.0 110.221 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.83 -168.62 54.82 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -77.49 -33.83 54.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -1.141 . . . . 0.0 110.151 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.476 ' CZ3' ' OH ' ' A' ' 15' ' ' TYR . 98.6 m95 -96.79 141.77 29.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 110.251 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.611 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 40.6 m0 -116.83 153.65 32.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.902 . . . . 0.0 110.199 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.515 ' CB ' ' HB3' ' A' ' 35' ' ' GLU . 12.0 tttt -99.9 140.5 34.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.372 -0.83 . . . . 0.0 109.409 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.587 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -150.36 176.48 10.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.069 -1.02 . . . . 0.0 110.662 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.637 ' HB2' HD11 ' A' ' 34' ' ' LEU . 62.0 tt0 -139.01 147.57 42.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.368 -0.832 . . . . 0.0 109.96 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.5 t -97.21 117.03 30.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.95 . . . . 0.0 110.303 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.5 mt -76.6 2.59 13.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.168 -0.958 . . . . 0.0 110.118 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.9 m -91.58 -35.58 14.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 110.163 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 70.8 p -118.62 -6.02 10.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -0.884 . . . . 0.0 110.237 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.93 43.73 64.5 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.46 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 7.0 mt-30 -121.17 149.61 42.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -1.177 . . . . 0.0 110.234 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.464 ' OE2' ' HE2' ' A' ' 42' ' ' LYS . 82.3 tt0 -122.83 145.47 48.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 110.132 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.465 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -174.36 163.71 34.51 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 90.4 m-85 -75.24 146.08 41.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.322 -1.105 . . . . 0.0 109.847 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.627 HD13 HG21 ' A' ' 59' ' ' VAL . 1.5 pp -140.02 140.46 24.06 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.135 -0.978 . . . . 0.0 110.544 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.635 ' CG ' ' CD2' ' A' ' 58' ' ' PHE . 44.6 Cg_endo -60.22 145.17 99.11 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.164 1.613 . . . . 0.0 110.062 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.585 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 21.9 p90 -82.7 -5.12 58.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 110.927 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -91.59 -27.48 18.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.928 -1.108 . . . . 0.0 110.648 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.635 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 18.2 m-30 -85.86 6.82 26.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.106 -0.997 . . . . 0.0 110.105 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.627 HG21 HD13 ' A' ' 54' ' ' ILE . 26.4 t -141.85 169.46 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.882 . . . . 0.0 109.769 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.729 ' O ' HG12 ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.089 -1.007 . . . . 0.0 110.267 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.448 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.5 tp . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.203 0.525 . . . . 0.0 110.065 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.078 HG21 HD11 ' A' ' 33' ' ' ILE . 4.1 m -152.32 172.96 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.129 -0.982 . . . . 0.0 110.464 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.6 mt -120.14 140.46 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.406 -0.809 . . . . 0.0 109.511 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.573 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -74.22 114.69 12.86 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.176 -0.952 . . . . 0.0 110.33 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.418 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 23.9 tp -71.18 -21.58 62.14 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 109.264 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.418 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 65.5 m-70 -154.94 -163.63 1.61 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.607 -0.683 . . . . 0.0 109.733 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.407 ' O ' ' OE2' ' A' ' 16' ' ' GLU . 30.1 t -106.91 135.76 47.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.085 -1.009 . . . . 0.0 109.756 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.607 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 81.5 t80 -97.15 151.79 19.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.993 -1.067 . . . . 0.0 110.4 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.407 ' OE2' ' O ' ' A' ' 14' ' ' SER . 1.9 mp0 -117.09 102.71 52.59 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.337 -0.852 . . . . 0.0 110.209 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.485 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 46.9 Cg_endo -62.99 98.91 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.013 1.533 . . . . 0.0 110.366 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.548 ' O ' ' CD2' ' A' ' 19' ' ' HIS . 97.8 p -81.25 7.43 11.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.144 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.548 ' CD2' ' O ' ' A' ' 18' ' ' SER . 49.0 m80 -154.27 -177.59 6.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 110.143 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -88.49 130.69 35.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.11 -0.994 . . . . 0.0 110.239 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.76 13.45 25.69 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -109.3 159.18 17.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.165 -1.197 . . . . 0.0 110.403 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.505 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 15.7 tp -115.26 120.07 38.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 110.177 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.49 ' HA2' ' HB3' ' A' ' 15' ' ' TYR . . . -101.54 58.41 0.64 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.607 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 34.9 p90 -52.94 171.35 0.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.14 -1.212 . . . . 0.0 111.326 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.516 ' N ' ' OE1' ' A' ' 29' ' ' GLU . 94.4 mt-10 -105.06 178.35 4.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.565 -0.71 . . . . 0.0 109.949 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -69.84 129.46 39.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.117 -0.989 . . . . 0.0 110.3 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.45 -15.04 56.36 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.551 ' OE2' HD21 ' A' ' 31' ' ' LEU . 24.4 tt0 -59.02 124.4 19.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.134 -1.215 . . . . 0.0 110.063 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.44 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 88.9 mt-30 -79.9 134.18 36.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.139 -0.976 . . . . 0.0 109.991 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.551 HD21 ' OE2' ' A' ' 29' ' ' GLU . 10.8 mt -133.07 154.04 50.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.204 -0.935 . . . . 0.0 110.313 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 14.5 ttt180 -97.33 132.69 42.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.853 . . . . 0.0 109.686 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.078 HD11 HG21 ' A' ' 9' ' ' VAL . 23.4 mm -77.85 118.92 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.179 -0.951 . . . . 0.0 110.396 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.528 HD21 ' HB2' ' A' ' 44' ' ' GLN . 45.7 mt -87.78 -34.55 18.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 109.94 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -172.72 125.49 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.448 -0.782 . . . . 0.0 109.956 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.58 ' HA ' ' CG ' ' A' ' 41' ' ' TRP . 95.1 mt-30 -101.87 62.88 0.91 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.931 . . . . 0.0 110.304 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.5 m -108.54 136.18 48.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.347 -0.846 . . . . 0.0 110.129 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.56 -175.04 53.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -65.47 -36.88 85.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -1.125 . . . . 0.0 110.181 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.561 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 91.8 m95 -95.12 140.32 30.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.9 . . . . 0.0 110.32 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.58 ' CG ' ' HA ' ' A' ' 36' ' ' GLN . 52.3 m0 -113.63 148.89 35.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.303 -0.873 . . . . 0.0 110.257 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.505 ' CB ' ' HB2' ' A' ' 34' ' ' LEU . 24.5 mttm -86.25 141.8 29.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.261 -0.9 . . . . 0.0 109.703 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.626 ' HB2' HG12 ' A' ' 54' ' ' ILE . . . -146.28 167.03 24.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.127 -0.983 . . . . 0.0 110.485 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.528 ' HB2' HD21 ' A' ' 34' ' ' LEU . 58.7 tt0 -137.63 145.48 42.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.339 -0.85 . . . . 0.0 110.148 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.6 t -90.56 113.31 25.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.113 -0.992 . . . . 0.0 109.892 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 78.5 mt -74.82 3.49 8.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -0.963 . . . . 0.0 110.541 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.0 m -96.54 -33.33 11.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.107 -0.996 . . . . 0.0 110.032 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.6 m -119.17 -7.63 10.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 110.24 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.05 42.45 51.59 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -119.52 148.02 43.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -1.143 . . . . 0.0 110.073 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.501 ' HG2' ' CG ' ' A' ' 44' ' ' GLN . 90.9 mt-10 -118.07 138.27 52.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.948 . . . . 0.0 110.325 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.505 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -159.27 154.91 25.99 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.418 ' HE1' ' HZ3' ' A' ' 42' ' ' LYS . 99.0 m-85 -68.56 146.22 53.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.121 -1.223 . . . . 0.0 110.198 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.626 HG12 ' HB2' ' A' ' 43' ' ' ALA . 1.3 pt -136.41 147.9 61.9 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.868 . . . . 0.0 110.215 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.598 ' HD3' ' CD1' ' A' ' 15' ' ' TYR . 43.7 Cg_endo -72.76 145.46 41.07 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 124.046 1.551 . . . . 0.0 110.327 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.64 ' CE2' ' ND2' ' A' ' 57' ' ' ASN . 21.0 p90 -81.56 -0.02 40.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.518 -0.739 . . . . 0.0 110.592 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.64 ' ND2' ' CE2' ' A' ' 56' ' ' PHE . 24.6 m120 -98.74 -27.56 13.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.051 -1.031 . . . . 0.0 110.942 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.54 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 18.2 m-30 -90.88 5.86 46.84 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.93 -1.106 . . . . 0.0 110.482 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.561 HG12 ' HB ' ' A' ' 9' ' ' VAL . 8.4 t -145.06 164.2 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 0.0 110.137 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.793 ' O ' HG12 ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.0 110.295 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.417 ' C ' HG13 ' A' ' 9' ' ' VAL . 36.5 mt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.168 0.509 . . . . 0.0 110.189 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.592 HG11 HD11 ' A' ' 33' ' ' ILE . 12.6 m -150.95 170.63 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.342 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 19.6 mm -114.35 143.34 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.87 . . . . 0.0 110.076 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.824 ' HB1' ' CE1' ' A' ' 25' ' ' PHE . . . -79.63 110.82 15.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.119 -0.988 . . . . 0.0 110.134 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.439 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 15.9 tp -63.68 -24.67 67.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.05 -1.032 . . . . 0.0 109.529 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.439 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 37.0 m-70 -156.57 158.55 37.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.481 -0.762 . . . . 0.0 109.818 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.555 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 28.3 p -67.32 142.11 56.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.118 -0.989 . . . . 0.0 110.161 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.595 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 81.8 t80 -97.67 158.34 15.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 0.0 110.339 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.491 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -110.11 126.92 27.97 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 110.055 179.925 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.478 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.1 Cg_endo -82.91 81.16 2.47 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.976 1.514 . . . . 0.0 110.382 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 55.8 p -79.76 -1.08 37.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 110.078 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -142.69 169.46 17.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.155 -0.966 . . . . 0.0 110.136 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -83.87 130.6 34.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 110.216 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.26 4.01 53.68 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -98.88 161.15 13.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.171 -1.194 . . . . 0.0 110.238 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.58 HD13 ' HG3' ' A' ' 50' ' ' GLN . 31.9 tp -114.71 120.11 38.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.875 . . . . 0.0 110.141 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.478 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -100.92 50.52 1.02 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.824 ' CE1' ' HB1' ' A' ' 11' ' ' ALA . 48.0 p90 -50.76 176.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.122 -1.222 . . . . 0.0 111.12 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.555 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 83.4 mt-10 -107.63 174.11 6.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.52 -0.738 . . . . 0.0 110.253 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -68.37 139.76 55.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.122 -0.986 . . . . 0.0 110.405 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.26 -13.27 55.72 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 38.0 mm-40 -67.92 125.59 26.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.015 -1.285 . . . . 0.0 110.262 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.984 ' C ' HD12 ' A' ' 31' ' ' LEU . 80.4 mt-30 -79.53 138.69 37.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 109.663 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.984 HD12 ' C ' ' A' ' 30' ' ' GLN . 8.3 mp -136.56 156.78 48.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.046 -1.034 . . . . 0.0 110.633 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.588 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 15.9 mtm180 -103.92 131.32 51.26 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.387 -0.821 . . . . 0.0 109.394 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.592 HD11 HG11 ' A' ' 9' ' ' VAL . 99.4 mt -88.71 93.5 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.087 -1.008 . . . . 0.0 110.669 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 1.02 HD12 ' HA ' ' A' ' 43' ' ' ALA . 1.6 mp -79.25 -31.55 43.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.342 -0.849 . . . . 0.0 110.85 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.526 ' HB2' ' CB ' ' A' ' 42' ' ' LYS . 79.5 mt-10 -127.62 140.03 52.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.848 -1.158 . . . . 0.0 110.191 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.637 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 49.7 tt0 -135.06 59.7 1.72 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 110.263 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.8 t -125.2 130.98 53.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.897 . . . . 0.0 110.219 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.35 177.29 51.82 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.27 -30.89 71.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.236 -1.155 . . . . 0.0 110.281 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -98.33 144.45 27.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.0 110.263 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.637 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 43.6 m0 -126.08 157.88 36.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.37 -0.831 . . . . 0.0 110.166 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.526 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 28.7 tttt -100.03 146.78 26.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.886 . . . . 0.0 109.327 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 1.02 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -157.94 -175.97 5.66 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.916 -1.115 . . . . 0.0 110.834 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -146.03 154.31 41.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.416 -0.803 . . . . 0.0 109.622 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.3 t -101.71 125.68 48.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 110.392 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.463 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 44.0 tp -81.39 6.12 15.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.387 -0.821 . . . . 0.0 110.135 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.9 m -93.29 -37.96 11.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 110.226 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.8 p -125.39 -7.52 6.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.231 -0.918 . . . . 0.0 110.188 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.91 27.28 56.82 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.58 ' HG3' HD13 ' A' ' 23' ' ' LEU . 70.3 tp60 -90.79 131.71 36.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.318 -1.107 . . . . 0.0 110.3 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 51' ' ' GLU . 22.7 pt-20 -115.97 134.33 55.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.322 -0.861 . . . . 0.0 110.057 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.438 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -172.49 166.21 38.88 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 59.4 m-85 -69.05 142.31 54.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -1.142 . . . . 0.0 110.288 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.668 HD12 ' O ' ' A' ' 55' ' ' PRO . 1.6 pp -136.19 138.51 27.47 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 110.107 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.668 ' O ' HD12 ' A' ' 54' ' ' ILE . 47.3 Cg_endo -64.61 154.94 69.55 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.916 1.482 . . . . 0.0 110.289 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.608 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 22.3 p90 -83.97 -1.46 54.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.318 -0.864 . . . . 0.0 110.643 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.567 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 87.3 m-20 -98.39 -26.1 14.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.043 -1.036 . . . . 0.0 110.965 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 14.9 m-85 -83.16 -0.61 50.05 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.925 -1.109 . . . . 0.0 110.285 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.527 HG11 HD13 ' A' ' 54' ' ' ILE . 27.8 m -135.16 147.21 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.092 -1.005 . . . . 0.0 110.304 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.548 ' O ' HG12 ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.931 . . . . 0.0 110.223 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.668 HD12 ' N ' ' A' ' 8' ' ' LEU . 7.0 mp . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.287 0.565 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.769 HG21 HG11 ' A' ' 59' ' ' VAL . 13.2 m -152.3 171.32 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.889 . . . . 0.0 110.306 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.3 mt -112.88 144.12 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -0.844 . . . . 0.0 109.923 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.625 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -80.25 111.0 16.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 110.268 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.634 HD22 ' N ' ' A' ' 12' ' ' LEU . 4.1 mm? -64.6 -26.2 68.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.17 -0.956 . . . . 0.0 109.448 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.47 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 52.5 m80 -156.9 154.56 29.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.54 -0.725 . . . . 0.0 109.661 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.56 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 53.8 p -64.69 143.4 57.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.985 -1.072 . . . . 0.0 110.056 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.594 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 89.1 t80 -100.57 164.1 12.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.036 -1.04 . . . . 0.0 110.26 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.459 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -117.94 125.32 28.07 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.367 -0.833 . . . . 0.0 110.098 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.475 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.3 Cg_endo -78.39 82.25 2.52 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.016 1.535 . . . . 0.0 110.369 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 72.6 m -79.74 -2.53 43.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.88 . . . . 0.0 109.966 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.437 ' CG ' ' N ' ' A' ' 20' ' ' ASP . 86.4 t60 -145.09 172.2 13.42 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.369 -0.832 . . . . 0.0 110.095 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . 0.437 ' N ' ' CG ' ' A' ' 19' ' ' HIS . 21.8 t70 -80.32 129.51 34.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.175 -0.953 . . . . 0.0 110.223 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.46 18.01 29.56 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -106.9 150.02 26.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -1.118 . . . . 0.0 110.284 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.467 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 15.3 tp -105.75 112.08 25.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 110.042 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.475 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -95.28 45.23 2.08 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.625 ' CE2' ' HB1' ' A' ' 11' ' ' ALA . 40.6 p90 -46.64 171.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -1.175 . . . . 0.0 110.865 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.56 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 88.0 mt-10 -101.74 177.29 4.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.464 -0.773 . . . . 0.0 110.259 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -69.69 126.65 30.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.266 -0.896 . . . . 0.0 110.272 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.71 -8.66 74.01 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.443 ' CD ' ' HB2' ' A' ' 25' ' ' PHE . 20.9 tt0 -67.27 126.03 27.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -1.18 . . . . 0.0 110.317 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.704 ' O ' HD23 ' A' ' 31' ' ' LEU . 89.4 mt-30 -79.49 138.22 37.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 109.929 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.704 HD23 ' O ' ' A' ' 30' ' ' GLN . 14.4 mt -140.44 162.74 34.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.909 . . . . 0.0 110.38 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.603 ' CD ' HD21 ' A' ' 34' ' ' LEU . 25.2 ttp180 -106.01 133.33 50.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 0.0 109.682 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.537 ' CD1' HG11 ' A' ' 9' ' ' VAL . 15.5 mt -97.82 94.67 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.104 -0.997 . . . . 0.0 110.623 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.603 HD21 ' CD ' ' A' ' 32' ' ' ARG . 50.0 mt -79.46 -22.48 44.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.932 . . . . 0.0 110.777 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.553 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 83.2 tt0 -136.39 129.69 31.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.961 -1.087 . . . . 0.0 110.33 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.628 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 97.0 mt-30 -126.32 54.19 1.58 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.842 . . . . 0.0 110.122 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.5 p -119.47 157.91 27.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.913 . . . . 0.0 110.278 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.23 -172.1 26.97 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -72.54 -34.66 67.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -1.166 . . . . 0.0 110.28 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.409 ' HZ3' ' CE1' ' A' ' 15' ' ' TYR . 69.1 m95 -101.81 150.07 23.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.228 -0.92 . . . . 0.0 110.441 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.628 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 50.8 m0 -120.75 154.69 35.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.357 -0.84 . . . . 0.0 110.264 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.553 ' CB ' ' HB3' ' A' ' 35' ' ' GLU . 67.3 tttt -95.53 143.49 26.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.569 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -153.27 176.89 11.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.933 -1.104 . . . . 0.0 111.085 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 50' ' ' GLN . 48.7 tt0 -143.67 152.01 40.8 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.591 -0.693 . . . . 0.0 109.722 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.413 ' CB ' ' OG1' ' A' ' 48' ' ' THR . 17.3 m -85.1 149.35 25.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.164 -0.96 . . . . 0.0 110.298 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.699 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.6 mp -98.39 -13.2 20.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.325 -0.859 . . . . 0.0 109.964 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.8 p -101.04 -27.49 13.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.84 . . . . 0.0 110.234 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.413 ' OG1' ' CB ' ' A' ' 45' ' ' SER . 81.4 p -107.62 -18.57 13.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 110.316 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.99 41.82 80.28 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.486 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 7.2 mt-30 -119.21 150.21 40.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -1.118 . . . . 0.0 110.281 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 81.9 tt0 -116.43 134.08 55.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.93 . . . . 0.0 110.181 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.467 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -160.03 154.88 25.96 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -69.26 142.56 54.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -1.134 . . . . 0.0 109.984 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.452 ' O ' HG13 ' A' ' 54' ' ' ILE . 1.7 pt -131.97 132.35 23.1 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.949 . . . . 0.0 110.437 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.591 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 47.9 Cg_endo -61.1 156.11 46.77 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.981 1.517 . . . . 0.0 109.884 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.551 ' CE1' ' OD1' ' A' ' 57' ' ' ASN . 41.7 p90 -80.12 -8.14 59.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 111.326 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.551 ' OD1' ' CE1' ' A' ' 56' ' ' PHE . 58.7 m-20 -92.49 -26.59 17.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.766 -1.209 . . . . 0.0 110.98 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.59 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 21.8 m-85 -82.94 -6.38 59.45 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.999 -1.063 . . . . 0.0 110.048 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.769 HG11 HG21 ' A' ' 9' ' ' VAL . 58.1 t -132.38 174.71 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.845 . . . . 0.0 109.723 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.576 ' N ' HG12 ' A' ' 59' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 0.0 110.244 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.555 ' O ' HG13 ' A' ' 9' ' ' VAL . 41.4 tp . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.292 0.567 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 60' ' ' ALA . 3.7 m -155.36 173.33 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -0.915 . . . . 0.0 110.271 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.1 mt -117.38 142.09 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.857 . . . . 0.0 109.807 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.817 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -78.58 113.76 16.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.972 . . . . 0.0 110.257 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.53 HD12 ' N ' ' A' ' 12' ' ' LEU . 7.2 mp -66.71 -26.83 67.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.071 -1.018 . . . . 0.0 109.542 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -149.95 155.4 39.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.459 -0.775 . . . . 0.0 109.764 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.547 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 53.0 p -68.59 143.04 54.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.089 -1.007 . . . . 0.0 110.05 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.584 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 81.2 t80 -101.69 164.53 11.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.014 -1.054 . . . . 0.0 110.354 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.563 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 28.2 mm-40 -118.01 129.67 25.21 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 110.126 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.482 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 49.2 Cg_endo -81.56 81.91 2.51 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.926 1.487 . . . . 0.0 110.535 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 81.0 p -79.72 -1.97 40.88 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.172 -0.955 . . . . 0.0 110.06 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -144.06 -176.8 5.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.941 . . . . 0.0 110.135 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -92.69 131.61 37.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.0 110.072 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.36 -5.33 57.27 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.07 157.38 18.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.14 -1.212 . . . . 0.0 110.294 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.471 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 32.1 tp -115.3 120.06 38.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 110.079 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.482 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -97.74 47.85 1.52 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.817 ' CE2' ' HB1' ' A' ' 11' ' ' ALA . 46.6 p90 -49.29 174.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -1.153 . . . . 0.0 111.305 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.547 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 95.8 mt-10 -107.63 173.68 6.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.523 -0.736 . . . . 0.0 109.943 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -68.39 139.45 55.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.098 -1.001 . . . . 0.0 110.355 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.16 -15.41 49.41 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.516 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 22.8 tt0 -62.28 124.4 20.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.116 -1.226 . . . . 0.0 110.016 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.973 ' C ' HD12 ' A' ' 31' ' ' LEU . 91.9 mt-30 -79.9 136.87 36.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -0.887 . . . . 0.0 109.902 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.973 HD12 ' C ' ' A' ' 30' ' ' GLN . 6.6 mp -141.65 163.61 32.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.126 -0.984 . . . . 0.0 110.533 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.83 ' HE ' HD11 ' A' ' 34' ' ' LEU . 10.5 ptt180 -112.72 136.85 51.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.351 -0.843 . . . . 0.0 109.575 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.467 HD11 HG11 ' A' ' 9' ' ' VAL . 61.8 mt -90.74 95.28 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.175 -0.953 . . . . 0.0 110.655 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.83 HD11 ' HE ' ' A' ' 32' ' ' ARG . 1.2 mt -79.46 -30.49 42.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 110.778 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.547 ' CG ' ' HB3' ' A' ' 42' ' ' LYS . 39.8 mm-40 -135.07 139.76 45.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.885 -1.135 . . . . 0.0 110.438 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.626 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 16.9 mt-30 -130.9 54.67 1.89 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.282 -0.886 . . . . 0.0 110.158 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.0 m -116.87 145.7 43.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.237 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.28 172.15 10.6 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.3 -28.01 66.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.181 -1.188 . . . . 0.0 110.16 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.569 ' CZ3' ' OH ' ' A' ' 15' ' ' TYR . 94.8 m95 -99.53 144.67 28.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 110.282 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.626 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.6 m0 -120.79 156.36 32.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.864 . . . . 0.0 110.149 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.547 ' HB3' ' CG ' ' A' ' 35' ' ' GLU . 24.6 tttp -98.32 140.25 32.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.372 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.634 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -156.25 -178.41 7.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.061 -1.024 . . . . 0.0 110.618 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.514 ' HB3' ' CD ' ' A' ' 32' ' ' ARG . 48.4 tt0 -151.09 158.81 44.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.479 -0.763 . . . . 0.0 109.72 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -108.01 140.04 41.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.155 -0.966 . . . . 0.0 110.357 -179.8 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.42 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 22.7 tp -90.85 11.2 23.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -0.86 . . . . 0.0 110.07 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.4 m -97.03 -38.6 9.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.0 110.241 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.1 p -119.35 -8.84 10.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.217 -0.927 . . . . 0.0 110.207 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.47 36.21 49.99 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.478 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 3.1 mt-30 -108.75 141.76 40.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -1.109 . . . . 0.0 110.14 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.512 ' CA ' ' HG3' ' A' ' 44' ' ' GLN . 83.4 tt0 -121.61 143.08 49.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.216 -0.928 . . . . 0.0 110.124 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.471 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -173.47 165.63 37.7 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -71.77 145.45 48.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.401 -1.058 . . . . 0.0 110.075 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.46 ' O ' HG13 ' A' ' 54' ' ' ILE . 1.3 pt -136.97 137.66 23.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.182 -0.949 . . . . 0.0 110.198 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.596 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 46.6 Cg_endo -62.06 145.16 96.68 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.944 1.497 . . . . 0.0 110.049 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.594 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 31.1 p90 -73.27 -3.96 30.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.365 -0.835 . . . . 0.0 110.902 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -96.09 -26.23 15.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.912 -1.117 . . . . 0.0 111.066 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.596 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 15.3 m-85 -83.43 3.07 33.58 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.96 -1.087 . . . . 0.0 110.242 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.522 HG12 ' HB ' ' A' ' 9' ' ' VAL . 16.0 t -146.41 168.19 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 109.907 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.634 ' O ' HG12 ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 110.26 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.524 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.7 mp . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.239 0.543 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.728 ' CG1' HD11 ' A' ' 33' ' ' ILE . 13.6 m -150.25 169.83 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.185 -0.947 . . . . 0.0 110.387 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 57.0 mt -116.79 141.86 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.311 -0.868 . . . . 0.0 109.559 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.764 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -80.26 113.74 18.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.122 -0.986 . . . . 0.0 110.515 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.458 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 82.5 mt -67.07 -24.28 65.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.061 -1.024 . . . . 0.0 109.121 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.458 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 42.8 m80 -157.31 150.83 24.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.602 -0.686 . . . . 0.0 109.547 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 36.8 p -62.31 142.17 57.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.93 -1.106 . . . . 0.0 110.069 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 82.1 t80 -100.82 162.64 12.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.078 -1.014 . . . . 0.0 110.472 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -119.71 121.59 29.75 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.334 -0.854 . . . . 0.0 109.911 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.496 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 47.6 Cg_endo -79.42 94.36 1.06 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.037 1.546 . . . . 0.0 110.521 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.401 ' HG ' ' CE1' ' A' ' 19' ' ' HIS . 50.6 p -79.89 0.97 28.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 110.005 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.401 ' CE1' ' HG ' ' A' ' 18' ' ' SER . 48.4 m80 -145.08 165.71 27.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.893 . . . . 0.0 109.888 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -77.46 131.74 38.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.133 -0.979 . . . . 0.0 110.185 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.27 -7.13 40.04 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 4.3 m-20 -91.58 165.35 13.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.231 -1.158 . . . . 0.0 110.201 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.526 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 20.1 tp -122.81 128.5 50.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 109.978 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.496 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -106.77 55.34 0.53 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.764 ' CE2' ' HB1' ' A' ' 11' ' ' ALA . 37.3 p90 -45.31 171.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -1.14 . . . . 0.0 110.882 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.474 ' N ' ' OE1' ' A' ' 29' ' ' GLU . 94.9 mt-10 -97.66 174.48 6.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.412 -0.805 . . . . 0.0 110.239 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -70.66 122.68 20.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.873 . . . . 0.0 110.349 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.01 -7.1 76.64 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.474 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 39.1 tt0 -70.34 129.57 39.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.001 -1.293 . . . . 0.0 110.06 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.599 ' O ' HD23 ' A' ' 31' ' ' LEU . 92.8 mt-30 -79.46 138.35 37.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.885 . . . . 0.0 109.981 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.642 HD11 ' CG ' ' A' ' 25' ' ' PHE . 16.9 mt -135.56 156.41 48.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.149 -0.969 . . . . 0.0 110.47 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 31.3 ttm180 -98.37 130.99 45.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.379 -0.826 . . . . 0.0 109.918 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.728 HD11 ' CG1' ' A' ' 9' ' ' VAL . 34.5 mt -76.03 119.7 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 110.164 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.686 HD21 ' HB2' ' A' ' 44' ' ' GLN . 96.9 mt -87.75 -35.19 18.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.334 -0.854 . . . . 0.0 110.179 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -150.56 175.08 12.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -0.921 . . . . 0.0 110.314 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.626 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 27.1 mt-30 -151.09 57.8 0.9 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.281 -0.887 . . . . 0.0 110.192 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.3 t -125.2 130.36 51.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 110.152 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.88 -170.79 42.14 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -75.65 -34.24 60.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.194 -1.18 . . . . 0.0 110.178 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.561 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 94.8 m95 -97.84 146.4 25.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -0.89 . . . . 0.0 110.155 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.626 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.2 m0 -124.42 155.76 38.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.289 -0.882 . . . . 0.0 110.18 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 34' ' ' LEU . 19.7 mttt -91.12 146.3 23.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 109.663 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.665 ' HB2' HG12 ' A' ' 54' ' ' ILE . . . -144.05 165.92 26.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.221 -0.924 . . . . 0.0 110.635 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.686 ' HB2' HD21 ' A' ' 34' ' ' LEU . 59.5 tt0 -134.59 142.89 47.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.415 -0.803 . . . . 0.0 109.957 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.9 m -76.99 140.06 40.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 110.14 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 14.2 tp -88.31 -19.69 26.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.913 . . . . 0.0 109.968 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.0 p -102.92 -28.13 12.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.828 . . . . 0.0 110.404 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m -96.3 -20.94 18.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.081 -1.012 . . . . 0.0 110.107 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.71 47.49 67.59 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 61.2 mt-30 -133.86 158.59 43.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.325 -1.103 . . . . 0.0 110.191 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 92.5 mt-10 -119.77 143.67 47.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.083 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.526 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -154.63 -152.05 6.01 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -122.16 134.33 54.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.368 -1.078 . . . . 0.0 110.056 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.869 HD12 HG21 ' A' ' 59' ' ' VAL . 1.8 pt -129.11 140.48 38.74 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.965 . . . . 0.0 110.183 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.594 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 47.3 Cg_endo -73.0 157.34 51.25 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.958 1.504 . . . . 0.0 110.12 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -78.84 -5.01 52.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -0.858 . . . . 0.0 111.009 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -98.44 -26.51 14.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.897 -1.127 . . . . 0.0 111.215 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.594 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 13.1 m-85 -83.63 -9.18 59.07 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.929 -1.107 . . . . 0.0 110.469 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.869 HG21 HD12 ' A' ' 54' ' ' ILE . 31.0 m -133.98 145.0 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.166 -0.959 . . . . 0.0 110.383 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.836 . . . . 0.0 110.119 179.905 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.538 ' C ' HG13 ' A' ' 9' ' ' VAL . 23.6 tp . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.263 0.554 . . . . 0.0 110.115 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.538 HG13 ' C ' ' A' ' 8' ' ' LEU . 31.7 m -153.7 172.03 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.192 -0.943 . . . . 0.0 110.37 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 54.8 mt -113.9 146.11 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.319 -0.863 . . . . 0.0 109.712 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.802 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -80.13 110.12 15.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.13 -0.982 . . . . 0.0 110.287 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.993 HD13 ' O ' ' A' ' 12' ' ' LEU . 2.0 tm? -65.61 -25.07 67.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.065 -1.022 . . . . 0.0 109.405 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.683 ' CD2' HD12 ' A' ' 12' ' ' LEU . 8.5 m-70 -155.69 158.95 39.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.51 -0.744 . . . . 0.0 109.744 179.669 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.553 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 47.3 p -68.41 139.89 55.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.999 -1.063 . . . . 0.0 110.105 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.597 ' CD1' ' HD3' ' A' ' 55' ' ' PRO . 87.9 t80 -95.72 156.42 16.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.046 -1.034 . . . . 0.0 110.33 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.563 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -99.4 127.13 35.3 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.322 -0.861 . . . . 0.0 110.062 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.475 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.0 Cg_endo -89.5 86.78 0.43 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.033 1.544 . . . . 0.0 110.397 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.9 p -79.98 1.3 28.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -0.943 . . . . 0.0 110.111 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.403 ' HB2' ' CG ' ' A' ' 22' ' ' ASP . 38.8 m80 -134.7 -168.31 2.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.078 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.7 p30 -105.79 -6.19 19.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.187 -0.945 . . . . 0.0 110.196 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.48 -0.53 23.39 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.403 ' CG ' ' HB2' ' A' ' 19' ' ' HIS . 61.3 m-20 -88.13 163.17 16.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.127 -1.22 . . . . 0.0 110.243 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.493 HD13 ' HG2' ' A' ' 50' ' ' GLN . 22.2 tp -114.53 120.49 40.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.298 -0.876 . . . . 0.0 110.086 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.475 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -103.7 54.81 0.65 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.802 ' CE2' ' HB1' ' A' ' 11' ' ' ALA . 50.6 p90 -53.39 176.57 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -1.155 . . . . 0.0 111.022 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.553 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 92.5 mt-10 -110.39 178.27 4.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.442 -0.786 . . . . 0.0 110.026 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 12' ' ' LEU . 27.9 tttt -67.38 136.45 54.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.124 -0.985 . . . . 0.0 110.421 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.47 -16.13 50.91 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.574 ' HG2' HD21 ' A' ' 31' ' ' LEU . 10.3 tt0 -60.83 123.21 16.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.131 -1.217 . . . . 0.0 110.41 -179.666 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.484 ' O ' HD23 ' A' ' 31' ' ' LEU . 94.0 mt-30 -79.75 134.52 36.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.35 -0.844 . . . . 0.0 109.79 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.574 HD21 ' HG2' ' A' ' 29' ' ' GLU . 15.5 mt -137.99 159.38 42.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.949 . . . . 0.0 110.319 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.704 ' HE ' HD11 ' A' ' 34' ' ' LEU . 3.7 ptt180 -109.25 134.98 51.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.278 -0.889 . . . . 0.0 109.614 179.357 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 61.1 mt -91.39 95.17 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.094 -1.004 . . . . 0.0 110.758 -179.281 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.704 HD11 ' HE ' ' A' ' 32' ' ' ARG . 1.6 mt -78.86 -29.45 44.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 110.622 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 42' ' ' LYS . 74.1 tt0 -128.6 140.76 51.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.002 -1.062 . . . . 0.0 110.274 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.621 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 47.7 tt0 -138.42 68.4 1.39 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 110.222 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.4 p -131.81 132.83 44.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.0 110.207 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.84 -162.56 41.15 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -80.96 -31.17 34.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -1.163 . . . . 0.0 110.208 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.56 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 91.4 m95 -98.87 146.51 25.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.269 -0.894 . . . . 0.0 110.352 -179.79 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.621 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 47.3 m0 -125.35 156.46 38.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 110.21 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.513 ' HB3' ' HB3' ' A' ' 35' ' ' GLU . 25.7 tttp -97.6 145.32 26.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.14 179.217 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.58 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -160.35 -173.57 4.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.908 -1.12 . . . . 0.0 110.947 -179.638 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.54 ' HB3' ' CD ' ' A' ' 32' ' ' ARG . 39.2 tt0 -155.15 162.18 41.05 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.576 -0.702 . . . . 0.0 109.475 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.532 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 1.7 m -103.22 128.42 50.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.068 -1.02 . . . . 0.0 110.276 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.455 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 25.4 tp -82.44 1.89 35.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.337 -0.852 . . . . 0.0 110.154 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.0 m -96.96 -34.48 11.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 110.205 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.0 p -115.99 -16.31 11.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.935 . . . . 0.0 110.183 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.8 25.68 55.55 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.493 ' HG2' HD13 ' A' ' 23' ' ' LEU . 56.9 tt0 -97.18 135.65 38.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -1.154 . . . . 0.0 110.243 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.445 ' HG3' ' HB2' ' A' ' 44' ' ' GLN . 82.1 tt0 -120.02 141.13 50.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.253 -0.905 . . . . 0.0 109.939 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.476 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -167.32 -137.84 2.32 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -125.91 138.42 53.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.416 -1.049 . . . . 0.0 109.947 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.748 HD12 HG11 ' A' ' 59' ' ' VAL . 16.9 pt -128.23 148.78 69.16 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 110.255 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.598 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 45.3 Cg_endo -80.42 148.31 18.45 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.017 1.535 . . . . 0.0 109.728 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.594 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 35.8 p90 -69.87 -4.61 21.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 111.021 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -98.21 -26.44 14.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.831 -1.168 . . . . 0.0 111.396 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.598 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 8.1 m-85 -84.41 -2.84 57.81 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.938 -1.101 . . . . 0.0 110.395 -179.666 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.748 HG11 HD12 ' A' ' 54' ' ' ILE . 33.4 m -131.32 141.71 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.131 -0.981 . . . . 0.0 110.1 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.114 -0.991 . . . . 0.0 110.38 -179.977 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.895 HD13 ' N ' ' A' ' 9' ' ' VAL . 3.2 tm? . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.127 0.489 . . . . 0.0 110.192 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.895 ' N ' HD13 ' A' ' 8' ' ' LEU . 27.1 m -146.6 167.66 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.312 -0.867 . . . . 0.0 110.345 180.0 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.6 mm -112.54 141.34 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.705 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.607 ' HB1' ' CE1' ' A' ' 25' ' ' PHE . . . -79.03 109.64 13.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.057 -1.027 . . . . 0.0 110.268 -179.817 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.44 ' HG ' ' CE1' ' A' ' 13' ' ' HIS . 16.6 tp -67.39 -24.96 65.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.09 -1.006 . . . . 0.0 109.255 179.39 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.44 ' CE1' ' HG ' ' A' ' 12' ' ' LEU . 66.1 m80 -153.51 151.4 29.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.551 -0.718 . . . . 0.0 109.622 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.549 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 52.7 p -65.4 143.66 57.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 109.996 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.571 ' CD1' ' HG3' ' A' ' 55' ' ' PRO . 22.3 t80 -92.77 150.31 20.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.106 -0.996 . . . . 0.0 110.287 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -106.9 79.48 0.67 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.895 . . . . 0.0 110.268 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.437 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 47.5 Cg_endo -47.45 109.62 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.08 1.568 . . . . 0.0 110.396 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.41 ' O ' ' CD2' ' A' ' 19' ' ' HIS . 91.6 p -90.35 12.1 19.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.213 -0.93 . . . . 0.0 110.217 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.41 ' CD2' ' O ' ' A' ' 18' ' ' SER . 45.0 m80 -147.54 -178.97 6.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.207 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -98.7 116.59 31.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.247 -0.908 . . . . 0.0 110.203 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.4 7.54 6.89 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.425 ' HB2' ' HB3' ' A' ' 17' ' ' PRO . 10.4 m-20 -105.8 171.85 7.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.16 -1.2 . . . . 0.0 110.152 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.529 HD21 ' HB2' ' A' ' 45' ' ' SER . 18.7 tp -113.32 115.59 28.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.303 -0.873 . . . . 0.0 109.876 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.437 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -99.12 55.21 0.97 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.607 ' CE1' ' HB1' ' A' ' 11' ' ' ALA . 37.0 p90 -54.76 175.99 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -1.118 . . . . 0.0 111.208 -179.498 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.549 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 96.0 mt-10 -110.25 177.97 4.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.546 -0.721 . . . . 0.0 110.056 179.797 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.7 tttt -67.22 139.23 57.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.11 -0.994 . . . . 0.0 110.505 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.63 -14.72 54.89 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.853 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 3.1 mt-10 -65.05 125.59 25.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.06 -1.259 . . . . 0.0 110.293 -179.698 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.978 ' C ' HD12 ' A' ' 31' ' ' LEU . 52.1 tt0 -79.62 136.16 36.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 109.916 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.978 HD12 ' C ' ' A' ' 30' ' ' GLN . 7.6 mp -138.94 160.02 40.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 110.467 -179.698 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.605 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 46.7 ttt180 -105.82 131.7 52.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.414 -0.804 . . . . 0.0 109.427 179.4 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.66 HD11 HG21 ' A' ' 9' ' ' VAL . 35.0 mm -92.35 94.39 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.093 -1.004 . . . . 0.0 110.623 -179.551 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.492 HD21 ' CZ ' ' A' ' 32' ' ' ARG . 11.8 mt -79.84 -29.91 40.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.278 -0.889 . . . . 0.0 110.751 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.495 ' HB3' ' HB3' ' A' ' 42' ' ' LYS . 41.5 tp10 -131.03 142.96 50.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.908 -1.12 . . . . 0.0 110.383 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.641 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 13.6 mt-30 -138.01 54.88 1.78 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.88 . . . . 0.0 110.017 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.1 m -120.38 137.47 54.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.935 . . . . 0.0 110.237 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.26 -171.66 55.15 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -74.83 -33.67 62.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -1.17 . . . . 0.0 110.212 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.443 ' CZ3' ' OH ' ' A' ' 15' ' ' TYR . 95.6 m95 -93.77 139.83 30.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 110.212 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.641 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 32.2 m0 -118.17 154.97 31.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.041 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 35' ' ' GLU . 16.3 tttm -100.95 138.78 37.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.312 -0.868 . . . . 0.0 109.145 179.235 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.605 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -150.74 177.57 9.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.998 -1.064 . . . . 0.0 110.965 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.473 ' CG ' ' HG2' ' A' ' 51' ' ' GLU . 47.2 tt0 -138.27 146.77 42.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.48 -0.763 . . . . 0.0 109.788 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.529 ' HB2' HD21 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -96.52 116.12 28.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.13 -0.981 . . . . 0.0 110.255 -179.884 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.6 mt -75.71 1.65 14.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.888 . . . . 0.0 110.307 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 47.9 p -89.92 -32.33 16.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.124 -0.985 . . . . 0.0 110.144 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.5 p -120.56 -3.8 9.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 110.082 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.24 48.16 60.25 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.471 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 10.8 mt-30 -130.17 155.65 45.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -1.142 . . . . 0.0 110.349 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.473 ' HG2' ' CG ' ' A' ' 44' ' ' GLN . 97.9 mt-10 -121.41 147.86 45.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.325 -0.859 . . . . 0.0 109.944 179.785 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.501 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -164.75 -153.6 7.55 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -119.67 135.08 54.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.505 -0.997 . . . . 0.0 109.719 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.788 ' CD1' HG21 ' A' ' 59' ' ' VAL . 1.0 OUTLIER -126.7 149.42 68.33 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.126 -0.984 . . . . 0.0 110.568 -179.668 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.574 ' O ' HG22 ' A' ' 59' ' ' VAL . 46.3 Cg_endo -77.78 132.6 12.04 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.057 1.556 . . . . 0.0 109.965 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.582 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 15.0 p90 -66.46 -9.68 36.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 111.017 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -87.28 -26.41 23.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.883 -1.136 . . . . 0.0 110.841 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.568 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 16.8 m-30 -96.28 7.18 47.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.045 -1.034 . . . . 0.0 110.259 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.788 HG21 ' CD1' ' A' ' 54' ' ' ILE . 35.2 m -135.55 142.26 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 0.0 110.091 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.232 -0.917 . . . . 0.0 110.219 -179.948 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.454 ' C ' HG13 ' A' ' 9' ' ' VAL . 21.7 tp . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.197 0.523 . . . . 0.0 110.105 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.749 HG11 HD11 ' A' ' 33' ' ' ILE . 30.2 m -150.02 169.87 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.159 -0.963 . . . . 0.0 110.367 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 85.9 mt -112.27 144.91 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 109.728 179.575 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . -77.83 114.89 17.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.13 -0.981 . . . . 0.0 110.349 -179.712 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.575 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 73.1 mt -73.7 -24.93 60.0 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.071 -1.018 . . . . 0.0 109.316 179.409 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 40.5 m80 -161.38 146.47 13.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.612 -0.68 . . . . 0.0 109.543 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 53.5 p -60.59 142.07 55.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.919 -1.113 . . . . 0.0 109.904 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.541 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 45.8 t80 -99.0 159.12 15.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.015 -1.053 . . . . 0.0 110.587 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -109.4 82.08 1.98 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.411 -0.806 . . . . 0.0 110.067 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.547 ' CB ' ' HB2' ' A' ' 22' ' ' ASP . 47.4 Cg_endo -48.55 104.55 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.034 1.544 . . . . 0.0 110.44 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.522 ' OG ' ' CE1' ' A' ' 19' ' ' HIS . 64.5 p -80.67 0.1 35.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.201 -0.937 . . . . 0.0 110.169 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.522 ' CE1' ' OG ' ' A' ' 18' ' ' SER . 64.5 m80 -134.85 176.73 8.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.143 -0.973 . . . . 0.0 110.147 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -82.38 -11.86 58.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 110.461 -179.79 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -105.66 25.05 25.5 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.547 ' HB2' ' CB ' ' A' ' 17' ' ' PRO . 52.4 m-20 -111.92 161.83 15.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.157 -1.202 . . . . 0.0 110.364 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.495 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 23.7 tp -116.18 120.46 39.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.773 179.713 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.537 ' CA ' ' HD3' ' A' ' 17' ' ' PRO . . . -98.02 51.06 1.31 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.866 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.557 ' CG ' HD11 ' A' ' 31' ' ' LEU . 22.2 p90 -47.34 170.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -1.155 . . . . 0.0 110.568 -179.649 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -100.01 179.05 4.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.391 -0.818 . . . . 0.0 110.282 -179.649 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -71.96 120.47 17.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.326 -0.859 . . . . 0.0 110.033 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 96.63 -9.18 66.47 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.513 ' OE2' ' CB ' ' A' ' 25' ' ' PHE . 31.4 tt0 -60.7 133.21 55.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.168 -1.195 . . . . 0.0 110.27 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -79.93 129.06 34.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.0 109.888 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.557 HD11 ' CG ' ' A' ' 25' ' ' PHE . 27.0 mt -130.11 150.7 51.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.168 -0.958 . . . . 0.0 110.437 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.499 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 30.5 ttp180 -106.01 140.64 38.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.349 -0.845 . . . . 0.0 109.824 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.749 HD11 HG11 ' A' ' 9' ' ' VAL . 55.8 mt -91.51 136.09 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 110.173 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.452 ' CD1' ' HB2' ' A' ' 44' ' ' GLN . 91.6 mt -129.94 -30.89 1.98 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.371 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.479 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 78.6 tt0 -128.25 146.64 50.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 110.307 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.593 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 52.6 tt0 -142.25 58.1 1.46 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.254 -0.904 . . . . 0.0 110.144 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.4 t -118.22 114.38 22.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.269 -0.894 . . . . 0.0 110.229 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.3 -160.93 20.62 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -84.18 -29.59 26.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.189 -1.183 . . . . 0.0 110.251 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.551 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 91.3 m95 -96.06 145.05 25.79 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.288 -0.883 . . . . 0.0 110.169 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.593 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 48.8 m0 -119.17 153.1 35.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.226 -0.922 . . . . 0.0 110.281 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.482 ' HE2' ' OE2' ' A' ' 51' ' ' GLU . 9.9 tttp -99.43 110.58 23.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 110.043 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.499 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -112.37 175.46 5.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.229 -0.919 . . . . 0.0 110.708 -179.588 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.49 ' CG ' ' O ' ' A' ' 50' ' ' GLN . 44.4 tt0 -138.18 146.59 42.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.338 -0.851 . . . . 0.0 109.951 -179.799 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.42 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 6.9 t -79.01 137.78 37.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.109 -0.994 . . . . 0.0 110.174 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.463 ' HA ' HD12 ' A' ' 46' ' ' LEU . 21.2 tp -80.7 -21.06 41.58 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.596 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 95.9 m -83.35 -50.68 8.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.447 -0.783 . . . . 0.0 110.241 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 50' ' ' GLN . 18.0 p -100.22 1.69 42.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.079 -1.013 . . . . 0.0 110.32 -179.694 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 45' ' ' SER . . . 54.03 18.92 9.79 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.49 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 37.2 mt-30 -78.7 153.67 30.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -1.148 . . . . 0.0 110.281 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.482 ' OE2' ' HE2' ' A' ' 42' ' ' LYS . 86.6 tt0 -120.36 142.82 48.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 110.13 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.495 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -165.83 156.81 28.98 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -71.55 141.0 50.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -1.175 . . . . 0.0 109.961 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.796 HD12 ' O ' ' A' ' 55' ' ' PRO . 1.9 pp -141.21 124.8 10.05 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.302 -0.874 . . . . 0.0 110.146 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.796 ' O ' HD12 ' A' ' 54' ' ' ILE . 46.2 Cg_endo -46.37 167.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.931 1.49 . . . . 0.0 110.098 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -95.69 -1.84 49.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 110.539 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -99.18 -24.58 14.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.141 -0.974 . . . . 0.0 110.724 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.585 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 27.4 m-85 -79.64 -12.87 59.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.988 -1.07 . . . . 0.0 110.515 -179.66 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.795 HG21 ' CD1' ' A' ' 54' ' ' ILE . 30.6 m -131.25 143.32 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.106 -0.996 . . . . 0.0 110.187 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.301 -0.874 . . . . 0.0 110.172 -179.916 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.533 ' C ' HG13 ' A' ' 9' ' ' VAL . 6.6 tp . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.244 0.545 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.546 HG11 HD11 ' A' ' 33' ' ' ILE . 28.7 m -154.84 172.73 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 0.0 110.287 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 62.8 mt -112.49 145.43 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 109.806 179.618 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.717 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -80.11 111.69 16.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.046 -1.034 . . . . 0.0 110.273 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 58' ' ' PHE . 6.1 mp -64.87 -28.46 69.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.068 -1.02 . . . . 0.0 109.356 179.451 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.444 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 30.7 m80 -155.39 157.66 37.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.564 -0.71 . . . . 0.0 109.794 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.556 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 10.3 t -64.92 140.61 58.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.099 -1.0 . . . . 0.0 109.939 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.605 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 86.3 t80 -94.5 151.69 19.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.02 -1.05 . . . . 0.0 110.474 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.411 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 4.2 tp10 -114.02 91.89 24.2 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.409 -0.807 . . . . 0.0 110.076 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.513 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 46.8 Cg_endo -59.26 114.12 1.89 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.055 1.555 . . . . 0.0 110.476 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.2 p -89.54 11.33 19.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.275 -0.891 . . . . 0.0 109.996 179.826 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -145.95 -177.11 5.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 0.0 110.15 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -100.33 118.89 37.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 110.139 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.95 -14.33 7.51 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -85.24 174.13 9.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -1.121 . . . . 0.0 110.339 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.52 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 20.2 tp -118.42 122.43 42.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 110.011 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.513 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -102.17 57.08 0.64 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.717 ' CE2' ' HB1' ' A' ' 11' ' ' ALA . 48.6 p90 -53.67 174.13 0.05 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.167 -1.196 . . . . 0.0 110.86 -179.805 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.556 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 73.6 mm-40 -108.0 -179.48 3.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.463 -0.773 . . . . 0.0 110.137 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -68.37 134.52 50.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.928 . . . . 0.0 110.365 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.17 -13.19 62.23 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.457 ' HG3' HD21 ' A' ' 31' ' ' LEU . 26.1 tp10 -62.08 122.99 16.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -1.16 . . . . 0.0 110.409 -179.712 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.635 ' O ' HD23 ' A' ' 31' ' ' LEU . 97.0 mt-30 -79.91 136.42 36.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.33 -0.856 . . . . 0.0 109.879 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.635 HD23 ' O ' ' A' ' 30' ' ' GLN . 17.4 mt -139.04 160.87 38.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.418 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.594 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 4.1 tpt180 -106.4 134.03 50.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.381 -0.825 . . . . 0.0 109.498 179.533 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.546 HD11 HG11 ' A' ' 9' ' ' VAL . 35.4 mt -95.77 92.84 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.139 -0.976 . . . . 0.0 110.485 -179.669 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.764 HD12 ' HA ' ' A' ' 43' ' ' ALA . 1.1 mt -79.2 -24.97 42.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.274 -0.891 . . . . 0.0 110.631 -179.406 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 42' ' ' LYS . 70.7 tt0 -135.82 136.3 40.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.026 -1.046 . . . . 0.0 110.253 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.642 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 12.0 mt-30 -132.23 53.86 1.98 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.879 . . . . 0.0 110.188 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.0 m -115.9 138.4 51.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -0.882 . . . . 0.0 110.099 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.95 -172.89 55.2 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -72.73 -34.43 67.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.188 -1.184 . . . . 0.0 110.234 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.565 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 99.5 m95 -96.73 143.62 27.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 110.139 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.642 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 51.2 m0 -121.78 155.64 34.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.317 -0.865 . . . . 0.0 110.096 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 35' ' ' GLU . 46.7 tttm -96.32 141.98 29.0 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.277 -0.89 . . . . 0.0 109.237 179.282 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.764 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -150.03 174.13 13.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.927 -1.108 . . . . 0.0 111.023 -179.456 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 50' ' ' GLN . 58.7 tt0 -137.82 146.06 43.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.613 -0.679 . . . . 0.0 109.771 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 t -92.92 107.3 19.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 110.136 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 44.7 mt -70.01 -3.04 14.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.24 -0.913 . . . . 0.0 110.429 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.428 ' OG1' HG23 ' A' ' 48' ' ' THR . 30.1 p -89.07 -30.16 18.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.124 -0.985 . . . . 0.0 109.799 179.656 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.428 HG23 ' OG1' ' A' ' 47' ' ' THR . 49.2 p -120.81 -7.32 9.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.28 -0.887 . . . . 0.0 110.068 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.26 44.07 60.98 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.467 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 23.2 mt-30 -123.47 151.55 42.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -1.154 . . . . 0.0 110.301 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 97.1 mt-10 -119.3 141.56 48.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.322 -0.861 . . . . 0.0 109.998 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.52 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -159.1 -151.92 6.28 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -124.27 138.28 54.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.398 -1.06 . . . . 0.0 109.818 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.446 ' O ' HG13 ' A' ' 54' ' ' ILE . 2.9 pt -133.53 144.37 51.86 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.157 -0.964 . . . . 0.0 110.343 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.593 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 47.0 Cg_endo -72.64 151.86 52.85 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.06 1.558 . . . . 0.0 109.985 179.736 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.597 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 31.6 p90 -73.99 -4.26 34.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 111.134 -179.375 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -98.6 -26.14 14.49 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.895 -1.128 . . . . 0.0 111.341 -179.305 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.593 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 8.5 m-85 -82.65 -2.53 54.25 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.803 -1.186 . . . . 0.0 110.346 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 30.9 m -133.74 143.21 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.161 -0.962 . . . . 0.0 110.117 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.446 ' HB2' HD11 ' A' ' 12' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 110.246 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.4 mp . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.254 0.55 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.632 HG21 HD11 ' A' ' 33' ' ' ILE . 4.2 m -145.95 167.72 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.267 -0.895 . . . . 0.0 110.288 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 61.8 mt -113.43 140.11 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.865 . . . . 0.0 109.781 179.661 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.555 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -80.66 110.22 15.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.137 -0.977 . . . . 0.0 110.555 -179.631 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 58' ' ' PHE . 52.4 mt -67.52 -22.94 65.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.08 -1.013 . . . . 0.0 109.162 179.164 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.439 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 21.8 m80 -157.37 146.72 20.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.641 -0.662 . . . . 0.0 109.408 179.704 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 81.9 p -61.5 146.38 48.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.998 -1.064 . . . . 0.0 110.14 -179.831 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 25.1 t80 -95.76 156.93 16.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.978 -1.076 . . . . 0.0 110.348 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 17' ' ' PRO . 46.1 mt-10 -114.07 73.87 2.58 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.326 -0.859 . . . . 0.0 110.121 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.515 ' HB3' ' HB2' ' A' ' 22' ' ' ASP . 47.7 Cg_endo -40.6 110.35 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.043 1.549 . . . . 0.0 110.429 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 59.6 p -87.25 8.21 25.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.348 -0.845 . . . . 0.0 110.168 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.467 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 52.0 m80 -145.48 170.54 16.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.09 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -87.25 126.89 35.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.266 -0.896 . . . . 0.0 110.294 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.27 -14.0 13.66 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.515 ' HB2' ' HB3' ' A' ' 17' ' ' PRO . 2.4 m-20 -86.68 174.66 8.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -1.152 . . . . 0.0 110.262 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.497 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 19.2 tp -120.63 124.66 45.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.868 . . . . 0.0 110.062 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.493 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -104.13 57.52 0.53 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.759 ' CG ' HD11 ' A' ' 31' ' ' LEU . 28.6 p90 -47.07 169.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.259 -1.142 . . . . 0.0 110.878 -179.532 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.486 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 90.7 mt-10 -98.84 177.48 5.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.495 -0.753 . . . . 0.0 110.14 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -71.55 119.89 16.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.184 -0.947 . . . . 0.0 110.348 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.9 -6.75 58.68 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.503 ' OE1' ' CA ' ' A' ' 25' ' ' PHE . 71.6 tt0 -73.71 127.43 32.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.008 -1.289 . . . . 0.0 110.172 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.43 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 58.2 mt-30 -79.25 142.67 36.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 110.004 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.759 HD11 ' CG ' ' A' ' 25' ' ' PHE . 73.0 mt -141.36 163.83 31.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.243 -0.91 . . . . 0.0 110.348 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.753 ' CD ' HD21 ' A' ' 34' ' ' LEU . 19.0 ttt180 -105.85 133.25 50.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.885 . . . . 0.0 109.63 179.553 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.632 HD11 HG21 ' A' ' 9' ' ' VAL . 31.0 mm -96.53 93.78 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.12 -0.987 . . . . 0.0 110.417 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.795 HD11 ' OE1' ' A' ' 44' ' ' GLN . 41.8 mt -79.83 -24.52 41.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.258 -0.901 . . . . 0.0 110.859 -179.543 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.516 ' CB ' ' HB3' ' A' ' 42' ' ' LYS . 17.9 tt0 -136.18 140.87 43.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.992 -1.067 . . . . 0.0 110.345 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.625 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 84.3 mt-30 -135.29 55.18 1.89 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.158 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -119.27 142.13 48.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.178 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.0 -171.16 54.62 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -74.16 -34.77 63.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -1.166 . . . . 0.0 110.132 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.561 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 95.3 m95 -96.28 144.5 26.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.302 -0.874 . . . . 0.0 110.272 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.625 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.9 m0 -118.85 156.09 30.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 110.217 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.516 ' HB3' ' CB ' ' A' ' 35' ' ' GLU . 29.0 tttt -96.18 137.57 35.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.358 -0.839 . . . . 0.0 109.408 179.412 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.589 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -152.77 176.65 11.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.01 . . . . 0.0 110.666 -179.554 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.795 ' OE1' HD11 ' A' ' 34' ' ' LEU . 14.5 pt20 -148.18 156.67 42.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.455 -0.778 . . . . 0.0 109.819 179.719 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.8 t -98.55 116.91 31.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.122 -0.987 . . . . 0.0 110.275 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.502 HD21 HE21 ' A' ' 44' ' ' GLN . 60.3 mt -74.51 -0.78 18.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 110.094 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 70.7 p -94.63 -27.22 16.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.36 -0.838 . . . . 0.0 110.166 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 47.4 p -114.25 -13.02 12.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 110.157 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.42 39.46 50.7 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -128.16 155.51 44.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -1.154 . . . . 0.0 110.276 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.485 ' HG2' ' CB ' ' A' ' 44' ' ' GLN . 73.6 mt-10 -123.8 152.56 42.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.905 . . . . 0.0 110.031 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.497 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -165.94 -149.89 6.09 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -127.74 143.63 51.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.46 -1.024 . . . . 0.0 109.683 179.61 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.504 HD12 ' O ' ' A' ' 55' ' ' PRO . 1.7 pp -141.01 139.2 18.94 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.132 -0.98 . . . . 0.0 110.696 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.608 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 44.8 Cg_endo -59.39 156.97 33.09 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.093 1.575 . . . . 0.0 109.907 179.465 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.727 ' CZ ' ' ND2' ' A' ' 57' ' ' ASN . 20.8 p90 -84.56 -2.28 57.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.097 -1.002 . . . . 0.0 110.766 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.727 ' ND2' ' CZ ' ' A' ' 56' ' ' PHE . 62.3 m-20 -103.65 13.22 33.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.984 -1.073 . . . . 0.0 110.696 -179.654 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.608 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 6.1 m-85 -111.32 -6.41 14.52 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.097 -1.002 . . . . 0.0 110.028 179.694 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 7.8 m -138.46 145.47 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.334 -0.854 . . . . 0.0 110.032 179.801 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.165 -0.959 . . . . 0.0 110.398 -179.863 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.746 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.2 mp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.235 0.54 . . . . 0.0 110.231 . . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.479 HG13 ' C ' ' A' ' 8' ' ' LEU . 30.9 m -150.9 170.21 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 110.289 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.9 mt -112.27 148.7 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -0.83 . . . . 0.0 109.887 179.729 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.53 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . -80.12 112.01 17.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.131 -0.981 . . . . 0.0 110.422 -179.779 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.658 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.9 mm? -71.71 -22.41 61.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.192 -0.942 . . . . 0.0 109.442 179.442 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.422 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 86.0 m-70 -153.62 151.13 29.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.464 -0.772 . . . . 0.0 109.75 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.555 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 54.2 p -67.25 142.83 56.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.059 -1.026 . . . . 0.0 109.97 179.861 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.594 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 88.5 t80 -99.08 160.17 14.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.072 -1.017 . . . . 0.0 110.414 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.551 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 2.4 mm-40 -104.69 124.4 37.06 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.356 -0.84 . . . . 0.0 110.063 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.472 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 49.6 Cg_endo -81.06 82.84 2.34 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.945 1.497 . . . . 0.0 110.429 -179.843 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 59.6 p -79.99 -2.73 45.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 110.213 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -129.13 -159.34 0.95 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.933 . . . . 0.0 110.266 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -107.72 -19.1 13.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.191 -0.943 . . . . 0.0 110.235 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.23 10.48 31.28 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -89.95 155.94 18.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -1.184 . . . . 0.0 110.157 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.448 ' O ' ' CD2' ' A' ' 15' ' ' TYR . 14.5 tp -111.65 116.31 30.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.301 -0.874 . . . . 0.0 110.169 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.472 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -97.06 47.59 1.63 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.589 ' CE1' ' HB2' ' A' ' 15' ' ' TYR . 43.7 p90 -48.43 173.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -1.159 . . . . 0.0 111.006 -179.828 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.555 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 95.5 mt-10 -109.36 179.05 4.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.458 -0.776 . . . . 0.0 110.191 179.903 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -68.42 136.46 53.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 110.439 -179.914 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.35 -14.39 57.87 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.789 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.473 ' HG3' ' HB2' ' A' ' 26' ' ' GLU . 3.2 mt-10 -62.98 124.08 20.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -1.2 . . . . 0.0 110.393 -179.746 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.476 ' O ' HD23 ' A' ' 31' ' ' LEU . 86.8 mt-30 -79.75 136.64 36.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.24 -0.913 . . . . 0.0 109.832 179.768 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 45' ' ' SER . 15.1 mt -137.74 158.51 44.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.069 -1.019 . . . . 0.0 110.653 -179.723 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.717 ' HD2' HD21 ' A' ' 46' ' ' LEU . 25.4 mtp180 -108.05 134.37 51.03 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.436 -0.79 . . . . 0.0 109.142 179.295 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.4 mm -90.82 93.97 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.047 -1.033 . . . . 0.0 110.737 -179.502 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.9 mt -79.38 -29.79 42.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 110.842 -179.507 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.505 ' HB2' ' CB ' ' A' ' 42' ' ' LYS . 74.0 mt-10 -129.54 143.93 51.04 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.923 -1.111 . . . . 0.0 110.366 -179.957 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.635 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 15.1 pt20 -138.04 55.87 1.76 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.363 -0.836 . . . . 0.0 110.241 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.6 t -120.66 142.06 49.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.171 -0.956 . . . . 0.0 110.204 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.35 -176.01 50.55 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -70.57 -28.28 64.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -1.1 . . . . 0.0 110.211 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.506 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 95.4 m95 -100.27 147.59 25.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 110.345 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.635 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 47.1 m0 -124.27 156.17 37.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.192 -179.985 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.505 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 13.5 tttp -98.94 145.23 27.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.413 179.421 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.593 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -158.21 -177.33 6.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.011 -1.056 . . . . 0.0 111.002 -179.596 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.504 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 58.4 tt0 -144.45 152.87 41.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.454 -0.779 . . . . 0.0 109.365 179.584 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.546 ' HA ' HD23 ' A' ' 31' ' ' LEU . 10.5 t -102.76 128.12 49.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.026 -1.046 . . . . 0.0 110.515 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.717 HD21 ' HD2' ' A' ' 32' ' ' ARG . 37.8 mt -83.17 8.31 13.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.886 . . . . 0.0 109.917 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.43 ' OG1' HG23 ' A' ' 48' ' ' THR . 20.4 p -98.48 -42.07 7.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.348 -0.845 . . . . 0.0 110.11 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.43 HG23 ' OG1' ' A' ' 47' ' ' THR . 58.2 p -113.05 -10.78 13.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 110.101 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.11 38.93 46.43 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.852 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -112.61 142.52 45.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -1.138 . . . . 0.0 110.197 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -117.9 136.67 53.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 110.092 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -171.44 165.15 38.11 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 97.0 m-85 -71.09 145.3 49.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -1.078 . . . . 0.0 110.145 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.573 ' CD1' HG21 ' A' ' 59' ' ' VAL . 1.2 pp -136.68 140.07 31.0 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 110.216 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.595 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 47.7 Cg_endo -65.14 149.73 88.59 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.021 1.537 . . . . 0.0 110.073 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.592 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 39.6 p90 -75.61 -5.45 45.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 110.931 -179.449 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -95.44 -25.74 16.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.955 -1.091 . . . . 0.0 111.039 -179.363 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.595 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 9.3 m-85 -82.22 0.26 42.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.905 -1.122 . . . . 0.0 110.453 -179.741 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.573 HG21 ' CD1' ' A' ' 54' ' ' ILE . 23.3 m -141.95 154.11 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 0.0 110.097 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.241 -0.912 . . . . 0.0 110.227 -179.97 . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.2 tp . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.13 0.49 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.038 HG11 HD11 ' A' ' 33' ' ' ILE . 27.8 m -141.78 165.74 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.129 -0.982 . . . . 0.0 110.465 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 72.4 mt -112.5 148.01 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.337 -0.852 . . . . 0.0 109.684 179.561 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.548 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . -78.56 111.18 14.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.063 -1.023 . . . . 0.0 110.347 -179.71 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.442 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 49.9 mt -70.05 -25.68 63.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.088 -1.008 . . . . 0.0 109.16 179.322 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.442 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 80.7 m-70 -155.62 151.92 28.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.692 -0.63 . . . . 0.0 109.506 179.703 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 30.2 p -64.91 140.0 58.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.951 -1.093 . . . . 0.0 109.774 179.75 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.61 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 85.6 t80 -97.59 157.13 16.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.014 -1.054 . . . . 0.0 110.332 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -111.44 124.61 32.21 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.909 . . . . 0.0 110.188 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.478 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.4 Cg_endo -80.21 81.67 2.69 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.02 1.537 . . . . 0.0 110.47 -179.884 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.473 ' OG ' ' ND1' ' A' ' 19' ' ' HIS . 92.2 p -79.81 -1.96 41.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.135 -0.978 . . . . 0.0 110.013 179.904 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.473 ' ND1' ' OG ' ' A' ' 18' ' ' SER . 72.4 m80 -140.34 172.86 12.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 110.076 -179.997 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -90.07 125.3 35.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.238 -0.913 . . . . 0.0 110.248 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.09 6.99 31.51 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.997 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -104.16 164.37 11.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -1.164 . . . . 0.0 110.28 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.483 ' CD1' ' CD ' ' A' ' 50' ' ' GLN . 22.8 tp -114.82 119.63 37.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.174 -179.961 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.478 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -99.91 54.21 0.94 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.866 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.751 ' CD1' HD21 ' A' ' 31' ' ' LEU . 45.9 p90 -53.12 173.73 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.235 -1.156 . . . . 0.0 111.131 -179.482 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 96.0 mt-10 -105.61 176.57 5.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.553 -0.717 . . . . 0.0 110.288 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.7 tttm -70.97 135.67 48.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.058 -1.026 . . . . 0.0 110.322 179.772 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.0 -13.67 53.07 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.591 ' OE1' HG21 ' A' ' 47' ' ' THR . 30.6 mm-40 -63.91 136.18 57.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.035 -1.274 . . . . 0.0 109.99 -179.764 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.821 ' C ' HD12 ' A' ' 31' ' ' LEU . 88.3 mt-30 -79.6 128.1 32.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.895 . . . . 0.0 110.075 -179.873 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.821 HD12 ' C ' ' A' ' 30' ' ' GLN . 10.4 mp -124.31 141.63 51.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 110.393 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.749 ' HB2' HD11 ' A' ' 46' ' ' LEU . 15.7 ttt85 -100.95 134.58 43.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.336 -0.852 . . . . 0.0 109.588 179.633 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 1.038 HD11 HG11 ' A' ' 9' ' ' VAL . 27.0 mt -85.78 132.58 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.163 -0.96 . . . . 0.0 110.307 -179.925 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.0 mt -118.71 -31.75 4.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.363 -0.835 . . . . 0.0 110.112 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.514 ' HB2' ' CB ' ' A' ' 42' ' ' LYS . 85.7 mt-10 -135.58 149.87 49.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.19 -0.944 . . . . 0.0 110.198 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.626 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 93.2 mt-30 -135.84 59.01 1.73 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.268 -0.895 . . . . 0.0 110.15 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.7 t -124.24 135.59 53.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.235 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.7 176.65 45.76 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.97 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.9 -27.44 69.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.204 -1.174 . . . . 0.0 110.236 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.556 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 98.3 m95 -98.96 146.28 26.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.22 -0.925 . . . . 0.0 110.241 -179.897 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.626 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 40.9 m0 -122.88 156.48 34.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.901 . . . . 0.0 110.14 179.795 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.514 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 20.7 tttt -93.75 142.3 27.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.956 . . . . 0.0 109.776 179.581 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.513 ' CB ' HG12 ' A' ' 54' ' ' ILE . . . -155.9 178.83 9.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.115 -0.991 . . . . 0.0 110.771 -179.803 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.414 ' CG ' ' HG2' ' A' ' 51' ' ' GLU . 46.3 tt0 -141.82 150.14 41.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.394 -0.816 . . . . 0.0 109.909 179.697 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 t -95.3 119.63 34.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 110.276 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 46' ' ' LEU . . . . . 0.749 HD11 ' HB2' ' A' ' 32' ' ' ARG . 4.9 mp -78.13 6.28 8.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -0.9 . . . . 0.0 110.412 -179.98 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.591 HG21 ' OE1' ' A' ' 29' ' ' GLU . 65.5 p -96.57 -37.29 10.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 110.019 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.1 p -120.13 -6.09 9.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 110.098 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.67 40.6 52.96 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.483 ' CD ' ' CD1' ' A' ' 23' ' ' LEU . 62.1 tt0 -110.29 141.15 43.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -1.14 . . . . 0.0 110.288 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.414 ' HG2' ' CG ' ' A' ' 44' ' ' GLN . 92.6 mt-10 -117.15 136.57 52.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.341 -0.849 . . . . 0.0 109.938 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.428 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -170.14 164.7 38.05 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -69.1 144.59 53.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -1.13 . . . . 0.0 110.029 179.894 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.558 ' CD1' HG21 ' A' ' 59' ' ' VAL . 1.1 pt -136.0 139.53 30.59 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 110.257 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.574 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 45.4 Cg_endo -63.94 150.45 88.37 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.911 1.479 . . . . 0.0 110.188 179.739 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.596 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 16.2 p90 -85.41 1.3 49.23 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.348 -0.845 . . . . 0.0 111.18 -179.402 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.538 ' OD1' ' N ' ' A' ' 58' ' ' PHE . 48.9 p30 -100.41 -24.03 14.6 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.955 -1.091 . . . . 0.0 111.178 -179.365 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.544 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 14.1 m-30 -94.18 1.34 56.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.87 -1.144 . . . . 0.0 110.591 -179.812 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.558 HG21 ' CD1' ' A' ' 54' ' ' ILE . 33.9 m -130.69 146.22 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.178 -0.951 . . . . 0.0 110.198 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.448 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.318 -0.864 . . . . 0.0 110.271 -179.945 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.77 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.3 mp . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.203 0.525 . . . . 0.0 110.101 . . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.817 ' CG1' HD11 ' A' ' 33' ' ' ILE . 15.5 m -151.86 171.95 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.172 -0.955 . . . . 0.0 110.448 179.911 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 52.7 mt -118.02 143.32 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.418 -0.801 . . . . 0.0 109.927 179.754 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.582 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -76.9 112.61 13.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.179 -0.95 . . . . 0.0 110.514 -179.659 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.481 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 52.5 mt -72.99 -22.32 60.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.089 -1.007 . . . . 0.0 109.314 179.262 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.481 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 77.8 m-70 -156.83 151.68 25.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.651 -0.656 . . . . 0.0 109.521 179.881 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 34.9 p -65.26 136.83 57.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.899 -1.126 . . . . 0.0 109.895 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 67.0 t80 -97.78 157.08 16.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.085 -1.009 . . . . 0.0 110.119 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.558 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 3.0 mt-10 -111.74 136.07 21.14 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.852 . . . . 0.0 110.295 -179.82 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.457 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 46.8 Cg_endo -94.32 87.17 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.065 1.561 . . . . 0.0 110.272 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 90.1 p -80.51 0.86 31.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 110.242 -179.921 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -142.12 -177.92 5.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 110.278 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -97.72 126.11 42.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 110.169 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.33 -9.87 26.55 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.984 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 1.1 m-20 -92.12 171.05 9.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -1.171 . . . . 0.0 110.129 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.506 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 15.5 tp -127.12 132.31 50.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 110.052 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.475 ' HA2' ' HB3' ' A' ' 15' ' ' TYR . . . -109.2 60.29 0.33 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.653 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.794 ' CG ' HD11 ' A' ' 31' ' ' LEU . 39.6 p90 -52.61 175.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.156 -1.202 . . . . 0.0 110.92 -179.684 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 96.3 mt-10 -109.75 -179.5 3.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.401 -0.812 . . . . 0.0 110.323 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.0 tttt -70.87 130.34 41.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.093 -1.005 . . . . 0.0 110.187 179.674 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.9 -18.47 47.31 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 -179.991 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 22.3 mm-40 -61.45 123.91 19.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.081 -1.246 . . . . 0.0 110.086 -179.667 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.466 ' NE2' HD23 ' A' ' 8' ' ' LEU . 48.9 tt0 -79.46 134.47 36.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.335 -0.853 . . . . 0.0 110.28 -179.76 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.794 HD11 ' CG ' ' A' ' 25' ' ' PHE . 41.8 mt -129.85 150.03 51.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -0.854 . . . . 0.0 110.176 -179.895 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 19.4 ttt180 -94.59 133.35 38.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.329 -0.857 . . . . 0.0 110.065 179.809 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.817 HD11 ' CG1' ' A' ' 9' ' ' VAL . 34.8 mt -80.89 121.48 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.202 -0.936 . . . . 0.0 110.031 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.44 HD13 ' OE2' ' A' ' 51' ' ' GLU . 4.6 mt -99.49 -33.15 10.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.272 -0.892 . . . . 0.0 110.317 -179.777 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.523 ' OE1' ' CE ' ' A' ' 42' ' ' LYS . 79.6 tt0 -150.98 146.97 26.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.176 -0.953 . . . . 0.0 110.194 -179.924 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.623 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 27.6 mt-30 -128.82 55.17 1.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.895 . . . . 0.0 110.195 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.1 t -111.23 125.99 54.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 110.249 -179.89 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.74 -175.05 53.25 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -67.91 -37.08 81.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -1.104 . . . . 0.0 110.203 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.418 ' HZ3' ' CE1' ' A' ' 15' ' ' TYR . 85.7 m95 -91.47 141.31 28.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 0.0 110.149 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.623 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 50.9 m0 -122.28 153.75 38.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 0.0 110.391 -179.97 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.523 ' CE ' ' OE1' ' A' ' 35' ' ' GLU . 50.2 mttt -89.13 146.42 24.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.302 -0.874 . . . . 0.0 109.558 179.472 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.771 ' HB2' HG12 ' A' ' 54' ' ' ILE . . . -148.71 170.08 18.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.085 -1.01 . . . . 0.0 110.653 -179.61 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 42.8 tt0 -137.51 145.25 42.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.383 -0.823 . . . . 0.0 109.878 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.462 ' OG ' HD21 ' A' ' 23' ' ' LEU . 53.4 m -74.2 139.34 44.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 110.256 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.8 tp -82.34 -26.14 33.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.183 -0.948 . . . . 0.0 110.224 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.3 p -98.96 -28.23 13.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 110.158 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.14 -18.94 18.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.241 -0.912 . . . . 0.0 110.091 179.836 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.95 6.04 35.72 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.634 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 29.3 mt-30 -83.13 155.18 23.94 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.04 -1.271 . . . . 0.0 110.485 -179.803 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.44 ' OE2' HD13 ' A' ' 34' ' ' LEU . 69.1 tt0 -114.99 134.81 54.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.326 -0.859 . . . . 0.0 109.951 179.813 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.506 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -145.6 -152.14 5.57 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.68 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -122.9 134.25 54.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.481 -1.011 . . . . 0.0 109.614 179.638 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.771 HG12 ' HB2' ' A' ' 43' ' ' ALA . 1.2 pp -127.46 133.73 25.4 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.116 -0.99 . . . . 0.0 110.631 -179.617 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.574 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 43.0 Cg_endo -66.08 157.42 59.66 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.149 1.605 . . . . 0.0 110.187 179.611 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.474 ' HB2' ' CH2' ' A' ' 41' ' ' TRP . 18.9 p90 -88.19 -1.63 58.13 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.274 -0.891 . . . . 0.0 111.36 -179.06 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 58' ' ' PHE . 42.3 p30 -99.43 -25.83 14.33 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.82 -1.175 . . . . 0.0 111.066 -179.451 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.569 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 11.7 m-30 -92.43 -3.97 54.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.89 -1.131 . . . . 0.0 110.54 -179.78 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.682 HG21 ' CD1' ' A' ' 54' ' ' ILE . 21.8 m -126.91 144.32 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.1 -1.0 . . . . 0.0 110.095 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.914 . . . . 0.0 110.362 -179.856 . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.532 ' O ' HG13 ' A' ' 9' ' ' VAL . 44.0 mt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.159 0.504 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.649 HG21 HG11 ' A' ' 59' ' ' VAL . 4.2 m -154.48 172.68 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.862 . . . . 0.0 110.333 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 60.0 mt -113.69 141.51 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.342 -0.849 . . . . 0.0 109.943 179.783 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.538 ' HB1' ' CE1' ' A' ' 25' ' ' PHE . . . -80.46 111.89 17.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.143 -0.973 . . . . 0.0 110.119 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.416 ' O ' ' ND1' ' A' ' 13' ' ' HIS . 24.2 tp -66.43 -27.86 68.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.099 -1.0 . . . . 0.0 109.543 179.529 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.416 ' ND1' ' O ' ' A' ' 12' ' ' LEU . 89.5 m-70 -150.8 155.73 39.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.472 -0.767 . . . . 0.0 109.836 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.531 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 52.5 p -68.15 144.28 55.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.14 -0.975 . . . . 0.0 110.019 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.573 ' CD1' ' HG3' ' A' ' 55' ' ' PRO . 27.4 t80 -94.44 153.71 17.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.042 -1.036 . . . . 0.0 110.323 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.446 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 19.0 tp10 -110.45 77.83 1.34 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 110.216 -179.911 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.508 ' HB3' ' HB2' ' A' ' 22' ' ' ASP . 48.1 Cg_endo -41.52 98.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.127 1.593 . . . . 0.0 110.422 179.895 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.489 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 87.5 p -82.31 9.27 9.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 110.25 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.489 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 87.3 m-70 -148.3 164.23 34.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 110.192 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -80.93 118.94 22.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 110.304 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.08 14.8 6.4 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.508 ' HB2' ' HB3' ' A' ' 17' ' ' PRO . 13.0 m-20 -111.32 168.47 9.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.174 -1.192 . . . . 0.0 110.284 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.506 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 17.1 tp -110.22 113.38 26.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 109.998 179.872 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.505 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -96.43 53.25 1.54 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.901 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.551 ' HE2' HG22 ' A' ' 54' ' ' ILE . 35.8 p90 -54.13 174.5 0.06 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.248 -1.148 . . . . 0.0 111.123 -179.557 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.531 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 94.3 mt-10 -109.43 177.23 4.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.499 -0.751 . . . . 0.0 109.964 179.78 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -66.95 139.59 57.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -0.955 . . . . 0.0 110.378 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.96 -14.02 57.98 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 3.7 mt-10 -66.6 126.16 28.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -1.215 . . . . 0.0 110.308 -179.865 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.975 ' C ' HD12 ' A' ' 31' ' ' LEU . 44.7 tt0 -79.7 137.33 37.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.814 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.975 HD12 ' C ' ' A' ' 30' ' ' GLN . 8.3 mp -136.89 156.99 47.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -0.909 . . . . 0.0 110.627 -179.553 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.592 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 38.5 ttt180 -106.26 131.65 53.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.412 -0.805 . . . . 0.0 109.24 179.247 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.458 HD11 HG11 ' A' ' 9' ' ' VAL . 87.6 mt -90.8 94.35 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.109 -0.994 . . . . 0.0 110.713 -179.318 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.93 HD12 ' HA ' ' A' ' 43' ' ' ALA . 1.1 mp -79.85 -32.69 40.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 110.379 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.495 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 67.3 tt0 -130.58 135.46 47.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.119 -0.988 . . . . 0.0 110.253 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.624 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 58.8 tt0 -131.41 55.7 1.84 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 110.174 179.984 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.2 m -120.65 145.42 47.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.281 -0.887 . . . . 0.0 110.231 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.89 -174.66 48.61 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -71.8 -30.68 65.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.236 -1.155 . . . . 0.0 110.128 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.555 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 99.3 m95 -99.38 145.71 27.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 110.23 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.624 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.6 m0 -121.2 157.04 31.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 110.207 179.896 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.495 ' CB ' ' HB3' ' A' ' 35' ' ' GLU . 43.8 tttp -101.37 138.69 38.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 109.012 179.065 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.93 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -149.93 177.38 9.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.838 -1.164 . . . . 0.0 110.998 -179.419 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 44' ' ' GLN . . . . . 0.518 ' HG3' ' CG ' ' A' ' 51' ' ' GLU . 39.4 tt0 -140.14 148.42 41.62 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.53 -0.731 . . . . 0.0 109.886 179.81 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.0 t -96.4 111.32 23.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.121 -0.987 . . . . 0.0 110.283 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 66.3 mt -71.19 -2.89 17.45 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 110.34 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.501 ' OG1' HG23 ' A' ' 48' ' ' THR . 31.3 p -85.53 -32.38 22.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.219 -0.926 . . . . 0.0 110.005 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' THR . . . . . 0.501 HG23 ' OG1' ' A' ' 47' ' ' THR . 23.6 p -120.82 -3.74 9.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 0.0 110.134 179.88 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.05 48.07 61.87 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.84 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.478 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 49.6 mt-30 -129.41 155.67 45.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -1.18 . . . . 0.0 110.428 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.518 ' CG ' ' HG3' ' A' ' 44' ' ' GLN . 95.4 mt-10 -119.56 160.77 21.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.337 -0.852 . . . . 0.0 109.844 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.506 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -178.32 -157.69 19.52 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -120.79 136.09 54.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.457 -1.025 . . . . 0.0 109.973 179.833 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.551 HG22 ' HE2' ' A' ' 25' ' ' PHE . 5.2 pt -130.91 149.71 74.49 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 110.417 -179.773 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.609 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 44.8 Cg_endo -78.13 143.2 19.98 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 124.023 1.538 . . . . 0.0 109.848 179.702 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.562 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 35.2 p90 -66.86 -8.95 32.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.241 -0.912 . . . . 0.0 110.962 -179.311 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -90.81 -26.13 19.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.911 -1.118 . . . . 0.0 110.939 -179.355 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.609 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 7.2 m-85 -84.18 6.67 21.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.005 -1.059 . . . . 0.0 110.215 -179.761 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.649 HG11 HG21 ' A' ' 9' ' ' VAL . 15.2 t -147.3 169.11 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.918 . . . . 0.0 110.136 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.625 ' O ' HG12 ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 110.374 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 8' ' ' LEU . . . . . 0.743 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.1 mp . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.175 0.512 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.849 HG21 HD11 ' A' ' 33' ' ' ILE . 25.3 m -140.69 164.34 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.265 -0.897 . . . . 0.0 110.29 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.5 mm -109.39 140.71 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.361 -0.837 . . . . 0.0 109.75 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 11' ' ' ALA . . . . . 0.499 ' HB1' ' CE1' ' A' ' 25' ' ' PHE . . . -80.0 107.25 12.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.178 -0.951 . . . . 0.0 110.311 -179.828 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 12' ' ' LEU . 7.6 mp -67.63 -23.19 65.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.097 -1.002 . . . . 0.0 109.173 179.366 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' HIS . . . . . 0.417 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 90.8 m-70 -153.33 146.45 24.64 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.621 -0.674 . . . . 0.0 109.576 179.75 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 55.4 p -63.01 147.28 51.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.044 -1.035 . . . . 0.0 109.8 179.917 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 38.6 t80 -99.08 161.32 13.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.141 -0.974 . . . . 0.0 110.398 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 16' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -118.96 85.17 28.23 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 0.0 110.148 179.92 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.539 ' CB ' ' HB2' ' A' ' 22' ' ' ASP . 47.4 Cg_endo -44.36 96.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.02 1.537 . . . . 0.0 110.546 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 16' ' ' GLU . 25.2 p -83.24 3.9 29.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.905 . . . . 0.0 109.955 179.783 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' HIS . . . . . 0.442 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 84.9 t60 -148.2 166.9 26.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.342 -0.849 . . . . 0.0 110.116 -179.92 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -75.81 130.72 39.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.201 -0.937 . . . . 0.0 110.139 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.45 15.36 21.35 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.539 ' HB2' ' CB ' ' A' ' 17' ' ' PRO . 27.8 m-20 -111.74 161.04 16.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -1.159 . . . . 0.0 110.439 -179.862 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.495 ' HA ' HD12 ' A' ' 23' ' ' LEU . 13.6 tp -116.2 120.03 37.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.283 -0.886 . . . . 0.0 109.801 179.927 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.51 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -97.78 50.51 1.38 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.792 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 30.2 p90 -48.71 172.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.227 -1.161 . . . . 0.0 111.19 -179.847 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.434 ' N ' ' OE1' ' A' ' 29' ' ' GLU . 81.0 mt-10 -102.78 173.46 6.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.565 -0.71 . . . . 0.0 110.078 179.635 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 pttm -70.11 136.8 50.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.134 -0.979 . . . . 0.0 110.159 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.77 -10.23 73.16 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' GLU . . . . . 0.465 ' OE1' ' HB2' ' A' ' 25' ' ' PHE . 67.2 tt0 -73.43 128.31 35.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.05 -1.264 . . . . 0.0 110.124 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 30' ' ' GLN . . . . . 0.834 ' O ' HD23 ' A' ' 31' ' ' LEU . 46.4 tt0 -79.61 141.46 36.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.93 . . . . 0.0 109.82 179.906 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.834 HD23 ' O ' ' A' ' 30' ' ' GLN . 17.4 mt -140.64 161.97 36.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.924 . . . . 0.0 110.515 -179.693 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.587 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 7.2 tpt180 -103.67 129.91 51.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.414 -0.804 . . . . 0.0 109.617 179.487 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.849 HD11 HG21 ' A' ' 9' ' ' VAL . 25.3 mm -93.67 94.26 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.179 -0.951 . . . . 0.0 110.458 -179.744 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.584 HD12 ' HA ' ' A' ' 43' ' ' ALA . 1.2 mt -79.92 -28.08 39.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -0.888 . . . . 0.0 110.775 -179.675 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.465 ' HB2' ' CB ' ' A' ' 42' ' ' LYS . 62.1 mt-10 -131.19 138.38 49.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.965 -1.084 . . . . 0.0 110.489 -179.83 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' GLN . . . . . 0.626 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 22.3 mt-30 -135.03 54.28 1.95 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 110.043 179.892 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.6 t -120.49 142.52 49.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 110.205 179.972 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.63 -169.88 54.96 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.889 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -76.6 -33.96 58.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -1.12 . . . . 0.0 110.146 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' TRP . . . . . 0.559 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 98.7 m95 -96.93 143.37 27.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 110.42 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 41' ' ' TRP . . . . . 0.626 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.5 m0 -120.1 156.19 31.5 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.284 -0.885 . . . . 0.0 110.238 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 53' ' ' PHE . 12.6 tttp -100.28 141.78 32.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.329 -0.857 . . . . 0.0 109.368 179.372 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.587 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -153.69 179.44 8.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.053 -1.029 . . . . 0.0 110.94 -179.612 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -142.01 150.61 41.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 109.876 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.551 ' OG ' HD22 ' A' ' 31' ' ' LEU . 13.3 m -99.02 121.97 41.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.118 -0.989 . . . . 0.0 110.356 -179.952 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 71.6 mt -79.2 5.04 13.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 110.179 179.888 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.52 -42.07 4.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.283 -0.885 . . . . 0.0 110.159 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.2 p -90.65 -27.41 19.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -0.898 . . . . 0.0 110.135 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.8 33.42 24.44 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -128.34 153.02 47.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.268 -1.136 . . . . 0.0 110.306 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.437 ' OE2' ' HE2' ' A' ' 42' ' ' LYS . 84.8 tt0 -120.43 142.57 49.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 110.231 179.85 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 52' ' ' GLY . . . . . 0.423 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -168.55 161.62 35.35 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.856 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 53' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 95.4 m-85 -71.72 146.92 47.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -1.101 . . . . 0.0 109.854 179.591 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 54' ' ' ILE . . . . . 0.736 HD12 HG21 ' A' ' 59' ' ' VAL . 1.1 pt -136.87 136.47 21.4 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.195 -0.941 . . . . 0.0 110.357 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.574 ' HD3' ' CD1' ' A' ' 15' ' ' TYR . 45.0 Cg_endo -58.7 147.66 86.68 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.048 1.551 . . . . 0.0 110.045 179.651 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.703 ' CZ ' ' ND2' ' A' ' 57' ' ' ASN . 19.1 p90 -82.89 -5.64 59.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 110.999 -179.419 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 57' ' ' ASN . . . . . 0.703 ' ND2' ' CZ ' ' A' ' 56' ' ' PHE . 28.8 m120 -89.54 -25.58 21.3 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.927 -1.108 . . . . 0.0 110.632 -179.642 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 58' ' ' PHE . . . . . 0.542 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 17.3 m-30 -93.55 2.22 56.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.064 -1.023 . . . . 0.0 110.268 179.968 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.736 HG21 HD12 ' A' ' 54' ' ' ILE . 34.1 m -137.2 143.38 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.215 -0.928 . . . . 0.0 110.12 179.763 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 60' ' ' ALA . . . . . 0.468 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.215 -0.928 . . . . 0.0 110.411 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.1 134.34 22.2 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.246 -1.15 . . . . 0.0 110.16 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -56.94 -19.72 33.36 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.008 1.531 . . . . 0.0 110.352 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.742 HD13 ' N ' ' A' ' 5' ' ' GLN . 3.0 tm? -95.09 129.06 42.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.892 . . . . 0.0 110.228 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.742 ' N ' HD13 ' A' ' 4' ' ' LEU . 63.5 tt0 -107.02 119.18 38.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 110.216 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 48.0 p30 -100.54 13.55 34.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.906 . . . . 0.0 110.227 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.453 ' O ' HG13 ' A' ' 33' ' ' ILE . 19.4 m120 -84.19 9.58 12.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 110.252 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.738 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.8 mp -92.33 150.07 21.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.194 -0.941 . . . . 0.0 110.198 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.684 HG11 HD11 ' A' ' 33' ' ' ILE . 18.2 m -147.67 168.9 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.2 -0.938 . . . . 0.0 110.309 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 81.8 mt -112.24 145.3 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.388 -0.82 . . . . 0.0 109.671 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . -77.56 114.94 16.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.077 -1.014 . . . . 0.0 110.367 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.483 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 37.6 tp -71.4 -26.9 62.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.104 -0.997 . . . . 0.0 109.386 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.483 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 25.8 m80 -158.22 149.41 20.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.469 -0.769 . . . . 0.0 109.7 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 44.2 p -61.97 141.44 58.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.026 -1.046 . . . . 0.0 110.092 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 77.1 t80 -102.76 165.05 11.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.079 -1.013 . . . . 0.0 110.408 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.579 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 35.8 mt-10 -113.52 129.64 24.46 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 110.228 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.485 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 49.9 Cg_endo -85.21 88.67 0.88 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.983 1.518 . . . . 0.0 110.509 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.0 m -79.59 -6.99 58.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.925 . . . . 0.0 110.084 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 -128.23 -155.35 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 110.007 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -112.36 -4.63 14.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 110.27 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.68 5.53 16.59 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -92.21 159.32 15.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -1.187 . . . . 0.0 110.232 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.492 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 35.5 tp -116.78 122.28 43.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.248 -0.908 . . . . 0.0 110.119 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.485 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -99.33 47.83 1.32 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.658 ' CD1' HD21 ' A' ' 31' ' ' LEU . 35.9 p90 -45.57 171.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -1.189 . . . . 0.0 110.834 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -98.71 176.85 5.49 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.415 -0.803 . . . . 0.0 110.446 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -71.8 122.95 21.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.262 -0.899 . . . . 0.0 110.239 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 92.96 -8.85 76.05 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.453 ' N ' ' HB3' ' A' ' 11' ' ' ALA . 27.3 tt0 -61.3 137.27 58.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.137 -1.214 . . . . 0.0 110.112 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.798 ' C ' HD12 ' A' ' 31' ' ' LEU . 87.8 mt-30 -79.63 126.85 31.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 0.0 109.965 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.798 HD12 ' C ' ' A' ' 30' ' ' GLN . 10.3 mp -126.36 145.45 50.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.919 . . . . 0.0 110.468 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.557 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 25.3 ttt180 -103.23 139.71 38.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.828 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.684 HD11 HG11 ' A' ' 9' ' ' VAL . 11.8 mt -87.45 130.14 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.14 -0.975 . . . . 0.0 110.263 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.58 HD11 ' HB2' ' A' ' 44' ' ' GLN . 60.6 mt -117.43 -30.44 5.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 110.193 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 42' ' ' LYS . 83.0 tt0 -139.15 149.65 44.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -0.907 . . . . 0.0 110.232 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.588 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 96.9 mt-30 -139.54 58.79 1.61 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 110.212 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.5 t -123.93 130.31 52.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 0.0 110.246 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.86 -162.8 33.0 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -82.79 -32.33 27.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -1.136 . . . . 0.0 110.075 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.549 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 92.1 m95 -98.03 146.08 25.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.922 . . . . 0.0 110.134 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.588 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 49.3 m0 -120.9 154.95 35.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.297 -0.877 . . . . 0.0 110.302 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 35' ' ' GLU . 79.1 tttt -93.48 143.56 26.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.919 . . . . 0.0 109.798 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.557 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -152.14 175.17 12.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.135 -0.978 . . . . 0.0 110.632 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.58 ' HB2' HD11 ' A' ' 34' ' ' LEU . 39.4 tt0 -139.22 147.49 41.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.43 -0.794 . . . . 0.0 109.884 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.481 ' HB2' ' OG1' ' A' ' 48' ' ' THR . 21.6 m -79.79 145.79 32.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.088 -1.007 . . . . 0.0 110.222 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.635 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.9 mp -94.73 -11.89 28.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.311 -0.868 . . . . 0.0 109.855 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.2 p -105.43 -30.09 9.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.405 -0.809 . . . . 0.0 110.435 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.481 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 17.6 p -99.84 -17.82 17.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.1 -1.0 . . . . 0.0 110.451 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.88 48.79 63.26 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.487 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 38.3 mt-30 -132.76 157.34 45.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.358 -1.084 . . . . 0.0 110.115 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.457 ' HG2' ' HG3' ' A' ' 44' ' ' GLN . 94.3 mt-10 -119.6 141.69 49.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.925 . . . . 0.0 110.097 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.492 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -166.29 159.16 32.38 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -70.24 142.73 52.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.243 -1.151 . . . . 0.0 110.045 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.872 ' CD1' HG21 ' A' ' 59' ' ' VAL . 1.8 pp -137.65 131.1 17.03 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 110.158 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.586 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 46.0 Cg_endo -55.94 160.9 9.26 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.03 1.542 . . . . 0.0 110.07 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -88.45 -2.36 58.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 110.911 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 -100.09 -25.83 14.16 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.987 -1.071 . . . . 0.0 111.054 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.569 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 26.5 m-85 -80.24 -11.93 59.68 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.017 -1.052 . . . . 0.0 110.446 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.872 HG21 ' CD1' ' A' ' 54' ' ' ILE . 26.9 m -132.22 145.55 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.95 . . . . 0.0 110.24 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.38 161.07 33.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 110.286 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.533 ' HA ' HG12 ' A' ' 9' ' ' VAL . 86.6 tttt -69.26 132.0 45.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 110.214 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.79 150.61 32.06 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 110.235 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.191 -179.979 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.6 t -124.84 69.82 57.55 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.227 -1.161 . . . . 0.0 110.146 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -58.77 138.14 84.01 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.011 1.532 . . . . 0.0 110.33 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.405 ' HA ' HD12 ' A' ' 4' ' ' LEU . 45.0 tp -56.85 -32.04 65.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.266 -0.896 . . . . 0.0 110.084 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -102.23 105.3 15.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 110.19 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -146.73 84.29 1.61 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.279 -0.888 . . . . 0.0 110.151 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.59 ' HB3' HD12 ' A' ' 33' ' ' ILE . 85.3 m-20 -100.0 105.0 16.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.308 -0.87 . . . . 0.0 110.377 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.685 ' CD1' HD11 ' A' ' 46' ' ' LEU . 21.1 tp -113.98 143.58 44.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.886 . . . . 0.0 109.957 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.839 HG11 HD11 ' A' ' 33' ' ' ILE . 31.2 m -145.63 167.84 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 110.378 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 86.1 mt -112.6 148.99 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.395 -0.816 . . . . 0.0 109.702 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . -80.17 113.39 18.31 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.128 -0.983 . . . . 0.0 110.443 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.642 HD13 ' O ' ' A' ' 12' ' ' LEU . 0.2 OUTLIER -70.74 -25.31 62.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.115 -0.991 . . . . 0.0 109.091 179.202 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.51 ' CD2' ' O ' ' A' ' 12' ' ' LEU . 14.0 m170 -159.13 151.05 20.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.703 -0.623 . . . . 0.0 109.481 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 41.6 p -63.38 140.83 58.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.907 -1.121 . . . . 0.0 109.883 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 65.5 t80 -100.89 162.81 12.64 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.063 -1.023 . . . . 0.0 110.255 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.571 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 29.8 tt0 -118.12 128.31 26.06 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.24 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.477 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 46.9 Cg_endo -82.17 84.6 1.82 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.111 1.585 . . . . 0.0 110.55 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 86.1 p -79.78 -3.94 49.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.932 . . . . 0.0 109.974 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.451 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 37.7 m80 -139.85 151.21 45.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 0.0 110.136 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -65.35 125.47 25.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 110.117 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.59 11.43 28.88 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.451 ' OD2' ' HB2' ' A' ' 19' ' ' HIS . 11.4 m-20 -105.94 160.08 15.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.151 -1.205 . . . . 0.0 110.308 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.507 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 20.5 tp -116.4 122.99 46.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.338 -0.851 . . . . 0.0 110.18 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.477 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -104.39 51.28 0.81 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 33.0 p90 -45.32 172.19 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.197 -1.178 . . . . 0.0 110.9 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -99.26 176.0 5.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.405 -0.809 . . . . 0.0 110.554 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.9 tttm -71.18 124.88 25.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.364 -0.835 . . . . 0.0 110.28 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 90.39 -8.62 79.5 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.491 ' OE2' HD21 ' A' ' 31' ' ' LEU . 27.0 tt0 -62.39 132.45 52.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.103 -1.234 . . . . 0.0 110.365 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.524 ' O ' HD23 ' A' ' 31' ' ' LEU . 90.6 mt-30 -79.87 130.59 35.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 109.842 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.524 HD23 ' O ' ' A' ' 30' ' ' GLN . 17.6 mt -130.67 150.43 51.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.934 . . . . 0.0 110.501 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.865 ' HB2' HD21 ' A' ' 46' ' ' LEU . 40.3 ttt180 -100.82 135.77 41.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.434 -0.791 . . . . 0.0 109.75 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.839 HD11 HG11 ' A' ' 9' ' ' VAL . 11.2 mt -83.37 127.87 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 110.317 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.035 HD11 ' HB2' ' A' ' 44' ' ' GLN . 75.1 mt -107.13 -30.98 8.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.284 -0.885 . . . . 0.0 110.215 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -143.39 153.42 42.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 0.0 110.197 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.493 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 20.9 mt-30 -138.58 54.21 1.77 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 110.242 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 75.3 m -121.81 134.48 54.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.908 . . . . 0.0 110.101 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.68 -172.11 47.98 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -74.45 -34.26 63.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -1.144 . . . . 0.0 110.178 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.402 ' HZ3' ' CE1' ' A' ' 15' ' ' TYR . 72.6 m95 -97.17 145.78 25.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -0.921 . . . . 0.0 110.08 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.493 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 52.1 m0 -120.69 153.81 36.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.256 -0.903 . . . . 0.0 110.056 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -90.07 144.5 25.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -0.953 . . . . 0.0 109.749 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 32' ' ' ARG . . . -148.54 170.41 18.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.086 -1.009 . . . . 0.0 110.611 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 1.035 ' HB2' HD11 ' A' ' 34' ' ' LEU . 51.9 tt0 -137.89 146.11 42.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.371 -0.831 . . . . 0.0 109.827 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.7 m -76.77 142.08 40.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.097 -1.002 . . . . 0.0 110.376 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.865 HD21 ' HB2' ' A' ' 32' ' ' ARG . 36.3 mt -88.66 -18.48 27.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.35 -0.844 . . . . 0.0 109.848 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.5 p -106.41 -30.06 9.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -0.862 . . . . 0.0 110.37 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.0 m -92.07 -24.31 19.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.064 -1.022 . . . . 0.0 110.421 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.78 46.29 54.17 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 59.1 mt-30 -134.28 158.75 42.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -1.121 . . . . 0.0 110.204 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.431 ' HG2' ' HB2' ' A' ' 44' ' ' GLN . 92.4 mt-10 -121.02 143.71 48.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.35 -0.844 . . . . 0.0 110.148 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -163.65 157.27 29.43 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -69.4 141.92 54.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -1.156 . . . . 0.0 109.926 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.577 HD12 HG21 ' A' ' 59' ' ' VAL . 1.3 pt -135.84 145.71 53.98 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 110.066 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.602 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 45.5 Cg_endo -72.45 162.62 40.94 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.987 1.519 . . . . 0.0 110.065 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.445 ' CE2' ' OD1' ' A' ' 57' ' ' ASN . 31.7 p90 -88.07 -3.98 58.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.959 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.445 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 60.3 m-20 -98.5 -26.57 14.39 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.899 -1.126 . . . . 0.0 111.062 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.602 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 34.2 m-85 -81.52 -10.85 59.38 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.939 -1.1 . . . . 0.0 110.326 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.577 HG21 HD12 ' A' ' 54' ' ' ILE . 25.3 m -131.05 142.66 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 110.273 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.51 161.59 32.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.193 -0.942 . . . . 0.0 110.122 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.463 ' HA ' HG12 ' A' ' 9' ' ' VAL . 42.2 mttp -76.95 127.44 32.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.901 . . . . 0.0 110.249 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.85 -36.42 84.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.303 -0.873 . . . . 0.0 110.146 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.407 ' OD1' ' C ' ' A' ' 63' ' ' ASN . 41.8 p-10 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.17 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.2 m -65.06 145.31 99.12 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.197 -1.178 . . . . 0.0 110.236 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -58.41 -16.78 30.59 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.981 1.516 . . . . 0.0 110.387 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.452 ' O ' ' OD1' ' A' ' 7' ' ' ASN . 2.6 mp -70.05 -34.59 73.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 110.255 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.5 ' HA ' ' CD1' ' A' ' 8' ' ' LEU . 97.1 mt-30 -65.24 -11.29 39.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 110.374 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -71.92 -30.14 65.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.251 -0.906 . . . . 0.0 110.21 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.517 ' O ' ' CG1' ' A' ' 33' ' ' ILE . 19.3 p-10 -79.81 7.11 9.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.248 -0.907 . . . . 0.0 110.35 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.5 ' CD1' ' HA ' ' A' ' 5' ' ' GLN . 91.7 mt -81.84 142.66 32.34 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.212 -0.93 . . . . 0.0 109.98 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 61' ' ' LYS . 22.9 m -145.82 167.6 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.127 -0.983 . . . . 0.0 110.539 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 64.5 mt -111.05 149.45 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.377 -0.827 . . . . 0.0 109.621 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.542 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . -80.14 112.83 17.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.031 -1.043 . . . . 0.0 110.339 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.455 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 82.9 mt -69.58 -25.96 64.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.102 -0.999 . . . . 0.0 109.191 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.455 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 72.2 m80 -155.37 152.39 29.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.576 -0.702 . . . . 0.0 109.501 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 26.9 p -64.28 142.15 58.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.898 -1.126 . . . . 0.0 109.92 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 73.9 t80 -102.67 165.05 11.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.012 -1.055 . . . . 0.0 110.167 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.57 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 1.9 tp10 -119.5 132.84 23.86 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.285 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.484 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 49.2 Cg_endo -84.48 84.0 1.56 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.961 1.506 . . . . 0.0 110.299 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 83.3 p -79.59 -3.18 45.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.939 . . . . 0.0 110.051 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.457 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 51.5 m80 -144.86 165.95 26.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 110.039 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -76.87 126.21 30.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.911 . . . . 0.0 110.156 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.17 -1.9 35.19 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.457 ' OD2' ' HB2' ' A' ' 19' ' ' HIS . 17.2 m-20 -93.96 157.64 16.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.27 -1.135 . . . . 0.0 110.259 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.502 HD13 ' HG2' ' A' ' 50' ' ' GLN . 25.5 tp -115.6 120.91 40.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.296 -0.877 . . . . 0.0 109.988 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.484 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -100.62 51.47 0.99 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.586 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 40.7 p90 -48.46 172.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.192 -1.181 . . . . 0.0 110.995 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.4 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 68.8 mm-40 -100.82 174.99 5.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.507 -0.745 . . . . 0.0 110.189 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.4 pttm -71.39 131.62 43.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.137 -0.977 . . . . 0.0 110.102 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.48 -10.16 72.78 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.442 ' CD ' ' HB2' ' A' ' 25' ' ' PHE . 33.0 tt0 -64.5 132.88 51.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -1.168 . . . . 0.0 110.245 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.875 ' C ' HD12 ' A' ' 31' ' ' LEU . 95.1 mt-30 -79.68 131.47 35.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.784 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.875 HD12 ' C ' ' A' ' 30' ' ' GLN . 9.4 mp -129.84 148.58 51.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.92 . . . . 0.0 110.562 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.617 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 24.7 ttt180 -103.13 134.72 46.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.448 -0.782 . . . . 0.0 109.534 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.517 ' CG1' ' O ' ' A' ' 7' ' ' ASN . 21.9 mm -83.82 131.53 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.143 -0.973 . . . . 0.0 110.194 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.1 mt -115.57 -32.9 5.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.331 -0.855 . . . . 0.0 110.178 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 87.1 mt-10 -132.06 153.95 49.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 110.21 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.627 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 97.9 mt-30 -139.97 55.61 1.64 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.86 . . . . 0.0 110.204 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 99.1 p -125.24 126.8 45.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 110.287 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.61 174.8 49.43 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -63.34 -28.91 70.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -1.197 . . . . 0.0 110.208 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.555 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 97.3 m95 -97.54 145.26 26.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 110.226 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.627 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 35.9 m0 -124.7 157.0 36.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.289 -0.882 . . . . 0.0 110.1 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 35' ' ' GLU . 34.0 tttt -96.26 145.33 25.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.689 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.617 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -158.24 -177.71 6.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 110.56 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -145.52 153.85 41.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.424 -0.798 . . . . 0.0 109.982 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.8 t -98.89 126.02 44.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.115 -0.991 . . . . 0.0 110.17 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.1 mt -80.7 9.27 6.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.904 . . . . 0.0 110.312 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.504 HG22 HG23 ' A' ' 48' ' ' THR . 31.8 m -92.79 -35.59 13.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.175 -0.953 . . . . 0.0 110.194 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.504 HG23 HG22 ' A' ' 47' ' ' THR . 49.2 p -132.69 -0.98 3.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.389 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.32 30.85 56.26 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.502 ' HG2' HD13 ' A' ' 23' ' ' LEU . 54.7 tt0 -91.27 131.79 36.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -1.116 . . . . 0.0 110.135 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -117.22 136.24 53.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 0.0 110.082 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -171.88 166.18 39.06 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 91.5 m-85 -70.44 146.41 50.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -1.131 . . . . 0.0 110.113 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.682 HD13 HG11 ' A' ' 59' ' ' VAL . 2.2 pp -139.23 131.59 15.37 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.235 -0.916 . . . . 0.0 110.147 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.653 ' O ' HD12 ' A' ' 54' ' ' ILE . 47.3 Cg_endo -55.68 158.49 13.3 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.972 1.511 . . . . 0.0 110.102 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.572 ' CE2' ' OD1' ' A' ' 57' ' ' ASN . 18.8 p90 -87.41 -0.42 56.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 0.0 110.771 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.572 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 89.9 m-20 -99.65 -26.42 14.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.958 -1.089 . . . . 0.0 110.855 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.479 ' HB2' ' HG2' ' A' ' 55' ' ' PRO . 10.8 m-85 -83.47 -3.0 57.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.004 -1.06 . . . . 0.0 110.391 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.682 HG11 HD13 ' A' ' 54' ' ' ILE . 26.9 m -130.6 143.52 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 0.0 110.328 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.457 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . -127.8 156.41 42.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 110.149 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.47 ' HA ' HG12 ' A' ' 9' ' ' VAL . 17.6 mttp -76.24 132.89 40.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 110.23 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.437 ' O ' ' OD1' ' A' ' 63' ' ' ASN . . . -58.98 154.09 16.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.23 -0.919 . . . . 0.0 110.183 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 62' ' ' ALA . 78.3 m-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.262 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.39 154.61 69.24 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.218 -1.166 . . . . 0.0 110.216 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -46.06 144.79 5.86 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.996 1.524 . . . . 0.0 110.33 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 46.9 tp -104.87 125.45 50.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.915 . . . . 0.0 110.303 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.454 ' O ' ' NE ' ' A' ' 32' ' ' ARG . 94.7 mm-40 -111.54 155.86 22.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.18 -0.95 . . . . 0.0 110.115 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -112.42 23.37 13.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 0.0 110.273 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.473 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 73.0 m-20 -86.06 112.62 21.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.917 . . . . 0.0 110.367 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.617 ' CD1' HD11 ' A' ' 46' ' ' LEU . 19.7 tp -110.67 148.9 31.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 110.041 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.836 HG21 HD11 ' A' ' 33' ' ' ILE . 33.0 m -145.84 167.98 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.129 -0.982 . . . . 0.0 110.415 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.3 mt -113.44 149.9 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.366 -0.834 . . . . 0.0 109.596 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.487 ' HB3' ' N ' ' A' ' 29' ' ' GLU . . . -80.38 114.52 19.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.169 -0.957 . . . . 0.0 110.679 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.458 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 16.8 tp -78.95 -19.74 50.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 109.256 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.458 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 39.8 m-70 -159.98 142.05 13.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.566 -0.709 . . . . 0.0 109.511 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.0 p -60.56 139.73 57.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.818 -1.176 . . . . 0.0 110.101 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.612 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 81.6 t80 -99.93 161.97 13.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.124 -0.985 . . . . 0.0 110.296 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.46 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 2.1 mp0 -117.46 129.03 25.62 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.322 -0.861 . . . . 0.0 110.12 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.468 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.2 Cg_endo -83.06 83.77 1.87 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.081 1.569 . . . . 0.0 110.381 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.563 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 56.8 p -79.8 -3.88 49.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 110.121 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.563 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 89.4 m-70 -141.61 168.49 19.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 0.0 110.264 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -82.01 125.12 30.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.27 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.15 18.36 11.4 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -114.97 161.03 18.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.259 -1.142 . . . . 0.0 110.127 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.498 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 17.6 tp -115.76 120.77 40.39 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 110.28 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.468 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -101.72 54.63 0.77 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.629 ' CG ' HD11 ' A' ' 31' ' ' LEU . 44.0 p90 -50.26 171.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.31 -1.112 . . . . 0.0 110.908 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -100.39 178.33 4.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 110.488 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -71.86 123.07 21.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -0.88 . . . . 0.0 110.246 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 91.76 -10.09 75.38 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.488 ' OE1' ' HA ' ' A' ' 25' ' ' PHE . 16.6 tt0 -61.65 131.93 51.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -1.17 . . . . 0.0 110.135 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.557 ' O ' HD23 ' A' ' 31' ' ' LEU . 96.3 mt-30 -79.98 130.81 35.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.305 -0.872 . . . . 0.0 110.192 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.629 HD11 ' CG ' ' A' ' 25' ' ' PHE . 32.3 mt -126.76 145.65 50.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -0.954 . . . . 0.0 110.459 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.928 ' HB2' HD21 ' A' ' 46' ' ' LEU . 5.4 tpt180 -93.72 137.74 32.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.366 -0.834 . . . . 0.0 109.531 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.836 HD11 HG21 ' A' ' 9' ' ' VAL . 18.7 mm -90.99 129.13 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.131 -0.981 . . . . 0.0 110.287 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.992 HD11 ' HB2' ' A' ' 44' ' ' GLN . 49.9 mt -112.94 -26.4 8.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.902 . . . . 0.0 110.068 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 75.3 mt-10 -150.45 156.33 41.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 110.147 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.612 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 26.6 mt-30 -142.09 58.6 1.47 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 110.238 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -119.0 140.36 50.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.254 -0.904 . . . . 0.0 110.156 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.8 -168.3 53.47 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -76.37 -34.43 58.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -1.162 . . . . 0.0 110.128 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.554 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 96.8 m95 -96.25 143.75 27.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 110.251 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.612 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.9 m0 -116.53 152.29 34.39 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -0.897 . . . . 0.0 110.261 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 35' ' ' GLU . 18.1 tttt -89.95 141.43 28.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.254 -0.904 . . . . 0.0 109.987 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.531 ' CB ' HG12 ' A' ' 54' ' ' ILE . . . -147.87 170.22 18.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.16 -0.963 . . . . 0.0 110.428 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.992 ' HB2' HD11 ' A' ' 34' ' ' LEU . 59.2 tt0 -130.48 136.31 48.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 110.037 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.447 ' OG ' HD21 ' A' ' 23' ' ' LEU . 66.1 m -68.45 138.02 54.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.127 -0.983 . . . . 0.0 110.242 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.928 HD21 ' HB2' ' A' ' 32' ' ' ARG . 54.2 mt -87.65 -12.52 45.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.094 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.9 p -101.34 -28.42 12.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.863 . . . . 0.0 110.285 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 46.2 p -113.37 -3.6 13.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.169 -0.957 . . . . 0.0 110.366 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 58.67 14.15 20.75 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -86.93 157.19 19.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.122 -1.222 . . . . 0.0 110.39 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 94.9 mt-10 -117.4 138.68 51.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.355 -0.84 . . . . 0.0 109.972 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.498 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -161.07 156.7 28.14 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -68.68 144.5 54.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.247 -1.149 . . . . 0.0 109.899 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.73 HD12 HG21 ' A' ' 59' ' ' VAL . 1.1 pt -137.37 123.43 13.18 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.142 -0.974 . . . . 0.0 110.38 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.608 ' HG3' ' CD2' ' A' ' 58' ' ' PHE . 43.5 Cg_endo -47.16 159.35 0.39 Allowed 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.963 1.507 . . . . 0.0 110.068 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -96.48 0.78 50.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 110.736 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -100.18 -26.73 13.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.027 -1.046 . . . . 0.0 110.694 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.608 ' CD2' ' HG3' ' A' ' 55' ' ' PRO . 7.9 m-30 -89.19 -8.18 54.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.143 -0.973 . . . . 0.0 110.494 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.73 HG21 HD12 ' A' ' 54' ' ' ILE . 26.9 m -125.02 143.42 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.087 -1.008 . . . . 0.0 110.187 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.458 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . -134.48 164.74 26.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.224 -0.922 . . . . 0.0 110.211 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.493 ' HA ' HG12 ' A' ' 9' ' ' VAL . 17.2 tptm -76.38 136.39 39.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.273 -0.892 . . . . 0.0 110.188 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.46 147.58 47.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.328 -0.857 . . . . 0.0 110.155 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 40.5 p-10 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.176 -179.98 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 m -124.67 75.89 64.24 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.25 -1.147 . . . . 0.0 110.168 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -57.65 -28.87 83.33 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.977 1.514 . . . . 0.0 110.321 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 39.9 mt -97.97 140.33 32.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.277 -0.89 . . . . 0.0 110.251 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.501 ' O ' HD13 ' A' ' 8' ' ' LEU . 90.0 mt-30 -117.78 156.32 28.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.349 -0.844 . . . . 0.0 110.191 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -100.68 14.35 31.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.206 -0.934 . . . . 0.0 110.197 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.453 ' O ' HG13 ' A' ' 33' ' ' ILE . 22.5 m120 -88.03 7.33 31.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 110.28 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.77 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.2 mp -94.1 150.63 20.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.897 . . . . 0.0 110.147 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.634 HG12 ' HA ' ' A' ' 61' ' ' LYS . 9.4 m -157.62 174.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.286 -0.884 . . . . 0.0 110.328 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 80.0 mt -115.75 141.88 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.392 -0.818 . . . . 0.0 109.721 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.713 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -80.17 116.69 20.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 0.0 110.427 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.47 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 10.1 tp -70.06 -23.13 63.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.113 -0.992 . . . . 0.0 109.284 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.47 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 30.0 m80 -158.28 147.73 19.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.537 -0.727 . . . . 0.0 109.568 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 55.9 p -60.87 144.34 53.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.943 -1.098 . . . . 0.0 109.919 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 89.4 t80 -101.45 163.39 12.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.001 -1.062 . . . . 0.0 110.579 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.411 ' N ' ' CG ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -110.62 113.58 55.57 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.317 -0.864 . . . . 0.0 109.891 179.678 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.492 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 51.0 Cg_endo -74.36 96.85 0.99 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.066 1.561 . . . . 0.0 110.514 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.3 p -79.65 -1.54 38.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 110.103 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -133.49 -178.91 5.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 110.118 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -93.23 -2.26 55.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.285 -0.884 . . . . 0.0 110.194 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.474 ' O ' ' CD2' ' A' ' 53' ' ' PHE . . . -115.11 5.98 21.78 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 4.1 m-20 -98.77 167.81 10.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.241 -1.152 . . . . 0.0 110.346 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.507 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 31.0 tp -123.44 127.45 48.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.281 -0.887 . . . . 0.0 110.15 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.492 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -104.22 54.87 0.63 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.713 ' CE2' ' HB1' ' A' ' 11' ' ' ALA . 40.3 p90 -44.78 169.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -1.124 . . . . 0.0 110.922 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.451 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 95.6 mt-10 -98.6 176.92 5.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.448 -0.783 . . . . 0.0 110.225 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -70.84 127.09 31.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.167 -0.958 . . . . 0.0 110.225 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.98 -7.66 81.65 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.559 ' OE2' HD11 ' A' ' 31' ' ' LEU . 19.0 tt0 -66.12 131.93 47.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.132 -1.216 . . . . 0.0 110.238 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.854 ' O ' HD12 ' A' ' 31' ' ' LEU . 98.1 mt-30 -79.54 133.42 36.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.259 -0.901 . . . . 0.0 109.903 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.854 HD12 ' O ' ' A' ' 30' ' ' GLN . 8.4 mp -132.19 152.17 51.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.254 -0.904 . . . . 0.0 110.483 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.655 HH22 HD11 ' A' ' 8' ' ' LEU . 26.1 ttm-85 -102.21 134.01 46.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.431 -0.793 . . . . 0.0 109.837 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.497 HD11 HG11 ' A' ' 9' ' ' VAL . 12.3 mt -88.46 137.18 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.921 . . . . 0.0 110.101 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.969 HD12 ' HA ' ' A' ' 43' ' ' ALA . 1.3 mt -122.6 -29.25 4.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 110.095 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.47 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 73.9 mm-40 -135.3 147.67 49.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.182 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.615 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 95.3 mt-30 -137.95 56.63 1.74 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.898 . . . . 0.0 110.198 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.8 p -120.73 130.3 54.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 110.237 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.81 -164.8 41.39 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -81.16 -31.32 34.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.241 -1.152 . . . . 0.0 110.197 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.561 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 98.5 m95 -96.07 144.41 26.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 110.223 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.615 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 48.8 m0 -123.21 156.52 34.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 110.335 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 35' ' ' GLU . 36.1 tttt -95.16 143.04 26.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 109.735 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.969 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -157.61 -178.77 7.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.942 . . . . 0.0 110.444 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.684 ' OE1' HD21 ' A' ' 34' ' ' LEU . 17.3 pt20 -151.46 159.68 44.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.399 -0.813 . . . . 0.0 110.104 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.1 t -97.37 115.61 28.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.206 -0.934 . . . . 0.0 110.14 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.6 mt -73.26 -1.2 16.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.271 -0.893 . . . . 0.0 110.356 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.5 m -92.81 -28.57 16.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 110.059 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.8 p -116.86 -10.3 11.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.898 . . . . 0.0 110.088 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.02 41.86 53.45 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 44' ' ' GLN . 37.8 mt-30 -124.07 151.83 43.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -1.167 . . . . 0.0 110.231 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 43.7 mt-10 -122.92 147.09 46.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 110.067 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -162.39 -146.27 4.62 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.474 ' CD2' ' O ' ' A' ' 21' ' ' GLY . 81.0 m-85 -128.44 142.62 51.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -1.092 . . . . 0.0 110.129 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.771 ' CD1' HG21 ' A' ' 59' ' ' VAL . 2.0 pp -138.23 145.06 45.71 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.266 -0.897 . . . . 0.0 110.251 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.596 ' HD3' ' CD1' ' A' ' 15' ' ' TYR . 45.4 Cg_endo -70.37 156.35 61.93 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.953 1.502 . . . . 0.0 110.037 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.591 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 27.4 p90 -78.51 -3.21 42.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.271 -0.893 . . . . 0.0 111.01 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -99.92 -25.74 14.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.985 -1.072 . . . . 0.0 111.197 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.593 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 9.8 m-85 -82.17 -5.16 58.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.954 -1.091 . . . . 0.0 110.467 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.771 HG21 ' CD1' ' A' ' 54' ' ' ILE . 27.6 m -134.47 145.54 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.123 -0.986 . . . . 0.0 110.187 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 9' ' ' VAL . . . -125.51 148.09 49.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.237 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.634 ' HA ' HG12 ' A' ' 9' ' ' VAL . 66.8 mttm -67.18 121.57 15.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 110.223 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.38 138.34 13.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.871 . . . . 0.0 110.232 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.213 179.934 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 m -124.74 81.68 60.88 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.274 -1.133 . . . . 0.0 110.214 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -56.77 144.62 86.56 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.0 1.526 . . . . 0.0 110.343 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 63.9 mt -101.4 142.25 33.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.296 -0.878 . . . . 0.0 110.22 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -67.32 -16.53 64.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.932 . . . . 0.0 110.226 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 47.41 44.92 16.9 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.913 . . . . 0.0 110.165 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -81.19 0.66 35.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.289 -0.882 . . . . 0.0 110.151 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.735 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.7 mp -79.67 142.3 35.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 110.239 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.569 HG13 ' C ' ' A' ' 8' ' ' LEU . 34.4 m -155.03 172.55 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.319 -0.863 . . . . 0.0 110.157 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.452 HD13 ' O ' ' A' ' 9' ' ' VAL . 19.0 mm -114.36 154.66 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.915 . . . . 0.0 109.778 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.528 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -79.72 109.86 14.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.1 -1.0 . . . . 0.0 110.226 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 20.2 tp -70.61 -20.85 62.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.003 -1.061 . . . . 0.0 109.339 179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 96.7 m-70 -150.88 -164.08 1.93 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.525 -0.734 . . . . 0.0 109.863 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 20.7 t -111.6 138.94 47.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.155 -0.966 . . . . 0.0 110.077 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.604 ' CD2' ' HD3' ' A' ' 55' ' ' PRO . 53.2 t80 -103.19 164.16 11.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.064 -1.022 . . . . 0.0 110.128 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.565 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 74.7 mm-40 -120.69 125.37 27.15 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.226 -0.921 . . . . 0.0 110.209 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.483 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.9 Cg_endo -74.91 81.94 2.09 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.985 1.519 . . . . 0.0 110.33 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.643 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 83.4 p -79.62 -1.8 39.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.141 -0.975 . . . . 0.0 110.187 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.643 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 90.1 m-70 -147.62 143.97 28.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 110.167 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -54.83 128.49 33.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.176 -0.952 . . . . 0.0 110.335 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.401 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . 104.94 -13.28 49.55 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -82.95 158.21 22.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -1.139 . . . . 0.0 110.328 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.543 ' O ' ' CD1' ' A' ' 15' ' ' TYR . 15.8 tp -119.82 125.99 49.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.353 -0.842 . . . . 0.0 110.073 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.483 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -105.21 55.89 0.55 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.528 ' CD1' ' HB1' ' A' ' 11' ' ' ALA . 40.4 p90 -50.14 173.53 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.088 -1.242 . . . . 0.0 110.942 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -111.78 -177.44 3.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.475 -0.765 . . . . 0.0 110.027 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -67.96 129.57 40.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.15 -0.969 . . . . 0.0 110.328 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.1 -17.93 57.24 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.457 ' HG2' HD21 ' A' ' 31' ' ' LEU . 8.6 tt0 -55.43 122.71 11.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.179 -1.189 . . . . 0.0 110.382 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.411 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 29.5 tt0 -79.97 131.42 35.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 109.901 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.519 HD11 ' CG ' ' A' ' 25' ' ' PHE . 38.7 mt -137.19 158.72 43.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.953 . . . . 0.0 110.316 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.696 ' HD3' HD21 ' A' ' 34' ' ' LEU . 17.8 ttt180 -108.14 135.75 48.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 0.0 109.867 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.4 mt -91.75 92.03 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.175 -0.953 . . . . 0.0 110.325 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.696 HD21 ' HD3' ' A' ' 32' ' ' ARG . 81.1 mt -78.91 -27.79 43.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.267 -0.896 . . . . 0.0 110.554 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.54 ' HB2' ' CB ' ' A' ' 42' ' ' LYS . 95.7 mt-10 -131.33 136.11 47.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.145 -0.972 . . . . 0.0 110.16 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.629 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 19.0 pt20 -133.79 55.41 1.9 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 110.185 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.0 t -117.13 142.78 46.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.181 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.09 -165.61 54.77 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -79.61 -33.53 41.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -1.113 . . . . 0.0 110.086 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 52.1 m95 -95.71 144.12 26.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.305 -0.872 . . . . 0.0 110.113 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.629 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 47.4 m0 -124.5 155.62 38.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 110.419 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.54 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 22.9 tttt -98.99 146.31 26.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.331 -0.856 . . . . 0.0 109.317 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -148.79 175.27 11.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.988 -1.07 . . . . 0.0 110.821 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 46.9 tt0 -138.81 147.51 42.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.416 -0.802 . . . . 0.0 109.837 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.47 ' OG ' HD21 ' A' ' 23' ' ' LEU . 42.5 m -95.97 117.23 30.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.115 -0.991 . . . . 0.0 110.075 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 76.6 mt -75.22 1.61 13.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 0.0 110.315 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 65.9 p -99.57 -33.2 10.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.925 . . . . 0.0 109.977 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.7 p -110.32 -15.23 14.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.891 . . . . 0.0 110.063 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.13 40.6 50.09 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -127.51 154.39 45.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -1.164 . . . . 0.0 110.335 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 64.6 tt0 -120.2 143.89 48.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.266 -0.896 . . . . 0.0 109.919 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.522 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -153.41 -153.94 6.56 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -119.98 132.45 55.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.492 -1.005 . . . . 0.0 109.915 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.499 HD12 HG21 ' A' ' 59' ' ' VAL . 11.3 pt -125.77 145.25 51.03 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.167 -0.958 . . . . 0.0 110.439 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.609 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 45.8 Cg_endo -78.97 151.51 24.13 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.987 1.52 . . . . 0.0 109.833 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.589 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 33.3 p90 -71.05 -4.8 26.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.235 -0.916 . . . . 0.0 111.034 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.49 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 65.8 m-20 -98.1 -25.99 14.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.88 -1.138 . . . . 0.0 111.274 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.609 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 8.5 m-85 -85.16 -4.03 59.01 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.859 -1.151 . . . . 0.0 110.36 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.499 HG21 HD12 ' A' ' 54' ' ' ILE . 36.0 m -132.21 139.74 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -0.937 . . . . 0.0 110.106 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -130.44 148.22 52.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 110.384 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -52.28 128.6 25.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.307 -0.871 . . . . 0.0 110.166 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.1 139.86 58.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 0.0 110.222 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.212 179.993 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.26 163.47 45.93 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.226 -1.161 . . . . 0.0 110.187 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -58.9 142.15 98.84 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.969 1.51 . . . . 0.0 110.359 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 58.7 mt -90.99 148.45 22.4 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.25 -0.907 . . . . 0.0 110.273 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -64.18 -39.36 93.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -0.93 . . . . 0.0 110.197 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -77.23 52.55 0.92 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 110.241 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.407 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 55.2 m-20 -86.96 90.27 8.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.314 -0.866 . . . . 0.0 110.214 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.428 ' O ' HG13 ' A' ' 9' ' ' VAL . 13.8 tp -96.22 148.37 22.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.898 . . . . 0.0 110.115 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.705 HG12 ' O ' ' A' ' 60' ' ' ALA . 4.5 m -151.8 170.9 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.869 . . . . 0.0 110.329 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.3 mt -113.64 142.33 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.852 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 58' ' ' PHE . . . -80.3 114.34 19.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.147 -0.971 . . . . 0.0 110.192 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.52 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 75.3 mt -68.84 -22.6 64.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.068 -1.02 . . . . 0.0 109.471 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 82.2 m-70 -157.98 152.43 24.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.548 -0.72 . . . . 0.0 109.762 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 54.2 p -65.26 144.76 56.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.989 -1.07 . . . . 0.0 110.075 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 36.2 t80 -97.37 157.11 16.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.086 -1.009 . . . . 0.0 110.502 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -111.2 85.34 5.34 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.263 -0.898 . . . . 0.0 110.116 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.535 ' HD3' ' CA ' ' A' ' 24' ' ' GLY . 47.1 Cg_endo -55.86 120.61 8.55 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.101 1.579 . . . . 0.0 110.502 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 98.7 p -92.1 10.53 28.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 110.119 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 63.1 m80 -141.02 -158.25 0.84 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 110.214 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 56.7 p30 -112.03 4.8 18.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -0.867 . . . . 0.0 110.135 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -118.15 4.37 16.03 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.534 ' HB2' ' CB ' ' A' ' 17' ' ' PRO . 42.6 m-20 -95.07 165.18 12.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.181 -1.188 . . . . 0.0 110.272 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.512 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 16.0 tp -113.5 116.21 29.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.273 -0.892 . . . . 0.0 110.003 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.535 ' CA ' ' HD3' ' A' ' 17' ' ' PRO . . . -96.33 51.85 1.6 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.58 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 25.4 p90 -49.91 171.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -1.152 . . . . 0.0 110.882 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.433 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 95.7 mt-10 -103.16 178.38 4.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.465 -0.772 . . . . 0.0 110.004 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -68.88 132.78 47.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.209 -0.932 . . . . 0.0 110.284 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.56 -9.65 74.98 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.481 ' OE2' ' CB ' ' A' ' 25' ' ' PHE . 21.8 tt0 -65.27 125.94 26.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.124 -1.221 . . . . 0.0 110.202 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.801 ' O ' HD23 ' A' ' 31' ' ' LEU . 85.9 mt-30 -79.72 137.94 37.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 110.04 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.801 HD23 ' O ' ' A' ' 30' ' ' GLN . 29.2 mt -141.58 163.78 32.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.194 -0.941 . . . . 0.0 110.358 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.588 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 5.8 ttt180 -107.18 134.21 50.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.376 -0.828 . . . . 0.0 109.485 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.464 ' CG2' ' CG ' ' A' ' 36' ' ' GLN . 25.5 mm -96.11 93.38 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.133 -0.979 . . . . 0.0 110.515 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.002 HD12 ' HA ' ' A' ' 43' ' ' ALA . 1.5 mp -79.49 -25.75 41.76 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.305 -0.872 . . . . 0.0 110.654 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.457 ' O ' ' HB3' ' A' ' 41' ' ' TRP . 11.0 mt-10 -136.38 139.65 42.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.057 -1.027 . . . . 0.0 110.39 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.633 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 20.8 mt-30 -134.21 54.47 1.94 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.368 -0.832 . . . . 0.0 110.044 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -112.69 146.91 37.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.403 -0.811 . . . . 0.0 110.224 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.18 -167.38 31.65 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -77.5 -34.13 54.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.319 -1.107 . . . . 0.0 110.154 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.53 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 99.3 m95 -92.96 137.98 31.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.191 -0.943 . . . . 0.0 110.326 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.633 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 50.6 m0 -120.42 156.08 32.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.32 -0.863 . . . . 0.0 110.023 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.438 ' HB2' ' HB2' ' A' ' 35' ' ' GLU . 20.3 mttp -98.25 139.55 33.87 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 109.275 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 1.002 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -148.57 174.24 12.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.015 -1.053 . . . . 0.0 110.694 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 50' ' ' GLN . 47.3 tt0 -140.68 149.27 42.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.409 -0.807 . . . . 0.0 109.9 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 t -96.08 110.64 22.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.924 . . . . 0.0 110.161 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 70.2 mt -71.55 -2.35 16.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.298 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 91.5 m -85.84 -28.23 24.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 0.0 109.948 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.1 p -127.89 -4.61 5.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 110.172 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.77 39.69 65.61 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.487 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 32.6 mt-30 -114.97 148.11 39.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.171 -1.193 . . . . 0.0 110.242 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 37.3 tt0 -120.94 144.47 48.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 0.0 109.887 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.512 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -162.19 -152.54 6.77 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -124.56 140.16 53.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.419 -1.048 . . . . 0.0 109.946 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.943 HD13 HG21 ' A' ' 59' ' ' VAL . 1.6 pp -136.09 137.73 25.64 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.18 -0.95 . . . . 0.0 110.491 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.612 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 45.1 Cg_endo -64.75 152.4 82.18 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.006 1.53 . . . . 0.0 109.964 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.593 ' HB2' ' CH2' ' A' ' 41' ' ' TRP . 30.1 p90 -72.36 -8.04 52.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.253 -0.904 . . . . 0.0 111.267 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -94.11 -26.12 16.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.817 -1.177 . . . . 0.0 110.993 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.612 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 6.5 m-85 -81.81 0.15 40.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.048 -1.033 . . . . 0.0 110.146 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.943 HG21 HD13 ' A' ' 54' ' ' ILE . 27.9 t -144.79 170.2 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.328 -0.858 . . . . 0.0 109.956 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.705 ' O ' HG12 ' A' ' 9' ' ' VAL . . . -157.36 151.39 24.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.204 -0.935 . . . . 0.0 110.305 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -65.18 122.86 18.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 110.218 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.52 -35.5 70.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 0.0 110.241 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 51.7 t30 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.195 179.983 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 m -76.58 153.66 83.57 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.224 -1.162 . . . . 0.0 110.155 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -53.69 147.73 38.98 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.039 1.547 . . . . 0.0 110.41 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.769 HD12 ' N ' ' A' ' 4' ' ' LEU . 5.6 mp -99.24 139.03 35.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.283 -0.885 . . . . 0.0 110.143 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -118.18 143.52 46.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.913 . . . . 0.0 110.234 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -97.3 -2.3 42.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.243 -0.911 . . . . 0.0 110.238 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 33' ' ' ILE . 10.3 t-20 -80.03 2.86 22.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 0.0 110.246 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.8 mt -86.62 155.04 20.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -0.911 . . . . 0.0 110.183 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.672 HG11 ' CD1' ' A' ' 33' ' ' ILE . 15.0 m -147.08 168.15 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 110.271 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.426 HG12 ' HB2' ' A' ' 62' ' ' ALA . 29.1 mm -111.83 139.26 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 0.0 109.936 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.655 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -80.42 115.61 20.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 110.448 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.444 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 61.4 mt -74.74 -19.81 60.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.991 -1.068 . . . . 0.0 109.436 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.444 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 51.9 m-70 -157.33 143.66 17.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.538 -0.726 . . . . 0.0 109.668 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 52.0 p -58.92 145.21 42.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.006 -1.059 . . . . 0.0 110.01 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.597 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 85.2 t80 -105.6 167.33 9.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.152 -0.968 . . . . 0.0 110.292 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.576 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 25.1 mt-10 -114.9 127.54 26.73 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 110.018 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.479 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 50.9 Cg_endo -79.79 89.63 1.32 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.917 1.483 . . . . 0.0 110.393 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.4 p -79.18 -10.09 59.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.867 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 32.8 m170 -126.96 -179.51 4.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.858 . . . . 0.0 110.073 179.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -86.92 1.91 51.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 110.267 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.487 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -123.29 -15.78 3.66 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -67.84 156.38 37.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.126 -1.22 . . . . 0.0 110.35 -179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.46 ' HA ' HD12 ' A' ' 23' ' ' LEU . 21.9 tp -116.51 120.31 38.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 109.829 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.479 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -97.53 53.16 1.31 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.655 ' CE2' ' HB1' ' A' ' 11' ' ' ALA . 42.7 p90 -48.28 168.72 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.211 -1.17 . . . . 0.0 110.948 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -96.9 176.98 5.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.475 -0.766 . . . . 0.0 110.349 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -71.33 127.03 31.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 110.161 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.61 -6.08 83.32 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.444 ' CD ' ' HB2' ' A' ' 25' ' ' PHE . 20.5 tt0 -65.99 130.04 41.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.114 -1.227 . . . . 0.0 110.054 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.432 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 50.8 tt0 -79.54 136.46 36.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.826 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.626 HD11 ' CG ' ' A' ' 25' ' ' PHE . 54.2 mt -139.65 162.36 35.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 0.0 110.528 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.582 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 11.3 ttt180 -111.83 138.77 47.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.394 -0.816 . . . . 0.0 109.558 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.672 ' CD1' HG11 ' A' ' 9' ' ' VAL . 57.9 mt -98.68 92.35 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.121 -0.987 . . . . 0.0 110.392 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.533 HD21 ' CD ' ' A' ' 32' ' ' ARG . 73.4 mt -79.49 -21.79 44.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 0.0 110.908 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.527 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 75.9 tt0 -138.12 131.54 30.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.993 -1.067 . . . . 0.0 110.234 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.635 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 21.1 mt-30 -126.25 56.75 1.43 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 110.25 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.7 t -115.84 150.26 37.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.296 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.58 -168.88 34.58 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -75.71 -32.72 60.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.306 -1.114 . . . . 0.0 110.088 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.553 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 95.4 m95 -97.9 144.71 27.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -0.901 . . . . 0.0 110.008 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.635 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 50.0 m0 -119.72 154.62 33.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.336 -0.852 . . . . 0.0 110.094 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.527 ' CB ' ' HB3' ' A' ' 35' ' ' GLU . 18.4 tttp -92.96 140.43 29.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.324 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.582 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -148.92 171.66 15.96 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.046 -1.034 . . . . 0.0 110.932 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 4.8 tt0 -139.57 147.78 41.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.56 -0.713 . . . . 0.0 109.622 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.0 t -94.22 109.81 21.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.15 -0.969 . . . . 0.0 110.144 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.435 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 16.5 tp -71.93 -1.58 14.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.437 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 98.0 m -90.87 -31.11 16.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -0.909 . . . . 0.0 110.142 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.0 p -120.73 -8.94 9.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.284 -0.885 . . . . 0.0 110.201 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.65 36.86 47.32 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -112.43 144.47 41.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -1.127 . . . . 0.0 110.268 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 83.8 tt0 -120.69 141.69 50.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.23 -0.919 . . . . 0.0 110.168 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 21' ' ' GLY . . . -172.95 163.93 35.82 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 91.7 m-85 -74.37 147.31 42.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -1.15 . . . . 0.0 109.832 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.815 HD12 ' O ' ' A' ' 55' ' ' PRO . 1.7 pp -142.67 137.86 15.64 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.281 -0.887 . . . . 0.0 110.285 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.815 ' O ' HD12 ' A' ' 54' ' ' ILE . 45.4 Cg_endo -57.89 156.81 26.7 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.112 1.585 . . . . 0.0 110.169 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.596 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 20.8 p90 -92.78 -0.9 57.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.375 -0.828 . . . . 0.0 111.243 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 58' ' ' PHE . 49.1 p-10 -98.32 -26.63 14.44 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.824 -1.172 . . . . 0.0 111.051 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.522 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 16.8 m-30 -88.65 2.3 53.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.938 -1.102 . . . . 0.0 110.502 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.799 HG11 HD13 ' A' ' 54' ' ' ILE . 33.2 m -132.19 146.64 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.111 -0.993 . . . . 0.0 110.208 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' A' ' 9' ' ' VAL . . . -135.67 168.26 19.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.316 -0.865 . . . . 0.0 110.181 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.559 ' HA ' HG12 ' A' ' 9' ' ' VAL . 85.7 mttt -78.21 131.41 37.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 110.281 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.426 ' HB2' HG12 ' A' ' 10' ' ' ILE . . . -96.39 154.39 17.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.0 110.176 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.238 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.2 79.08 59.81 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.26 -1.141 . . . . 0.0 110.18 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -58.98 146.29 94.53 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.933 1.491 . . . . 0.0 110.395 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.523 HD23 ' OD1' ' A' ' 6' ' ' ASP . 13.4 tp -105.29 123.93 48.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 0.0 110.227 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -55.94 -25.65 44.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.15 -0.969 . . . . 0.0 110.163 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.523 ' OD1' HD23 ' A' ' 4' ' ' LEU . 46.8 m-20 55.02 57.02 5.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.307 -0.87 . . . . 0.0 110.277 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.419 ' O ' HG13 ' A' ' 33' ' ' ILE . 24.7 m120 -80.96 -10.0 59.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.243 -0.91 . . . . 0.0 110.263 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.437 ' C ' HG13 ' A' ' 9' ' ' VAL . 15.2 tp -70.31 142.83 52.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -0.926 . . . . 0.0 110.155 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.917 HG11 HD11 ' A' ' 33' ' ' ILE . 24.5 m -149.48 168.78 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 110.269 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.2 mt -111.15 141.44 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.93 . . . . 0.0 109.886 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.433 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -80.12 109.86 14.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.167 -0.958 . . . . 0.0 110.316 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.414 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 71.6 mt -69.93 -24.52 63.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.02 -1.05 . . . . 0.0 109.247 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.414 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 74.2 m80 -152.84 148.23 26.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.561 -0.712 . . . . 0.0 109.632 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.527 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 51.4 p -63.75 144.76 56.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.037 -1.039 . . . . 0.0 109.987 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 39.5 t80 -97.68 157.38 16.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.026 -1.046 . . . . 0.0 110.357 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -110.32 99.82 41.91 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.372 -0.83 . . . . 0.0 109.998 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.494 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.3 Cg_endo -59.96 91.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.069 1.563 . . . . 0.0 110.461 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.9 m -83.28 1.33 41.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 110.102 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.462 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 77.3 m80 -146.67 152.35 38.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -0.887 . . . . 0.0 110.135 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -65.04 130.01 41.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -0.917 . . . . 0.0 110.189 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.07 13.58 24.78 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.462 ' OD2' ' HB2' ' A' ' 19' ' ' HIS . 13.8 m-20 -108.29 158.24 17.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.29 -1.123 . . . . 0.0 110.448 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.665 HD13 ' HG2' ' A' ' 50' ' ' GLN . 13.5 tp -109.3 111.89 23.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 109.834 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.494 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -93.24 49.87 2.43 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 31.7 p90 -53.36 174.42 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -1.127 . . . . 0.0 110.89 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.527 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 91.6 mt-10 -109.33 178.74 4.35 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.471 -0.768 . . . . 0.0 109.918 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -68.29 140.57 55.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.081 -1.012 . . . . 0.0 110.287 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.07 -14.31 50.02 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.465 ' HG3' ' HB2' ' A' ' 26' ' ' GLU . 3.6 mt-10 -65.8 126.59 28.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.175 -1.191 . . . . 0.0 110.37 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.975 ' C ' HD12 ' A' ' 31' ' ' LEU . 10.0 pt20 -79.76 136.33 36.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 109.958 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.975 HD12 ' C ' ' A' ' 30' ' ' GLN . 7.7 mp -137.95 158.88 43.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -0.96 . . . . 0.0 110.536 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.594 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 5.8 tpt180 -106.29 132.33 52.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.406 -0.809 . . . . 0.0 109.332 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.917 HD11 HG11 ' A' ' 9' ' ' VAL . 23.3 mt -90.79 93.73 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.083 -1.01 . . . . 0.0 110.544 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.438 ' CD2' ' HG3' ' A' ' 32' ' ' ARG . 67.1 mt -79.58 -29.94 41.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.367 -0.833 . . . . 0.0 110.844 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 42' ' ' LYS . 85.3 tt0 -130.91 140.48 50.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.947 -1.096 . . . . 0.0 110.406 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.627 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 76.5 mt-30 -134.52 54.88 1.92 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 110.111 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 51.4 m -119.65 148.18 43.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -0.876 . . . . 0.0 110.167 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.11 -177.87 27.52 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -69.18 -29.85 67.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -1.205 . . . . 0.0 110.333 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.459 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 99.2 m95 -98.61 144.15 28.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 110.378 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.627 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 43.5 m0 -121.02 155.87 33.41 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.349 -0.844 . . . . 0.0 110.176 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 35' ' ' GLU . 77.9 tttt -101.1 143.54 31.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 109.331 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.594 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -153.98 -179.9 8.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.014 -1.054 . . . . 0.0 110.85 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 48.3 tt0 -141.24 149.94 41.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.379 -0.825 . . . . 0.0 109.691 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.469 ' HB2' HD21 ' A' ' 23' ' ' LEU . 18.0 t -100.49 123.95 45.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.05 -1.031 . . . . 0.0 110.3 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.6 mt -80.85 6.21 13.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 110.051 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 87.0 m -91.07 -35.62 14.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 110.071 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.7 p -127.27 -3.55 6.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 110.093 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.2 35.24 57.25 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.665 ' HG2' HD13 ' A' ' 23' ' ' LEU . 63.1 tt0 -104.87 140.76 37.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -1.13 . . . . 0.0 110.283 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 86.3 tt0 -119.51 139.09 52.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.892 . . . . 0.0 110.18 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -170.81 163.17 36.25 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 94.4 m-85 -69.36 141.85 54.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.308 -1.113 . . . . 0.0 110.0 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.689 HD12 HG21 ' A' ' 59' ' ' VAL . 1.6 pt -131.57 142.37 45.06 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.194 -0.941 . . . . 0.0 110.38 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.579 ' O ' HG22 ' A' ' 59' ' ' VAL . 44.8 Cg_endo -68.49 140.89 49.11 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.066 1.561 . . . . 0.0 110.08 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.57 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 25.1 p90 -75.54 -7.03 53.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 0.0 111.144 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -90.34 -26.48 19.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.899 -1.126 . . . . 0.0 110.725 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.557 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 17.8 m-30 -92.71 4.16 54.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.091 -1.006 . . . . 0.0 110.22 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.689 HG21 HD12 ' A' ' 54' ' ' ILE . 35.6 m -136.04 143.49 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.263 -0.898 . . . . 0.0 110.103 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -136.82 160.15 39.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.956 . . . . 0.0 110.343 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.637 ' HA ' HG12 ' A' ' 9' ' ' VAL . 11.1 mtmt -69.07 140.06 54.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.286 -0.884 . . . . 0.0 110.232 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.68 148.44 49.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.262 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.28 179.922 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.462 ' HA3' HD12 ' A' ' 4' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.52 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 0.4 OUTLIER -44.64 -57.57 6.55 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.166 -1.196 . . . . 0.0 110.186 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 2' ' ' SER . 47.3 Cg_endo -66.12 -30.48 46.78 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.957 1.504 . . . . 0.0 110.241 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.462 HD12 ' HA3' ' A' ' 1' ' ' GLY . 43.1 mt -62.12 -34.07 75.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -0.87 . . . . 0.0 110.211 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -57.67 -39.73 77.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 110.105 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -51.3 -35.35 37.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 110.118 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.582 ' HA ' HD12 ' A' ' 33' ' ' ILE . 20.9 m120 -85.77 12.12 9.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.246 -0.909 . . . . 0.0 110.142 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 1.011 HD13 ' N ' ' A' ' 9' ' ' VAL . 2.9 tm? -94.79 145.84 24.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.859 . . . . 0.0 110.111 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.011 ' N ' HD13 ' A' ' 8' ' ' LEU . 30.1 m -150.41 170.02 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.178 -0.951 . . . . 0.0 110.319 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 58.0 mt -115.16 145.05 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.377 -0.827 . . . . 0.0 109.954 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.608 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . -80.33 109.15 14.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.124 -0.985 . . . . 0.0 110.337 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.469 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 57.6 mt -67.05 -24.3 65.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.985 -1.072 . . . . 0.0 109.353 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.469 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 58.1 m80 -157.09 155.16 30.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.611 -0.681 . . . . 0.0 109.487 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 47.7 t -66.49 139.15 57.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.972 -1.08 . . . . 0.0 109.98 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.59 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 73.5 t80 -95.96 155.27 16.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.084 -1.01 . . . . 0.0 110.375 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.584 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 1.2 mp0 -105.66 128.71 25.95 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.361 -0.837 . . . . 0.0 110.11 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.426 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.5 Cg_endo -87.31 81.28 1.28 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.875 1.461 . . . . 0.0 110.448 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 97.1 p -79.88 -2.33 43.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.385 -0.822 . . . . 0.0 109.942 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.416 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 63.8 m80 -138.95 149.81 45.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.888 . . . . 0.0 110.18 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -69.21 129.1 38.9 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.287 -0.883 . . . . 0.0 110.227 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.83 -4.41 39.26 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.416 ' OD2' ' HB2' ' A' ' 19' ' ' HIS . 34.9 m-20 -92.25 165.99 12.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.225 -1.162 . . . . 0.0 110.464 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.489 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 18.0 tp -117.85 124.33 48.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.272 -0.893 . . . . 0.0 110.011 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 15' ' ' TYR . . . -105.68 52.7 0.69 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.608 ' CD2' ' HB1' ' A' ' 11' ' ' ALA . 41.3 p90 -48.74 175.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -1.18 . . . . 0.0 110.841 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.496 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 73.5 mm-40 -109.76 179.34 4.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.445 -0.784 . . . . 0.0 110.157 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -69.41 133.48 47.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.008 -1.058 . . . . 0.0 110.478 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.28 -15.53 55.95 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 3.3 mt-10 -64.25 122.56 16.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.034 -1.274 . . . . 0.0 110.454 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.43 ' O ' HD23 ' A' ' 31' ' ' LEU . 99.0 mt-30 -79.4 137.15 37.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -0.879 . . . . 0.0 109.651 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.525 HD11 ' CG ' ' A' ' 25' ' ' PHE . 15.7 mt -133.77 154.35 51.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.174 -0.954 . . . . 0.0 110.488 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 14.9 ttm180 -98.79 130.89 45.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.397 -0.815 . . . . 0.0 109.931 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' A' ' 7' ' ' ASN . 69.2 mt -73.72 113.95 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.186 -0.946 . . . . 0.0 110.109 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.914 HD11 ' HB2' ' A' ' 44' ' ' GLN . 35.7 mt -86.49 -38.83 16.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.87 . . . . 0.0 110.201 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.457 ' O ' ' HB3' ' A' ' 41' ' ' TRP . 94.4 mt-10 -139.25 161.45 37.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.343 -0.848 . . . . 0.0 109.946 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.631 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 45.7 tt0 -143.78 61.2 1.37 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 0.0 110.141 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.9 t -131.81 122.48 25.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 110.196 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.35 176.69 41.84 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.75 -34.39 75.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.365 -1.079 . . . . 0.0 110.249 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.434 ' O ' ' CD1' ' A' ' 41' ' ' TRP . 73.4 m95 -100.08 150.16 22.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.89 . . . . 0.0 110.242 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.631 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 40.1 m0 -130.84 160.03 35.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.29 -0.881 . . . . 0.0 110.381 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.421 ' HD3' ' HB3' ' A' ' 34' ' ' LEU . 80.0 tttt -88.89 146.6 24.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.914 . . . . 0.0 109.605 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.664 ' HB2' HG12 ' A' ' 54' ' ' ILE . . . -147.14 167.82 23.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.029 -1.045 . . . . 0.0 110.759 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.914 ' HB2' HD11 ' A' ' 34' ' ' LEU . 43.4 tt0 -145.69 154.22 41.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.433 -0.792 . . . . 0.0 110.025 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.5 t -83.09 145.4 29.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.065 -1.022 . . . . 0.0 110.196 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.3 tp -91.38 -21.14 21.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 110.132 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.7 t -105.45 -26.49 11.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 0.0 110.429 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.3 m -100.35 -29.22 12.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.122 -0.986 . . . . 0.0 110.108 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.06 22.04 64.2 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 62.0 tt0 -92.75 134.48 35.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.442 -1.034 . . . . 0.0 110.259 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.54 ' HG2' ' CG ' ' A' ' 44' ' ' GLN . 79.9 mt-10 -114.96 133.09 56.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.282 -0.887 . . . . 0.0 109.934 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -161.26 157.03 28.58 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -67.07 142.19 57.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.349 -1.089 . . . . 0.0 110.159 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.664 HG12 ' HB2' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -133.63 162.13 59.52 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 110.137 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.59 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 47.8 Cg_endo -90.26 162.88 4.63 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.993 1.523 . . . . 0.0 110.09 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -87.34 -2.23 58.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -0.924 . . . . 0.0 110.819 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -100.1 -25.74 14.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.036 -1.04 . . . . 0.0 110.987 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.586 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 22.4 m-85 -84.26 -9.26 58.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.924 -1.11 . . . . 0.0 110.53 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 22.4 m -131.16 143.24 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 110.301 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -130.33 156.72 44.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.185 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.407 ' HA ' HG12 ' A' ' 9' ' ' VAL . 93.1 mttt -68.53 133.52 48.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.32 -0.863 . . . . 0.0 110.177 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.9 -31.78 68.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.931 . . . . 0.0 110.148 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.208 -179.984 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 m -125.87 76.09 71.02 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.222 -1.164 . . . . 0.0 110.171 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -56.56 -17.21 21.31 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.086 1.571 . . . . 0.0 110.263 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.7 tp -91.91 132.72 36.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.295 -0.878 . . . . 0.0 110.212 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -84.55 119.76 25.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.159 -0.963 . . . . 0.0 110.183 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.426 ' C ' ' OD1' ' A' ' 6' ' ' ASP . 55.9 p30 -92.44 10.19 31.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.322 -0.861 . . . . 0.0 110.308 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.44 ' O ' HG13 ' A' ' 33' ' ' ILE . 29.0 m120 -86.89 4.58 40.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.165 -0.959 . . . . 0.0 110.364 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.461 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.4 tp -91.85 151.83 20.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.216 -0.928 . . . . 0.0 110.204 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.786 HG12 ' O ' ' A' ' 60' ' ' ALA . 4.2 m -153.18 173.39 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 0.0 110.532 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 62.1 mt -120.63 142.6 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.376 -0.828 . . . . 0.0 109.527 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.443 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -77.54 115.77 17.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.116 -0.99 . . . . 0.0 110.342 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 12' ' ' LEU . 15.5 tp -73.55 -20.3 60.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.14 -0.975 . . . . 0.0 109.086 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -149.35 -158.95 0.97 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.586 -0.696 . . . . 0.0 109.693 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 93.8 p -118.07 140.51 49.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.164 -0.96 . . . . 0.0 110.151 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.593 ' CD2' ' HD3' ' A' ' 55' ' ' PRO . 60.2 t80 -103.53 162.6 12.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.067 -1.021 . . . . 0.0 110.223 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.567 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 47.0 tt0 -119.91 130.32 24.91 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 110.273 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.458 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.1 Cg_endo -81.22 84.46 1.97 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.02 1.537 . . . . 0.0 110.403 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.587 ' O ' ' CD2' ' A' ' 19' ' ' HIS . 77.0 p -79.83 -1.19 37.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.925 . . . . 0.0 110.093 179.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.587 ' CD2' ' O ' ' A' ' 18' ' ' SER . 37.2 m80 -150.28 158.16 43.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 110.02 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -66.09 127.47 32.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 110.217 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.415 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . 107.12 -10.91 40.34 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.445 ' OD2' ' HB2' ' A' ' 19' ' ' HIS . 41.5 m-20 -83.18 152.45 25.23 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.231 -1.158 . . . . 0.0 110.316 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.546 ' O ' ' CD1' ' A' ' 15' ' ' TYR . 14.2 tp -114.22 120.01 39.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.308 -0.87 . . . . 0.0 110.036 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.458 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -102.86 56.71 0.61 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.563 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 36.2 p90 -50.8 171.6 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.185 -1.185 . . . . 0.0 110.874 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -103.62 178.59 4.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.545 -0.722 . . . . 0.0 109.981 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.9 mttp -69.69 124.56 24.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 110.328 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.45 -12.26 70.15 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.439 ' CD ' ' HB2' ' A' ' 25' ' ' PHE . 41.4 tt0 -59.74 127.68 33.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.129 -1.218 . . . . 0.0 110.395 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -79.83 131.93 36.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.929 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.475 HD11 ' CG ' ' A' ' 25' ' ' PHE . 18.9 mt -131.58 151.31 51.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -0.938 . . . . 0.0 110.408 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.65 ' NH1' HD13 ' A' ' 46' ' ' LEU . 20.2 mtp85 -98.54 133.66 42.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.341 -0.849 . . . . 0.0 109.523 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.517 HD11 HG11 ' A' ' 9' ' ' VAL . 27.3 mt -77.1 118.12 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.978 . . . . 0.0 110.067 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.699 HD11 ' HB2' ' A' ' 44' ' ' GLN . 86.3 mt -95.68 -36.74 11.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 0.0 110.273 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.406 ' HA ' ' OE1' ' A' ' 35' ' ' GLU . 67.3 mm-40 -139.96 153.17 46.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 110.213 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.581 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 20.8 mt-30 -135.48 55.14 1.89 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.304 -0.873 . . . . 0.0 110.215 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.3 m -120.03 135.72 54.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.272 -0.892 . . . . 0.0 110.148 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.44 178.42 42.75 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.97 -33.19 75.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.359 -1.083 . . . . 0.0 110.355 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.565 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 98.7 m95 -91.89 140.81 29.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.174 -0.954 . . . . 0.0 110.153 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.581 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 40.7 m0 -122.01 152.99 39.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.9 . . . . 0.0 110.212 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.5 tttm -91.85 148.23 22.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 0.0 109.589 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.695 ' HB3' HG21 ' A' ' 54' ' ' ILE . . . -155.49 178.11 10.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.0 -1.062 . . . . 0.0 110.622 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.699 ' HB2' HD11 ' A' ' 34' ' ' LEU . 28.4 tt0 -150.9 159.67 44.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.296 -0.878 . . . . 0.0 109.724 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 6.4 t -82.27 147.56 28.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.072 -1.018 . . . . 0.0 109.933 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.65 HD13 ' NH1' ' A' ' 32' ' ' ARG . 30.3 tp -91.68 -21.31 20.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.927 . . . . 0.0 109.945 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.4 p -107.77 -28.14 9.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.354 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.3 m -94.43 -31.16 14.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.124 -0.985 . . . . 0.0 110.233 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.55 24.02 59.36 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.496 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 65.2 tp60 -97.55 136.66 37.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.358 -1.084 . . . . 0.0 110.022 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.55 ' HG2' ' CG ' ' A' ' 44' ' ' GLN . 31.2 mt-10 -117.52 136.73 53.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.094 -1.004 . . . . 0.0 110.244 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.49 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -167.79 162.52 36.31 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -66.37 141.94 57.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.297 -1.119 . . . . 0.0 110.217 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.695 HG21 ' HB3' ' A' ' 43' ' ' ALA . 1.3 pp -133.4 144.35 51.92 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.255 -0.903 . . . . 0.0 110.171 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.593 ' HD3' ' CD2' ' A' ' 15' ' ' TYR . 44.6 Cg_endo -71.23 152.57 61.71 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.023 1.538 . . . . 0.0 110.373 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.566 ' CE2' ' OD1' ' A' ' 57' ' ' ASN . 20.1 p90 -89.89 -1.08 57.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.335 -0.853 . . . . 0.0 110.68 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.566 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 92.3 m-20 -95.64 -27.14 15.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.089 -1.007 . . . . 0.0 110.668 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.565 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 12.8 m-30 -90.46 4.39 51.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.096 -1.002 . . . . 0.0 110.465 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.508 HG12 ' HB ' ' A' ' 9' ' ' VAL . 10.7 t -140.93 163.84 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 110.206 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.786 ' O ' HG12 ' A' ' 9' ' ' VAL . . . -152.7 173.86 14.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -0.846 . . . . 0.0 110.193 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -68.51 132.14 46.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.173 -0.955 . . . . 0.0 110.164 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.3 148.08 51.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.223 -0.923 . . . . 0.0 110.185 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.232 -179.988 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 m -92.17 132.99 30.94 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.294 -1.121 . . . . 0.0 110.155 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -63.38 -12.02 28.56 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.086 1.572 . . . . 0.0 110.323 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 25.9 tp -62.93 -26.8 68.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 110.275 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -129.21 146.4 51.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 110.185 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.973 ' OD1' HD11 ' A' ' 8' ' ' LEU . 43.3 t0 -136.72 78.13 1.68 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.151 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.547 ' C ' HD12 ' A' ' 8' ' ' LEU . 43.9 t-20 -87.01 108.73 18.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 110.34 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.973 HD11 ' OD1' ' A' ' 6' ' ' ASP . 6.7 mp -109.57 142.41 40.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.238 -0.914 . . . . 0.0 110.048 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.859 HG11 HD11 ' A' ' 33' ' ' ILE . 27.3 m -143.5 166.99 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.228 -0.92 . . . . 0.0 110.404 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.432 ' O ' HD12 ' A' ' 12' ' ' LEU . 21.3 mm -110.73 146.23 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.86 . . . . 0.0 109.754 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.48 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -80.15 113.51 18.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.116 -0.99 . . . . 0.0 110.381 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.697 HD12 ' N ' ' A' ' 12' ' ' LEU . 8.2 mp -74.57 -19.98 60.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 0.0 109.371 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.513 ' ND1' ' O ' ' A' ' 12' ' ' LEU . 71.9 m80 -155.61 145.17 21.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.497 -0.752 . . . . 0.0 109.611 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.556 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 33.1 p -64.03 145.98 54.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.94 -1.1 . . . . 0.0 110.129 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 82.9 t80 -104.35 166.7 10.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.101 -0.999 . . . . 0.0 110.211 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.24 120.08 29.26 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.912 . . . . 0.0 110.125 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.487 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 49.5 Cg_endo -70.19 84.35 0.73 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.949 1.5 . . . . 0.0 110.219 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.501 ' OG ' ' ND1' ' A' ' 19' ' ' HIS . 73.8 p -79.9 -3.84 49.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -0.881 . . . . 0.0 110.082 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.501 ' ND1' ' OG ' ' A' ' 18' ' ' SER . 50.9 m80 -145.94 140.5 26.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 110.195 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -53.45 124.48 14.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 110.279 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.76 16.02 12.35 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -114.69 159.85 20.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -1.184 . . . . 0.0 110.303 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.501 ' HA ' HD12 ' A' ' 23' ' ' LEU . 15.4 tp -115.23 118.41 33.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.329 -0.857 . . . . 0.0 110.081 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.487 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -95.9 47.59 1.84 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 40.2 p90 -47.36 171.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.269 -1.136 . . . . 0.0 111.042 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.556 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 92.4 mt-10 -105.95 178.82 4.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.412 -0.805 . . . . 0.0 110.069 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.6 tttt -69.32 138.0 53.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.083 -1.011 . . . . 0.0 110.136 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.09 -12.31 60.48 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.581 ' HG2' HD11 ' A' ' 31' ' ' LEU . 8.4 tt0 -63.57 128.17 34.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.174 -1.191 . . . . 0.0 110.118 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.97 ' C ' HD12 ' A' ' 31' ' ' LEU . 92.6 mt-30 -79.55 134.53 36.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 109.992 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.97 HD12 ' C ' ' A' ' 30' ' ' GLN . 8.5 mp -136.11 156.87 48.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.919 . . . . 0.0 110.736 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.586 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 22.8 ttt180 -107.76 135.81 48.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.442 -0.786 . . . . 0.0 109.138 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.859 HD11 HG11 ' A' ' 9' ' ' VAL . 54.4 mt -91.39 92.35 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.042 -1.036 . . . . 0.0 110.879 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 44' ' ' GLN . 11.0 mt -79.08 -29.84 43.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.581 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.546 ' CB ' ' HB3' ' A' ' 42' ' ' LYS . 45.7 tt0 -134.6 132.86 39.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.961 -1.087 . . . . 0.0 110.234 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.633 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 53.3 tt0 -129.08 59.31 1.58 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.286 -0.884 . . . . 0.0 110.119 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 89.5 p -121.53 146.12 47.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 110.237 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.02 -170.26 47.57 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -74.6 -33.1 62.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -1.138 . . . . 0.0 110.072 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.494 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 99.0 m95 -96.44 142.8 28.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.212 -0.93 . . . . 0.0 110.16 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.633 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 43.1 m0 -119.94 154.97 33.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.22 -0.925 . . . . 0.0 110.192 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.546 ' HB3' ' CB ' ' A' ' 35' ' ' GLU . 34.3 tttp -97.63 141.17 31.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.343 -0.848 . . . . 0.0 109.132 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.586 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -152.52 177.77 10.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.94 -1.1 . . . . 0.0 110.803 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.485 ' HB2' HD11 ' A' ' 34' ' ' LEU . 58.6 tt0 -142.65 150.62 40.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.438 -0.789 . . . . 0.0 109.912 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.1 t -97.16 114.75 26.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.989 . . . . 0.0 110.229 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.7 mt -74.63 0.18 15.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -0.944 . . . . 0.0 110.118 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 54.9 m -86.16 -33.26 20.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 110.045 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.8 p -128.39 -3.58 5.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.159 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.2 33.77 56.23 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -101.86 139.96 36.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.289 -1.124 . . . . 0.0 110.148 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.448 ' OE2' ' HE3' ' A' ' 42' ' ' LYS . 78.6 tt0 -120.77 140.77 51.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 0.0 110.163 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -174.12 164.53 35.81 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 81.7 m-85 -74.06 146.37 43.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.174 -1.192 . . . . 0.0 109.758 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.986 HD13 HG11 ' A' ' 59' ' ' VAL . 1.8 pp -140.71 143.16 31.16 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.183 -0.948 . . . . 0.0 110.501 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.762 ' O ' HD12 ' A' ' 54' ' ' ILE . 44.6 Cg_endo -63.1 148.39 93.35 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.157 1.609 . . . . 0.0 110.109 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.695 ' CE2' ' ND2' ' A' ' 57' ' ' ASN . 20.4 p90 -84.67 -1.42 56.08 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.294 -0.879 . . . . 0.0 110.895 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.695 ' ND2' ' CE2' ' A' ' 56' ' ' PHE . 22.5 m120 -94.6 -26.24 16.45 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.984 -1.073 . . . . 0.0 110.634 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.622 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 13.1 m-30 -90.87 6.84 42.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.087 -1.008 . . . . 0.0 110.391 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.986 HG11 HD13 ' A' ' 54' ' ' ILE . 31.0 m -132.53 142.18 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 0.0 110.053 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.437 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . -131.38 158.92 39.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.914 . . . . 0.0 110.247 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.673 ' HA ' HG12 ' A' ' 9' ' ' VAL . 74.9 mttt -75.28 125.23 28.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 110.259 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.96 150.39 44.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.924 . . . . 0.0 110.245 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.166 -179.965 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 4' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.529 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 0.5 OUTLIER -44.48 -52.61 16.82 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.273 -1.133 . . . . 0.0 110.285 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 2' ' ' SER . 47.0 Cg_endo -72.2 -15.87 28.51 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.892 1.469 . . . . 0.0 110.327 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 1' ' ' GLY . 19.6 tp -102.29 136.88 41.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 110.237 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -107.77 127.85 54.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.235 -0.916 . . . . 0.0 110.181 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.895 ' OD1' HD11 ' A' ' 8' ' ' LEU . 50.1 t0 -143.39 83.07 1.76 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.268 -0.895 . . . . 0.0 110.213 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.663 ' HB3' HD12 ' A' ' 33' ' ' ILE . 97.5 m-20 -90.63 112.38 24.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.267 -0.896 . . . . 0.0 110.268 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.895 HD11 ' OD1' ' A' ' 6' ' ' ASP . 5.4 mp -114.71 139.97 49.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 110.094 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.696 ' CG1' HD11 ' A' ' 33' ' ' ILE . 21.5 m -138.33 163.78 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.144 -0.973 . . . . 0.0 110.44 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 90.7 mt -112.77 143.39 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.367 -0.833 . . . . 0.0 109.802 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.65 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . -80.57 110.62 16.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.159 -0.963 . . . . 0.0 110.505 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.525 HD12 ' N ' ' A' ' 12' ' ' LEU . 6.3 mp -68.56 -22.99 64.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.985 -1.072 . . . . 0.0 109.031 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.497 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 75.3 m-70 -158.29 149.26 20.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.593 -0.692 . . . . 0.0 109.342 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 54.3 p -61.65 142.75 56.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.928 -1.108 . . . . 0.0 109.982 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 80.1 t80 -98.66 159.97 14.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.084 -1.01 . . . . 0.0 110.443 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -105.63 112.32 64.62 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 109.999 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.474 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 49.3 Cg_endo -72.66 89.76 0.84 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.965 1.508 . . . . 0.0 110.513 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.6 p -79.68 -4.07 50.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.929 . . . . 0.0 110.183 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.3 m80 -130.47 -176.01 3.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.216 -0.927 . . . . 0.0 110.213 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -92.38 -10.85 36.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 0.0 110.247 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.32 32.69 5.95 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -117.8 159.33 23.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -1.131 . . . . 0.0 110.385 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.503 ' HA ' HD12 ' A' ' 23' ' ' LEU . 14.5 tp -114.18 118.43 33.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.357 -0.84 . . . . 0.0 109.763 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.474 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -96.23 50.36 1.67 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.65 ' CD2' ' HB1' ' A' ' 11' ' ' ALA . 41.5 p90 -48.1 170.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -1.171 . . . . 0.0 110.823 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.442 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 77.2 mm-40 -101.39 178.49 4.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.421 -0.8 . . . . 0.0 110.237 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 12' ' ' LEU . 50.0 tttm -70.55 124.07 23.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.171 -0.956 . . . . 0.0 110.379 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.86 -8.19 73.61 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.438 ' CD ' ' HB2' ' A' ' 25' ' ' PHE . 45.7 tt0 -67.25 125.54 26.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.116 -1.226 . . . . 0.0 110.374 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.441 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 96.4 mt-30 -79.72 138.29 37.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.21 -0.931 . . . . 0.0 109.859 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.577 HD11 ' CG ' ' A' ' 25' ' ' PHE . 21.1 mt -137.32 159.0 43.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 110.398 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 9.4 ttt180 -101.62 132.32 47.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.401 -0.812 . . . . 0.0 109.526 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.696 HD11 ' CG1' ' A' ' 9' ' ' VAL . 6.8 mt -72.92 115.04 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.172 -0.955 . . . . 0.0 110.39 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.578 HD11 ' HG2' ' A' ' 51' ' ' GLU . 38.3 mt -83.32 -38.05 22.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.929 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.432 ' C ' ' HG3' ' A' ' 36' ' ' GLN . 87.3 mt-10 -148.62 170.63 17.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.309 -0.869 . . . . 0.0 110.26 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.517 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 27.1 mt-30 -147.33 60.46 1.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 110.201 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.1 p -130.34 136.47 49.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 110.222 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.95 -170.97 44.17 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -75.88 -31.89 59.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.191 -1.182 . . . . 0.0 110.31 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.556 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 85.8 m95 -100.45 149.43 23.68 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.228 -0.92 . . . . 0.0 110.089 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.517 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 38.2 m0 -119.95 153.28 36.16 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.222 -0.924 . . . . 0.0 110.425 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 34' ' ' LEU . 41.9 tttp -89.4 142.98 27.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.349 -0.844 . . . . 0.0 109.662 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.842 ' HB2' HG12 ' A' ' 54' ' ' ILE . . . -137.22 158.04 45.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.138 -0.976 . . . . 0.0 110.805 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 56.3 tt0 -129.04 138.35 51.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.484 -0.76 . . . . 0.0 109.962 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.465 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 6.5 t -79.14 140.0 37.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.115 -0.991 . . . . 0.0 110.011 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.444 HD21 ' HB2' ' A' ' 32' ' ' ARG . 61.9 mt -92.94 -13.04 29.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.885 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.7 m -99.4 -25.73 14.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.426 -0.796 . . . . 0.0 110.349 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.465 ' OG1' ' HB3' ' A' ' 45' ' ' SER . 40.6 p -114.59 -13.42 12.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.063 -1.023 . . . . 0.0 110.398 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 64.88 45.83 91.31 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 20.2 mt-30 -120.76 152.03 38.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.368 -1.078 . . . . 0.0 110.17 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.578 ' HG2' HD11 ' A' ' 34' ' ' LEU . 96.7 mt-10 -116.81 134.52 54.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -0.871 . . . . 0.0 110.173 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -155.58 151.83 23.36 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -70.56 143.52 51.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -1.182 . . . . 0.0 110.094 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.985 ' CD1' HG21 ' A' ' 59' ' ' VAL . 1.9 pp -138.46 134.73 17.62 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.9 . . . . 0.0 110.117 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.59 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 46.0 Cg_endo -59.1 158.92 23.73 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.94 1.495 . . . . 0.0 110.286 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.476 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 23.5 p90 -84.14 -5.07 59.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 110.885 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -96.28 -25.13 15.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.048 -1.032 . . . . 0.0 110.931 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.59 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 19.2 m-85 -83.92 -8.63 59.13 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.022 -1.049 . . . . 0.0 110.306 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.985 HG21 ' CD1' ' A' ' 54' ' ' ILE . 33.6 m -136.22 146.0 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.138 -0.977 . . . . 0.0 110.359 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -132.56 154.72 49.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.271 -0.893 . . . . 0.0 110.22 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.532 ' HA ' HG12 ' A' ' 9' ' ' VAL . 41.0 mttp -68.55 125.07 25.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 110.243 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.71 -37.95 71.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 110.208 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.175 -179.96 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m -65.57 153.98 89.27 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.287 -1.125 . . . . 0.0 110.287 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.427 ' O ' ' OD1' ' A' ' 6' ' ' ASP . 46.4 Cg_endo -59.99 142.09 97.75 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.022 1.538 . . . . 0.0 110.303 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.843 HD13 ' O ' ' A' ' 4' ' ' LEU . 3.1 tm? -62.52 -37.72 87.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 110.21 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.403 ' O ' ' HB2' ' A' ' 6' ' ' ASP . 96.4 mt-30 -58.24 -30.49 66.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.0 110.25 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 3' ' ' PRO . 94.8 m-20 54.04 44.31 29.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.216 -0.927 . . . . 0.0 110.182 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -82.53 5.19 21.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.204 -0.935 . . . . 0.0 110.309 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.795 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.5 mp -89.99 154.94 19.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.907 . . . . 0.0 110.197 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 31' ' ' LEU . 27.8 m -148.32 168.87 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.197 -0.94 . . . . 0.0 110.389 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.413 HD13 ' O ' ' A' ' 9' ' ' VAL . 26.1 mm -112.57 146.44 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.376 -0.827 . . . . 0.0 109.842 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.504 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . -80.18 112.29 17.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.14 -0.975 . . . . 0.0 110.388 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 27.0 tp -75.27 -22.45 57.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.108 -0.995 . . . . 0.0 109.621 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.501 ' HA ' ' HG2' ' A' ' 27' ' ' LYS . 94.7 m-70 -151.97 149.75 29.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.492 -0.755 . . . . 0.0 109.762 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.5 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 15.9 t -68.35 141.88 55.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.011 -1.056 . . . . 0.0 109.941 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.593 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 85.8 t80 -98.83 160.08 14.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.938 . . . . 0.0 110.246 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.503 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 2.1 tm-20 -112.38 128.54 25.38 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 0.0 110.169 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.478 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 47.3 Cg_endo -83.39 82.28 2.11 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.028 1.541 . . . . 0.0 110.532 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.588 ' O ' ' CD2' ' A' ' 19' ' ' HIS . 88.9 p -80.8 -0.97 41.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 110.137 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.588 ' CD2' ' O ' ' A' ' 18' ' ' SER . 33.8 m80 -145.68 179.59 7.33 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.906 . . . . 0.0 110.167 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -90.39 127.92 36.33 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 110.106 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.76 -3.13 41.89 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -89.97 154.66 19.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -1.138 . . . . 0.0 110.278 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.5 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 22.5 tp -109.63 114.6 28.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.171 -0.956 . . . . 0.0 110.067 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.478 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -96.17 47.41 1.8 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.589 ' CE1' ' HB2' ' A' ' 15' ' ' TYR . 46.4 p90 -50.43 174.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.149 -1.206 . . . . 0.0 111.164 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.5 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 83.2 mt-10 -110.59 177.9 4.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.464 -0.772 . . . . 0.0 110.216 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.501 ' HG2' ' HA ' ' A' ' 13' ' ' HIS . 5.4 mtmm -69.16 139.39 54.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.036 -1.04 . . . . 0.0 110.231 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.15 -16.24 49.16 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 39.0 mm-40 -66.4 125.61 26.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.051 -1.264 . . . . 0.0 110.012 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.406 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 22.5 tt0 -79.48 137.77 37.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.875 . . . . 0.0 110.168 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.574 ' O ' HG22 ' A' ' 9' ' ' VAL . 41.4 mt -137.84 159.87 40.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.316 -0.865 . . . . 0.0 110.211 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.579 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 37.0 ttp180 -108.48 135.78 49.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.623 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.522 HD11 HG21 ' A' ' 9' ' ' VAL . 36.9 mm -96.18 92.63 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.166 -0.959 . . . . 0.0 110.435 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.494 HD21 ' NE ' ' A' ' 32' ' ' ARG . 17.2 mt -79.45 -24.91 42.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.214 -0.929 . . . . 0.0 110.777 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.456 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 45.1 tp10 -136.2 134.67 38.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.954 -1.091 . . . . 0.0 110.388 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.636 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 75.3 mt-30 -129.41 54.87 1.79 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.347 -0.846 . . . . 0.0 110.153 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.4 m -114.86 154.01 29.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 110.183 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.26 -173.27 8.53 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -72.2 -31.91 66.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -1.136 . . . . 0.0 110.181 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.425 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 92.5 m95 -97.77 143.06 28.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.258 -0.902 . . . . 0.0 110.34 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.636 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 51.2 m0 -120.15 155.41 33.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.367 -0.833 . . . . 0.0 110.115 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.491 ' NZ ' ' OE2' ' A' ' 51' ' ' GLU . 48.8 tttt -96.55 141.34 29.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.882 . . . . 0.0 109.365 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.579 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -149.97 174.58 12.54 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.078 -1.014 . . . . 0.0 110.815 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 61.3 tt0 -141.12 149.53 41.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.451 -0.781 . . . . 0.0 109.765 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.0 t -95.48 111.88 23.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.197 -0.94 . . . . 0.0 110.161 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.433 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 18.5 tp -71.85 -1.85 15.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -0.896 . . . . 0.0 110.415 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.1 m -88.57 -29.1 20.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.237 -0.915 . . . . 0.0 110.098 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.7 p -126.67 -6.15 6.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 110.163 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.21 36.63 59.95 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.414 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 30.8 mt-30 -109.63 144.98 37.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -1.159 . . . . 0.0 110.228 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.491 ' OE2' ' NZ ' ' A' ' 42' ' ' LYS . 83.5 tt0 -118.52 138.92 52.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.898 . . . . 0.0 110.033 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -166.88 158.17 31.01 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -72.55 143.81 48.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -1.132 . . . . 0.0 110.18 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.713 HD13 HG11 ' A' ' 59' ' ' VAL . 1.0 OUTLIER -137.47 145.47 49.47 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 110.213 -179.866 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.607 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 47.3 Cg_endo -69.51 149.14 68.11 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.98 1.516 . . . . 0.0 110.156 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.593 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 36.3 p90 -74.99 -4.78 40.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.969 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -96.17 -25.33 15.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.875 -1.141 . . . . 0.0 110.954 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.607 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 9.0 m-85 -83.14 -2.16 54.73 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.055 -1.028 . . . . 0.0 110.284 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.713 HG11 HD13 ' A' ' 54' ' ' ILE . 33.1 m -136.32 144.08 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 110.071 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -135.23 151.5 50.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.138 -0.977 . . . . 0.0 110.242 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -62.74 128.03 34.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 0.0 110.242 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.4 -31.49 72.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 110.149 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.5 m120 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.233 179.973 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p -64.13 150.17 92.73 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.195 -1.179 . . . . 0.0 110.226 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.516 ' CG ' ' NH1' ' A' ' 32' ' ' ARG . 46.6 Cg_endo -55.81 139.87 84.36 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.04 1.547 . . . . 0.0 110.336 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 49.9 mt -71.71 -8.19 52.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 0.0 110.211 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 6' ' ' ASP . 15.2 tt0 -81.43 -34.02 31.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.216 -0.927 . . . . 0.0 110.233 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.613 ' O ' HD12 ' A' ' 8' ' ' LEU . 57.0 m-20 42.99 51.11 5.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.299 -0.876 . . . . 0.0 110.209 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -84.91 102.33 13.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 110.339 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.708 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.5 mp -99.92 146.03 27.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.894 . . . . 0.0 110.206 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 60' ' ' ALA . 11.8 m -144.65 167.04 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.181 -0.949 . . . . 0.0 110.334 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.8 mt -111.41 145.51 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.0 109.707 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.401 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -79.2 112.9 16.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.97 . . . . 0.0 110.303 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.505 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 55.2 mt -71.55 -21.35 61.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.105 -0.997 . . . . 0.0 109.487 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.505 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 62.7 m-70 -157.61 148.86 21.58 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.574 -0.704 . . . . 0.0 109.628 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 58.6 p -63.06 143.31 57.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.981 -1.075 . . . . 0.0 109.919 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.578 ' CD1' ' HG3' ' A' ' 55' ' ' PRO . 24.4 t80 -96.65 155.05 16.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.055 -1.028 . . . . 0.0 110.269 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.419 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -110.11 75.28 0.88 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.854 . . . . 0.0 110.17 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.537 ' HD3' ' CA ' ' A' ' 24' ' ' GLY . 46.8 Cg_endo -46.96 122.5 6.26 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.047 1.551 . . . . 0.0 110.372 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 58.4 m -91.89 10.69 27.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.366 -0.834 . . . . 0.0 110.128 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 49.9 m-70 -140.55 -158.26 0.84 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.303 -0.873 . . . . 0.0 110.192 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.4 p30 -112.67 3.92 16.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.193 -0.942 . . . . 0.0 110.187 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.43 -9.36 17.49 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.5 ' HB2' ' CB ' ' A' ' 17' ' ' PRO . 84.2 m-20 -81.65 165.7 20.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.214 -1.168 . . . . 0.0 110.4 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.503 ' HA ' HD12 ' A' ' 23' ' ' LEU . 14.7 tp -113.39 115.19 27.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 0.0 109.779 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.537 ' CA ' ' HD3' ' A' ' 17' ' ' PRO . . . -96.18 55.46 1.53 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 17.9 p90 -54.2 172.71 0.08 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.367 -1.078 . . . . 0.0 110.97 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -103.53 178.39 4.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.514 -0.741 . . . . 0.0 110.145 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -69.97 132.78 46.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.966 . . . . 0.0 110.101 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.13 -10.64 72.25 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.483 ' OE2' ' CB ' ' A' ' 25' ' ' PHE . 22.2 tt0 -64.09 126.58 28.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -1.222 . . . . 0.0 110.032 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.947 ' C ' HD12 ' A' ' 31' ' ' LEU . 38.1 tt0 -79.47 136.79 37.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.178 -0.952 . . . . 0.0 109.857 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.947 HD12 ' C ' ' A' ' 30' ' ' GLN . 7.1 mp -139.8 161.87 36.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 110.593 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.587 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 2.7 tpt180 -109.28 135.9 49.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.406 -0.809 . . . . 0.0 109.257 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.62 HD11 HG21 ' A' ' 9' ' ' VAL . 33.7 mm -91.21 92.42 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.102 -0.998 . . . . 0.0 110.567 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.637 HD11 ' HB2' ' A' ' 44' ' ' GLN . 1.5 mt -79.54 -30.01 41.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 110.789 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.515 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 77.5 tt0 -133.6 137.12 45.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.017 -1.052 . . . . 0.0 110.45 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.611 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 24.5 mt-30 -133.65 54.78 1.93 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 110.092 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -120.75 143.25 48.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.917 . . . . 0.0 110.221 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.83 -168.62 54.82 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -77.49 -33.83 54.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -1.141 . . . . 0.0 110.151 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.476 ' CZ3' ' OH ' ' A' ' 15' ' ' TYR . 98.6 m95 -96.79 141.77 29.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 110.251 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.611 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 40.6 m0 -116.83 153.65 32.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.902 . . . . 0.0 110.199 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.515 ' CB ' ' HB3' ' A' ' 35' ' ' GLU . 12.0 tttt -99.9 140.5 34.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.372 -0.83 . . . . 0.0 109.409 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.587 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -150.36 176.48 10.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.069 -1.02 . . . . 0.0 110.662 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.637 ' HB2' HD11 ' A' ' 34' ' ' LEU . 62.0 tt0 -139.01 147.57 42.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.368 -0.832 . . . . 0.0 109.96 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.5 t -97.21 117.03 30.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.95 . . . . 0.0 110.303 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.5 mt -76.6 2.59 13.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.168 -0.958 . . . . 0.0 110.118 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.9 m -91.58 -35.58 14.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 110.163 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 70.8 p -118.62 -6.02 10.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -0.884 . . . . 0.0 110.237 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.93 43.73 64.5 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.46 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 7.0 mt-30 -121.17 149.61 42.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -1.177 . . . . 0.0 110.234 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.464 ' OE2' ' HE2' ' A' ' 42' ' ' LYS . 82.3 tt0 -122.83 145.47 48.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 110.132 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.465 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -174.36 163.71 34.51 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 90.4 m-85 -75.24 146.08 41.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.322 -1.105 . . . . 0.0 109.847 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.627 HD13 HG21 ' A' ' 59' ' ' VAL . 1.5 pp -140.02 140.46 24.06 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.135 -0.978 . . . . 0.0 110.544 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.635 ' CG ' ' CD2' ' A' ' 58' ' ' PHE . 44.6 Cg_endo -60.22 145.17 99.11 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.164 1.613 . . . . 0.0 110.062 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.585 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 21.9 p90 -82.7 -5.12 58.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 110.927 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -91.59 -27.48 18.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.928 -1.108 . . . . 0.0 110.648 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.635 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 18.2 m-30 -85.86 6.82 26.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.106 -0.997 . . . . 0.0 110.105 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.627 HG21 HD13 ' A' ' 54' ' ' ILE . 26.4 t -141.85 169.46 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.882 . . . . 0.0 109.769 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.729 ' O ' HG12 ' A' ' 9' ' ' VAL . . . -159.91 156.3 27.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.089 -1.007 . . . . 0.0 110.267 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.432 ' HA ' HG12 ' A' ' 9' ' ' VAL . 48.5 tttm -56.74 129.5 41.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.206 -0.934 . . . . 0.0 110.3 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.06 148.83 48.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 110.236 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.309 179.927 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.513 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 0.3 OUTLIER -45.17 -58.39 5.78 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.221 -1.164 . . . . 0.0 110.162 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 2' ' ' SER . 47.4 Cg_endo -66.64 147.9 82.39 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.033 1.544 . . . . 0.0 110.337 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 20.0 tp -104.2 132.44 50.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 110.256 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -121.48 161.73 21.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 0.0 110.214 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -147.1 81.18 1.54 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 0.0 110.182 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.417 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 70.4 m-20 -98.56 101.75 13.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 110.358 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.448 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.5 tp -110.8 153.09 25.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -0.869 . . . . 0.0 110.065 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.078 HG21 HD11 ' A' ' 33' ' ' ILE . 4.1 m -152.32 172.96 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.129 -0.982 . . . . 0.0 110.464 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.6 mt -120.14 140.46 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.406 -0.809 . . . . 0.0 109.511 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.573 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -74.22 114.69 12.86 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.176 -0.952 . . . . 0.0 110.33 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.418 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 23.9 tp -71.18 -21.58 62.14 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 109.264 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.418 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 65.5 m-70 -154.94 -163.63 1.61 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.607 -0.683 . . . . 0.0 109.733 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.407 ' O ' ' OE2' ' A' ' 16' ' ' GLU . 30.1 t -106.91 135.76 47.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.085 -1.009 . . . . 0.0 109.756 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.607 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 81.5 t80 -97.15 151.79 19.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.993 -1.067 . . . . 0.0 110.4 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.407 ' OE2' ' O ' ' A' ' 14' ' ' SER . 1.9 mp0 -117.09 102.71 52.59 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.337 -0.852 . . . . 0.0 110.209 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.485 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 46.9 Cg_endo -62.99 98.91 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.013 1.533 . . . . 0.0 110.366 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.548 ' O ' ' CD2' ' A' ' 19' ' ' HIS . 97.8 p -81.25 7.43 11.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.144 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.548 ' CD2' ' O ' ' A' ' 18' ' ' SER . 49.0 m80 -154.27 -177.59 6.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 110.143 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -88.49 130.69 35.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.11 -0.994 . . . . 0.0 110.239 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.76 13.45 25.69 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -109.3 159.18 17.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.165 -1.197 . . . . 0.0 110.403 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.505 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 15.7 tp -115.26 120.07 38.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 110.177 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.49 ' HA2' ' HB3' ' A' ' 15' ' ' TYR . . . -101.54 58.41 0.64 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.607 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 34.9 p90 -52.94 171.35 0.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.14 -1.212 . . . . 0.0 111.326 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.516 ' N ' ' OE1' ' A' ' 29' ' ' GLU . 94.4 mt-10 -105.06 178.35 4.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.565 -0.71 . . . . 0.0 109.949 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -69.84 129.46 39.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.117 -0.989 . . . . 0.0 110.3 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.45 -15.04 56.36 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.551 ' OE2' HD21 ' A' ' 31' ' ' LEU . 24.4 tt0 -59.02 124.4 19.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.134 -1.215 . . . . 0.0 110.063 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.44 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 88.9 mt-30 -79.9 134.18 36.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.139 -0.976 . . . . 0.0 109.991 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.551 HD21 ' OE2' ' A' ' 29' ' ' GLU . 10.8 mt -133.07 154.04 50.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.204 -0.935 . . . . 0.0 110.313 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 14.5 ttt180 -97.33 132.69 42.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.853 . . . . 0.0 109.686 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.078 HD11 HG21 ' A' ' 9' ' ' VAL . 23.4 mm -77.85 118.92 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.179 -0.951 . . . . 0.0 110.396 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.528 HD21 ' HB2' ' A' ' 44' ' ' GLN . 45.7 mt -87.78 -34.55 18.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 109.94 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -172.72 125.49 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.448 -0.782 . . . . 0.0 109.956 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.58 ' HA ' ' CG ' ' A' ' 41' ' ' TRP . 95.1 mt-30 -101.87 62.88 0.91 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.931 . . . . 0.0 110.304 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.5 m -108.54 136.18 48.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.347 -0.846 . . . . 0.0 110.129 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.56 -175.04 53.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -65.47 -36.88 85.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -1.125 . . . . 0.0 110.181 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.561 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 91.8 m95 -95.12 140.32 30.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.9 . . . . 0.0 110.32 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.58 ' CG ' ' HA ' ' A' ' 36' ' ' GLN . 52.3 m0 -113.63 148.89 35.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.303 -0.873 . . . . 0.0 110.257 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.505 ' CB ' ' HB2' ' A' ' 34' ' ' LEU . 24.5 mttm -86.25 141.8 29.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.261 -0.9 . . . . 0.0 109.703 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.626 ' HB2' HG12 ' A' ' 54' ' ' ILE . . . -146.28 167.03 24.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.127 -0.983 . . . . 0.0 110.485 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.528 ' HB2' HD21 ' A' ' 34' ' ' LEU . 58.7 tt0 -137.63 145.48 42.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.339 -0.85 . . . . 0.0 110.148 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.6 t -90.56 113.31 25.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.113 -0.992 . . . . 0.0 109.892 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 78.5 mt -74.82 3.49 8.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -0.963 . . . . 0.0 110.541 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.0 m -96.54 -33.33 11.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.107 -0.996 . . . . 0.0 110.032 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.6 m -119.17 -7.63 10.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 110.24 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.05 42.45 51.59 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -119.52 148.02 43.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -1.143 . . . . 0.0 110.073 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.501 ' HG2' ' CG ' ' A' ' 44' ' ' GLN . 90.9 mt-10 -118.07 138.27 52.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.948 . . . . 0.0 110.325 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.505 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -159.27 154.91 25.99 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.418 ' HE1' ' HZ3' ' A' ' 42' ' ' LYS . 99.0 m-85 -68.56 146.22 53.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.121 -1.223 . . . . 0.0 110.198 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.626 HG12 ' HB2' ' A' ' 43' ' ' ALA . 1.3 pt -136.41 147.9 61.9 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.868 . . . . 0.0 110.215 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.598 ' HD3' ' CD1' ' A' ' 15' ' ' TYR . 43.7 Cg_endo -72.76 145.46 41.07 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 124.046 1.551 . . . . 0.0 110.327 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.64 ' CE2' ' ND2' ' A' ' 57' ' ' ASN . 21.0 p90 -81.56 -0.02 40.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.518 -0.739 . . . . 0.0 110.592 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.64 ' ND2' ' CE2' ' A' ' 56' ' ' PHE . 24.6 m120 -98.74 -27.56 13.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.051 -1.031 . . . . 0.0 110.942 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.54 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 18.2 m-30 -90.88 5.86 46.84 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.93 -1.106 . . . . 0.0 110.482 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.561 HG12 ' HB ' ' A' ' 9' ' ' VAL . 8.4 t -145.06 164.2 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 0.0 110.137 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.793 ' O ' HG12 ' A' ' 9' ' ' VAL . . . -154.97 167.6 29.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.0 110.295 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.436 ' HA ' HG12 ' A' ' 9' ' ' VAL . 64.6 tttt -70.97 132.67 45.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.286 -0.884 . . . . 0.0 110.165 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.83 147.2 28.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.934 . . . . 0.0 110.195 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.167 179.971 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.436 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.6 OUTLIER -128.45 68.94 78.37 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.308 -1.113 . . . . 0.0 110.1 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 5' ' ' GLN . 47.1 Cg_endo -48.01 -45.95 23.54 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.044 1.549 . . . . 0.0 110.379 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 3' ' ' PRO . 35.0 mt 55.86 -85.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -0.906 . . . . 0.0 110.257 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 3' ' ' PRO . 98.2 mt-30 -109.41 140.73 42.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 110.315 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 35.1 p-10 -92.17 7.62 41.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.218 -0.926 . . . . 0.0 110.157 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -86.71 2.47 48.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 110.23 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.417 ' C ' HG13 ' A' ' 9' ' ' VAL . 36.5 mt -83.64 140.68 32.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.193 -0.942 . . . . 0.0 110.189 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.689 HG12 ' HA ' ' A' ' 61' ' ' LYS . 12.6 m -150.95 170.63 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.342 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 19.6 mm -114.35 143.34 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.87 . . . . 0.0 110.076 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.824 ' HB1' ' CE1' ' A' ' 25' ' ' PHE . . . -79.63 110.82 15.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.119 -0.988 . . . . 0.0 110.134 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.439 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 15.9 tp -63.68 -24.67 67.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.05 -1.032 . . . . 0.0 109.529 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.439 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 37.0 m-70 -156.57 158.55 37.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.481 -0.762 . . . . 0.0 109.818 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.555 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 28.3 p -67.32 142.11 56.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.118 -0.989 . . . . 0.0 110.161 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.595 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 81.8 t80 -97.67 158.34 15.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 0.0 110.339 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.491 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -110.11 126.92 27.97 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 110.055 179.925 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.478 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.1 Cg_endo -82.91 81.16 2.47 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.976 1.514 . . . . 0.0 110.382 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 55.8 p -79.76 -1.08 37.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 110.078 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -142.69 169.46 17.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.155 -0.966 . . . . 0.0 110.136 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -83.87 130.6 34.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 110.216 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.26 4.01 53.68 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -98.88 161.15 13.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.171 -1.194 . . . . 0.0 110.238 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.58 HD13 ' HG3' ' A' ' 50' ' ' GLN . 31.9 tp -114.71 120.11 38.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.875 . . . . 0.0 110.141 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.478 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -100.92 50.52 1.02 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.824 ' CE1' ' HB1' ' A' ' 11' ' ' ALA . 48.0 p90 -50.76 176.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.122 -1.222 . . . . 0.0 111.12 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.555 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 83.4 mt-10 -107.63 174.11 6.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.52 -0.738 . . . . 0.0 110.253 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -68.37 139.76 55.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.122 -0.986 . . . . 0.0 110.405 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.26 -13.27 55.72 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 38.0 mm-40 -67.92 125.59 26.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.015 -1.285 . . . . 0.0 110.262 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.984 ' C ' HD12 ' A' ' 31' ' ' LEU . 80.4 mt-30 -79.53 138.69 37.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 109.663 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.984 HD12 ' C ' ' A' ' 30' ' ' GLN . 8.3 mp -136.56 156.78 48.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.046 -1.034 . . . . 0.0 110.633 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.588 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 15.9 mtm180 -103.92 131.32 51.26 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.387 -0.821 . . . . 0.0 109.394 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.592 HD11 HG11 ' A' ' 9' ' ' VAL . 99.4 mt -88.71 93.5 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.087 -1.008 . . . . 0.0 110.669 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 1.02 HD12 ' HA ' ' A' ' 43' ' ' ALA . 1.6 mp -79.25 -31.55 43.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.342 -0.849 . . . . 0.0 110.85 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.526 ' HB2' ' CB ' ' A' ' 42' ' ' LYS . 79.5 mt-10 -127.62 140.03 52.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.848 -1.158 . . . . 0.0 110.191 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.637 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 49.7 tt0 -135.06 59.7 1.72 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 110.263 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.8 t -125.2 130.98 53.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.897 . . . . 0.0 110.219 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.35 177.29 51.82 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.27 -30.89 71.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.236 -1.155 . . . . 0.0 110.281 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -98.33 144.45 27.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.0 110.263 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.637 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 43.6 m0 -126.08 157.88 36.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.37 -0.831 . . . . 0.0 110.166 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.526 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 28.7 tttt -100.03 146.78 26.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.886 . . . . 0.0 109.327 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 1.02 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -157.94 -175.97 5.66 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.916 -1.115 . . . . 0.0 110.834 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -146.03 154.31 41.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.416 -0.803 . . . . 0.0 109.622 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.3 t -101.71 125.68 48.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 110.392 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.463 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 44.0 tp -81.39 6.12 15.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.387 -0.821 . . . . 0.0 110.135 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.9 m -93.29 -37.96 11.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 110.226 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.8 p -125.39 -7.52 6.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.231 -0.918 . . . . 0.0 110.188 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.91 27.28 56.82 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.58 ' HG3' HD13 ' A' ' 23' ' ' LEU . 70.3 tp60 -90.79 131.71 36.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.318 -1.107 . . . . 0.0 110.3 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 51' ' ' GLU . 22.7 pt-20 -115.97 134.33 55.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.322 -0.861 . . . . 0.0 110.057 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.438 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -172.49 166.21 38.88 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 59.4 m-85 -69.05 142.31 54.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -1.142 . . . . 0.0 110.288 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.668 HD12 ' O ' ' A' ' 55' ' ' PRO . 1.6 pp -136.19 138.51 27.47 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 110.107 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.668 ' O ' HD12 ' A' ' 54' ' ' ILE . 47.3 Cg_endo -64.61 154.94 69.55 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.916 1.482 . . . . 0.0 110.289 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.608 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 22.3 p90 -83.97 -1.46 54.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.318 -0.864 . . . . 0.0 110.643 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.567 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 87.3 m-20 -98.39 -26.1 14.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.043 -1.036 . . . . 0.0 110.965 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 14.9 m-85 -83.16 -0.61 50.05 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.925 -1.109 . . . . 0.0 110.285 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.527 HG11 HD13 ' A' ' 54' ' ' ILE . 27.8 m -135.16 147.21 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.092 -1.005 . . . . 0.0 110.304 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.548 ' O ' HG12 ' A' ' 9' ' ' VAL . . . -125.0 162.33 24.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.931 . . . . 0.0 110.223 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.689 ' HA ' HG12 ' A' ' 9' ' ' VAL . 39.6 mttp -77.36 130.82 37.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.873 . . . . 0.0 110.21 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.6 144.9 5.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 110.248 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 27.2 t30 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.159 179.994 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.27 144.61 98.23 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.262 -1.14 . . . . 0.0 110.23 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -56.7 153.65 35.27 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.047 1.551 . . . . 0.0 110.349 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 33.9 mt -61.21 -29.5 69.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 110.197 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.464 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 93.6 mt-30 -60.56 -33.47 72.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 0.0 110.233 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.468 ' O ' ' CD1' ' A' ' 8' ' ' LEU . 81.3 m-20 -88.04 6.8 34.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.27 -0.894 . . . . 0.0 110.236 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.54 ' C ' HD12 ' A' ' 8' ' ' LEU . 2.1 t-20 -84.31 109.91 18.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.293 -0.88 . . . . 0.0 110.212 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.668 HD12 ' N ' ' A' ' 8' ' ' LEU . 7.0 mp -110.47 156.05 21.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.197 -0.939 . . . . 0.0 110.217 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.769 HG21 HG11 ' A' ' 59' ' ' VAL . 13.2 m -152.3 171.32 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.889 . . . . 0.0 110.306 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.3 mt -112.88 144.12 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -0.844 . . . . 0.0 109.923 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.625 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -80.25 111.0 16.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 110.268 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.634 HD22 ' N ' ' A' ' 12' ' ' LEU . 4.1 mm? -64.6 -26.2 68.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.17 -0.956 . . . . 0.0 109.448 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.47 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 52.5 m80 -156.9 154.56 29.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.54 -0.725 . . . . 0.0 109.661 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.56 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 53.8 p -64.69 143.4 57.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.985 -1.072 . . . . 0.0 110.056 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.594 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 89.1 t80 -100.57 164.1 12.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.036 -1.04 . . . . 0.0 110.26 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.459 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -117.94 125.32 28.07 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.367 -0.833 . . . . 0.0 110.098 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.475 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.3 Cg_endo -78.39 82.25 2.52 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.016 1.535 . . . . 0.0 110.369 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 72.6 m -79.74 -2.53 43.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.88 . . . . 0.0 109.966 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.437 ' CG ' ' N ' ' A' ' 20' ' ' ASP . 86.4 t60 -145.09 172.2 13.42 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.369 -0.832 . . . . 0.0 110.095 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . 0.437 ' N ' ' CG ' ' A' ' 19' ' ' HIS . 21.8 t70 -80.32 129.51 34.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.175 -0.953 . . . . 0.0 110.223 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.46 18.01 29.56 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -106.9 150.02 26.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -1.118 . . . . 0.0 110.284 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.467 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 15.3 tp -105.75 112.08 25.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 110.042 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.475 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -95.28 45.23 2.08 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.625 ' CE2' ' HB1' ' A' ' 11' ' ' ALA . 40.6 p90 -46.64 171.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -1.175 . . . . 0.0 110.865 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.56 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 88.0 mt-10 -101.74 177.29 4.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.464 -0.773 . . . . 0.0 110.259 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -69.69 126.65 30.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.266 -0.896 . . . . 0.0 110.272 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.71 -8.66 74.01 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.443 ' CD ' ' HB2' ' A' ' 25' ' ' PHE . 20.9 tt0 -67.27 126.03 27.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -1.18 . . . . 0.0 110.317 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.704 ' O ' HD23 ' A' ' 31' ' ' LEU . 89.4 mt-30 -79.49 138.22 37.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 109.929 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.704 HD23 ' O ' ' A' ' 30' ' ' GLN . 14.4 mt -140.44 162.74 34.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.909 . . . . 0.0 110.38 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.603 ' CD ' HD21 ' A' ' 34' ' ' LEU . 25.2 ttp180 -106.01 133.33 50.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 0.0 109.682 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.537 ' CD1' HG11 ' A' ' 9' ' ' VAL . 15.5 mt -97.82 94.67 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.104 -0.997 . . . . 0.0 110.623 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.603 HD21 ' CD ' ' A' ' 32' ' ' ARG . 50.0 mt -79.46 -22.48 44.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.932 . . . . 0.0 110.777 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.553 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 83.2 tt0 -136.39 129.69 31.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.961 -1.087 . . . . 0.0 110.33 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.628 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 23.1 mt-30 -126.32 54.19 1.58 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.842 . . . . 0.0 110.122 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.5 p -119.47 157.91 27.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.913 . . . . 0.0 110.278 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.23 -172.1 26.97 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -72.54 -34.66 67.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -1.166 . . . . 0.0 110.28 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.409 ' HZ3' ' CE1' ' A' ' 15' ' ' TYR . 69.1 m95 -101.81 150.07 23.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.228 -0.92 . . . . 0.0 110.441 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.628 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 50.8 m0 -120.75 154.69 35.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.357 -0.84 . . . . 0.0 110.264 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.553 ' CB ' ' HB3' ' A' ' 35' ' ' GLU . 67.3 tttt -95.53 143.49 26.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.569 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -153.27 176.89 11.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.933 -1.104 . . . . 0.0 111.085 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 50' ' ' GLN . 48.7 tt0 -143.67 152.01 40.8 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.591 -0.693 . . . . 0.0 109.722 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.413 ' CB ' ' OG1' ' A' ' 48' ' ' THR . 17.3 m -85.1 149.35 25.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.164 -0.96 . . . . 0.0 110.298 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.699 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.6 mp -98.39 -13.2 20.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.325 -0.859 . . . . 0.0 109.964 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.8 p -101.04 -27.49 13.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.84 . . . . 0.0 110.234 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.413 ' OG1' ' CB ' ' A' ' 45' ' ' SER . 81.4 p -107.62 -18.57 13.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 110.316 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.99 41.82 80.28 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.486 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 7.2 mt-30 -119.21 150.21 40.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -1.118 . . . . 0.0 110.281 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 81.9 tt0 -116.43 134.08 55.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.93 . . . . 0.0 110.181 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.467 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -160.03 154.88 25.96 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -69.26 142.56 54.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -1.134 . . . . 0.0 109.984 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.452 ' O ' HG13 ' A' ' 54' ' ' ILE . 1.7 pt -131.97 132.35 23.1 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.949 . . . . 0.0 110.437 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.591 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 47.9 Cg_endo -61.1 156.11 46.77 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.981 1.517 . . . . 0.0 109.884 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.551 ' CE1' ' OD1' ' A' ' 57' ' ' ASN . 41.7 p90 -80.12 -8.14 59.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 111.326 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.551 ' OD1' ' CE1' ' A' ' 56' ' ' PHE . 58.7 m-20 -92.49 -26.59 17.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.766 -1.209 . . . . 0.0 110.98 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.59 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 21.8 m-85 -82.94 -6.38 59.45 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.999 -1.063 . . . . 0.0 110.048 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.769 HG11 HG21 ' A' ' 9' ' ' VAL . 58.1 t -132.38 174.71 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.845 . . . . 0.0 109.723 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.576 ' N ' HG12 ' A' ' 59' ' ' VAL . . . -159.98 149.97 18.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 0.0 110.244 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 62' ' ' ALA . 66.2 mttm -68.51 113.86 6.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.89 . . . . 0.0 110.289 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 61' ' ' LYS . . . -42.94 141.3 1.15 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 0.0 110.269 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 28.1 m120 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.247 -179.972 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.7 t -132.99 76.61 69.95 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.17 -1.194 . . . . 0.0 110.23 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -43.25 146.74 1.0 Allowed 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.039 1.547 . . . . 0.0 110.328 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.8 tp -108.67 121.28 44.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.903 . . . . 0.0 110.275 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -120.1 161.69 20.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.259 -0.901 . . . . 0.0 110.199 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -67.64 -30.33 69.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 110.19 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -88.18 -12.74 43.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.138 -0.976 . . . . 0.0 110.264 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.555 ' O ' HG13 ' A' ' 9' ' ' VAL . 41.4 tp -71.47 143.81 49.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 0.0 110.177 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 60' ' ' ALA . 3.7 m -155.36 173.33 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -0.915 . . . . 0.0 110.271 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.1 mt -117.38 142.09 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.857 . . . . 0.0 109.807 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.817 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -78.58 113.76 16.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.972 . . . . 0.0 110.257 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.53 HD12 ' N ' ' A' ' 12' ' ' LEU . 7.2 mp -66.71 -26.83 67.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.071 -1.018 . . . . 0.0 109.542 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -149.95 155.4 39.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.459 -0.775 . . . . 0.0 109.764 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.547 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 53.0 p -68.59 143.04 54.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.089 -1.007 . . . . 0.0 110.05 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.584 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 81.2 t80 -101.69 164.53 11.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.014 -1.054 . . . . 0.0 110.354 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.563 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 28.2 mm-40 -118.01 129.67 25.21 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 110.126 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.482 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 49.2 Cg_endo -81.56 81.91 2.51 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.926 1.487 . . . . 0.0 110.535 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 81.0 p -79.72 -1.97 40.88 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.172 -0.955 . . . . 0.0 110.06 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -144.06 -176.8 5.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.941 . . . . 0.0 110.135 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -92.69 131.61 37.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.0 110.072 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.36 -5.33 57.27 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.07 157.38 18.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.14 -1.212 . . . . 0.0 110.294 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.471 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 32.1 tp -115.3 120.06 38.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 110.079 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.482 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -97.74 47.85 1.52 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.817 ' CE2' ' HB1' ' A' ' 11' ' ' ALA . 46.6 p90 -49.29 174.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -1.153 . . . . 0.0 111.305 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.547 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 95.8 mt-10 -107.63 173.68 6.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.523 -0.736 . . . . 0.0 109.943 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -68.39 139.45 55.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.098 -1.001 . . . . 0.0 110.355 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.16 -15.41 49.41 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.516 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 22.8 tt0 -62.28 124.4 20.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.116 -1.226 . . . . 0.0 110.016 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.973 ' C ' HD12 ' A' ' 31' ' ' LEU . 91.9 mt-30 -79.9 136.87 36.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -0.887 . . . . 0.0 109.902 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.973 HD12 ' C ' ' A' ' 30' ' ' GLN . 6.6 mp -141.65 163.61 32.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.126 -0.984 . . . . 0.0 110.533 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.83 ' HE ' HD11 ' A' ' 34' ' ' LEU . 10.5 ptt180 -112.72 136.85 51.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.351 -0.843 . . . . 0.0 109.575 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.467 HD11 HG11 ' A' ' 9' ' ' VAL . 61.8 mt -90.74 95.28 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.175 -0.953 . . . . 0.0 110.655 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.83 HD11 ' HE ' ' A' ' 32' ' ' ARG . 1.2 mt -79.46 -30.49 42.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 110.778 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.547 ' CG ' ' HB3' ' A' ' 42' ' ' LYS . 39.8 mm-40 -135.07 139.76 45.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.885 -1.135 . . . . 0.0 110.438 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.626 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 16.9 mt-30 -130.9 54.67 1.89 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.282 -0.886 . . . . 0.0 110.158 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.0 m -116.87 145.7 43.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.237 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.28 172.15 10.6 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.3 -28.01 66.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.181 -1.188 . . . . 0.0 110.16 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.569 ' CZ3' ' OH ' ' A' ' 15' ' ' TYR . 94.8 m95 -99.53 144.67 28.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 110.282 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.626 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.6 m0 -120.79 156.36 32.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.864 . . . . 0.0 110.149 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.547 ' HB3' ' CG ' ' A' ' 35' ' ' GLU . 24.6 tttp -98.32 140.25 32.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.372 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.634 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -156.25 -178.41 7.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.061 -1.024 . . . . 0.0 110.618 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.514 ' HB3' ' CD ' ' A' ' 32' ' ' ARG . 48.4 tt0 -151.09 158.81 44.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.479 -0.763 . . . . 0.0 109.72 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -108.01 140.04 41.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.155 -0.966 . . . . 0.0 110.357 -179.8 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.42 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 22.7 tp -90.85 11.2 23.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -0.86 . . . . 0.0 110.07 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.4 m -97.03 -38.6 9.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.0 110.241 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.1 p -119.35 -8.84 10.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.217 -0.927 . . . . 0.0 110.207 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.47 36.21 49.99 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.478 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 3.1 mt-30 -108.75 141.76 40.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -1.109 . . . . 0.0 110.14 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.512 ' CA ' ' HG3' ' A' ' 44' ' ' GLN . 83.4 tt0 -121.61 143.08 49.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.216 -0.928 . . . . 0.0 110.124 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.471 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -173.47 165.63 37.7 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -71.77 145.45 48.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.401 -1.058 . . . . 0.0 110.075 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.46 ' O ' HG13 ' A' ' 54' ' ' ILE . 1.3 pt -136.97 137.66 23.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.182 -0.949 . . . . 0.0 110.198 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.596 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 46.6 Cg_endo -62.06 145.16 96.68 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.944 1.497 . . . . 0.0 110.049 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.594 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 31.1 p90 -73.27 -3.96 30.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.365 -0.835 . . . . 0.0 110.902 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -96.09 -26.23 15.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.912 -1.117 . . . . 0.0 111.066 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.596 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 15.3 m-85 -83.43 3.07 33.58 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.96 -1.087 . . . . 0.0 110.242 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.522 HG12 ' HB ' ' A' ' 9' ' ' VAL . 16.0 t -146.41 168.19 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 109.907 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.634 ' O ' HG12 ' A' ' 9' ' ' VAL . . . -158.96 160.83 36.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 110.26 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 62' ' ' ALA . 92.2 mttt -69.28 121.92 17.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -0.904 . . . . 0.0 110.169 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 61' ' ' LYS . . . -43.45 154.97 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 110.187 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.8 t30 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.176 -179.979 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p -124.82 80.17 63.07 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.295 -1.121 . . . . 0.0 110.171 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -51.27 146.35 24.24 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.973 1.512 . . . . 0.0 110.4 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 48.9 mt -58.34 -37.95 76.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.236 -0.915 . . . . 0.0 110.181 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.408 ' HB3' ' OD1' ' A' ' 7' ' ' ASN . 87.6 mt-30 -51.53 -29.66 17.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.162 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 5' ' ' GLN . 92.0 m-20 54.09 51.13 15.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 110.197 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.45 ' O ' HG13 ' A' ' 33' ' ' ILE . 23.9 m120 -87.51 11.09 15.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.898 . . . . 0.0 110.266 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.524 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.7 mp -96.48 149.34 21.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.945 . . . . 0.0 110.14 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.728 ' CG1' HD11 ' A' ' 33' ' ' ILE . 13.6 m -150.25 169.83 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.185 -0.947 . . . . 0.0 110.387 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 57.0 mt -116.79 141.86 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.311 -0.868 . . . . 0.0 109.559 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.764 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -80.26 113.74 18.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.122 -0.986 . . . . 0.0 110.515 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.458 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 82.5 mt -67.07 -24.28 65.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.061 -1.024 . . . . 0.0 109.121 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.458 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 42.8 m80 -157.31 150.83 24.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.602 -0.686 . . . . 0.0 109.547 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 36.8 p -62.31 142.17 57.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.93 -1.106 . . . . 0.0 110.069 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 82.1 t80 -100.82 162.64 12.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.078 -1.014 . . . . 0.0 110.472 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -119.71 121.59 29.75 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.334 -0.854 . . . . 0.0 109.911 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.496 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 47.6 Cg_endo -79.42 94.36 1.06 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.037 1.546 . . . . 0.0 110.521 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.401 ' HG ' ' CE1' ' A' ' 19' ' ' HIS . 50.6 p -79.89 0.97 28.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 110.005 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.401 ' CE1' ' HG ' ' A' ' 18' ' ' SER . 48.4 m80 -145.08 165.71 27.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.893 . . . . 0.0 109.888 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -77.46 131.74 38.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.133 -0.979 . . . . 0.0 110.185 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.27 -7.13 40.04 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 4.3 m-20 -91.58 165.35 13.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.231 -1.158 . . . . 0.0 110.201 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.526 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 20.1 tp -122.81 128.5 50.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 109.978 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.496 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -106.77 55.34 0.53 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.764 ' CE2' ' HB1' ' A' ' 11' ' ' ALA . 37.3 p90 -45.31 171.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -1.14 . . . . 0.0 110.882 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.474 ' N ' ' OE1' ' A' ' 29' ' ' GLU . 94.9 mt-10 -97.66 174.48 6.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.412 -0.805 . . . . 0.0 110.239 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -70.66 122.68 20.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.873 . . . . 0.0 110.349 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.01 -7.1 76.64 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.474 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 39.1 tt0 -70.34 129.57 39.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.001 -1.293 . . . . 0.0 110.06 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.599 ' O ' HD23 ' A' ' 31' ' ' LEU . 92.8 mt-30 -79.46 138.35 37.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.885 . . . . 0.0 109.981 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.642 HD11 ' CG ' ' A' ' 25' ' ' PHE . 16.9 mt -135.56 156.41 48.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.149 -0.969 . . . . 0.0 110.47 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 31.3 ttm180 -98.37 130.99 45.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.379 -0.826 . . . . 0.0 109.918 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.728 HD11 ' CG1' ' A' ' 9' ' ' VAL . 34.5 mt -76.03 119.7 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 110.164 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.686 HD21 ' HB2' ' A' ' 44' ' ' GLN . 96.9 mt -87.75 -35.19 18.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.334 -0.854 . . . . 0.0 110.179 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -150.56 175.08 12.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -0.921 . . . . 0.0 110.314 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.626 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 27.1 mt-30 -151.09 57.8 0.9 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.281 -0.887 . . . . 0.0 110.192 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.3 t -125.2 130.36 51.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 110.152 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.88 -170.79 42.14 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -75.65 -34.24 60.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.194 -1.18 . . . . 0.0 110.178 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.561 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 94.8 m95 -97.84 146.4 25.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -0.89 . . . . 0.0 110.155 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.626 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.2 m0 -124.42 155.76 38.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.289 -0.882 . . . . 0.0 110.18 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 34' ' ' LEU . 19.7 mttt -91.12 146.3 23.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 109.663 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.665 ' HB2' HG12 ' A' ' 54' ' ' ILE . . . -144.05 165.92 26.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.221 -0.924 . . . . 0.0 110.635 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.686 ' HB2' HD21 ' A' ' 34' ' ' LEU . 59.5 tt0 -134.59 142.89 47.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.415 -0.803 . . . . 0.0 109.957 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.9 m -76.99 140.06 40.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 110.14 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 14.2 tp -88.31 -19.69 26.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.913 . . . . 0.0 109.968 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.0 p -102.92 -28.13 12.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.828 . . . . 0.0 110.404 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m -96.3 -20.94 18.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.081 -1.012 . . . . 0.0 110.107 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.71 47.49 67.59 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 61.2 mt-30 -133.86 158.59 43.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.325 -1.103 . . . . 0.0 110.191 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 92.5 mt-10 -119.77 143.67 47.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.083 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.526 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -154.63 -152.05 6.01 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -122.16 134.33 54.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.368 -1.078 . . . . 0.0 110.056 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.869 HD12 HG21 ' A' ' 59' ' ' VAL . 1.8 pt -129.11 140.48 38.74 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.965 . . . . 0.0 110.183 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.594 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 47.3 Cg_endo -73.0 157.34 51.25 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.958 1.504 . . . . 0.0 110.12 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -78.84 -5.01 52.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -0.858 . . . . 0.0 111.009 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -98.44 -26.51 14.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.897 -1.127 . . . . 0.0 111.215 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.594 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 13.1 m-85 -83.63 -9.18 59.07 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.929 -1.107 . . . . 0.0 110.469 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.869 HG21 HD12 ' A' ' 54' ' ' ILE . 31.0 m -133.98 145.0 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.166 -0.959 . . . . 0.0 110.383 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -129.12 159.21 36.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.836 . . . . 0.0 110.119 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.507 ' HA ' HG12 ' A' ' 9' ' ' VAL . 89.9 mttt -76.22 118.7 19.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -0.959 . . . . 0.0 110.177 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.79 144.45 8.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 110.204 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 30.6 m120 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.234 -179.952 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.62 78.44 68.66 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.227 -1.161 . . . . 0.0 110.251 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -51.18 146.01 24.63 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.948 1.499 . . . . 0.0 110.347 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.412 ' HA ' HD12 ' A' ' 4' ' ' LEU . 43.2 tp -65.2 -29.39 70.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.235 -0.916 . . . . 0.0 110.232 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.48 ' HB3' ' OD1' ' A' ' 7' ' ' ASN . 98.7 mt-30 -59.64 -27.01 65.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.889 . . . . 0.0 110.22 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 50.57 44.93 27.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 110.185 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.48 ' OD1' ' HB3' ' A' ' 5' ' ' GLN . 22.8 m120 -79.74 -1.13 37.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.145 -0.972 . . . . 0.0 110.251 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.538 ' C ' HG13 ' A' ' 9' ' ' VAL . 23.6 tp -80.06 148.59 30.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.115 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.538 HG13 ' C ' ' A' ' 8' ' ' LEU . 31.7 m -153.7 172.03 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.192 -0.943 . . . . 0.0 110.37 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 54.8 mt -113.9 146.11 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.319 -0.863 . . . . 0.0 109.712 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.802 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -80.13 110.12 15.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.13 -0.982 . . . . 0.0 110.287 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.993 HD13 ' O ' ' A' ' 12' ' ' LEU . 2.0 tm? -65.61 -25.07 67.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.065 -1.022 . . . . 0.0 109.405 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.683 ' CD2' HD12 ' A' ' 12' ' ' LEU . 8.5 m-70 -155.69 158.95 39.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.51 -0.744 . . . . 0.0 109.744 179.669 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.553 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 47.3 p -68.41 139.89 55.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.999 -1.063 . . . . 0.0 110.105 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.597 ' CD1' ' HD3' ' A' ' 55' ' ' PRO . 87.9 t80 -95.72 156.42 16.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.046 -1.034 . . . . 0.0 110.33 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.563 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -99.4 127.13 35.3 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.322 -0.861 . . . . 0.0 110.062 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.475 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.0 Cg_endo -89.5 86.78 0.43 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.033 1.544 . . . . 0.0 110.397 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.9 p -79.98 1.3 28.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -0.943 . . . . 0.0 110.111 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.403 ' HB2' ' CG ' ' A' ' 22' ' ' ASP . 38.8 m80 -134.7 -168.31 2.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.078 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.7 p30 -105.79 -6.19 19.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.187 -0.945 . . . . 0.0 110.196 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.48 -0.53 23.39 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.403 ' CG ' ' HB2' ' A' ' 19' ' ' HIS . 61.3 m-20 -88.13 163.17 16.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.127 -1.22 . . . . 0.0 110.243 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.493 HD13 ' HG2' ' A' ' 50' ' ' GLN . 22.2 tp -114.53 120.49 40.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.298 -0.876 . . . . 0.0 110.086 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.475 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -103.7 54.81 0.65 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.802 ' CE2' ' HB1' ' A' ' 11' ' ' ALA . 50.6 p90 -53.39 176.57 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -1.155 . . . . 0.0 111.022 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.553 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 92.5 mt-10 -110.39 178.27 4.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.442 -0.786 . . . . 0.0 110.026 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 12' ' ' LEU . 27.9 tttt -67.38 136.45 54.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.124 -0.985 . . . . 0.0 110.421 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.47 -16.13 50.91 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.574 ' HG2' HD21 ' A' ' 31' ' ' LEU . 10.3 tt0 -60.83 123.21 16.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.131 -1.217 . . . . 0.0 110.41 -179.666 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.484 ' O ' HD23 ' A' ' 31' ' ' LEU . 94.0 mt-30 -79.75 134.52 36.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.35 -0.844 . . . . 0.0 109.79 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.574 HD21 ' HG2' ' A' ' 29' ' ' GLU . 15.5 mt -137.99 159.38 42.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.949 . . . . 0.0 110.319 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.704 ' HE ' HD11 ' A' ' 34' ' ' LEU . 3.7 ptt180 -109.25 134.98 51.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.278 -0.889 . . . . 0.0 109.614 179.357 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 61.1 mt -91.39 95.17 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.094 -1.004 . . . . 0.0 110.758 -179.281 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.704 HD11 ' HE ' ' A' ' 32' ' ' ARG . 1.6 mt -78.86 -29.45 44.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 110.622 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 42' ' ' LYS . 74.1 tt0 -128.6 140.76 51.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.002 -1.062 . . . . 0.0 110.274 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.621 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 47.7 tt0 -138.42 68.4 1.39 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 110.222 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.4 p -131.81 132.83 44.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.0 110.207 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.84 -162.56 41.15 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -80.96 -31.17 34.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -1.163 . . . . 0.0 110.208 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.56 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 91.4 m95 -98.87 146.51 25.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.269 -0.894 . . . . 0.0 110.352 -179.79 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.621 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 47.3 m0 -125.35 156.46 38.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 110.21 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.513 ' HB3' ' HB3' ' A' ' 35' ' ' GLU . 25.7 tttp -97.6 145.32 26.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.14 179.217 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.58 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -160.35 -173.57 4.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.908 -1.12 . . . . 0.0 110.947 -179.638 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.54 ' HB3' ' CD ' ' A' ' 32' ' ' ARG . 39.2 tt0 -155.15 162.18 41.05 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.576 -0.702 . . . . 0.0 109.475 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.532 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 1.7 m -103.22 128.42 50.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.068 -1.02 . . . . 0.0 110.276 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.455 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 25.4 tp -82.44 1.89 35.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.337 -0.852 . . . . 0.0 110.154 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.0 m -96.96 -34.48 11.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 110.205 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.0 p -115.99 -16.31 11.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.935 . . . . 0.0 110.183 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.8 25.68 55.55 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.493 ' HG2' HD13 ' A' ' 23' ' ' LEU . 56.9 tt0 -97.18 135.65 38.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -1.154 . . . . 0.0 110.243 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.445 ' HG3' ' HB2' ' A' ' 44' ' ' GLN . 82.1 tt0 -120.02 141.13 50.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.253 -0.905 . . . . 0.0 109.939 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.476 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -167.32 -137.84 2.32 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -125.91 138.42 53.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.416 -1.049 . . . . 0.0 109.947 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.748 HD12 HG11 ' A' ' 59' ' ' VAL . 16.9 pt -128.23 148.78 69.16 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 110.255 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.598 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 45.3 Cg_endo -80.42 148.31 18.45 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.017 1.535 . . . . 0.0 109.728 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.594 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 35.8 p90 -69.87 -4.61 21.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 111.021 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -98.21 -26.44 14.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.831 -1.168 . . . . 0.0 111.396 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.598 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 8.1 m-85 -84.41 -2.84 57.81 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.938 -1.101 . . . . 0.0 110.395 -179.666 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.748 HG11 HD12 ' A' ' 54' ' ' ILE . 33.4 m -131.32 141.71 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.131 -0.981 . . . . 0.0 110.1 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.65 157.66 31.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.114 -0.991 . . . . 0.0 110.38 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -65.65 128.12 34.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 0.0 110.169 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.82 145.67 19.16 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.311 -0.868 . . . . 0.0 110.154 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 42.6 t30 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.204 -179.983 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 m -65.95 145.57 99.01 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.265 -1.138 . . . . 0.0 110.202 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -57.51 142.37 95.37 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.085 1.571 . . . . 0.0 110.315 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 62.1 mt -59.1 -36.17 74.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 110.183 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.445 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . 98.0 mt-30 -123.02 137.63 54.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.313 -0.867 . . . . 0.0 110.21 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -60.49 -29.92 69.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.909 . . . . 0.0 110.191 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -83.43 3.86 30.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.314 -0.866 . . . . 0.0 110.207 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.895 HD13 ' N ' ' A' ' 9' ' ' VAL . 3.2 tm? -82.19 137.43 34.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.33 -0.856 . . . . 0.0 110.192 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.895 ' N ' HD13 ' A' ' 8' ' ' LEU . 27.1 m -146.6 167.66 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.312 -0.867 . . . . 0.0 110.345 180.0 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.6 mm -112.54 141.34 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.705 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.607 ' HB1' ' CE1' ' A' ' 25' ' ' PHE . . . -79.03 109.64 13.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.057 -1.027 . . . . 0.0 110.268 -179.817 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.44 ' HG ' ' CE1' ' A' ' 13' ' ' HIS . 16.6 tp -67.39 -24.96 65.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.09 -1.006 . . . . 0.0 109.255 179.39 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.44 ' CE1' ' HG ' ' A' ' 12' ' ' LEU . 66.1 m80 -153.51 151.4 29.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.551 -0.718 . . . . 0.0 109.622 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.549 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 52.7 p -65.4 143.66 57.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 109.996 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.571 ' CD1' ' HG3' ' A' ' 55' ' ' PRO . 22.3 t80 -92.77 150.31 20.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.106 -0.996 . . . . 0.0 110.287 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -106.9 79.48 0.67 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.895 . . . . 0.0 110.268 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.437 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 47.5 Cg_endo -47.45 109.62 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.08 1.568 . . . . 0.0 110.396 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.41 ' O ' ' CD2' ' A' ' 19' ' ' HIS . 91.6 p -90.35 12.1 19.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.213 -0.93 . . . . 0.0 110.217 -179.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.41 ' CD2' ' O ' ' A' ' 18' ' ' SER . 45.0 m80 -147.54 -178.97 6.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.207 179.979 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -98.7 116.59 31.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.247 -0.908 . . . . 0.0 110.203 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.4 7.54 6.89 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.425 ' HB2' ' HB3' ' A' ' 17' ' ' PRO . 10.4 m-20 -105.8 171.85 7.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.16 -1.2 . . . . 0.0 110.152 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.529 HD21 ' HB2' ' A' ' 45' ' ' SER . 18.7 tp -113.32 115.59 28.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.303 -0.873 . . . . 0.0 109.876 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.437 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -99.12 55.21 0.97 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.607 ' CE1' ' HB1' ' A' ' 11' ' ' ALA . 37.0 p90 -54.76 175.99 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -1.118 . . . . 0.0 111.208 -179.498 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.549 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 96.0 mt-10 -110.25 177.97 4.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.546 -0.721 . . . . 0.0 110.056 179.797 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.7 tttt -67.22 139.23 57.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.11 -0.994 . . . . 0.0 110.505 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.63 -14.72 54.89 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.853 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 3.1 mt-10 -65.05 125.59 25.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.06 -1.259 . . . . 0.0 110.293 -179.698 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.978 ' C ' HD12 ' A' ' 31' ' ' LEU . 52.1 tt0 -79.62 136.16 36.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 109.916 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.978 HD12 ' C ' ' A' ' 30' ' ' GLN . 7.6 mp -138.94 160.02 40.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 110.467 -179.698 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.605 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 46.7 ttt180 -105.82 131.7 52.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.414 -0.804 . . . . 0.0 109.427 179.4 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.66 HD11 HG21 ' A' ' 9' ' ' VAL . 35.0 mm -92.35 94.39 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.093 -1.004 . . . . 0.0 110.623 -179.551 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.492 HD21 ' CZ ' ' A' ' 32' ' ' ARG . 11.8 mt -79.84 -29.91 40.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.278 -0.889 . . . . 0.0 110.751 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.495 ' HB3' ' HB3' ' A' ' 42' ' ' LYS . 41.5 tp10 -131.03 142.96 50.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.908 -1.12 . . . . 0.0 110.383 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.641 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 13.6 mt-30 -138.01 54.88 1.78 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.88 . . . . 0.0 110.017 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.1 m -120.38 137.47 54.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.935 . . . . 0.0 110.237 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.26 -171.66 55.15 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -74.83 -33.67 62.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -1.17 . . . . 0.0 110.212 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.443 ' CZ3' ' OH ' ' A' ' 15' ' ' TYR . 95.6 m95 -93.77 139.83 30.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 110.212 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.641 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 32.2 m0 -118.17 154.97 31.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.041 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 35' ' ' GLU . 16.3 tttm -100.95 138.78 37.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.312 -0.868 . . . . 0.0 109.145 179.235 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.605 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -150.74 177.57 9.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.998 -1.064 . . . . 0.0 110.965 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.473 ' CG ' ' HG2' ' A' ' 51' ' ' GLU . 47.2 tt0 -138.27 146.77 42.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.48 -0.763 . . . . 0.0 109.788 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.529 ' HB2' HD21 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -96.52 116.12 28.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.13 -0.981 . . . . 0.0 110.255 -179.884 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.6 mt -75.71 1.65 14.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.888 . . . . 0.0 110.307 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 47.9 p -89.92 -32.33 16.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.124 -0.985 . . . . 0.0 110.144 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.5 p -120.56 -3.8 9.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 110.082 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.24 48.16 60.25 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.471 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 10.8 mt-30 -130.17 155.65 45.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -1.142 . . . . 0.0 110.349 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.473 ' HG2' ' CG ' ' A' ' 44' ' ' GLN . 97.9 mt-10 -121.41 147.86 45.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.325 -0.859 . . . . 0.0 109.944 179.785 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.501 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -164.75 -153.6 7.55 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -119.67 135.08 54.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.505 -0.997 . . . . 0.0 109.719 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.788 ' CD1' HG21 ' A' ' 59' ' ' VAL . 1.0 OUTLIER -126.7 149.42 68.33 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.126 -0.984 . . . . 0.0 110.568 -179.668 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.574 ' O ' HG22 ' A' ' 59' ' ' VAL . 46.3 Cg_endo -77.78 132.6 12.04 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.057 1.556 . . . . 0.0 109.965 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.582 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 15.0 p90 -66.46 -9.68 36.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 111.017 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -87.28 -26.41 23.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.883 -1.136 . . . . 0.0 110.841 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.568 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 16.8 m-30 -96.28 7.18 47.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.045 -1.034 . . . . 0.0 110.259 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.788 HG21 ' CD1' ' A' ' 54' ' ' ILE . 35.2 m -135.55 142.26 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 0.0 110.091 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -145.34 154.96 42.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.232 -0.917 . . . . 0.0 110.219 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.485 ' HA ' HG12 ' A' ' 9' ' ' VAL . 79.3 tttt -65.64 128.12 34.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 110.204 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.51 142.75 58.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.904 . . . . 0.0 110.184 -179.966 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 60.5 m-20 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.209 -179.999 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 p -79.06 152.91 77.18 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.209 -1.171 . . . . 0.0 110.185 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -57.79 145.69 89.22 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.001 1.527 . . . . 0.0 110.327 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 56.8 tp -91.36 132.53 36.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.243 -0.91 . . . . 0.0 110.268 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -144.01 156.14 44.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 110.267 179.967 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.407 ' C ' ' OD1' ' A' ' 6' ' ' ASP . 58.1 p30 -82.27 4.68 22.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.894 . . . . 0.0 110.176 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.436 ' O ' HG13 ' A' ' 33' ' ' ILE . 24.3 m120 -84.65 1.44 46.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.903 . . . . 0.0 110.269 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.454 ' C ' HG13 ' A' ' 9' ' ' VAL . 21.7 tp -81.72 146.23 30.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.275 -0.89 . . . . 0.0 110.105 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.749 HG11 HD11 ' A' ' 33' ' ' ILE . 30.2 m -150.02 169.87 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.159 -0.963 . . . . 0.0 110.367 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 85.9 mt -112.27 144.91 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 109.728 179.575 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . -77.83 114.89 17.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.13 -0.981 . . . . 0.0 110.349 -179.712 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.575 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 73.1 mt -73.7 -24.93 60.0 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.071 -1.018 . . . . 0.0 109.316 179.409 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.575 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 40.5 m80 -161.38 146.47 13.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.612 -0.68 . . . . 0.0 109.543 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 53.5 p -60.59 142.07 55.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.919 -1.113 . . . . 0.0 109.904 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.541 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 45.8 t80 -99.0 159.12 15.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.015 -1.053 . . . . 0.0 110.587 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -109.4 82.08 1.98 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.411 -0.806 . . . . 0.0 110.067 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.547 ' CB ' ' HB2' ' A' ' 22' ' ' ASP . 47.4 Cg_endo -48.55 104.55 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.034 1.544 . . . . 0.0 110.44 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.522 ' OG ' ' CE1' ' A' ' 19' ' ' HIS . 64.5 p -80.67 0.1 35.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.201 -0.937 . . . . 0.0 110.169 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.522 ' CE1' ' OG ' ' A' ' 18' ' ' SER . 64.5 m80 -134.85 176.73 8.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.143 -0.973 . . . . 0.0 110.147 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -82.38 -11.86 58.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 110.461 -179.79 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -105.66 25.05 25.5 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.547 ' HB2' ' CB ' ' A' ' 17' ' ' PRO . 52.4 m-20 -111.92 161.83 15.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.157 -1.202 . . . . 0.0 110.364 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.495 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 23.7 tp -116.18 120.46 39.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.773 179.713 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.537 ' CA ' ' HD3' ' A' ' 17' ' ' PRO . . . -98.02 51.06 1.31 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.866 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.557 ' CG ' HD11 ' A' ' 31' ' ' LEU . 22.2 p90 -47.34 170.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -1.155 . . . . 0.0 110.568 -179.649 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -100.01 179.05 4.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.391 -0.818 . . . . 0.0 110.282 -179.649 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 20.6 tttt -71.96 120.47 17.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.326 -0.859 . . . . 0.0 110.033 179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 96.63 -9.18 66.47 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.513 ' OE2' ' CB ' ' A' ' 25' ' ' PHE . 31.4 tt0 -60.7 133.21 55.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.168 -1.195 . . . . 0.0 110.27 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -79.93 129.06 34.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.0 109.888 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.557 HD11 ' CG ' ' A' ' 25' ' ' PHE . 27.0 mt -130.11 150.7 51.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.168 -0.958 . . . . 0.0 110.437 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.499 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 30.5 ttp180 -106.01 140.64 38.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.349 -0.845 . . . . 0.0 109.824 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.749 HD11 HG11 ' A' ' 9' ' ' VAL . 55.8 mt -91.51 136.09 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 110.173 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.452 ' CD1' ' HB2' ' A' ' 44' ' ' GLN . 91.6 mt -129.94 -30.89 1.98 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.371 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.479 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 78.6 tt0 -128.25 146.64 50.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 110.307 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.593 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 52.6 tt0 -142.25 58.1 1.46 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.254 -0.904 . . . . 0.0 110.144 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.4 t -118.22 114.38 22.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.269 -0.894 . . . . 0.0 110.229 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.3 -160.93 20.62 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -84.18 -29.59 26.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.189 -1.183 . . . . 0.0 110.251 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.551 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 91.3 m95 -96.06 145.05 25.79 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.288 -0.883 . . . . 0.0 110.169 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.593 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 48.8 m0 -119.17 153.1 35.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.226 -0.922 . . . . 0.0 110.281 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.482 ' HE2' ' OE2' ' A' ' 51' ' ' GLU . 9.9 tttp -99.43 110.58 23.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 110.043 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.499 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -112.37 175.46 5.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.229 -0.919 . . . . 0.0 110.708 -179.588 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.49 ' CG ' ' O ' ' A' ' 50' ' ' GLN . 44.4 tt0 -138.18 146.59 42.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.338 -0.851 . . . . 0.0 109.951 -179.799 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.42 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 6.9 t -79.01 137.78 37.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.109 -0.994 . . . . 0.0 110.174 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.463 ' HA ' HD12 ' A' ' 46' ' ' LEU . 21.2 tp -80.7 -21.06 41.58 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.596 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 95.9 m -83.35 -50.68 8.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.447 -0.783 . . . . 0.0 110.241 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 50' ' ' GLN . 18.0 p -100.22 1.69 42.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.079 -1.013 . . . . 0.0 110.32 -179.694 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 45' ' ' SER . . . 54.03 18.92 9.79 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.49 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 37.2 mt-30 -78.7 153.67 30.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -1.148 . . . . 0.0 110.281 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.482 ' OE2' ' HE2' ' A' ' 42' ' ' LYS . 86.6 tt0 -120.36 142.82 48.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 110.13 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.495 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -165.83 156.81 28.98 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -71.55 141.0 50.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -1.175 . . . . 0.0 109.961 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.796 HD12 ' O ' ' A' ' 55' ' ' PRO . 1.9 pp -141.21 124.8 10.05 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.302 -0.874 . . . . 0.0 110.146 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.796 ' O ' HD12 ' A' ' 54' ' ' ILE . 46.2 Cg_endo -46.37 167.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.931 1.49 . . . . 0.0 110.098 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -95.69 -1.84 49.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 110.539 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -99.18 -24.58 14.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.141 -0.974 . . . . 0.0 110.724 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.585 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 27.4 m-85 -79.64 -12.87 59.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.988 -1.07 . . . . 0.0 110.515 -179.66 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.795 HG21 ' CD1' ' A' ' 54' ' ' ILE . 30.6 m -131.25 143.32 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.106 -0.996 . . . . 0.0 110.187 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -129.57 151.27 50.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.301 -0.874 . . . . 0.0 110.172 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.648 ' HA ' HG12 ' A' ' 9' ' ' VAL . 78.7 tttt -67.83 115.38 7.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.287 -0.883 . . . . 0.0 110.269 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 49.62 -145.73 0.41 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -0.888 . . . . 0.0 110.219 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.155 -179.958 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.92 137.07 97.03 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.212 -1.169 . . . . 0.0 110.179 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -53.05 142.91 52.61 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.083 1.57 . . . . 0.0 110.425 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.4 mt -70.53 -31.51 68.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 110.224 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.444 ' HB3' ' CB ' ' A' ' 8' ' ' LEU . 96.3 mt-30 51.04 48.55 22.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 110.238 179.93 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -63.46 -34.39 77.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.333 -0.854 . . . . 0.0 110.186 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.453 ' O ' HG13 ' A' ' 33' ' ' ILE . 77.7 m-20 -84.0 -5.42 59.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 110.287 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.533 ' C ' HG13 ' A' ' 9' ' ' VAL . 6.6 tp -75.89 141.42 42.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -0.952 . . . . 0.0 110.142 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.546 HG11 HD11 ' A' ' 33' ' ' ILE . 28.7 m -154.84 172.73 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 0.0 110.287 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 62.8 mt -112.49 145.43 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 109.806 179.618 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.717 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -80.11 111.69 16.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.046 -1.034 . . . . 0.0 110.273 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 58' ' ' PHE . 6.1 mp -64.87 -28.46 69.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.068 -1.02 . . . . 0.0 109.356 179.451 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.444 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 30.7 m80 -155.39 157.66 37.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.564 -0.71 . . . . 0.0 109.794 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.556 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 10.3 t -64.92 140.61 58.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.099 -1.0 . . . . 0.0 109.939 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.605 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 86.3 t80 -94.5 151.69 19.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.02 -1.05 . . . . 0.0 110.474 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.411 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 4.2 tp10 -114.02 91.89 24.2 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.409 -0.807 . . . . 0.0 110.076 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.513 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 46.8 Cg_endo -59.26 114.12 1.89 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.055 1.555 . . . . 0.0 110.476 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 74.2 p -89.54 11.33 19.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.275 -0.891 . . . . 0.0 109.996 179.826 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 46.3 m80 -145.95 -177.11 5.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 0.0 110.15 -179.939 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -100.33 118.89 37.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 110.139 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.95 -14.33 7.51 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -85.24 174.13 9.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -1.121 . . . . 0.0 110.339 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.52 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 20.2 tp -118.42 122.43 42.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 110.011 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.513 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -102.17 57.08 0.64 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.717 ' CE2' ' HB1' ' A' ' 11' ' ' ALA . 48.6 p90 -53.67 174.13 0.05 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.167 -1.196 . . . . 0.0 110.86 -179.805 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.556 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 73.6 mm-40 -108.0 -179.48 3.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.463 -0.773 . . . . 0.0 110.137 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -68.37 134.52 50.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.928 . . . . 0.0 110.365 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.17 -13.19 62.23 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.457 ' HG3' HD21 ' A' ' 31' ' ' LEU . 26.1 tp10 -62.08 122.99 16.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -1.16 . . . . 0.0 110.409 -179.712 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.635 ' O ' HD23 ' A' ' 31' ' ' LEU . 97.0 mt-30 -79.91 136.42 36.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.33 -0.856 . . . . 0.0 109.879 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.635 HD23 ' O ' ' A' ' 30' ' ' GLN . 17.4 mt -139.04 160.87 38.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.418 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.594 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 4.1 tpt180 -106.4 134.03 50.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.381 -0.825 . . . . 0.0 109.498 179.533 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.546 HD11 HG11 ' A' ' 9' ' ' VAL . 35.4 mt -95.77 92.84 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.139 -0.976 . . . . 0.0 110.485 -179.669 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.764 HD12 ' HA ' ' A' ' 43' ' ' ALA . 1.1 mt -79.2 -24.97 42.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.274 -0.891 . . . . 0.0 110.631 -179.406 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 42' ' ' LYS . 70.7 tt0 -135.82 136.3 40.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.026 -1.046 . . . . 0.0 110.253 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.642 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 12.0 mt-30 -132.23 53.86 1.98 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.879 . . . . 0.0 110.188 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.0 m -115.9 138.4 51.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -0.882 . . . . 0.0 110.099 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.95 -172.89 55.2 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -72.73 -34.43 67.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.188 -1.184 . . . . 0.0 110.234 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.565 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 99.5 m95 -96.73 143.62 27.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 110.139 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.642 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 51.2 m0 -121.78 155.64 34.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.317 -0.865 . . . . 0.0 110.096 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 35' ' ' GLU . 46.7 tttm -96.32 141.98 29.0 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.277 -0.89 . . . . 0.0 109.237 179.282 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.764 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -150.03 174.13 13.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.927 -1.108 . . . . 0.0 111.023 -179.456 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 50' ' ' GLN . 58.7 tt0 -137.82 146.06 43.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.613 -0.679 . . . . 0.0 109.771 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 t -92.92 107.3 19.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 110.136 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 44.7 mt -70.01 -3.04 14.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.24 -0.913 . . . . 0.0 110.429 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.428 ' OG1' HG23 ' A' ' 48' ' ' THR . 30.1 p -89.07 -30.16 18.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.124 -0.985 . . . . 0.0 109.799 179.656 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.428 HG23 ' OG1' ' A' ' 47' ' ' THR . 49.2 p -120.81 -7.32 9.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.28 -0.887 . . . . 0.0 110.068 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.26 44.07 60.98 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.467 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 23.2 mt-30 -123.47 151.55 42.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -1.154 . . . . 0.0 110.301 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 97.1 mt-10 -119.3 141.56 48.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.322 -0.861 . . . . 0.0 109.998 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.52 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -159.1 -151.92 6.28 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -124.27 138.28 54.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.398 -1.06 . . . . 0.0 109.818 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.446 ' O ' HG13 ' A' ' 54' ' ' ILE . 2.9 pt -133.53 144.37 51.86 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.157 -0.964 . . . . 0.0 110.343 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.593 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 47.0 Cg_endo -72.64 151.86 52.85 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.06 1.558 . . . . 0.0 109.985 179.736 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.597 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 31.6 p90 -73.99 -4.26 34.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 111.134 -179.375 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -98.6 -26.14 14.49 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.895 -1.128 . . . . 0.0 111.341 -179.305 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.593 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 8.5 m-85 -82.65 -2.53 54.25 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.803 -1.186 . . . . 0.0 110.346 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 30.9 m -133.74 143.21 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.161 -0.962 . . . . 0.0 110.117 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.446 ' HB2' HD11 ' A' ' 12' ' ' LEU . . . -127.25 155.97 42.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 110.246 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.444 ' HA ' HG12 ' A' ' 9' ' ' VAL . 60.8 mttp -71.66 134.64 46.46 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.284 -0.885 . . . . 0.0 110.162 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.98 -34.82 76.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 0.0 110.241 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.959 -1.019 . . . . 0.0 110.212 -179.971 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.28 71.33 64.04 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.258 -1.142 . . . . 0.0 110.228 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -59.95 140.51 93.22 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.927 1.488 . . . . 0.0 110.369 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.8 tp -65.52 -34.43 78.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 110.218 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.71 -37.86 83.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.875 . . . . 0.0 110.257 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' ASP . . . . . 0.816 ' OD1' HD11 ' A' ' 8' ' ' LEU . 48.2 t0 -141.92 75.51 1.5 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.302 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -86.14 113.06 21.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.217 -0.927 . . . . 0.0 110.227 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.816 HD11 ' OD1' ' A' ' 6' ' ' ASP . 5.4 mp -112.91 150.86 31.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.297 -0.877 . . . . 0.0 110.31 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.73 HG12 ' HA ' ' A' ' 62' ' ' ALA . 4.2 m -145.95 167.72 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.267 -0.895 . . . . 0.0 110.288 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ILE . . . . . 0.767 HD12 ' CD ' ' A' ' 61' ' ' LYS . 61.8 mt -113.43 140.11 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.865 . . . . 0.0 109.781 179.661 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.555 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -80.66 110.22 15.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.137 -0.977 . . . . 0.0 110.555 -179.631 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 58' ' ' PHE . 52.4 mt -67.52 -22.94 65.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.08 -1.013 . . . . 0.0 109.162 179.164 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.439 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 21.8 m80 -157.37 146.72 20.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.641 -0.662 . . . . 0.0 109.408 179.704 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 81.9 p -61.5 146.38 48.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.998 -1.064 . . . . 0.0 110.14 -179.831 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 25.1 t80 -95.76 156.93 16.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.978 -1.076 . . . . 0.0 110.348 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 17' ' ' PRO . 46.1 mt-10 -114.07 73.87 2.58 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.326 -0.859 . . . . 0.0 110.121 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.515 ' HB3' ' HB2' ' A' ' 22' ' ' ASP . 47.7 Cg_endo -40.6 110.35 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.043 1.549 . . . . 0.0 110.429 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 59.6 p -87.25 8.21 25.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.348 -0.845 . . . . 0.0 110.168 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.467 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 52.0 m80 -145.48 170.54 16.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.09 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -87.25 126.89 35.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.266 -0.896 . . . . 0.0 110.294 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.27 -14.0 13.66 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.515 ' HB2' ' HB3' ' A' ' 17' ' ' PRO . 2.4 m-20 -86.68 174.66 8.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -1.152 . . . . 0.0 110.262 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.497 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 19.2 tp -120.63 124.66 45.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.868 . . . . 0.0 110.062 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.493 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -104.13 57.52 0.53 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.759 ' CG ' HD11 ' A' ' 31' ' ' LEU . 28.6 p90 -47.07 169.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.259 -1.142 . . . . 0.0 110.878 -179.532 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.486 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 90.7 mt-10 -98.84 177.48 5.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.495 -0.753 . . . . 0.0 110.14 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -71.55 119.89 16.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.184 -0.947 . . . . 0.0 110.348 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.9 -6.75 58.68 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.503 ' OE1' ' CA ' ' A' ' 25' ' ' PHE . 71.6 tt0 -73.71 127.43 32.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.008 -1.289 . . . . 0.0 110.172 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.43 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 58.2 mt-30 -79.25 142.67 36.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 110.004 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.759 HD11 ' CG ' ' A' ' 25' ' ' PHE . 73.0 mt -141.36 163.83 31.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.243 -0.91 . . . . 0.0 110.348 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.753 ' CD ' HD21 ' A' ' 34' ' ' LEU . 19.0 ttt180 -105.85 133.25 50.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.885 . . . . 0.0 109.63 179.553 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.632 HD11 HG21 ' A' ' 9' ' ' VAL . 31.0 mm -96.53 93.78 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.12 -0.987 . . . . 0.0 110.417 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.795 HD11 ' OE1' ' A' ' 44' ' ' GLN . 41.8 mt -79.83 -24.52 41.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.258 -0.901 . . . . 0.0 110.859 -179.543 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.516 ' CB ' ' HB3' ' A' ' 42' ' ' LYS . 17.9 tt0 -136.18 140.87 43.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.992 -1.067 . . . . 0.0 110.345 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.625 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 16.8 mt-30 -135.29 55.18 1.89 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.158 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -119.27 142.13 48.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.178 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.0 -171.16 54.62 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -74.16 -34.77 63.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -1.166 . . . . 0.0 110.132 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.561 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 95.3 m95 -96.28 144.5 26.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.302 -0.874 . . . . 0.0 110.272 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.625 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.9 m0 -118.85 156.09 30.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 110.217 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.516 ' HB3' ' CB ' ' A' ' 35' ' ' GLU . 29.0 tttt -96.18 137.57 35.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.358 -0.839 . . . . 0.0 109.408 179.412 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.589 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -152.77 176.65 11.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.01 . . . . 0.0 110.666 -179.554 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.795 ' OE1' HD11 ' A' ' 34' ' ' LEU . 14.5 pt20 -148.18 156.67 42.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.455 -0.778 . . . . 0.0 109.819 179.719 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.8 t -98.55 116.91 31.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.122 -0.987 . . . . 0.0 110.275 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.502 HD21 HE21 ' A' ' 44' ' ' GLN . 60.3 mt -74.51 -0.78 18.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 110.094 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 70.7 p -94.63 -27.22 16.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.36 -0.838 . . . . 0.0 110.166 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 47.4 p -114.25 -13.02 12.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 110.157 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.42 39.46 50.7 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -128.16 155.51 44.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -1.154 . . . . 0.0 110.276 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.485 ' HG2' ' CB ' ' A' ' 44' ' ' GLN . 73.6 mt-10 -123.8 152.56 42.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.905 . . . . 0.0 110.031 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.497 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -165.94 -149.89 6.09 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -127.74 143.63 51.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.46 -1.024 . . . . 0.0 109.683 179.61 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.504 HD12 ' O ' ' A' ' 55' ' ' PRO . 1.7 pp -141.01 139.2 18.94 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.132 -0.98 . . . . 0.0 110.696 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.608 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 44.8 Cg_endo -59.39 156.97 33.09 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.093 1.575 . . . . 0.0 109.907 179.465 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.727 ' CZ ' ' ND2' ' A' ' 57' ' ' ASN . 20.8 p90 -84.56 -2.28 57.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.097 -1.002 . . . . 0.0 110.766 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.727 ' ND2' ' CZ ' ' A' ' 56' ' ' PHE . 62.3 m-20 -103.65 13.22 33.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.984 -1.073 . . . . 0.0 110.696 -179.654 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.608 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 6.1 m-85 -111.32 -6.41 14.52 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.097 -1.002 . . . . 0.0 110.028 179.694 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 7.8 m -138.46 145.47 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.334 -0.854 . . . . 0.0 110.032 179.801 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 61' ' ' LYS . . . -160.26 -41.28 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.165 -0.959 . . . . 0.0 110.398 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.767 ' CD ' HD12 ' A' ' 10' ' ' ILE . 91.2 mttt -41.93 -29.18 0.2 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.87 . . . . 0.0 110.319 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.73 ' HA ' HG12 ' A' ' 9' ' ' VAL . . . 49.18 25.13 1.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.328 -0.857 . . . . 0.0 110.23 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.2 t30 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.268 -179.939 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.13 146.27 92.32 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.279 -1.13 . . . . 0.0 110.234 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -53.34 -29.13 46.49 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.012 1.532 . . . . 0.0 110.446 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 39.3 mt -88.91 146.65 24.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.153 -0.967 . . . . 0.0 110.21 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.533 ' O ' HD13 ' A' ' 8' ' ' LEU . 89.0 mt-30 -116.68 138.76 51.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.178 -0.952 . . . . 0.0 110.184 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -102.14 13.7 33.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.357 -0.84 . . . . 0.0 110.175 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -80.31 6.84 10.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.24 -0.913 . . . . 0.0 110.207 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.746 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.2 mp -84.23 140.92 31.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.208 -0.932 . . . . 0.0 110.231 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 61' ' ' LYS . 30.9 m -150.9 170.21 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 110.289 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.9 mt -112.27 148.7 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -0.83 . . . . 0.0 109.887 179.729 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.53 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . -80.12 112.01 17.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.131 -0.981 . . . . 0.0 110.422 -179.779 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.658 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.9 mm? -71.71 -22.41 61.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.192 -0.942 . . . . 0.0 109.442 179.442 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.422 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 86.0 m-70 -153.62 151.13 29.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.464 -0.772 . . . . 0.0 109.75 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.555 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 54.2 p -67.25 142.83 56.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.059 -1.026 . . . . 0.0 109.97 179.861 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.594 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 88.5 t80 -99.08 160.17 14.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.072 -1.017 . . . . 0.0 110.414 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.551 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 2.4 mm-40 -104.69 124.4 37.06 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.356 -0.84 . . . . 0.0 110.063 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.472 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 49.6 Cg_endo -81.06 82.84 2.34 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.945 1.497 . . . . 0.0 110.429 -179.843 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 59.6 p -79.99 -2.73 45.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 110.213 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -129.13 -159.34 0.95 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.933 . . . . 0.0 110.266 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -107.72 -19.1 13.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.191 -0.943 . . . . 0.0 110.235 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.23 10.48 31.28 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -89.95 155.94 18.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -1.184 . . . . 0.0 110.157 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.448 ' O ' ' CD2' ' A' ' 15' ' ' TYR . 14.5 tp -111.65 116.31 30.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.301 -0.874 . . . . 0.0 110.169 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.472 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -97.06 47.59 1.63 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.589 ' CE1' ' HB2' ' A' ' 15' ' ' TYR . 43.7 p90 -48.43 173.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -1.159 . . . . 0.0 111.006 -179.828 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.555 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 95.5 mt-10 -109.36 179.05 4.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.458 -0.776 . . . . 0.0 110.191 179.903 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -68.42 136.46 53.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 110.439 -179.914 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.35 -14.39 57.87 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.789 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.473 ' HG3' ' HB2' ' A' ' 26' ' ' GLU . 3.2 mt-10 -62.98 124.08 20.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -1.2 . . . . 0.0 110.393 -179.746 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.476 ' O ' HD23 ' A' ' 31' ' ' LEU . 86.8 mt-30 -79.75 136.64 36.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.24 -0.913 . . . . 0.0 109.832 179.768 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 45' ' ' SER . 15.1 mt -137.74 158.51 44.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.069 -1.019 . . . . 0.0 110.653 -179.723 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.717 ' HD2' HD21 ' A' ' 46' ' ' LEU . 25.4 mtp180 -108.05 134.37 51.03 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.436 -0.79 . . . . 0.0 109.142 179.295 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.4 mm -90.82 93.97 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.047 -1.033 . . . . 0.0 110.737 -179.502 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.9 mt -79.38 -29.79 42.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 110.842 -179.507 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.505 ' HB2' ' CB ' ' A' ' 42' ' ' LYS . 74.0 mt-10 -129.54 143.93 51.04 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.923 -1.111 . . . . 0.0 110.366 -179.957 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.635 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 15.1 pt20 -138.04 55.87 1.76 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.363 -0.836 . . . . 0.0 110.241 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.6 t -120.66 142.06 49.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.171 -0.956 . . . . 0.0 110.204 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.35 -176.01 50.55 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -70.57 -28.28 64.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -1.1 . . . . 0.0 110.211 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.506 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 95.4 m95 -100.27 147.59 25.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 110.345 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.635 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 47.1 m0 -124.27 156.17 37.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.192 -179.985 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.505 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 13.5 tttp -98.94 145.23 27.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.413 179.421 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.593 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -158.21 -177.33 6.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.011 -1.056 . . . . 0.0 111.002 -179.596 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.504 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 58.4 tt0 -144.45 152.87 41.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.454 -0.779 . . . . 0.0 109.365 179.584 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.546 ' HA ' HD23 ' A' ' 31' ' ' LEU . 10.5 t -102.76 128.12 49.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.026 -1.046 . . . . 0.0 110.515 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.717 HD21 ' HD2' ' A' ' 32' ' ' ARG . 37.8 mt -83.17 8.31 13.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.886 . . . . 0.0 109.917 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.43 ' OG1' HG23 ' A' ' 48' ' ' THR . 20.4 p -98.48 -42.07 7.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.348 -0.845 . . . . 0.0 110.11 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.43 HG23 ' OG1' ' A' ' 47' ' ' THR . 58.2 p -113.05 -10.78 13.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 110.101 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.11 38.93 46.43 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.852 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -112.61 142.52 45.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -1.138 . . . . 0.0 110.197 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -117.9 136.67 53.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 110.092 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -171.44 165.15 38.11 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 97.0 m-85 -71.09 145.3 49.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -1.078 . . . . 0.0 110.145 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.573 ' CD1' HG21 ' A' ' 59' ' ' VAL . 1.2 pp -136.68 140.07 31.0 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 110.216 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.595 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 47.7 Cg_endo -65.14 149.73 88.59 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.021 1.537 . . . . 0.0 110.073 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.592 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 39.6 p90 -75.61 -5.45 45.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 110.931 -179.449 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -95.44 -25.74 16.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.955 -1.091 . . . . 0.0 111.039 -179.363 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.595 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 9.3 m-85 -82.22 0.26 42.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.905 -1.122 . . . . 0.0 110.453 -179.741 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.573 HG21 ' CD1' ' A' ' 54' ' ' ILE . 23.3 m -141.95 154.11 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 0.0 110.097 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -148.73 157.51 43.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.241 -0.912 . . . . 0.0 110.227 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.528 ' HA ' HG12 ' A' ' 9' ' ' VAL . 31.1 mttt -67.93 123.26 20.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.264 -0.898 . . . . 0.0 110.257 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.79 -29.51 69.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.167 -0.958 . . . . 0.0 110.175 -179.952 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.5 t30 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.187 -179.93 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 4' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.503 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.3 OUTLIER -47.32 -66.3 0.56 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.222 -1.164 . . . . 0.0 110.165 179.959 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.503 ' CD ' ' CB ' ' A' ' 2' ' ' SER . 46.5 Cg_endo -58.42 -31.17 93.48 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.05 1.553 . . . . 0.0 110.29 -179.945 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.99 HD13 ' O ' ' A' ' 4' ' ' LEU . 2.9 tm? -56.51 -26.15 53.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.282 -0.886 . . . . 0.0 110.179 179.963 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -73.31 -19.83 60.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.282 -0.886 . . . . 0.0 110.256 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 45.81 43.9 10.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.17 -0.956 . . . . 0.0 110.027 -179.932 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 7' ' ' ASN . . . . . 0.817 ' CG ' HD12 ' A' ' 33' ' ' ILE . 44.9 t-20 -92.37 99.94 12.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 110.393 -179.844 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.2 tp -103.78 143.24 33.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.262 -0.899 . . . . 0.0 109.973 179.885 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.038 HG11 HD11 ' A' ' 33' ' ' ILE . 27.8 m -141.78 165.74 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.129 -0.982 . . . . 0.0 110.465 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 72.4 mt -112.5 148.01 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.337 -0.852 . . . . 0.0 109.684 179.561 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.548 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . -78.56 111.18 14.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.063 -1.023 . . . . 0.0 110.347 -179.71 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.442 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 49.9 mt -70.05 -25.68 63.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.088 -1.008 . . . . 0.0 109.16 179.322 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.442 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 80.7 m-70 -155.62 151.92 28.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.692 -0.63 . . . . 0.0 109.506 179.703 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 30.2 p -64.91 140.0 58.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.951 -1.093 . . . . 0.0 109.774 179.75 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.61 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 85.6 t80 -97.59 157.13 16.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.014 -1.054 . . . . 0.0 110.332 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -111.44 124.61 32.21 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.909 . . . . 0.0 110.188 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.478 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.4 Cg_endo -80.21 81.67 2.69 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.02 1.537 . . . . 0.0 110.47 -179.884 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.473 ' OG ' ' ND1' ' A' ' 19' ' ' HIS . 92.2 p -79.81 -1.96 41.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.135 -0.978 . . . . 0.0 110.013 179.904 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.473 ' ND1' ' OG ' ' A' ' 18' ' ' SER . 72.4 m80 -140.34 172.86 12.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 110.076 -179.997 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -90.07 125.3 35.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.238 -0.913 . . . . 0.0 110.248 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.09 6.99 31.51 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.997 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -104.16 164.37 11.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -1.164 . . . . 0.0 110.28 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.483 ' CD1' ' CD ' ' A' ' 50' ' ' GLN . 22.8 tp -114.82 119.63 37.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.174 -179.961 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.478 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -99.91 54.21 0.94 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.866 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.751 ' CD1' HD21 ' A' ' 31' ' ' LEU . 45.9 p90 -53.12 173.73 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.235 -1.156 . . . . 0.0 111.131 -179.482 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 96.0 mt-10 -105.61 176.57 5.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.553 -0.717 . . . . 0.0 110.288 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.7 tttm -70.97 135.67 48.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.058 -1.026 . . . . 0.0 110.322 179.772 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.0 -13.67 53.07 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.591 ' OE1' HG21 ' A' ' 47' ' ' THR . 30.6 mm-40 -63.91 136.18 57.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.035 -1.274 . . . . 0.0 109.99 -179.764 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.821 ' C ' HD12 ' A' ' 31' ' ' LEU . 88.3 mt-30 -79.6 128.1 32.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.895 . . . . 0.0 110.075 -179.873 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.821 HD12 ' C ' ' A' ' 30' ' ' GLN . 10.4 mp -124.31 141.63 51.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 110.393 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.749 ' HB2' HD11 ' A' ' 46' ' ' LEU . 15.7 ttt85 -100.95 134.58 43.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.336 -0.852 . . . . 0.0 109.588 179.633 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 1.038 HD11 HG11 ' A' ' 9' ' ' VAL . 27.0 mt -85.78 132.58 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.163 -0.96 . . . . 0.0 110.307 -179.925 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.0 mt -118.71 -31.75 4.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.363 -0.835 . . . . 0.0 110.112 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.514 ' HB2' ' CB ' ' A' ' 42' ' ' LYS . 85.7 mt-10 -135.58 149.87 49.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.19 -0.944 . . . . 0.0 110.198 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.626 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 93.2 mt-30 -135.84 59.01 1.73 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.268 -0.895 . . . . 0.0 110.15 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.7 t -124.24 135.59 53.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.235 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.7 176.65 45.76 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.97 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.9 -27.44 69.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.204 -1.174 . . . . 0.0 110.236 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.556 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 98.3 m95 -98.96 146.28 26.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.22 -0.925 . . . . 0.0 110.241 -179.897 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.626 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 40.9 m0 -122.88 156.48 34.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.901 . . . . 0.0 110.14 179.795 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.514 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 20.7 tttt -93.75 142.3 27.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.956 . . . . 0.0 109.776 179.581 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.513 ' CB ' HG12 ' A' ' 54' ' ' ILE . . . -155.9 178.83 9.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.115 -0.991 . . . . 0.0 110.771 -179.803 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.414 ' CG ' ' HG2' ' A' ' 51' ' ' GLU . 46.3 tt0 -141.82 150.14 41.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.394 -0.816 . . . . 0.0 109.909 179.697 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 t -95.3 119.63 34.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 110.276 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 46' ' ' LEU . . . . . 0.749 HD11 ' HB2' ' A' ' 32' ' ' ARG . 4.9 mp -78.13 6.28 8.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -0.9 . . . . 0.0 110.412 -179.98 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.591 HG21 ' OE1' ' A' ' 29' ' ' GLU . 65.5 p -96.57 -37.29 10.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 110.019 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.1 p -120.13 -6.09 9.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 110.098 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.67 40.6 52.96 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.483 ' CD ' ' CD1' ' A' ' 23' ' ' LEU . 62.1 tt0 -110.29 141.15 43.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -1.14 . . . . 0.0 110.288 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.414 ' HG2' ' CG ' ' A' ' 44' ' ' GLN . 92.6 mt-10 -117.15 136.57 52.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.341 -0.849 . . . . 0.0 109.938 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.428 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -170.14 164.7 38.05 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -69.1 144.59 53.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -1.13 . . . . 0.0 110.029 179.894 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.558 ' CD1' HG21 ' A' ' 59' ' ' VAL . 1.1 pt -136.0 139.53 30.59 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 110.257 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.574 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 45.4 Cg_endo -63.94 150.45 88.37 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.911 1.479 . . . . 0.0 110.188 179.739 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.596 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 16.2 p90 -85.41 1.3 49.23 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.348 -0.845 . . . . 0.0 111.18 -179.402 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.538 ' OD1' ' N ' ' A' ' 58' ' ' PHE . 48.9 p30 -100.41 -24.03 14.6 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.955 -1.091 . . . . 0.0 111.178 -179.365 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.544 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 14.1 m-30 -94.18 1.34 56.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.87 -1.144 . . . . 0.0 110.591 -179.812 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.558 HG21 ' CD1' ' A' ' 54' ' ' ILE . 33.9 m -130.69 146.22 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.178 -0.951 . . . . 0.0 110.198 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.448 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . -140.41 160.59 39.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.318 -0.864 . . . . 0.0 110.271 -179.945 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.549 ' HA ' HG12 ' A' ' 9' ' ' VAL . 22.4 mttm -74.8 134.68 41.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.953 . . . . 0.0 110.23 -179.988 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.97 -34.72 72.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.881 . . . . 0.0 110.179 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.207 179.983 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 m -67.31 138.27 94.22 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.282 -1.128 . . . . 0.0 110.177 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -57.52 145.21 89.81 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.054 1.555 . . . . 0.0 110.376 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 57.3 mt -62.15 -38.31 88.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.217 -0.927 . . . . 0.0 110.107 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -123.72 151.16 43.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.892 . . . . 0.0 110.199 179.96 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -104.28 16.61 25.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 110.133 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -87.82 15.8 6.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.93 . . . . 0.0 110.283 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.77 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.3 mp -102.67 151.82 21.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.204 -0.935 . . . . 0.0 110.101 179.917 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.817 ' CG1' HD11 ' A' ' 33' ' ' ILE . 15.5 m -151.86 171.95 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.172 -0.955 . . . . 0.0 110.448 179.911 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 52.7 mt -118.02 143.32 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.418 -0.801 . . . . 0.0 109.927 179.754 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.582 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -76.9 112.61 13.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.179 -0.95 . . . . 0.0 110.514 -179.659 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.481 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 52.5 mt -72.99 -22.32 60.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.089 -1.007 . . . . 0.0 109.314 179.262 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.481 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 77.8 m-70 -156.83 151.68 25.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.651 -0.656 . . . . 0.0 109.521 179.881 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 34.9 p -65.26 136.83 57.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.899 -1.126 . . . . 0.0 109.895 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 67.0 t80 -97.78 157.08 16.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.085 -1.009 . . . . 0.0 110.119 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.558 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 3.0 mt-10 -111.74 136.07 21.14 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.852 . . . . 0.0 110.295 -179.82 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.457 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 46.8 Cg_endo -94.32 87.17 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.065 1.561 . . . . 0.0 110.272 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 90.1 p -80.51 0.86 31.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 110.242 -179.921 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 41.5 m80 -142.12 -177.92 5.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 110.278 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -97.72 126.11 42.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 110.169 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.33 -9.87 26.55 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.984 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 1.1 m-20 -92.12 171.05 9.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -1.171 . . . . 0.0 110.129 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.506 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 15.5 tp -127.12 132.31 50.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 110.052 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.475 ' HA2' ' HB3' ' A' ' 15' ' ' TYR . . . -109.2 60.29 0.33 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.653 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.794 ' CG ' HD11 ' A' ' 31' ' ' LEU . 39.6 p90 -52.61 175.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.156 -1.202 . . . . 0.0 110.92 -179.684 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 96.3 mt-10 -109.75 -179.5 3.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.401 -0.812 . . . . 0.0 110.323 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.0 tttt -70.87 130.34 41.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.093 -1.005 . . . . 0.0 110.187 179.674 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.9 -18.47 47.31 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 -179.991 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 22.3 mm-40 -61.45 123.91 19.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.081 -1.246 . . . . 0.0 110.086 -179.667 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.466 ' NE2' HD23 ' A' ' 8' ' ' LEU . 48.9 tt0 -79.46 134.47 36.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.335 -0.853 . . . . 0.0 110.28 -179.76 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.794 HD11 ' CG ' ' A' ' 25' ' ' PHE . 41.8 mt -129.85 150.03 51.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -0.854 . . . . 0.0 110.176 -179.895 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 19.4 ttt180 -94.59 133.35 38.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.329 -0.857 . . . . 0.0 110.065 179.809 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.817 HD11 ' CG1' ' A' ' 9' ' ' VAL . 34.8 mt -80.89 121.48 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.202 -0.936 . . . . 0.0 110.031 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.44 HD13 ' OE2' ' A' ' 51' ' ' GLU . 4.6 mt -99.49 -33.15 10.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.272 -0.892 . . . . 0.0 110.317 -179.777 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.523 ' OE1' ' CE ' ' A' ' 42' ' ' LYS . 79.6 tt0 -150.98 146.97 26.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.176 -0.953 . . . . 0.0 110.194 -179.924 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.623 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 27.6 mt-30 -128.82 55.17 1.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.895 . . . . 0.0 110.195 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.1 t -111.23 125.99 54.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 110.249 -179.89 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.74 -175.05 53.25 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -67.91 -37.08 81.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -1.104 . . . . 0.0 110.203 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.418 ' HZ3' ' CE1' ' A' ' 15' ' ' TYR . 85.7 m95 -91.47 141.31 28.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 0.0 110.149 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.623 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 50.9 m0 -122.28 153.75 38.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 0.0 110.391 -179.97 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.523 ' CE ' ' OE1' ' A' ' 35' ' ' GLU . 50.2 mttt -89.13 146.42 24.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.302 -0.874 . . . . 0.0 109.558 179.472 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.771 ' HB2' HG12 ' A' ' 54' ' ' ILE . . . -148.71 170.08 18.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.085 -1.01 . . . . 0.0 110.653 -179.61 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 42.8 tt0 -137.51 145.25 42.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.383 -0.823 . . . . 0.0 109.878 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.462 ' OG ' HD21 ' A' ' 23' ' ' LEU . 53.4 m -74.2 139.34 44.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 110.256 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.8 tp -82.34 -26.14 33.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.183 -0.948 . . . . 0.0 110.224 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.3 p -98.96 -28.23 13.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 110.158 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.14 -18.94 18.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.241 -0.912 . . . . 0.0 110.091 179.836 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.95 6.04 35.72 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.634 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 29.3 mt-30 -83.13 155.18 23.94 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.04 -1.271 . . . . 0.0 110.485 -179.803 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.44 ' OE2' HD13 ' A' ' 34' ' ' LEU . 69.1 tt0 -114.99 134.81 54.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.326 -0.859 . . . . 0.0 109.951 179.813 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.506 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -145.6 -152.14 5.57 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.68 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -122.9 134.25 54.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.481 -1.011 . . . . 0.0 109.614 179.638 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.771 HG12 ' HB2' ' A' ' 43' ' ' ALA . 1.2 pp -127.46 133.73 25.4 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.116 -0.99 . . . . 0.0 110.631 -179.617 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.574 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 43.0 Cg_endo -66.08 157.42 59.66 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.149 1.605 . . . . 0.0 110.187 179.611 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.474 ' HB2' ' CH2' ' A' ' 41' ' ' TRP . 18.9 p90 -88.19 -1.63 58.13 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.274 -0.891 . . . . 0.0 111.36 -179.06 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 58' ' ' PHE . 42.3 p30 -99.43 -25.83 14.33 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.82 -1.175 . . . . 0.0 111.066 -179.451 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.569 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 11.7 m-30 -92.43 -3.97 54.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.89 -1.131 . . . . 0.0 110.54 -179.78 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.682 HG21 ' CD1' ' A' ' 54' ' ' ILE . 21.8 m -126.91 144.32 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.1 -1.0 . . . . 0.0 110.095 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -137.22 167.19 22.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.914 . . . . 0.0 110.362 -179.856 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -66.49 133.34 50.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.336 -0.852 . . . . 0.0 110.194 179.98 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.18 146.77 49.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 110.208 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.187 179.993 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.4 m -123.22 80.07 52.41 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.262 -1.14 . . . . 0.0 110.173 -179.964 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -59.51 -18.93 49.49 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.014 1.534 . . . . 0.0 110.336 -179.991 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.9 tp -56.02 -38.35 70.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.912 . . . . 0.0 110.256 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.539 ' HA ' ' CD1' ' A' ' 8' ' ' LEU . 99.0 mt-30 -62.24 -32.73 73.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 110.27 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -61.7 -26.05 67.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.893 . . . . 0.0 110.315 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -86.94 -6.04 58.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.162 -0.961 . . . . 0.0 110.256 -179.989 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.539 ' CD1' ' HA ' ' A' ' 5' ' ' GLN . 44.0 mt -79.07 146.97 32.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.273 -0.892 . . . . 0.0 110.215 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.649 HG21 HG11 ' A' ' 59' ' ' VAL . 4.2 m -154.48 172.68 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.862 . . . . 0.0 110.333 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 60.0 mt -113.69 141.51 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.342 -0.849 . . . . 0.0 109.943 179.783 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.538 ' HB1' ' CE1' ' A' ' 25' ' ' PHE . . . -80.46 111.89 17.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.143 -0.973 . . . . 0.0 110.119 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.416 ' O ' ' ND1' ' A' ' 13' ' ' HIS . 24.2 tp -66.43 -27.86 68.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.099 -1.0 . . . . 0.0 109.543 179.529 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.416 ' ND1' ' O ' ' A' ' 12' ' ' LEU . 89.5 m-70 -150.8 155.73 39.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.472 -0.767 . . . . 0.0 109.836 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.531 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 52.5 p -68.15 144.28 55.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.14 -0.975 . . . . 0.0 110.019 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.573 ' CD1' ' HG3' ' A' ' 55' ' ' PRO . 27.4 t80 -94.44 153.71 17.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.042 -1.036 . . . . 0.0 110.323 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.446 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 19.0 tp10 -110.45 77.83 1.34 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 110.216 -179.911 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.508 ' HB3' ' HB2' ' A' ' 22' ' ' ASP . 48.1 Cg_endo -41.52 98.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.127 1.593 . . . . 0.0 110.422 179.895 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.489 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 87.5 p -82.31 9.27 9.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 110.25 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.489 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 87.3 m-70 -148.3 164.23 34.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 110.192 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -80.93 118.94 22.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 110.304 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.08 14.8 6.4 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.508 ' HB2' ' HB3' ' A' ' 17' ' ' PRO . 13.0 m-20 -111.32 168.47 9.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.174 -1.192 . . . . 0.0 110.284 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.506 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 17.1 tp -110.22 113.38 26.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 109.998 179.872 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.505 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -96.43 53.25 1.54 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.901 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.551 ' HE2' HG22 ' A' ' 54' ' ' ILE . 35.8 p90 -54.13 174.5 0.06 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.248 -1.148 . . . . 0.0 111.123 -179.557 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.531 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 94.3 mt-10 -109.43 177.23 4.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.499 -0.751 . . . . 0.0 109.964 179.78 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -66.95 139.59 57.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -0.955 . . . . 0.0 110.378 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.96 -14.02 57.98 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 3.7 mt-10 -66.6 126.16 28.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -1.215 . . . . 0.0 110.308 -179.865 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.975 ' C ' HD12 ' A' ' 31' ' ' LEU . 44.7 tt0 -79.7 137.33 37.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.814 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.975 HD12 ' C ' ' A' ' 30' ' ' GLN . 8.3 mp -136.89 156.99 47.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -0.909 . . . . 0.0 110.627 -179.553 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.592 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 38.5 ttt180 -106.26 131.65 53.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.412 -0.805 . . . . 0.0 109.24 179.247 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.458 HD11 HG11 ' A' ' 9' ' ' VAL . 87.6 mt -90.8 94.35 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.109 -0.994 . . . . 0.0 110.713 -179.318 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.93 HD12 ' HA ' ' A' ' 43' ' ' ALA . 1.1 mp -79.85 -32.69 40.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 110.379 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.495 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 67.3 tt0 -130.58 135.46 47.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.119 -0.988 . . . . 0.0 110.253 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.624 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 58.8 tt0 -131.41 55.7 1.84 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 110.174 179.984 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.2 m -120.65 145.42 47.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.281 -0.887 . . . . 0.0 110.231 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.89 -174.66 48.61 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -71.8 -30.68 65.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.236 -1.155 . . . . 0.0 110.128 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.555 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 99.3 m95 -99.38 145.71 27.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 110.23 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.624 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.6 m0 -121.2 157.04 31.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 110.207 179.896 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.495 ' CB ' ' HB3' ' A' ' 35' ' ' GLU . 43.8 tttp -101.37 138.69 38.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 109.012 179.065 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.93 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -149.93 177.38 9.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.838 -1.164 . . . . 0.0 110.998 -179.419 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 44' ' ' GLN . . . . . 0.518 ' HG3' ' CG ' ' A' ' 51' ' ' GLU . 39.4 tt0 -140.14 148.42 41.62 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.53 -0.731 . . . . 0.0 109.886 179.81 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.0 t -96.4 111.32 23.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.121 -0.987 . . . . 0.0 110.283 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 66.3 mt -71.19 -2.89 17.45 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 110.34 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.501 ' OG1' HG23 ' A' ' 48' ' ' THR . 31.3 p -85.53 -32.38 22.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.219 -0.926 . . . . 0.0 110.005 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' THR . . . . . 0.501 HG23 ' OG1' ' A' ' 47' ' ' THR . 23.6 p -120.82 -3.74 9.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 0.0 110.134 179.88 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.05 48.07 61.87 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.84 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.478 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 49.6 mt-30 -129.41 155.67 45.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -1.18 . . . . 0.0 110.428 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.518 ' CG ' ' HG3' ' A' ' 44' ' ' GLN . 95.4 mt-10 -119.56 160.77 21.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.337 -0.852 . . . . 0.0 109.844 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.506 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -178.32 -157.69 19.52 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -120.79 136.09 54.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.457 -1.025 . . . . 0.0 109.973 179.833 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.551 HG22 ' HE2' ' A' ' 25' ' ' PHE . 5.2 pt -130.91 149.71 74.49 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 110.417 -179.773 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.609 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 44.8 Cg_endo -78.13 143.2 19.98 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 124.023 1.538 . . . . 0.0 109.848 179.702 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.562 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 35.2 p90 -66.86 -8.95 32.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.241 -0.912 . . . . 0.0 110.962 -179.311 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -90.81 -26.13 19.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.911 -1.118 . . . . 0.0 110.939 -179.355 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.609 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 7.2 m-85 -84.18 6.67 21.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.005 -1.059 . . . . 0.0 110.215 -179.761 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.649 HG11 HG21 ' A' ' 9' ' ' VAL . 15.2 t -147.3 169.11 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.918 . . . . 0.0 110.136 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.625 ' O ' HG12 ' A' ' 9' ' ' VAL . . . -159.02 166.03 32.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 110.374 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -76.51 121.37 23.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.263 -0.898 . . . . 0.0 110.2 179.935 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.31 -34.36 23.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 0.0 110.194 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.193 -179.961 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.7 m -124.7 152.03 68.7 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.273 -1.133 . . . . 0.0 110.159 179.93 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' PRO . . . . . 0.452 ' HG2' HD12 ' A' ' 4' ' ' LEU . 46.6 Cg_endo -55.79 -20.88 30.32 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.032 1.543 . . . . 0.0 110.44 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.452 HD12 ' HG2' ' A' ' 3' ' ' PRO . 5.7 mp -94.6 136.87 34.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.935 . . . . 0.0 110.206 -179.963 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 5' ' ' GLN . . . . . 0.53 ' O ' HD13 ' A' ' 8' ' ' LEU . 93.2 mt-30 -105.55 148.5 27.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.261 -0.899 . . . . 0.0 110.08 179.995 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -104.47 11.13 34.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.299 -0.876 . . . . 0.0 110.077 179.863 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -86.71 4.85 38.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.874 . . . . 0.0 110.175 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 8' ' ' LEU . . . . . 0.743 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.1 mp -83.63 136.46 34.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 0.0 110.267 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.849 HG21 HD11 ' A' ' 33' ' ' ILE . 25.3 m -140.69 164.34 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.265 -0.897 . . . . 0.0 110.29 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.5 mm -109.39 140.71 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.361 -0.837 . . . . 0.0 109.75 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 11' ' ' ALA . . . . . 0.499 ' HB1' ' CE1' ' A' ' 25' ' ' PHE . . . -80.0 107.25 12.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.178 -0.951 . . . . 0.0 110.311 -179.828 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 12' ' ' LEU . 7.6 mp -67.63 -23.19 65.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.097 -1.002 . . . . 0.0 109.173 179.366 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 13' ' ' HIS . . . . . 0.417 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 90.8 m-70 -153.33 146.45 24.64 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.621 -0.674 . . . . 0.0 109.576 179.75 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 55.4 p -63.01 147.28 51.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.044 -1.035 . . . . 0.0 109.8 179.917 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 38.6 t80 -99.08 161.32 13.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.141 -0.974 . . . . 0.0 110.398 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -118.96 85.17 28.23 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 0.0 110.148 179.92 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.539 ' CB ' ' HB2' ' A' ' 22' ' ' ASP . 47.4 Cg_endo -44.36 96.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.02 1.537 . . . . 0.0 110.546 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 16' ' ' GLU . 25.2 p -83.24 3.9 29.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.905 . . . . 0.0 109.955 179.783 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' HIS . . . . . 0.442 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 84.9 t60 -148.2 166.9 26.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.342 -0.849 . . . . 0.0 110.116 -179.92 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -75.81 130.72 39.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.201 -0.937 . . . . 0.0 110.139 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.45 15.36 21.35 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.539 ' HB2' ' CB ' ' A' ' 17' ' ' PRO . 27.8 m-20 -111.74 161.04 16.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -1.159 . . . . 0.0 110.439 -179.862 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.495 ' HA ' HD12 ' A' ' 23' ' ' LEU . 13.6 tp -116.2 120.03 37.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.283 -0.886 . . . . 0.0 109.801 179.927 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.51 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -97.78 50.51 1.38 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.792 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 30.2 p90 -48.71 172.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.227 -1.161 . . . . 0.0 111.19 -179.847 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.434 ' N ' ' OE1' ' A' ' 29' ' ' GLU . 81.0 mt-10 -102.78 173.46 6.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.565 -0.71 . . . . 0.0 110.078 179.635 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 pttm -70.11 136.8 50.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.134 -0.979 . . . . 0.0 110.159 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.77 -10.23 73.16 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' GLU . . . . . 0.465 ' OE1' ' HB2' ' A' ' 25' ' ' PHE . 67.2 tt0 -73.43 128.31 35.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.05 -1.264 . . . . 0.0 110.124 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 30' ' ' GLN . . . . . 0.834 ' O ' HD23 ' A' ' 31' ' ' LEU . 46.4 tt0 -79.61 141.46 36.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.93 . . . . 0.0 109.82 179.906 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.834 HD23 ' O ' ' A' ' 30' ' ' GLN . 17.4 mt -140.64 161.97 36.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.924 . . . . 0.0 110.515 -179.693 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.587 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 7.2 tpt180 -103.67 129.91 51.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.414 -0.804 . . . . 0.0 109.617 179.487 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.849 HD11 HG21 ' A' ' 9' ' ' VAL . 25.3 mm -93.67 94.26 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.179 -0.951 . . . . 0.0 110.458 -179.744 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.584 HD12 ' HA ' ' A' ' 43' ' ' ALA . 1.2 mt -79.92 -28.08 39.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -0.888 . . . . 0.0 110.775 -179.675 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.465 ' HB2' ' CB ' ' A' ' 42' ' ' LYS . 62.1 mt-10 -131.19 138.38 49.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.965 -1.084 . . . . 0.0 110.489 -179.83 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.626 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 22.3 mt-30 -135.03 54.28 1.95 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 110.043 179.892 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.6 t -120.49 142.52 49.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 110.205 179.972 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.63 -169.88 54.96 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.889 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -76.6 -33.96 58.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -1.12 . . . . 0.0 110.146 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' TRP . . . . . 0.559 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 98.7 m95 -96.93 143.37 27.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 110.42 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 41' ' ' TRP . . . . . 0.626 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.5 m0 -120.1 156.19 31.5 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.284 -0.885 . . . . 0.0 110.238 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 53' ' ' PHE . 12.6 tttp -100.28 141.78 32.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.329 -0.857 . . . . 0.0 109.368 179.372 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.587 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -153.69 179.44 8.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.053 -1.029 . . . . 0.0 110.94 -179.612 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -142.01 150.61 41.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 109.876 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.551 ' OG ' HD22 ' A' ' 31' ' ' LEU . 13.3 m -99.02 121.97 41.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.118 -0.989 . . . . 0.0 110.356 -179.952 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 71.6 mt -79.2 5.04 13.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 110.179 179.888 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.52 -42.07 4.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.283 -0.885 . . . . 0.0 110.159 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.2 p -90.65 -27.41 19.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -0.898 . . . . 0.0 110.135 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.8 33.42 24.44 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -128.34 153.02 47.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.268 -1.136 . . . . 0.0 110.306 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.437 ' OE2' ' HE2' ' A' ' 42' ' ' LYS . 84.8 tt0 -120.43 142.57 49.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 110.231 179.85 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 52' ' ' GLY . . . . . 0.423 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -168.55 161.62 35.35 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.856 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 53' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 95.4 m-85 -71.72 146.92 47.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -1.101 . . . . 0.0 109.854 179.591 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 54' ' ' ILE . . . . . 0.736 HD12 HG21 ' A' ' 59' ' ' VAL . 1.1 pt -136.87 136.47 21.4 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.195 -0.941 . . . . 0.0 110.357 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.574 ' HD3' ' CD1' ' A' ' 15' ' ' TYR . 45.0 Cg_endo -58.7 147.66 86.68 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.048 1.551 . . . . 0.0 110.045 179.651 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.703 ' CZ ' ' ND2' ' A' ' 57' ' ' ASN . 19.1 p90 -82.89 -5.64 59.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 110.999 -179.419 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 57' ' ' ASN . . . . . 0.703 ' ND2' ' CZ ' ' A' ' 56' ' ' PHE . 28.8 m120 -89.54 -25.58 21.3 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.927 -1.108 . . . . 0.0 110.632 -179.642 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 58' ' ' PHE . . . . . 0.542 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 17.3 m-30 -93.55 2.22 56.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.064 -1.023 . . . . 0.0 110.268 179.968 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.736 HG21 HD12 ' A' ' 54' ' ' ILE . 34.1 m -137.2 143.38 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.215 -0.928 . . . . 0.0 110.12 179.763 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 60' ' ' ALA . . . . . 0.468 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . -135.09 161.55 34.99 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.215 -0.928 . . . . 0.0 110.411 -179.875 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' LYS . . . . . 0.581 ' HA ' HG12 ' A' ' 9' ' ' VAL . 54.6 mttp -71.45 136.52 47.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 0.0 110.161 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.25 -35.61 80.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.291 -0.881 . . . . 0.0 110.254 179.925 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.228 -179.973 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.738 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.8 mp . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.221 0.534 . . . . 0.0 110.198 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.684 HG11 HD11 ' A' ' 33' ' ' ILE . 18.2 m -147.67 168.9 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.2 -0.938 . . . . 0.0 110.309 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 81.8 mt -112.24 145.3 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.388 -0.82 . . . . 0.0 109.671 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . -77.56 114.94 16.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.077 -1.014 . . . . 0.0 110.367 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.483 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 37.6 tp -71.4 -26.9 62.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.104 -0.997 . . . . 0.0 109.386 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.483 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 25.8 m80 -158.22 149.41 20.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.469 -0.769 . . . . 0.0 109.7 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 44.2 p -61.97 141.44 58.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.026 -1.046 . . . . 0.0 110.092 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 77.1 t80 -102.76 165.05 11.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.079 -1.013 . . . . 0.0 110.408 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.579 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 35.8 mt-10 -113.52 129.64 24.46 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 110.228 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.485 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 49.9 Cg_endo -85.21 88.67 0.88 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.983 1.518 . . . . 0.0 110.509 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.0 m -79.59 -6.99 58.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.925 . . . . 0.0 110.084 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 -128.23 -155.35 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 110.007 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -112.36 -4.63 14.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 110.27 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.68 5.53 16.59 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -92.21 159.32 15.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -1.187 . . . . 0.0 110.232 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.492 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 35.5 tp -116.78 122.28 43.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.248 -0.908 . . . . 0.0 110.119 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.485 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -99.33 47.83 1.32 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.658 ' CD1' HD21 ' A' ' 31' ' ' LEU . 35.9 p90 -45.57 171.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -1.189 . . . . 0.0 110.834 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -98.71 176.85 5.49 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.415 -0.803 . . . . 0.0 110.446 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -71.8 122.95 21.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.262 -0.899 . . . . 0.0 110.239 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 92.96 -8.85 76.05 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.453 ' N ' ' HB3' ' A' ' 11' ' ' ALA . 27.3 tt0 -61.3 137.27 58.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.137 -1.214 . . . . 0.0 110.112 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.798 ' C ' HD12 ' A' ' 31' ' ' LEU . 87.8 mt-30 -79.63 126.85 31.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 0.0 109.965 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.798 HD12 ' C ' ' A' ' 30' ' ' GLN . 10.3 mp -126.36 145.45 50.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.919 . . . . 0.0 110.468 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.557 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 25.3 ttt180 -103.23 139.71 38.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.828 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.684 HD11 HG11 ' A' ' 9' ' ' VAL . 11.8 mt -87.45 130.14 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.14 -0.975 . . . . 0.0 110.263 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.58 HD11 ' HB2' ' A' ' 44' ' ' GLN . 60.6 mt -117.43 -30.44 5.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 110.193 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 42' ' ' LYS . 83.0 tt0 -139.15 149.65 44.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -0.907 . . . . 0.0 110.232 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.588 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 96.9 mt-30 -139.54 58.79 1.61 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 110.212 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.5 t -123.93 130.31 52.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 0.0 110.246 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.86 -162.8 33.0 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -82.79 -32.33 27.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -1.136 . . . . 0.0 110.075 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.549 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 92.1 m95 -98.03 146.08 25.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.922 . . . . 0.0 110.134 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.588 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 49.3 m0 -120.9 154.95 35.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.297 -0.877 . . . . 0.0 110.302 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 35' ' ' GLU . 79.1 tttt -93.48 143.56 26.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.919 . . . . 0.0 109.798 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.557 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -152.14 175.17 12.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.135 -0.978 . . . . 0.0 110.632 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.58 ' HB2' HD11 ' A' ' 34' ' ' LEU . 39.4 tt0 -139.22 147.49 41.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.43 -0.794 . . . . 0.0 109.884 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.481 ' HB2' ' OG1' ' A' ' 48' ' ' THR . 21.6 m -79.79 145.79 32.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.088 -1.007 . . . . 0.0 110.222 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.635 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.9 mp -94.73 -11.89 28.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.311 -0.868 . . . . 0.0 109.855 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.2 p -105.43 -30.09 9.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.405 -0.809 . . . . 0.0 110.435 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.481 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 17.6 p -99.84 -17.82 17.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.1 -1.0 . . . . 0.0 110.451 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.88 48.79 63.26 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.487 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 38.3 mt-30 -132.76 157.34 45.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.358 -1.084 . . . . 0.0 110.115 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.457 ' HG2' ' HG3' ' A' ' 44' ' ' GLN . 94.3 mt-10 -119.6 141.69 49.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.925 . . . . 0.0 110.097 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.492 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -166.29 159.16 32.38 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -70.24 142.73 52.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.243 -1.151 . . . . 0.0 110.045 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.872 ' CD1' HG21 ' A' ' 59' ' ' VAL . 1.8 pp -137.65 131.1 17.03 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 110.158 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.586 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 46.0 Cg_endo -55.94 160.9 9.26 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.03 1.542 . . . . 0.0 110.07 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -88.45 -2.36 58.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 110.911 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 -100.09 -25.83 14.16 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.987 -1.071 . . . . 0.0 111.054 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.569 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 26.5 m-85 -80.24 -11.93 59.68 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.017 -1.052 . . . . 0.0 110.446 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.872 HG21 ' CD1' ' A' ' 54' ' ' ILE . 26.9 m -132.22 145.55 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.95 . . . . 0.0 110.24 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 110.286 179.997 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.685 ' CD1' HD11 ' A' ' 46' ' ' LEU . 21.1 tp . . . . . 0 N--CA 1.492 1.631 0 CA-C-O 121.182 0.515 . . . . 0.0 109.957 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.839 HG11 HD11 ' A' ' 33' ' ' ILE . 31.2 m -145.63 167.84 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 110.378 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 86.1 mt -112.6 148.99 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.395 -0.816 . . . . 0.0 109.702 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . -80.17 113.39 18.31 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.128 -0.983 . . . . 0.0 110.443 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.642 HD13 ' O ' ' A' ' 12' ' ' LEU . 0.2 OUTLIER -70.74 -25.31 62.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.115 -0.991 . . . . 0.0 109.091 179.202 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.545 ' CD2' HD12 ' A' ' 12' ' ' LEU . 23.9 m-70 -159.13 151.05 20.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.703 -0.623 . . . . 0.0 109.481 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 41.6 p -63.38 140.83 58.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.907 -1.121 . . . . 0.0 109.883 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 65.5 t80 -100.89 162.81 12.64 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.063 -1.023 . . . . 0.0 110.255 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.571 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 29.8 tt0 -118.12 128.31 26.06 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.24 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.477 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 46.9 Cg_endo -82.17 84.6 1.82 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.111 1.585 . . . . 0.0 110.55 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.46 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 86.1 p -79.78 -3.94 49.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.932 . . . . 0.0 109.974 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.46 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 90.3 m-70 -139.85 151.21 45.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 0.0 110.136 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -65.35 125.47 25.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 110.117 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.59 11.43 28.88 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.451 ' OD2' ' HB2' ' A' ' 19' ' ' HIS . 11.4 m-20 -105.94 160.08 15.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.151 -1.205 . . . . 0.0 110.308 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.507 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 20.5 tp -116.4 122.99 46.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.338 -0.851 . . . . 0.0 110.18 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.477 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -104.39 51.28 0.81 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 33.0 p90 -45.32 172.19 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.197 -1.178 . . . . 0.0 110.9 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -99.26 176.0 5.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.405 -0.809 . . . . 0.0 110.554 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.9 tttm -71.18 124.88 25.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.364 -0.835 . . . . 0.0 110.28 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 90.39 -8.62 79.5 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.491 ' OE2' HD21 ' A' ' 31' ' ' LEU . 27.0 tt0 -62.39 132.45 52.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.103 -1.234 . . . . 0.0 110.365 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.524 ' O ' HD23 ' A' ' 31' ' ' LEU . 90.6 mt-30 -79.87 130.59 35.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 109.842 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.524 HD23 ' O ' ' A' ' 30' ' ' GLN . 17.6 mt -130.67 150.43 51.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.934 . . . . 0.0 110.501 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.865 ' HB2' HD21 ' A' ' 46' ' ' LEU . 40.3 ttt180 -100.82 135.77 41.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.434 -0.791 . . . . 0.0 109.75 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.839 HD11 HG11 ' A' ' 9' ' ' VAL . 11.2 mt -83.37 127.87 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 110.317 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.035 HD11 ' HB2' ' A' ' 44' ' ' GLN . 75.1 mt -107.13 -30.98 8.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.284 -0.885 . . . . 0.0 110.215 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -143.39 153.42 42.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 0.0 110.197 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.63 HE21 HG21 ' A' ' 33' ' ' ILE . 93.0 mt-30 -138.58 54.21 1.77 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 110.242 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 75.3 m -121.81 134.48 54.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.908 . . . . 0.0 110.101 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.68 -172.11 47.98 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -74.45 -34.26 63.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -1.144 . . . . 0.0 110.178 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.402 ' HZ3' ' CE1' ' A' ' 15' ' ' TYR . 72.6 m95 -97.17 145.78 25.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -0.921 . . . . 0.0 110.08 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.493 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 52.1 m0 -120.69 153.81 36.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.256 -0.903 . . . . 0.0 110.056 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -90.07 144.5 25.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -0.953 . . . . 0.0 109.749 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 32' ' ' ARG . . . -148.54 170.41 18.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.086 -1.009 . . . . 0.0 110.611 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 1.035 ' HB2' HD11 ' A' ' 34' ' ' LEU . 51.9 tt0 -137.89 146.11 42.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.371 -0.831 . . . . 0.0 109.827 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.7 m -76.77 142.08 40.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.097 -1.002 . . . . 0.0 110.376 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.865 HD21 ' HB2' ' A' ' 32' ' ' ARG . 36.3 mt -88.66 -18.48 27.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.35 -0.844 . . . . 0.0 109.848 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.5 p -106.41 -30.06 9.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -0.862 . . . . 0.0 110.37 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.0 m -92.07 -24.31 19.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.064 -1.022 . . . . 0.0 110.421 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.78 46.29 54.17 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 59.1 mt-30 -134.28 158.75 42.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -1.121 . . . . 0.0 110.204 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.431 ' HG2' ' HB2' ' A' ' 44' ' ' GLN . 92.4 mt-10 -121.02 143.71 48.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.35 -0.844 . . . . 0.0 110.148 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -163.65 157.27 29.43 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -69.4 141.92 54.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -1.156 . . . . 0.0 109.926 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.577 HD12 HG21 ' A' ' 59' ' ' VAL . 1.3 pt -135.84 145.71 53.98 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 110.066 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.602 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 45.5 Cg_endo -72.45 162.62 40.94 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.987 1.519 . . . . 0.0 110.065 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.445 ' CE2' ' OD1' ' A' ' 57' ' ' ASN . 31.7 p90 -88.07 -3.98 58.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.959 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.445 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 60.3 m-20 -98.5 -26.57 14.39 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.899 -1.126 . . . . 0.0 111.062 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.602 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 34.2 m-85 -81.52 -10.85 59.38 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.939 -1.1 . . . . 0.0 110.326 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.577 HG21 HD12 ' A' ' 54' ' ' ILE . 25.3 m -131.05 142.66 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 110.273 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.193 -0.942 . . . . 0.0 110.122 179.995 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.414 ' C ' HG13 ' A' ' 9' ' ' VAL . 91.7 mt . . . . . 0 N--CA 1.493 1.696 0 CA-C-O 121.187 0.518 . . . . 0.0 109.98 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.457 ' HB ' ' O ' ' A' ' 60' ' ' ALA . 22.9 m -145.82 167.6 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.127 -0.983 . . . . 0.0 110.539 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 64.5 mt -111.05 149.45 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.377 -0.827 . . . . 0.0 109.621 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.542 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . -80.14 112.83 17.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.031 -1.043 . . . . 0.0 110.339 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.455 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 82.9 mt -69.58 -25.96 64.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.102 -0.999 . . . . 0.0 109.191 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.455 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 72.2 m80 -155.37 152.39 29.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.576 -0.702 . . . . 0.0 109.501 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 26.9 p -64.28 142.15 58.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.898 -1.126 . . . . 0.0 109.92 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 73.9 t80 -102.67 165.05 11.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.012 -1.055 . . . . 0.0 110.167 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.57 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 1.9 tp10 -119.5 132.84 23.86 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.285 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.484 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 49.2 Cg_endo -84.48 84.0 1.56 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.961 1.506 . . . . 0.0 110.299 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 83.3 p -79.59 -3.18 45.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.939 . . . . 0.0 110.051 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.457 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 51.5 m80 -144.86 165.95 26.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 110.039 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -76.87 126.21 30.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.911 . . . . 0.0 110.156 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.17 -1.9 35.19 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.457 ' OD2' ' HB2' ' A' ' 19' ' ' HIS . 17.2 m-20 -93.96 157.64 16.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.27 -1.135 . . . . 0.0 110.259 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.502 HD13 ' HG2' ' A' ' 50' ' ' GLN . 25.5 tp -115.6 120.91 40.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.296 -0.877 . . . . 0.0 109.988 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.484 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -100.62 51.47 0.99 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.586 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 40.7 p90 -48.46 172.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.192 -1.181 . . . . 0.0 110.995 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.4 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 68.8 mm-40 -100.82 174.99 5.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.507 -0.745 . . . . 0.0 110.189 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.4 pttm -71.39 131.62 43.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.137 -0.977 . . . . 0.0 110.102 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.48 -10.16 72.78 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.442 ' CD ' ' HB2' ' A' ' 25' ' ' PHE . 33.0 tt0 -64.5 132.88 51.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -1.168 . . . . 0.0 110.245 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.875 ' C ' HD12 ' A' ' 31' ' ' LEU . 95.1 mt-30 -79.68 131.47 35.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.784 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.875 HD12 ' C ' ' A' ' 30' ' ' GLN . 9.4 mp -129.84 148.58 51.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.92 . . . . 0.0 110.562 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.617 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 24.7 ttt180 -103.13 134.72 46.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.448 -0.782 . . . . 0.0 109.534 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 21.9 mm -83.82 131.53 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.143 -0.973 . . . . 0.0 110.194 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.1 mt -115.57 -32.9 5.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.331 -0.855 . . . . 0.0 110.178 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 87.1 mt-10 -132.06 153.95 49.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 110.21 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.627 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 97.9 mt-30 -139.97 55.61 1.64 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.86 . . . . 0.0 110.204 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 99.1 p -125.24 126.8 45.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 110.287 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.61 174.8 49.43 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -63.34 -28.91 70.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -1.197 . . . . 0.0 110.208 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.555 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 97.3 m95 -97.54 145.26 26.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 110.226 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.627 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 35.9 m0 -124.7 157.0 36.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.289 -0.882 . . . . 0.0 110.1 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 35' ' ' GLU . 34.0 tttt -96.26 145.33 25.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.689 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.617 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -158.24 -177.71 6.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 110.56 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -145.52 153.85 41.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.424 -0.798 . . . . 0.0 109.982 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.8 t -98.89 126.02 44.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.115 -0.991 . . . . 0.0 110.17 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.1 mt -80.7 9.27 6.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.904 . . . . 0.0 110.312 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.504 HG22 HG23 ' A' ' 48' ' ' THR . 31.8 m -92.79 -35.59 13.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.175 -0.953 . . . . 0.0 110.194 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.504 HG23 HG22 ' A' ' 47' ' ' THR . 49.2 p -132.69 -0.98 3.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.389 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.32 30.85 56.26 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.502 ' HG2' HD13 ' A' ' 23' ' ' LEU . 54.7 tt0 -91.27 131.79 36.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -1.116 . . . . 0.0 110.135 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -117.22 136.24 53.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 0.0 110.082 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -171.88 166.18 39.06 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 91.5 m-85 -70.44 146.41 50.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -1.131 . . . . 0.0 110.113 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.682 HD13 HG11 ' A' ' 59' ' ' VAL . 2.2 pp -139.23 131.59 15.37 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.235 -0.916 . . . . 0.0 110.147 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.653 ' O ' HD12 ' A' ' 54' ' ' ILE . 47.3 Cg_endo -55.68 158.49 13.3 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.972 1.511 . . . . 0.0 110.102 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.572 ' CE2' ' OD1' ' A' ' 57' ' ' ASN . 18.8 p90 -87.41 -0.42 56.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 0.0 110.771 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.572 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 89.9 m-20 -99.65 -26.42 14.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.958 -1.089 . . . . 0.0 110.855 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.479 ' HB2' ' HG2' ' A' ' 55' ' ' PRO . 10.8 m-85 -83.47 -3.0 57.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.004 -1.06 . . . . 0.0 110.391 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.682 HG11 HD13 ' A' ' 54' ' ' ILE . 26.9 m -130.6 143.52 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 0.0 110.328 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.457 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 110.149 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.617 ' CD1' HD11 ' A' ' 46' ' ' LEU . 19.7 tp . . . . . 0 N--CA 1.491 1.577 0 CA-C-O 121.133 0.492 . . . . 0.0 110.041 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.836 HG21 HD11 ' A' ' 33' ' ' ILE . 33.0 m -145.84 167.98 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.129 -0.982 . . . . 0.0 110.415 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.3 mt -113.44 149.9 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.366 -0.834 . . . . 0.0 109.596 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.487 ' HB3' ' N ' ' A' ' 29' ' ' GLU . . . -80.38 114.52 19.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.169 -0.957 . . . . 0.0 110.679 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.458 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 16.8 tp -78.95 -19.74 50.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 109.256 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.458 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 39.8 m-70 -159.98 142.05 13.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.566 -0.709 . . . . 0.0 109.511 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.0 p -60.56 139.73 57.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.818 -1.176 . . . . 0.0 110.101 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.612 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 81.6 t80 -99.93 161.97 13.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.124 -0.985 . . . . 0.0 110.296 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.46 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 2.1 mp0 -117.46 129.03 25.62 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.322 -0.861 . . . . 0.0 110.12 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.468 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.2 Cg_endo -83.06 83.77 1.87 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.081 1.569 . . . . 0.0 110.381 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.563 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 56.8 p -79.8 -3.88 49.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 110.121 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.563 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 89.4 m-70 -141.61 168.49 19.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 0.0 110.264 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -82.01 125.12 30.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.27 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.15 18.36 11.4 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -114.97 161.03 18.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.259 -1.142 . . . . 0.0 110.127 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.498 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 17.6 tp -115.76 120.77 40.39 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 110.28 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.468 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -101.72 54.63 0.77 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.629 ' CG ' HD11 ' A' ' 31' ' ' LEU . 44.0 p90 -50.26 171.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.31 -1.112 . . . . 0.0 110.908 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -100.39 178.33 4.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 110.488 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -71.86 123.07 21.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -0.88 . . . . 0.0 110.246 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 91.76 -10.09 75.38 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.488 ' OE1' ' HA ' ' A' ' 25' ' ' PHE . 16.6 tt0 -61.65 131.93 51.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -1.17 . . . . 0.0 110.135 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.557 ' O ' HD23 ' A' ' 31' ' ' LEU . 96.3 mt-30 -79.98 130.81 35.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.305 -0.872 . . . . 0.0 110.192 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.629 HD11 ' CG ' ' A' ' 25' ' ' PHE . 32.3 mt -126.76 145.65 50.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -0.954 . . . . 0.0 110.459 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.928 ' HB2' HD21 ' A' ' 46' ' ' LEU . 5.4 tpt180 -93.72 137.74 32.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.366 -0.834 . . . . 0.0 109.531 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.836 HD11 HG21 ' A' ' 9' ' ' VAL . 18.7 mm -90.99 129.13 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.131 -0.981 . . . . 0.0 110.287 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.992 HD11 ' HB2' ' A' ' 44' ' ' GLN . 49.9 mt -112.94 -26.4 8.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.902 . . . . 0.0 110.068 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 75.3 mt-10 -150.45 156.33 41.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 110.147 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.612 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 97.6 mt-30 -142.09 58.6 1.47 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 110.238 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -119.0 140.36 50.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.254 -0.904 . . . . 0.0 110.156 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.8 -168.3 53.47 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -76.37 -34.43 58.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -1.162 . . . . 0.0 110.128 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.554 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 96.8 m95 -96.25 143.75 27.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 110.251 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.612 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.9 m0 -116.53 152.29 34.39 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -0.897 . . . . 0.0 110.261 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 35' ' ' GLU . 18.1 tttt -89.95 141.43 28.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.254 -0.904 . . . . 0.0 109.987 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.531 ' CB ' HG12 ' A' ' 54' ' ' ILE . . . -147.87 170.22 18.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.16 -0.963 . . . . 0.0 110.428 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.992 ' HB2' HD11 ' A' ' 34' ' ' LEU . 59.2 tt0 -130.48 136.31 48.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 110.037 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.447 ' OG ' HD21 ' A' ' 23' ' ' LEU . 66.1 m -68.45 138.02 54.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.127 -0.983 . . . . 0.0 110.242 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.928 HD21 ' HB2' ' A' ' 32' ' ' ARG . 54.2 mt -87.65 -12.52 45.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.094 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.9 p -101.34 -28.42 12.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.863 . . . . 0.0 110.285 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 46.2 p -113.37 -3.6 13.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.169 -0.957 . . . . 0.0 110.366 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 58.67 14.15 20.75 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -86.93 157.19 19.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.122 -1.222 . . . . 0.0 110.39 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 94.9 mt-10 -117.4 138.68 51.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.355 -0.84 . . . . 0.0 109.972 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.498 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -161.07 156.7 28.14 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -68.68 144.5 54.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.247 -1.149 . . . . 0.0 109.899 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.73 HD12 HG21 ' A' ' 59' ' ' VAL . 1.1 pt -137.37 123.43 13.18 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.142 -0.974 . . . . 0.0 110.38 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.608 ' HG3' ' CD2' ' A' ' 58' ' ' PHE . 43.5 Cg_endo -47.16 159.35 0.39 Allowed 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.963 1.507 . . . . 0.0 110.068 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -96.48 0.78 50.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 110.736 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -100.18 -26.73 13.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.027 -1.046 . . . . 0.0 110.694 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.608 ' CD2' ' HG3' ' A' ' 55' ' ' PRO . 7.9 m-30 -89.19 -8.18 54.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.143 -0.973 . . . . 0.0 110.494 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.73 HG21 HD12 ' A' ' 54' ' ' ILE . 26.9 m -125.02 143.42 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.087 -1.008 . . . . 0.0 110.187 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.458 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.622 0 O-C-N 121.224 -0.922 . . . . 0.0 110.211 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.77 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.2 mp . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 121.178 0.513 . . . . 0.0 110.147 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.627 HG13 ' O ' ' A' ' 8' ' ' LEU . 9.4 m -157.62 174.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.286 -0.884 . . . . 0.0 110.328 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 80.0 mt -115.75 141.88 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.392 -0.818 . . . . 0.0 109.721 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.713 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -80.17 116.69 20.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 0.0 110.427 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.47 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 10.1 tp -70.06 -23.13 63.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.113 -0.992 . . . . 0.0 109.284 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.47 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 30.0 m80 -158.28 147.73 19.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.537 -0.727 . . . . 0.0 109.568 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 55.9 p -60.87 144.34 53.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.943 -1.098 . . . . 0.0 109.919 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 89.4 t80 -101.45 163.39 12.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.001 -1.062 . . . . 0.0 110.579 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.411 ' N ' ' CG ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -110.62 113.58 55.57 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.317 -0.864 . . . . 0.0 109.891 179.678 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.492 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 51.0 Cg_endo -74.36 96.85 0.99 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.066 1.561 . . . . 0.0 110.514 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.3 p -79.65 -1.54 38.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 110.103 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -133.49 -178.91 5.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 110.118 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -93.23 -2.26 55.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.285 -0.884 . . . . 0.0 110.194 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.474 ' O ' ' CD2' ' A' ' 53' ' ' PHE . . . -115.11 5.98 21.78 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 4.1 m-20 -98.77 167.81 10.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.241 -1.152 . . . . 0.0 110.346 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.507 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 31.0 tp -123.44 127.45 48.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.281 -0.887 . . . . 0.0 110.15 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.492 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -104.22 54.87 0.63 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.713 ' CE2' ' HB1' ' A' ' 11' ' ' ALA . 40.3 p90 -44.78 169.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -1.124 . . . . 0.0 110.922 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.451 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 95.6 mt-10 -98.6 176.92 5.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.448 -0.783 . . . . 0.0 110.225 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -70.84 127.09 31.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.167 -0.958 . . . . 0.0 110.225 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.98 -7.66 81.65 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.559 ' OE2' HD11 ' A' ' 31' ' ' LEU . 19.0 tt0 -66.12 131.93 47.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.132 -1.216 . . . . 0.0 110.238 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.854 ' O ' HD12 ' A' ' 31' ' ' LEU . 98.1 mt-30 -79.54 133.42 36.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.259 -0.901 . . . . 0.0 109.903 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.854 HD12 ' O ' ' A' ' 30' ' ' GLN . 8.4 mp -132.19 152.17 51.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.254 -0.904 . . . . 0.0 110.483 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.655 HH22 HD11 ' A' ' 8' ' ' LEU . 26.1 ttm-85 -102.21 134.01 46.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.431 -0.793 . . . . 0.0 109.837 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.497 HD11 HG11 ' A' ' 9' ' ' VAL . 12.3 mt -88.46 137.18 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.921 . . . . 0.0 110.101 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.969 HD12 ' HA ' ' A' ' 43' ' ' ALA . 1.3 mt -122.6 -29.25 4.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 110.095 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.47 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 73.9 mm-40 -135.3 147.67 49.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.182 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.615 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 95.3 mt-30 -137.95 56.63 1.74 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.898 . . . . 0.0 110.198 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.8 p -120.73 130.3 54.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 110.237 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.81 -164.8 41.39 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -81.16 -31.32 34.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.241 -1.152 . . . . 0.0 110.197 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.561 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 98.5 m95 -96.07 144.41 26.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 110.223 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.615 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 48.8 m0 -123.21 156.52 34.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 110.335 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 35' ' ' GLU . 36.1 tttt -95.16 143.04 26.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 109.735 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.969 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -157.61 -178.77 7.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.942 . . . . 0.0 110.444 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.684 ' OE1' HD21 ' A' ' 34' ' ' LEU . 17.3 pt20 -151.46 159.68 44.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.399 -0.813 . . . . 0.0 110.104 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.1 t -97.37 115.61 28.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.206 -0.934 . . . . 0.0 110.14 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.6 mt -73.26 -1.2 16.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.271 -0.893 . . . . 0.0 110.356 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.5 m -92.81 -28.57 16.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 110.059 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.8 p -116.86 -10.3 11.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.898 . . . . 0.0 110.088 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.02 41.86 53.45 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 44' ' ' GLN . 37.8 mt-30 -124.07 151.83 43.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -1.167 . . . . 0.0 110.231 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 43.7 mt-10 -122.92 147.09 46.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 110.067 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -162.39 -146.27 4.62 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.474 ' CD2' ' O ' ' A' ' 21' ' ' GLY . 81.0 m-85 -128.44 142.62 51.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -1.092 . . . . 0.0 110.129 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.771 ' CD1' HG21 ' A' ' 59' ' ' VAL . 2.0 pp -138.23 145.06 45.71 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.266 -0.897 . . . . 0.0 110.251 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.596 ' HD3' ' CD1' ' A' ' 15' ' ' TYR . 45.4 Cg_endo -70.37 156.35 61.93 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.953 1.502 . . . . 0.0 110.037 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.591 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 27.4 p90 -78.51 -3.21 42.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.271 -0.893 . . . . 0.0 111.01 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -99.92 -25.74 14.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.985 -1.072 . . . . 0.0 111.197 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.593 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 9.8 m-85 -82.17 -5.16 58.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.954 -1.091 . . . . 0.0 110.467 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.771 HG21 ' CD1' ' A' ' 54' ' ' ILE . 27.6 m -134.47 145.54 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.123 -0.986 . . . . 0.0 110.187 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.237 179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.735 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.7 mp . . . . . 0 N--CA 1.49 1.55 0 CA-C-O 121.221 0.534 . . . . 0.0 110.239 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.569 HG13 ' C ' ' A' ' 8' ' ' LEU . 34.4 m -155.03 172.55 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.319 -0.863 . . . . 0.0 110.157 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.452 HD13 ' O ' ' A' ' 9' ' ' VAL . 19.0 mm -114.36 154.66 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.915 . . . . 0.0 109.778 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.528 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -79.72 109.86 14.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.1 -1.0 . . . . 0.0 110.226 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.557 ' HG ' ' CE1' ' A' ' 13' ' ' HIS . 20.2 tp -70.61 -20.85 62.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.003 -1.061 . . . . 0.0 109.339 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.557 ' CE1' ' HG ' ' A' ' 12' ' ' LEU . 71.3 m80 -150.88 -164.08 1.93 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.525 -0.734 . . . . 0.0 109.863 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 20.7 t -111.6 138.94 47.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.155 -0.966 . . . . 0.0 110.077 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.604 ' CD2' ' HD3' ' A' ' 55' ' ' PRO . 53.2 t80 -103.19 164.16 11.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.064 -1.022 . . . . 0.0 110.128 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.565 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 74.7 mm-40 -120.69 125.37 27.15 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.226 -0.921 . . . . 0.0 110.209 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.483 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.9 Cg_endo -74.91 81.94 2.09 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.985 1.519 . . . . 0.0 110.33 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.554 ' OG ' ' CE1' ' A' ' 19' ' ' HIS . 83.4 p -79.62 -1.8 39.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.141 -0.975 . . . . 0.0 110.187 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.554 ' CE1' ' OG ' ' A' ' 18' ' ' SER . 36.5 m80 -147.62 143.97 28.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 110.167 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -54.83 128.49 33.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.176 -0.952 . . . . 0.0 110.335 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.401 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . 104.94 -13.28 49.55 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -82.95 158.21 22.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -1.139 . . . . 0.0 110.328 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.543 ' O ' ' CD1' ' A' ' 15' ' ' TYR . 15.8 tp -119.82 125.99 49.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.353 -0.842 . . . . 0.0 110.073 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.483 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -105.21 55.89 0.55 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.528 ' CD1' ' HB1' ' A' ' 11' ' ' ALA . 40.4 p90 -50.14 173.53 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.088 -1.242 . . . . 0.0 110.942 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -111.78 -177.44 3.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.475 -0.765 . . . . 0.0 110.027 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -67.96 129.57 40.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.15 -0.969 . . . . 0.0 110.328 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.1 -17.93 57.24 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.457 ' HG2' HD21 ' A' ' 31' ' ' LEU . 8.6 tt0 -55.43 122.71 11.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.179 -1.189 . . . . 0.0 110.382 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.411 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 29.5 tt0 -79.97 131.42 35.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 109.901 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.519 HD11 ' CG ' ' A' ' 25' ' ' PHE . 38.7 mt -137.19 158.72 43.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.953 . . . . 0.0 110.316 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.696 ' HD3' HD21 ' A' ' 34' ' ' LEU . 17.8 ttt180 -108.14 135.75 48.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 0.0 109.867 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.4 mt -91.75 92.03 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.175 -0.953 . . . . 0.0 110.325 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.696 HD21 ' HD3' ' A' ' 32' ' ' ARG . 81.1 mt -78.91 -27.79 43.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.267 -0.896 . . . . 0.0 110.554 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.54 ' HB2' ' CB ' ' A' ' 42' ' ' LYS . 95.7 mt-10 -131.33 136.11 47.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.145 -0.972 . . . . 0.0 110.16 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.629 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 19.0 pt20 -133.79 55.41 1.9 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 110.185 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.0 t -117.13 142.78 46.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.181 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.09 -165.61 54.77 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -79.61 -33.53 41.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -1.113 . . . . 0.0 110.086 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 52.1 m95 -95.71 144.12 26.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.305 -0.872 . . . . 0.0 110.113 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.629 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 47.4 m0 -124.5 155.62 38.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 110.419 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.54 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 22.9 tttt -98.99 146.31 26.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.331 -0.856 . . . . 0.0 109.317 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -148.79 175.27 11.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.988 -1.07 . . . . 0.0 110.821 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 46.9 tt0 -138.81 147.51 42.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.416 -0.802 . . . . 0.0 109.837 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.47 ' OG ' HD21 ' A' ' 23' ' ' LEU . 42.5 m -95.97 117.23 30.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.115 -0.991 . . . . 0.0 110.075 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 76.6 mt -75.22 1.61 13.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 0.0 110.315 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 65.9 p -99.57 -33.2 10.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.925 . . . . 0.0 109.977 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.7 p -110.32 -15.23 14.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.891 . . . . 0.0 110.063 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.13 40.6 50.09 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -127.51 154.39 45.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -1.164 . . . . 0.0 110.335 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 64.6 tt0 -120.2 143.89 48.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.266 -0.896 . . . . 0.0 109.919 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.522 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -153.41 -153.94 6.56 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -119.98 132.45 55.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.492 -1.005 . . . . 0.0 109.915 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.499 HD12 HG21 ' A' ' 59' ' ' VAL . 11.3 pt -125.77 145.25 51.03 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.167 -0.958 . . . . 0.0 110.439 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.609 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 45.8 Cg_endo -78.97 151.51 24.13 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.987 1.52 . . . . 0.0 109.833 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.589 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 33.3 p90 -71.05 -4.8 26.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.235 -0.916 . . . . 0.0 111.034 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.49 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 65.8 m-20 -98.1 -25.99 14.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.88 -1.138 . . . . 0.0 111.274 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.609 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 8.5 m-85 -85.16 -4.03 59.01 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.859 -1.151 . . . . 0.0 110.36 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.499 HG21 HD12 ' A' ' 54' ' ' ILE . 36.0 m -132.21 139.74 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -0.937 . . . . 0.0 110.106 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 110.384 -179.888 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.428 ' O ' HG13 ' A' ' 9' ' ' VAL . 13.8 tp . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.189 0.518 . . . . 0.0 110.115 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.705 HG12 ' O ' ' A' ' 60' ' ' ALA . 4.5 m -151.8 170.9 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.869 . . . . 0.0 110.329 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.3 mt -113.64 142.33 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.852 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 58' ' ' PHE . . . -80.3 114.34 19.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.147 -0.971 . . . . 0.0 110.192 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.52 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 75.3 mt -68.84 -22.6 64.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.068 -1.02 . . . . 0.0 109.471 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 82.2 m-70 -157.98 152.43 24.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.548 -0.72 . . . . 0.0 109.762 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 54.2 p -65.26 144.76 56.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.989 -1.07 . . . . 0.0 110.075 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 36.2 t80 -97.37 157.11 16.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.086 -1.009 . . . . 0.0 110.502 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -111.2 85.34 5.34 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.263 -0.898 . . . . 0.0 110.116 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.535 ' HD3' ' CA ' ' A' ' 24' ' ' GLY . 47.1 Cg_endo -55.86 120.61 8.55 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.101 1.579 . . . . 0.0 110.502 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.459 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 98.7 p -92.1 10.53 28.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 110.119 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.459 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 98.6 m-70 -141.02 -158.25 0.84 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 110.214 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 56.7 p30 -112.03 4.8 18.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -0.867 . . . . 0.0 110.135 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -118.15 4.37 16.03 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.534 ' HB2' ' CB ' ' A' ' 17' ' ' PRO . 42.6 m-20 -95.07 165.18 12.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.181 -1.188 . . . . 0.0 110.272 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.512 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 16.0 tp -113.5 116.21 29.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.273 -0.892 . . . . 0.0 110.003 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.535 ' CA ' ' HD3' ' A' ' 17' ' ' PRO . . . -96.33 51.85 1.6 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.58 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 25.4 p90 -49.91 171.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -1.152 . . . . 0.0 110.882 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.433 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 95.7 mt-10 -103.16 178.38 4.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.465 -0.772 . . . . 0.0 110.004 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -68.88 132.78 47.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.209 -0.932 . . . . 0.0 110.284 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.56 -9.65 74.98 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.481 ' OE2' ' CB ' ' A' ' 25' ' ' PHE . 21.8 tt0 -65.27 125.94 26.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.124 -1.221 . . . . 0.0 110.202 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.801 ' O ' HD23 ' A' ' 31' ' ' LEU . 85.9 mt-30 -79.72 137.94 37.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 110.04 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.801 HD23 ' O ' ' A' ' 30' ' ' GLN . 29.2 mt -141.58 163.78 32.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.194 -0.941 . . . . 0.0 110.358 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.588 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 5.8 ttt180 -107.18 134.21 50.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.376 -0.828 . . . . 0.0 109.485 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.758 HG21 HE21 ' A' ' 36' ' ' GLN . 25.5 mm -96.11 93.38 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.133 -0.979 . . . . 0.0 110.515 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.002 HD12 ' HA ' ' A' ' 43' ' ' ALA . 1.5 mp -79.49 -25.75 41.76 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.305 -0.872 . . . . 0.0 110.654 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.457 ' O ' ' HB3' ' A' ' 41' ' ' TRP . 11.0 mt-10 -136.38 139.65 42.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.057 -1.027 . . . . 0.0 110.39 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.758 HE21 HG21 ' A' ' 33' ' ' ILE . 96.2 mt-30 -134.21 54.47 1.94 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.368 -0.832 . . . . 0.0 110.044 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -112.69 146.91 37.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.403 -0.811 . . . . 0.0 110.224 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.18 -167.38 31.65 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -77.5 -34.13 54.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.319 -1.107 . . . . 0.0 110.154 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.53 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 99.3 m95 -92.96 137.98 31.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.191 -0.943 . . . . 0.0 110.326 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.633 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 50.6 m0 -120.42 156.08 32.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.32 -0.863 . . . . 0.0 110.023 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.438 ' HB2' ' HB2' ' A' ' 35' ' ' GLU . 20.3 mttp -98.25 139.55 33.87 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 109.275 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 1.002 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -148.57 174.24 12.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.015 -1.053 . . . . 0.0 110.694 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 50' ' ' GLN . 47.3 tt0 -140.68 149.27 42.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.409 -0.807 . . . . 0.0 109.9 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 t -96.08 110.64 22.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.924 . . . . 0.0 110.161 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 70.2 mt -71.55 -2.35 16.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.298 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 91.5 m -85.84 -28.23 24.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 0.0 109.948 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.1 p -127.89 -4.61 5.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 110.172 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.77 39.69 65.61 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.487 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 32.6 mt-30 -114.97 148.11 39.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.171 -1.193 . . . . 0.0 110.242 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 37.3 tt0 -120.94 144.47 48.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 0.0 109.887 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.512 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -162.19 -152.54 6.77 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -124.56 140.16 53.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.419 -1.048 . . . . 0.0 109.946 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.943 HD13 HG21 ' A' ' 59' ' ' VAL . 1.6 pp -136.09 137.73 25.64 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.18 -0.95 . . . . 0.0 110.491 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.612 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 45.1 Cg_endo -64.75 152.4 82.18 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.006 1.53 . . . . 0.0 109.964 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.593 ' HB2' ' CH2' ' A' ' 41' ' ' TRP . 30.1 p90 -72.36 -8.04 52.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.253 -0.904 . . . . 0.0 111.267 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -94.11 -26.12 16.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.817 -1.177 . . . . 0.0 110.993 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.612 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 6.5 m-85 -81.81 0.15 40.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.048 -1.033 . . . . 0.0 110.146 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.943 HG21 HD13 ' A' ' 54' ' ' ILE . 27.9 t -144.79 170.2 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.328 -0.858 . . . . 0.0 109.956 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.705 ' O ' HG12 ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.204 -0.935 . . . . 0.0 110.305 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.8 mt . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.196 0.522 . . . . 0.0 110.183 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.672 HG11 ' CD1' ' A' ' 33' ' ' ILE . 15.0 m -147.08 168.15 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 110.271 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 29.1 mm -111.83 139.26 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 0.0 109.936 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.655 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -80.42 115.61 20.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 110.448 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.444 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 61.4 mt -74.74 -19.81 60.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.991 -1.068 . . . . 0.0 109.436 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.444 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 51.9 m-70 -157.33 143.66 17.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.538 -0.726 . . . . 0.0 109.668 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 52.0 p -58.92 145.21 42.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.006 -1.059 . . . . 0.0 110.01 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.597 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 85.2 t80 -105.6 167.33 9.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.152 -0.968 . . . . 0.0 110.292 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.576 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 25.1 mt-10 -114.9 127.54 26.73 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 110.018 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.479 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 50.9 Cg_endo -79.79 89.63 1.32 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.917 1.483 . . . . 0.0 110.393 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.4 p -79.18 -10.09 59.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.867 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.439 ' CD2' ' OD2' ' A' ' 22' ' ' ASP . 44.7 m-70 -126.96 -179.51 4.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.858 . . . . 0.0 110.073 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -86.92 1.91 51.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 110.267 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.487 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -123.29 -15.78 3.66 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.439 ' OD2' ' CD2' ' A' ' 19' ' ' HIS . 87.5 m-20 -67.84 156.38 37.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.126 -1.22 . . . . 0.0 110.35 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.46 ' HA ' HD12 ' A' ' 23' ' ' LEU . 21.9 tp -116.51 120.31 38.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 109.829 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.479 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -97.53 53.16 1.31 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.655 ' CE2' ' HB1' ' A' ' 11' ' ' ALA . 42.7 p90 -48.28 168.72 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.211 -1.17 . . . . 0.0 110.948 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -96.9 176.98 5.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.475 -0.766 . . . . 0.0 110.349 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -71.33 127.03 31.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 110.161 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.61 -6.08 83.32 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.444 ' CD ' ' HB2' ' A' ' 25' ' ' PHE . 20.5 tt0 -65.99 130.04 41.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.114 -1.227 . . . . 0.0 110.054 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.432 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 50.8 tt0 -79.54 136.46 36.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.826 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.626 HD11 ' CG ' ' A' ' 25' ' ' PHE . 54.2 mt -139.65 162.36 35.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 0.0 110.528 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.582 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 11.3 ttt180 -111.83 138.77 47.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.394 -0.816 . . . . 0.0 109.558 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.672 ' CD1' HG11 ' A' ' 9' ' ' VAL . 57.9 mt -98.68 92.35 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.121 -0.987 . . . . 0.0 110.392 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.533 HD21 ' CD ' ' A' ' 32' ' ' ARG . 73.4 mt -79.49 -21.79 44.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 0.0 110.908 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.527 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 75.9 tt0 -138.12 131.54 30.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.993 -1.067 . . . . 0.0 110.234 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.635 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 95.4 mt-30 -126.25 56.75 1.43 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 110.25 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.7 t -115.84 150.26 37.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.296 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.58 -168.88 34.58 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -75.71 -32.72 60.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.306 -1.114 . . . . 0.0 110.088 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.553 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 95.4 m95 -97.9 144.71 27.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -0.901 . . . . 0.0 110.008 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.635 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 50.0 m0 -119.72 154.62 33.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.336 -0.852 . . . . 0.0 110.094 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.527 ' CB ' ' HB3' ' A' ' 35' ' ' GLU . 18.4 tttp -92.96 140.43 29.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.324 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.582 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -148.92 171.66 15.96 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.046 -1.034 . . . . 0.0 110.932 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 4.8 tt0 -139.57 147.78 41.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.56 -0.713 . . . . 0.0 109.622 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.0 t -94.22 109.81 21.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.15 -0.969 . . . . 0.0 110.144 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.435 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 16.5 tp -71.93 -1.58 14.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.437 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 98.0 m -90.87 -31.11 16.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -0.909 . . . . 0.0 110.142 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.0 p -120.73 -8.94 9.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.284 -0.885 . . . . 0.0 110.201 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.65 36.86 47.32 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -112.43 144.47 41.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -1.127 . . . . 0.0 110.268 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 83.8 tt0 -120.69 141.69 50.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.23 -0.919 . . . . 0.0 110.168 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 21' ' ' GLY . . . -172.95 163.93 35.82 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 91.7 m-85 -74.37 147.31 42.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -1.15 . . . . 0.0 109.832 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.815 HD12 ' O ' ' A' ' 55' ' ' PRO . 1.7 pp -142.67 137.86 15.64 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.281 -0.887 . . . . 0.0 110.285 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.815 ' O ' HD12 ' A' ' 54' ' ' ILE . 45.4 Cg_endo -57.89 156.81 26.7 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.112 1.585 . . . . 0.0 110.169 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.596 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 20.8 p90 -92.78 -0.9 57.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.375 -0.828 . . . . 0.0 111.243 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 58' ' ' PHE . 49.1 p-10 -98.32 -26.63 14.44 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.824 -1.172 . . . . 0.0 111.051 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.522 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 16.8 m-30 -88.65 2.3 53.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.938 -1.102 . . . . 0.0 110.502 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.799 HG11 HD13 ' A' ' 54' ' ' ILE . 33.2 m -132.19 146.64 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.111 -0.993 . . . . 0.0 110.208 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.316 -0.865 . . . . 0.0 110.181 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.437 ' C ' HG13 ' A' ' 9' ' ' VAL . 15.2 tp . . . . . 0 N--CA 1.491 1.578 0 CA-C-O 121.259 0.552 . . . . 0.0 110.155 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.917 HG11 HD11 ' A' ' 33' ' ' ILE . 24.5 m -149.48 168.78 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 110.269 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.2 mt -111.15 141.44 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.93 . . . . 0.0 109.886 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.433 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -80.12 109.86 14.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.167 -0.958 . . . . 0.0 110.316 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.414 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 71.6 mt -69.93 -24.52 63.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.02 -1.05 . . . . 0.0 109.247 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.414 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 74.2 m80 -152.84 148.23 26.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.561 -0.712 . . . . 0.0 109.632 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.527 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 51.4 p -63.75 144.76 56.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.037 -1.039 . . . . 0.0 109.987 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 39.5 t80 -97.68 157.38 16.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.026 -1.046 . . . . 0.0 110.357 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -110.32 99.82 41.91 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.372 -0.83 . . . . 0.0 109.998 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.494 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.3 Cg_endo -59.96 91.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.069 1.563 . . . . 0.0 110.461 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.9 m -83.28 1.33 41.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 110.102 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.462 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 77.3 m80 -146.67 152.35 38.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -0.887 . . . . 0.0 110.135 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -65.04 130.01 41.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -0.917 . . . . 0.0 110.189 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.07 13.58 24.78 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.462 ' OD2' ' HB2' ' A' ' 19' ' ' HIS . 13.8 m-20 -108.29 158.24 17.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.29 -1.123 . . . . 0.0 110.448 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.665 HD13 ' HG2' ' A' ' 50' ' ' GLN . 13.5 tp -109.3 111.89 23.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 109.834 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.494 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -93.24 49.87 2.43 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 31.7 p90 -53.36 174.42 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -1.127 . . . . 0.0 110.89 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.527 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 91.6 mt-10 -109.33 178.74 4.35 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.471 -0.768 . . . . 0.0 109.918 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -68.29 140.57 55.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.081 -1.012 . . . . 0.0 110.287 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.07 -14.31 50.02 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.465 ' HG3' ' HB2' ' A' ' 26' ' ' GLU . 3.6 mt-10 -65.8 126.59 28.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.175 -1.191 . . . . 0.0 110.37 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.975 ' C ' HD12 ' A' ' 31' ' ' LEU . 19.4 pt20 -79.76 136.33 36.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 109.958 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.975 HD12 ' C ' ' A' ' 30' ' ' GLN . 7.7 mp -137.95 158.88 43.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -0.96 . . . . 0.0 110.536 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.594 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 5.8 tpt180 -106.29 132.33 52.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.406 -0.809 . . . . 0.0 109.332 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.917 HD11 HG11 ' A' ' 9' ' ' VAL . 23.3 mt -90.79 93.73 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.083 -1.01 . . . . 0.0 110.544 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.438 ' CD2' ' HG3' ' A' ' 32' ' ' ARG . 67.1 mt -79.58 -29.94 41.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.367 -0.833 . . . . 0.0 110.844 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 42' ' ' LYS . 85.3 tt0 -130.91 140.48 50.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.947 -1.096 . . . . 0.0 110.406 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.627 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 76.5 mt-30 -134.52 54.88 1.92 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 110.111 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 51.4 m -119.65 148.18 43.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -0.876 . . . . 0.0 110.167 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.11 -177.87 27.52 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -69.18 -29.85 67.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -1.205 . . . . 0.0 110.333 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.459 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 99.2 m95 -98.61 144.15 28.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 110.378 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.627 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 43.5 m0 -121.02 155.87 33.41 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.349 -0.844 . . . . 0.0 110.176 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 35' ' ' GLU . 77.9 tttt -101.1 143.54 31.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 109.331 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.594 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -153.98 -179.9 8.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.014 -1.054 . . . . 0.0 110.85 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 48.3 tt0 -141.24 149.94 41.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.379 -0.825 . . . . 0.0 109.691 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.469 ' HB2' HD21 ' A' ' 23' ' ' LEU . 18.0 t -100.49 123.95 45.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.05 -1.031 . . . . 0.0 110.3 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.6 mt -80.85 6.21 13.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 110.051 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 87.0 m -91.07 -35.62 14.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 110.071 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.7 p -127.27 -3.55 6.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 110.093 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.2 35.24 57.25 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.665 ' HG2' HD13 ' A' ' 23' ' ' LEU . 63.1 tt0 -104.87 140.76 37.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -1.13 . . . . 0.0 110.283 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 86.3 tt0 -119.51 139.09 52.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.892 . . . . 0.0 110.18 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -170.81 163.17 36.25 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 94.4 m-85 -69.36 141.85 54.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.308 -1.113 . . . . 0.0 110.0 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.689 HD12 HG21 ' A' ' 59' ' ' VAL . 1.6 pt -131.57 142.37 45.06 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.194 -0.941 . . . . 0.0 110.38 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.579 ' O ' HG22 ' A' ' 59' ' ' VAL . 44.8 Cg_endo -68.49 140.89 49.11 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.066 1.561 . . . . 0.0 110.08 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.57 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 25.1 p90 -75.54 -7.03 53.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 0.0 111.144 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -90.34 -26.48 19.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.899 -1.126 . . . . 0.0 110.725 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.557 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 17.8 m-30 -92.71 4.16 54.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.091 -1.006 . . . . 0.0 110.22 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.689 HG21 HD12 ' A' ' 54' ' ' ILE . 35.6 m -136.04 143.49 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.263 -0.898 . . . . 0.0 110.103 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.956 . . . . 0.0 110.343 -179.956 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 1.011 HD13 ' N ' ' A' ' 9' ' ' VAL . 2.9 tm? . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 121.165 0.507 . . . . 0.0 110.111 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.011 ' N ' HD13 ' A' ' 8' ' ' LEU . 30.1 m -150.41 170.02 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.178 -0.951 . . . . 0.0 110.319 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 58.0 mt -115.16 145.05 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.377 -0.827 . . . . 0.0 109.954 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.608 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . -80.33 109.15 14.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.124 -0.985 . . . . 0.0 110.337 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.469 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 57.6 mt -67.05 -24.3 65.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.985 -1.072 . . . . 0.0 109.353 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.469 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 58.1 m80 -157.09 155.16 30.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.611 -0.681 . . . . 0.0 109.487 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 47.7 t -66.49 139.15 57.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.972 -1.08 . . . . 0.0 109.98 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.59 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 73.5 t80 -95.96 155.27 16.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.084 -1.01 . . . . 0.0 110.375 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.584 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 1.2 mp0 -105.66 128.71 25.95 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.361 -0.837 . . . . 0.0 110.11 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.426 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.5 Cg_endo -87.31 81.28 1.28 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.875 1.461 . . . . 0.0 110.448 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 97.1 p -79.88 -2.33 43.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.385 -0.822 . . . . 0.0 109.942 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.416 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 63.8 m80 -138.95 149.81 45.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.888 . . . . 0.0 110.18 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -69.21 129.1 38.9 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.287 -0.883 . . . . 0.0 110.227 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.83 -4.41 39.26 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.416 ' OD2' ' HB2' ' A' ' 19' ' ' HIS . 34.9 m-20 -92.25 165.99 12.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.225 -1.162 . . . . 0.0 110.464 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.489 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 18.0 tp -117.85 124.33 48.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.272 -0.893 . . . . 0.0 110.011 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 15' ' ' TYR . . . -105.68 52.7 0.69 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.608 ' CD2' ' HB1' ' A' ' 11' ' ' ALA . 41.3 p90 -48.74 175.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -1.18 . . . . 0.0 110.841 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.496 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 73.5 mm-40 -109.76 179.34 4.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.445 -0.784 . . . . 0.0 110.157 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -69.41 133.48 47.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.008 -1.058 . . . . 0.0 110.478 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.28 -15.53 55.95 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 3.3 mt-10 -64.25 122.56 16.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.034 -1.274 . . . . 0.0 110.454 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.43 ' O ' HD23 ' A' ' 31' ' ' LEU . 99.0 mt-30 -79.4 137.15 37.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -0.879 . . . . 0.0 109.651 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.525 HD11 ' CG ' ' A' ' 25' ' ' PHE . 15.7 mt -133.77 154.35 51.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.174 -0.954 . . . . 0.0 110.488 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 14.9 ttm180 -98.79 130.89 45.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.397 -0.815 . . . . 0.0 109.931 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.562 HD11 ' CG1' ' A' ' 9' ' ' VAL . 69.2 mt -73.72 113.95 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.186 -0.946 . . . . 0.0 110.109 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.914 HD11 ' HB2' ' A' ' 44' ' ' GLN . 35.7 mt -86.49 -38.83 16.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.87 . . . . 0.0 110.201 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.457 ' O ' ' HB3' ' A' ' 41' ' ' TRP . 94.4 mt-10 -139.25 161.45 37.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.343 -0.848 . . . . 0.0 109.946 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.631 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 45.7 tt0 -143.78 61.2 1.37 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 0.0 110.141 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.9 t -131.81 122.48 25.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 110.196 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.35 176.69 41.84 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.75 -34.39 75.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.365 -1.079 . . . . 0.0 110.249 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.434 ' O ' ' CD1' ' A' ' 41' ' ' TRP . 73.4 m95 -100.08 150.16 22.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.89 . . . . 0.0 110.242 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.631 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 40.1 m0 -130.84 160.03 35.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.29 -0.881 . . . . 0.0 110.381 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.421 ' HD3' ' HB3' ' A' ' 34' ' ' LEU . 80.0 tttt -88.89 146.6 24.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.914 . . . . 0.0 109.605 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.664 ' HB2' HG12 ' A' ' 54' ' ' ILE . . . -147.14 167.82 23.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.029 -1.045 . . . . 0.0 110.759 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.914 ' HB2' HD11 ' A' ' 34' ' ' LEU . 43.4 tt0 -145.69 154.22 41.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.433 -0.792 . . . . 0.0 110.025 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.5 t -83.09 145.4 29.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.065 -1.022 . . . . 0.0 110.196 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.3 tp -91.38 -21.14 21.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 110.132 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.7 t -105.45 -26.49 11.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 0.0 110.429 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.3 m -100.35 -29.22 12.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.122 -0.986 . . . . 0.0 110.108 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.06 22.04 64.2 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 62.0 tt0 -92.75 134.48 35.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.442 -1.034 . . . . 0.0 110.259 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.54 ' HG2' ' CG ' ' A' ' 44' ' ' GLN . 79.9 mt-10 -114.96 133.09 56.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.282 -0.887 . . . . 0.0 109.934 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -161.26 157.03 28.58 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -67.07 142.19 57.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.349 -1.089 . . . . 0.0 110.159 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.664 HG12 ' HB2' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -133.63 162.13 59.52 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 110.137 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.59 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 47.8 Cg_endo -90.26 162.88 4.63 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.993 1.523 . . . . 0.0 110.09 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -87.34 -2.23 58.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -0.924 . . . . 0.0 110.819 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -100.1 -25.74 14.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.036 -1.04 . . . . 0.0 110.987 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.586 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 22.4 m-85 -84.26 -9.26 58.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.924 -1.11 . . . . 0.0 110.53 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 22.4 m -131.16 143.24 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 110.301 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.185 179.942 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.461 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.4 tp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.155 0.502 . . . . 0.0 110.204 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.786 HG12 ' O ' ' A' ' 60' ' ' ALA . 4.2 m -153.18 173.39 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 0.0 110.532 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 62.1 mt -120.63 142.6 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.376 -0.828 . . . . 0.0 109.527 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.443 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -77.54 115.77 17.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.116 -0.99 . . . . 0.0 110.342 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 12' ' ' LEU . 15.5 tp -73.55 -20.3 60.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.14 -0.975 . . . . 0.0 109.086 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -149.35 -158.95 0.97 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.586 -0.696 . . . . 0.0 109.693 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 93.8 p -118.07 140.51 49.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.164 -0.96 . . . . 0.0 110.151 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.593 ' CD2' ' HD3' ' A' ' 55' ' ' PRO . 60.2 t80 -103.53 162.6 12.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.067 -1.021 . . . . 0.0 110.223 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.567 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 47.0 tt0 -119.91 130.32 24.91 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 110.273 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.458 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.1 Cg_endo -81.22 84.46 1.97 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.02 1.537 . . . . 0.0 110.403 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 77.0 p -79.83 -1.19 37.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.925 . . . . 0.0 110.093 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.445 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 82.2 m-70 -150.28 158.16 43.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 110.02 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -66.09 127.47 32.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 110.217 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.415 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . 107.12 -10.91 40.34 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.445 ' OD2' ' HB2' ' A' ' 19' ' ' HIS . 41.5 m-20 -83.18 152.45 25.23 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.231 -1.158 . . . . 0.0 110.316 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.546 ' O ' ' CD1' ' A' ' 15' ' ' TYR . 14.2 tp -114.22 120.01 39.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.308 -0.87 . . . . 0.0 110.036 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.458 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -102.86 56.71 0.61 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.563 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 36.2 p90 -50.8 171.6 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.185 -1.185 . . . . 0.0 110.874 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -103.62 178.59 4.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.545 -0.722 . . . . 0.0 109.981 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.9 mttp -69.69 124.56 24.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 110.328 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.45 -12.26 70.15 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.439 ' CD ' ' HB2' ' A' ' 25' ' ' PHE . 41.4 tt0 -59.74 127.68 33.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.129 -1.218 . . . . 0.0 110.395 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -79.83 131.93 36.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.929 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.475 HD11 ' CG ' ' A' ' 25' ' ' PHE . 18.9 mt -131.58 151.31 51.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -0.938 . . . . 0.0 110.408 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.65 ' NH1' HD13 ' A' ' 46' ' ' LEU . 20.2 mtp85 -98.54 133.66 42.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.341 -0.849 . . . . 0.0 109.523 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.62 HG21 HE21 ' A' ' 36' ' ' GLN . 27.3 mt -77.1 118.12 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.978 . . . . 0.0 110.067 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.699 HD11 ' HB2' ' A' ' 44' ' ' GLN . 86.3 mt -95.68 -36.74 11.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 0.0 110.273 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.406 ' HA ' ' OE1' ' A' ' 35' ' ' GLU . 67.3 mm-40 -139.96 153.17 46.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 110.213 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.62 HE21 HG21 ' A' ' 33' ' ' ILE . 96.1 mt-30 -135.48 55.14 1.89 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.304 -0.873 . . . . 0.0 110.215 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.3 m -120.03 135.72 54.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.272 -0.892 . . . . 0.0 110.148 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.44 178.42 42.75 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.97 -33.19 75.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.359 -1.083 . . . . 0.0 110.355 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.565 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 98.7 m95 -91.89 140.81 29.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.174 -0.954 . . . . 0.0 110.153 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.581 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 40.7 m0 -122.01 152.99 39.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.9 . . . . 0.0 110.212 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.5 tttm -91.85 148.23 22.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 0.0 109.589 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.695 ' HB3' HG21 ' A' ' 54' ' ' ILE . . . -155.49 178.11 10.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.0 -1.062 . . . . 0.0 110.622 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.699 ' HB2' HD11 ' A' ' 34' ' ' LEU . 28.4 tt0 -150.9 159.67 44.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.296 -0.878 . . . . 0.0 109.724 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 6.4 t -82.27 147.56 28.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.072 -1.018 . . . . 0.0 109.933 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.65 HD13 ' NH1' ' A' ' 32' ' ' ARG . 30.3 tp -91.68 -21.31 20.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.927 . . . . 0.0 109.945 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.4 p -107.77 -28.14 9.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.354 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.3 m -94.43 -31.16 14.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.124 -0.985 . . . . 0.0 110.233 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.55 24.02 59.36 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.496 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 65.2 tp60 -97.55 136.66 37.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.358 -1.084 . . . . 0.0 110.022 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.55 ' HG2' ' CG ' ' A' ' 44' ' ' GLN . 31.2 mt-10 -117.52 136.73 53.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.094 -1.004 . . . . 0.0 110.244 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.49 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -167.79 162.52 36.31 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -66.37 141.94 57.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.297 -1.119 . . . . 0.0 110.217 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.695 HG21 ' HB3' ' A' ' 43' ' ' ALA . 1.3 pp -133.4 144.35 51.92 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.255 -0.903 . . . . 0.0 110.171 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.593 ' HD3' ' CD2' ' A' ' 15' ' ' TYR . 44.6 Cg_endo -71.23 152.57 61.71 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.023 1.538 . . . . 0.0 110.373 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.566 ' CE2' ' OD1' ' A' ' 57' ' ' ASN . 20.1 p90 -89.89 -1.08 57.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.335 -0.853 . . . . 0.0 110.68 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.566 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 92.3 m-20 -95.64 -27.14 15.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.089 -1.007 . . . . 0.0 110.668 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.565 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 12.8 m-30 -90.46 4.39 51.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.096 -1.002 . . . . 0.0 110.465 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.508 HG12 ' HB ' ' A' ' 9' ' ' VAL . 10.7 t -140.93 163.84 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 110.206 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.786 ' O ' HG12 ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.619 0 O-C-N 121.346 -0.846 . . . . 0.0 110.193 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.713 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.7 mp . . . . . 0 N--CA 1.492 1.635 0 CA-C-O 121.158 0.504 . . . . 0.0 110.048 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.859 HG11 HD11 ' A' ' 33' ' ' ILE . 27.3 m -143.5 166.99 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.228 -0.92 . . . . 0.0 110.404 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.432 ' O ' HD12 ' A' ' 12' ' ' LEU . 21.3 mm -110.73 146.23 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.86 . . . . 0.0 109.754 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.48 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -80.15 113.51 18.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.116 -0.99 . . . . 0.0 110.381 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.697 HD12 ' N ' ' A' ' 12' ' ' LEU . 8.2 mp -74.57 -19.98 60.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 0.0 109.371 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.513 ' ND1' ' O ' ' A' ' 12' ' ' LEU . 71.9 m80 -155.61 145.17 21.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.497 -0.752 . . . . 0.0 109.611 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.556 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 33.1 p -64.03 145.98 54.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.94 -1.1 . . . . 0.0 110.129 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 82.9 t80 -104.35 166.7 10.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.101 -0.999 . . . . 0.0 110.211 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.24 120.08 29.26 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.912 . . . . 0.0 110.125 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.487 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 49.5 Cg_endo -70.19 84.35 0.73 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.949 1.5 . . . . 0.0 110.219 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.501 ' OG ' ' ND1' ' A' ' 19' ' ' HIS . 73.8 p -79.9 -3.84 49.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -0.881 . . . . 0.0 110.082 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.501 ' ND1' ' OG ' ' A' ' 18' ' ' SER . 50.9 m80 -145.94 140.5 26.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 110.195 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -53.45 124.48 14.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 110.279 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.76 16.02 12.35 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -114.69 159.85 20.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -1.184 . . . . 0.0 110.303 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.501 ' HA ' HD12 ' A' ' 23' ' ' LEU . 15.4 tp -115.23 118.41 33.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.329 -0.857 . . . . 0.0 110.081 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.487 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -95.9 47.59 1.84 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 40.2 p90 -47.36 171.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.269 -1.136 . . . . 0.0 111.042 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.556 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 92.4 mt-10 -105.95 178.82 4.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.412 -0.805 . . . . 0.0 110.069 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.6 tttt -69.32 138.0 53.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.083 -1.011 . . . . 0.0 110.136 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.09 -12.31 60.48 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.581 ' HG2' HD11 ' A' ' 31' ' ' LEU . 8.4 tt0 -63.57 128.17 34.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.174 -1.191 . . . . 0.0 110.118 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.97 ' C ' HD12 ' A' ' 31' ' ' LEU . 92.6 mt-30 -79.55 134.53 36.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 109.992 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.97 HD12 ' C ' ' A' ' 30' ' ' GLN . 8.5 mp -136.11 156.87 48.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.919 . . . . 0.0 110.736 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.586 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 22.8 ttt180 -107.76 135.81 48.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.442 -0.786 . . . . 0.0 109.138 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.859 HD11 HG11 ' A' ' 9' ' ' VAL . 54.4 mt -91.39 92.35 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.042 -1.036 . . . . 0.0 110.879 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 44' ' ' GLN . 11.0 mt -79.08 -29.84 43.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.581 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.546 ' CB ' ' HB3' ' A' ' 42' ' ' LYS . 45.7 tt0 -134.6 132.86 39.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.961 -1.087 . . . . 0.0 110.234 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.633 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 53.3 tt0 -129.08 59.31 1.58 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.286 -0.884 . . . . 0.0 110.119 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 89.5 p -121.53 146.12 47.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 110.237 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.02 -170.26 47.57 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -74.6 -33.1 62.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -1.138 . . . . 0.0 110.072 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.494 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 99.0 m95 -96.44 142.8 28.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.212 -0.93 . . . . 0.0 110.16 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.633 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 43.1 m0 -119.94 154.97 33.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.22 -0.925 . . . . 0.0 110.192 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.546 ' HB3' ' CB ' ' A' ' 35' ' ' GLU . 34.3 tttp -97.63 141.17 31.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.343 -0.848 . . . . 0.0 109.132 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.586 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -152.52 177.77 10.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.94 -1.1 . . . . 0.0 110.803 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.485 ' HB2' HD11 ' A' ' 34' ' ' LEU . 58.6 tt0 -142.65 150.62 40.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.438 -0.789 . . . . 0.0 109.912 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.1 t -97.16 114.75 26.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.989 . . . . 0.0 110.229 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.7 mt -74.63 0.18 15.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -0.944 . . . . 0.0 110.118 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 54.9 m -86.16 -33.26 20.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 110.045 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.8 p -128.39 -3.58 5.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.159 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.2 33.77 56.23 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -101.86 139.96 36.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.289 -1.124 . . . . 0.0 110.148 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.448 ' OE2' ' HE3' ' A' ' 42' ' ' LYS . 78.6 tt0 -120.77 140.77 51.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 0.0 110.163 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -174.12 164.53 35.81 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 81.7 m-85 -74.06 146.37 43.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.174 -1.192 . . . . 0.0 109.758 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.986 HD13 HG11 ' A' ' 59' ' ' VAL . 1.8 pp -140.71 143.16 31.16 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.183 -0.948 . . . . 0.0 110.501 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.762 ' O ' HD12 ' A' ' 54' ' ' ILE . 44.6 Cg_endo -63.1 148.39 93.35 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.157 1.609 . . . . 0.0 110.109 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.593 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 20.4 p90 -84.67 -1.42 56.08 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.294 -0.879 . . . . 0.0 110.895 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.539 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 87.8 m-20 -94.6 -26.24 16.45 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.984 -1.073 . . . . 0.0 110.634 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.622 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 13.1 m-30 -90.87 6.84 42.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.087 -1.008 . . . . 0.0 110.391 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.986 HG11 HD13 ' A' ' 54' ' ' ILE . 31.0 m -132.53 142.18 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 0.0 110.053 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.437 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.914 . . . . 0.0 110.247 -179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.477 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.4 mp . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 121.217 0.532 . . . . 0.0 110.094 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.696 ' CG1' HD11 ' A' ' 33' ' ' ILE . 21.5 m -138.33 163.78 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.144 -0.973 . . . . 0.0 110.44 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 90.7 mt -112.77 143.39 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.367 -0.833 . . . . 0.0 109.802 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.65 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . -80.57 110.62 16.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.159 -0.963 . . . . 0.0 110.505 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.525 HD12 ' N ' ' A' ' 12' ' ' LEU . 6.3 mp -68.56 -22.99 64.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.985 -1.072 . . . . 0.0 109.031 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.497 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 75.3 m-70 -158.29 149.26 20.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.593 -0.692 . . . . 0.0 109.342 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 54.3 p -61.65 142.75 56.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.928 -1.108 . . . . 0.0 109.982 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 80.1 t80 -98.66 159.97 14.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.084 -1.01 . . . . 0.0 110.443 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -105.63 112.32 64.62 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 109.999 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.474 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 49.3 Cg_endo -72.66 89.76 0.84 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.965 1.508 . . . . 0.0 110.513 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.6 p -79.68 -4.07 50.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.929 . . . . 0.0 110.183 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -130.47 -176.01 3.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.216 -0.927 . . . . 0.0 110.213 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -92.38 -10.85 36.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 0.0 110.247 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.32 32.69 5.95 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -117.8 159.33 23.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -1.131 . . . . 0.0 110.385 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.503 ' HA ' HD12 ' A' ' 23' ' ' LEU . 14.5 tp -114.18 118.43 33.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.357 -0.84 . . . . 0.0 109.763 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.474 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -96.23 50.36 1.67 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.65 ' CD2' ' HB1' ' A' ' 11' ' ' ALA . 41.5 p90 -48.1 170.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -1.171 . . . . 0.0 110.823 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.442 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 77.2 mm-40 -101.39 178.49 4.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.421 -0.8 . . . . 0.0 110.237 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 12' ' ' LEU . 50.0 tttm -70.55 124.07 23.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.171 -0.956 . . . . 0.0 110.379 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.86 -8.19 73.61 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.438 ' CD ' ' HB2' ' A' ' 25' ' ' PHE . 45.7 tt0 -67.25 125.54 26.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.116 -1.226 . . . . 0.0 110.374 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.441 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 96.4 mt-30 -79.72 138.29 37.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.21 -0.931 . . . . 0.0 109.859 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.577 HD11 ' CG ' ' A' ' 25' ' ' PHE . 21.1 mt -137.32 159.0 43.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 110.398 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 9.4 ttt180 -101.62 132.32 47.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.401 -0.812 . . . . 0.0 109.526 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.696 HD11 ' CG1' ' A' ' 9' ' ' VAL . 6.8 mt -72.92 115.04 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.172 -0.955 . . . . 0.0 110.39 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.578 HD11 ' HG2' ' A' ' 51' ' ' GLU . 38.3 mt -83.32 -38.05 22.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.929 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.432 ' C ' ' HG3' ' A' ' 36' ' ' GLN . 87.3 mt-10 -148.62 170.63 17.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.309 -0.869 . . . . 0.0 110.26 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.526 HE21 HG21 ' A' ' 33' ' ' ILE . 98.5 mt-30 -147.33 60.46 1.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 110.201 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.1 p -130.34 136.47 49.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 110.222 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.95 -170.97 44.17 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -75.88 -31.89 59.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.191 -1.182 . . . . 0.0 110.31 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.556 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 85.8 m95 -100.45 149.43 23.68 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.228 -0.92 . . . . 0.0 110.089 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.517 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 38.2 m0 -119.95 153.28 36.16 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.222 -0.924 . . . . 0.0 110.425 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 34' ' ' LEU . 41.9 tttp -89.4 142.98 27.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.349 -0.844 . . . . 0.0 109.662 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.842 ' HB2' HG12 ' A' ' 54' ' ' ILE . . . -137.22 158.04 45.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.138 -0.976 . . . . 0.0 110.805 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 56.3 tt0 -129.04 138.35 51.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.484 -0.76 . . . . 0.0 109.962 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.465 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 6.5 t -79.14 140.0 37.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.115 -0.991 . . . . 0.0 110.011 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.444 HD21 ' HB2' ' A' ' 32' ' ' ARG . 61.9 mt -92.94 -13.04 29.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.885 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.7 m -99.4 -25.73 14.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.426 -0.796 . . . . 0.0 110.349 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.465 ' OG1' ' HB3' ' A' ' 45' ' ' SER . 40.6 p -114.59 -13.42 12.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.063 -1.023 . . . . 0.0 110.398 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 64.88 45.83 91.31 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 20.2 mt-30 -120.76 152.03 38.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.368 -1.078 . . . . 0.0 110.17 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.578 ' HG2' HD11 ' A' ' 34' ' ' LEU . 96.7 mt-10 -116.81 134.52 54.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -0.871 . . . . 0.0 110.173 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -155.58 151.83 23.36 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -70.56 143.52 51.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -1.182 . . . . 0.0 110.094 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.985 ' CD1' HG21 ' A' ' 59' ' ' VAL . 1.9 pp -138.46 134.73 17.62 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.9 . . . . 0.0 110.117 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.59 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 46.0 Cg_endo -59.1 158.92 23.73 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.94 1.495 . . . . 0.0 110.286 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.476 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 23.5 p90 -84.14 -5.07 59.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 110.885 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -96.28 -25.13 15.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.048 -1.032 . . . . 0.0 110.931 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.59 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 19.2 m-85 -83.92 -8.63 59.13 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.022 -1.049 . . . . 0.0 110.306 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.985 HG21 ' CD1' ' A' ' 54' ' ' ILE . 33.6 m -136.22 146.0 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.138 -0.977 . . . . 0.0 110.359 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.642 0 O-C-N 121.271 -0.893 . . . . 0.0 110.22 -180.0 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.795 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.5 mp . . . . . 0 N--CA 1.49 1.548 0 CA-C-O 121.185 0.517 . . . . 0.0 110.197 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 31' ' ' LEU . 27.8 m -148.32 168.87 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.197 -0.94 . . . . 0.0 110.389 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.413 HD13 ' O ' ' A' ' 9' ' ' VAL . 26.1 mm -112.57 146.44 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.376 -0.827 . . . . 0.0 109.842 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.504 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . -80.18 112.29 17.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.14 -0.975 . . . . 0.0 110.388 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 27.0 tp -75.27 -22.45 57.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.108 -0.995 . . . . 0.0 109.621 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.501 ' HA ' ' HG2' ' A' ' 27' ' ' LYS . 94.7 m-70 -151.97 149.75 29.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.492 -0.755 . . . . 0.0 109.762 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.5 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 15.9 t -68.35 141.88 55.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.011 -1.056 . . . . 0.0 109.941 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.593 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 85.8 t80 -98.83 160.08 14.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.938 . . . . 0.0 110.246 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.503 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 2.1 tm-20 -112.38 128.54 25.38 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 0.0 110.169 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.478 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 47.3 Cg_endo -83.39 82.28 2.11 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.028 1.541 . . . . 0.0 110.532 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.513 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 88.9 p -80.8 -0.97 41.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 110.137 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.513 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 84.2 m-70 -145.68 179.59 7.33 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.906 . . . . 0.0 110.167 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -90.39 127.92 36.33 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 110.106 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.76 -3.13 41.89 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -89.97 154.66 19.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -1.138 . . . . 0.0 110.278 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.5 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 22.5 tp -109.63 114.6 28.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.171 -0.956 . . . . 0.0 110.067 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.478 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -96.17 47.41 1.8 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.589 ' CE1' ' HB2' ' A' ' 15' ' ' TYR . 46.4 p90 -50.43 174.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.149 -1.206 . . . . 0.0 111.164 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.5 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 83.2 mt-10 -110.59 177.9 4.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.464 -0.772 . . . . 0.0 110.216 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.501 ' HG2' ' HA ' ' A' ' 13' ' ' HIS . 5.4 mtmm -69.16 139.39 54.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.036 -1.04 . . . . 0.0 110.231 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.15 -16.24 49.16 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 39.0 mm-40 -66.4 125.61 26.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.051 -1.264 . . . . 0.0 110.012 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.406 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 22.5 tt0 -79.48 137.77 37.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.875 . . . . 0.0 110.168 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.574 ' O ' HG22 ' A' ' 9' ' ' VAL . 41.4 mt -137.84 159.87 40.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.316 -0.865 . . . . 0.0 110.211 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.579 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 37.0 ttp180 -108.48 135.78 49.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.623 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.522 HD11 HG21 ' A' ' 9' ' ' VAL . 36.9 mm -96.18 92.63 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.166 -0.959 . . . . 0.0 110.435 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.494 HD21 ' NE ' ' A' ' 32' ' ' ARG . 17.2 mt -79.45 -24.91 42.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.214 -0.929 . . . . 0.0 110.777 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.456 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 45.1 tp10 -136.2 134.67 38.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.954 -1.091 . . . . 0.0 110.388 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.636 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 75.3 mt-30 -129.41 54.87 1.79 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.347 -0.846 . . . . 0.0 110.153 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.4 m -114.86 154.01 29.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 110.183 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.26 -173.27 8.53 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -72.2 -31.91 66.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -1.136 . . . . 0.0 110.181 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.425 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 92.5 m95 -97.77 143.06 28.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.258 -0.902 . . . . 0.0 110.34 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.636 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 51.2 m0 -120.15 155.41 33.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.367 -0.833 . . . . 0.0 110.115 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.491 ' NZ ' ' OE2' ' A' ' 51' ' ' GLU . 48.8 tttt -96.55 141.34 29.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.882 . . . . 0.0 109.365 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.579 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -149.97 174.58 12.54 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.078 -1.014 . . . . 0.0 110.815 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 61.3 tt0 -141.12 149.53 41.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.451 -0.781 . . . . 0.0 109.765 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.0 t -95.48 111.88 23.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.197 -0.94 . . . . 0.0 110.161 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.433 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 18.5 tp -71.85 -1.85 15.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -0.896 . . . . 0.0 110.415 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.1 m -88.57 -29.1 20.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.237 -0.915 . . . . 0.0 110.098 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.7 p -126.67 -6.15 6.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 110.163 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.21 36.63 59.95 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.414 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 30.8 mt-30 -109.63 144.98 37.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -1.159 . . . . 0.0 110.228 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.491 ' OE2' ' NZ ' ' A' ' 42' ' ' LYS . 83.5 tt0 -118.52 138.92 52.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.898 . . . . 0.0 110.033 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -166.88 158.17 31.01 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -72.55 143.81 48.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -1.132 . . . . 0.0 110.18 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.713 HD13 HG11 ' A' ' 59' ' ' VAL . 1.0 OUTLIER -137.47 145.47 49.47 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 110.213 -179.866 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.607 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 47.3 Cg_endo -69.51 149.14 68.11 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.98 1.516 . . . . 0.0 110.156 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.593 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 36.3 p90 -74.99 -4.78 40.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.969 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -96.17 -25.33 15.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.875 -1.141 . . . . 0.0 110.954 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.607 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 9.0 m-85 -83.14 -2.16 54.73 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.055 -1.028 . . . . 0.0 110.284 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.713 HG11 HD13 ' A' ' 54' ' ' ILE . 33.1 m -136.32 144.08 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 110.071 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.609 0 O-C-N 121.138 -0.977 . . . . 0.0 110.242 -179.981 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.708 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.5 mp . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 121.207 0.527 . . . . 0.0 110.206 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 60' ' ' ALA . 11.8 m -144.65 167.04 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.181 -0.949 . . . . 0.0 110.334 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.8 mt -111.41 145.51 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.0 109.707 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.401 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -79.2 112.9 16.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.97 . . . . 0.0 110.303 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.505 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 55.2 mt -71.55 -21.35 61.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.105 -0.997 . . . . 0.0 109.487 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.505 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 62.7 m-70 -157.61 148.86 21.58 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.574 -0.704 . . . . 0.0 109.628 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 58.6 p -63.06 143.31 57.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.981 -1.075 . . . . 0.0 109.919 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.578 ' CD1' ' HG3' ' A' ' 55' ' ' PRO . 24.4 t80 -96.65 155.05 16.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.055 -1.028 . . . . 0.0 110.269 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.419 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -110.11 75.28 0.88 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.854 . . . . 0.0 110.17 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.537 ' HD3' ' CA ' ' A' ' 24' ' ' GLY . 46.8 Cg_endo -46.96 122.5 6.26 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.047 1.551 . . . . 0.0 110.372 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.499 ' O ' ' CD2' ' A' ' 19' ' ' HIS . 58.4 m -91.89 10.69 27.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.366 -0.834 . . . . 0.0 110.128 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.499 ' CD2' ' O ' ' A' ' 18' ' ' SER . 33.8 m170 -140.55 -158.26 0.84 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.303 -0.873 . . . . 0.0 110.192 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.4 p30 -112.67 3.92 16.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.193 -0.942 . . . . 0.0 110.187 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.43 -9.36 17.49 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.5 ' HB2' ' CB ' ' A' ' 17' ' ' PRO . 84.2 m-20 -81.65 165.7 20.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.214 -1.168 . . . . 0.0 110.4 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.503 ' HA ' HD12 ' A' ' 23' ' ' LEU . 14.7 tp -113.39 115.19 27.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 0.0 109.779 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.537 ' CA ' ' HD3' ' A' ' 17' ' ' PRO . . . -96.18 55.46 1.53 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 17.9 p90 -54.2 172.71 0.08 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.367 -1.078 . . . . 0.0 110.97 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -103.53 178.39 4.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.514 -0.741 . . . . 0.0 110.145 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -69.97 132.78 46.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.966 . . . . 0.0 110.101 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.13 -10.64 72.25 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.483 ' OE2' ' CB ' ' A' ' 25' ' ' PHE . 22.2 tt0 -64.09 126.58 28.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -1.222 . . . . 0.0 110.032 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.947 ' C ' HD12 ' A' ' 31' ' ' LEU . 38.1 tt0 -79.47 136.79 37.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.178 -0.952 . . . . 0.0 109.857 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.947 HD12 ' C ' ' A' ' 30' ' ' GLN . 7.1 mp -139.8 161.87 36.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 110.593 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.587 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 2.7 tpt180 -109.28 135.9 49.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.406 -0.809 . . . . 0.0 109.257 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.62 HD11 HG21 ' A' ' 9' ' ' VAL . 33.7 mm -91.21 92.42 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.102 -0.998 . . . . 0.0 110.567 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.637 HD11 ' HB2' ' A' ' 44' ' ' GLN . 1.5 mt -79.54 -30.01 41.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 110.789 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.515 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 77.5 tt0 -133.6 137.12 45.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.017 -1.052 . . . . 0.0 110.45 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.611 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 75.6 mt-30 -133.65 54.78 1.93 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 110.092 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -120.75 143.25 48.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.917 . . . . 0.0 110.221 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.83 -168.62 54.82 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -77.49 -33.83 54.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -1.141 . . . . 0.0 110.151 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.476 ' CZ3' ' OH ' ' A' ' 15' ' ' TYR . 98.6 m95 -96.79 141.77 29.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 110.251 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.611 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 40.6 m0 -116.83 153.65 32.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.902 . . . . 0.0 110.199 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.515 ' CB ' ' HB3' ' A' ' 35' ' ' GLU . 12.0 tttt -99.9 140.5 34.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.372 -0.83 . . . . 0.0 109.409 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.587 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -150.36 176.48 10.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.069 -1.02 . . . . 0.0 110.662 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.637 ' HB2' HD11 ' A' ' 34' ' ' LEU . 62.0 tt0 -139.01 147.57 42.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.368 -0.832 . . . . 0.0 109.96 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.5 t -97.21 117.03 30.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.95 . . . . 0.0 110.303 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.5 mt -76.6 2.59 13.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.168 -0.958 . . . . 0.0 110.118 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.9 m -91.58 -35.58 14.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 110.163 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 70.8 p -118.62 -6.02 10.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -0.884 . . . . 0.0 110.237 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.93 43.73 64.5 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.46 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 7.0 mt-30 -121.17 149.61 42.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -1.177 . . . . 0.0 110.234 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.464 ' OE2' ' HE2' ' A' ' 42' ' ' LYS . 82.3 tt0 -122.83 145.47 48.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 110.132 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.465 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -174.36 163.71 34.51 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 90.4 m-85 -75.24 146.08 41.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.322 -1.105 . . . . 0.0 109.847 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.627 HD13 HG21 ' A' ' 59' ' ' VAL . 1.5 pp -140.02 140.46 24.06 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.135 -0.978 . . . . 0.0 110.544 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.635 ' CG ' ' CD2' ' A' ' 58' ' ' PHE . 44.6 Cg_endo -60.22 145.17 99.11 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.164 1.613 . . . . 0.0 110.062 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.585 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 21.9 p90 -82.7 -5.12 58.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 110.927 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -91.59 -27.48 18.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.928 -1.108 . . . . 0.0 110.648 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.635 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 18.2 m-30 -85.86 6.82 26.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.106 -0.997 . . . . 0.0 110.105 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.627 HG21 HD13 ' A' ' 54' ' ' ILE . 26.4 t -141.85 169.46 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.882 . . . . 0.0 109.769 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.729 ' O ' HG12 ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.089 -1.007 . . . . 0.0 110.267 -179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.448 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.5 tp . . . . . 0 N--CA 1.492 1.644 0 CA-C-O 121.203 0.525 . . . . 0.0 110.065 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.078 HG21 HD11 ' A' ' 33' ' ' ILE . 4.1 m -152.32 172.96 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.129 -0.982 . . . . 0.0 110.464 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.6 mt -120.14 140.46 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.406 -0.809 . . . . 0.0 109.511 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.573 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -74.22 114.69 12.86 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.176 -0.952 . . . . 0.0 110.33 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.418 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 23.9 tp -71.18 -21.58 62.14 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 109.264 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.418 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 65.5 m-70 -154.94 -163.63 1.61 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.607 -0.683 . . . . 0.0 109.733 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.407 ' O ' ' OE2' ' A' ' 16' ' ' GLU . 30.1 t -106.91 135.76 47.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.085 -1.009 . . . . 0.0 109.756 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.607 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 81.5 t80 -97.15 151.79 19.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.993 -1.067 . . . . 0.0 110.4 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.407 ' OE2' ' O ' ' A' ' 14' ' ' SER . 1.9 mp0 -117.09 102.71 52.59 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.337 -0.852 . . . . 0.0 110.209 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.485 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 46.9 Cg_endo -62.99 98.91 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.013 1.533 . . . . 0.0 110.366 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.566 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 97.8 p -81.25 7.43 11.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.144 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.566 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 97.8 m-70 -154.27 -177.59 6.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 110.143 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -88.49 130.69 35.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.11 -0.994 . . . . 0.0 110.239 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.76 13.45 25.69 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -109.3 159.18 17.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.165 -1.197 . . . . 0.0 110.403 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.505 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 15.7 tp -115.26 120.07 38.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 110.177 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.49 ' HA2' ' HB3' ' A' ' 15' ' ' TYR . . . -101.54 58.41 0.64 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.607 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 34.9 p90 -52.94 171.35 0.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.14 -1.212 . . . . 0.0 111.326 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.516 ' N ' ' OE1' ' A' ' 29' ' ' GLU . 94.4 mt-10 -105.06 178.35 4.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.565 -0.71 . . . . 0.0 109.949 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -69.84 129.46 39.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.117 -0.989 . . . . 0.0 110.3 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.45 -15.04 56.36 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.551 ' OE2' HD21 ' A' ' 31' ' ' LEU . 24.4 tt0 -59.02 124.4 19.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.134 -1.215 . . . . 0.0 110.063 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.44 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 88.9 mt-30 -79.9 134.18 36.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.139 -0.976 . . . . 0.0 109.991 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.551 HD21 ' OE2' ' A' ' 29' ' ' GLU . 10.8 mt -133.07 154.04 50.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.204 -0.935 . . . . 0.0 110.313 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 14.5 ttt180 -97.33 132.69 42.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.853 . . . . 0.0 109.686 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.078 HD11 HG21 ' A' ' 9' ' ' VAL . 23.4 mm -77.85 118.92 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.179 -0.951 . . . . 0.0 110.396 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.528 HD21 ' HB2' ' A' ' 44' ' ' GLN . 45.7 mt -87.78 -34.55 18.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 109.94 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -172.72 125.49 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.448 -0.782 . . . . 0.0 109.956 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.58 ' HA ' ' CG ' ' A' ' 41' ' ' TRP . 95.1 mt-30 -101.87 62.88 0.91 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.931 . . . . 0.0 110.304 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.5 m -108.54 136.18 48.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.347 -0.846 . . . . 0.0 110.129 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.56 -175.04 53.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -65.47 -36.88 85.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -1.125 . . . . 0.0 110.181 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.561 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 91.8 m95 -95.12 140.32 30.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.9 . . . . 0.0 110.32 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.58 ' CG ' ' HA ' ' A' ' 36' ' ' GLN . 52.3 m0 -113.63 148.89 35.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.303 -0.873 . . . . 0.0 110.257 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.505 ' CB ' ' HB2' ' A' ' 34' ' ' LEU . 24.5 mttm -86.25 141.8 29.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.261 -0.9 . . . . 0.0 109.703 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.626 ' HB2' HG12 ' A' ' 54' ' ' ILE . . . -146.28 167.03 24.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.127 -0.983 . . . . 0.0 110.485 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.528 ' HB2' HD21 ' A' ' 34' ' ' LEU . 58.7 tt0 -137.63 145.48 42.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.339 -0.85 . . . . 0.0 110.148 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.6 t -90.56 113.31 25.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.113 -0.992 . . . . 0.0 109.892 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 78.5 mt -74.82 3.49 8.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -0.963 . . . . 0.0 110.541 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.0 m -96.54 -33.33 11.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.107 -0.996 . . . . 0.0 110.032 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.6 m -119.17 -7.63 10.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 110.24 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.05 42.45 51.59 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -119.52 148.02 43.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -1.143 . . . . 0.0 110.073 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.501 ' HG2' ' CG ' ' A' ' 44' ' ' GLN . 90.9 mt-10 -118.07 138.27 52.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.948 . . . . 0.0 110.325 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.505 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -159.27 154.91 25.99 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.418 ' HE1' ' HZ3' ' A' ' 42' ' ' LYS . 99.0 m-85 -68.56 146.22 53.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.121 -1.223 . . . . 0.0 110.198 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.626 HG12 ' HB2' ' A' ' 43' ' ' ALA . 1.3 pt -136.41 147.9 61.9 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.868 . . . . 0.0 110.215 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.598 ' HD3' ' CD1' ' A' ' 15' ' ' TYR . 43.7 Cg_endo -72.76 145.46 41.07 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 124.046 1.551 . . . . 0.0 110.327 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.534 ' HB2' ' CH2' ' A' ' 41' ' ' TRP . 21.0 p90 -81.56 -0.02 40.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.518 -0.739 . . . . 0.0 110.592 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.491 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 85.5 m-20 -98.74 -27.56 13.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.051 -1.031 . . . . 0.0 110.942 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.54 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 18.2 m-30 -90.88 5.86 46.84 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.93 -1.106 . . . . 0.0 110.482 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.561 HG12 ' HB ' ' A' ' 9' ' ' VAL . 8.4 t -145.06 164.2 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 0.0 110.137 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.793 ' O ' HG12 ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.0 110.295 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.417 ' C ' HG13 ' A' ' 9' ' ' VAL . 36.5 mt . . . . . 0 N--CA 1.49 1.574 0 CA-C-O 121.168 0.509 . . . . 0.0 110.189 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.592 HG11 HD11 ' A' ' 33' ' ' ILE . 12.6 m -150.95 170.63 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.342 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 19.6 mm -114.35 143.34 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.87 . . . . 0.0 110.076 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.824 ' HB1' ' CE1' ' A' ' 25' ' ' PHE . . . -79.63 110.82 15.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.119 -0.988 . . . . 0.0 110.134 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.439 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 15.9 tp -63.68 -24.67 67.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.05 -1.032 . . . . 0.0 109.529 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.439 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 37.0 m-70 -156.57 158.55 37.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.481 -0.762 . . . . 0.0 109.818 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.555 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 28.3 p -67.32 142.11 56.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.118 -0.989 . . . . 0.0 110.161 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.595 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 81.8 t80 -97.67 158.34 15.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 0.0 110.339 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.491 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -110.11 126.92 27.97 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 110.055 179.925 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.478 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.1 Cg_endo -82.91 81.16 2.47 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.976 1.514 . . . . 0.0 110.382 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 55.8 p -79.76 -1.08 37.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 110.078 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -142.69 169.46 17.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.155 -0.966 . . . . 0.0 110.136 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -83.87 130.6 34.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 110.216 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.26 4.01 53.68 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -98.88 161.15 13.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.171 -1.194 . . . . 0.0 110.238 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.58 HD13 ' HG3' ' A' ' 50' ' ' GLN . 31.9 tp -114.71 120.11 38.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.875 . . . . 0.0 110.141 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.478 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -100.92 50.52 1.02 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.824 ' CE1' ' HB1' ' A' ' 11' ' ' ALA . 48.0 p90 -50.76 176.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.122 -1.222 . . . . 0.0 111.12 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.555 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 83.4 mt-10 -107.63 174.11 6.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.52 -0.738 . . . . 0.0 110.253 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -68.37 139.76 55.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.122 -0.986 . . . . 0.0 110.405 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.26 -13.27 55.72 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 38.0 mm-40 -67.92 125.59 26.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.015 -1.285 . . . . 0.0 110.262 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.984 ' C ' HD12 ' A' ' 31' ' ' LEU . 80.4 mt-30 -79.53 138.69 37.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 109.663 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.984 HD12 ' C ' ' A' ' 30' ' ' GLN . 8.3 mp -136.56 156.78 48.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.046 -1.034 . . . . 0.0 110.633 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.588 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 15.9 mtm180 -103.92 131.32 51.26 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.387 -0.821 . . . . 0.0 109.394 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.592 HD11 HG11 ' A' ' 9' ' ' VAL . 99.4 mt -88.71 93.5 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.087 -1.008 . . . . 0.0 110.669 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 1.02 HD12 ' HA ' ' A' ' 43' ' ' ALA . 1.6 mp -79.25 -31.55 43.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.342 -0.849 . . . . 0.0 110.85 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.526 ' HB2' ' CB ' ' A' ' 42' ' ' LYS . 79.5 mt-10 -127.62 140.03 52.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.848 -1.158 . . . . 0.0 110.191 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.637 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 49.7 tt0 -135.06 59.7 1.72 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 110.263 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.8 t -125.2 130.98 53.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.897 . . . . 0.0 110.219 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.35 177.29 51.82 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.27 -30.89 71.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.236 -1.155 . . . . 0.0 110.281 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -98.33 144.45 27.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.0 110.263 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.637 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 43.6 m0 -126.08 157.88 36.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.37 -0.831 . . . . 0.0 110.166 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.526 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 28.7 tttt -100.03 146.78 26.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.886 . . . . 0.0 109.327 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 1.02 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -157.94 -175.97 5.66 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.916 -1.115 . . . . 0.0 110.834 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -146.03 154.31 41.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.416 -0.803 . . . . 0.0 109.622 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.3 t -101.71 125.68 48.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 110.392 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.463 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 44.0 tp -81.39 6.12 15.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.387 -0.821 . . . . 0.0 110.135 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.9 m -93.29 -37.96 11.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 110.226 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.8 p -125.39 -7.52 6.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.231 -0.918 . . . . 0.0 110.188 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.91 27.28 56.82 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.58 ' HG3' HD13 ' A' ' 23' ' ' LEU . 70.3 tp60 -90.79 131.71 36.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.318 -1.107 . . . . 0.0 110.3 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 51' ' ' GLU . 22.7 pt-20 -115.97 134.33 55.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.322 -0.861 . . . . 0.0 110.057 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.438 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -172.49 166.21 38.88 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 59.4 m-85 -69.05 142.31 54.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -1.142 . . . . 0.0 110.288 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.668 HD12 ' O ' ' A' ' 55' ' ' PRO . 1.6 pp -136.19 138.51 27.47 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 110.107 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.668 ' O ' HD12 ' A' ' 54' ' ' ILE . 47.3 Cg_endo -64.61 154.94 69.55 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.916 1.482 . . . . 0.0 110.289 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.608 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 22.3 p90 -83.97 -1.46 54.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.318 -0.864 . . . . 0.0 110.643 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.567 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 87.3 m-20 -98.39 -26.1 14.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.043 -1.036 . . . . 0.0 110.965 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 14.9 m-85 -83.16 -0.61 50.05 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.925 -1.109 . . . . 0.0 110.285 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.527 HG11 HD13 ' A' ' 54' ' ' ILE . 27.8 m -135.16 147.21 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.092 -1.005 . . . . 0.0 110.304 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.548 ' O ' HG12 ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.931 . . . . 0.0 110.223 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.668 HD12 ' N ' ' A' ' 8' ' ' LEU . 7.0 mp . . . . . 0 N--CA 1.491 1.623 0 CA-C-O 121.287 0.565 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.769 HG21 HG11 ' A' ' 59' ' ' VAL . 13.2 m -152.3 171.32 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.889 . . . . 0.0 110.306 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.3 mt -112.88 144.12 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -0.844 . . . . 0.0 109.923 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.625 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -80.25 111.0 16.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 110.268 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.634 HD22 ' N ' ' A' ' 12' ' ' LEU . 4.1 mm? -64.6 -26.2 68.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.17 -0.956 . . . . 0.0 109.448 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.47 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 52.5 m80 -156.9 154.56 29.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.54 -0.725 . . . . 0.0 109.661 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.56 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 53.8 p -64.69 143.4 57.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.985 -1.072 . . . . 0.0 110.056 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.594 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 89.1 t80 -100.57 164.1 12.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.036 -1.04 . . . . 0.0 110.26 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.459 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -117.94 125.32 28.07 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.367 -0.833 . . . . 0.0 110.098 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.475 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.3 Cg_endo -78.39 82.25 2.52 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.016 1.535 . . . . 0.0 110.369 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 72.6 m -79.74 -2.53 43.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.88 . . . . 0.0 109.966 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.437 ' CG ' ' N ' ' A' ' 20' ' ' ASP . 86.4 t60 -145.09 172.2 13.42 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.369 -0.832 . . . . 0.0 110.095 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . 0.437 ' N ' ' CG ' ' A' ' 19' ' ' HIS . 21.8 t70 -80.32 129.51 34.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.175 -0.953 . . . . 0.0 110.223 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.46 18.01 29.56 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -106.9 150.02 26.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -1.118 . . . . 0.0 110.284 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.467 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 15.3 tp -105.75 112.08 25.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 110.042 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.475 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -95.28 45.23 2.08 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.625 ' CE2' ' HB1' ' A' ' 11' ' ' ALA . 40.6 p90 -46.64 171.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -1.175 . . . . 0.0 110.865 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.56 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 88.0 mt-10 -101.74 177.29 4.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.464 -0.773 . . . . 0.0 110.259 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -69.69 126.65 30.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.266 -0.896 . . . . 0.0 110.272 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.71 -8.66 74.01 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.443 ' CD ' ' HB2' ' A' ' 25' ' ' PHE . 20.9 tt0 -67.27 126.03 27.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -1.18 . . . . 0.0 110.317 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.704 ' O ' HD23 ' A' ' 31' ' ' LEU . 89.4 mt-30 -79.49 138.22 37.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 109.929 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.704 HD23 ' O ' ' A' ' 30' ' ' GLN . 14.4 mt -140.44 162.74 34.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.909 . . . . 0.0 110.38 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.603 ' CD ' HD21 ' A' ' 34' ' ' LEU . 25.2 ttp180 -106.01 133.33 50.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 0.0 109.682 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.537 ' CD1' HG11 ' A' ' 9' ' ' VAL . 15.5 mt -97.82 94.67 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.104 -0.997 . . . . 0.0 110.623 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.603 HD21 ' CD ' ' A' ' 32' ' ' ARG . 50.0 mt -79.46 -22.48 44.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.932 . . . . 0.0 110.777 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.553 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 83.2 tt0 -136.39 129.69 31.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.961 -1.087 . . . . 0.0 110.33 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.628 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 97.0 mt-30 -126.32 54.19 1.58 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.842 . . . . 0.0 110.122 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.5 p -119.47 157.91 27.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.913 . . . . 0.0 110.278 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.23 -172.1 26.97 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -72.54 -34.66 67.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -1.166 . . . . 0.0 110.28 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.409 ' HZ3' ' CE1' ' A' ' 15' ' ' TYR . 69.1 m95 -101.81 150.07 23.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.228 -0.92 . . . . 0.0 110.441 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.628 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 50.8 m0 -120.75 154.69 35.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.357 -0.84 . . . . 0.0 110.264 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.553 ' CB ' ' HB3' ' A' ' 35' ' ' GLU . 67.3 tttt -95.53 143.49 26.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.569 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -153.27 176.89 11.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.933 -1.104 . . . . 0.0 111.085 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 50' ' ' GLN . 48.7 tt0 -143.67 152.01 40.8 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.591 -0.693 . . . . 0.0 109.722 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.413 ' CB ' ' OG1' ' A' ' 48' ' ' THR . 17.3 m -85.1 149.35 25.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.164 -0.96 . . . . 0.0 110.298 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.699 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.6 mp -98.39 -13.2 20.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.325 -0.859 . . . . 0.0 109.964 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.8 p -101.04 -27.49 13.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.84 . . . . 0.0 110.234 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.413 ' OG1' ' CB ' ' A' ' 45' ' ' SER . 81.4 p -107.62 -18.57 13.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 110.316 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.99 41.82 80.28 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.486 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 7.2 mt-30 -119.21 150.21 40.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -1.118 . . . . 0.0 110.281 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 81.9 tt0 -116.43 134.08 55.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.93 . . . . 0.0 110.181 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.467 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -160.03 154.88 25.96 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -69.26 142.56 54.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -1.134 . . . . 0.0 109.984 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.452 ' O ' HG13 ' A' ' 54' ' ' ILE . 1.7 pt -131.97 132.35 23.1 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.949 . . . . 0.0 110.437 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.591 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 47.9 Cg_endo -61.1 156.11 46.77 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.981 1.517 . . . . 0.0 109.884 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.551 ' CE1' ' OD1' ' A' ' 57' ' ' ASN . 41.7 p90 -80.12 -8.14 59.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 111.326 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.551 ' OD1' ' CE1' ' A' ' 56' ' ' PHE . 58.7 m-20 -92.49 -26.59 17.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.766 -1.209 . . . . 0.0 110.98 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.59 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 21.8 m-85 -82.94 -6.38 59.45 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.999 -1.063 . . . . 0.0 110.048 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.769 HG11 HG21 ' A' ' 9' ' ' VAL . 58.1 t -132.38 174.71 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.845 . . . . 0.0 109.723 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.576 ' N ' HG12 ' A' ' 59' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 0.0 110.244 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.555 ' O ' HG13 ' A' ' 9' ' ' VAL . 41.4 tp . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.292 0.567 . . . . 0.0 110.177 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 60' ' ' ALA . 3.7 m -155.36 173.33 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -0.915 . . . . 0.0 110.271 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.1 mt -117.38 142.09 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.857 . . . . 0.0 109.807 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.817 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -78.58 113.76 16.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.972 . . . . 0.0 110.257 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.53 HD12 ' N ' ' A' ' 12' ' ' LEU . 7.2 mp -66.71 -26.83 67.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.071 -1.018 . . . . 0.0 109.542 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -149.95 155.4 39.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.459 -0.775 . . . . 0.0 109.764 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.547 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 53.0 p -68.59 143.04 54.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.089 -1.007 . . . . 0.0 110.05 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.584 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 81.2 t80 -101.69 164.53 11.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.014 -1.054 . . . . 0.0 110.354 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.563 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 28.2 mm-40 -118.01 129.67 25.21 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 110.126 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.482 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 49.2 Cg_endo -81.56 81.91 2.51 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.926 1.487 . . . . 0.0 110.535 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 81.0 p -79.72 -1.97 40.88 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.172 -0.955 . . . . 0.0 110.06 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -144.06 -176.8 5.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.941 . . . . 0.0 110.135 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -92.69 131.61 37.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.0 110.072 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.36 -5.33 57.27 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.07 157.38 18.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.14 -1.212 . . . . 0.0 110.294 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.471 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 32.1 tp -115.3 120.06 38.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 110.079 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.482 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -97.74 47.85 1.52 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.817 ' CE2' ' HB1' ' A' ' 11' ' ' ALA . 46.6 p90 -49.29 174.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -1.153 . . . . 0.0 111.305 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.547 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 95.8 mt-10 -107.63 173.68 6.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.523 -0.736 . . . . 0.0 109.943 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -68.39 139.45 55.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.098 -1.001 . . . . 0.0 110.355 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.16 -15.41 49.41 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.516 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 22.8 tt0 -62.28 124.4 20.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.116 -1.226 . . . . 0.0 110.016 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.973 ' C ' HD12 ' A' ' 31' ' ' LEU . 91.9 mt-30 -79.9 136.87 36.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -0.887 . . . . 0.0 109.902 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.973 HD12 ' C ' ' A' ' 30' ' ' GLN . 6.6 mp -141.65 163.61 32.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.126 -0.984 . . . . 0.0 110.533 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.83 ' HE ' HD11 ' A' ' 34' ' ' LEU . 10.5 ptt180 -112.72 136.85 51.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.351 -0.843 . . . . 0.0 109.575 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.662 HG21 HE21 ' A' ' 36' ' ' GLN . 61.8 mt -90.74 95.28 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.175 -0.953 . . . . 0.0 110.655 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.83 HD11 ' HE ' ' A' ' 32' ' ' ARG . 1.2 mt -79.46 -30.49 42.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 110.778 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.547 ' CG ' ' HB3' ' A' ' 42' ' ' LYS . 39.8 mm-40 -135.07 139.76 45.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.885 -1.135 . . . . 0.0 110.438 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.662 HE21 HG21 ' A' ' 33' ' ' ILE . 86.7 mt-30 -130.9 54.67 1.89 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.282 -0.886 . . . . 0.0 110.158 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.0 m -116.87 145.7 43.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.237 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.28 172.15 10.6 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.3 -28.01 66.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.181 -1.188 . . . . 0.0 110.16 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.569 ' CZ3' ' OH ' ' A' ' 15' ' ' TYR . 94.8 m95 -99.53 144.67 28.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 110.282 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.626 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.6 m0 -120.79 156.36 32.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.864 . . . . 0.0 110.149 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.547 ' HB3' ' CG ' ' A' ' 35' ' ' GLU . 24.6 tttp -98.32 140.25 32.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.372 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.634 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -156.25 -178.41 7.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.061 -1.024 . . . . 0.0 110.618 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.514 ' HB3' ' CD ' ' A' ' 32' ' ' ARG . 48.4 tt0 -151.09 158.81 44.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.479 -0.763 . . . . 0.0 109.72 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -108.01 140.04 41.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.155 -0.966 . . . . 0.0 110.357 -179.8 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.42 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 22.7 tp -90.85 11.2 23.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -0.86 . . . . 0.0 110.07 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.4 m -97.03 -38.6 9.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.0 110.241 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.1 p -119.35 -8.84 10.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.217 -0.927 . . . . 0.0 110.207 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.47 36.21 49.99 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.478 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 3.1 mt-30 -108.75 141.76 40.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -1.109 . . . . 0.0 110.14 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.512 ' CA ' ' HG3' ' A' ' 44' ' ' GLN . 83.4 tt0 -121.61 143.08 49.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.216 -0.928 . . . . 0.0 110.124 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.471 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -173.47 165.63 37.7 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -71.77 145.45 48.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.401 -1.058 . . . . 0.0 110.075 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.46 ' O ' HG13 ' A' ' 54' ' ' ILE . 1.3 pt -136.97 137.66 23.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.182 -0.949 . . . . 0.0 110.198 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.596 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 46.6 Cg_endo -62.06 145.16 96.68 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.944 1.497 . . . . 0.0 110.049 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.594 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 31.1 p90 -73.27 -3.96 30.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.365 -0.835 . . . . 0.0 110.902 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -96.09 -26.23 15.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.912 -1.117 . . . . 0.0 111.066 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.596 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 15.3 m-85 -83.43 3.07 33.58 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.96 -1.087 . . . . 0.0 110.242 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.522 HG12 ' HB ' ' A' ' 9' ' ' VAL . 16.0 t -146.41 168.19 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 109.907 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.634 ' O ' HG12 ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 110.26 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.524 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.7 mp . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 121.239 0.543 . . . . 0.0 110.14 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.728 ' CG1' HD11 ' A' ' 33' ' ' ILE . 13.6 m -150.25 169.83 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.185 -0.947 . . . . 0.0 110.387 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 57.0 mt -116.79 141.86 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.311 -0.868 . . . . 0.0 109.559 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.764 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -80.26 113.74 18.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.122 -0.986 . . . . 0.0 110.515 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.458 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 82.5 mt -67.07 -24.28 65.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.061 -1.024 . . . . 0.0 109.121 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.458 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 42.8 m80 -157.31 150.83 24.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.602 -0.686 . . . . 0.0 109.547 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 36.8 p -62.31 142.17 57.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.93 -1.106 . . . . 0.0 110.069 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 82.1 t80 -100.82 162.64 12.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.078 -1.014 . . . . 0.0 110.472 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -119.71 121.59 29.75 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.334 -0.854 . . . . 0.0 109.911 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.496 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 47.6 Cg_endo -79.42 94.36 1.06 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.037 1.546 . . . . 0.0 110.521 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.401 ' HG ' ' CE1' ' A' ' 19' ' ' HIS . 50.6 p -79.89 0.97 28.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 110.005 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.401 ' CE1' ' HG ' ' A' ' 18' ' ' SER . 48.4 m80 -145.08 165.71 27.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.893 . . . . 0.0 109.888 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -77.46 131.74 38.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.133 -0.979 . . . . 0.0 110.185 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.27 -7.13 40.04 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 4.3 m-20 -91.58 165.35 13.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.231 -1.158 . . . . 0.0 110.201 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.526 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 20.1 tp -122.81 128.5 50.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 109.978 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.496 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -106.77 55.34 0.53 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.764 ' CE2' ' HB1' ' A' ' 11' ' ' ALA . 37.3 p90 -45.31 171.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -1.14 . . . . 0.0 110.882 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.474 ' N ' ' OE1' ' A' ' 29' ' ' GLU . 94.9 mt-10 -97.66 174.48 6.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.412 -0.805 . . . . 0.0 110.239 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -70.66 122.68 20.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.873 . . . . 0.0 110.349 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.01 -7.1 76.64 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.474 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 39.1 tt0 -70.34 129.57 39.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.001 -1.293 . . . . 0.0 110.06 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.599 ' O ' HD23 ' A' ' 31' ' ' LEU . 92.8 mt-30 -79.46 138.35 37.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.885 . . . . 0.0 109.981 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.642 HD11 ' CG ' ' A' ' 25' ' ' PHE . 16.9 mt -135.56 156.41 48.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.149 -0.969 . . . . 0.0 110.47 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 31.3 ttm180 -98.37 130.99 45.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.379 -0.826 . . . . 0.0 109.918 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.728 HD11 ' CG1' ' A' ' 9' ' ' VAL . 34.5 mt -76.03 119.7 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 110.164 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.686 HD21 ' HB2' ' A' ' 44' ' ' GLN . 96.9 mt -87.75 -35.19 18.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.334 -0.854 . . . . 0.0 110.179 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -150.56 175.08 12.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -0.921 . . . . 0.0 110.314 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.626 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 88.9 mt-30 -151.09 57.8 0.9 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.281 -0.887 . . . . 0.0 110.192 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.3 t -125.2 130.36 51.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 110.152 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.88 -170.79 42.14 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -75.65 -34.24 60.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.194 -1.18 . . . . 0.0 110.178 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.561 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 94.8 m95 -97.84 146.4 25.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -0.89 . . . . 0.0 110.155 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.626 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.2 m0 -124.42 155.76 38.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.289 -0.882 . . . . 0.0 110.18 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 34' ' ' LEU . 19.7 mttt -91.12 146.3 23.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 109.663 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.665 ' HB2' HG12 ' A' ' 54' ' ' ILE . . . -144.05 165.92 26.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.221 -0.924 . . . . 0.0 110.635 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.686 ' HB2' HD21 ' A' ' 34' ' ' LEU . 59.5 tt0 -134.59 142.89 47.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.415 -0.803 . . . . 0.0 109.957 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.9 m -76.99 140.06 40.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 110.14 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 14.2 tp -88.31 -19.69 26.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.913 . . . . 0.0 109.968 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.0 p -102.92 -28.13 12.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.828 . . . . 0.0 110.404 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m -96.3 -20.94 18.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.081 -1.012 . . . . 0.0 110.107 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.71 47.49 67.59 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 61.2 mt-30 -133.86 158.59 43.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.325 -1.103 . . . . 0.0 110.191 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 92.5 mt-10 -119.77 143.67 47.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.083 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.526 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -154.63 -152.05 6.01 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -122.16 134.33 54.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.368 -1.078 . . . . 0.0 110.056 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.869 HD12 HG21 ' A' ' 59' ' ' VAL . 1.8 pt -129.11 140.48 38.74 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.965 . . . . 0.0 110.183 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.594 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 47.3 Cg_endo -73.0 157.34 51.25 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.958 1.504 . . . . 0.0 110.12 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -78.84 -5.01 52.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -0.858 . . . . 0.0 111.009 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -98.44 -26.51 14.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.897 -1.127 . . . . 0.0 111.215 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.594 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 13.1 m-85 -83.63 -9.18 59.07 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.929 -1.107 . . . . 0.0 110.469 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.869 HG21 HD12 ' A' ' 54' ' ' ILE . 31.0 m -133.98 145.0 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.166 -0.959 . . . . 0.0 110.383 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.836 . . . . 0.0 110.119 179.905 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.538 ' C ' HG13 ' A' ' 9' ' ' VAL . 23.6 tp . . . . . 0 N--CA 1.491 1.612 0 CA-C-O 121.263 0.554 . . . . 0.0 110.115 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.538 HG13 ' C ' ' A' ' 8' ' ' LEU . 31.7 m -153.7 172.03 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.192 -0.943 . . . . 0.0 110.37 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 54.8 mt -113.9 146.11 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.319 -0.863 . . . . 0.0 109.712 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.802 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -80.13 110.12 15.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.13 -0.982 . . . . 0.0 110.287 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.993 HD13 ' O ' ' A' ' 12' ' ' LEU . 2.0 tm? -65.61 -25.07 67.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.065 -1.022 . . . . 0.0 109.405 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.485 ' ND1' HD12 ' A' ' 12' ' ' LEU . 11.5 m170 -155.69 158.95 39.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.51 -0.744 . . . . 0.0 109.744 179.669 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.553 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 47.3 p -68.41 139.89 55.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.999 -1.063 . . . . 0.0 110.105 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.597 ' CD1' ' HD3' ' A' ' 55' ' ' PRO . 87.9 t80 -95.72 156.42 16.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.046 -1.034 . . . . 0.0 110.33 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.563 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -99.4 127.13 35.3 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.322 -0.861 . . . . 0.0 110.062 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.475 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.0 Cg_endo -89.5 86.78 0.43 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.033 1.544 . . . . 0.0 110.397 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.9 p -79.98 1.3 28.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -0.943 . . . . 0.0 110.111 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.403 ' HB2' ' CG ' ' A' ' 22' ' ' ASP . 38.8 m80 -134.7 -168.31 2.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.078 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.7 p30 -105.79 -6.19 19.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.187 -0.945 . . . . 0.0 110.196 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.48 -0.53 23.39 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.403 ' CG ' ' HB2' ' A' ' 19' ' ' HIS . 61.3 m-20 -88.13 163.17 16.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.127 -1.22 . . . . 0.0 110.243 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.493 HD13 ' HG2' ' A' ' 50' ' ' GLN . 22.2 tp -114.53 120.49 40.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.298 -0.876 . . . . 0.0 110.086 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.475 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -103.7 54.81 0.65 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.802 ' CE2' ' HB1' ' A' ' 11' ' ' ALA . 50.6 p90 -53.39 176.57 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -1.155 . . . . 0.0 111.022 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.553 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 92.5 mt-10 -110.39 178.27 4.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.442 -0.786 . . . . 0.0 110.026 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 12' ' ' LEU . 27.9 tttt -67.38 136.45 54.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.124 -0.985 . . . . 0.0 110.421 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.47 -16.13 50.91 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.574 ' HG2' HD21 ' A' ' 31' ' ' LEU . 10.3 tt0 -60.83 123.21 16.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.131 -1.217 . . . . 0.0 110.41 -179.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.484 ' O ' HD23 ' A' ' 31' ' ' LEU . 94.0 mt-30 -79.75 134.52 36.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.35 -0.844 . . . . 0.0 109.79 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.574 HD21 ' HG2' ' A' ' 29' ' ' GLU . 15.5 mt -137.99 159.38 42.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.949 . . . . 0.0 110.319 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.704 ' HE ' HD11 ' A' ' 34' ' ' LEU . 3.7 ptt180 -109.25 134.98 51.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.278 -0.889 . . . . 0.0 109.614 179.357 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 61.1 mt -91.39 95.17 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.094 -1.004 . . . . 0.0 110.758 -179.281 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.704 HD11 ' HE ' ' A' ' 32' ' ' ARG . 1.6 mt -78.86 -29.45 44.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 110.622 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 42' ' ' LYS . 74.1 tt0 -128.6 140.76 51.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.002 -1.062 . . . . 0.0 110.274 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.621 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 47.7 tt0 -138.42 68.4 1.39 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 110.222 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.4 p -131.81 132.83 44.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.0 110.207 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.84 -162.56 41.15 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -80.96 -31.17 34.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -1.163 . . . . 0.0 110.208 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.56 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 91.4 m95 -98.87 146.51 25.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.269 -0.894 . . . . 0.0 110.352 -179.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.621 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 47.3 m0 -125.35 156.46 38.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 110.21 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.513 ' HB3' ' HB3' ' A' ' 35' ' ' GLU . 25.7 tttp -97.6 145.32 26.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.14 179.217 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.58 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -160.35 -173.57 4.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.908 -1.12 . . . . 0.0 110.947 -179.638 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.54 ' HB3' ' CD ' ' A' ' 32' ' ' ARG . 39.2 tt0 -155.15 162.18 41.05 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.576 -0.702 . . . . 0.0 109.475 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.532 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 1.7 m -103.22 128.42 50.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.068 -1.02 . . . . 0.0 110.276 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.455 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 25.4 tp -82.44 1.89 35.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.337 -0.852 . . . . 0.0 110.154 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.0 m -96.96 -34.48 11.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 110.205 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.0 p -115.99 -16.31 11.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.935 . . . . 0.0 110.183 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.8 25.68 55.55 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.493 ' HG2' HD13 ' A' ' 23' ' ' LEU . 56.9 tt0 -97.18 135.65 38.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -1.154 . . . . 0.0 110.243 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.445 ' HG3' ' HB2' ' A' ' 44' ' ' GLN . 82.1 tt0 -120.02 141.13 50.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.253 -0.905 . . . . 0.0 109.939 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.476 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -167.32 -137.84 2.32 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -125.91 138.42 53.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.416 -1.049 . . . . 0.0 109.947 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.748 HD12 HG11 ' A' ' 59' ' ' VAL . 16.9 pt -128.23 148.78 69.16 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 110.255 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.598 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 45.3 Cg_endo -80.42 148.31 18.45 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.017 1.535 . . . . 0.0 109.728 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.594 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 35.8 p90 -69.87 -4.61 21.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 111.021 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -98.21 -26.44 14.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.831 -1.168 . . . . 0.0 111.396 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.598 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 8.1 m-85 -84.41 -2.84 57.81 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.938 -1.101 . . . . 0.0 110.395 -179.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.748 HG11 HD12 ' A' ' 54' ' ' ILE . 33.4 m -131.32 141.71 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.131 -0.981 . . . . 0.0 110.1 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.575 0 O-C-N 121.114 -0.991 . . . . 0.0 110.38 -179.977 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.895 HD13 ' N ' ' A' ' 9' ' ' VAL . 3.2 tm? . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 121.127 0.489 . . . . 0.0 110.192 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.895 ' N ' HD13 ' A' ' 8' ' ' LEU . 27.1 m -146.6 167.66 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.312 -0.867 . . . . 0.0 110.345 180.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.6 mm -112.54 141.34 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.705 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.607 ' HB1' ' CE1' ' A' ' 25' ' ' PHE . . . -79.03 109.64 13.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.057 -1.027 . . . . 0.0 110.268 -179.817 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.44 ' HG ' ' CE1' ' A' ' 13' ' ' HIS . 16.6 tp -67.39 -24.96 65.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.09 -1.006 . . . . 0.0 109.255 179.39 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.44 ' CE1' ' HG ' ' A' ' 12' ' ' LEU . 66.1 m80 -153.51 151.4 29.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.551 -0.718 . . . . 0.0 109.622 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.549 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 52.7 p -65.4 143.66 57.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 109.996 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.571 ' CD1' ' HG3' ' A' ' 55' ' ' PRO . 22.3 t80 -92.77 150.31 20.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.106 -0.996 . . . . 0.0 110.287 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -106.9 79.48 0.67 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.895 . . . . 0.0 110.268 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.437 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 47.5 Cg_endo -47.45 109.62 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.08 1.568 . . . . 0.0 110.396 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 91.6 p -90.35 12.1 19.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.213 -0.93 . . . . 0.0 110.217 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -147.54 -178.97 6.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.207 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -98.7 116.59 31.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.247 -0.908 . . . . 0.0 110.203 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.4 7.54 6.89 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.425 ' HB2' ' HB3' ' A' ' 17' ' ' PRO . 10.4 m-20 -105.8 171.85 7.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.16 -1.2 . . . . 0.0 110.152 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.529 HD21 ' HB2' ' A' ' 45' ' ' SER . 18.7 tp -113.32 115.59 28.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.303 -0.873 . . . . 0.0 109.876 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.437 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -99.12 55.21 0.97 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.607 ' CE1' ' HB1' ' A' ' 11' ' ' ALA . 37.0 p90 -54.76 175.99 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -1.118 . . . . 0.0 111.208 -179.498 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.549 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 96.0 mt-10 -110.25 177.97 4.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.546 -0.721 . . . . 0.0 110.056 179.797 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.7 tttt -67.22 139.23 57.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.11 -0.994 . . . . 0.0 110.505 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.63 -14.72 54.89 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.853 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 3.1 mt-10 -65.05 125.59 25.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.06 -1.259 . . . . 0.0 110.293 -179.698 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.978 ' C ' HD12 ' A' ' 31' ' ' LEU . 52.1 tt0 -79.62 136.16 36.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 109.916 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.978 HD12 ' C ' ' A' ' 30' ' ' GLN . 7.6 mp -138.94 160.02 40.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 110.467 -179.698 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.605 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 46.7 ttt180 -105.82 131.7 52.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.414 -0.804 . . . . 0.0 109.427 179.4 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.66 HD11 HG21 ' A' ' 9' ' ' VAL . 35.0 mm -92.35 94.39 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.093 -1.004 . . . . 0.0 110.623 -179.551 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.492 HD21 ' CZ ' ' A' ' 32' ' ' ARG . 11.8 mt -79.84 -29.91 40.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.278 -0.889 . . . . 0.0 110.751 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.495 ' HB3' ' HB3' ' A' ' 42' ' ' LYS . 41.5 tp10 -131.03 142.96 50.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.908 -1.12 . . . . 0.0 110.383 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.641 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 78.3 mt-30 -138.01 54.88 1.78 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.88 . . . . 0.0 110.017 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.1 m -120.38 137.47 54.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.935 . . . . 0.0 110.237 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.26 -171.66 55.15 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -74.83 -33.67 62.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -1.17 . . . . 0.0 110.212 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.443 ' CZ3' ' OH ' ' A' ' 15' ' ' TYR . 95.6 m95 -93.77 139.83 30.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 110.212 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.641 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 32.2 m0 -118.17 154.97 31.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.041 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 35' ' ' GLU . 16.3 tttm -100.95 138.78 37.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.312 -0.868 . . . . 0.0 109.145 179.235 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.605 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -150.74 177.57 9.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.998 -1.064 . . . . 0.0 110.965 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.473 ' CG ' ' HG2' ' A' ' 51' ' ' GLU . 47.2 tt0 -138.27 146.77 42.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.48 -0.763 . . . . 0.0 109.788 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.529 ' HB2' HD21 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -96.52 116.12 28.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.13 -0.981 . . . . 0.0 110.255 -179.884 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.6 mt -75.71 1.65 14.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.888 . . . . 0.0 110.307 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 47.9 p -89.92 -32.33 16.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.124 -0.985 . . . . 0.0 110.144 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.5 p -120.56 -3.8 9.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 110.082 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.24 48.16 60.25 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.471 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 10.8 mt-30 -130.17 155.65 45.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -1.142 . . . . 0.0 110.349 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.473 ' HG2' ' CG ' ' A' ' 44' ' ' GLN . 97.9 mt-10 -121.41 147.86 45.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.325 -0.859 . . . . 0.0 109.944 179.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.501 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -164.75 -153.6 7.55 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -119.67 135.08 54.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.505 -0.997 . . . . 0.0 109.719 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.788 ' CD1' HG21 ' A' ' 59' ' ' VAL . 1.0 OUTLIER -126.7 149.42 68.33 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.126 -0.984 . . . . 0.0 110.568 -179.668 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.574 ' O ' HG22 ' A' ' 59' ' ' VAL . 46.3 Cg_endo -77.78 132.6 12.04 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.057 1.556 . . . . 0.0 109.965 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.582 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 15.0 p90 -66.46 -9.68 36.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 111.017 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -87.28 -26.41 23.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.883 -1.136 . . . . 0.0 110.841 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.568 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 16.8 m-30 -96.28 7.18 47.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.045 -1.034 . . . . 0.0 110.259 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.788 HG21 ' CD1' ' A' ' 54' ' ' ILE . 35.2 m -135.55 142.26 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 0.0 110.091 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.232 -0.917 . . . . 0.0 110.219 -179.948 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.454 ' C ' HG13 ' A' ' 9' ' ' VAL . 21.7 tp . . . . . 0 N--CA 1.492 1.662 0 CA-C-O 121.197 0.523 . . . . 0.0 110.105 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.749 HG11 HD11 ' A' ' 33' ' ' ILE . 30.2 m -150.02 169.87 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.159 -0.963 . . . . 0.0 110.367 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 85.9 mt -112.27 144.91 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 109.728 179.575 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . -77.83 114.89 17.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.13 -0.981 . . . . 0.0 110.349 -179.712 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.575 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 73.1 mt -73.7 -24.93 60.0 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.071 -1.018 . . . . 0.0 109.316 179.409 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.579 ' CE1' ' HE3' ' A' ' 27' ' ' LYS . 77.0 m-70 -161.38 146.47 13.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.612 -0.68 . . . . 0.0 109.543 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 53.5 p -60.59 142.07 55.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.919 -1.113 . . . . 0.0 109.904 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.541 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 45.8 t80 -99.0 159.12 15.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.015 -1.053 . . . . 0.0 110.587 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -109.4 82.08 1.98 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.411 -0.806 . . . . 0.0 110.067 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.547 ' CB ' ' HB2' ' A' ' 22' ' ' ASP . 47.4 Cg_endo -48.55 104.55 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.034 1.544 . . . . 0.0 110.44 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.522 ' OG ' ' CE1' ' A' ' 19' ' ' HIS . 64.5 p -80.67 0.1 35.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.201 -0.937 . . . . 0.0 110.169 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.522 ' CE1' ' OG ' ' A' ' 18' ' ' SER . 64.5 m80 -134.85 176.73 8.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.143 -0.973 . . . . 0.0 110.147 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -82.38 -11.86 58.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 110.461 -179.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -105.66 25.05 25.5 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.547 ' HB2' ' CB ' ' A' ' 17' ' ' PRO . 52.4 m-20 -111.92 161.83 15.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.157 -1.202 . . . . 0.0 110.364 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.495 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 23.7 tp -116.18 120.46 39.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.773 179.713 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.537 ' CA ' ' HD3' ' A' ' 17' ' ' PRO . . . -98.02 51.06 1.31 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.557 ' CG ' HD11 ' A' ' 31' ' ' LEU . 22.2 p90 -47.34 170.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -1.155 . . . . 0.0 110.568 -179.649 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -100.01 179.05 4.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.391 -0.818 . . . . 0.0 110.282 -179.649 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.579 ' HE3' ' CE1' ' A' ' 13' ' ' HIS . 20.6 tttt -71.96 120.47 17.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.326 -0.859 . . . . 0.0 110.033 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 96.63 -9.18 66.47 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.513 ' OE2' ' CB ' ' A' ' 25' ' ' PHE . 31.4 tt0 -60.7 133.21 55.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.168 -1.195 . . . . 0.0 110.27 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -79.93 129.06 34.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.0 109.888 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.557 HD11 ' CG ' ' A' ' 25' ' ' PHE . 27.0 mt -130.11 150.7 51.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.168 -0.958 . . . . 0.0 110.437 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.499 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 30.5 ttp180 -106.01 140.64 38.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.349 -0.845 . . . . 0.0 109.824 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.749 HD11 HG11 ' A' ' 9' ' ' VAL . 55.8 mt -91.51 136.09 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 110.173 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.452 ' CD1' ' HB2' ' A' ' 44' ' ' GLN . 91.6 mt -129.94 -30.89 1.98 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.371 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.479 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 78.6 tt0 -128.25 146.64 50.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 110.307 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.593 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 52.6 tt0 -142.25 58.1 1.46 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.254 -0.904 . . . . 0.0 110.144 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.4 t -118.22 114.38 22.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.269 -0.894 . . . . 0.0 110.229 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.3 -160.93 20.62 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -84.18 -29.59 26.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.189 -1.183 . . . . 0.0 110.251 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.551 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 91.3 m95 -96.06 145.05 25.79 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.288 -0.883 . . . . 0.0 110.169 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.593 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 48.8 m0 -119.17 153.1 35.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.226 -0.922 . . . . 0.0 110.281 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.482 ' HE2' ' OE2' ' A' ' 51' ' ' GLU . 9.9 tttp -99.43 110.58 23.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 110.043 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.499 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -112.37 175.46 5.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.229 -0.919 . . . . 0.0 110.708 -179.588 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.49 ' CG ' ' O ' ' A' ' 50' ' ' GLN . 44.4 tt0 -138.18 146.59 42.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.338 -0.851 . . . . 0.0 109.951 -179.799 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.42 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 6.9 t -79.01 137.78 37.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.109 -0.994 . . . . 0.0 110.174 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.463 ' HA ' HD12 ' A' ' 46' ' ' LEU . 21.2 tp -80.7 -21.06 41.58 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.596 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 95.9 m -83.35 -50.68 8.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.447 -0.783 . . . . 0.0 110.241 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 50' ' ' GLN . 18.0 p -100.22 1.69 42.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.079 -1.013 . . . . 0.0 110.32 -179.694 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 45' ' ' SER . . . 54.03 18.92 9.79 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.49 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 37.2 mt-30 -78.7 153.67 30.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -1.148 . . . . 0.0 110.281 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.482 ' OE2' ' HE2' ' A' ' 42' ' ' LYS . 86.6 tt0 -120.36 142.82 48.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 110.13 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.495 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -165.83 156.81 28.98 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -71.55 141.0 50.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -1.175 . . . . 0.0 109.961 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.796 HD12 ' O ' ' A' ' 55' ' ' PRO . 1.9 pp -141.21 124.8 10.05 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.302 -0.874 . . . . 0.0 110.146 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.796 ' O ' HD12 ' A' ' 54' ' ' ILE . 46.2 Cg_endo -46.37 167.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.931 1.49 . . . . 0.0 110.098 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -95.69 -1.84 49.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 110.539 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -99.18 -24.58 14.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.141 -0.974 . . . . 0.0 110.724 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.585 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 27.4 m-85 -79.64 -12.87 59.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.988 -1.07 . . . . 0.0 110.515 -179.66 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.795 HG21 ' CD1' ' A' ' 54' ' ' ILE . 30.6 m -131.25 143.32 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.106 -0.996 . . . . 0.0 110.187 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.623 0 O-C-N 121.301 -0.874 . . . . 0.0 110.172 -179.916 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.533 ' C ' HG13 ' A' ' 9' ' ' VAL . 6.6 tp . . . . . 0 N--CA 1.491 1.592 0 CA-C-O 121.244 0.545 . . . . 0.0 110.142 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.546 HG11 HD11 ' A' ' 33' ' ' ILE . 28.7 m -154.84 172.73 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 0.0 110.287 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 62.8 mt -112.49 145.43 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 109.806 179.618 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.717 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -80.11 111.69 16.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.046 -1.034 . . . . 0.0 110.273 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 58' ' ' PHE . 6.1 mp -64.87 -28.46 69.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.068 -1.02 . . . . 0.0 109.356 179.451 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.444 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 30.7 m80 -155.39 157.66 37.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.564 -0.71 . . . . 0.0 109.794 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.556 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 10.3 t -64.92 140.61 58.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.099 -1.0 . . . . 0.0 109.939 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.605 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 86.3 t80 -94.5 151.69 19.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.02 -1.05 . . . . 0.0 110.474 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.411 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 4.2 tp10 -114.02 91.89 24.2 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.409 -0.807 . . . . 0.0 110.076 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.513 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 46.8 Cg_endo -59.26 114.12 1.89 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.055 1.555 . . . . 0.0 110.476 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.459 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 74.2 p -89.54 11.33 19.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.275 -0.891 . . . . 0.0 109.996 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.459 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 98.6 m-70 -145.95 -177.11 5.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 0.0 110.15 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -100.33 118.89 37.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 110.139 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.95 -14.33 7.51 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -85.24 174.13 9.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -1.121 . . . . 0.0 110.339 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.52 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 20.2 tp -118.42 122.43 42.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 110.011 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.513 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -102.17 57.08 0.64 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.717 ' CE2' ' HB1' ' A' ' 11' ' ' ALA . 48.6 p90 -53.67 174.13 0.05 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.167 -1.196 . . . . 0.0 110.86 -179.805 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.556 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 73.6 mm-40 -108.0 -179.48 3.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.463 -0.773 . . . . 0.0 110.137 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -68.37 134.52 50.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.928 . . . . 0.0 110.365 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.17 -13.19 62.23 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.457 ' HG3' HD21 ' A' ' 31' ' ' LEU . 26.1 tp10 -62.08 122.99 16.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -1.16 . . . . 0.0 110.409 -179.712 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.635 ' O ' HD23 ' A' ' 31' ' ' LEU . 97.0 mt-30 -79.91 136.42 36.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.33 -0.856 . . . . 0.0 109.879 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.635 HD23 ' O ' ' A' ' 30' ' ' GLN . 17.4 mt -139.04 160.87 38.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.418 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.594 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 4.1 tpt180 -106.4 134.03 50.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.381 -0.825 . . . . 0.0 109.498 179.533 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.546 HD11 HG11 ' A' ' 9' ' ' VAL . 35.4 mt -95.77 92.84 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.139 -0.976 . . . . 0.0 110.485 -179.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.764 HD12 ' HA ' ' A' ' 43' ' ' ALA . 1.1 mt -79.2 -24.97 42.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.274 -0.891 . . . . 0.0 110.631 -179.406 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 42' ' ' LYS . 70.7 tt0 -135.82 136.3 40.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.026 -1.046 . . . . 0.0 110.253 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.642 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 79.7 mt-30 -132.23 53.86 1.98 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.879 . . . . 0.0 110.188 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.0 m -115.9 138.4 51.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -0.882 . . . . 0.0 110.099 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.95 -172.89 55.2 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -72.73 -34.43 67.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.188 -1.184 . . . . 0.0 110.234 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.565 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 99.5 m95 -96.73 143.62 27.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 110.139 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.642 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 51.2 m0 -121.78 155.64 34.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.317 -0.865 . . . . 0.0 110.096 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 35' ' ' GLU . 46.7 tttm -96.32 141.98 29.0 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.277 -0.89 . . . . 0.0 109.237 179.282 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.764 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -150.03 174.13 13.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.927 -1.108 . . . . 0.0 111.023 -179.456 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 50' ' ' GLN . 58.7 tt0 -137.82 146.06 43.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.613 -0.679 . . . . 0.0 109.771 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 t -92.92 107.3 19.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 110.136 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 44.7 mt -70.01 -3.04 14.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.24 -0.913 . . . . 0.0 110.429 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.428 ' OG1' HG23 ' A' ' 48' ' ' THR . 30.1 p -89.07 -30.16 18.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.124 -0.985 . . . . 0.0 109.799 179.656 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.428 HG23 ' OG1' ' A' ' 47' ' ' THR . 49.2 p -120.81 -7.32 9.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.28 -0.887 . . . . 0.0 110.068 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.26 44.07 60.98 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.467 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 23.2 mt-30 -123.47 151.55 42.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -1.154 . . . . 0.0 110.301 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 97.1 mt-10 -119.3 141.56 48.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.322 -0.861 . . . . 0.0 109.998 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.52 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -159.1 -151.92 6.28 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -124.27 138.28 54.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.398 -1.06 . . . . 0.0 109.818 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.446 ' O ' HG13 ' A' ' 54' ' ' ILE . 2.9 pt -133.53 144.37 51.86 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.157 -0.964 . . . . 0.0 110.343 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.593 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 47.0 Cg_endo -72.64 151.86 52.85 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.06 1.558 . . . . 0.0 109.985 179.736 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.597 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 31.6 p90 -73.99 -4.26 34.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 111.134 -179.375 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -98.6 -26.14 14.49 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.895 -1.128 . . . . 0.0 111.341 -179.305 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.593 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 8.5 m-85 -82.65 -2.53 54.25 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.803 -1.186 . . . . 0.0 110.346 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 30.9 m -133.74 143.21 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.161 -0.962 . . . . 0.0 110.117 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.446 ' HB2' HD11 ' A' ' 12' ' ' LEU . . . . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 110.246 -179.968 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.453 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.4 mp . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 121.254 0.55 . . . . 0.0 110.31 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.632 HG21 HD11 ' A' ' 33' ' ' ILE . 4.2 m -145.95 167.72 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.267 -0.895 . . . . 0.0 110.288 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . 0.464 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 61.8 mt -113.43 140.11 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.865 . . . . 0.0 109.781 179.661 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.555 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -80.66 110.22 15.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.137 -0.977 . . . . 0.0 110.555 -179.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 58' ' ' PHE . 52.4 mt -67.52 -22.94 65.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.08 -1.013 . . . . 0.0 109.162 179.164 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.439 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 21.8 m80 -157.37 146.72 20.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.641 -0.662 . . . . 0.0 109.408 179.704 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 81.9 p -61.5 146.38 48.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.998 -1.064 . . . . 0.0 110.14 -179.831 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 25.1 t80 -95.76 156.93 16.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.978 -1.076 . . . . 0.0 110.348 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 17' ' ' PRO . 46.1 mt-10 -114.07 73.87 2.58 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.326 -0.859 . . . . 0.0 110.121 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.515 ' HB3' ' HB2' ' A' ' 22' ' ' ASP . 47.7 Cg_endo -40.6 110.35 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.043 1.549 . . . . 0.0 110.429 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.469 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 59.6 p -87.25 8.21 25.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.348 -0.845 . . . . 0.0 110.168 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.469 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 96.2 m-70 -145.48 170.54 16.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.09 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -87.25 126.89 35.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.266 -0.896 . . . . 0.0 110.294 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.27 -14.0 13.66 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.515 ' HB2' ' HB3' ' A' ' 17' ' ' PRO . 2.4 m-20 -86.68 174.66 8.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -1.152 . . . . 0.0 110.262 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.497 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 19.2 tp -120.63 124.66 45.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.868 . . . . 0.0 110.062 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.493 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -104.13 57.52 0.53 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.759 ' CG ' HD11 ' A' ' 31' ' ' LEU . 28.6 p90 -47.07 169.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.259 -1.142 . . . . 0.0 110.878 -179.532 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.486 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 90.7 mt-10 -98.84 177.48 5.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.495 -0.753 . . . . 0.0 110.14 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -71.55 119.89 16.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.184 -0.947 . . . . 0.0 110.348 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.9 -6.75 58.68 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.503 ' OE1' ' CA ' ' A' ' 25' ' ' PHE . 71.6 tt0 -73.71 127.43 32.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.008 -1.289 . . . . 0.0 110.172 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.43 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 58.2 mt-30 -79.25 142.67 36.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 110.004 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.759 HD11 ' CG ' ' A' ' 25' ' ' PHE . 73.0 mt -141.36 163.83 31.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.243 -0.91 . . . . 0.0 110.348 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.753 ' CD ' HD21 ' A' ' 34' ' ' LEU . 19.0 ttt180 -105.85 133.25 50.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.885 . . . . 0.0 109.63 179.553 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.632 HD11 HG21 ' A' ' 9' ' ' VAL . 31.0 mm -96.53 93.78 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.12 -0.987 . . . . 0.0 110.417 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.795 HD11 ' OE1' ' A' ' 44' ' ' GLN . 41.8 mt -79.83 -24.52 41.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.258 -0.901 . . . . 0.0 110.859 -179.543 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.516 ' CB ' ' HB3' ' A' ' 42' ' ' LYS . 17.9 tt0 -136.18 140.87 43.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.992 -1.067 . . . . 0.0 110.345 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.625 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 84.3 mt-30 -135.29 55.18 1.89 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.158 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -119.27 142.13 48.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.178 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.0 -171.16 54.62 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -74.16 -34.77 63.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -1.166 . . . . 0.0 110.132 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.561 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 95.3 m95 -96.28 144.5 26.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.302 -0.874 . . . . 0.0 110.272 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.625 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.9 m0 -118.85 156.09 30.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 110.217 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.516 ' HB3' ' CB ' ' A' ' 35' ' ' GLU . 29.0 tttt -96.18 137.57 35.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.358 -0.839 . . . . 0.0 109.408 179.412 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.589 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -152.77 176.65 11.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.01 . . . . 0.0 110.666 -179.554 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.795 ' OE1' HD11 ' A' ' 34' ' ' LEU . 14.5 pt20 -148.18 156.67 42.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.455 -0.778 . . . . 0.0 109.819 179.719 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.8 t -98.55 116.91 31.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.122 -0.987 . . . . 0.0 110.275 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.502 HD21 HE21 ' A' ' 44' ' ' GLN . 60.3 mt -74.51 -0.78 18.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 110.094 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 70.7 p -94.63 -27.22 16.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.36 -0.838 . . . . 0.0 110.166 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 47.4 p -114.25 -13.02 12.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 110.157 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.42 39.46 50.7 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -128.16 155.51 44.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -1.154 . . . . 0.0 110.276 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.485 ' HG2' ' CB ' ' A' ' 44' ' ' GLN . 73.6 mt-10 -123.8 152.56 42.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.905 . . . . 0.0 110.031 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.497 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -165.94 -149.89 6.09 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -127.74 143.63 51.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.46 -1.024 . . . . 0.0 109.683 179.61 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.504 HD12 ' O ' ' A' ' 55' ' ' PRO . 1.7 pp -141.01 139.2 18.94 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.132 -0.98 . . . . 0.0 110.696 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.608 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 44.8 Cg_endo -59.39 156.97 33.09 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.093 1.575 . . . . 0.0 109.907 179.465 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.577 ' CZ ' ' OD1' ' A' ' 57' ' ' ASN . 20.8 p90 -84.56 -2.28 57.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.097 -1.002 . . . . 0.0 110.766 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.577 ' OD1' ' CZ ' ' A' ' 56' ' ' PHE . 8.6 m120 -103.65 13.22 33.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.984 -1.073 . . . . 0.0 110.696 -179.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.608 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 6.1 m-85 -111.32 -6.41 14.52 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.097 -1.002 . . . . 0.0 110.028 179.694 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 7.8 m -138.46 145.47 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.334 -0.854 . . . . 0.0 110.032 179.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.639 0 O-C-N 121.165 -0.959 . . . . 0.0 110.398 -179.863 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.746 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.2 mp . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.235 0.54 . . . . 0.0 110.231 . . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.479 HG13 ' C ' ' A' ' 8' ' ' LEU . 30.9 m -150.9 170.21 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 110.289 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.9 mt -112.27 148.7 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -0.83 . . . . 0.0 109.887 179.729 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.53 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . -80.12 112.01 17.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.131 -0.981 . . . . 0.0 110.422 -179.779 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.658 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.9 mm? -71.71 -22.41 61.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.192 -0.942 . . . . 0.0 109.442 179.442 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.422 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 86.0 m-70 -153.62 151.13 29.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.464 -0.772 . . . . 0.0 109.75 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.555 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 54.2 p -67.25 142.83 56.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.059 -1.026 . . . . 0.0 109.97 179.861 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.594 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 88.5 t80 -99.08 160.17 14.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.072 -1.017 . . . . 0.0 110.414 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.551 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 2.4 mm-40 -104.69 124.4 37.06 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.356 -0.84 . . . . 0.0 110.063 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.472 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 49.6 Cg_endo -81.06 82.84 2.34 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.945 1.497 . . . . 0.0 110.429 -179.843 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 59.6 p -79.99 -2.73 45.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 110.213 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -129.13 -159.34 0.95 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.933 . . . . 0.0 110.266 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -107.72 -19.1 13.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.191 -0.943 . . . . 0.0 110.235 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.23 10.48 31.28 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -89.95 155.94 18.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -1.184 . . . . 0.0 110.157 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.448 ' O ' ' CD2' ' A' ' 15' ' ' TYR . 14.5 tp -111.65 116.31 30.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.301 -0.874 . . . . 0.0 110.169 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.472 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -97.06 47.59 1.63 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.589 ' CE1' ' HB2' ' A' ' 15' ' ' TYR . 43.7 p90 -48.43 173.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -1.159 . . . . 0.0 111.006 -179.828 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.555 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 95.5 mt-10 -109.36 179.05 4.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.458 -0.776 . . . . 0.0 110.191 179.903 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -68.42 136.46 53.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 110.439 -179.914 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.35 -14.39 57.87 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.473 ' HG3' ' HB2' ' A' ' 26' ' ' GLU . 3.2 mt-10 -62.98 124.08 20.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -1.2 . . . . 0.0 110.393 -179.746 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.476 ' O ' HD23 ' A' ' 31' ' ' LEU . 86.8 mt-30 -79.75 136.64 36.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.24 -0.913 . . . . 0.0 109.832 179.768 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 45' ' ' SER . 15.1 mt -137.74 158.51 44.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.069 -1.019 . . . . 0.0 110.653 -179.723 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.717 ' HD2' HD21 ' A' ' 46' ' ' LEU . 25.4 mtp180 -108.05 134.37 51.03 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.436 -0.79 . . . . 0.0 109.142 179.295 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.4 mm -90.82 93.97 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.047 -1.033 . . . . 0.0 110.737 -179.502 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.9 mt -79.38 -29.79 42.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 110.842 -179.507 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.505 ' HB2' ' CB ' ' A' ' 42' ' ' LYS . 74.0 mt-10 -129.54 143.93 51.04 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.923 -1.111 . . . . 0.0 110.366 -179.957 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.635 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 15.1 pt20 -138.04 55.87 1.76 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.363 -0.836 . . . . 0.0 110.241 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.6 t -120.66 142.06 49.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.171 -0.956 . . . . 0.0 110.204 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.35 -176.01 50.55 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -70.57 -28.28 64.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -1.1 . . . . 0.0 110.211 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.506 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 95.4 m95 -100.27 147.59 25.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 110.345 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.635 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 47.1 m0 -124.27 156.17 37.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.192 -179.985 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.505 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 13.5 tttp -98.94 145.23 27.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.413 179.421 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.593 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -158.21 -177.33 6.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.011 -1.056 . . . . 0.0 111.002 -179.596 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.504 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 58.4 tt0 -144.45 152.87 41.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.454 -0.779 . . . . 0.0 109.365 179.584 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.546 ' HA ' HD23 ' A' ' 31' ' ' LEU . 10.5 t -102.76 128.12 49.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.026 -1.046 . . . . 0.0 110.515 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.717 HD21 ' HD2' ' A' ' 32' ' ' ARG . 37.8 mt -83.17 8.31 13.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.886 . . . . 0.0 109.917 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.43 ' OG1' HG23 ' A' ' 48' ' ' THR . 20.4 p -98.48 -42.07 7.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.348 -0.845 . . . . 0.0 110.11 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.43 HG23 ' OG1' ' A' ' 47' ' ' THR . 58.2 p -113.05 -10.78 13.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 110.101 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.11 38.93 46.43 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.852 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -112.61 142.52 45.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -1.138 . . . . 0.0 110.197 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -117.9 136.67 53.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 110.092 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -171.44 165.15 38.11 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 97.0 m-85 -71.09 145.3 49.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -1.078 . . . . 0.0 110.145 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.573 ' CD1' HG21 ' A' ' 59' ' ' VAL . 1.2 pp -136.68 140.07 31.0 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 110.216 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.595 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 47.7 Cg_endo -65.14 149.73 88.59 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.021 1.537 . . . . 0.0 110.073 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.592 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 39.6 p90 -75.61 -5.45 45.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 110.931 -179.449 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -95.44 -25.74 16.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.955 -1.091 . . . . 0.0 111.039 -179.363 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.595 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 9.3 m-85 -82.22 0.26 42.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.905 -1.122 . . . . 0.0 110.453 -179.741 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.573 HG21 ' CD1' ' A' ' 54' ' ' ILE . 23.3 m -141.95 154.11 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 0.0 110.097 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.241 -0.912 . . . . 0.0 110.227 -179.97 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.2 tp . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.13 0.49 . . . . 0.0 109.973 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.038 HG11 HD11 ' A' ' 33' ' ' ILE . 27.8 m -141.78 165.74 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.129 -0.982 . . . . 0.0 110.465 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 72.4 mt -112.5 148.01 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.337 -0.852 . . . . 0.0 109.684 179.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.548 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . -78.56 111.18 14.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.063 -1.023 . . . . 0.0 110.347 -179.71 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.442 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 49.9 mt -70.05 -25.68 63.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.088 -1.008 . . . . 0.0 109.16 179.322 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.442 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 80.7 m-70 -155.62 151.92 28.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.692 -0.63 . . . . 0.0 109.506 179.703 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 30.2 p -64.91 140.0 58.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.951 -1.093 . . . . 0.0 109.774 179.75 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.61 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 85.6 t80 -97.59 157.13 16.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.014 -1.054 . . . . 0.0 110.332 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -111.44 124.61 32.21 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.909 . . . . 0.0 110.188 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.478 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.4 Cg_endo -80.21 81.67 2.69 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.02 1.537 . . . . 0.0 110.47 -179.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.473 ' OG ' ' ND1' ' A' ' 19' ' ' HIS . 92.2 p -79.81 -1.96 41.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.135 -0.978 . . . . 0.0 110.013 179.904 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.473 ' ND1' ' OG ' ' A' ' 18' ' ' SER . 72.4 m80 -140.34 172.86 12.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 110.076 -179.997 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -90.07 125.3 35.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.238 -0.913 . . . . 0.0 110.248 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.09 6.99 31.51 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.997 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -104.16 164.37 11.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -1.164 . . . . 0.0 110.28 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.483 ' CD1' ' CD ' ' A' ' 50' ' ' GLN . 22.8 tp -114.82 119.63 37.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.174 -179.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.478 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -99.91 54.21 0.94 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.866 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.751 ' CD1' HD21 ' A' ' 31' ' ' LEU . 45.9 p90 -53.12 173.73 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.235 -1.156 . . . . 0.0 111.131 -179.482 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 96.0 mt-10 -105.61 176.57 5.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.553 -0.717 . . . . 0.0 110.288 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.7 tttm -70.97 135.67 48.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.058 -1.026 . . . . 0.0 110.322 179.772 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.0 -13.67 53.07 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.591 ' OE1' HG21 ' A' ' 47' ' ' THR . 30.6 mm-40 -63.91 136.18 57.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.035 -1.274 . . . . 0.0 109.99 -179.764 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.821 ' C ' HD12 ' A' ' 31' ' ' LEU . 88.3 mt-30 -79.6 128.1 32.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.895 . . . . 0.0 110.075 -179.873 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.821 HD12 ' C ' ' A' ' 30' ' ' GLN . 10.4 mp -124.31 141.63 51.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 110.393 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.749 ' HB2' HD11 ' A' ' 46' ' ' LEU . 15.7 ttt85 -100.95 134.58 43.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.336 -0.852 . . . . 0.0 109.588 179.633 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 1.038 HD11 HG11 ' A' ' 9' ' ' VAL . 27.0 mt -85.78 132.58 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.163 -0.96 . . . . 0.0 110.307 -179.925 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.0 mt -118.71 -31.75 4.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.363 -0.835 . . . . 0.0 110.112 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.514 ' HB2' ' CB ' ' A' ' 42' ' ' LYS . 85.7 mt-10 -135.58 149.87 49.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.19 -0.944 . . . . 0.0 110.198 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.626 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 93.2 mt-30 -135.84 59.01 1.73 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.268 -0.895 . . . . 0.0 110.15 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.7 t -124.24 135.59 53.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.235 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.7 176.65 45.76 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.9 -27.44 69.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.204 -1.174 . . . . 0.0 110.236 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.556 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 98.3 m95 -98.96 146.28 26.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.22 -0.925 . . . . 0.0 110.241 -179.897 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.626 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 40.9 m0 -122.88 156.48 34.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.901 . . . . 0.0 110.14 179.795 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.514 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 20.7 tttt -93.75 142.3 27.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.956 . . . . 0.0 109.776 179.581 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.513 ' CB ' HG12 ' A' ' 54' ' ' ILE . . . -155.9 178.83 9.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.115 -0.991 . . . . 0.0 110.771 -179.803 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.414 ' CG ' ' HG2' ' A' ' 51' ' ' GLU . 46.3 tt0 -141.82 150.14 41.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.394 -0.816 . . . . 0.0 109.909 179.697 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 t -95.3 119.63 34.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 110.276 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . 0.749 HD11 ' HB2' ' A' ' 32' ' ' ARG . 4.9 mp -78.13 6.28 8.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -0.9 . . . . 0.0 110.412 -179.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.591 HG21 ' OE1' ' A' ' 29' ' ' GLU . 65.5 p -96.57 -37.29 10.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 110.019 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.1 p -120.13 -6.09 9.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 110.098 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.67 40.6 52.96 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.483 ' CD ' ' CD1' ' A' ' 23' ' ' LEU . 62.1 tt0 -110.29 141.15 43.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -1.14 . . . . 0.0 110.288 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.414 ' HG2' ' CG ' ' A' ' 44' ' ' GLN . 92.6 mt-10 -117.15 136.57 52.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.341 -0.849 . . . . 0.0 109.938 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.428 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -170.14 164.7 38.05 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -69.1 144.59 53.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -1.13 . . . . 0.0 110.029 179.894 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.558 ' CD1' HG21 ' A' ' 59' ' ' VAL . 1.1 pt -136.0 139.53 30.59 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 110.257 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.574 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 45.4 Cg_endo -63.94 150.45 88.37 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.911 1.479 . . . . 0.0 110.188 179.739 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.596 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 16.2 p90 -85.41 1.3 49.23 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.348 -0.845 . . . . 0.0 111.18 -179.402 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.538 ' OD1' ' N ' ' A' ' 58' ' ' PHE . 48.9 p30 -100.41 -24.03 14.6 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.955 -1.091 . . . . 0.0 111.178 -179.365 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.544 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 14.1 m-30 -94.18 1.34 56.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.87 -1.144 . . . . 0.0 110.591 -179.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.558 HG21 ' CD1' ' A' ' 54' ' ' ILE . 33.9 m -130.69 146.22 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.178 -0.951 . . . . 0.0 110.198 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.448 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.654 0 O-C-N 121.318 -0.864 . . . . 0.0 110.271 -179.945 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.77 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.3 mp . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.203 0.525 . . . . 0.0 110.101 . . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.817 ' CG1' HD11 ' A' ' 33' ' ' ILE . 15.5 m -151.86 171.95 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.172 -0.955 . . . . 0.0 110.448 179.911 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 52.7 mt -118.02 143.32 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.418 -0.801 . . . . 0.0 109.927 179.754 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.582 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -76.9 112.61 13.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.179 -0.95 . . . . 0.0 110.514 -179.659 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.481 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 52.5 mt -72.99 -22.32 60.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.089 -1.007 . . . . 0.0 109.314 179.262 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.481 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 77.8 m-70 -156.83 151.68 25.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.651 -0.656 . . . . 0.0 109.521 179.881 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 34.9 p -65.26 136.83 57.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.899 -1.126 . . . . 0.0 109.895 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 67.0 t80 -97.78 157.08 16.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.085 -1.009 . . . . 0.0 110.119 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.558 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 3.0 mt-10 -111.74 136.07 21.14 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.852 . . . . 0.0 110.295 -179.82 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.457 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 46.8 Cg_endo -94.32 87.17 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.065 1.561 . . . . 0.0 110.272 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 90.1 p -80.51 0.86 31.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 110.242 -179.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -142.12 -177.92 5.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 110.278 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -97.72 126.11 42.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 110.169 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.33 -9.87 26.55 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.984 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 1.1 m-20 -92.12 171.05 9.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -1.171 . . . . 0.0 110.129 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.506 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 15.5 tp -127.12 132.31 50.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 110.052 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.475 ' HA2' ' HB3' ' A' ' 15' ' ' TYR . . . -109.2 60.29 0.33 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.653 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.794 ' CG ' HD11 ' A' ' 31' ' ' LEU . 39.6 p90 -52.61 175.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.156 -1.202 . . . . 0.0 110.92 -179.684 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 96.3 mt-10 -109.75 -179.5 3.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.401 -0.812 . . . . 0.0 110.323 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.0 tttt -70.87 130.34 41.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.093 -1.005 . . . . 0.0 110.187 179.674 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.9 -18.47 47.31 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 -179.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 22.3 mm-40 -61.45 123.91 19.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.081 -1.246 . . . . 0.0 110.086 -179.667 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.466 ' NE2' HD23 ' A' ' 8' ' ' LEU . 48.9 tt0 -79.46 134.47 36.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.335 -0.853 . . . . 0.0 110.28 -179.76 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.794 HD11 ' CG ' ' A' ' 25' ' ' PHE . 41.8 mt -129.85 150.03 51.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -0.854 . . . . 0.0 110.176 -179.895 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 19.4 ttt180 -94.59 133.35 38.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.329 -0.857 . . . . 0.0 110.065 179.809 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.817 HD11 ' CG1' ' A' ' 9' ' ' VAL . 34.8 mt -80.89 121.48 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.202 -0.936 . . . . 0.0 110.031 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.44 HD13 ' OE2' ' A' ' 51' ' ' GLU . 4.6 mt -99.49 -33.15 10.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.272 -0.892 . . . . 0.0 110.317 -179.777 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.523 ' OE1' ' CE ' ' A' ' 42' ' ' LYS . 79.6 tt0 -150.98 146.97 26.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.176 -0.953 . . . . 0.0 110.194 -179.924 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.623 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 98.2 mt-30 -128.82 55.17 1.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.895 . . . . 0.0 110.195 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.1 t -111.23 125.99 54.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 110.249 -179.89 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.74 -175.05 53.25 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -67.91 -37.08 81.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -1.104 . . . . 0.0 110.203 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.418 ' HZ3' ' CE1' ' A' ' 15' ' ' TYR . 85.7 m95 -91.47 141.31 28.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 0.0 110.149 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.623 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 50.9 m0 -122.28 153.75 38.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 0.0 110.391 -179.97 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.523 ' CE ' ' OE1' ' A' ' 35' ' ' GLU . 50.2 mttt -89.13 146.42 24.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.302 -0.874 . . . . 0.0 109.558 179.472 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.771 ' HB2' HG12 ' A' ' 54' ' ' ILE . . . -148.71 170.08 18.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.085 -1.01 . . . . 0.0 110.653 -179.61 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 42.8 tt0 -137.51 145.25 42.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.383 -0.823 . . . . 0.0 109.878 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.462 ' OG ' HD21 ' A' ' 23' ' ' LEU . 53.4 m -74.2 139.34 44.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 110.256 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.8 tp -82.34 -26.14 33.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.183 -0.948 . . . . 0.0 110.224 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.3 p -98.96 -28.23 13.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 110.158 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.14 -18.94 18.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.241 -0.912 . . . . 0.0 110.091 179.836 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.95 6.04 35.72 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.634 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 29.3 mt-30 -83.13 155.18 23.94 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.04 -1.271 . . . . 0.0 110.485 -179.803 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.44 ' OE2' HD13 ' A' ' 34' ' ' LEU . 69.1 tt0 -114.99 134.81 54.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.326 -0.859 . . . . 0.0 109.951 179.813 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.506 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -145.6 -152.14 5.57 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.68 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -122.9 134.25 54.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.481 -1.011 . . . . 0.0 109.614 179.638 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.771 HG12 ' HB2' ' A' ' 43' ' ' ALA . 1.2 pp -127.46 133.73 25.4 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.116 -0.99 . . . . 0.0 110.631 -179.617 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.574 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 43.0 Cg_endo -66.08 157.42 59.66 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.149 1.605 . . . . 0.0 110.187 179.611 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.474 ' HB2' ' CH2' ' A' ' 41' ' ' TRP . 18.9 p90 -88.19 -1.63 58.13 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.274 -0.891 . . . . 0.0 111.36 -179.06 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 58' ' ' PHE . 42.3 p30 -99.43 -25.83 14.33 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.82 -1.175 . . . . 0.0 111.066 -179.451 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.569 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 11.7 m-30 -92.43 -3.97 54.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.89 -1.131 . . . . 0.0 110.54 -179.78 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.682 HG21 ' CD1' ' A' ' 54' ' ' ILE . 21.8 m -126.91 144.32 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.1 -1.0 . . . . 0.0 110.095 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.914 . . . . 0.0 110.362 -179.856 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.532 ' O ' HG13 ' A' ' 9' ' ' VAL . 44.0 mt . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 121.159 0.504 . . . . 0.0 110.215 . . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.649 HG21 HG11 ' A' ' 59' ' ' VAL . 4.2 m -154.48 172.68 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.862 . . . . 0.0 110.333 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 60.0 mt -113.69 141.51 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.342 -0.849 . . . . 0.0 109.943 179.783 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.538 ' HB1' ' CE1' ' A' ' 25' ' ' PHE . . . -80.46 111.89 17.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.143 -0.973 . . . . 0.0 110.119 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.416 ' O ' ' ND1' ' A' ' 13' ' ' HIS . 24.2 tp -66.43 -27.86 68.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.099 -1.0 . . . . 0.0 109.543 179.529 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.416 ' ND1' ' O ' ' A' ' 12' ' ' LEU . 89.5 m-70 -150.8 155.73 39.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.472 -0.767 . . . . 0.0 109.836 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.531 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 52.5 p -68.15 144.28 55.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.14 -0.975 . . . . 0.0 110.019 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.573 ' CD1' ' HG3' ' A' ' 55' ' ' PRO . 27.4 t80 -94.44 153.71 17.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.042 -1.036 . . . . 0.0 110.323 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.446 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 19.0 tp10 -110.45 77.83 1.34 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 110.216 -179.911 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.508 ' HB3' ' HB2' ' A' ' 22' ' ' ASP . 48.1 Cg_endo -41.52 98.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.127 1.593 . . . . 0.0 110.422 179.895 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.489 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 87.5 p -82.31 9.27 9.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 110.25 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.489 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 87.3 m-70 -148.3 164.23 34.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 110.192 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -80.93 118.94 22.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 110.304 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.08 14.8 6.4 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.508 ' HB2' ' HB3' ' A' ' 17' ' ' PRO . 13.0 m-20 -111.32 168.47 9.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.174 -1.192 . . . . 0.0 110.284 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.506 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 17.1 tp -110.22 113.38 26.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 109.998 179.872 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.505 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -96.43 53.25 1.54 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.901 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.551 ' HE2' HG22 ' A' ' 54' ' ' ILE . 35.8 p90 -54.13 174.5 0.06 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.248 -1.148 . . . . 0.0 111.123 -179.557 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.531 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 94.3 mt-10 -109.43 177.23 4.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.499 -0.751 . . . . 0.0 109.964 179.78 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -66.95 139.59 57.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -0.955 . . . . 0.0 110.378 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.96 -14.02 57.98 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 3.7 mt-10 -66.6 126.16 28.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -1.215 . . . . 0.0 110.308 -179.865 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.975 ' C ' HD12 ' A' ' 31' ' ' LEU . 44.7 tt0 -79.7 137.33 37.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.814 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.975 HD12 ' C ' ' A' ' 30' ' ' GLN . 8.3 mp -136.89 156.99 47.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -0.909 . . . . 0.0 110.627 -179.553 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.592 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 38.5 ttt180 -106.26 131.65 53.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.412 -0.805 . . . . 0.0 109.24 179.247 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.458 HD11 HG11 ' A' ' 9' ' ' VAL . 87.6 mt -90.8 94.35 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.109 -0.994 . . . . 0.0 110.713 -179.318 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.93 HD12 ' HA ' ' A' ' 43' ' ' ALA . 1.1 mp -79.85 -32.69 40.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 110.379 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.495 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 67.3 tt0 -130.58 135.46 47.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.119 -0.988 . . . . 0.0 110.253 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.624 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 58.8 tt0 -131.41 55.7 1.84 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 110.174 179.984 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.2 m -120.65 145.42 47.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.281 -0.887 . . . . 0.0 110.231 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.89 -174.66 48.61 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -71.8 -30.68 65.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.236 -1.155 . . . . 0.0 110.128 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.555 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 99.3 m95 -99.38 145.71 27.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 110.23 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.624 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.6 m0 -121.2 157.04 31.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 110.207 179.896 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.495 ' CB ' ' HB3' ' A' ' 35' ' ' GLU . 43.8 tttp -101.37 138.69 38.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 109.012 179.065 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.93 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -149.93 177.38 9.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.838 -1.164 . . . . 0.0 110.998 -179.419 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . 0.518 ' HG3' ' CG ' ' A' ' 51' ' ' GLU . 39.4 tt0 -140.14 148.42 41.62 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.53 -0.731 . . . . 0.0 109.886 179.81 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.0 t -96.4 111.32 23.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.121 -0.987 . . . . 0.0 110.283 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 66.3 mt -71.19 -2.89 17.45 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 110.34 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.501 ' OG1' HG23 ' A' ' 48' ' ' THR . 31.3 p -85.53 -32.38 22.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.219 -0.926 . . . . 0.0 110.005 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . 0.501 HG23 ' OG1' ' A' ' 47' ' ' THR . 23.6 p -120.82 -3.74 9.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 0.0 110.134 179.88 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.05 48.07 61.87 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.84 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.478 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 49.6 mt-30 -129.41 155.67 45.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -1.18 . . . . 0.0 110.428 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.518 ' CG ' ' HG3' ' A' ' 44' ' ' GLN . 95.4 mt-10 -119.56 160.77 21.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.337 -0.852 . . . . 0.0 109.844 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.506 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -178.32 -157.69 19.52 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -120.79 136.09 54.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.457 -1.025 . . . . 0.0 109.973 179.833 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.551 HG22 ' HE2' ' A' ' 25' ' ' PHE . 5.2 pt -130.91 149.71 74.49 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 110.417 -179.773 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.609 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 44.8 Cg_endo -78.13 143.2 19.98 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 124.023 1.538 . . . . 0.0 109.848 179.702 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.562 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 35.2 p90 -66.86 -8.95 32.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.241 -0.912 . . . . 0.0 110.962 -179.311 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -90.81 -26.13 19.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.911 -1.118 . . . . 0.0 110.939 -179.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.609 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 7.2 m-85 -84.18 6.67 21.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.005 -1.059 . . . . 0.0 110.215 -179.761 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.649 HG11 HG21 ' A' ' 9' ' ' VAL . 15.2 t -147.3 169.11 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.918 . . . . 0.0 110.136 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.625 ' O ' HG12 ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 110.374 -179.968 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' LEU . . . . . 0.743 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.1 mp . . . . . 0 N--CA 1.491 1.587 0 CA-C-O 121.175 0.512 . . . . 0.0 110.267 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.849 HG21 HD11 ' A' ' 33' ' ' ILE . 25.3 m -140.69 164.34 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.265 -0.897 . . . . 0.0 110.29 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.5 mm -109.39 140.71 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.361 -0.837 . . . . 0.0 109.75 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' ALA . . . . . 0.499 ' HB1' ' CE1' ' A' ' 25' ' ' PHE . . . -80.0 107.25 12.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.178 -0.951 . . . . 0.0 110.311 -179.828 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 12' ' ' LEU . 7.6 mp -67.63 -23.19 65.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.097 -1.002 . . . . 0.0 109.173 179.366 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' HIS . . . . . 0.417 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 90.8 m-70 -153.33 146.45 24.64 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.621 -0.674 . . . . 0.0 109.576 179.75 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 55.4 p -63.01 147.28 51.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.044 -1.035 . . . . 0.0 109.8 179.917 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 38.6 t80 -99.08 161.32 13.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.141 -0.974 . . . . 0.0 110.398 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -118.96 85.17 28.23 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 0.0 110.148 179.92 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.539 ' CB ' ' HB2' ' A' ' 22' ' ' ASP . 47.4 Cg_endo -44.36 96.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.02 1.537 . . . . 0.0 110.546 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 16' ' ' GLU . 25.2 p -83.24 3.9 29.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.905 . . . . 0.0 109.955 179.783 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' HIS . . . . . 0.442 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 84.9 t60 -148.2 166.9 26.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.342 -0.849 . . . . 0.0 110.116 -179.92 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -75.81 130.72 39.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.201 -0.937 . . . . 0.0 110.139 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.45 15.36 21.35 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.539 ' HB2' ' CB ' ' A' ' 17' ' ' PRO . 27.8 m-20 -111.74 161.04 16.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -1.159 . . . . 0.0 110.439 -179.862 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.495 ' HA ' HD12 ' A' ' 23' ' ' LEU . 13.6 tp -116.2 120.03 37.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.283 -0.886 . . . . 0.0 109.801 179.927 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.51 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -97.78 50.51 1.38 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.792 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 30.2 p90 -48.71 172.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.227 -1.161 . . . . 0.0 111.19 -179.847 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.434 ' N ' ' OE1' ' A' ' 29' ' ' GLU . 81.0 mt-10 -102.78 173.46 6.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.565 -0.71 . . . . 0.0 110.078 179.635 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 pttm -70.11 136.8 50.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.134 -0.979 . . . . 0.0 110.159 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.77 -10.23 73.16 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' GLU . . . . . 0.465 ' OE1' ' HB2' ' A' ' 25' ' ' PHE . 67.2 tt0 -73.43 128.31 35.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.05 -1.264 . . . . 0.0 110.124 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' GLN . . . . . 0.834 ' O ' HD23 ' A' ' 31' ' ' LEU . 46.4 tt0 -79.61 141.46 36.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.93 . . . . 0.0 109.82 179.906 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.834 HD23 ' O ' ' A' ' 30' ' ' GLN . 17.4 mt -140.64 161.97 36.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.924 . . . . 0.0 110.515 -179.693 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.587 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 7.2 tpt180 -103.67 129.91 51.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.414 -0.804 . . . . 0.0 109.617 179.487 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.849 HD11 HG21 ' A' ' 9' ' ' VAL . 25.3 mm -93.67 94.26 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.179 -0.951 . . . . 0.0 110.458 -179.744 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.584 HD12 ' HA ' ' A' ' 43' ' ' ALA . 1.2 mt -79.92 -28.08 39.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -0.888 . . . . 0.0 110.775 -179.675 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.465 ' HB2' ' CB ' ' A' ' 42' ' ' LYS . 62.1 mt-10 -131.19 138.38 49.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.965 -1.084 . . . . 0.0 110.489 -179.83 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' GLN . . . . . 0.638 HE21 HG21 ' A' ' 33' ' ' ILE . 98.8 mt-30 -135.03 54.28 1.95 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 110.043 179.892 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.6 t -120.49 142.52 49.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 110.205 179.972 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.63 -169.88 54.96 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.889 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -76.6 -33.96 58.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -1.12 . . . . 0.0 110.146 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' TRP . . . . . 0.559 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 98.7 m95 -96.93 143.37 27.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 110.42 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' TRP . . . . . 0.626 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.5 m0 -120.1 156.19 31.5 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.284 -0.885 . . . . 0.0 110.238 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 53' ' ' PHE . 12.6 tttp -100.28 141.78 32.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.329 -0.857 . . . . 0.0 109.368 179.372 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.587 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -153.69 179.44 8.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.053 -1.029 . . . . 0.0 110.94 -179.612 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -142.01 150.61 41.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 109.876 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.551 ' OG ' HD22 ' A' ' 31' ' ' LEU . 13.3 m -99.02 121.97 41.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.118 -0.989 . . . . 0.0 110.356 -179.952 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 71.6 mt -79.2 5.04 13.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 110.179 179.888 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.52 -42.07 4.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.283 -0.885 . . . . 0.0 110.159 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.2 p -90.65 -27.41 19.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -0.898 . . . . 0.0 110.135 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.8 33.42 24.44 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -128.34 153.02 47.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.268 -1.136 . . . . 0.0 110.306 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.437 ' OE2' ' HE2' ' A' ' 42' ' ' LYS . 84.8 tt0 -120.43 142.57 49.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 110.231 179.85 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' GLY . . . . . 0.423 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -168.55 161.62 35.35 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.856 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 95.4 m-85 -71.72 146.92 47.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -1.101 . . . . 0.0 109.854 179.591 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' ILE . . . . . 0.736 HD12 HG21 ' A' ' 59' ' ' VAL . 1.1 pt -136.87 136.47 21.4 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.195 -0.941 . . . . 0.0 110.357 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.574 ' HD3' ' CD1' ' A' ' 15' ' ' TYR . 45.0 Cg_endo -58.7 147.66 86.68 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.048 1.551 . . . . 0.0 110.045 179.651 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.585 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 19.1 p90 -82.89 -5.64 59.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 110.999 -179.419 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' ASN . . . . . 0.56 ' OD1' ' CZ ' ' A' ' 56' ' ' PHE . 83.6 m-20 -89.54 -25.58 21.3 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.927 -1.108 . . . . 0.0 110.632 -179.642 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . 0.542 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 17.3 m-30 -93.55 2.22 56.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.064 -1.023 . . . . 0.0 110.268 179.968 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.736 HG21 HD12 ' A' ' 54' ' ' ILE . 34.1 m -137.2 143.38 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.215 -0.928 . . . . 0.0 110.12 179.763 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' ALA . . . . . 0.468 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . . . . . . 0 N--CA 1.492 1.658 0 O-C-N 121.215 -0.928 . . . . 0.0 110.411 -179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.252 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -98.1 134.34 22.2 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.246 -1.15 . . . . 0.0 110.16 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -56.94 -19.72 33.36 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.008 1.531 . . . . 0.0 110.352 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.742 HD13 ' N ' ' A' ' 5' ' ' GLN . 3.0 tm? -95.09 129.06 42.33 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.274 -0.892 . . . . 0.0 110.228 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.742 ' N ' HD13 ' A' ' 4' ' ' LEU . 63.5 tt0 -107.02 119.18 38.68 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.25 -0.906 . . . . 0.0 110.216 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 48.0 p30 -100.54 13.55 34.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.251 -0.906 . . . . 0.0 110.227 179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.453 ' O ' HG13 ' A' ' 33' ' ' ILE . 19.4 m120 -84.19 9.58 12.46 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.265 -0.897 . . . . 0.0 110.252 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.738 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.8 mp -92.33 150.07 21.06 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.194 -0.941 . . . . 0.0 110.198 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.684 HG11 HD11 ' A' ' 33' ' ' ILE . 18.2 m -147.67 168.9 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.2 -0.938 . . . . 0.0 110.309 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 81.8 mt -112.24 145.3 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.388 -0.82 . . . . 0.0 109.671 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.472 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . -77.56 114.94 16.91 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.077 -1.014 . . . . 0.0 110.367 -179.755 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.483 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 37.6 tp -71.4 -26.9 62.97 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.104 -0.997 . . . . 0.0 109.386 179.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.483 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 25.8 m80 -158.22 149.41 20.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.469 -0.769 . . . . 0.0 109.7 179.827 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 44.2 p -61.97 141.44 58.03 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.026 -1.046 . . . . 0.0 110.092 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.606 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 77.1 t80 -102.76 165.05 11.28 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.079 -1.013 . . . . 0.0 110.408 179.979 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.579 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 35.8 mt-10 -113.52 129.64 24.46 Favored Pre-proline 0 N--CA 1.493 1.677 0 O-C-N 121.282 -0.886 . . . . 0.0 110.228 -179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.485 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 49.9 Cg_endo -85.21 88.67 0.88 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 123.983 1.518 . . . . 0.0 110.509 -179.763 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 51.0 m -79.59 -6.99 58.21 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.221 -0.925 . . . . 0.0 110.084 179.88 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 37.5 m-70 -128.23 -155.35 0.69 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.293 -0.879 . . . . 0.0 110.007 179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 66.2 m-20 -112.36 -4.63 14.24 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.251 -0.906 . . . . 0.0 110.27 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -117.68 5.53 16.59 Favored Glycine 0 N--CA 1.49 2.259 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 92.7 m-20 -92.21 159.32 15.69 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.183 -1.187 . . . . 0.0 110.232 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.492 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 35.5 tp -116.78 122.28 43.99 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.248 -0.908 . . . . 0.0 110.119 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.485 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -99.33 47.83 1.32 Allowed Glycine 0 N--CA 1.492 2.383 0 N-CA-C 109.722 -1.351 . . . . 0.0 109.722 -179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.658 ' CD1' HD21 ' A' ' 31' ' ' LEU . 35.9 p90 -45.57 171.11 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.179 -1.189 . . . . 0.0 110.834 -179.694 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -98.71 176.85 5.49 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.415 -0.803 . . . . 0.0 110.446 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.9 ttpm? -71.8 122.95 21.59 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.262 -0.899 . . . . 0.0 110.239 179.771 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.472 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 92.96 -8.85 76.05 Favored Glycine 0 N--CA 1.489 2.199 0 N-CA-C 109.403 -1.479 . . . . 0.0 109.403 179.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.453 ' N ' ' HB3' ' A' ' 11' ' ' ALA . 27.3 tt0 -61.3 137.27 58.24 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.137 -1.214 . . . . 0.0 110.112 -179.825 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.798 ' C ' HD12 ' A' ' 31' ' ' LEU . 87.8 mt-30 -79.63 126.85 31.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.231 -0.918 . . . . 0.0 109.965 -179.982 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.798 HD12 ' C ' ' A' ' 30' ' ' GLN . 10.3 mp -126.36 145.45 50.44 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.23 -0.919 . . . . 0.0 110.468 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.557 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 25.3 ttt180 -103.23 139.71 38.34 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.29 -0.881 . . . . 0.0 109.828 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.684 HD11 HG11 ' A' ' 9' ' ' VAL . 11.8 mt -87.45 130.14 37.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.14 -0.975 . . . . 0.0 110.263 -179.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.58 HD11 ' HB2' ' A' ' 44' ' ' GLN . 60.6 mt -117.43 -30.44 5.55 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.285 -0.884 . . . . 0.0 110.193 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.493 ' HB3' ' HB3' ' A' ' 42' ' ' LYS . 83.0 tt0 -139.15 149.65 44.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.249 -0.907 . . . . 0.0 110.232 179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.588 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 96.9 mt-30 -139.54 58.79 1.61 Allowed 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.257 -0.902 . . . . 0.0 110.212 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.5 t -123.93 130.31 52.38 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.254 -0.904 . . . . 0.0 110.246 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.86 -162.8 33.0 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 63.2 mt-10 -82.79 -32.33 27.76 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.268 -1.136 . . . . 0.0 110.075 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.549 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 92.1 m95 -98.03 146.08 25.88 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.224 -0.922 . . . . 0.0 110.134 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.588 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 49.3 m0 -120.9 154.95 35.19 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.297 -0.877 . . . . 0.0 110.302 -179.992 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.493 ' HB3' ' HB3' ' A' ' 35' ' ' GLU . 79.1 tttt -93.48 143.56 26.18 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.229 -0.919 . . . . 0.0 109.798 179.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.557 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -152.14 175.17 12.85 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.135 -0.978 . . . . 0.0 110.632 -179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.58 ' HB2' HD11 ' A' ' 34' ' ' LEU . 39.4 tt0 -139.22 147.49 41.84 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.43 -0.794 . . . . 0.0 109.884 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.481 ' HB2' ' OG1' ' A' ' 48' ' ' THR . 21.6 m -79.79 145.79 32.65 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.088 -1.007 . . . . 0.0 110.222 -179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.635 ' N ' HD12 ' A' ' 46' ' ' LEU . 5.9 mp -94.73 -11.89 28.23 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.311 -0.868 . . . . 0.0 109.855 179.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.2 p -105.43 -30.09 9.8 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.405 -0.809 . . . . 0.0 110.435 -179.815 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.481 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 17.6 p -99.84 -17.82 17.46 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.1 -1.0 . . . . 0.0 110.451 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 65.88 48.79 63.26 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.11 -1.596 . . . . 0.0 109.11 -179.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.487 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 38.3 mt-30 -132.76 157.34 45.19 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.358 -1.084 . . . . 0.0 110.115 -179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.457 ' HG2' ' HG3' ' A' ' 44' ' ' GLN . 94.3 mt-10 -119.6 141.69 49.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.221 -0.925 . . . . 0.0 110.097 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.492 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -166.29 159.16 32.38 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 74.3 m-85 -70.24 142.73 52.32 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.243 -1.151 . . . . 0.0 110.045 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.872 ' CD1' HG21 ' A' ' 59' ' ' VAL . 1.8 pp -137.65 131.1 17.03 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.216 -0.928 . . . . 0.0 110.158 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.586 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 46.0 Cg_endo -55.94 160.9 9.26 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.03 1.542 . . . . 0.0 110.07 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 25.8 p90 -88.45 -2.36 58.55 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.297 -0.877 . . . . 0.0 110.911 -179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 23.5 m-20 -100.09 -25.83 14.16 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.987 -1.071 . . . . 0.0 111.054 -179.452 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.569 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 26.5 m-85 -80.24 -11.93 59.68 Favored 'General case' 0 N--CA 1.494 1.725 0 O-C-N 121.017 -1.052 . . . . 0.0 110.446 -179.655 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.872 HG21 ' CD1' ' A' ' 54' ' ' ILE . 26.9 m -132.22 145.55 34.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.179 -0.95 . . . . 0.0 110.24 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.38 161.07 33.25 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.234 -0.916 . . . . 0.0 110.286 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.533 ' HA ' HG12 ' A' ' 9' ' ' VAL . 86.6 tttt -69.26 132.0 45.77 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.252 -0.905 . . . . 0.0 110.214 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.79 150.61 32.06 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.248 -0.908 . . . . 0.0 110.235 179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 42.9 t-20 . . . . . 0 N--CA 1.491 1.594 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.191 -179.979 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.6 t -124.84 69.82 57.55 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.227 -1.161 . . . . 0.0 110.146 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -58.77 138.14 84.01 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.011 1.532 . . . . 0.0 110.33 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.405 ' HA ' HD12 ' A' ' 4' ' ' LEU . 45.0 tp -56.85 -32.04 65.39 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.266 -0.896 . . . . 0.0 110.084 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 62.1 tt0 -102.23 105.3 15.94 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.299 -0.876 . . . . 0.0 110.19 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.8 t70 -146.73 84.29 1.61 Allowed 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.279 -0.888 . . . . 0.0 110.151 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.59 ' HB3' HD12 ' A' ' 33' ' ' ILE . 85.3 m-20 -100.0 105.0 16.63 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.308 -0.87 . . . . 0.0 110.377 -179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.685 ' CD1' HD11 ' A' ' 46' ' ' LEU . 21.1 tp -113.98 143.58 44.5 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.283 -0.886 . . . . 0.0 109.957 179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.839 HG11 HD11 ' A' ' 33' ' ' ILE . 31.2 m -145.63 167.84 8.52 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.202 -0.936 . . . . 0.0 110.378 -179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 86.1 mt -112.6 148.99 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.395 -0.816 . . . . 0.0 109.702 179.582 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.45 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . -80.17 113.39 18.31 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.128 -0.983 . . . . 0.0 110.443 -179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.642 HD13 ' O ' ' A' ' 12' ' ' LEU . 0.2 OUTLIER -70.74 -25.31 62.87 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.115 -0.991 . . . . 0.0 109.091 179.202 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.545 ' CD2' HD12 ' A' ' 12' ' ' LEU . 23.9 m-70 -159.13 151.05 20.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.703 -0.623 . . . . 0.0 109.481 179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.466 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 41.6 p -63.38 140.83 58.91 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.907 -1.121 . . . . 0.0 109.883 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 65.5 t80 -100.89 162.81 12.64 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.063 -1.023 . . . . 0.0 110.255 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.571 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 29.8 tt0 -118.12 128.31 26.06 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.277 -0.889 . . . . 0.0 110.24 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.477 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 46.9 Cg_endo -82.17 84.6 1.82 Allowed 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.111 1.585 . . . . 0.0 110.55 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.46 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 86.1 p -79.78 -3.94 49.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.932 . . . . 0.0 109.974 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.46 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 90.3 m-70 -139.85 151.21 45.49 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 0.0 110.136 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -65.35 125.47 25.2 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.18 -0.95 . . . . 0.0 110.117 179.749 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.59 11.43 28.88 Favored Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.451 ' OD2' ' HB2' ' A' ' 19' ' ' HIS . 11.4 m-20 -105.94 160.08 15.55 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.151 -1.205 . . . . 0.0 110.308 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.507 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 20.5 tp -116.4 122.99 46.43 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.338 -0.851 . . . . 0.0 110.18 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.477 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -104.39 51.28 0.81 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.604 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 33.0 p90 -45.32 172.19 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.197 -1.178 . . . . 0.0 110.9 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 74.9 mm-40 -99.26 176.0 5.69 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.405 -0.809 . . . . 0.0 110.554 -179.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.9 tttm -71.18 124.88 25.49 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.364 -0.835 . . . . 0.0 110.28 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.45 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 90.39 -8.62 79.5 Favored Glycine 0 N--CA 1.489 2.197 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.491 ' OE2' HD21 ' A' ' 31' ' ' LEU . 27.0 tt0 -62.39 132.45 52.6 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.103 -1.234 . . . . 0.0 110.365 -179.711 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.524 ' O ' HD23 ' A' ' 31' ' ' LEU . 90.6 mt-30 -79.87 130.59 35.43 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.24 -0.912 . . . . 0.0 109.842 179.688 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.524 HD23 ' O ' ' A' ' 30' ' ' GLN . 17.6 mt -130.67 150.43 51.86 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.934 . . . . 0.0 110.501 -179.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.865 ' HB2' HD21 ' A' ' 46' ' ' LEU . 40.3 ttt180 -100.82 135.77 41.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.434 -0.791 . . . . 0.0 109.75 179.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.839 HD11 HG11 ' A' ' 9' ' ' VAL . 11.2 mt -83.37 127.87 39.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.175 -0.953 . . . . 0.0 110.317 -179.752 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.035 HD11 ' HB2' ' A' ' 44' ' ' GLN . 75.1 mt -107.13 -30.98 8.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.284 -0.885 . . . . 0.0 110.215 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 92.4 mt-10 -143.39 153.42 42.67 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.247 -0.908 . . . . 0.0 110.197 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.63 HE21 HG21 ' A' ' 33' ' ' ILE . 93.0 mt-30 -138.58 54.21 1.77 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.198 -0.939 . . . . 0.0 110.242 179.979 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 75.3 m -121.81 134.48 54.9 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.248 -0.908 . . . . 0.0 110.101 179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.68 -172.11 47.98 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -74.45 -34.26 63.14 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.255 -1.144 . . . . 0.0 110.178 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.402 ' HZ3' ' CE1' ' A' ' 15' ' ' TYR . 72.6 m95 -97.17 145.78 25.7 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.227 -0.921 . . . . 0.0 110.08 179.872 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.493 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 52.1 m0 -120.69 153.81 36.41 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.256 -0.903 . . . . 0.0 110.056 179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -90.07 144.5 25.84 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.175 -0.953 . . . . 0.0 109.749 179.532 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 32' ' ' ARG . . . -148.54 170.41 18.13 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.086 -1.009 . . . . 0.0 110.611 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 1.035 ' HB2' HD11 ' A' ' 34' ' ' LEU . 51.9 tt0 -137.89 146.11 42.95 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.371 -0.831 . . . . 0.0 109.827 179.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 50.7 m -76.77 142.08 40.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.097 -1.002 . . . . 0.0 110.376 -179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.865 HD21 ' HB2' ' A' ' 32' ' ' ARG . 36.3 mt -88.66 -18.48 27.86 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.35 -0.844 . . . . 0.0 109.848 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 41.5 p -106.41 -30.06 9.35 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.321 -0.862 . . . . 0.0 110.37 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 2.0 m -92.07 -24.31 19.2 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.064 -1.022 . . . . 0.0 110.421 -179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.78 46.29 54.17 Favored Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.414 -1.474 . . . . 0.0 109.414 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.498 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 59.1 mt-30 -134.28 158.75 42.96 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.294 -1.121 . . . . 0.0 110.204 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.431 ' HG2' ' HB2' ' A' ' 44' ' ' GLN . 92.4 mt-10 -121.02 143.71 48.91 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.35 -0.844 . . . . 0.0 110.148 179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -163.65 157.27 29.43 Favored Glycine 0 N--CA 1.489 2.193 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -69.4 141.92 54.01 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.234 -1.156 . . . . 0.0 109.926 179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.577 HD12 HG21 ' A' ' 59' ' ' VAL . 1.3 pt -135.84 145.71 53.98 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.271 -0.893 . . . . 0.0 110.066 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.602 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 45.5 Cg_endo -72.45 162.62 40.94 Favored 'Trans proline' 0 C--N 1.304 -1.798 0 O-C-N 123.987 1.519 . . . . 0.0 110.065 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.445 ' CE2' ' OD1' ' A' ' 57' ' ' ASN . 31.7 p90 -88.07 -3.98 58.83 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.28 -0.887 . . . . 0.0 110.959 -179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.445 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 60.3 m-20 -98.5 -26.57 14.39 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.899 -1.126 . . . . 0.0 111.062 -179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.602 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 34.2 m-85 -81.52 -10.85 59.38 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.939 -1.1 . . . . 0.0 110.326 -179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.577 HG21 HD12 ' A' ' 54' ' ' ILE . 25.3 m -131.05 142.66 43.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.191 -0.943 . . . . 0.0 110.273 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -131.51 161.59 32.21 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.193 -0.942 . . . . 0.0 110.122 179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.463 ' HA ' HG12 ' A' ' 9' ' ' VAL . 42.2 mttp -76.95 127.44 32.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.258 -0.901 . . . . 0.0 110.249 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.85 -36.42 84.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.303 -0.873 . . . . 0.0 110.146 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.407 ' OD1' ' C ' ' A' ' 63' ' ' ASN . 41.8 p-10 . . . . . 0 N--CA 1.491 1.584 0 CA-C-O 117.994 -1.003 . . . . 0.0 110.17 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 109.389 -1.485 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 51.2 m -65.06 145.31 99.12 Favored Pre-proline 0 N--CA 1.492 1.631 0 O-C-N 121.197 -1.178 . . . . 0.0 110.236 179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -58.41 -16.78 30.59 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 123.981 1.516 . . . . 0.0 110.387 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.452 ' O ' ' OD1' ' A' ' 7' ' ' ASN . 2.6 mp -70.05 -34.59 73.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.238 -0.914 . . . . 0.0 110.255 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.5 ' HA ' ' CD1' ' A' ' 8' ' ' LEU . 97.1 mt-30 -65.24 -11.29 39.57 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.239 -0.913 . . . . 0.0 110.374 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 98.2 m-20 -71.92 -30.14 65.03 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.251 -0.906 . . . . 0.0 110.21 -179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.517 ' O ' ' CG1' ' A' ' 33' ' ' ILE . 19.3 p-10 -79.81 7.11 9.31 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.248 -0.907 . . . . 0.0 110.35 -179.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.5 ' CD1' ' HA ' ' A' ' 5' ' ' GLN . 91.7 mt -81.84 142.66 32.34 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.212 -0.93 . . . . 0.0 109.98 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.47 HG12 ' HA ' ' A' ' 61' ' ' LYS . 22.9 m -145.82 167.6 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.127 -0.983 . . . . 0.0 110.539 -179.899 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.422 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 64.5 mt -111.05 149.45 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.377 -0.827 . . . . 0.0 109.621 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.542 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . -80.14 112.83 17.83 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.031 -1.043 . . . . 0.0 110.339 -179.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.455 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 82.9 mt -69.58 -25.96 64.24 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.102 -0.999 . . . . 0.0 109.191 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.455 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 72.2 m80 -155.37 152.39 29.05 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.576 -0.702 . . . . 0.0 109.501 179.783 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.444 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 26.9 p -64.28 142.15 58.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.898 -1.126 . . . . 0.0 109.92 179.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.586 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 73.9 t80 -102.67 165.05 11.29 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.012 -1.055 . . . . 0.0 110.167 179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.57 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 1.9 tp10 -119.5 132.84 23.86 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.223 -0.923 . . . . 0.0 110.285 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.484 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 49.2 Cg_endo -84.48 84.0 1.56 Allowed 'Trans proline' 0 C--N 1.305 -1.751 0 O-C-N 123.961 1.506 . . . . 0.0 110.299 -179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 83.3 p -79.59 -3.18 45.86 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.198 -0.939 . . . . 0.0 110.051 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.457 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 51.5 m80 -144.86 165.95 26.66 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.25 -0.906 . . . . 0.0 110.039 179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -76.87 126.21 30.59 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.243 -0.911 . . . . 0.0 110.156 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 107.17 -1.9 35.19 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.559 -1.416 . . . . 0.0 109.559 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.457 ' OD2' ' HB2' ' A' ' 19' ' ' HIS . 17.2 m-20 -93.96 157.64 16.01 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.27 -1.135 . . . . 0.0 110.259 -179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.502 HD13 ' HG2' ' A' ' 50' ' ' GLN . 25.5 tp -115.6 120.91 40.99 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.296 -0.877 . . . . 0.0 109.988 179.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.484 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -100.62 51.47 0.99 Allowed Glycine 0 N--CA 1.491 2.358 0 N-CA-C 109.613 -1.395 . . . . 0.0 109.613 -179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.586 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 40.7 p90 -48.46 172.5 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.192 -1.181 . . . . 0.0 110.995 -179.658 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.4 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 68.8 mm-40 -100.82 174.99 5.78 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.507 -0.745 . . . . 0.0 110.189 179.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.4 pttm -71.39 131.62 43.64 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.137 -0.977 . . . . 0.0 110.102 179.765 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.48 -10.16 72.78 Favored Glycine 0 N--CA 1.487 2.067 0 N-CA-C 109.329 -1.509 . . . . 0.0 109.329 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.442 ' CD ' ' HB2' ' A' ' 25' ' ' PHE . 33.0 tt0 -64.5 132.88 51.19 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.214 -1.168 . . . . 0.0 110.245 -179.726 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.875 ' C ' HD12 ' A' ' 31' ' ' LEU . 95.1 mt-30 -79.68 131.47 35.97 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.279 -0.888 . . . . 0.0 109.784 179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.875 HD12 ' C ' ' A' ' 30' ' ' GLN . 9.4 mp -129.84 148.58 51.72 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.227 -0.92 . . . . 0.0 110.562 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.617 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 24.7 ttt180 -103.13 134.72 46.09 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.448 -0.782 . . . . 0.0 109.534 179.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.517 ' CG1' ' O ' ' A' ' 7' ' ' ASN . 21.9 mm -83.82 131.53 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.143 -0.973 . . . . 0.0 110.194 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 39.1 mt -115.57 -32.9 5.4 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.331 -0.855 . . . . 0.0 110.178 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.465 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 87.1 mt-10 -132.06 153.95 49.91 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.265 -0.897 . . . . 0.0 110.21 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.627 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 97.9 mt-30 -139.97 55.61 1.64 Allowed 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.323 -0.86 . . . . 0.0 110.204 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 99.1 p -125.24 126.8 45.74 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.287 -0.883 . . . . 0.0 110.287 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.61 174.8 49.43 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 94.5 mt-10 -63.34 -28.91 70.33 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.166 -1.197 . . . . 0.0 110.208 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.555 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 97.3 m95 -97.54 145.26 26.41 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.177 -0.952 . . . . 0.0 110.226 179.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.627 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 35.9 m0 -124.7 157.0 36.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.289 -0.882 . . . . 0.0 110.1 179.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.465 ' HB3' ' HB2' ' A' ' 35' ' ' GLU . 34.0 tttt -96.26 145.33 25.66 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.282 -0.886 . . . . 0.0 109.689 179.632 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.617 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -158.24 -177.71 6.75 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.169 -0.957 . . . . 0.0 110.56 -179.799 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 54.8 tt0 -145.52 153.85 41.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.424 -0.798 . . . . 0.0 109.982 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.8 t -98.89 126.02 44.45 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.115 -0.991 . . . . 0.0 110.17 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 89.1 mt -80.7 9.27 6.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.253 -0.904 . . . . 0.0 110.312 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.504 HG22 HG23 ' A' ' 48' ' ' THR . 31.8 m -92.79 -35.59 13.33 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.175 -0.953 . . . . 0.0 110.194 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.504 HG23 HG22 ' A' ' 47' ' ' THR . 49.2 p -132.69 -0.98 3.46 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.209 -0.932 . . . . 0.0 110.389 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 76.32 30.85 56.26 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.314 -1.514 . . . . 0.0 109.314 -179.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.502 ' HG2' HD13 ' A' ' 23' ' ' LEU . 54.7 tt0 -91.27 131.79 36.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.304 -1.116 . . . . 0.0 110.135 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.6 tt0 -117.22 136.24 53.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.279 -0.888 . . . . 0.0 110.082 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.434 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -171.88 166.18 39.06 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.529 -1.429 . . . . 0.0 109.529 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 91.5 m-85 -70.44 146.41 50.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.278 -1.131 . . . . 0.0 110.113 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.682 HD13 HG11 ' A' ' 59' ' ' VAL . 2.2 pp -139.23 131.59 15.37 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.235 -0.916 . . . . 0.0 110.147 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.653 ' O ' HD12 ' A' ' 54' ' ' ILE . 47.3 Cg_endo -55.68 158.49 13.3 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.972 1.511 . . . . 0.0 110.102 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.572 ' CE2' ' OD1' ' A' ' 57' ' ' ASN . 18.8 p90 -87.41 -0.42 56.76 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.177 -0.952 . . . . 0.0 110.771 -179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.572 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 89.9 m-20 -99.65 -26.42 14.08 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.958 -1.089 . . . . 0.0 110.855 -179.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.479 ' HB2' ' HG2' ' A' ' 55' ' ' PRO . 10.8 m-85 -83.47 -3.0 57.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.004 -1.06 . . . . 0.0 110.391 -179.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.682 HG11 HD13 ' A' ' 54' ' ' ILE . 26.9 m -130.6 143.52 40.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.151 -0.968 . . . . 0.0 110.328 -179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.457 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . -127.8 156.41 42.53 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.307 -0.871 . . . . 0.0 110.149 -179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.47 ' HA ' HG12 ' A' ' 9' ' ' VAL . 17.6 mttp -76.24 132.89 40.16 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.227 -0.921 . . . . 0.0 110.23 179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.437 ' O ' ' OD1' ' A' ' 63' ' ' ASN . . . -58.98 154.09 16.17 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.23 -0.919 . . . . 0.0 110.183 -179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.437 ' OD1' ' O ' ' A' ' 62' ' ' ALA . 78.3 m-20 . . . . . 0 N--CA 1.491 1.598 0 CA-C-O 118.031 -0.985 . . . . 0.0 110.262 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.463 -1.455 . . . . 0.0 109.463 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -124.39 154.61 69.24 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.218 -1.166 . . . . 0.0 110.216 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -46.06 144.79 5.86 Favored 'Trans proline' 0 C--N 1.305 -1.725 0 O-C-N 123.996 1.524 . . . . 0.0 110.33 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 46.9 tp -104.87 125.45 50.91 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.235 -0.915 . . . . 0.0 110.303 -179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.454 ' O ' ' NE ' ' A' ' 32' ' ' ARG . 94.7 mm-40 -111.54 155.86 22.63 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.18 -0.95 . . . . 0.0 110.115 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 53.6 p-10 -112.42 23.37 13.67 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.196 -0.94 . . . . 0.0 110.273 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.473 ' HB2' ' HB ' ' A' ' 33' ' ' ILE . 73.0 m-20 -86.06 112.62 21.43 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.917 . . . . 0.0 110.367 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.617 ' CD1' HD11 ' A' ' 46' ' ' LEU . 19.7 tp -110.67 148.9 31.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.252 -0.905 . . . . 0.0 110.041 179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.836 HG21 HD11 ' A' ' 33' ' ' ILE . 33.0 m -145.84 167.98 7.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.601 0 O-C-N 121.129 -0.982 . . . . 0.0 110.415 -179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 64.3 mt -113.44 149.9 15.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.366 -0.834 . . . . 0.0 109.596 179.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.487 ' HB3' ' N ' ' A' ' 29' ' ' GLU . . . -80.38 114.52 19.34 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.169 -0.957 . . . . 0.0 110.679 -179.66 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.458 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 16.8 tp -78.95 -19.74 50.99 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 109.256 179.285 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.458 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 39.8 m-70 -159.98 142.05 13.1 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.566 -0.709 . . . . 0.0 109.511 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 14.0 p -60.56 139.73 57.66 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.818 -1.176 . . . . 0.0 110.101 179.845 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.612 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 81.6 t80 -99.93 161.97 13.28 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.124 -0.985 . . . . 0.0 110.296 179.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.46 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 2.1 mp0 -117.46 129.03 25.62 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.322 -0.861 . . . . 0.0 110.12 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.468 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.2 Cg_endo -83.06 83.77 1.87 Allowed 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 124.081 1.569 . . . . 0.0 110.381 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.563 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 56.8 p -79.8 -3.88 49.62 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.215 -0.928 . . . . 0.0 110.121 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.563 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 89.4 m-70 -141.61 168.49 19.63 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.258 -0.901 . . . . 0.0 110.264 -179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 56.8 t0 -82.01 125.12 30.42 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.255 -0.903 . . . . 0.0 110.27 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.15 18.36 11.4 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.493 -1.443 . . . . 0.0 109.493 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -114.97 161.03 18.86 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.259 -1.142 . . . . 0.0 110.127 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.498 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 17.6 tp -115.76 120.77 40.39 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.336 -0.853 . . . . 0.0 110.28 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.468 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -101.72 54.63 0.77 Allowed Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.629 ' CG ' HD11 ' A' ' 31' ' ' LEU . 44.0 p90 -50.26 171.74 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.31 -1.112 . . . . 0.0 110.908 -179.585 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 91.5 mt-10 -100.39 178.33 4.78 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.375 -0.828 . . . . 0.0 110.488 -179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.1 tttm -71.86 123.07 21.89 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.292 -0.88 . . . . 0.0 110.246 179.865 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.478 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 91.76 -10.09 75.38 Favored Glycine 0 N--CA 1.488 2.139 0 N-CA-C 109.501 -1.439 . . . . 0.0 109.501 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.488 ' OE1' ' HA ' ' A' ' 25' ' ' PHE . 16.6 tt0 -61.65 131.93 51.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.21 -1.17 . . . . 0.0 110.135 -179.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.557 ' O ' HD23 ' A' ' 31' ' ' LEU . 96.3 mt-30 -79.98 130.81 35.57 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.305 -0.872 . . . . 0.0 110.192 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.629 HD11 ' CG ' ' A' ' 25' ' ' PHE . 32.3 mt -126.76 145.65 50.53 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.174 -0.954 . . . . 0.0 110.459 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.928 ' HB2' HD21 ' A' ' 46' ' ' LEU . 5.4 tpt180 -93.72 137.74 32.66 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.366 -0.834 . . . . 0.0 109.531 179.38 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.836 HD11 HG21 ' A' ' 9' ' ' VAL . 18.7 mm -90.99 129.13 42.25 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.131 -0.981 . . . . 0.0 110.287 -179.794 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.992 HD11 ' HB2' ' A' ' 44' ' ' GLN . 49.9 mt -112.94 -26.4 8.53 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.256 -0.902 . . . . 0.0 110.068 179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.466 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 75.3 mt-10 -150.45 156.33 41.24 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.227 -0.921 . . . . 0.0 110.147 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.612 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 97.6 mt-30 -142.09 58.6 1.47 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.223 -0.923 . . . . 0.0 110.238 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -119.0 140.36 50.13 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.254 -0.904 . . . . 0.0 110.156 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.8 -168.3 53.47 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.416 -1.474 . . . . 0.0 109.416 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 64.1 mm-40 -76.37 -34.43 58.9 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.225 -1.162 . . . . 0.0 110.128 179.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.554 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 96.8 m95 -96.25 143.75 27.06 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.265 -0.897 . . . . 0.0 110.251 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.612 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.9 m0 -116.53 152.29 34.39 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.265 -0.897 . . . . 0.0 110.261 179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.466 ' HB3' ' HB2' ' A' ' 35' ' ' GLU . 18.1 tttt -89.95 141.43 28.66 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.254 -0.904 . . . . 0.0 109.987 179.804 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.531 ' CB ' HG12 ' A' ' 54' ' ' ILE . . . -147.87 170.22 18.13 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.16 -0.963 . . . . 0.0 110.428 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.992 ' HB2' HD11 ' A' ' 34' ' ' LEU . 59.2 tt0 -130.48 136.31 48.85 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.345 -0.847 . . . . 0.0 110.037 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.447 ' OG ' HD21 ' A' ' 23' ' ' LEU . 66.1 m -68.45 138.02 54.93 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.127 -0.983 . . . . 0.0 110.242 -179.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.928 HD21 ' HB2' ' A' ' 32' ' ' ARG . 54.2 mt -87.65 -12.52 45.27 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.232 -0.918 . . . . 0.0 110.094 179.8 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 67.9 p -101.34 -28.42 12.62 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.863 . . . . 0.0 110.285 -179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.416 ' OG1' ' HB2' ' A' ' 45' ' ' SER . 46.2 p -113.37 -3.6 13.75 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.169 -0.957 . . . . 0.0 110.366 -179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 58.67 14.15 20.75 Favored Glycine 0 N--CA 1.491 2.353 0 N-CA-C 109.832 -1.307 . . . . 0.0 109.832 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 41.3 mt-30 -86.93 157.19 19.55 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.122 -1.222 . . . . 0.0 110.39 -179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 94.9 mt-10 -117.4 138.68 51.66 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.355 -0.84 . . . . 0.0 109.972 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.498 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -161.07 156.7 28.14 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -68.68 144.5 54.41 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.247 -1.149 . . . . 0.0 109.899 179.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.73 HD12 HG21 ' A' ' 59' ' ' VAL . 1.1 pt -137.37 123.43 13.18 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.142 -0.974 . . . . 0.0 110.38 -179.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.608 ' HG3' ' CD2' ' A' ' 58' ' ' PHE . 43.5 Cg_endo -47.16 159.35 0.39 Allowed 'Trans proline' 0 C--N 1.303 -1.84 0 O-C-N 123.963 1.507 . . . . 0.0 110.068 179.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 16.8 p90 -96.48 0.78 50.8 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.209 -0.932 . . . . 0.0 110.736 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 72.7 m-20 -100.18 -26.73 13.84 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.027 -1.046 . . . . 0.0 110.694 -179.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.608 ' CD2' ' HG3' ' A' ' 55' ' ' PRO . 7.9 m-30 -89.19 -8.18 54.12 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.143 -0.973 . . . . 0.0 110.494 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.73 HG21 HD12 ' A' ' 54' ' ' ILE . 26.9 m -125.02 143.42 38.65 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.087 -1.008 . . . . 0.0 110.187 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.458 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . -134.48 164.74 26.77 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.224 -0.922 . . . . 0.0 110.211 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.493 ' HA ' HG12 ' A' ' 9' ' ' VAL . 17.2 tptm -76.38 136.39 39.5 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.273 -0.892 . . . . 0.0 110.188 -179.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.46 147.58 47.7 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.328 -0.857 . . . . 0.0 110.155 -179.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 40.5 p-10 . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 117.977 -1.011 . . . . 0.0 110.176 -179.98 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 109.507 -1.437 . . . . 0.0 109.507 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.7 m -124.67 75.89 64.24 Favored Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.25 -1.147 . . . . 0.0 110.168 179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -57.65 -28.87 83.33 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 123.977 1.514 . . . . 0.0 110.321 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 39.9 mt -97.97 140.33 32.48 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.277 -0.89 . . . . 0.0 110.251 179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.501 ' O ' HD13 ' A' ' 8' ' ' LEU . 90.0 mt-30 -117.78 156.32 28.53 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.349 -0.844 . . . . 0.0 110.191 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 91.4 m-20 -100.68 14.35 31.82 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.206 -0.934 . . . . 0.0 110.197 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.453 ' O ' HG13 ' A' ' 33' ' ' ILE . 22.5 m120 -88.03 7.33 31.8 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.242 -0.911 . . . . 0.0 110.28 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.77 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.2 mp -94.1 150.63 20.15 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.264 -0.897 . . . . 0.0 110.147 179.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.634 HG12 ' HA ' ' A' ' 61' ' ' LYS . 9.4 m -157.62 174.99 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.286 -0.884 . . . . 0.0 110.328 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 80.0 mt -115.75 141.88 31.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.392 -0.818 . . . . 0.0 109.721 179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.713 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -80.17 116.69 20.41 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.16 -0.963 . . . . 0.0 110.427 -179.827 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.47 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 10.1 tp -70.06 -23.13 63.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.113 -0.992 . . . . 0.0 109.284 179.336 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.47 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 30.0 m80 -158.28 147.73 19.51 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.537 -0.727 . . . . 0.0 109.568 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 55.9 p -60.87 144.34 53.05 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.943 -1.098 . . . . 0.0 109.919 179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.598 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 89.4 t80 -101.45 163.39 12.29 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.001 -1.062 . . . . 0.0 110.579 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.411 ' N ' ' CG ' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -110.62 113.58 55.57 Favored Pre-proline 0 N--CA 1.491 1.595 0 O-C-N 121.317 -0.864 . . . . 0.0 109.891 179.678 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.492 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 51.0 Cg_endo -74.36 96.85 0.99 Allowed 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 124.066 1.561 . . . . 0.0 110.514 -179.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.3 p -79.65 -1.54 38.69 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.219 -0.926 . . . . 0.0 110.103 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 34.2 m80 -133.49 -178.91 5.21 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.227 -0.921 . . . . 0.0 110.118 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -93.23 -2.26 55.3 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.285 -0.884 . . . . 0.0 110.194 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.474 ' O ' ' CD2' ' A' ' 53' ' ' PHE . . . -115.11 5.98 21.78 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.719 -1.352 . . . . 0.0 109.719 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.48 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 4.1 m-20 -98.77 167.81 10.53 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.241 -1.152 . . . . 0.0 110.346 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.507 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 31.0 tp -123.44 127.45 48.43 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.281 -0.887 . . . . 0.0 110.15 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.492 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -104.22 54.87 0.63 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.549 -1.42 . . . . 0.0 109.549 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.713 ' CE2' ' HB1' ' A' ' 11' ' ' ALA . 40.3 p90 -44.78 169.59 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.29 -1.124 . . . . 0.0 110.922 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.451 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 95.6 mt-10 -98.6 176.92 5.48 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.448 -0.783 . . . . 0.0 110.225 -179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 17.0 tttt -70.84 127.09 31.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.167 -0.958 . . . . 0.0 110.225 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.98 -7.66 81.65 Favored Glycine 0 N--CA 1.488 2.105 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.559 ' OE2' HD11 ' A' ' 31' ' ' LEU . 19.0 tt0 -66.12 131.93 47.31 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.132 -1.216 . . . . 0.0 110.238 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.854 ' O ' HD12 ' A' ' 31' ' ' LEU . 98.1 mt-30 -79.54 133.42 36.47 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.259 -0.901 . . . . 0.0 109.903 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.854 HD12 ' O ' ' A' ' 30' ' ' GLN . 8.4 mp -132.19 152.17 51.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.254 -0.904 . . . . 0.0 110.483 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.655 HH22 HD11 ' A' ' 8' ' ' LEU . 26.1 ttm-85 -102.21 134.01 46.16 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.431 -0.793 . . . . 0.0 109.837 179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.497 HD11 HG11 ' A' ' 9' ' ' VAL . 12.3 mt -88.46 137.18 21.64 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.226 -0.921 . . . . 0.0 110.101 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.969 HD12 ' HA ' ' A' ' 43' ' ' ALA . 1.3 mt -122.6 -29.25 4.08 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.221 -0.924 . . . . 0.0 110.095 179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.47 ' HB2' ' HB3' ' A' ' 42' ' ' LYS . 73.9 mm-40 -135.3 147.67 49.26 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.237 -0.914 . . . . 0.0 110.182 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.615 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 95.3 mt-30 -137.95 56.63 1.74 Allowed 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.264 -0.898 . . . . 0.0 110.198 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 82.8 p -120.73 130.3 54.0 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.243 -0.911 . . . . 0.0 110.237 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.81 -164.8 41.39 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 94.2 mt-10 -81.16 -31.32 34.15 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.241 -1.152 . . . . 0.0 110.197 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.561 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 98.5 m95 -96.07 144.41 26.35 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.214 -0.929 . . . . 0.0 110.223 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.615 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 48.8 m0 -123.21 156.52 34.98 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.258 -0.901 . . . . 0.0 110.335 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.47 ' HB3' ' HB2' ' A' ' 35' ' ' GLU . 36.1 tttt -95.16 143.04 26.91 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.316 -0.865 . . . . 0.0 109.735 179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.969 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -157.61 -178.77 7.57 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.194 -0.942 . . . . 0.0 110.444 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.684 ' OE1' HD21 ' A' ' 34' ' ' LEU . 17.3 pt20 -151.46 159.68 44.08 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.399 -0.813 . . . . 0.0 110.104 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.1 t -97.37 115.61 28.03 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.206 -0.934 . . . . 0.0 110.14 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.6 mt -73.26 -1.2 16.88 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.271 -0.893 . . . . 0.0 110.356 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 7.5 m -92.81 -28.57 16.47 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.239 -0.913 . . . . 0.0 110.059 179.83 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 53.8 p -116.86 -10.3 11.04 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.264 -0.898 . . . . 0.0 110.088 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.02 41.86 53.45 Favored Glycine 0 N--CA 1.491 2.327 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.412 ' O ' ' HB2' ' A' ' 44' ' ' GLN . 37.8 mt-30 -124.07 151.83 43.38 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.216 -1.167 . . . . 0.0 110.231 -179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.428 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 43.7 mt-10 -122.92 147.09 46.99 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.329 -0.857 . . . . 0.0 110.067 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.507 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -162.39 -146.27 4.62 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.78 -1.328 . . . . 0.0 109.78 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.474 ' CD2' ' O ' ' A' ' 21' ' ' GLY . 81.0 m-85 -128.44 142.62 51.04 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.344 -1.092 . . . . 0.0 110.129 179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.771 ' CD1' HG21 ' A' ' 59' ' ' VAL . 2.0 pp -138.23 145.06 45.71 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.266 -0.897 . . . . 0.0 110.251 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.596 ' HD3' ' CD1' ' A' ' 15' ' ' TYR . 45.4 Cg_endo -70.37 156.35 61.93 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.953 1.502 . . . . 0.0 110.037 179.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.591 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 27.4 p90 -78.51 -3.21 42.4 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.271 -0.893 . . . . 0.0 111.01 -179.32 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -99.92 -25.74 14.23 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 120.985 -1.072 . . . . 0.0 111.197 -179.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.593 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 9.8 m-85 -82.17 -5.16 58.27 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.954 -1.091 . . . . 0.0 110.467 -179.624 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.771 HG21 ' CD1' ' A' ' 54' ' ' ILE . 27.6 m -134.47 145.54 32.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.123 -0.986 . . . . 0.0 110.187 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.406 ' O ' HG12 ' A' ' 9' ' ' VAL . . . -125.51 148.09 49.01 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.223 -0.923 . . . . 0.0 110.237 179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.634 ' HA ' HG12 ' A' ' 9' ' ' VAL . 66.8 mttm -67.18 121.57 15.92 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.287 -0.883 . . . . 0.0 110.223 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.38 138.34 13.27 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.871 . . . . 0.0 110.232 -179.994 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 18.8 t-20 . . . . . 0 N--CA 1.492 1.649 0 CA-C-O 118.042 -0.98 . . . . 0.0 110.213 179.934 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.441 -1.464 . . . . 0.0 109.441 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 m -124.74 81.68 60.88 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.274 -1.133 . . . . 0.0 110.214 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -56.77 144.62 86.56 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.0 1.526 . . . . 0.0 110.343 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 63.9 mt -101.4 142.25 33.07 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.296 -0.878 . . . . 0.0 110.22 179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.0 mt-30 -67.32 -16.53 64.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.208 -0.932 . . . . 0.0 110.226 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 68.5 m-20 47.41 44.92 16.9 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.24 -0.913 . . . . 0.0 110.165 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.4 m120 -81.19 0.66 35.53 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.289 -0.882 . . . . 0.0 110.151 -179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.735 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.7 mp -79.67 142.3 35.66 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.225 -0.922 . . . . 0.0 110.239 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.569 HG13 ' C ' ' A' ' 8' ' ' LEU . 34.4 m -155.03 172.55 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.319 -0.863 . . . . 0.0 110.157 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.452 HD13 ' O ' ' A' ' 9' ' ' VAL . 19.0 mm -114.36 154.66 15.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.237 -0.915 . . . . 0.0 109.778 179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.528 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -79.72 109.86 14.53 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.1 -1.0 . . . . 0.0 110.226 -179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.557 ' HG ' ' CE1' ' A' ' 13' ' ' HIS . 20.2 tp -70.61 -20.85 62.72 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.003 -1.061 . . . . 0.0 109.339 179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.557 ' CE1' ' HG ' ' A' ' 12' ' ' LEU . 71.3 m80 -150.88 -164.08 1.93 Allowed 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.525 -0.734 . . . . 0.0 109.863 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.412 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 20.7 t -111.6 138.94 47.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.155 -0.966 . . . . 0.0 110.077 179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.604 ' CD2' ' HD3' ' A' ' 55' ' ' PRO . 53.2 t80 -103.19 164.16 11.8 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.064 -1.022 . . . . 0.0 110.128 179.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.565 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 74.7 mm-40 -120.69 125.37 27.15 Favored Pre-proline 0 N--CA 1.492 1.662 0 O-C-N 121.226 -0.921 . . . . 0.0 110.209 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.483 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.9 Cg_endo -74.91 81.94 2.09 Favored 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.985 1.519 . . . . 0.0 110.33 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.554 ' OG ' ' CE1' ' A' ' 19' ' ' HIS . 83.4 p -79.62 -1.8 39.75 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.141 -0.975 . . . . 0.0 110.187 -179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.554 ' CE1' ' OG ' ' A' ' 18' ' ' SER . 36.5 m80 -147.62 143.97 28.09 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.308 -0.87 . . . . 0.0 110.167 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 49.9 t0 -54.83 128.49 33.3 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.176 -0.952 . . . . 0.0 110.335 -179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.401 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . 104.94 -13.28 49.55 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 179.931 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -82.95 158.21 22.68 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.264 -1.139 . . . . 0.0 110.328 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.543 ' O ' ' CD1' ' A' ' 15' ' ' TYR . 15.8 tp -119.82 125.99 49.89 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.353 -0.842 . . . . 0.0 110.073 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.483 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -105.21 55.89 0.55 Allowed Glycine 0 N--CA 1.491 2.348 0 N-CA-C 109.861 -1.296 . . . . 0.0 109.861 -179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.528 ' CD1' ' HB1' ' A' ' 11' ' ' ALA . 40.4 p90 -50.14 173.53 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.088 -1.242 . . . . 0.0 110.942 -179.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 85.5 mt-10 -111.78 -177.44 3.18 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.475 -0.765 . . . . 0.0 110.027 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.9 mttp -67.96 129.57 40.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.15 -0.969 . . . . 0.0 110.328 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.1 -17.93 57.24 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.498 -1.441 . . . . 0.0 109.498 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.457 ' HG2' HD21 ' A' ' 31' ' ' LEU . 8.6 tt0 -55.43 122.71 11.81 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.179 -1.189 . . . . 0.0 110.382 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.411 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 29.5 tt0 -79.97 131.42 35.81 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.293 -0.88 . . . . 0.0 109.901 179.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.519 HD11 ' CG ' ' A' ' 25' ' ' PHE . 38.7 mt -137.19 158.72 43.81 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.174 -0.953 . . . . 0.0 110.316 -179.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.696 ' HD3' HD21 ' A' ' 34' ' ' LEU . 17.8 ttt180 -108.14 135.75 48.96 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.26 -0.9 . . . . 0.0 109.867 179.732 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 45.4 mt -91.75 92.03 3.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.175 -0.953 . . . . 0.0 110.325 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.696 HD21 ' HD3' ' A' ' 32' ' ' ARG . 81.1 mt -78.91 -27.79 43.83 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.267 -0.896 . . . . 0.0 110.554 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.54 ' HB2' ' CB ' ' A' ' 42' ' ' LYS . 95.7 mt-10 -131.33 136.11 47.83 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.145 -0.972 . . . . 0.0 110.16 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.629 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 19.0 pt20 -133.79 55.41 1.9 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.246 -0.909 . . . . 0.0 110.185 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.0 t -117.13 142.78 46.58 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 0.0 110.181 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.09 -165.61 54.77 Favored Glycine 0 N--CA 1.491 2.318 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 60.7 mm-40 -79.61 -33.53 41.45 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.307 -1.113 . . . . 0.0 110.086 179.948 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 52.1 m95 -95.71 144.12 26.39 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.305 -0.872 . . . . 0.0 110.113 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.629 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 47.4 m0 -124.5 155.62 38.65 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.23 -0.919 . . . . 0.0 110.419 -179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.54 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 22.9 tttt -98.99 146.31 26.16 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.331 -0.856 . . . . 0.0 109.317 179.343 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.597 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -148.79 175.27 11.38 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.988 -1.07 . . . . 0.0 110.821 -179.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.453 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 46.9 tt0 -138.81 147.51 42.63 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.416 -0.802 . . . . 0.0 109.837 179.658 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.47 ' OG ' HD21 ' A' ' 23' ' ' LEU . 42.5 m -95.97 117.23 30.24 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.115 -0.991 . . . . 0.0 110.075 -179.96 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 76.6 mt -75.22 1.61 13.05 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.28 -0.887 . . . . 0.0 110.315 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 65.9 p -99.57 -33.2 10.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.221 -0.925 . . . . 0.0 109.977 179.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 24.7 p -110.32 -15.23 14.0 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.275 -0.891 . . . . 0.0 110.063 179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.13 40.6 50.09 Favored Glycine 0 N--CA 1.491 2.323 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 24.2 mt-30 -127.51 154.39 45.19 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.221 -1.164 . . . . 0.0 110.335 -179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 64.6 tt0 -120.2 143.89 48.01 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.266 -0.896 . . . . 0.0 109.919 179.817 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.522 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -153.41 -153.94 6.56 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -119.98 132.45 55.5 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.492 -1.005 . . . . 0.0 109.915 179.792 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.499 HD12 HG21 ' A' ' 59' ' ' VAL . 11.3 pt -125.77 145.25 51.03 Favored Pre-proline 0 N--CA 1.489 1.509 0 O-C-N 121.167 -0.958 . . . . 0.0 110.439 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.609 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 45.8 Cg_endo -78.97 151.51 24.13 Favored 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.987 1.52 . . . . 0.0 109.833 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.589 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 33.3 p90 -71.05 -4.8 26.93 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.235 -0.916 . . . . 0.0 111.034 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.49 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 65.8 m-20 -98.1 -25.99 14.74 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.88 -1.138 . . . . 0.0 111.274 -179.306 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.609 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 8.5 m-85 -85.16 -4.03 59.01 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 120.859 -1.151 . . . . 0.0 110.36 -179.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.499 HG21 HD12 ' A' ' 54' ' ' ILE . 36.0 m -132.21 139.74 49.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.201 -0.937 . . . . 0.0 110.106 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -130.44 148.22 52.23 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.246 -0.909 . . . . 0.0 110.384 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 25.4 tttt -52.28 128.6 25.72 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.307 -0.871 . . . . 0.0 110.166 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.1 139.86 58.19 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.219 -0.926 . . . . 0.0 110.222 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 78.4 m-20 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 118.009 -0.996 . . . . 0.0 110.212 179.993 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.293 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -129.26 163.47 45.93 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.226 -1.161 . . . . 0.0 110.187 179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -58.9 142.15 98.84 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 O-C-N 123.969 1.51 . . . . 0.0 110.359 179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 58.7 mt -90.99 148.45 22.4 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.25 -0.907 . . . . 0.0 110.273 -179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.0 mt-30 -64.18 -39.36 93.84 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.212 -0.93 . . . . 0.0 110.197 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -77.23 52.55 0.92 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.356 -0.84 . . . . 0.0 110.241 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.407 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 55.2 m-20 -86.96 90.27 8.29 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.314 -0.866 . . . . 0.0 110.214 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.428 ' O ' HG13 ' A' ' 9' ' ' VAL . 13.8 tp -96.22 148.37 22.8 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.262 -0.898 . . . . 0.0 110.115 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.705 HG12 ' O ' ' A' ' 60' ' ' ALA . 4.5 m -151.8 170.9 1.17 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.309 -0.869 . . . . 0.0 110.329 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.3 mt -113.64 142.33 26.55 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.273 -0.892 . . . . 0.0 109.852 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 58' ' ' PHE . . . -80.3 114.34 19.13 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.147 -0.971 . . . . 0.0 110.192 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.52 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 75.3 mt -68.84 -22.6 64.22 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.068 -1.02 . . . . 0.0 109.471 179.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.52 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 82.2 m-70 -157.98 152.43 24.7 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.548 -0.72 . . . . 0.0 109.762 179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.507 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 54.2 p -65.26 144.76 56.94 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.989 -1.07 . . . . 0.0 110.075 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.58 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 36.2 t80 -97.37 157.11 16.15 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.086 -1.009 . . . . 0.0 110.502 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -111.2 85.34 5.34 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.263 -0.898 . . . . 0.0 110.116 179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.535 ' HD3' ' CA ' ' A' ' 24' ' ' GLY . 47.1 Cg_endo -55.86 120.61 8.55 Favored 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 124.101 1.579 . . . . 0.0 110.502 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.459 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 98.7 p -92.1 10.53 28.85 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.259 -0.901 . . . . 0.0 110.119 179.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.459 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 98.6 m-70 -141.02 -158.25 0.84 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.241 -0.912 . . . . 0.0 110.214 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 56.7 p30 -112.03 4.8 18.31 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.312 -0.867 . . . . 0.0 110.135 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -118.15 4.37 16.03 Favored Glycine 0 N--CA 1.49 2.295 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.534 ' HB2' ' CB ' ' A' ' 17' ' ' PRO . 42.6 m-20 -95.07 165.18 12.55 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.181 -1.188 . . . . 0.0 110.272 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.512 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 16.0 tp -113.5 116.21 29.22 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.273 -0.892 . . . . 0.0 110.003 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.535 ' CA ' ' HD3' ' A' ' 17' ' ' PRO . . . -96.33 51.85 1.6 Allowed Glycine 0 N--CA 1.491 2.367 0 N-CA-C 109.513 -1.435 . . . . 0.0 109.513 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.58 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 25.4 p90 -49.91 171.21 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.241 -1.152 . . . . 0.0 110.882 -179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.433 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 95.7 mt-10 -103.16 178.38 4.57 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.465 -0.772 . . . . 0.0 110.004 179.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.9 tttt -68.88 132.78 47.29 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.209 -0.932 . . . . 0.0 110.284 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.56 -9.65 74.98 Favored Glycine 0 N--CA 1.489 2.225 0 N-CA-C 109.594 -1.402 . . . . 0.0 109.594 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.481 ' OE2' ' CB ' ' A' ' 25' ' ' PHE . 21.8 tt0 -65.27 125.94 26.6 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.124 -1.221 . . . . 0.0 110.202 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.801 ' O ' HD23 ' A' ' 31' ' ' LEU . 85.9 mt-30 -79.72 137.94 37.18 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.266 -0.896 . . . . 0.0 110.04 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.801 HD23 ' O ' ' A' ' 30' ' ' GLN . 29.2 mt -141.58 163.78 32.01 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.194 -0.941 . . . . 0.0 110.358 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.588 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 5.8 ttt180 -107.18 134.21 50.63 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.376 -0.828 . . . . 0.0 109.485 179.464 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.758 HG21 HE21 ' A' ' 36' ' ' GLN . 25.5 mm -96.11 93.38 3.61 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.133 -0.979 . . . . 0.0 110.515 -179.756 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.002 HD12 ' HA ' ' A' ' 43' ' ' ALA . 1.5 mp -79.49 -25.75 41.76 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.305 -0.872 . . . . 0.0 110.654 -179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.457 ' O ' ' HB3' ' A' ' 41' ' ' TRP . 11.0 mt-10 -136.38 139.65 42.65 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.057 -1.027 . . . . 0.0 110.39 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.758 HE21 HG21 ' A' ' 33' ' ' ILE . 96.2 mt-30 -134.21 54.47 1.94 Allowed 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.368 -0.832 . . . . 0.0 110.044 179.873 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 t -112.69 146.91 37.86 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.403 -0.811 . . . . 0.0 110.224 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 65.18 -167.38 31.65 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.477 -1.449 . . . . 0.0 109.477 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 99.5 mt-10 -77.5 -34.13 54.2 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.319 -1.107 . . . . 0.0 110.154 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.53 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 99.3 m95 -92.96 137.98 31.89 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.191 -0.943 . . . . 0.0 110.326 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.633 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 50.6 m0 -120.42 156.08 32.16 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.32 -0.863 . . . . 0.0 110.023 179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.438 ' HB2' ' HB2' ' A' ' 35' ' ' GLU . 20.3 mttp -98.25 139.55 33.87 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.208 -0.933 . . . . 0.0 109.275 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 1.002 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -148.57 174.24 12.32 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.015 -1.053 . . . . 0.0 110.694 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.487 ' HG3' ' O ' ' A' ' 50' ' ' GLN . 47.3 tt0 -140.68 149.27 42.02 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.409 -0.807 . . . . 0.0 109.9 179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.9 t -96.08 110.64 22.86 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.222 -0.924 . . . . 0.0 110.161 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 70.2 mt -71.55 -2.35 16.64 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.241 -0.912 . . . . 0.0 110.298 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 91.5 m -85.84 -28.23 24.58 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 0.0 109.948 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 44.1 p -127.89 -4.61 5.73 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.345 -0.847 . . . . 0.0 110.172 179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.77 39.69 65.61 Favored Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.487 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 32.6 mt-30 -114.97 148.11 39.18 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.171 -1.193 . . . . 0.0 110.242 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.432 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 37.3 tt0 -120.94 144.47 48.44 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.261 -0.899 . . . . 0.0 109.887 179.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.512 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -162.19 -152.54 6.77 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -124.56 140.16 53.21 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.419 -1.048 . . . . 0.0 109.946 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.943 HD13 HG21 ' A' ' 59' ' ' VAL . 1.6 pp -136.09 137.73 25.64 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.18 -0.95 . . . . 0.0 110.491 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.612 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 45.1 Cg_endo -64.75 152.4 82.18 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.006 1.53 . . . . 0.0 109.964 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.593 ' HB2' ' CH2' ' A' ' 41' ' ' TRP . 30.1 p90 -72.36 -8.04 52.86 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.253 -0.904 . . . . 0.0 111.267 -179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 -94.11 -26.12 16.86 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.817 -1.177 . . . . 0.0 110.993 -179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.612 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 6.5 m-85 -81.81 0.15 40.68 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.048 -1.033 . . . . 0.0 110.146 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.943 HG21 HD13 ' A' ' 54' ' ' ILE . 27.9 t -144.79 170.2 7.48 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.328 -0.858 . . . . 0.0 109.956 179.842 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.705 ' O ' HG12 ' A' ' 9' ' ' VAL . . . -157.36 151.39 24.59 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.204 -0.935 . . . . 0.0 110.305 179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 19.6 tttp -65.18 122.86 18.05 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.228 -0.92 . . . . 0.0 110.218 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.52 -35.5 70.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 0.0 110.241 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 51.7 t30 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.006 -0.997 . . . . 0.0 110.195 179.983 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.294 0 N-CA-C 109.486 -1.446 . . . . 0.0 109.486 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 m -76.58 153.66 83.57 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.224 -1.162 . . . . 0.0 110.155 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -53.69 147.73 38.98 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 124.039 1.547 . . . . 0.0 110.41 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.769 HD12 ' N ' ' A' ' 4' ' ' LEU . 5.6 mp -99.24 139.03 35.49 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.283 -0.885 . . . . 0.0 110.143 -179.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 21.1 mt-30 -118.18 143.52 46.45 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.24 -0.913 . . . . 0.0 110.234 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 87.9 m-20 -97.3 -2.3 42.85 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.243 -0.911 . . . . 0.0 110.238 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.452 ' ND2' ' O ' ' A' ' 33' ' ' ILE . 10.3 t-20 -80.03 2.86 22.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.257 -0.902 . . . . 0.0 110.246 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 21.8 mt -86.62 155.04 20.59 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.242 -0.911 . . . . 0.0 110.183 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.672 HG11 ' CD1' ' A' ' 33' ' ' ILE . 15.0 m -147.08 168.15 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.237 -0.914 . . . . 0.0 110.271 -179.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.426 HG12 ' HB2' ' A' ' 62' ' ' ALA . 29.1 mm -111.83 139.26 37.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.255 -0.903 . . . . 0.0 109.936 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.655 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -80.42 115.61 20.04 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.225 -0.922 . . . . 0.0 110.448 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.444 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 61.4 mt -74.74 -19.81 60.07 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 120.991 -1.068 . . . . 0.0 109.436 179.465 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.444 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 51.9 m-70 -157.33 143.66 17.92 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.538 -0.726 . . . . 0.0 109.668 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.493 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 52.0 p -58.92 145.21 42.19 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.006 -1.059 . . . . 0.0 110.01 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.597 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 85.2 t80 -105.6 167.33 9.83 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.152 -0.968 . . . . 0.0 110.292 179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.576 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 25.1 mt-10 -114.9 127.54 26.73 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.248 -0.908 . . . . 0.0 110.018 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.479 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 50.9 Cg_endo -79.79 89.63 1.32 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 123.917 1.483 . . . . 0.0 110.393 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 61.4 p -79.18 -10.09 59.73 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.174 -0.954 . . . . 0.0 109.867 179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.439 ' CD2' ' OD2' ' A' ' 22' ' ' ASP . 44.7 m-70 -126.96 -179.51 4.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.328 -0.858 . . . . 0.0 110.073 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 67.1 m-20 -86.92 1.91 51.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.259 -0.901 . . . . 0.0 110.267 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.487 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . -123.29 -15.78 3.66 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.866 -1.293 . . . . 0.0 109.866 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.439 ' OD2' ' CD2' ' A' ' 19' ' ' HIS . 87.5 m-20 -67.84 156.38 37.23 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.126 -1.22 . . . . 0.0 110.35 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.46 ' HA ' HD12 ' A' ' 23' ' ' LEU . 21.9 tp -116.51 120.31 38.34 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.217 -0.927 . . . . 0.0 109.829 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.479 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -97.53 53.16 1.31 Allowed Glycine 0 N--CA 1.493 2.469 0 N-CA-C 109.872 -1.291 . . . . 0.0 109.872 -179.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.655 ' CE2' ' HB1' ' A' ' 11' ' ' ALA . 42.7 p90 -48.28 168.72 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.211 -1.17 . . . . 0.0 110.948 -179.785 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -96.9 176.98 5.78 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.475 -0.766 . . . . 0.0 110.349 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 56.4 tttm -71.33 127.03 31.23 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.268 -0.895 . . . . 0.0 110.161 179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.61 -6.08 83.32 Favored Glycine 0 N--CA 1.488 2.164 0 N-CA-C 109.398 -1.481 . . . . 0.0 109.398 -179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.444 ' CD ' ' HB2' ' A' ' 25' ' ' PHE . 20.5 tt0 -65.99 130.04 41.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.114 -1.227 . . . . 0.0 110.054 -179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.432 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 50.8 tt0 -79.54 136.46 36.89 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.258 -0.901 . . . . 0.0 109.826 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.626 HD11 ' CG ' ' A' ' 25' ' ' PHE . 54.2 mt -139.65 162.36 35.28 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 0.0 110.528 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.582 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 11.3 ttt180 -111.83 138.77 47.98 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.394 -0.816 . . . . 0.0 109.558 179.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.672 ' CD1' HG11 ' A' ' 9' ' ' VAL . 57.9 mt -98.68 92.35 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.121 -0.987 . . . . 0.0 110.392 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.533 HD21 ' CD ' ' A' ' 32' ' ' ARG . 73.4 mt -79.49 -21.79 44.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.22 -0.925 . . . . 0.0 110.908 -179.404 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.527 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 75.9 tt0 -138.12 131.54 30.63 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.993 -1.067 . . . . 0.0 110.234 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.635 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 95.4 mt-30 -126.25 56.75 1.43 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.263 -0.898 . . . . 0.0 110.25 -179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.7 t -115.84 150.26 37.28 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.207 -0.933 . . . . 0.0 110.296 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.58 -168.88 34.58 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 80.9 mt-10 -75.71 -32.72 60.18 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.306 -1.114 . . . . 0.0 110.088 179.899 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.553 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 95.4 m95 -97.9 144.71 27.18 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.258 -0.901 . . . . 0.0 110.008 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.635 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 50.0 m0 -119.72 154.62 33.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.336 -0.852 . . . . 0.0 110.094 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.527 ' CB ' ' HB3' ' A' ' 35' ' ' GLU . 18.4 tttp -92.96 140.43 29.49 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.238 -0.914 . . . . 0.0 109.324 179.261 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.582 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -148.92 171.66 15.96 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.046 -1.034 . . . . 0.0 110.932 -179.509 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.441 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 4.8 tt0 -139.57 147.78 41.64 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.56 -0.713 . . . . 0.0 109.622 179.699 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 5.0 t -94.22 109.81 21.59 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.15 -0.969 . . . . 0.0 110.144 -179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.435 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 16.5 tp -71.93 -1.58 14.92 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.437 -179.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 98.0 m -90.87 -31.11 16.56 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.246 -0.909 . . . . 0.0 110.142 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.0 p -120.73 -8.94 9.41 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.284 -0.885 . . . . 0.0 110.201 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.65 36.86 47.32 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 7.9 mt-30 -112.43 144.47 41.82 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.284 -1.127 . . . . 0.0 110.268 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.441 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 83.8 tt0 -120.69 141.69 50.18 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.23 -0.919 . . . . 0.0 110.168 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.487 ' HA2' ' O ' ' A' ' 21' ' ' GLY . . . -172.95 163.93 35.82 Favored Glycine 0 N--CA 1.49 2.299 0 N-CA-C 109.549 -1.421 . . . . 0.0 109.549 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.402 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 91.7 m-85 -74.37 147.31 42.27 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.244 -1.15 . . . . 0.0 109.832 179.68 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.815 HD12 ' O ' ' A' ' 55' ' ' PRO . 1.7 pp -142.67 137.86 15.64 Favored Pre-proline 0 N--CA 1.489 1.521 0 O-C-N 121.281 -0.887 . . . . 0.0 110.285 -179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.815 ' O ' HD12 ' A' ' 54' ' ' ILE . 45.4 Cg_endo -57.89 156.81 26.7 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 124.112 1.585 . . . . 0.0 110.169 179.805 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.596 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 20.8 p90 -92.78 -0.9 57.18 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.375 -0.828 . . . . 0.0 111.243 -179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.522 ' OD1' ' N ' ' A' ' 58' ' ' PHE . 49.1 p-10 -98.32 -26.63 14.44 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.824 -1.172 . . . . 0.0 111.051 -179.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.522 ' N ' ' OD1' ' A' ' 57' ' ' ASN . 16.8 m-30 -88.65 2.3 53.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.938 -1.102 . . . . 0.0 110.502 -179.704 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.799 HG11 HD13 ' A' ' 54' ' ' ILE . 33.2 m -132.19 146.64 32.8 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 O-C-N 121.111 -0.993 . . . . 0.0 110.208 -179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.514 ' O ' ' CB ' ' A' ' 9' ' ' VAL . . . -135.67 168.26 19.61 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.316 -0.865 . . . . 0.0 110.181 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.559 ' HA ' HG12 ' A' ' 9' ' ' VAL . 85.7 mttt -78.21 131.41 37.13 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.225 -0.922 . . . . 0.0 110.281 -179.955 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.426 ' HB2' HG12 ' A' ' 10' ' ' ILE . . . -96.39 154.39 17.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.297 -0.877 . . . . 0.0 110.176 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 93.4 m-20 . . . . . 0 N--CA 1.491 1.608 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.238 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.3 0 N-CA-C 109.525 -1.43 . . . . 0.0 109.525 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -124.2 79.08 59.81 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.26 -1.141 . . . . 0.0 110.18 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -58.98 146.29 94.53 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 123.933 1.491 . . . . 0.0 110.395 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.523 HD23 ' OD1' ' A' ' 6' ' ' ASP . 13.4 tp -105.29 123.93 48.69 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 0.0 110.227 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 44.2 tt0 -55.94 -25.65 44.37 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.15 -0.969 . . . . 0.0 110.163 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.523 ' OD1' HD23 ' A' ' 4' ' ' LEU . 46.8 m-20 55.02 57.02 5.94 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.307 -0.87 . . . . 0.0 110.277 179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.419 ' O ' HG13 ' A' ' 33' ' ' ILE . 24.7 m120 -80.96 -10.0 59.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.243 -0.91 . . . . 0.0 110.263 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.437 ' C ' HG13 ' A' ' 9' ' ' VAL . 15.2 tp -70.31 142.83 52.18 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.219 -0.926 . . . . 0.0 110.155 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.917 HG11 HD11 ' A' ' 33' ' ' ILE . 24.5 m -149.48 168.78 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.27 -0.894 . . . . 0.0 110.269 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 63.2 mt -111.15 141.44 26.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.211 -0.93 . . . . 0.0 109.886 179.74 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.433 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -80.12 109.86 14.98 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.167 -0.958 . . . . 0.0 110.316 -179.917 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.414 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 71.6 mt -69.93 -24.52 63.38 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.02 -1.05 . . . . 0.0 109.247 179.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.414 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 74.2 m80 -152.84 148.23 26.94 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.561 -0.712 . . . . 0.0 109.632 179.819 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.527 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 51.4 p -63.75 144.76 56.78 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.037 -1.039 . . . . 0.0 109.987 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 39.5 t80 -97.68 157.38 16.08 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.026 -1.046 . . . . 0.0 110.357 -179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 37.8 mt-10 -110.32 99.82 41.91 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.372 -0.83 . . . . 0.0 109.998 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.494 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.3 Cg_endo -59.96 91.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.069 1.563 . . . . 0.0 110.461 -179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 69.9 m -83.28 1.33 41.5 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 110.102 179.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.462 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 77.3 m80 -146.67 152.35 38.71 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.281 -0.887 . . . . 0.0 110.135 179.963 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 64.0 m-20 -65.04 130.01 41.81 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.232 -0.917 . . . . 0.0 110.189 179.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.07 13.58 24.78 Favored Glycine 0 N--CA 1.489 2.187 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.462 ' OD2' ' HB2' ' A' ' 19' ' ' HIS . 13.8 m-20 -108.29 158.24 17.64 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.29 -1.123 . . . . 0.0 110.448 -179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.665 HD13 ' HG2' ' A' ' 50' ' ' GLN . 13.5 tp -109.3 111.89 23.71 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.334 -0.854 . . . . 0.0 109.834 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.494 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -93.24 49.87 2.43 Favored Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 31.7 p90 -53.36 174.42 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.284 -1.127 . . . . 0.0 110.89 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.527 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 91.6 mt-10 -109.33 178.74 4.35 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.471 -0.768 . . . . 0.0 109.918 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 22.1 tttm -68.29 140.57 55.98 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.081 -1.012 . . . . 0.0 110.287 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.07 -14.31 50.02 Favored Glycine 0 N--CA 1.489 2.177 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.465 ' HG3' ' HB2' ' A' ' 26' ' ' GLU . 3.6 mt-10 -65.8 126.59 28.94 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.175 -1.191 . . . . 0.0 110.37 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.975 ' C ' HD12 ' A' ' 31' ' ' LEU . 19.4 pt20 -79.76 136.33 36.72 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.285 -0.884 . . . . 0.0 109.958 179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.975 HD12 ' C ' ' A' ' 30' ' ' GLN . 7.7 mp -137.95 158.88 43.42 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.163 -0.96 . . . . 0.0 110.536 -179.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.594 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 5.8 tpt180 -106.29 132.33 52.46 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.406 -0.809 . . . . 0.0 109.332 179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.917 HD11 HG11 ' A' ' 9' ' ' VAL . 23.3 mt -90.79 93.73 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.083 -1.01 . . . . 0.0 110.544 -179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.438 ' CD2' ' HG3' ' A' ' 32' ' ' ARG . 67.1 mt -79.58 -29.94 41.43 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.367 -0.833 . . . . 0.0 110.844 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.462 ' HB3' ' HB3' ' A' ' 42' ' ' LYS . 85.3 tt0 -130.91 140.48 50.2 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.947 -1.096 . . . . 0.0 110.406 -179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.627 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 76.5 mt-30 -134.52 54.88 1.92 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.318 -0.864 . . . . 0.0 110.111 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 51.4 m -119.65 148.18 43.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.298 -0.876 . . . . 0.0 110.167 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 69.11 -177.87 27.52 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -69.18 -29.85 67.94 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.151 -1.205 . . . . 0.0 110.333 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.459 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 99.2 m95 -98.61 144.15 28.22 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.175 -0.953 . . . . 0.0 110.378 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.627 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 43.5 m0 -121.02 155.87 33.41 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.349 -0.844 . . . . 0.0 110.176 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 35' ' ' GLU . 77.9 tttt -101.1 143.54 31.08 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.261 -0.9 . . . . 0.0 109.331 179.432 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.594 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -153.98 -179.9 8.29 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.014 -1.054 . . . . 0.0 110.85 -179.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 48.3 tt0 -141.24 149.94 41.99 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.379 -0.825 . . . . 0.0 109.691 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.469 ' HB2' HD21 ' A' ' 23' ' ' LEU . 18.0 t -100.49 123.95 45.38 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.05 -1.031 . . . . 0.0 110.3 -179.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.6 mt -80.85 6.21 13.77 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.321 -0.862 . . . . 0.0 110.051 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 87.0 m -91.07 -35.62 14.5 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 110.071 179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 81.7 p -127.27 -3.55 6.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.31 -0.869 . . . . 0.0 110.093 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.2 35.24 57.25 Favored Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -179.898 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.665 ' HG2' HD13 ' A' ' 23' ' ' LEU . 63.1 tt0 -104.87 140.76 37.67 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.279 -1.13 . . . . 0.0 110.283 -179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.422 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 86.3 tt0 -119.51 139.09 52.65 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -0.892 . . . . 0.0 110.18 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . . . . . . . . . . . -170.81 163.17 36.25 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 -179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.449 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 94.4 m-85 -69.36 141.85 54.1 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.308 -1.113 . . . . 0.0 110.0 179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.689 HD12 HG21 ' A' ' 59' ' ' VAL . 1.6 pt -131.57 142.37 45.06 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.194 -0.941 . . . . 0.0 110.38 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.579 ' O ' HG22 ' A' ' 59' ' ' VAL . 44.8 Cg_endo -68.49 140.89 49.11 Favored 'Trans proline' 0 C--N 1.304 -1.778 0 O-C-N 124.066 1.561 . . . . 0.0 110.08 179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.57 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 25.1 p90 -75.54 -7.03 53.14 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.231 -0.918 . . . . 0.0 111.144 -179.241 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 58.5 t-20 -90.34 -26.48 19.94 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.899 -1.126 . . . . 0.0 110.725 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.557 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 17.8 m-30 -92.71 4.16 54.25 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.091 -1.006 . . . . 0.0 110.22 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.689 HG21 HD12 ' A' ' 54' ' ' ILE . 35.6 m -136.04 143.49 35.9 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 O-C-N 121.263 -0.898 . . . . 0.0 110.103 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -136.82 160.15 39.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.171 -0.956 . . . . 0.0 110.343 -179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.637 ' HA ' HG12 ' A' ' 9' ' ' VAL . 11.1 mtmt -69.07 140.06 54.86 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.286 -0.884 . . . . 0.0 110.232 179.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.68 148.44 49.04 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.247 -0.908 . . . . 0.0 110.262 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.1 m-20 . . . . . 0 N--CA 1.491 1.62 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.28 179.922 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.462 ' HA3' HD12 ' A' ' 4' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.52 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 0.4 OUTLIER -44.64 -57.57 6.55 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.166 -1.196 . . . . 0.0 110.186 -179.99 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.52 ' HD2' ' N ' ' A' ' 2' ' ' SER . 47.3 Cg_endo -66.12 -30.48 46.78 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.957 1.504 . . . . 0.0 110.241 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.462 HD12 ' HA3' ' A' ' 1' ' ' GLY . 43.1 mt -62.12 -34.07 75.66 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.309 -0.87 . . . . 0.0 110.211 179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -57.67 -39.73 77.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.266 -0.896 . . . . 0.0 110.105 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 88.6 m-20 -51.3 -35.35 37.41 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 110.118 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.582 ' HA ' HD12 ' A' ' 33' ' ' ILE . 20.9 m120 -85.77 12.12 9.67 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.246 -0.909 . . . . 0.0 110.142 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 1.011 HD13 ' N ' ' A' ' 9' ' ' VAL . 2.9 tm? -94.79 145.84 24.6 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.325 -0.859 . . . . 0.0 110.111 179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.011 ' N ' HD13 ' A' ' 8' ' ' LEU . 30.1 m -150.41 170.02 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.178 -0.951 . . . . 0.0 110.319 -179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.4 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 58.0 mt -115.16 145.05 21.4 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 121.377 -0.827 . . . . 0.0 109.954 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.608 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . -80.33 109.15 14.54 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.124 -0.985 . . . . 0.0 110.337 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.469 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 57.6 mt -67.05 -24.3 65.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.985 -1.072 . . . . 0.0 109.353 179.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.469 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 58.1 m80 -157.09 155.16 30.63 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.611 -0.681 . . . . 0.0 109.487 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 47.7 t -66.49 139.15 57.94 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.972 -1.08 . . . . 0.0 109.98 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.59 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 73.5 t80 -95.96 155.27 16.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.084 -1.01 . . . . 0.0 110.375 179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.584 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 1.2 mp0 -105.66 128.71 25.95 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.361 -0.837 . . . . 0.0 110.11 -179.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.426 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.5 Cg_endo -87.31 81.28 1.28 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.875 1.461 . . . . 0.0 110.448 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 97.1 p -79.88 -2.33 43.1 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.385 -0.822 . . . . 0.0 109.942 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.416 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 63.8 m80 -138.95 149.81 45.19 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.28 -0.888 . . . . 0.0 110.18 -179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 82.0 m-20 -69.21 129.1 38.9 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.287 -0.883 . . . . 0.0 110.227 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 105.83 -4.41 39.26 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.416 ' OD2' ' HB2' ' A' ' 19' ' ' HIS . 34.9 m-20 -92.25 165.99 12.83 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.225 -1.162 . . . . 0.0 110.464 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.489 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 18.0 tp -117.85 124.33 48.06 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.272 -0.893 . . . . 0.0 110.011 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.453 ' HA2' ' HB3' ' A' ' 15' ' ' TYR . . . -105.68 52.7 0.69 Allowed Glycine 0 N--CA 1.49 2.281 0 N-CA-C 109.697 -1.361 . . . . 0.0 109.697 -179.751 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.608 ' CD2' ' HB1' ' A' ' 11' ' ' ALA . 41.3 p90 -48.74 175.78 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.194 -1.18 . . . . 0.0 110.841 -179.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.496 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 73.5 mm-40 -109.76 179.34 4.15 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.445 -0.784 . . . . 0.0 110.157 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.4 tttm -69.41 133.48 47.82 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.008 -1.058 . . . . 0.0 110.478 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.28 -15.53 55.95 Favored Glycine 0 N--CA 1.488 2.111 0 N-CA-C 109.791 -1.324 . . . . 0.0 109.791 179.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.49 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 3.3 mt-10 -64.25 122.56 16.93 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.034 -1.274 . . . . 0.0 110.454 -179.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.43 ' O ' HD23 ' A' ' 31' ' ' LEU . 99.0 mt-30 -79.4 137.15 37.17 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.293 -0.879 . . . . 0.0 109.651 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.525 HD11 ' CG ' ' A' ' 25' ' ' PHE . 15.7 mt -133.77 154.35 51.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.174 -0.954 . . . . 0.0 110.488 -179.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.502 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 14.9 ttm180 -98.79 130.89 45.25 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.397 -0.815 . . . . 0.0 109.931 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.582 HD12 ' HA ' ' A' ' 7' ' ' ASN . 69.2 mt -73.72 113.95 12.57 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.186 -0.946 . . . . 0.0 110.109 179.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.914 HD11 ' HB2' ' A' ' 44' ' ' GLN . 35.7 mt -86.49 -38.83 16.87 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.307 -0.87 . . . . 0.0 110.201 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.457 ' O ' ' HB3' ' A' ' 41' ' ' TRP . 94.4 mt-10 -139.25 161.45 37.4 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.343 -0.848 . . . . 0.0 109.946 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.631 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 45.7 tt0 -143.78 61.2 1.37 Allowed 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.255 -0.903 . . . . 0.0 110.141 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 24.9 t -131.81 122.48 25.84 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.316 -0.865 . . . . 0.0 110.196 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.35 176.69 41.84 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -61.75 -34.39 75.76 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.365 -1.079 . . . . 0.0 110.249 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.434 ' O ' ' CD1' ' A' ' 41' ' ' TRP . 73.4 m95 -100.08 150.16 22.76 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.277 -0.89 . . . . 0.0 110.242 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.631 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 40.1 m0 -130.84 160.03 35.61 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.29 -0.881 . . . . 0.0 110.381 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.421 ' HD3' ' HB3' ' A' ' 34' ' ' LEU . 80.0 tttt -88.89 146.6 24.84 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.237 -0.914 . . . . 0.0 109.605 179.3 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.664 ' HB2' HG12 ' A' ' 54' ' ' ILE . . . -147.14 167.82 23.17 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.029 -1.045 . . . . 0.0 110.759 -179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.914 ' HB2' HD11 ' A' ' 34' ' ' LEU . 43.4 tt0 -145.69 154.22 41.85 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.433 -0.792 . . . . 0.0 110.025 179.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.5 t -83.09 145.4 29.27 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.065 -1.022 . . . . 0.0 110.196 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 48.3 tp -91.38 -21.14 21.15 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.267 -0.896 . . . . 0.0 110.132 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 13.7 t -105.45 -26.49 11.91 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.268 -0.895 . . . . 0.0 110.429 -179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.3 m -100.35 -29.22 12.54 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.122 -0.986 . . . . 0.0 110.108 -179.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.06 22.04 64.2 Favored Glycine 0 N--CA 1.49 2.281 0 N-CA-C 108.925 -1.67 . . . . 0.0 108.925 -179.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.497 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 62.0 tt0 -92.75 134.48 35.01 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.442 -1.034 . . . . 0.0 110.259 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.54 ' HG2' ' CG ' ' A' ' 44' ' ' GLN . 79.9 mt-10 -114.96 133.09 56.31 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.282 -0.887 . . . . 0.0 109.934 179.724 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.489 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -161.26 157.03 28.58 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -67.07 142.19 57.24 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.349 -1.089 . . . . 0.0 110.159 -179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.664 HG12 ' HB2' ' A' ' 43' ' ' ALA . 1.0 OUTLIER -133.63 162.13 59.52 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.284 -0.885 . . . . 0.0 110.137 -179.856 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.59 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 47.8 Cg_endo -90.26 162.88 4.63 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 123.993 1.523 . . . . 0.0 110.09 179.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -87.34 -2.23 58.48 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.221 -0.924 . . . . 0.0 110.819 -179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 22.4 t-20 -100.1 -25.74 14.19 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.036 -1.04 . . . . 0.0 110.987 -179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.586 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 22.4 m-85 -84.26 -9.26 58.66 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.924 -1.11 . . . . 0.0 110.53 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 22.4 m -131.16 143.24 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.189 -0.944 . . . . 0.0 110.301 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -130.33 156.72 44.21 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.255 -0.903 . . . . 0.0 110.185 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.407 ' HA ' HG12 ' A' ' 9' ' ' VAL . 93.1 mttt -68.53 133.52 48.69 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.32 -0.863 . . . . 0.0 110.177 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.9 -31.78 68.92 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.211 -0.931 . . . . 0.0 110.148 179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.208 -179.984 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.221 0 N-CA-C 109.426 -1.47 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.6 m -125.87 76.09 71.02 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.222 -1.164 . . . . 0.0 110.171 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -56.56 -17.21 21.31 Favored 'Trans proline' 0 C--N 1.304 -1.812 0 O-C-N 124.086 1.571 . . . . 0.0 110.263 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.7 tp -91.91 132.72 36.28 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.295 -0.878 . . . . 0.0 110.212 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 61.3 tt0 -84.55 119.76 25.56 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.159 -0.963 . . . . 0.0 110.183 179.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.426 ' C ' ' OD1' ' A' ' 6' ' ' ASP . 55.9 p30 -92.44 10.19 31.08 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.322 -0.861 . . . . 0.0 110.308 -179.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.44 ' O ' HG13 ' A' ' 33' ' ' ILE . 29.0 m120 -86.89 4.58 40.85 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.165 -0.959 . . . . 0.0 110.364 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.461 ' O ' HG13 ' A' ' 9' ' ' VAL . 12.4 tp -91.85 151.83 20.38 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.216 -0.928 . . . . 0.0 110.204 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.786 HG12 ' O ' ' A' ' 60' ' ' ALA . 4.2 m -153.18 173.39 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.252 -0.905 . . . . 0.0 110.532 -179.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 62.1 mt -120.63 142.6 35.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.376 -0.828 . . . . 0.0 109.527 179.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.443 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -77.54 115.77 17.57 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.116 -0.99 . . . . 0.0 110.342 -179.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 12' ' ' LEU . 15.5 tp -73.55 -20.3 60.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.14 -0.975 . . . . 0.0 109.086 179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 -149.35 -158.95 0.97 Allowed 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.586 -0.696 . . . . 0.0 109.693 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 93.8 p -118.07 140.51 49.65 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.164 -0.96 . . . . 0.0 110.151 179.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.593 ' CD2' ' HD3' ' A' ' 55' ' ' PRO . 60.2 t80 -103.53 162.6 12.91 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.067 -1.021 . . . . 0.0 110.223 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.567 ' O ' ' CE1' ' A' ' 15' ' ' TYR . 47.0 tt0 -119.91 130.32 24.91 Favored Pre-proline 0 N--CA 1.491 1.604 0 O-C-N 121.201 -0.937 . . . . 0.0 110.273 -179.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.458 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.1 Cg_endo -81.22 84.46 1.97 Allowed 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.02 1.537 . . . . 0.0 110.403 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 77.0 p -79.83 -1.19 37.83 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.219 -0.925 . . . . 0.0 110.093 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.445 ' HB2' ' OD2' ' A' ' 22' ' ' ASP . 82.2 m-70 -150.28 158.16 43.85 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.199 -0.938 . . . . 0.0 110.02 179.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 83.4 m-20 -66.09 127.47 32.25 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.194 -0.941 . . . . 0.0 110.217 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.415 ' O ' ' HA2' ' A' ' 52' ' ' GLY . . . 107.12 -10.91 40.34 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.504 -1.438 . . . . 0.0 109.504 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.445 ' OD2' ' HB2' ' A' ' 19' ' ' HIS . 41.5 m-20 -83.18 152.45 25.23 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.231 -1.158 . . . . 0.0 110.316 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.546 ' O ' ' CD1' ' A' ' 15' ' ' TYR . 14.2 tp -114.22 120.01 39.01 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.308 -0.87 . . . . 0.0 110.036 179.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.458 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -102.86 56.71 0.61 Allowed Glycine 0 N--CA 1.492 2.372 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.563 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 36.2 p90 -50.8 171.6 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.185 -1.185 . . . . 0.0 110.874 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 -103.62 178.59 4.51 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.545 -0.722 . . . . 0.0 109.981 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 19.9 mttp -69.69 124.56 24.28 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.195 -0.941 . . . . 0.0 110.328 179.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 92.45 -12.26 70.15 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.786 -1.326 . . . . 0.0 109.786 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.439 ' CD ' ' HB2' ' A' ' 25' ' ' PHE . 41.4 tt0 -59.74 127.68 33.15 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.129 -1.218 . . . . 0.0 110.395 -179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -79.83 131.93 36.0 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.218 -0.926 . . . . 0.0 109.929 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.475 HD11 ' CG ' ' A' ' 25' ' ' PHE . 18.9 mt -131.58 151.31 51.7 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.199 -0.938 . . . . 0.0 110.408 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.65 ' NH1' HD13 ' A' ' 46' ' ' LEU . 20.2 mtp85 -98.54 133.66 42.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.341 -0.849 . . . . 0.0 109.523 179.711 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.62 HG21 HE21 ' A' ' 36' ' ' GLN . 27.3 mt -77.1 118.12 23.22 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.136 -0.978 . . . . 0.0 110.067 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.699 HD11 ' HB2' ' A' ' 44' ' ' GLN . 86.3 mt -95.68 -36.74 11.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.327 -0.858 . . . . 0.0 110.273 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.406 ' HA ' ' OE1' ' A' ' 35' ' ' GLU . 67.3 mm-40 -139.96 153.17 46.83 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.282 -0.886 . . . . 0.0 110.213 -179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.62 HE21 HG21 ' A' ' 33' ' ' ILE . 96.1 mt-30 -135.48 55.14 1.89 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.304 -0.873 . . . . 0.0 110.215 179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 50.3 m -120.03 135.72 54.82 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.272 -0.892 . . . . 0.0 110.148 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.44 178.42 42.75 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.464 -1.454 . . . . 0.0 109.464 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -64.97 -33.19 75.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.359 -1.083 . . . . 0.0 110.355 -179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.565 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 98.7 m95 -91.89 140.81 29.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.174 -0.954 . . . . 0.0 110.153 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.581 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 40.7 m0 -122.01 152.99 39.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.261 -0.9 . . . . 0.0 110.212 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . . . . . . . . . 17.5 tttm -91.85 148.23 22.38 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.28 -0.888 . . . . 0.0 109.589 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.695 ' HB3' HG21 ' A' ' 54' ' ' ILE . . . -155.49 178.11 10.61 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.0 -1.062 . . . . 0.0 110.622 -179.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.699 ' HB2' HD11 ' A' ' 34' ' ' LEU . 28.4 tt0 -150.9 159.67 44.4 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.296 -0.878 . . . . 0.0 109.724 179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.43 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 6.4 t -82.27 147.56 28.84 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.072 -1.018 . . . . 0.0 109.933 179.892 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.65 HD13 ' NH1' ' A' ' 32' ' ' ARG . 30.3 tp -91.68 -21.31 20.83 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.216 -0.927 . . . . 0.0 109.945 179.904 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 19.4 p -107.77 -28.14 9.85 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.284 -0.885 . . . . 0.0 110.354 -179.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 7.3 m -94.43 -31.16 14.1 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.124 -0.985 . . . . 0.0 110.233 -179.749 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.55 24.02 59.36 Favored Glycine 0 N--CA 1.49 2.263 0 N-CA-C 109.257 -1.537 . . . . 0.0 109.257 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.496 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 65.2 tp60 -97.55 136.66 37.64 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.358 -1.084 . . . . 0.0 110.022 179.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.55 ' HG2' ' CG ' ' A' ' 44' ' ' GLN . 31.2 mt-10 -117.52 136.73 53.04 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.094 -1.004 . . . . 0.0 110.244 -179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.49 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -167.79 162.52 36.31 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.553 -1.419 . . . . 0.0 109.553 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -66.37 141.94 57.79 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.297 -1.119 . . . . 0.0 110.217 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.695 HG21 ' HB3' ' A' ' 43' ' ' ALA . 1.3 pp -133.4 144.35 51.92 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.255 -0.903 . . . . 0.0 110.171 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.593 ' HD3' ' CD2' ' A' ' 15' ' ' TYR . 44.6 Cg_endo -71.23 152.57 61.71 Favored 'Trans proline' 0 C--N 1.305 -1.752 0 O-C-N 124.023 1.538 . . . . 0.0 110.373 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.566 ' CE2' ' OD1' ' A' ' 57' ' ' ASN . 20.1 p90 -89.89 -1.08 57.91 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.335 -0.853 . . . . 0.0 110.68 -179.71 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.566 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 92.3 m-20 -95.64 -27.14 15.45 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.089 -1.007 . . . . 0.0 110.668 -179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.565 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 12.8 m-30 -90.46 4.39 51.17 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.096 -1.002 . . . . 0.0 110.465 -179.858 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.508 HG12 ' HB ' ' A' ' 9' ' ' VAL . 10.7 t -140.93 163.84 21.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.208 -0.933 . . . . 0.0 110.206 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.786 ' O ' HG12 ' A' ' 9' ' ' VAL . . . -152.7 173.86 14.72 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.346 -0.846 . . . . 0.0 110.193 -179.973 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 16.4 tttt -68.51 132.14 46.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.173 -0.955 . . . . 0.0 110.164 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -68.3 148.08 51.26 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.223 -0.923 . . . . 0.0 110.185 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.1 m-20 . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.232 -179.988 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.364 0 N-CA-C 109.428 -1.469 . . . . 0.0 109.428 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.3 m -92.17 132.99 30.94 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 121.294 -1.121 . . . . 0.0 110.155 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -63.38 -12.02 28.56 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 124.086 1.572 . . . . 0.0 110.323 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 25.9 tp -62.93 -26.8 68.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 110.275 179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.7 mt-30 -129.21 146.4 51.13 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 110.185 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.973 ' OD1' HD11 ' A' ' 8' ' ' LEU . 43.3 t0 -136.72 78.13 1.68 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.236 -0.915 . . . . 0.0 110.151 179.966 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.547 ' C ' HD12 ' A' ' 8' ' ' LEU . 43.9 t-20 -87.01 108.73 18.98 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.275 -0.891 . . . . 0.0 110.34 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.973 HD11 ' OD1' ' A' ' 6' ' ' ASP . 6.7 mp -109.57 142.41 40.7 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.238 -0.914 . . . . 0.0 110.048 179.878 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.859 HG11 HD11 ' A' ' 33' ' ' ILE . 27.3 m -143.5 166.99 13.65 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.228 -0.92 . . . . 0.0 110.404 -179.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.432 ' O ' HD12 ' A' ' 12' ' ' LEU . 21.3 mm -110.73 146.23 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.325 -0.86 . . . . 0.0 109.754 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.48 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -80.15 113.51 18.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.116 -0.99 . . . . 0.0 110.381 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.697 HD12 ' N ' ' A' ' 12' ' ' LEU . 8.2 mp -74.57 -19.98 60.12 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.11 -0.994 . . . . 0.0 109.371 179.508 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.513 ' ND1' ' O ' ' A' ' 12' ' ' LEU . 71.9 m80 -155.61 145.17 21.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.497 -0.752 . . . . 0.0 109.611 179.8 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.556 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 33.1 p -64.03 145.98 54.94 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 120.94 -1.1 . . . . 0.0 110.129 -179.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.612 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 82.9 t80 -104.35 166.7 10.23 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.101 -0.999 . . . . 0.0 110.211 179.759 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -121.24 120.08 29.26 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.24 -0.912 . . . . 0.0 110.125 -179.973 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.487 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 49.5 Cg_endo -70.19 84.35 0.73 Allowed 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 123.949 1.5 . . . . 0.0 110.219 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.501 ' OG ' ' ND1' ' A' ' 19' ' ' HIS . 73.8 p -79.9 -3.84 49.78 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.291 -0.881 . . . . 0.0 110.082 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.501 ' ND1' ' OG ' ' A' ' 18' ' ' SER . 50.9 m80 -145.94 140.5 26.98 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.309 -0.869 . . . . 0.0 110.195 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.5 m-20 -53.45 124.48 14.96 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.232 -0.917 . . . . 0.0 110.279 179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.76 16.02 12.35 Favored Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -114.69 159.85 20.05 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.188 -1.184 . . . . 0.0 110.303 -179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.501 ' HA ' HD12 ' A' ' 23' ' ' LEU . 15.4 tp -115.23 118.41 33.24 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.329 -0.857 . . . . 0.0 110.081 179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.487 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -95.9 47.59 1.84 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.767 -1.333 . . . . 0.0 109.767 -179.793 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.612 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 40.2 p90 -47.36 171.88 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.269 -1.136 . . . . 0.0 111.042 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.556 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 92.4 mt-10 -105.95 178.82 4.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.412 -0.805 . . . . 0.0 110.069 179.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.6 tttt -69.32 138.0 53.41 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.083 -1.011 . . . . 0.0 110.136 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.09 -12.31 60.48 Favored Glycine 0 N--CA 1.488 2.156 0 N-CA-C 109.375 -1.49 . . . . 0.0 109.375 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.581 ' HG2' HD11 ' A' ' 31' ' ' LEU . 8.4 tt0 -63.57 128.17 34.63 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.174 -1.191 . . . . 0.0 110.118 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.97 ' C ' HD12 ' A' ' 31' ' ' LEU . 92.6 mt-30 -79.55 134.53 36.49 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.244 -0.91 . . . . 0.0 109.992 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.97 HD12 ' C ' ' A' ' 30' ' ' GLN . 8.5 mp -136.11 156.87 48.07 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.229 -0.919 . . . . 0.0 110.736 -179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.586 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 22.8 ttt180 -107.76 135.81 48.55 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.442 -0.786 . . . . 0.0 109.138 179.304 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.859 HD11 HG11 ' A' ' 9' ' ' VAL . 54.4 mt -91.39 92.35 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.042 -1.036 . . . . 0.0 110.879 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.485 HD11 ' HB2' ' A' ' 44' ' ' GLN . 11.0 mt -79.08 -29.84 43.58 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.581 -179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.546 ' CB ' ' HB3' ' A' ' 42' ' ' LYS . 45.7 tt0 -134.6 132.86 39.55 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.961 -1.087 . . . . 0.0 110.234 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.633 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 53.3 tt0 -129.08 59.31 1.58 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.286 -0.884 . . . . 0.0 110.119 -179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 89.5 p -121.53 146.12 47.26 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.209 -0.932 . . . . 0.0 110.237 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 71.02 -170.26 47.57 Favored Glycine 0 N--CA 1.49 2.258 0 N-CA-C 109.379 -1.488 . . . . 0.0 109.379 -179.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 93.3 mt-10 -74.6 -33.1 62.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.265 -1.138 . . . . 0.0 110.072 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.494 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 99.0 m95 -96.44 142.8 28.11 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.212 -0.93 . . . . 0.0 110.16 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.633 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 43.1 m0 -119.94 154.97 33.67 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.22 -0.925 . . . . 0.0 110.192 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.546 ' HB3' ' CB ' ' A' ' 35' ' ' GLU . 34.3 tttp -97.63 141.17 31.0 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.343 -0.848 . . . . 0.0 109.132 179.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.586 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -152.52 177.77 10.28 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.94 -1.1 . . . . 0.0 110.803 -179.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.485 ' HB2' HD11 ' A' ' 34' ' ' LEU . 58.6 tt0 -142.65 150.62 40.48 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.438 -0.789 . . . . 0.0 109.912 179.872 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.1 t -97.16 114.75 26.49 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.118 -0.989 . . . . 0.0 110.229 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.7 mt -74.63 0.18 15.86 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.19 -0.944 . . . . 0.0 110.118 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 54.9 m -86.16 -33.26 20.89 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.204 -0.935 . . . . 0.0 110.045 179.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 73.8 p -128.39 -3.58 5.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.236 -0.915 . . . . 0.0 110.159 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.2 33.77 56.23 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.539 -1.424 . . . . 0.0 109.539 179.894 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 17.2 mt-30 -101.86 139.96 36.79 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.289 -1.124 . . . . 0.0 110.148 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.448 ' OE2' ' HE3' ' A' ' 42' ' ' LYS . 78.6 tt0 -120.77 140.77 51.22 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.204 -0.935 . . . . 0.0 110.163 179.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -174.12 164.53 35.81 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 81.7 m-85 -74.06 146.37 43.73 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.174 -1.192 . . . . 0.0 109.758 179.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.986 HD13 HG11 ' A' ' 59' ' ' VAL . 1.8 pp -140.71 143.16 31.16 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.183 -0.948 . . . . 0.0 110.501 -179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.762 ' O ' HD12 ' A' ' 54' ' ' ILE . 44.6 Cg_endo -63.1 148.39 93.35 Favored 'Trans proline' 0 C--N 1.304 -1.803 0 O-C-N 124.157 1.609 . . . . 0.0 110.109 179.598 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.593 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 20.4 p90 -84.67 -1.42 56.08 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.294 -0.879 . . . . 0.0 110.895 -179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.539 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 87.8 m-20 -94.6 -26.24 16.45 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.984 -1.073 . . . . 0.0 110.634 -179.536 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.622 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 13.1 m-30 -90.87 6.84 42.81 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.087 -1.008 . . . . 0.0 110.391 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.986 HG11 HD13 ' A' ' 54' ' ' ILE . 31.0 m -132.53 142.18 43.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.216 -0.927 . . . . 0.0 110.053 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.437 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . -131.38 158.92 39.46 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.238 -0.914 . . . . 0.0 110.247 -179.892 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.673 ' HA ' HG12 ' A' ' 9' ' ' VAL . 74.9 mttt -75.28 125.23 28.54 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.252 -0.905 . . . . 0.0 110.259 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -71.96 150.39 44.15 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.222 -0.924 . . . . 0.0 110.245 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 94.9 m-20 . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.166 -179.965 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.459 ' O ' ' O ' ' A' ' 4' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.529 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 0.5 OUTLIER -44.48 -52.61 16.82 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.273 -1.133 . . . . 0.0 110.285 179.988 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.529 ' HD2' ' N ' ' A' ' 2' ' ' SER . 47.0 Cg_endo -72.2 -15.87 28.51 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 O-C-N 123.892 1.469 . . . . 0.0 110.327 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.459 ' O ' ' O ' ' A' ' 1' ' ' GLY . 19.6 tp -102.29 136.88 41.33 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.243 -0.911 . . . . 0.0 110.237 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 60.9 tt0 -107.77 127.85 54.07 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.235 -0.916 . . . . 0.0 110.181 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.895 ' OD1' HD11 ' A' ' 8' ' ' LEU . 50.1 t0 -143.39 83.07 1.76 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.268 -0.895 . . . . 0.0 110.213 179.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.663 ' HB3' HD12 ' A' ' 33' ' ' ILE . 97.5 m-20 -90.63 112.38 24.07 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.267 -0.896 . . . . 0.0 110.268 -179.916 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.895 HD11 ' OD1' ' A' ' 6' ' ' ASP . 5.4 mp -114.71 139.97 49.24 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.261 -0.899 . . . . 0.0 110.094 179.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.696 ' CG1' HD11 ' A' ' 33' ' ' ILE . 21.5 m -138.33 163.78 28.2 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.664 0 O-C-N 121.144 -0.973 . . . . 0.0 110.44 -179.852 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 90.7 mt -112.77 143.39 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.367 -0.833 . . . . 0.0 109.802 179.625 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.65 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . -80.57 110.62 16.22 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.159 -0.963 . . . . 0.0 110.505 -179.672 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.525 HD12 ' N ' ' A' ' 12' ' ' LEU . 6.3 mp -68.56 -22.99 64.45 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.985 -1.072 . . . . 0.0 109.031 179.178 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.497 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 75.3 m-70 -158.29 149.26 20.71 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.593 -0.692 . . . . 0.0 109.342 179.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 54.3 p -61.65 142.75 56.97 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.928 -1.108 . . . . 0.0 109.982 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.595 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 80.1 t80 -98.66 159.97 14.59 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.084 -1.01 . . . . 0.0 110.443 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.9 tp10 -105.63 112.32 64.62 Favored Pre-proline 0 N--CA 1.491 1.601 0 O-C-N 121.278 -0.889 . . . . 0.0 109.999 179.846 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.474 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 49.3 Cg_endo -72.66 89.76 0.84 Allowed 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.965 1.508 . . . . 0.0 110.513 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 60.6 p -79.68 -4.07 50.14 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.929 . . . . 0.0 110.183 179.867 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.0 m-70 -130.47 -176.01 3.83 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.216 -0.927 . . . . 0.0 110.213 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -92.38 -10.85 36.64 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.249 -0.907 . . . . 0.0 110.247 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.32 32.69 5.95 Favored Glycine 0 N--CA 1.49 2.254 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 -179.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 78.1 m-20 -117.8 159.33 23.23 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.278 -1.131 . . . . 0.0 110.385 -179.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.503 ' HA ' HD12 ' A' ' 23' ' ' LEU . 14.5 tp -114.18 118.43 33.98 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.357 -0.84 . . . . 0.0 109.763 179.848 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.474 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -96.23 50.36 1.67 Allowed Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.817 -1.313 . . . . 0.0 109.817 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.65 ' CD2' ' HB1' ' A' ' 11' ' ' ALA . 41.5 p90 -48.1 170.21 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.208 -1.171 . . . . 0.0 110.823 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.442 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 77.2 mm-40 -101.39 178.49 4.63 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.421 -0.8 . . . . 0.0 110.237 -179.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 12' ' ' LEU . 50.0 tttm -70.55 124.07 23.36 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.171 -0.956 . . . . 0.0 110.379 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.86 -8.19 73.61 Favored Glycine 0 N--CA 1.488 2.131 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 179.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.438 ' CD ' ' HB2' ' A' ' 25' ' ' PHE . 45.7 tt0 -67.25 125.54 26.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.116 -1.226 . . . . 0.0 110.374 -179.657 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.441 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 96.4 mt-30 -79.72 138.29 37.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.21 -0.931 . . . . 0.0 109.859 179.78 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.577 HD11 ' CG ' ' A' ' 25' ' ' PHE . 21.1 mt -137.32 159.0 43.19 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.23 -0.919 . . . . 0.0 110.398 -179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.514 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 9.4 ttt180 -101.62 132.32 47.36 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.401 -0.812 . . . . 0.0 109.526 179.415 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.696 HD11 ' CG1' ' A' ' 9' ' ' VAL . 6.8 mt -72.92 115.04 13.17 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.172 -0.955 . . . . 0.0 110.39 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.578 HD11 ' HG2' ' A' ' 51' ' ' GLU . 38.3 mt -83.32 -38.05 22.59 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.217 -0.927 . . . . 0.0 109.929 179.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.432 ' C ' ' HG3' ' A' ' 36' ' ' GLN . 87.3 mt-10 -148.62 170.63 17.7 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.309 -0.869 . . . . 0.0 110.26 -179.985 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.526 HE21 HG21 ' A' ' 33' ' ' ILE . 98.5 mt-30 -147.33 60.46 1.16 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.225 -0.922 . . . . 0.0 110.201 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 84.1 p -130.34 136.47 49.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.267 -0.896 . . . . 0.0 110.222 -179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.95 -170.97 44.17 Favored Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.508 -1.437 . . . . 0.0 109.508 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.9 mt-10 -75.88 -31.89 59.44 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.191 -1.182 . . . . 0.0 110.31 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.556 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 85.8 m95 -100.45 149.43 23.68 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.228 -0.92 . . . . 0.0 110.089 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.517 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 38.2 m0 -119.95 153.28 36.16 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.222 -0.924 . . . . 0.0 110.425 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.478 ' O ' ' N ' ' A' ' 34' ' ' LEU . 41.9 tttp -89.4 142.98 27.18 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.349 -0.844 . . . . 0.0 109.662 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.842 ' HB2' HG12 ' A' ' 54' ' ' ILE . . . -137.22 158.04 45.31 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.138 -0.976 . . . . 0.0 110.805 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.494 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 56.3 tt0 -129.04 138.35 51.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.484 -0.76 . . . . 0.0 109.962 179.701 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.465 ' HB3' ' OG1' ' A' ' 48' ' ' THR . 6.5 t -79.14 140.0 37.89 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.115 -0.991 . . . . 0.0 110.011 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.444 HD21 ' HB2' ' A' ' 32' ' ' ARG . 61.9 mt -92.94 -13.04 29.37 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.226 -0.921 . . . . 0.0 109.885 179.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 96.7 m -99.4 -25.73 14.37 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.426 -0.796 . . . . 0.0 110.349 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.465 ' OG1' ' HB3' ' A' ' 45' ' ' SER . 40.6 p -114.59 -13.42 12.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.063 -1.023 . . . . 0.0 110.398 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 64.88 45.83 91.31 Favored Glycine 0 N--CA 1.489 2.182 0 N-CA-C 109.224 -1.55 . . . . 0.0 109.224 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.494 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 20.2 mt-30 -120.76 152.03 38.82 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.368 -1.078 . . . . 0.0 110.17 -179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.578 ' HG2' HD11 ' A' ' 34' ' ' LEU . 96.7 mt-10 -116.81 134.52 54.68 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.306 -0.871 . . . . 0.0 110.173 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -155.58 151.83 23.36 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.456 -1.458 . . . . 0.0 109.456 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -70.56 143.52 51.56 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.19 -1.182 . . . . 0.0 110.094 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.985 ' CD1' HG21 ' A' ' 59' ' ' VAL . 1.9 pp -138.46 134.73 17.62 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.259 -0.9 . . . . 0.0 110.117 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.59 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 46.0 Cg_endo -59.1 158.92 23.73 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 O-C-N 123.94 1.495 . . . . 0.0 110.286 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.476 ' C ' ' CD1' ' A' ' 56' ' ' PHE . 23.5 p90 -84.14 -5.07 59.19 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.279 -0.888 . . . . 0.0 110.885 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 32.5 t-20 -96.28 -25.13 15.89 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.048 -1.032 . . . . 0.0 110.931 -179.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.59 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 19.2 m-85 -83.92 -8.63 59.13 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.022 -1.049 . . . . 0.0 110.306 -179.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.985 HG21 ' CD1' ' A' ' 54' ' ' ILE . 33.6 m -136.22 146.0 29.86 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.138 -0.977 . . . . 0.0 110.359 -179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -132.56 154.72 49.72 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.271 -0.893 . . . . 0.0 110.22 -180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.532 ' HA ' HG12 ' A' ' 9' ' ' VAL . 41.0 mttp -68.55 125.07 25.36 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.249 -0.907 . . . . 0.0 110.243 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -56.71 -37.95 71.65 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.263 -0.898 . . . . 0.0 110.208 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 84.0 m-20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 118.066 -0.969 . . . . 0.0 110.175 -179.96 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.9 m -65.57 153.98 89.27 Favored Pre-proline 0 N--CA 1.491 1.583 0 O-C-N 121.287 -1.125 . . . . 0.0 110.287 179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.427 ' O ' ' OD1' ' A' ' 6' ' ' ASP . 46.4 Cg_endo -59.99 142.09 97.75 Favored 'Trans proline' 0 C--N 1.304 -1.807 0 O-C-N 124.022 1.538 . . . . 0.0 110.303 -179.931 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.843 HD13 ' O ' ' A' ' 4' ' ' LEU . 3.1 tm? -62.52 -37.72 87.17 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.284 -0.885 . . . . 0.0 110.21 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.403 ' O ' ' HB2' ' A' ' 6' ' ' ASP . 96.4 mt-30 -58.24 -30.49 66.57 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.244 -0.91 . . . . 0.0 110.25 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.427 ' OD1' ' O ' ' A' ' 3' ' ' PRO . 94.8 m-20 54.04 44.31 29.49 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.216 -0.927 . . . . 0.0 110.182 -179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 13.2 t-20 -82.53 5.19 21.6 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.204 -0.935 . . . . 0.0 110.309 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.795 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.5 mp -89.99 154.94 19.44 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.248 -0.907 . . . . 0.0 110.197 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.574 HG22 ' O ' ' A' ' 31' ' ' LEU . 27.8 m -148.32 168.87 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.197 -0.94 . . . . 0.0 110.389 -179.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.413 HD13 ' O ' ' A' ' 9' ' ' VAL . 26.1 mm -112.57 146.44 17.31 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.652 0 O-C-N 121.376 -0.827 . . . . 0.0 109.842 179.694 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.504 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . -80.18 112.29 17.35 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.14 -0.975 . . . . 0.0 110.388 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . . . . . . . . . 27.0 tp -75.27 -22.45 57.78 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.108 -0.995 . . . . 0.0 109.621 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.501 ' HA ' ' HG2' ' A' ' 27' ' ' LYS . 94.7 m-70 -151.97 149.75 29.25 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.492 -0.755 . . . . 0.0 109.762 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.5 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 15.9 t -68.35 141.88 55.65 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.011 -1.056 . . . . 0.0 109.941 179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.593 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 85.8 t80 -98.83 160.08 14.51 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.2 -0.938 . . . . 0.0 110.246 179.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.503 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 2.1 tm-20 -112.38 128.54 25.38 Favored Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.297 -0.877 . . . . 0.0 110.169 -179.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.478 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 47.3 Cg_endo -83.39 82.28 2.11 Favored 'Trans proline' 0 C--N 1.305 -1.758 0 O-C-N 124.028 1.541 . . . . 0.0 110.532 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.513 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 88.9 p -80.8 -0.97 41.07 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.241 -0.912 . . . . 0.0 110.137 179.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.513 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 84.2 m-70 -145.68 179.59 7.33 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.25 -0.906 . . . . 0.0 110.167 179.893 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -90.39 127.92 36.33 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.203 -0.936 . . . . 0.0 110.106 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.76 -3.13 41.89 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 81.1 m-20 -89.97 154.66 19.67 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.266 -1.138 . . . . 0.0 110.278 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.5 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 22.5 tp -109.63 114.6 28.34 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.171 -0.956 . . . . 0.0 110.067 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.478 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -96.17 47.41 1.8 Allowed Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.753 -1.339 . . . . 0.0 109.753 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.589 ' CE1' ' HB2' ' A' ' 15' ' ' TYR . 46.4 p90 -50.43 174.44 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.149 -1.206 . . . . 0.0 111.164 -179.682 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.5 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 83.2 mt-10 -110.59 177.9 4.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.464 -0.772 . . . . 0.0 110.216 -179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.501 ' HG2' ' HA ' ' A' ' 13' ' ' HIS . 5.4 mtmm -69.16 139.39 54.64 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.036 -1.04 . . . . 0.0 110.231 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.15 -16.24 49.16 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 39.0 mm-40 -66.4 125.61 26.2 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.051 -1.264 . . . . 0.0 110.012 -179.845 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.406 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 22.5 tt0 -79.48 137.77 37.33 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.301 -0.875 . . . . 0.0 110.168 -179.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.574 ' O ' HG22 ' A' ' 9' ' ' VAL . 41.4 mt -137.84 159.87 40.83 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.316 -0.865 . . . . 0.0 110.211 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.579 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 37.0 ttp180 -108.48 135.78 49.19 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.324 -0.86 . . . . 0.0 109.623 179.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.522 HD11 HG21 ' A' ' 9' ' ' VAL . 36.9 mm -96.18 92.63 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.166 -0.959 . . . . 0.0 110.435 -179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.494 HD21 ' NE ' ' A' ' 32' ' ' ARG . 17.2 mt -79.45 -24.91 42.11 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.214 -0.929 . . . . 0.0 110.777 -179.546 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.456 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 45.1 tp10 -136.2 134.67 38.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.954 -1.091 . . . . 0.0 110.388 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.636 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 75.3 mt-30 -129.41 54.87 1.79 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.347 -0.846 . . . . 0.0 110.153 -179.969 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.4 m -114.86 154.01 29.43 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 0.0 110.183 -179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 62.26 -173.27 8.53 Favored Glycine 0 N--CA 1.489 2.21 0 N-CA-C 109.356 -1.497 . . . . 0.0 109.356 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 89.0 mt-10 -72.2 -31.91 66.3 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.269 -1.136 . . . . 0.0 110.181 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.425 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 92.5 m95 -97.77 143.06 28.79 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.258 -0.902 . . . . 0.0 110.34 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.636 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 51.2 m0 -120.15 155.41 33.14 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.367 -0.833 . . . . 0.0 110.115 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.491 ' NZ ' ' OE2' ' A' ' 51' ' ' GLU . 48.8 tttt -96.55 141.34 29.94 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.288 -0.882 . . . . 0.0 109.365 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.579 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -149.97 174.58 12.54 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.078 -1.014 . . . . 0.0 110.815 -179.599 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.428 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 61.3 tt0 -141.12 149.53 41.67 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.451 -0.781 . . . . 0.0 109.765 179.778 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.0 t -95.48 111.88 23.7 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.197 -0.94 . . . . 0.0 110.161 -179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.433 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 18.5 tp -71.85 -1.85 15.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.267 -0.896 . . . . 0.0 110.415 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 33.1 m -88.57 -29.1 20.28 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.237 -0.915 . . . . 0.0 110.098 179.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 77.7 p -126.67 -6.15 6.32 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.226 -0.921 . . . . 0.0 110.163 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.21 36.63 59.95 Favored Glycine 0 N--CA 1.489 2.185 0 N-CA-C 109.478 -1.449 . . . . 0.0 109.478 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.414 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 30.8 mt-30 -109.63 144.98 37.22 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.229 -1.159 . . . . 0.0 110.228 -179.919 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.491 ' OE2' ' NZ ' ' A' ' 42' ' ' LYS . 83.5 tt0 -118.52 138.92 52.19 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.264 -0.898 . . . . 0.0 110.033 179.825 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.5 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -166.88 158.17 31.01 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.573 -1.411 . . . . 0.0 109.573 -179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 90.0 m-85 -72.55 143.81 48.16 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.275 -1.132 . . . . 0.0 110.18 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.713 HD13 HG11 ' A' ' 59' ' ' VAL . 1.0 OUTLIER -137.47 145.47 49.47 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.213 -0.929 . . . . 0.0 110.213 -179.866 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.607 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 47.3 Cg_endo -69.51 149.14 68.11 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.98 1.516 . . . . 0.0 110.156 179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.593 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 36.3 p90 -74.99 -4.78 40.32 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.321 -0.862 . . . . 0.0 110.969 -179.523 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 28.3 t-20 -96.17 -25.33 15.88 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.875 -1.141 . . . . 0.0 110.954 -179.414 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.607 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 9.0 m-85 -83.14 -2.16 54.73 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.055 -1.028 . . . . 0.0 110.284 -179.732 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.713 HG11 HD13 ' A' ' 54' ' ' ILE . 33.1 m -136.32 144.08 33.96 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.222 -0.924 . . . . 0.0 110.071 179.946 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -135.23 151.5 50.66 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.138 -0.977 . . . . 0.0 110.242 -179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -62.74 128.03 34.03 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.188 -0.945 . . . . 0.0 110.242 179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.4 -31.49 72.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.236 -0.915 . . . . 0.0 110.149 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 9.5 m120 . . . . . 0 N--CA 1.491 1.606 0 CA-C-O 118.047 -0.978 . . . . 0.0 110.233 179.973 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.288 0 N-CA-C 109.421 -1.472 . . . . 0.0 109.421 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.5 p -64.13 150.17 92.73 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 121.195 -1.179 . . . . 0.0 110.226 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.516 ' CG ' ' NH1' ' A' ' 32' ' ' ARG . 46.6 Cg_endo -55.81 139.87 84.36 Favored 'Trans proline' 0 C--N 1.305 -1.719 0 O-C-N 124.04 1.547 . . . . 0.0 110.336 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 49.9 mt -71.71 -8.19 52.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.239 -0.913 . . . . 0.0 110.211 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.424 ' O ' ' C ' ' A' ' 6' ' ' ASP . 46.1 tt0 -81.43 -34.02 31.78 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.216 -0.927 . . . . 0.0 110.233 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.613 ' O ' HD12 ' A' ' 8' ' ' LEU . 57.0 m-20 42.99 51.11 5.36 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.299 -0.876 . . . . 0.0 110.209 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 63.4 t30 -84.91 102.33 13.04 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.23 -0.919 . . . . 0.0 110.339 -179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.708 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.5 mp -99.92 146.03 27.13 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.269 -0.894 . . . . 0.0 110.206 179.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.729 HG12 ' O ' ' A' ' 60' ' ' ALA . 11.8 m -144.65 167.04 11.56 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.181 -0.949 . . . . 0.0 110.334 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 54.8 mt -111.41 145.51 17.54 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 121.316 -0.865 . . . . 0.0 109.707 179.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.401 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -79.2 112.9 16.88 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.149 -0.97 . . . . 0.0 110.303 -179.761 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.505 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 55.2 mt -71.55 -21.35 61.9 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.105 -0.997 . . . . 0.0 109.487 179.485 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.505 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 62.7 m-70 -157.61 148.86 21.58 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.574 -0.704 . . . . 0.0 109.628 179.966 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.495 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 58.6 p -63.06 143.31 57.9 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.981 -1.075 . . . . 0.0 109.919 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.578 ' CD1' ' HG3' ' A' ' 55' ' ' PRO . 24.4 t80 -96.65 155.05 16.94 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.055 -1.028 . . . . 0.0 110.269 -179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.419 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 0.0 OUTLIER -110.11 75.28 0.88 Allowed Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.334 -0.854 . . . . 0.0 110.17 179.989 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.537 ' HD3' ' CA ' ' A' ' 24' ' ' GLY . 46.8 Cg_endo -46.96 122.5 6.26 Favored 'Trans proline' 0 C--N 1.304 -1.782 0 O-C-N 124.047 1.551 . . . . 0.0 110.372 -179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.499 ' O ' ' CD2' ' A' ' 19' ' ' HIS . 58.4 m -91.89 10.69 27.7 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.366 -0.834 . . . . 0.0 110.128 179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.499 ' CD2' ' O ' ' A' ' 18' ' ' SER . 33.8 m170 -140.55 -158.26 0.84 Allowed 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.303 -0.873 . . . . 0.0 110.192 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 44.4 p30 -112.67 3.92 16.88 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.193 -0.942 . . . . 0.0 110.187 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -113.43 -9.36 17.49 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.487 -1.445 . . . . 0.0 109.487 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.5 ' HB2' ' CB ' ' A' ' 17' ' ' PRO . 84.2 m-20 -81.65 165.7 20.8 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.214 -1.168 . . . . 0.0 110.4 -179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.503 ' HA ' HD12 ' A' ' 23' ' ' LEU . 14.7 tp -113.39 115.19 27.7 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.285 -0.884 . . . . 0.0 109.779 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.537 ' CA ' ' HD3' ' A' ' 17' ' ' PRO . . . -96.18 55.46 1.53 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.516 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 17.9 p90 -54.2 172.71 0.08 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.367 -1.078 . . . . 0.0 110.97 -179.607 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.0 mt-10 -103.53 178.39 4.57 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.514 -0.741 . . . . 0.0 110.145 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -69.97 132.78 46.47 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.154 -0.966 . . . . 0.0 110.101 179.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.13 -10.64 72.25 Favored Glycine 0 N--CA 1.487 2.063 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.483 ' OE2' ' CB ' ' A' ' 25' ' ' PHE . 22.2 tt0 -64.09 126.58 28.18 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.123 -1.222 . . . . 0.0 110.032 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.947 ' C ' HD12 ' A' ' 31' ' ' LEU . 38.1 tt0 -79.47 136.79 37.02 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.178 -0.952 . . . . 0.0 109.857 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.947 HD12 ' C ' ' A' ' 30' ' ' GLN . 7.1 mp -139.8 161.87 36.51 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.241 -0.912 . . . . 0.0 110.593 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.587 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 2.7 tpt180 -109.28 135.9 49.61 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.406 -0.809 . . . . 0.0 109.257 179.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.62 HD11 HG21 ' A' ' 9' ' ' VAL . 33.7 mm -91.21 92.42 3.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.102 -0.998 . . . . 0.0 110.567 -179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.637 HD11 ' HB2' ' A' ' 44' ' ' GLN . 1.5 mt -79.54 -30.01 41.63 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.286 -0.884 . . . . 0.0 110.789 -179.588 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.515 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 77.5 tt0 -133.6 137.12 45.3 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.017 -1.052 . . . . 0.0 110.45 -179.859 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.611 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 75.6 mt-30 -133.65 54.78 1.93 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.276 -0.89 . . . . 0.0 110.092 179.858 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.8 t -120.75 143.25 48.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.232 -0.917 . . . . 0.0 110.221 -179.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.83 -168.62 54.82 Favored Glycine 0 N--CA 1.489 2.167 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -77.49 -33.83 54.41 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.261 -1.141 . . . . 0.0 110.151 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.476 ' CZ3' ' OH ' ' A' ' 15' ' ' TYR . 98.6 m95 -96.79 141.77 29.61 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.3 -0.875 . . . . 0.0 110.251 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.611 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 40.6 m0 -116.83 153.65 32.12 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.256 -0.902 . . . . 0.0 110.199 -179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.515 ' CB ' ' HB3' ' A' ' 35' ' ' GLU . 12.0 tttt -99.9 140.5 34.03 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.372 -0.83 . . . . 0.0 109.409 179.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.587 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -150.36 176.48 10.87 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.069 -1.02 . . . . 0.0 110.662 -179.54 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.637 ' HB2' HD11 ' A' ' 34' ' ' LEU . 62.0 tt0 -139.01 147.57 42.3 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.368 -0.832 . . . . 0.0 109.96 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 1.5 t -97.21 117.03 30.51 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.181 -0.95 . . . . 0.0 110.303 -179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 55.5 mt -76.6 2.59 13.59 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.168 -0.958 . . . . 0.0 110.118 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 71.9 m -91.58 -35.58 14.18 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.257 -0.902 . . . . 0.0 110.163 179.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 70.8 p -118.62 -6.02 10.68 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.286 -0.884 . . . . 0.0 110.237 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 69.93 43.73 64.5 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.445 -1.462 . . . . 0.0 109.445 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.46 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 7.0 mt-30 -121.17 149.61 42.55 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.199 -1.177 . . . . 0.0 110.234 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.464 ' OE2' ' HE2' ' A' ' 42' ' ' LYS . 82.3 tt0 -122.83 145.47 48.4 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.246 -0.909 . . . . 0.0 110.132 179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.465 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -174.36 163.71 34.51 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.567 -1.413 . . . . 0.0 109.567 -179.988 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.436 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 90.4 m-85 -75.24 146.08 41.42 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.322 -1.105 . . . . 0.0 109.847 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.627 HD13 HG21 ' A' ' 59' ' ' VAL . 1.5 pp -140.02 140.46 24.06 Favored Pre-proline 0 N--CA 1.491 1.609 0 O-C-N 121.135 -0.978 . . . . 0.0 110.544 -179.7 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.635 ' CG ' ' CD2' ' A' ' 58' ' ' PHE . 44.6 Cg_endo -60.22 145.17 99.11 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.164 1.613 . . . . 0.0 110.062 179.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.585 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 21.9 p90 -82.7 -5.12 58.71 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.217 -0.927 . . . . 0.0 110.927 -179.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -91.59 -27.48 18.14 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.928 -1.108 . . . . 0.0 110.648 -179.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.635 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 18.2 m-30 -85.86 6.82 26.53 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.106 -0.997 . . . . 0.0 110.105 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.627 HG21 HD13 ' A' ' 54' ' ' ILE . 26.4 t -141.85 169.46 13.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.288 -0.882 . . . . 0.0 109.769 179.706 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.729 ' O ' HG12 ' A' ' 9' ' ' VAL . . . -159.91 156.3 27.02 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.089 -1.007 . . . . 0.0 110.267 -179.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.432 ' HA ' HG12 ' A' ' 9' ' ' VAL . 48.5 tttm -56.74 129.5 41.49 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.206 -0.934 . . . . 0.0 110.3 -179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.06 148.83 48.85 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.311 -0.868 . . . . 0.0 110.236 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 85.0 m-20 . . . . . 0 N--CA 1.49 1.549 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.309 179.927 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.263 0 N-CA-C 109.49 -1.444 . . . . 0.0 109.49 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.513 ' N ' ' HD2' ' A' ' 3' ' ' PRO . 0.3 OUTLIER -45.17 -58.39 5.78 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 121.221 -1.164 . . . . 0.0 110.162 -179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.513 ' HD2' ' N ' ' A' ' 2' ' ' SER . 47.4 Cg_endo -66.64 147.9 82.39 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.033 1.544 . . . . 0.0 110.337 179.952 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 20.0 tp -104.2 132.44 50.45 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.292 -0.88 . . . . 0.0 110.256 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 93.8 mt-30 -121.48 161.73 21.74 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.182 -0.949 . . . . 0.0 110.214 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -147.1 81.18 1.54 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.251 -0.906 . . . . 0.0 110.182 179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.417 ' HB3' ' HB ' ' A' ' 33' ' ' ILE . 70.4 m-20 -98.56 101.75 13.27 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.306 -0.871 . . . . 0.0 110.358 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.448 ' O ' HG13 ' A' ' 9' ' ' VAL . 9.5 tp -110.8 153.09 25.85 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.309 -0.869 . . . . 0.0 110.065 179.858 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.078 HG21 HD11 ' A' ' 33' ' ' ILE . 4.1 m -152.32 172.96 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 121.129 -0.982 . . . . 0.0 110.464 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 46.6 mt -120.14 140.46 44.11 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.576 0 O-C-N 121.406 -0.809 . . . . 0.0 109.511 179.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.573 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -74.22 114.69 12.86 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.176 -0.952 . . . . 0.0 110.33 -179.563 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.418 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 23.9 tp -71.18 -21.58 62.14 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.226 -0.921 . . . . 0.0 109.264 179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.418 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 65.5 m-70 -154.94 -163.63 1.61 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.607 -0.683 . . . . 0.0 109.733 179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.407 ' O ' ' OE2' ' A' ' 16' ' ' GLU . 30.1 t -106.91 135.76 47.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.085 -1.009 . . . . 0.0 109.756 179.663 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.607 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 81.5 t80 -97.15 151.79 19.44 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 120.993 -1.067 . . . . 0.0 110.4 -179.852 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.407 ' OE2' ' O ' ' A' ' 14' ' ' SER . 1.9 mp0 -117.09 102.71 52.59 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.337 -0.852 . . . . 0.0 110.209 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.485 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 46.9 Cg_endo -62.99 98.91 0.21 Allowed 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.013 1.533 . . . . 0.0 110.366 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.566 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 97.8 p -81.25 7.43 11.37 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.235 -0.916 . . . . 0.0 110.144 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.566 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 97.8 m-70 -154.27 -177.59 6.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.269 -0.894 . . . . 0.0 110.143 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -88.49 130.69 35.15 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.11 -0.994 . . . . 0.0 110.239 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.76 13.45 25.69 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.501 -1.44 . . . . 0.0 109.501 -179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 84.0 m-20 -109.3 159.18 17.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.165 -1.197 . . . . 0.0 110.403 -179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.505 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 15.7 tp -115.26 120.07 38.44 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.307 -0.871 . . . . 0.0 110.177 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.49 ' HA2' ' HB3' ' A' ' 15' ' ' TYR . . . -101.54 58.41 0.64 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.494 -1.442 . . . . 0.0 109.494 179.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.607 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 34.9 p90 -52.94 171.35 0.06 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.14 -1.212 . . . . 0.0 111.326 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.516 ' N ' ' OE1' ' A' ' 29' ' ' GLU . 94.4 mt-10 -105.06 178.35 4.59 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.565 -0.71 . . . . 0.0 109.949 179.729 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.7 ttpp -69.84 129.46 39.61 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.117 -0.989 . . . . 0.0 110.3 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.45 -15.04 56.36 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.59 -1.404 . . . . 0.0 109.59 179.82 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.551 ' OE2' HD21 ' A' ' 31' ' ' LEU . 24.4 tt0 -59.02 124.4 19.8 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.134 -1.215 . . . . 0.0 110.063 -179.879 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.44 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 88.9 mt-30 -79.9 134.18 36.28 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.139 -0.976 . . . . 0.0 109.991 179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.551 HD21 ' OE2' ' A' ' 29' ' ' GLU . 10.8 mt -133.07 154.04 50.93 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.204 -0.935 . . . . 0.0 110.313 -179.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.512 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 14.5 ttt180 -97.33 132.69 42.82 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.334 -0.853 . . . . 0.0 109.686 179.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.078 HD11 HG21 ' A' ' 9' ' ' VAL . 23.4 mm -77.85 118.92 25.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.179 -0.951 . . . . 0.0 110.396 -179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.528 HD21 ' HB2' ' A' ' 44' ' ' GLN . 45.7 mt -87.78 -34.55 18.27 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.231 -0.918 . . . . 0.0 109.94 179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -172.72 125.49 0.47 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.448 -0.782 . . . . 0.0 109.956 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.58 ' HA ' ' CG ' ' A' ' 41' ' ' TRP . 95.1 mt-30 -101.87 62.88 0.91 Allowed 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.211 -0.931 . . . . 0.0 110.304 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 57.5 m -108.54 136.18 48.58 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.347 -0.846 . . . . 0.0 110.129 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.56 -175.04 53.52 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.484 -1.446 . . . . 0.0 109.484 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.5 mt-10 -65.47 -36.88 85.21 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.288 -1.125 . . . . 0.0 110.181 -179.933 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.561 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 91.8 m95 -95.12 140.32 30.21 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.259 -0.9 . . . . 0.0 110.32 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.58 ' CG ' ' HA ' ' A' ' 36' ' ' GLN . 52.3 m0 -113.63 148.89 35.42 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.303 -0.873 . . . . 0.0 110.257 179.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.505 ' CB ' ' HB2' ' A' ' 34' ' ' LEU . 24.5 mttm -86.25 141.8 29.03 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.261 -0.9 . . . . 0.0 109.703 179.587 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.626 ' HB2' HG12 ' A' ' 54' ' ' ILE . . . -146.28 167.03 24.52 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.127 -0.983 . . . . 0.0 110.485 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.528 ' HB2' HD21 ' A' ' 34' ' ' LEU . 58.7 tt0 -137.63 145.48 42.78 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.339 -0.85 . . . . 0.0 110.148 -179.959 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 7.6 t -90.56 113.31 25.29 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.113 -0.992 . . . . 0.0 109.892 179.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 78.5 mt -74.82 3.49 8.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.159 -0.963 . . . . 0.0 110.541 -179.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 86.0 m -96.54 -33.33 11.86 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.107 -0.996 . . . . 0.0 110.032 179.81 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 3.6 m -119.17 -7.63 10.27 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.239 -0.913 . . . . 0.0 110.24 -179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.05 42.45 51.59 Favored Glycine 0 N--CA 1.489 2.2 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 4.9 mt-30 -119.52 148.02 43.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.257 -1.143 . . . . 0.0 110.073 179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.501 ' HG2' ' CG ' ' A' ' 44' ' ' GLN . 90.9 mt-10 -118.07 138.27 52.35 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.182 -0.948 . . . . 0.0 110.325 -179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.505 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -159.27 154.91 25.99 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.418 ' HE1' ' HZ3' ' A' ' 42' ' ' LYS . 99.0 m-85 -68.56 146.22 53.28 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.121 -1.223 . . . . 0.0 110.198 -179.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.626 HG12 ' HB2' ' A' ' 43' ' ' ALA . 1.3 pt -136.41 147.9 61.9 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.312 -0.868 . . . . 0.0 110.215 -179.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.598 ' HD3' ' CD1' ' A' ' 15' ' ' TYR . 43.7 Cg_endo -72.76 145.46 41.07 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 124.046 1.551 . . . . 0.0 110.327 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.534 ' HB2' ' CH2' ' A' ' 41' ' ' TRP . 21.0 p90 -81.56 -0.02 40.24 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.518 -0.739 . . . . 0.0 110.592 -179.684 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.491 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 85.5 m-20 -98.74 -27.56 13.9 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.051 -1.031 . . . . 0.0 110.942 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.54 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 18.2 m-30 -90.88 5.86 46.84 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 120.93 -1.106 . . . . 0.0 110.482 -179.734 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.561 HG12 ' HB ' ' A' ' 9' ' ' VAL . 8.4 t -145.06 164.2 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.188 -0.945 . . . . 0.0 110.137 179.777 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.793 ' O ' HG12 ' A' ' 9' ' ' VAL . . . -154.97 167.6 29.8 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.311 -0.868 . . . . 0.0 110.295 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.436 ' HA ' HG12 ' A' ' 9' ' ' VAL . 64.6 tttt -70.97 132.67 45.53 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.286 -0.884 . . . . 0.0 110.165 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -82.83 147.2 28.49 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.205 -0.934 . . . . 0.0 110.195 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 83.4 m-20 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 118.024 -0.989 . . . . 0.0 110.167 179.971 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.276 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.436 ' O ' ' HG ' ' A' ' 4' ' ' LEU . 0.6 OUTLIER -128.45 68.94 78.37 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.308 -1.113 . . . . 0.0 110.1 -179.991 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 5' ' ' GLN . 47.1 Cg_endo -48.01 -45.95 23.54 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.044 1.549 . . . . 0.0 110.379 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 3' ' ' PRO . 35.0 mt 55.86 -85.34 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.25 -0.906 . . . . 0.0 110.257 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.503 ' N ' ' O ' ' A' ' 3' ' ' PRO . 98.2 mt-30 -109.41 140.73 42.76 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.254 -0.904 . . . . 0.0 110.315 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.477 ' N ' ' OD1' ' A' ' 6' ' ' ASP . 35.1 p-10 -92.17 7.62 41.74 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.218 -0.926 . . . . 0.0 110.157 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 72.6 m-20 -86.71 2.47 48.51 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.246 -0.909 . . . . 0.0 110.23 -179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.417 ' C ' HG13 ' A' ' 9' ' ' VAL . 36.5 mt -83.64 140.68 32.04 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.193 -0.942 . . . . 0.0 110.189 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.689 HG12 ' HA ' ' A' ' 61' ' ' LYS . 12.6 m -150.95 170.63 1.41 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.611 0 O-C-N 121.249 -0.907 . . . . 0.0 110.342 -179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.483 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 19.6 mm -114.35 143.34 24.28 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.307 -0.87 . . . . 0.0 110.076 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.824 ' HB1' ' CE1' ' A' ' 25' ' ' PHE . . . -79.63 110.82 15.33 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.119 -0.988 . . . . 0.0 110.134 179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.439 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 15.9 tp -63.68 -24.67 67.88 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.05 -1.032 . . . . 0.0 109.529 179.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.439 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 37.0 m-70 -156.57 158.55 37.31 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.481 -0.762 . . . . 0.0 109.818 179.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.555 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 28.3 p -67.32 142.11 56.93 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.118 -0.989 . . . . 0.0 110.161 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.595 ' HB2' ' CE2' ' A' ' 25' ' ' PHE . 81.8 t80 -97.67 158.34 15.55 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.132 -0.98 . . . . 0.0 110.339 179.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.491 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -110.11 126.92 27.97 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.249 -0.907 . . . . 0.0 110.055 179.925 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.478 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.1 Cg_endo -82.91 81.16 2.47 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.976 1.514 . . . . 0.0 110.382 -179.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 55.8 p -79.76 -1.08 37.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.236 -0.915 . . . . 0.0 110.078 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 82.4 t60 -142.69 169.46 17.54 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.155 -0.966 . . . . 0.0 110.136 179.931 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -83.87 130.6 34.91 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.287 -0.883 . . . . 0.0 110.216 -179.916 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 101.26 4.01 53.68 Favored Glycine 0 N--CA 1.489 2.213 0 N-CA-C 109.628 -1.389 . . . . 0.0 109.628 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -98.88 161.15 13.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.171 -1.194 . . . . 0.0 110.238 179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.58 HD13 ' HG3' ' A' ' 50' ' ' GLN . 31.9 tp -114.71 120.11 38.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.299 -0.875 . . . . 0.0 110.141 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.478 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -100.92 50.52 1.02 Allowed Glycine 0 N--CA 1.491 2.351 0 N-CA-C 109.565 -1.414 . . . . 0.0 109.565 -179.901 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.824 ' CE1' ' HB1' ' A' ' 11' ' ' ALA . 48.0 p90 -50.76 176.33 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.122 -1.222 . . . . 0.0 111.12 -179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.555 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 83.4 mt-10 -107.63 174.11 6.03 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.52 -0.738 . . . . 0.0 110.253 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.3 pttp -68.37 139.76 55.84 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.122 -0.986 . . . . 0.0 110.405 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.26 -13.27 55.72 Favored Glycine 0 N--CA 1.488 2.108 0 N-CA-C 109.742 -1.343 . . . . 0.0 109.742 179.704 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.472 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 38.0 mm-40 -67.92 125.59 26.77 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.015 -1.285 . . . . 0.0 110.262 -179.778 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.984 ' C ' HD12 ' A' ' 31' ' ' LEU . 80.4 mt-30 -79.53 138.69 37.6 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.226 -0.921 . . . . 0.0 109.663 179.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.984 HD12 ' C ' ' A' ' 30' ' ' GLN . 8.3 mp -136.56 156.78 48.11 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.046 -1.034 . . . . 0.0 110.633 -179.429 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.588 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 15.9 mtm180 -103.92 131.32 51.26 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.387 -0.821 . . . . 0.0 109.394 179.409 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.592 HD11 HG11 ' A' ' 9' ' ' VAL . 99.4 mt -88.71 93.5 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.087 -1.008 . . . . 0.0 110.669 -179.571 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 1.02 HD12 ' HA ' ' A' ' 43' ' ' ALA . 1.6 mp -79.25 -31.55 43.55 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.342 -0.849 . . . . 0.0 110.85 -179.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.526 ' HB2' ' CB ' ' A' ' 42' ' ' LYS . 79.5 mt-10 -127.62 140.03 52.36 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 120.848 -1.158 . . . . 0.0 110.191 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.637 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 49.7 tt0 -135.06 59.7 1.72 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.322 -0.861 . . . . 0.0 110.263 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 28.8 t -125.2 130.98 53.21 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.264 -0.897 . . . . 0.0 110.219 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.35 177.29 51.82 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.27 -30.89 71.94 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.236 -1.155 . . . . 0.0 110.281 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . . . . . . . . . 94.0 m95 -98.33 144.45 27.71 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.234 -0.916 . . . . 0.0 110.263 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.637 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 43.6 m0 -126.08 157.88 36.87 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.37 -0.831 . . . . 0.0 110.166 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.526 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 28.7 tttt -100.03 146.78 26.35 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.283 -0.886 . . . . 0.0 109.327 179.34 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 1.02 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -157.94 -175.97 5.66 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.916 -1.115 . . . . 0.0 110.834 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 65.5 tt0 -146.03 154.31 41.72 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.416 -0.803 . . . . 0.0 109.622 179.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 23.3 t -101.71 125.68 48.42 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.105 -0.997 . . . . 0.0 110.392 -179.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.463 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 44.0 tp -81.39 6.12 15.44 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.387 -0.821 . . . . 0.0 110.135 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.9 m -93.29 -37.96 11.76 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.324 -0.86 . . . . 0.0 110.226 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 66.8 p -125.39 -7.52 6.97 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.231 -0.918 . . . . 0.0 110.188 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.91 27.28 56.82 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.58 ' HG3' HD13 ' A' ' 23' ' ' LEU . 70.3 tp60 -90.79 131.71 36.29 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.318 -1.107 . . . . 0.0 110.3 179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.458 ' HG3' ' O ' ' A' ' 51' ' ' GLU . 22.7 pt-20 -115.97 134.33 55.09 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.322 -0.861 . . . . 0.0 110.057 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.438 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -172.49 166.21 38.88 Favored Glycine 0 N--CA 1.49 2.282 0 N-CA-C 109.695 -1.362 . . . . 0.0 109.695 -179.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.496 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 59.4 m-85 -69.05 142.31 54.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.258 -1.142 . . . . 0.0 110.288 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.668 HD12 ' O ' ' A' ' 55' ' ' PRO . 1.6 pp -136.19 138.51 27.47 Favored Pre-proline 0 N--CA 1.491 1.62 0 O-C-N 121.292 -0.88 . . . . 0.0 110.107 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.668 ' O ' HD12 ' A' ' 54' ' ' ILE . 47.3 Cg_endo -64.61 154.94 69.55 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.916 1.482 . . . . 0.0 110.289 179.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.608 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 22.3 p90 -83.97 -1.46 54.7 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.318 -0.864 . . . . 0.0 110.643 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.567 ' OD1' ' CE2' ' A' ' 56' ' ' PHE . 87.3 m-20 -98.39 -26.1 14.59 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.043 -1.036 . . . . 0.0 110.965 -179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 11' ' ' ALA . 14.9 m-85 -83.16 -0.61 50.05 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.925 -1.109 . . . . 0.0 110.285 -179.628 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.527 HG11 HD13 ' A' ' 54' ' ' ILE . 27.8 m -135.16 147.21 29.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.092 -1.005 . . . . 0.0 110.304 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.548 ' O ' HG12 ' A' ' 9' ' ' VAL . . . -125.0 162.33 24.75 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.211 -0.931 . . . . 0.0 110.223 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.689 ' HA ' HG12 ' A' ' 9' ' ' VAL . 39.6 mttp -77.36 130.82 37.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.304 -0.873 . . . . 0.0 110.21 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -49.6 144.9 5.46 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.246 -0.909 . . . . 0.0 110.248 -179.956 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 27.2 t30 . . . . . 0 N--CA 1.492 1.645 0 CA-C-O 117.947 -1.025 . . . . 0.0 110.159 179.994 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 109.408 -1.477 . . . . 0.0 109.408 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -67.27 144.61 98.23 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.262 -1.14 . . . . 0.0 110.23 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -56.7 153.65 35.27 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 124.047 1.551 . . . . 0.0 110.349 -179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 33.9 mt -61.21 -29.5 69.86 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.233 -0.917 . . . . 0.0 110.197 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.464 ' HA ' ' CD2' ' A' ' 34' ' ' LEU . 93.6 mt-30 -60.56 -33.47 72.74 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.927 . . . . 0.0 110.233 179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.468 ' O ' ' CD1' ' A' ' 8' ' ' LEU . 81.3 m-20 -88.04 6.8 34.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.27 -0.894 . . . . 0.0 110.236 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.54 ' C ' HD12 ' A' ' 8' ' ' LEU . 4.8 t30 -84.31 109.91 18.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.293 -0.88 . . . . 0.0 110.212 179.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.668 HD12 ' N ' ' A' ' 8' ' ' LEU . 7.0 mp -110.47 156.05 21.39 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.197 -0.939 . . . . 0.0 110.217 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.769 HG21 HG11 ' A' ' 59' ' ' VAL . 13.2 m -152.3 171.32 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.277 -0.889 . . . . 0.0 110.306 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 70.3 mt -112.88 144.12 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 O-C-N 121.349 -0.844 . . . . 0.0 109.923 179.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.625 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -80.25 111.0 16.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.182 -0.949 . . . . 0.0 110.268 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.634 HD22 ' N ' ' A' ' 12' ' ' LEU . 4.1 mm? -64.6 -26.2 68.3 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.17 -0.956 . . . . 0.0 109.448 179.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.47 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 52.5 m80 -156.9 154.56 29.96 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.54 -0.725 . . . . 0.0 109.661 179.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.56 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 53.8 p -64.69 143.4 57.96 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.985 -1.072 . . . . 0.0 110.056 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.594 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 89.1 t80 -100.57 164.1 12.05 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.036 -1.04 . . . . 0.0 110.26 179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.459 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.4 OUTLIER -117.94 125.32 28.07 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.367 -0.833 . . . . 0.0 110.098 179.975 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.475 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.3 Cg_endo -78.39 82.25 2.52 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.016 1.535 . . . . 0.0 110.369 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 72.6 m -79.74 -2.53 43.47 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.291 -0.88 . . . . 0.0 109.966 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.437 ' CG ' ' N ' ' A' ' 20' ' ' ASP . 86.4 t60 -145.09 172.2 13.42 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.369 -0.832 . . . . 0.0 110.095 179.873 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . 0.437 ' N ' ' CG ' ' A' ' 19' ' ' HIS . 21.8 t70 -80.32 129.51 34.55 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.175 -0.953 . . . . 0.0 110.223 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 97.46 18.01 29.56 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.474 -1.45 . . . . 0.0 109.474 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 29.5 m-20 -106.9 150.02 26.85 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.3 -1.118 . . . . 0.0 110.284 179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.467 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 15.3 tp -105.75 112.08 25.01 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.311 -0.868 . . . . 0.0 110.042 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.475 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -95.28 45.23 2.08 Favored Glycine 0 N--CA 1.492 2.392 0 N-CA-C 109.808 -1.317 . . . . 0.0 109.808 -179.782 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.625 ' CE2' ' HB1' ' A' ' 11' ' ' ALA . 40.6 p90 -46.64 171.62 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.203 -1.175 . . . . 0.0 110.865 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.56 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 88.0 mt-10 -101.74 177.29 4.95 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.464 -0.773 . . . . 0.0 110.259 -179.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.4 tttm -69.69 126.65 30.37 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.266 -0.896 . . . . 0.0 110.272 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.71 -8.66 74.01 Favored Glycine 0 N--CA 1.489 2.173 0 N-CA-C 109.56 -1.416 . . . . 0.0 109.56 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.443 ' CD ' ' HB2' ' A' ' 25' ' ' PHE . 20.9 tt0 -67.27 126.03 27.95 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.195 -1.18 . . . . 0.0 110.317 -179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.704 ' O ' HD23 ' A' ' 31' ' ' LEU . 89.4 mt-30 -79.49 138.22 37.47 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.258 -0.901 . . . . 0.0 109.929 179.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.704 HD23 ' O ' ' A' ' 30' ' ' GLN . 14.4 mt -140.44 162.74 34.62 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.245 -0.909 . . . . 0.0 110.38 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.603 ' CD ' HD21 ' A' ' 34' ' ' LEU . 25.2 ttp180 -106.01 133.33 50.9 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.313 -0.867 . . . . 0.0 109.682 179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.537 ' CD1' HG11 ' A' ' 9' ' ' VAL . 15.5 mt -97.82 94.67 3.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.685 0 O-C-N 121.104 -0.997 . . . . 0.0 110.623 -179.756 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.603 HD21 ' CD ' ' A' ' 32' ' ' ARG . 50.0 mt -79.46 -22.48 44.05 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.208 -0.932 . . . . 0.0 110.777 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.553 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 83.2 tt0 -136.39 129.69 31.63 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.961 -1.087 . . . . 0.0 110.33 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.628 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 97.0 mt-30 -126.32 54.19 1.58 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.352 -0.842 . . . . 0.0 110.122 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.5 p -119.47 157.91 27.31 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.24 -0.913 . . . . 0.0 110.278 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 66.23 -172.1 26.97 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.9 mt-10 -72.54 -34.66 67.69 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.218 -1.166 . . . . 0.0 110.28 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.409 ' HZ3' ' CE1' ' A' ' 15' ' ' TYR . 69.1 m95 -101.81 150.07 23.53 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.228 -0.92 . . . . 0.0 110.441 -179.906 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.628 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 50.8 m0 -120.75 154.69 35.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.357 -0.84 . . . . 0.0 110.264 -179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.553 ' CB ' ' HB3' ' A' ' 35' ' ' GLU . 67.3 tttt -95.53 143.49 26.8 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.569 179.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.6 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -153.27 176.89 11.46 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.933 -1.104 . . . . 0.0 111.085 -179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.486 ' HG3' ' O ' ' A' ' 50' ' ' GLN . 48.7 tt0 -143.67 152.01 40.8 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.591 -0.693 . . . . 0.0 109.722 179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.413 ' CB ' ' OG1' ' A' ' 48' ' ' THR . 17.3 m -85.1 149.35 25.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.164 -0.96 . . . . 0.0 110.298 -179.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.699 ' N ' HD12 ' A' ' 46' ' ' LEU . 6.6 mp -98.39 -13.2 20.75 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.325 -0.859 . . . . 0.0 109.964 179.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 66.8 p -101.04 -27.49 13.24 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.355 -0.84 . . . . 0.0 110.234 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.413 ' OG1' ' CB ' ' A' ' 45' ' ' SER . 81.4 p -107.62 -18.57 13.8 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.215 -0.928 . . . . 0.0 110.316 -179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.99 41.82 80.28 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 109.254 -1.538 . . . . 0.0 109.254 -179.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.486 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 7.2 mt-30 -119.21 150.21 40.45 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.3 -1.118 . . . . 0.0 110.281 -179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 81.9 tt0 -116.43 134.08 55.28 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.211 -0.93 . . . . 0.0 110.181 179.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.467 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -160.03 154.88 25.96 Favored Glycine 0 N--CA 1.49 2.277 0 N-CA-C 109.459 -1.456 . . . . 0.0 109.459 -179.88 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -69.26 142.56 54.12 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.272 -1.134 . . . . 0.0 109.984 179.879 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.452 ' O ' HG13 ' A' ' 54' ' ' ILE . 1.7 pt -131.97 132.35 23.1 Favored Pre-proline 0 N--CA 1.491 1.617 0 O-C-N 121.182 -0.949 . . . . 0.0 110.437 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.591 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 47.9 Cg_endo -61.1 156.11 46.77 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.981 1.517 . . . . 0.0 109.884 179.714 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.551 ' CE1' ' OD1' ' A' ' 57' ' ' ASN . 41.7 p90 -80.12 -8.14 59.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.194 -0.941 . . . . 0.0 111.326 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.551 ' OD1' ' CE1' ' A' ' 56' ' ' PHE . 58.7 m-20 -92.49 -26.59 17.89 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.766 -1.209 . . . . 0.0 110.98 -179.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.59 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 21.8 m-85 -82.94 -6.38 59.45 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.999 -1.063 . . . . 0.0 110.048 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.769 HG11 HG21 ' A' ' 9' ' ' VAL . 58.1 t -132.38 174.71 12.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.347 -0.845 . . . . 0.0 109.723 179.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.576 ' N ' HG12 ' A' ' 59' ' ' VAL . . . -159.98 149.97 18.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.114 -0.991 . . . . 0.0 110.244 -179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.42 ' O ' ' C ' ' A' ' 62' ' ' ALA . 66.2 mttm -68.51 113.86 6.41 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.275 -0.89 . . . . 0.0 110.289 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 61' ' ' LYS . . . -42.94 141.3 1.15 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.286 -0.884 . . . . 0.0 110.269 -179.934 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 28.1 m120 . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.987 -1.006 . . . . 0.0 110.247 -179.972 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.325 0 N-CA-C 109.485 -1.446 . . . . 0.0 109.485 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 29.7 t -132.99 76.61 69.95 Favored Pre-proline 0 N--CA 1.492 1.628 0 O-C-N 121.17 -1.194 . . . . 0.0 110.23 -180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -43.25 146.74 1.0 Allowed 'Trans proline' 0 C--N 1.304 -1.766 0 O-C-N 124.039 1.547 . . . . 0.0 110.328 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 26.8 tp -108.67 121.28 44.7 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.256 -0.903 . . . . 0.0 110.275 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 91.0 mt-30 -120.1 161.69 20.56 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.259 -0.901 . . . . 0.0 110.199 -179.949 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 79.6 m-20 -67.64 -30.33 69.87 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.26 -0.9 . . . . 0.0 110.19 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 63.3 m-20 -88.18 -12.74 43.0 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.138 -0.976 . . . . 0.0 110.264 -179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.555 ' O ' HG13 ' A' ' 9' ' ' VAL . 41.4 tp -71.47 143.81 49.9 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.243 -0.91 . . . . 0.0 110.177 179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.634 HG12 ' O ' ' A' ' 60' ' ' ALA . 3.7 m -155.36 173.33 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.236 -0.915 . . . . 0.0 110.271 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 58.1 mt -117.38 142.09 33.04 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.328 -0.857 . . . . 0.0 109.807 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.817 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -78.58 113.76 16.89 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.144 -0.972 . . . . 0.0 110.257 -179.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.53 HD12 ' N ' ' A' ' 12' ' ' LEU . 7.2 mp -66.71 -26.83 67.2 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.071 -1.018 . . . . 0.0 109.542 179.536 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . . . . . . . . . 95.7 m-70 -149.95 155.4 39.91 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.459 -0.775 . . . . 0.0 109.764 179.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.547 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 53.0 p -68.59 143.04 54.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.089 -1.007 . . . . 0.0 110.05 179.92 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.584 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 81.2 t80 -101.69 164.53 11.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.014 -1.054 . . . . 0.0 110.354 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.563 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 28.2 mm-40 -118.01 129.67 25.21 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.314 -0.866 . . . . 0.0 110.126 179.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.482 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 49.2 Cg_endo -81.56 81.91 2.51 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.926 1.487 . . . . 0.0 110.535 -179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 81.0 p -79.72 -1.97 40.88 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.172 -0.955 . . . . 0.0 110.06 179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 74.7 m80 -144.06 -176.8 5.15 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.194 -0.941 . . . . 0.0 110.135 179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -92.69 131.61 37.62 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.266 -0.896 . . . . 0.0 110.072 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.36 -5.33 57.27 Favored Glycine 0 N--CA 1.489 2.202 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.0 m-20 -89.07 157.38 18.35 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.14 -1.212 . . . . 0.0 110.294 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.471 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 32.1 tp -115.3 120.06 38.38 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.29 -0.881 . . . . 0.0 110.079 179.837 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.482 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -97.74 47.85 1.52 Allowed Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.951 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.817 ' CE2' ' HB1' ' A' ' 11' ' ' ALA . 46.6 p90 -49.29 174.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.24 -1.153 . . . . 0.0 111.305 -179.69 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.547 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 95.8 mt-10 -107.63 173.68 6.22 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.523 -0.736 . . . . 0.0 109.943 179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 33.3 tttm -68.39 139.45 55.81 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.098 -1.001 . . . . 0.0 110.355 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.16 -15.41 49.41 Favored Glycine 0 N--CA 1.488 2.116 0 N-CA-C 109.439 -1.464 . . . . 0.0 109.439 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.516 ' O ' ' CD1' ' A' ' 31' ' ' LEU . 22.8 tt0 -62.28 124.4 20.79 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.116 -1.226 . . . . 0.0 110.016 -179.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.973 ' C ' HD12 ' A' ' 31' ' ' LEU . 91.9 mt-30 -79.9 136.87 36.76 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.281 -0.887 . . . . 0.0 109.902 179.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.973 HD12 ' C ' ' A' ' 30' ' ' GLN . 6.6 mp -141.65 163.61 32.46 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.126 -0.984 . . . . 0.0 110.533 -179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.83 ' HE ' HD11 ' A' ' 34' ' ' LEU . 10.5 ptt180 -112.72 136.85 51.84 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.351 -0.843 . . . . 0.0 109.575 179.305 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.662 HG21 HE21 ' A' ' 36' ' ' GLN . 61.8 mt -90.74 95.28 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.175 -0.953 . . . . 0.0 110.655 -179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.83 HD11 ' HE ' ' A' ' 32' ' ' ARG . 1.2 mt -79.46 -30.49 42.16 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.303 -0.873 . . . . 0.0 110.778 -179.517 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.547 ' CG ' ' HB3' ' A' ' 42' ' ' LYS . 39.8 mm-40 -135.07 139.76 45.0 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.885 -1.135 . . . . 0.0 110.438 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.662 HE21 HG21 ' A' ' 33' ' ' ILE . 86.7 mt-30 -130.9 54.67 1.89 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.282 -0.886 . . . . 0.0 110.158 179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.0 m -116.87 145.7 43.4 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.285 -0.884 . . . . 0.0 110.237 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 70.28 172.15 10.6 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.3 -28.01 66.38 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.181 -1.188 . . . . 0.0 110.16 179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.569 ' CZ3' ' OH ' ' A' ' 15' ' ' TYR . 94.8 m95 -99.53 144.67 28.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.287 -0.883 . . . . 0.0 110.282 -179.977 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.626 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.6 m0 -120.79 156.36 32.04 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.318 -0.864 . . . . 0.0 110.149 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.547 ' HB3' ' CG ' ' A' ' 35' ' ' GLU . 24.6 tttp -98.32 140.25 32.88 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.23 -0.919 . . . . 0.0 109.372 179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.634 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -156.25 -178.41 7.3 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.061 -1.024 . . . . 0.0 110.618 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.514 ' HB3' ' CD ' ' A' ' 32' ' ' ARG . 48.4 tt0 -151.09 158.81 44.53 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.479 -0.763 . . . . 0.0 109.72 179.762 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.418 ' HA ' ' HA ' ' A' ' 31' ' ' LEU . 0.7 OUTLIER -108.01 140.04 41.76 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.155 -0.966 . . . . 0.0 110.357 -179.8 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.42 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 22.7 tp -90.85 11.2 23.31 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.324 -0.86 . . . . 0.0 110.07 179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 90.4 m -97.03 -38.6 9.71 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.277 -0.889 . . . . 0.0 110.241 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 74.1 p -119.35 -8.84 10.01 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.217 -0.927 . . . . 0.0 110.207 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.47 36.21 49.99 Favored Glycine 0 N--CA 1.489 2.211 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.478 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 3.1 mt-30 -108.75 141.76 40.27 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.314 -1.109 . . . . 0.0 110.14 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.512 ' CA ' ' HG3' ' A' ' 44' ' ' GLN . 83.4 tt0 -121.61 143.08 49.52 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.216 -0.928 . . . . 0.0 110.124 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.471 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -173.47 165.63 37.7 Favored Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.0 m-85 -71.77 145.45 48.72 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.401 -1.058 . . . . 0.0 110.075 -179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.46 ' O ' HG13 ' A' ' 54' ' ' ILE . 1.3 pt -136.97 137.66 23.69 Favored Pre-proline 0 N--CA 1.491 1.581 0 O-C-N 121.182 -0.949 . . . . 0.0 110.198 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.596 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 46.6 Cg_endo -62.06 145.16 96.68 Favored 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 123.944 1.497 . . . . 0.0 110.049 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.594 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 31.1 p90 -73.27 -3.96 30.2 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.365 -0.835 . . . . 0.0 110.902 -179.435 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -96.09 -26.23 15.58 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.912 -1.117 . . . . 0.0 111.066 -179.383 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.596 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 15.3 m-85 -83.43 3.07 33.58 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.96 -1.087 . . . . 0.0 110.242 -179.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.522 HG12 ' HB ' ' A' ' 9' ' ' VAL . 16.0 t -146.41 168.19 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.289 -0.882 . . . . 0.0 109.907 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.634 ' O ' HG12 ' A' ' 9' ' ' VAL . . . -158.96 160.83 36.47 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.199 -0.938 . . . . 0.0 110.26 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.406 ' O ' ' C ' ' A' ' 62' ' ' ALA . 92.2 mttt -69.28 121.92 17.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.254 -0.904 . . . . 0.0 110.169 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.406 ' C ' ' O ' ' A' ' 61' ' ' LYS . . . -43.45 154.97 0.07 Allowed 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.242 -0.911 . . . . 0.0 110.187 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 44.8 t30 . . . . . 0 N--CA 1.491 1.614 0 CA-C-O 118.067 -0.968 . . . . 0.0 110.176 -179.979 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.532 -1.427 . . . . 0.0 109.532 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 p -124.82 80.17 63.07 Favored Pre-proline 0 N--CA 1.491 1.599 0 O-C-N 121.295 -1.121 . . . . 0.0 110.171 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_endo -51.27 146.35 24.24 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 123.973 1.512 . . . . 0.0 110.4 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 48.9 mt -58.34 -37.95 76.18 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.236 -0.915 . . . . 0.0 110.181 179.887 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.408 ' HB3' ' OD1' ' A' ' 7' ' ' ASN . 87.6 mt-30 -51.53 -29.66 17.67 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.275 -0.891 . . . . 0.0 110.162 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.403 ' HB2' ' O ' ' A' ' 5' ' ' GLN . 92.0 m-20 54.09 51.13 15.12 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.265 -0.897 . . . . 0.0 110.197 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.45 ' O ' HG13 ' A' ' 33' ' ' ILE . 23.9 m120 -87.51 11.09 15.67 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.264 -0.898 . . . . 0.0 110.266 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.524 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.7 mp -96.48 149.34 21.84 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.189 -0.945 . . . . 0.0 110.14 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.728 ' CG1' HD11 ' A' ' 33' ' ' ILE . 13.6 m -150.25 169.83 1.88 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.185 -0.947 . . . . 0.0 110.387 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 57.0 mt -116.79 141.86 33.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.311 -0.868 . . . . 0.0 109.559 179.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.764 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -80.26 113.74 18.65 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.122 -0.986 . . . . 0.0 110.515 -179.633 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.458 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 82.5 mt -67.07 -24.28 65.95 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.061 -1.024 . . . . 0.0 109.121 179.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.458 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 42.8 m80 -157.31 150.83 24.05 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.602 -0.686 . . . . 0.0 109.547 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.469 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 36.8 p -62.31 142.17 57.9 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.93 -1.106 . . . . 0.0 110.069 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.604 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 82.1 t80 -100.82 162.64 12.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.078 -1.014 . . . . 0.0 110.472 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -119.71 121.59 29.75 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.334 -0.854 . . . . 0.0 109.911 179.725 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.496 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 47.6 Cg_endo -79.42 94.36 1.06 Allowed 'Trans proline' 0 C--N 1.305 -1.734 0 O-C-N 124.037 1.546 . . . . 0.0 110.521 -179.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.401 ' HG ' ' CE1' ' A' ' 19' ' ' HIS . 50.6 p -79.89 0.97 28.96 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.218 -0.926 . . . . 0.0 110.005 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.401 ' CE1' ' HG ' ' A' ' 18' ' ' SER . 48.4 m80 -145.08 165.71 27.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.272 -0.893 . . . . 0.0 109.888 179.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -77.46 131.74 38.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.133 -0.979 . . . . 0.0 110.185 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 106.27 -7.13 40.04 Favored Glycine 0 N--CA 1.491 2.307 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.499 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 4.3 m-20 -91.58 165.35 13.39 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.231 -1.158 . . . . 0.0 110.201 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.526 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 20.1 tp -122.81 128.5 50.5 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.24 -0.912 . . . . 0.0 109.978 179.93 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.496 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -106.77 55.34 0.53 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 109.707 -1.357 . . . . 0.0 109.707 -179.857 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.764 ' CE2' ' HB1' ' A' ' 11' ' ' ALA . 37.3 p90 -45.31 171.13 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.261 -1.14 . . . . 0.0 110.882 -179.667 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.474 ' N ' ' OE1' ' A' ' 29' ' ' GLU . 94.9 mt-10 -97.66 174.48 6.61 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.412 -0.805 . . . . 0.0 110.239 -179.925 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.489 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -70.66 122.68 20.25 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.302 -0.873 . . . . 0.0 110.349 179.996 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 93.01 -7.1 76.64 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.952 -1.259 . . . . 0.0 109.952 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.474 ' OE1' ' N ' ' A' ' 26' ' ' GLU . 39.1 tt0 -70.34 129.57 39.65 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.001 -1.293 . . . . 0.0 110.06 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.599 ' O ' HD23 ' A' ' 31' ' ' LEU . 92.8 mt-30 -79.46 138.35 37.55 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.285 -0.885 . . . . 0.0 109.981 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.642 HD11 ' CG ' ' A' ' 25' ' ' PHE . 16.9 mt -135.56 156.41 48.92 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.149 -0.969 . . . . 0.0 110.47 -179.669 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.484 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 31.3 ttm180 -98.37 130.99 45.02 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.379 -0.826 . . . . 0.0 109.918 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.728 HD11 ' CG1' ' A' ' 9' ' ' VAL . 34.5 mt -76.03 119.7 24.56 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 110.164 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.686 HD21 ' HB2' ' A' ' 44' ' ' GLN . 96.9 mt -87.75 -35.19 18.03 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.334 -0.854 . . . . 0.0 110.179 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 77.4 mt-10 -150.56 175.08 12.24 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.226 -0.921 . . . . 0.0 110.314 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.626 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 88.9 mt-30 -151.09 57.8 0.9 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.281 -0.887 . . . . 0.0 110.192 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.3 t -125.2 130.36 51.96 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.266 -0.896 . . . . 0.0 110.152 -179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 86.88 -170.79 42.14 Favored Glycine 0 N--CA 1.49 2.247 0 N-CA-C 109.411 -1.475 . . . . 0.0 109.411 -179.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 87.1 mt-10 -75.65 -34.24 60.5 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.194 -1.18 . . . . 0.0 110.178 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.561 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 94.8 m95 -97.84 146.4 25.46 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.276 -0.89 . . . . 0.0 110.155 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.626 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.2 m0 -124.42 155.76 38.3 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.289 -0.882 . . . . 0.0 110.18 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 34' ' ' LEU . 19.7 mttt -91.12 146.3 23.95 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.245 -0.909 . . . . 0.0 109.663 179.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.665 ' HB2' HG12 ' A' ' 54' ' ' ILE . . . -144.05 165.92 26.45 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.221 -0.924 . . . . 0.0 110.635 -179.738 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.686 ' HB2' HD21 ' A' ' 34' ' ' LEU . 59.5 tt0 -134.59 142.89 47.07 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.415 -0.803 . . . . 0.0 109.957 179.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 49.9 m -76.99 140.06 40.28 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.201 -0.937 . . . . 0.0 110.14 -179.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 14.2 tp -88.31 -19.69 26.4 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.24 -0.913 . . . . 0.0 109.968 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 51.0 p -102.92 -28.13 12.22 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.376 -0.828 . . . . 0.0 110.404 -179.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 1.1 m -96.3 -20.94 18.14 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.081 -1.012 . . . . 0.0 110.107 -179.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.71 47.49 67.59 Favored Glycine 0 N--CA 1.489 2.209 0 N-CA-C 109.15 -1.58 . . . . 0.0 109.15 -179.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.506 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 61.2 mt-30 -133.86 158.59 43.02 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.325 -1.103 . . . . 0.0 110.191 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 92.5 mt-10 -119.77 143.67 47.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.276 -0.89 . . . . 0.0 110.083 179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.526 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -154.63 -152.05 6.01 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.649 -1.381 . . . . 0.0 109.649 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -122.16 134.33 54.73 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.368 -1.078 . . . . 0.0 110.056 179.819 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.869 HD12 HG21 ' A' ' 59' ' ' VAL . 1.8 pt -129.11 140.48 38.74 Favored Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.157 -0.965 . . . . 0.0 110.183 179.937 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.594 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 47.3 Cg_endo -73.0 157.34 51.25 Favored 'Trans proline' 0 C--N 1.304 -1.79 0 O-C-N 123.958 1.504 . . . . 0.0 110.12 179.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -78.84 -5.01 52.39 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.327 -0.858 . . . . 0.0 111.009 -179.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 50.0 t-20 -98.44 -26.51 14.43 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 120.897 -1.127 . . . . 0.0 111.215 -179.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.594 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 13.1 m-85 -83.63 -9.18 59.07 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 120.929 -1.107 . . . . 0.0 110.469 -179.657 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.869 HG21 HD12 ' A' ' 54' ' ' ILE . 31.0 m -133.98 145.0 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.166 -0.959 . . . . 0.0 110.383 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -129.12 159.21 36.71 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.363 -0.836 . . . . 0.0 110.119 179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.507 ' HA ' HG12 ' A' ' 9' ' ' VAL . 89.9 mttt -76.22 118.7 19.22 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.165 -0.959 . . . . 0.0 110.177 -179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.79 144.45 8.35 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.279 -0.888 . . . . 0.0 110.204 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 30.6 m120 . . . . . 0 N--CA 1.491 1.583 0 CA-C-O 117.97 -1.014 . . . . 0.0 110.234 -179.952 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.266 0 N-CA-C 109.494 -1.443 . . . . 0.0 109.494 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -125.62 78.44 68.66 Favored Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.227 -1.161 . . . . 0.0 110.251 179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -51.18 146.01 24.63 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 123.948 1.499 . . . . 0.0 110.347 -179.948 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.412 ' HA ' HD12 ' A' ' 4' ' ' LEU . 43.2 tp -65.2 -29.39 70.2 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.235 -0.916 . . . . 0.0 110.232 179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.48 ' HB3' ' OD1' ' A' ' 7' ' ' ASN . 98.7 mt-30 -59.64 -27.01 65.97 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.277 -0.889 . . . . 0.0 110.22 -179.971 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 50.57 44.93 27.18 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.27 -0.894 . . . . 0.0 110.185 -179.928 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.48 ' OD1' ' HB3' ' A' ' 5' ' ' GLN . 22.8 m120 -79.74 -1.13 37.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.145 -0.972 . . . . 0.0 110.251 -179.907 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.538 ' C ' HG13 ' A' ' 9' ' ' VAL . 23.6 tp -80.06 148.59 30.99 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.23 -0.919 . . . . 0.0 110.115 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.538 HG13 ' C ' ' A' ' 8' ' ' LEU . 31.7 m -153.7 172.03 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 O-C-N 121.192 -0.943 . . . . 0.0 110.37 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.421 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 54.8 mt -113.9 146.11 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.319 -0.863 . . . . 0.0 109.712 179.654 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.802 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -80.13 110.12 15.23 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.13 -0.982 . . . . 0.0 110.287 -179.81 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.993 HD13 ' O ' ' A' ' 12' ' ' LEU . 2.0 tm? -65.61 -25.07 67.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.065 -1.022 . . . . 0.0 109.405 179.501 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.485 ' ND1' HD12 ' A' ' 12' ' ' LEU . 11.5 m170 -155.69 158.95 39.1 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.51 -0.744 . . . . 0.0 109.744 179.669 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.553 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 47.3 p -68.41 139.89 55.79 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.999 -1.063 . . . . 0.0 110.105 179.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.597 ' CD1' ' HD3' ' A' ' 55' ' ' PRO . 87.9 t80 -95.72 156.42 16.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.046 -1.034 . . . . 0.0 110.33 179.911 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.563 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 0.7 OUTLIER -99.4 127.13 35.3 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.322 -0.861 . . . . 0.0 110.062 179.964 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.475 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.0 Cg_endo -89.5 86.78 0.43 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.033 1.544 . . . . 0.0 110.397 -179.955 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.9 p -79.98 1.3 28.03 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.191 -0.943 . . . . 0.0 110.111 179.98 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.403 ' HB2' ' CG ' ' A' ' 22' ' ' ASP . 38.8 m80 -134.7 -168.31 2.13 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.256 -0.903 . . . . 0.0 110.078 -179.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 45.7 p30 -105.79 -6.19 19.23 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.187 -0.945 . . . . 0.0 110.196 179.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -114.48 -0.53 23.39 Favored Glycine 0 N--CA 1.491 2.3 0 N-CA-C 109.632 -1.387 . . . . 0.0 109.632 -179.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.403 ' CG ' ' HB2' ' A' ' 19' ' ' HIS . 61.3 m-20 -88.13 163.17 16.34 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.127 -1.22 . . . . 0.0 110.243 -179.905 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.493 HD13 ' HG2' ' A' ' 50' ' ' GLN . 22.2 tp -114.53 120.49 40.41 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.298 -0.876 . . . . 0.0 110.086 -179.993 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.475 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -103.7 54.81 0.65 Allowed Glycine 0 N--CA 1.492 2.398 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.764 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.802 ' CE2' ' HB1' ' A' ' 11' ' ' ALA . 50.6 p90 -53.39 176.57 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.236 -1.155 . . . . 0.0 111.022 -179.793 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.553 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 92.5 mt-10 -110.39 178.27 4.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.442 -0.786 . . . . 0.0 110.026 179.805 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.407 ' HG3' ' O ' ' A' ' 12' ' ' LEU . 27.9 tttt -67.38 136.45 54.78 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.124 -0.985 . . . . 0.0 110.421 179.969 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.47 -16.13 50.91 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.557 -1.417 . . . . 0.0 109.557 179.827 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.574 ' HG2' HD21 ' A' ' 31' ' ' LEU . 10.3 tt0 -60.83 123.21 16.85 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.131 -1.217 . . . . 0.0 110.41 -179.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.484 ' O ' HD23 ' A' ' 31' ' ' LEU . 94.0 mt-30 -79.75 134.52 36.38 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.35 -0.844 . . . . 0.0 109.79 179.752 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.574 HD21 ' HG2' ' A' ' 29' ' ' GLU . 15.5 mt -137.99 159.38 42.16 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.182 -0.949 . . . . 0.0 110.319 -179.789 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.704 ' HE ' HD11 ' A' ' 34' ' ' LEU . 3.7 ptt180 -109.25 134.98 51.08 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.278 -0.889 . . . . 0.0 109.614 179.357 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 61.1 mt -91.39 95.17 5.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 O-C-N 121.094 -1.004 . . . . 0.0 110.758 -179.281 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.704 HD11 ' HE ' ' A' ' 32' ' ' ARG . 1.6 mt -78.86 -29.45 44.53 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.262 -0.899 . . . . 0.0 110.622 -179.72 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.513 ' HB3' ' HB3' ' A' ' 42' ' ' LYS . 74.1 tt0 -128.6 140.76 51.62 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.002 -1.062 . . . . 0.0 110.274 179.887 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.621 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 47.7 tt0 -138.42 68.4 1.39 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.25 -0.906 . . . . 0.0 110.222 -179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 92.4 p -131.81 132.83 44.08 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.223 -0.923 . . . . 0.0 110.207 179.958 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.84 -162.56 41.15 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.384 -1.486 . . . . 0.0 109.384 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 99.2 mt-10 -80.96 -31.17 34.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.223 -1.163 . . . . 0.0 110.208 -179.985 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.56 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 91.4 m95 -98.87 146.51 25.89 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.269 -0.894 . . . . 0.0 110.352 -179.79 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.621 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 47.3 m0 -125.35 156.46 38.68 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.269 -0.894 . . . . 0.0 110.21 179.894 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.513 ' HB3' ' HB3' ' A' ' 35' ' ' GLU . 25.7 tttp -97.6 145.32 26.39 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.295 -0.878 . . . . 0.0 109.14 179.217 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.58 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -160.35 -173.57 4.07 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 120.908 -1.12 . . . . 0.0 110.947 -179.638 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.54 ' HB3' ' CD ' ' A' ' 32' ' ' ARG . 39.2 tt0 -155.15 162.18 41.05 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.576 -0.702 . . . . 0.0 109.475 179.892 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.532 ' N ' ' HG2' ' A' ' 44' ' ' GLN . 1.7 m -103.22 128.42 50.22 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.068 -1.02 . . . . 0.0 110.276 -179.954 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.455 ' O ' ' HG ' ' A' ' 46' ' ' LEU . 25.4 tp -82.44 1.89 35.3 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.337 -0.852 . . . . 0.0 110.154 179.966 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 85.0 m -96.96 -34.48 11.2 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.233 -0.917 . . . . 0.0 110.205 -179.944 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 19.0 p -115.99 -16.31 11.1 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.205 -0.935 . . . . 0.0 110.183 179.922 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.8 25.68 55.55 Favored Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.551 -1.42 . . . . 0.0 109.551 179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.493 ' HG2' HD13 ' A' ' 23' ' ' LEU . 56.9 tt0 -97.18 135.65 38.82 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.238 -1.154 . . . . 0.0 110.243 -179.972 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.445 ' HG3' ' HB2' ' A' ' 44' ' ' GLN . 82.1 tt0 -120.02 141.13 50.0 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.253 -0.905 . . . . 0.0 109.939 179.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.476 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -167.32 -137.84 2.32 Favored Glycine 0 N--CA 1.489 2.206 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -179.96 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -125.91 138.42 53.78 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.416 -1.049 . . . . 0.0 109.947 179.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.748 HD12 HG11 ' A' ' 59' ' ' VAL . 16.9 pt -128.23 148.78 69.16 Favored Pre-proline 0 N--CA 1.49 1.571 0 O-C-N 121.278 -0.889 . . . . 0.0 110.255 -179.898 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.598 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 45.3 Cg_endo -80.42 148.31 18.45 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 O-C-N 124.017 1.535 . . . . 0.0 109.728 179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.594 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 35.8 p90 -69.87 -4.61 21.09 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.222 -0.924 . . . . 0.0 111.021 -179.351 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 65.4 t30 -98.21 -26.44 14.54 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.831 -1.168 . . . . 0.0 111.396 -179.187 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.598 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 8.1 m-85 -84.41 -2.84 57.81 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 120.938 -1.101 . . . . 0.0 110.395 -179.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.748 HG11 HD12 ' A' ' 54' ' ' ILE . 33.4 m -131.32 141.71 45.24 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.131 -0.981 . . . . 0.0 110.1 179.977 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -122.65 157.66 31.74 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.114 -0.991 . . . . 0.0 110.38 -179.977 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 56.2 tttm -65.65 128.12 34.65 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.265 -0.897 . . . . 0.0 110.169 179.937 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -54.82 145.67 19.16 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.311 -0.868 . . . . 0.0 110.154 -179.968 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 42.6 t30 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.946 -1.026 . . . . 0.0 110.204 -179.983 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.251 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 2.0 m -65.95 145.57 99.01 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 121.265 -1.138 . . . . 0.0 110.202 179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -57.51 142.37 95.37 Favored 'Trans proline' 0 C--N 1.305 -1.748 0 O-C-N 124.085 1.571 . . . . 0.0 110.315 -179.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 62.1 mt -59.1 -36.17 74.69 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.254 -0.904 . . . . 0.0 110.183 179.923 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.445 ' HB2' ' HB2' ' A' ' 8' ' ' LEU . 98.0 mt-30 -123.02 137.63 54.9 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.313 -0.867 . . . . 0.0 110.21 179.973 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 65.4 m-20 -60.49 -29.92 69.38 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.245 -0.909 . . . . 0.0 110.191 179.938 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 30.0 m120 -83.43 3.86 30.15 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.314 -0.866 . . . . 0.0 110.207 -179.985 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.895 HD13 ' N ' ' A' ' 9' ' ' VAL . 3.2 tm? -82.19 137.43 34.92 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.33 -0.856 . . . . 0.0 110.192 179.924 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.895 ' N ' HD13 ' A' ' 8' ' ' LEU . 27.1 m -146.6 167.66 6.54 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.312 -0.867 . . . . 0.0 110.345 180.0 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 23.6 mm -112.54 141.34 28.42 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.319 -0.863 . . . . 0.0 109.705 179.526 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.607 ' HB1' ' CE1' ' A' ' 25' ' ' PHE . . . -79.03 109.64 13.52 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.057 -1.027 . . . . 0.0 110.268 -179.817 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.44 ' HG ' ' CE1' ' A' ' 13' ' ' HIS . 16.6 tp -67.39 -24.96 65.73 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.09 -1.006 . . . . 0.0 109.255 179.39 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.44 ' CE1' ' HG ' ' A' ' 12' ' ' LEU . 66.1 m80 -153.51 151.4 29.77 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.551 -0.718 . . . . 0.0 109.622 179.728 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.549 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 52.7 p -65.4 143.66 57.58 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.051 -1.031 . . . . 0.0 109.996 179.967 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.571 ' CD1' ' HG3' ' A' ' 55' ' ' PRO . 22.3 t80 -92.77 150.31 20.72 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.106 -0.996 . . . . 0.0 110.287 -179.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -106.9 79.48 0.67 Allowed Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.269 -0.895 . . . . 0.0 110.268 179.961 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.437 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 47.5 Cg_endo -47.45 109.62 0.24 Allowed 'Trans proline' 0 C--N 1.305 -1.735 0 O-C-N 124.08 1.568 . . . . 0.0 110.396 179.954 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 91.6 p -90.35 12.1 19.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.213 -0.93 . . . . 0.0 110.217 -179.964 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 97.6 m-70 -147.54 -178.97 6.53 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.241 -0.912 . . . . 0.0 110.207 179.979 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -98.7 116.59 31.26 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.247 -0.908 . . . . 0.0 110.203 -179.939 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 123.4 7.54 6.89 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 179.988 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.425 ' HB2' ' HB3' ' A' ' 17' ' ' PRO . 10.4 m-20 -105.8 171.85 7.12 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.16 -1.2 . . . . 0.0 110.152 -179.927 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.529 HD21 ' HB2' ' A' ' 45' ' ' SER . 18.7 tp -113.32 115.59 28.39 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.303 -0.873 . . . . 0.0 109.876 -179.969 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.437 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -99.12 55.21 0.97 Allowed Glycine 0 N--CA 1.491 2.337 0 N-CA-C 109.25 -1.54 . . . . 0.0 109.25 179.963 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.607 ' CE1' ' HB1' ' A' ' 11' ' ' ALA . 37.0 p90 -54.76 175.99 0.05 OUTLIER 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.299 -1.118 . . . . 0.0 111.208 -179.498 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.549 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 96.0 mt-10 -110.25 177.97 4.54 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.546 -0.721 . . . . 0.0 110.056 179.797 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 37.7 tttt -67.22 139.23 57.38 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.11 -0.994 . . . . 0.0 110.505 179.993 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.63 -14.72 54.89 Favored Glycine 0 N--CA 1.488 2.122 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 179.853 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.463 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 3.1 mt-10 -65.05 125.59 25.41 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.06 -1.259 . . . . 0.0 110.293 -179.698 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.978 ' C ' HD12 ' A' ' 31' ' ' LEU . 52.1 tt0 -79.62 136.16 36.76 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.303 -0.873 . . . . 0.0 109.916 179.997 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.978 HD12 ' C ' ' A' ' 30' ' ' GLN . 7.6 mp -138.94 160.02 40.75 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 110.467 -179.698 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.605 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 46.7 ttt180 -105.82 131.7 52.84 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.414 -0.804 . . . . 0.0 109.427 179.4 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.66 HD11 HG21 ' A' ' 9' ' ' VAL . 35.0 mm -92.35 94.39 4.76 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.093 -1.004 . . . . 0.0 110.623 -179.551 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.492 HD21 ' CZ ' ' A' ' 32' ' ' ARG . 11.8 mt -79.84 -29.91 40.23 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.278 -0.889 . . . . 0.0 110.751 -179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.495 ' HB3' ' HB3' ' A' ' 42' ' ' LYS . 41.5 tp10 -131.03 142.96 50.37 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 120.908 -1.12 . . . . 0.0 110.383 -179.825 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.641 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 78.3 mt-30 -138.01 54.88 1.78 Allowed 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.291 -0.88 . . . . 0.0 110.017 179.878 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 67.1 m -120.38 137.47 54.28 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.205 -0.935 . . . . 0.0 110.237 -179.957 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.26 -171.66 55.15 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.381 -1.488 . . . . 0.0 109.381 -179.991 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 88.6 mt-10 -74.83 -33.67 62.2 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.211 -1.17 . . . . 0.0 110.212 -179.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.443 ' CZ3' ' OH ' ' A' ' 15' ' ' TYR . 95.6 m95 -93.77 139.83 30.37 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.233 -0.917 . . . . 0.0 110.212 -179.95 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.641 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 32.2 m0 -118.17 154.97 31.28 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.242 -0.911 . . . . 0.0 110.041 179.893 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 35' ' ' GLU . 16.3 tttm -100.95 138.78 37.54 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.312 -0.868 . . . . 0.0 109.145 179.235 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.605 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -150.74 177.57 9.96 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.998 -1.064 . . . . 0.0 110.965 -179.433 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.473 ' CG ' ' HG2' ' A' ' 51' ' ' GLU . 47.2 tt0 -138.27 146.77 42.91 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.48 -0.763 . . . . 0.0 109.788 179.855 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.529 ' HB2' HD21 ' A' ' 23' ' ' LEU . 0.8 OUTLIER -96.52 116.12 28.55 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.13 -0.981 . . . . 0.0 110.255 -179.884 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 54.6 mt -75.71 1.65 14.11 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.28 -0.888 . . . . 0.0 110.307 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 47.9 p -89.92 -32.33 16.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.124 -0.985 . . . . 0.0 110.144 179.889 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 75.5 p -120.56 -3.8 9.83 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.313 -0.867 . . . . 0.0 110.082 179.855 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.24 48.16 60.25 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 179.966 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.471 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 10.8 mt-30 -130.17 155.65 45.88 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.259 -1.142 . . . . 0.0 110.349 -179.956 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.473 ' HG2' ' CG ' ' A' ' 44' ' ' GLN . 97.9 mt-10 -121.41 147.86 45.17 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.325 -0.859 . . . . 0.0 109.944 179.785 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.501 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -164.75 -153.6 7.55 Favored Glycine 0 N--CA 1.489 2.203 0 N-CA-C 109.926 -1.27 . . . . 0.0 109.926 -179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -119.67 135.08 54.97 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.505 -0.997 . . . . 0.0 109.719 179.666 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.788 ' CD1' HG21 ' A' ' 59' ' ' VAL . 1.0 OUTLIER -126.7 149.42 68.33 Favored Pre-proline 0 N--CA 1.489 1.52 0 O-C-N 121.126 -0.984 . . . . 0.0 110.568 -179.668 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.574 ' O ' HG22 ' A' ' 59' ' ' VAL . 46.3 Cg_endo -77.78 132.6 12.04 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 124.057 1.556 . . . . 0.0 109.965 179.725 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.582 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 15.0 p90 -66.46 -9.68 36.65 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.286 -0.884 . . . . 0.0 111.017 -179.272 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -87.28 -26.41 23.45 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.883 -1.136 . . . . 0.0 110.841 -179.572 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.568 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 16.8 m-30 -96.28 7.18 47.11 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.045 -1.034 . . . . 0.0 110.259 -179.94 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.788 HG21 ' CD1' ' A' ' 54' ' ' ILE . 35.2 m -135.55 142.26 39.97 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.271 -0.893 . . . . 0.0 110.091 179.89 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -145.34 154.96 42.88 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.232 -0.917 . . . . 0.0 110.219 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.485 ' HA ' HG12 ' A' ' 9' ' ' VAL . 79.3 tttt -65.64 128.12 34.68 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.308 -0.87 . . . . 0.0 110.204 179.978 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.405 ' O ' ' ND2' ' A' ' 63' ' ' ASN . . . -64.51 142.75 58.31 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.254 -0.904 . . . . 0.0 110.184 -179.966 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . 0.405 ' ND2' ' O ' ' A' ' 62' ' ' ALA . 15.6 m120 . . . . . 0 N--CA 1.491 1.61 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.209 -179.999 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.2 p -79.06 152.91 77.18 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.209 -1.171 . . . . 0.0 110.185 179.989 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -57.79 145.69 89.22 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.001 1.527 . . . . 0.0 110.327 179.988 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 56.8 tp -91.36 132.53 36.12 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.243 -0.91 . . . . 0.0 110.268 179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.501 ' NE2' ' HB2' ' A' ' 7' ' ' ASN . 14.2 pt20 -144.01 156.14 44.28 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.205 -0.934 . . . . 0.0 110.267 179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.407 ' C ' ' OD1' ' A' ' 6' ' ' ASP . 58.1 p30 -82.27 4.68 22.7 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.269 -0.894 . . . . 0.0 110.176 -179.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.501 ' HB2' ' NE2' ' A' ' 5' ' ' GLN . 24.3 m120 -84.65 1.44 46.21 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.256 -0.903 . . . . 0.0 110.269 179.998 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.454 ' C ' HG13 ' A' ' 9' ' ' VAL . 21.7 tp -81.72 146.23 30.1 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.275 -0.89 . . . . 0.0 110.105 179.884 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.749 HG11 HD11 ' A' ' 33' ' ' ILE . 30.2 m -150.02 169.87 1.98 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.159 -0.963 . . . . 0.0 110.367 -179.952 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 85.9 mt -112.27 144.91 19.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.345 -0.847 . . . . 0.0 109.728 179.575 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.489 ' O ' ' N ' ' A' ' 28' ' ' GLY . . . -77.83 114.89 17.13 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.13 -0.981 . . . . 0.0 110.349 -179.712 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.575 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 73.1 mt -73.7 -24.93 60.0 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.071 -1.018 . . . . 0.0 109.316 179.409 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.579 ' CE1' ' HE3' ' A' ' 27' ' ' LYS . 77.0 m-70 -161.38 146.47 13.68 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.612 -0.68 . . . . 0.0 109.543 179.987 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.502 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 53.5 p -60.59 142.07 55.9 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.919 -1.113 . . . . 0.0 109.904 179.804 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.541 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 45.8 t80 -99.0 159.12 15.18 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.015 -1.053 . . . . 0.0 110.587 -179.854 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -109.4 82.08 1.98 Allowed Pre-proline 0 N--CA 1.491 1.586 0 O-C-N 121.411 -0.806 . . . . 0.0 110.067 179.861 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.547 ' CB ' ' HB2' ' A' ' 22' ' ' ASP . 47.4 Cg_endo -48.55 104.55 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.754 0 O-C-N 124.034 1.544 . . . . 0.0 110.44 -179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.522 ' OG ' ' CE1' ' A' ' 19' ' ' HIS . 64.5 p -80.67 0.1 35.82 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.201 -0.937 . . . . 0.0 110.169 179.847 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.522 ' CE1' ' OG ' ' A' ' 18' ' ' SER . 64.5 m80 -134.85 176.73 8.38 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.143 -0.973 . . . . 0.0 110.147 179.982 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 50.7 m-20 -82.38 -11.86 58.29 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.212 -0.93 . . . . 0.0 110.461 -179.79 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -105.66 25.05 25.5 Favored Glycine 0 N--CA 1.489 2.23 0 N-CA-C 109.653 -1.379 . . . . 0.0 109.653 -179.865 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.547 ' HB2' ' CB ' ' A' ' 17' ' ' PRO . 52.4 m-20 -111.92 161.83 15.98 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.157 -1.202 . . . . 0.0 110.364 -179.989 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.495 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 23.7 tp -116.18 120.46 39.07 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.295 -0.878 . . . . 0.0 109.773 179.713 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.537 ' CA ' ' HD3' ' A' ' 17' ' ' PRO . . . -98.02 51.06 1.31 Allowed Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.561 -1.416 . . . . 0.0 109.561 -179.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.557 ' CG ' HD11 ' A' ' 31' ' ' LEU . 22.2 p90 -47.34 170.6 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.237 -1.155 . . . . 0.0 110.568 -179.649 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 -100.01 179.05 4.62 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.391 -0.818 . . . . 0.0 110.282 -179.649 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.579 ' HE3' ' CE1' ' A' ' 13' ' ' HIS . 20.6 tttt -71.96 120.47 17.6 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.326 -0.859 . . . . 0.0 110.033 179.722 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.489 ' N ' ' O ' ' A' ' 11' ' ' ALA . . . 96.63 -9.18 66.47 Favored Glycine 0 N--CA 1.489 2.208 0 N-CA-C 109.297 -1.521 . . . . 0.0 109.297 -179.815 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.513 ' OE2' ' CB ' ' A' ' 25' ' ' PHE . 31.4 tt0 -60.7 133.21 55.87 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.168 -1.195 . . . . 0.0 110.27 -179.758 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . . . . . . . . . 17.5 mt-30 -79.93 129.06 34.19 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.255 -0.903 . . . . 0.0 109.888 179.867 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.557 HD11 ' CG ' ' A' ' 25' ' ' PHE . 27.0 mt -130.11 150.7 51.26 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.168 -0.958 . . . . 0.0 110.437 -179.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.499 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 30.5 ttp180 -106.01 140.64 38.69 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.349 -0.845 . . . . 0.0 109.824 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.749 HD11 HG11 ' A' ' 9' ' ' VAL . 55.8 mt -91.51 136.09 25.27 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.258 -0.901 . . . . 0.0 110.173 -179.903 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.452 ' CD1' ' HB2' ' A' ' 44' ' ' GLN . 91.6 mt -129.94 -30.89 1.98 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.279 -0.888 . . . . 0.0 110.371 -179.964 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.479 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 78.6 tt0 -128.25 146.64 50.68 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.207 -0.933 . . . . 0.0 110.307 -179.93 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.593 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 52.6 tt0 -142.25 58.1 1.46 Allowed 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.254 -0.904 . . . . 0.0 110.144 179.916 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.4 t -118.22 114.38 22.93 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.269 -0.894 . . . . 0.0 110.229 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 98.3 -160.93 20.62 Favored Glycine 0 N--CA 1.49 2.242 0 N-CA-C 109.546 -1.422 . . . . 0.0 109.546 -179.983 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 95.1 mt-10 -84.18 -29.59 26.49 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.189 -1.183 . . . . 0.0 110.251 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.551 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 91.3 m95 -96.06 145.05 25.79 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.288 -0.883 . . . . 0.0 110.169 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.593 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 48.8 m0 -119.17 153.1 35.42 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.226 -0.922 . . . . 0.0 110.281 179.996 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.482 ' HE2' ' OE2' ' A' ' 51' ' ' GLU . 9.9 tttp -99.43 110.58 23.05 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.278 -0.889 . . . . 0.0 110.043 179.843 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.499 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -112.37 175.46 5.42 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.229 -0.919 . . . . 0.0 110.708 -179.588 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.49 ' CG ' ' O ' ' A' ' 50' ' ' GLN . 44.4 tt0 -138.18 146.59 42.89 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.338 -0.851 . . . . 0.0 109.951 -179.799 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.42 ' O ' ' HA2' ' A' ' 49' ' ' GLY . 6.9 t -79.01 137.78 37.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.109 -0.994 . . . . 0.0 110.174 -179.967 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.463 ' HA ' HD12 ' A' ' 46' ' ' LEU . 21.2 tp -80.7 -21.06 41.58 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.209 -0.932 . . . . 0.0 109.596 179.593 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 95.9 m -83.35 -50.68 8.11 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.447 -0.783 . . . . 0.0 110.241 179.986 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.458 ' OG1' ' HB2' ' A' ' 50' ' ' GLN . 18.0 p -100.22 1.69 42.11 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.079 -1.013 . . . . 0.0 110.32 -179.694 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.42 ' HA2' ' O ' ' A' ' 45' ' ' SER . . . 54.03 18.92 9.79 Favored Glycine 0 N--CA 1.488 2.155 0 N-CA-C 109.338 -1.505 . . . . 0.0 109.338 -179.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.49 ' O ' ' CG ' ' A' ' 44' ' ' GLN . 37.2 mt-30 -78.7 153.67 30.73 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.248 -1.148 . . . . 0.0 110.281 -179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.482 ' OE2' ' HE2' ' A' ' 42' ' ' LYS . 86.6 tt0 -120.36 142.82 48.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.3 -0.875 . . . . 0.0 110.13 -179.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.495 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -165.83 156.81 28.98 Favored Glycine 0 N--CA 1.489 2.169 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.951 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -71.55 141.0 50.1 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.202 -1.175 . . . . 0.0 109.961 179.836 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.796 HD12 ' O ' ' A' ' 55' ' ' PRO . 1.9 pp -141.21 124.8 10.05 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 121.302 -0.874 . . . . 0.0 110.146 -179.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.796 ' O ' HD12 ' A' ' 54' ' ' ILE . 46.2 Cg_endo -46.37 167.41 0.06 OUTLIER 'Trans proline' 0 C--N 1.305 -1.741 0 O-C-N 123.931 1.49 . . . . 0.0 110.098 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 28.6 p90 -95.69 -1.84 49.21 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.22 -0.925 . . . . 0.0 110.539 -179.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 35.8 m-20 -99.18 -24.58 14.82 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.141 -0.974 . . . . 0.0 110.724 -179.722 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.585 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 27.4 m-85 -79.64 -12.87 59.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.988 -1.07 . . . . 0.0 110.515 -179.66 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.795 HG21 ' CD1' ' A' ' 54' ' ' ILE . 30.6 m -131.25 143.32 41.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.106 -0.996 . . . . 0.0 110.187 179.932 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -129.57 151.27 50.37 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.301 -0.874 . . . . 0.0 110.172 -179.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.648 ' HA ' HG12 ' A' ' 9' ' ' VAL . 78.7 tttt -67.83 115.38 7.31 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.287 -0.883 . . . . 0.0 110.269 179.968 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . 49.62 -145.73 0.41 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.278 -0.888 . . . . 0.0 110.219 179.998 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 31.4 t-20 . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.039 -0.981 . . . . 0.0 110.155 -179.958 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.291 0 N-CA-C 109.473 -1.451 . . . . 0.0 109.473 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -64.92 137.07 97.03 Favored Pre-proline 0 N--CA 1.492 1.659 0 O-C-N 121.212 -1.169 . . . . 0.0 110.179 179.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_endo -53.05 142.91 52.61 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.083 1.57 . . . . 0.0 110.425 179.961 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 85.4 mt -70.53 -31.51 68.6 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -0.92 . . . . 0.0 110.224 -179.958 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.444 ' HB3' ' CB ' ' A' ' 8' ' ' LEU . 96.3 mt-30 51.04 48.55 22.87 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.257 -0.902 . . . . 0.0 110.238 179.93 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -63.46 -34.39 77.66 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.333 -0.854 . . . . 0.0 110.186 179.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.453 ' O ' HG13 ' A' ' 33' ' ' ILE . 77.7 m-20 -84.0 -5.42 59.22 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.239 -0.913 . . . . 0.0 110.287 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.533 ' C ' HG13 ' A' ' 9' ' ' VAL . 6.6 tp -75.89 141.42 42.36 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.176 -0.952 . . . . 0.0 110.142 179.943 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.546 HG11 HD11 ' A' ' 33' ' ' ILE . 28.7 m -154.84 172.73 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.286 -0.884 . . . . 0.0 110.287 -179.934 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.45 ' O ' ' HA ' ' A' ' 59' ' ' VAL . 62.8 mt -112.49 145.43 18.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.334 -0.854 . . . . 0.0 109.806 179.618 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.717 ' HB1' ' CE2' ' A' ' 25' ' ' PHE . . . -80.11 111.69 16.7 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.046 -1.034 . . . . 0.0 110.273 -179.787 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.484 ' N ' ' O ' ' A' ' 58' ' ' PHE . 6.1 mp -64.87 -28.46 69.56 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.068 -1.02 . . . . 0.0 109.356 179.451 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.444 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 30.7 m80 -155.39 157.66 37.43 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.564 -0.71 . . . . 0.0 109.794 179.753 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.556 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 10.3 t -64.92 140.61 58.88 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.099 -1.0 . . . . 0.0 109.939 179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.605 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 86.3 t80 -94.5 151.69 19.15 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.02 -1.05 . . . . 0.0 110.474 -179.96 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.411 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 4.2 tp10 -114.02 91.89 24.2 Favored Pre-proline 0 N--CA 1.491 1.612 0 O-C-N 121.409 -0.807 . . . . 0.0 110.076 179.932 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.513 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 46.8 Cg_endo -59.26 114.12 1.89 Allowed 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.055 1.555 . . . . 0.0 110.476 -179.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.459 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 74.2 p -89.54 11.33 19.83 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.275 -0.891 . . . . 0.0 109.996 179.826 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.459 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 98.6 m-70 -145.95 -177.11 5.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.307 -0.871 . . . . 0.0 110.15 -179.939 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.8 t0 -100.33 118.89 37.53 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.226 -0.921 . . . . 0.0 110.139 179.878 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 124.95 -14.33 7.51 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 109.43 -1.468 . . . . 0.0 109.43 -179.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -85.24 174.13 9.86 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.294 -1.121 . . . . 0.0 110.339 179.953 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.52 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 20.2 tp -118.42 122.43 42.75 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.284 -0.885 . . . . 0.0 110.011 179.994 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.513 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -102.17 57.08 0.64 Allowed Glycine 0 N--CA 1.492 2.382 0 N-CA-C 109.72 -1.352 . . . . 0.0 109.72 -179.825 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.717 ' CE2' ' HB1' ' A' ' 11' ' ' ALA . 48.6 p90 -53.67 174.13 0.05 Allowed 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.167 -1.196 . . . . 0.0 110.86 -179.805 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.556 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 73.6 mm-40 -108.0 -179.48 3.91 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.463 -0.773 . . . . 0.0 110.137 179.893 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.4 tttm -68.37 134.52 50.37 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.216 -0.928 . . . . 0.0 110.365 179.821 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.17 -13.19 62.23 Favored Glycine 0 N--CA 1.49 2.235 0 N-CA-C 109.518 -1.433 . . . . 0.0 109.518 179.96 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.457 ' HG3' HD21 ' A' ' 31' ' ' LEU . 26.1 tp10 -62.08 122.99 16.92 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.228 -1.16 . . . . 0.0 110.409 -179.712 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.635 ' O ' HD23 ' A' ' 31' ' ' LEU . 97.0 mt-30 -79.91 136.42 36.65 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.33 -0.856 . . . . 0.0 109.879 179.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.635 HD23 ' O ' ' A' ' 30' ' ' GLN . 17.4 mt -139.04 160.87 38.74 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.161 -0.962 . . . . 0.0 110.418 -179.799 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.594 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 4.1 tpt180 -106.4 134.03 50.17 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.381 -0.825 . . . . 0.0 109.498 179.533 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.546 HD11 HG11 ' A' ' 9' ' ' VAL . 35.4 mt -95.77 92.84 3.41 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 O-C-N 121.139 -0.976 . . . . 0.0 110.485 -179.669 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.764 HD12 ' HA ' ' A' ' 43' ' ' ALA . 1.1 mt -79.2 -24.97 42.79 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.274 -0.891 . . . . 0.0 110.631 -179.406 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.477 ' HB3' ' HB3' ' A' ' 42' ' ' LYS . 70.7 tt0 -135.82 136.3 40.54 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.026 -1.046 . . . . 0.0 110.253 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.642 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 79.7 mt-30 -132.23 53.86 1.98 Allowed 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.294 -0.879 . . . . 0.0 110.188 -179.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 68.0 m -115.9 138.4 51.2 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.289 -0.882 . . . . 0.0 110.099 179.935 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.95 -172.89 55.2 Favored Glycine 0 N--CA 1.49 2.288 0 N-CA-C 109.33 -1.508 . . . . 0.0 109.33 -179.963 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -72.73 -34.43 67.06 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.188 -1.184 . . . . 0.0 110.234 -179.99 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.565 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 99.5 m95 -96.73 143.62 27.5 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.243 -0.911 . . . . 0.0 110.139 -179.947 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.642 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 51.2 m0 -121.78 155.64 34.86 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.317 -0.865 . . . . 0.0 110.096 179.933 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.477 ' HB3' ' HB3' ' A' ' 35' ' ' GLU . 46.7 tttm -96.32 141.98 29.0 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.277 -0.89 . . . . 0.0 109.237 179.282 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.764 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -150.03 174.13 13.08 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 120.927 -1.108 . . . . 0.0 111.023 -179.456 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 50' ' ' GLN . 58.7 tt0 -137.82 146.06 43.06 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.613 -0.679 . . . . 0.0 109.771 179.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.8 t -92.92 107.3 19.11 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.204 -0.935 . . . . 0.0 110.136 179.971 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 44.7 mt -70.01 -3.04 14.5 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.24 -0.913 . . . . 0.0 110.429 -179.837 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.428 ' OG1' HG23 ' A' ' 48' ' ' THR . 30.1 p -89.07 -30.16 18.88 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.124 -0.985 . . . . 0.0 109.799 179.656 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.428 HG23 ' OG1' ' A' ' 47' ' ' THR . 49.2 p -120.81 -7.32 9.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.28 -0.887 . . . . 0.0 110.068 179.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.26 44.07 60.98 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 179.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.467 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 23.2 mt-30 -123.47 151.55 42.62 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.238 -1.154 . . . . 0.0 110.301 -179.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 44' ' ' GLN . 97.1 mt-10 -119.3 141.56 48.88 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.322 -0.861 . . . . 0.0 109.998 179.828 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.52 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -159.1 -151.92 6.28 Favored Glycine 0 N--CA 1.489 2.218 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -179.857 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 95.7 m-85 -124.27 138.28 54.41 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.398 -1.06 . . . . 0.0 109.818 179.829 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.446 ' O ' HG13 ' A' ' 54' ' ' ILE . 2.9 pt -133.53 144.37 51.86 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 121.157 -0.964 . . . . 0.0 110.343 -179.866 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.593 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 47.0 Cg_endo -72.64 151.86 52.85 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.06 1.558 . . . . 0.0 109.985 179.736 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.597 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 31.6 p90 -73.99 -4.26 34.22 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.29 -0.881 . . . . 0.0 111.134 -179.375 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 52.9 t30 -98.6 -26.14 14.49 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.895 -1.128 . . . . 0.0 111.341 -179.305 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.593 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 8.5 m-85 -82.65 -2.53 54.25 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.803 -1.186 . . . . 0.0 110.346 -179.693 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.45 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 30.9 m -133.74 143.21 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.161 -0.962 . . . . 0.0 110.117 179.978 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.446 ' HB2' HD11 ' A' ' 12' ' ' LEU . . . -127.25 155.97 42.63 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.241 -0.912 . . . . 0.0 110.246 -179.968 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.444 ' HA ' HG12 ' A' ' 9' ' ' VAL . 60.8 mttp -71.66 134.64 46.46 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.284 -0.885 . . . . 0.0 110.162 179.996 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.98 -34.82 76.87 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.235 -0.916 . . . . 0.0 110.241 -179.988 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 117.959 -1.019 . . . . 0.0 110.212 -179.971 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.309 0 N-CA-C 109.453 -1.459 . . . . 0.0 109.453 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -125.28 71.33 64.04 Favored Pre-proline 0 N--CA 1.492 1.634 0 O-C-N 121.258 -1.142 . . . . 0.0 110.228 179.986 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_endo -59.95 140.51 93.22 Favored 'Trans proline' 0 C--N 1.305 -1.711 0 O-C-N 123.927 1.488 . . . . 0.0 110.369 179.971 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 27.8 tp -65.52 -34.43 78.25 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.246 -0.909 . . . . 0.0 110.218 -180.0 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 96.5 mt-30 -60.71 -37.86 83.12 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.301 -0.875 . . . . 0.0 110.257 -179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . 0.816 ' OD1' HD11 ' A' ' 8' ' ' LEU . 48.2 t0 -141.92 75.51 1.5 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.215 -0.928 . . . . 0.0 110.302 -179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 64.5 t-20 -86.14 113.06 21.89 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.217 -0.927 . . . . 0.0 110.227 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.816 HD11 ' OD1' ' A' ' 6' ' ' ASP . 5.4 mp -112.91 150.86 31.2 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.297 -0.877 . . . . 0.0 110.31 179.963 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.73 HG12 ' HA ' ' A' ' 62' ' ' ALA . 4.2 m -145.95 167.72 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.267 -0.895 . . . . 0.0 110.288 179.93 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . 0.767 HD12 ' CD ' ' A' ' 61' ' ' LYS . 61.8 mt -113.43 140.11 35.37 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.315 -0.865 . . . . 0.0 109.781 179.661 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.555 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -80.66 110.22 15.94 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.137 -0.977 . . . . 0.0 110.555 -179.631 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.447 ' N ' ' O ' ' A' ' 58' ' ' PHE . 52.4 mt -67.52 -22.94 65.41 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.08 -1.013 . . . . 0.0 109.162 179.164 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.439 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 21.8 m80 -157.37 146.72 20.12 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.641 -0.662 . . . . 0.0 109.408 179.704 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.5 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 81.9 p -61.5 146.38 48.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.998 -1.064 . . . . 0.0 110.14 -179.831 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.566 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 25.1 t80 -95.76 156.93 16.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.978 -1.076 . . . . 0.0 110.348 179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 17' ' ' PRO . 46.1 mt-10 -114.07 73.87 2.58 Favored Pre-proline 0 N--CA 1.492 1.632 0 O-C-N 121.326 -0.859 . . . . 0.0 110.121 179.983 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.515 ' HB3' ' HB2' ' A' ' 22' ' ' ASP . 47.7 Cg_endo -40.6 110.35 0.12 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 124.043 1.549 . . . . 0.0 110.429 -179.989 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.469 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 59.6 p -87.25 8.21 25.09 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.348 -0.845 . . . . 0.0 110.168 -179.994 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.469 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 96.2 m-70 -145.48 170.54 16.19 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.287 -0.883 . . . . 0.0 110.09 179.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -87.25 126.89 35.1 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.266 -0.896 . . . . 0.0 110.294 -179.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 117.27 -14.0 13.66 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.495 -1.442 . . . . 0.0 109.495 179.852 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.515 ' HB2' ' HB3' ' A' ' 17' ' ' PRO . 2.4 m-20 -86.68 174.66 8.71 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.242 -1.152 . . . . 0.0 110.262 -179.999 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.497 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 19.2 tp -120.63 124.66 45.78 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.312 -0.868 . . . . 0.0 110.062 -179.95 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.493 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -104.13 57.52 0.53 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.883 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.759 ' CG ' HD11 ' A' ' 31' ' ' LEU . 28.6 p90 -47.07 169.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.259 -1.142 . . . . 0.0 110.878 -179.532 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.486 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 90.7 mt-10 -98.84 177.48 5.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.495 -0.753 . . . . 0.0 110.14 -179.867 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 76.0 tttt -71.55 119.89 16.34 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.184 -0.947 . . . . 0.0 110.348 179.751 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 99.9 -6.75 58.68 Favored Glycine 0 N--CA 1.488 2.12 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 179.691 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.503 ' OE1' ' CA ' ' A' ' 25' ' ' PHE . 71.6 tt0 -73.71 127.43 32.77 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.008 -1.289 . . . . 0.0 110.172 179.98 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.43 ' C ' ' HG ' ' A' ' 31' ' ' LEU . 58.2 mt-30 -79.25 142.67 36.01 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.217 -0.927 . . . . 0.0 110.004 -179.948 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.759 HD11 ' CG ' ' A' ' 25' ' ' PHE . 73.0 mt -141.36 163.83 31.88 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.243 -0.91 . . . . 0.0 110.348 -179.799 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.753 ' CD ' HD21 ' A' ' 34' ' ' LEU . 19.0 ttt180 -105.85 133.25 50.87 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.285 -0.885 . . . . 0.0 109.63 179.553 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.632 HD11 HG21 ' A' ' 9' ' ' VAL . 31.0 mm -96.53 93.78 3.74 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.12 -0.987 . . . . 0.0 110.417 -179.833 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.795 HD11 ' OE1' ' A' ' 44' ' ' GLN . 41.8 mt -79.83 -24.52 41.29 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.258 -0.901 . . . . 0.0 110.859 -179.543 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.516 ' CB ' ' HB3' ' A' ' 42' ' ' LYS . 17.9 tt0 -136.18 140.87 43.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.992 -1.067 . . . . 0.0 110.345 -179.889 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.625 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 84.3 mt-30 -135.29 55.18 1.89 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.25 -0.906 . . . . 0.0 110.158 179.985 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 22.9 t -119.27 142.13 48.34 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.28 -0.887 . . . . 0.0 110.178 -179.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.0 -171.16 54.62 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 109.367 -1.493 . . . . 0.0 109.367 179.994 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -74.16 -34.77 63.94 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.218 -1.166 . . . . 0.0 110.132 179.937 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.561 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 95.3 m95 -96.28 144.5 26.41 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.302 -0.874 . . . . 0.0 110.272 -179.888 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.625 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.9 m0 -118.85 156.09 30.08 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.242 -0.911 . . . . 0.0 110.217 179.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.516 ' HB3' ' CB ' ' A' ' 35' ' ' GLU . 29.0 tttt -96.18 137.57 35.06 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.358 -0.839 . . . . 0.0 109.408 179.412 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.589 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -152.77 176.65 11.55 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.083 -1.01 . . . . 0.0 110.666 -179.554 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.795 ' OE1' HD11 ' A' ' 34' ' ' LEU . 14.5 pt20 -148.18 156.67 42.86 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.455 -0.778 . . . . 0.0 109.819 179.719 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 3.8 t -98.55 116.91 31.79 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.122 -0.987 . . . . 0.0 110.275 -179.922 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.502 HD21 HE21 ' A' ' 44' ' ' GLN . 60.3 mt -74.51 -0.78 18.7 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.241 -0.912 . . . . 0.0 110.094 179.96 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 70.7 p -94.63 -27.22 16.0 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.36 -0.838 . . . . 0.0 110.166 179.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 47.4 p -114.25 -13.02 12.38 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.294 -0.879 . . . . 0.0 110.157 179.985 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 73.42 39.46 50.7 Favored Glycine 0 N--CA 1.49 2.249 0 N-CA-C 109.516 -1.434 . . . . 0.0 109.516 -179.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.3 mt-30 -128.16 155.51 44.36 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.238 -1.154 . . . . 0.0 110.276 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.485 ' HG2' ' CB ' ' A' ' 44' ' ' GLN . 73.6 mt-10 -123.8 152.56 42.09 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.251 -0.905 . . . . 0.0 110.031 179.866 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.497 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -165.94 -149.89 6.09 Favored Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.764 -1.334 . . . . 0.0 109.764 -179.832 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 92.6 m-85 -127.74 143.63 51.13 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.46 -1.024 . . . . 0.0 109.683 179.61 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.504 HD12 ' O ' ' A' ' 55' ' ' PRO . 1.7 pp -141.01 139.2 18.94 Favored Pre-proline 0 N--CA 1.49 1.555 0 O-C-N 121.132 -0.98 . . . . 0.0 110.696 -179.55 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.608 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 44.8 Cg_endo -59.39 156.97 33.09 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 124.093 1.575 . . . . 0.0 109.907 179.465 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.577 ' CZ ' ' OD1' ' A' ' 57' ' ' ASN . 20.8 p90 -84.56 -2.28 57.13 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.097 -1.002 . . . . 0.0 110.766 -179.615 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.577 ' OD1' ' CZ ' ' A' ' 56' ' ' PHE . 8.6 m120 -103.65 13.22 33.68 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.984 -1.073 . . . . 0.0 110.696 -179.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.608 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 6.1 m-85 -111.32 -6.41 14.52 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.097 -1.002 . . . . 0.0 110.028 179.694 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.464 ' HA ' ' O ' ' A' ' 10' ' ' ILE . 7.8 m -138.46 145.47 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.334 -0.854 . . . . 0.0 110.032 179.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.413 ' O ' ' C ' ' A' ' 61' ' ' LYS . . . -160.26 -41.28 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.165 -0.959 . . . . 0.0 110.398 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.767 ' CD ' HD12 ' A' ' 10' ' ' ILE . 91.2 mttt -41.93 -29.18 0.2 Allowed 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.309 -0.87 . . . . 0.0 110.319 -179.863 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.73 ' HA ' HG12 ' A' ' 9' ' ' VAL . . . 49.18 25.13 1.1 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.328 -0.857 . . . . 0.0 110.23 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.2 t30 . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.268 -179.939 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.446 -1.462 . . . . 0.0 109.446 . . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -71.13 146.27 92.32 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.279 -1.13 . . . . 0.0 110.234 179.99 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 47.4 Cg_endo -53.34 -29.13 46.49 Favored 'Trans proline' 0 C--N 1.304 -1.771 0 O-C-N 124.012 1.532 . . . . 0.0 110.446 -179.967 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 39.3 mt -88.91 146.65 24.79 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.153 -0.967 . . . . 0.0 110.21 179.984 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.533 ' O ' HD13 ' A' ' 8' ' ' LEU . 89.0 mt-30 -116.68 138.76 51.22 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.178 -0.952 . . . . 0.0 110.184 179.945 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 82.2 m-20 -102.14 13.7 33.99 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.357 -0.84 . . . . 0.0 110.175 179.956 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 21.8 m120 -80.31 6.84 10.91 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.24 -0.913 . . . . 0.0 110.207 -179.972 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.746 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.2 mp -84.23 140.92 31.37 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.208 -0.932 . . . . 0.0 110.231 -179.996 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.528 HG12 ' HA ' ' A' ' 61' ' ' LYS . 30.9 m -150.9 170.21 1.5 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.166 -0.959 . . . . 0.0 110.289 179.958 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 67.9 mt -112.27 148.7 15.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.373 -0.83 . . . . 0.0 109.887 179.729 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.53 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . -80.12 112.01 17.03 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.131 -0.981 . . . . 0.0 110.422 -179.779 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.658 HD22 ' N ' ' A' ' 12' ' ' LEU . 3.9 mm? -71.71 -22.41 61.64 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.192 -0.942 . . . . 0.0 109.442 179.442 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.422 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 86.0 m-70 -153.62 151.13 29.36 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.464 -0.772 . . . . 0.0 109.75 179.894 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.555 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 54.2 p -67.25 142.83 56.77 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.059 -1.026 . . . . 0.0 109.97 179.861 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.594 ' CE1' ' HD3' ' A' ' 55' ' ' PRO . 88.5 t80 -99.08 160.17 14.46 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.072 -1.017 . . . . 0.0 110.414 179.898 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.551 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 2.4 mm-40 -104.69 124.4 37.06 Favored Pre-proline 0 N--CA 1.492 1.644 0 O-C-N 121.356 -0.84 . . . . 0.0 110.063 179.938 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.472 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 49.6 Cg_endo -81.06 82.84 2.34 Favored 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.945 1.497 . . . . 0.0 110.429 -179.843 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 59.6 p -79.99 -2.73 45.33 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.255 -0.903 . . . . 0.0 110.213 -179.933 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 60.2 m80 -129.13 -159.34 0.95 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.208 -0.933 . . . . 0.0 110.266 -179.918 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 93.5 m-20 -107.72 -19.1 13.65 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.191 -0.943 . . . . 0.0 110.235 179.98 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -110.23 10.48 31.28 Favored Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.609 -1.396 . . . . 0.0 109.609 -179.915 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -89.95 155.94 18.77 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.188 -1.184 . . . . 0.0 110.157 179.958 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.448 ' O ' ' CD2' ' A' ' 15' ' ' TYR . 14.5 tp -111.65 116.31 30.57 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.301 -0.874 . . . . 0.0 110.169 -179.979 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.472 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -97.06 47.59 1.63 Allowed Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.644 -1.382 . . . . 0.0 109.644 -179.919 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.589 ' CE1' ' HB2' ' A' ' 15' ' ' TYR . 43.7 p90 -48.43 173.43 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.23 -1.159 . . . . 0.0 111.006 -179.828 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.555 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 95.5 mt-10 -109.36 179.05 4.26 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.458 -0.776 . . . . 0.0 110.191 179.903 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.0 ttpp -68.42 136.46 53.32 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.209 -0.932 . . . . 0.0 110.439 -179.914 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 87.35 -14.39 57.87 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.693 -1.363 . . . . 0.0 109.693 179.789 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.473 ' HG3' ' HB2' ' A' ' 26' ' ' GLU . 3.2 mt-10 -62.98 124.08 20.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.16 -1.2 . . . . 0.0 110.393 -179.746 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.476 ' O ' HD23 ' A' ' 31' ' ' LEU . 86.8 mt-30 -79.75 136.64 36.8 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.24 -0.913 . . . . 0.0 109.832 179.768 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.546 HD23 ' HA ' ' A' ' 45' ' ' SER . 15.1 mt -137.74 158.51 44.22 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.069 -1.019 . . . . 0.0 110.653 -179.723 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.717 ' HD2' HD21 ' A' ' 46' ' ' LEU . 25.4 mtp180 -108.05 134.37 51.03 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.436 -0.79 . . . . 0.0 109.142 179.295 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.4 mm -90.82 93.97 4.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.047 -1.033 . . . . 0.0 110.737 -179.502 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.9 mt -79.38 -29.79 42.22 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.292 -0.88 . . . . 0.0 110.842 -179.507 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.505 ' HB2' ' CB ' ' A' ' 42' ' ' LYS . 74.0 mt-10 -129.54 143.93 51.04 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.923 -1.111 . . . . 0.0 110.366 -179.957 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.635 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 15.1 pt20 -138.04 55.87 1.76 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.363 -0.836 . . . . 0.0 110.241 -179.97 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.6 t -120.66 142.06 49.8 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.171 -0.956 . . . . 0.0 110.204 -179.887 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 75.35 -176.01 50.55 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.418 -1.473 . . . . 0.0 109.418 179.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -70.57 -28.28 64.78 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.33 -1.1 . . . . 0.0 110.211 179.996 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.506 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 95.4 m95 -100.27 147.59 25.59 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.255 -0.903 . . . . 0.0 110.345 -179.974 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.635 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 47.1 m0 -124.27 156.17 37.37 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.302 -0.874 . . . . 0.0 110.192 -179.985 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.505 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 13.5 tttp -98.94 145.23 27.24 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.263 -0.898 . . . . 0.0 109.413 179.421 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.593 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -158.21 -177.33 6.47 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.011 -1.056 . . . . 0.0 111.002 -179.596 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.504 ' O ' ' HA ' ' A' ' 31' ' ' LEU . 58.4 tt0 -144.45 152.87 41.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.454 -0.779 . . . . 0.0 109.365 179.584 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.546 ' HA ' HD23 ' A' ' 31' ' ' LEU . 10.5 t -102.76 128.12 49.63 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.026 -1.046 . . . . 0.0 110.515 -179.638 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.717 HD21 ' HD2' ' A' ' 32' ' ' ARG . 37.8 mt -83.17 8.31 13.55 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.283 -0.886 . . . . 0.0 109.917 179.769 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.43 ' OG1' HG23 ' A' ' 48' ' ' THR . 20.4 p -98.48 -42.07 7.48 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.348 -0.845 . . . . 0.0 110.11 -179.993 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.43 HG23 ' OG1' ' A' ' 47' ' ' THR . 58.2 p -113.05 -10.78 13.43 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.22 -0.925 . . . . 0.0 110.101 -179.895 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.11 38.93 46.43 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.305 -1.518 . . . . 0.0 109.305 -179.852 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.8 tt0 -112.61 142.52 45.1 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.266 -1.138 . . . . 0.0 110.197 -179.891 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -117.9 136.67 53.32 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.265 -0.897 . . . . 0.0 110.092 179.872 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.433 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -171.44 165.15 38.11 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 109.701 -1.36 . . . . 0.0 109.701 -179.9 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.448 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 97.0 m-85 -71.09 145.3 49.93 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.367 -1.078 . . . . 0.0 110.145 179.951 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.573 ' CD1' HG21 ' A' ' 59' ' ' VAL . 1.2 pp -136.68 140.07 31.0 Favored Pre-proline 0 N--CA 1.492 1.629 0 O-C-N 121.262 -0.899 . . . . 0.0 110.216 179.981 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.595 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 47.7 Cg_endo -65.14 149.73 88.59 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 O-C-N 124.021 1.537 . . . . 0.0 110.073 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.592 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 39.6 p90 -75.61 -5.45 45.48 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.34 -0.85 . . . . 0.0 110.931 -179.449 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 42.5 t30 -95.44 -25.74 16.13 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.955 -1.091 . . . . 0.0 111.039 -179.363 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.595 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 9.3 m-85 -82.22 0.26 42.0 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.905 -1.122 . . . . 0.0 110.453 -179.741 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.573 HG21 ' CD1' ' A' ' 54' ' ' ILE . 23.3 m -141.95 154.11 19.08 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.205 -0.934 . . . . 0.0 110.097 179.953 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -148.73 157.51 43.5 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.241 -0.912 . . . . 0.0 110.227 -179.97 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.528 ' HA ' HG12 ' A' ' 9' ' ' VAL . 31.1 mttt -67.93 123.26 20.1 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.264 -0.898 . . . . 0.0 110.257 179.885 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -60.79 -29.51 69.49 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.167 -0.958 . . . . 0.0 110.175 -179.952 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 47.5 t30 . . . . . 0 N--CA 1.491 1.593 0 CA-C-O 117.943 -1.027 . . . . 0.0 110.187 -179.93 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.448 ' O ' ' HB3' ' A' ' 4' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.272 0 N-CA-C 109.458 -1.457 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.503 ' CB ' ' CD ' ' A' ' 3' ' ' PRO . 0.3 OUTLIER -47.32 -66.3 0.56 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.222 -1.164 . . . . 0.0 110.165 179.959 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.503 ' CD ' ' CB ' ' A' ' 2' ' ' SER . 46.5 Cg_endo -58.42 -31.17 93.48 Favored 'Trans proline' 0 C--N 1.304 -1.769 0 O-C-N 124.05 1.553 . . . . 0.0 110.29 -179.945 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.99 HD13 ' O ' ' A' ' 4' ' ' LEU . 2.9 tm? -56.51 -26.15 53.68 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.282 -0.886 . . . . 0.0 110.179 179.963 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 92.7 mt-30 -73.31 -19.83 60.94 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.282 -0.886 . . . . 0.0 110.256 -179.996 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 58.3 m-20 45.81 43.9 10.35 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.17 -0.956 . . . . 0.0 110.027 -179.932 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . 0.817 ' CG ' HD12 ' A' ' 33' ' ' ILE . 44.9 t-20 -92.37 99.94 12.6 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.338 -0.851 . . . . 0.0 110.393 -179.844 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . . . . . . . . . 22.2 tp -103.78 143.24 33.08 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.262 -0.899 . . . . 0.0 109.973 179.885 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.038 HG11 HD11 ' A' ' 33' ' ' ILE . 27.8 m -141.78 165.74 17.78 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.129 -0.982 . . . . 0.0 110.465 -179.868 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 72.4 mt -112.5 148.01 15.84 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.337 -0.852 . . . . 0.0 109.684 179.561 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.548 ' HB1' ' CD2' ' A' ' 25' ' ' PHE . . . -78.56 111.18 14.35 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.063 -1.023 . . . . 0.0 110.347 -179.71 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.442 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 49.9 mt -70.05 -25.68 63.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.088 -1.008 . . . . 0.0 109.16 179.322 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.442 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 80.7 m-70 -155.62 151.92 28.09 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.692 -0.63 . . . . 0.0 109.506 179.703 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.43 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 30.2 p -64.91 140.0 58.82 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.951 -1.093 . . . . 0.0 109.774 179.75 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.61 ' HB2' ' CE1' ' A' ' 25' ' ' PHE . 85.6 t80 -97.59 157.13 16.19 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.014 -1.054 . . . . 0.0 110.332 -179.994 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -111.44 124.61 32.21 Favored Pre-proline 0 N--CA 1.491 1.587 0 O-C-N 121.245 -0.909 . . . . 0.0 110.188 179.926 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.478 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 48.4 Cg_endo -80.21 81.67 2.69 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 124.02 1.537 . . . . 0.0 110.47 -179.884 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.473 ' OG ' ' ND1' ' A' ' 19' ' ' HIS . 92.2 p -79.81 -1.96 41.22 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.135 -0.978 . . . . 0.0 110.013 179.904 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.473 ' ND1' ' OG ' ' A' ' 18' ' ' SER . 72.4 m80 -140.34 172.86 12.13 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.289 -0.882 . . . . 0.0 110.076 -179.997 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -90.07 125.3 35.37 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.238 -0.913 . . . . 0.0 110.248 179.906 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 108.09 6.99 31.51 Favored Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 -179.997 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 22.9 m-20 -104.16 164.37 11.76 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.221 -1.164 . . . . 0.0 110.28 -179.984 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.483 ' CD1' ' CD ' ' A' ' 50' ' ' GLN . 22.8 tp -114.82 119.63 37.28 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.252 -0.905 . . . . 0.0 110.174 -179.961 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.478 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -99.91 54.21 0.94 Allowed Glycine 0 N--CA 1.49 2.273 0 N-CA-C 109.661 -1.376 . . . . 0.0 109.661 -179.866 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.751 ' CD1' HD21 ' A' ' 31' ' ' LEU . 45.9 p90 -53.12 173.73 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.235 -1.156 . . . . 0.0 111.131 -179.482 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.458 ' O ' ' HB2' ' A' ' 29' ' ' GLU . 96.0 mt-10 -105.61 176.57 5.12 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.553 -0.717 . . . . 0.0 110.288 -179.858 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.7 tttm -70.97 135.67 48.0 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.058 -1.026 . . . . 0.0 110.322 179.772 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 85.0 -13.67 53.07 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 179.887 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.591 ' OE1' HG21 ' A' ' 47' ' ' THR . 30.6 mm-40 -63.91 136.18 57.15 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.035 -1.274 . . . . 0.0 109.99 -179.764 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.821 ' C ' HD12 ' A' ' 31' ' ' LEU . 88.3 mt-30 -79.6 128.1 32.97 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.267 -0.895 . . . . 0.0 110.075 -179.873 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.821 HD12 ' C ' ' A' ' 30' ' ' GLN . 10.4 mp -124.31 141.63 51.92 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.208 -0.932 . . . . 0.0 110.393 -179.929 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.749 ' HB2' HD11 ' A' ' 46' ' ' LEU . 15.7 ttt85 -100.95 134.58 43.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.336 -0.852 . . . . 0.0 109.588 179.633 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 1.038 HD11 HG11 ' A' ' 9' ' ' VAL . 27.0 mt -85.78 132.58 31.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 O-C-N 121.163 -0.96 . . . . 0.0 110.307 -179.925 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.0 mt -118.71 -31.75 4.75 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.363 -0.835 . . . . 0.0 110.112 -179.994 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.514 ' HB2' ' CB ' ' A' ' 42' ' ' LYS . 85.7 mt-10 -135.58 149.87 49.52 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.19 -0.944 . . . . 0.0 110.198 179.999 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.626 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 93.2 mt-30 -135.84 59.01 1.73 Allowed 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.268 -0.895 . . . . 0.0 110.15 -179.977 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.7 t -124.24 135.59 53.53 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.274 -0.891 . . . . 0.0 110.235 179.989 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.7 176.65 45.76 Favored Glycine 0 N--CA 1.49 2.287 0 N-CA-C 109.471 -1.451 . . . . 0.0 109.471 -179.97 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -63.9 -27.44 69.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.204 -1.174 . . . . 0.0 110.236 -179.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.556 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 98.3 m95 -98.96 146.28 26.17 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.22 -0.925 . . . . 0.0 110.241 -179.897 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.626 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 40.9 m0 -122.88 156.48 34.54 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.259 -0.901 . . . . 0.0 110.14 179.795 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.514 ' CB ' ' HB2' ' A' ' 35' ' ' GLU . 20.7 tttt -93.75 142.3 27.52 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.171 -0.956 . . . . 0.0 109.776 179.581 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.513 ' CB ' HG12 ' A' ' 54' ' ' ILE . . . -155.9 178.83 9.82 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.115 -0.991 . . . . 0.0 110.771 -179.803 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.414 ' CG ' ' HG2' ' A' ' 51' ' ' GLU . 46.3 tt0 -141.82 150.14 41.26 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.394 -0.816 . . . . 0.0 109.909 179.697 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 16.2 t -95.3 119.63 34.13 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.191 -0.943 . . . . 0.0 110.276 -179.907 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . 0.749 HD11 ' HB2' ' A' ' 32' ' ' ARG . 4.9 mp -78.13 6.28 8.36 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.26 -0.9 . . . . 0.0 110.412 -179.98 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.591 HG21 ' OE1' ' A' ' 29' ' ' GLU . 65.5 p -96.57 -37.29 10.44 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.249 -0.907 . . . . 0.0 110.019 179.853 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 68.1 p -120.13 -6.09 9.96 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.225 -0.922 . . . . 0.0 110.098 179.879 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.67 40.6 52.96 Favored Glycine 0 N--CA 1.49 2.296 0 N-CA-C 109.328 -1.509 . . . . 0.0 109.328 -179.937 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.483 ' CD ' ' CD1' ' A' ' 23' ' ' LEU . 62.1 tt0 -110.29 141.15 43.68 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.263 -1.14 . . . . 0.0 110.288 -179.967 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.414 ' HG2' ' CG ' ' A' ' 44' ' ' GLN . 92.6 mt-10 -117.15 136.57 52.93 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.341 -0.849 . . . . 0.0 109.938 179.937 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.428 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -170.14 164.7 38.05 Favored Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.649 -1.38 . . . . 0.0 109.649 -179.981 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -69.1 144.59 53.87 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.279 -1.13 . . . . 0.0 110.029 179.894 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.558 ' CD1' HG21 ' A' ' 59' ' ' VAL . 1.1 pt -136.0 139.53 30.59 Favored Pre-proline 0 N--CA 1.49 1.542 0 O-C-N 121.223 -0.923 . . . . 0.0 110.257 -179.865 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.574 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 45.4 Cg_endo -63.94 150.45 88.37 Favored 'Trans proline' 0 C--N 1.305 -1.76 0 O-C-N 123.911 1.479 . . . . 0.0 110.188 179.739 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.596 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 16.2 p90 -85.41 1.3 49.23 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.348 -0.845 . . . . 0.0 111.18 -179.402 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.538 ' OD1' ' N ' ' A' ' 58' ' ' PHE . 48.9 p30 -100.41 -24.03 14.6 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.955 -1.091 . . . . 0.0 111.178 -179.365 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.544 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 14.1 m-30 -94.18 1.34 56.07 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.87 -1.144 . . . . 0.0 110.591 -179.812 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.558 HG21 ' CD1' ' A' ' 54' ' ' ILE . 33.9 m -130.69 146.22 34.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.178 -0.951 . . . . 0.0 110.198 179.871 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.448 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . -140.41 160.59 39.64 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.318 -0.864 . . . . 0.0 110.271 -179.945 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.549 ' HA ' HG12 ' A' ' 9' ' ' VAL . 22.4 mttm -74.8 134.68 41.73 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.176 -0.953 . . . . 0.0 110.23 -179.988 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.97 -34.72 72.12 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.291 -0.881 . . . . 0.0 110.179 179.971 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 36.7 t-20 . . . . . 0 N--CA 1.492 1.63 0 CA-C-O 117.966 -1.016 . . . . 0.0 110.207 179.983 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.26 0 N-CA-C 109.504 -1.439 . . . . 0.0 109.504 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 3.7 m -67.31 138.27 94.22 Favored Pre-proline 0 N--CA 1.492 1.661 0 O-C-N 121.282 -1.128 . . . . 0.0 110.177 -179.988 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.0 Cg_endo -57.52 145.21 89.81 Favored 'Trans proline' 0 C--N 1.304 -1.775 0 O-C-N 124.054 1.555 . . . . 0.0 110.376 -179.924 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 57.3 mt -62.15 -38.31 88.5 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.217 -0.927 . . . . 0.0 110.107 179.964 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -123.72 151.16 43.49 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.272 -0.892 . . . . 0.0 110.199 179.96 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -104.28 16.61 25.81 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.31 -0.869 . . . . 0.0 110.133 179.911 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 22.9 m120 -87.82 15.8 6.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.211 -0.93 . . . . 0.0 110.283 179.997 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.77 HD12 ' N ' ' A' ' 8' ' ' LEU . 5.3 mp -102.67 151.82 21.93 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.204 -0.935 . . . . 0.0 110.101 179.917 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.817 ' CG1' HD11 ' A' ' 33' ' ' ILE . 15.5 m -151.86 171.95 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.172 -0.955 . . . . 0.0 110.448 179.911 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 52.7 mt -118.02 143.32 29.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 121.418 -0.801 . . . . 0.0 109.927 179.754 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.582 ' HB1' ' CD1' ' A' ' 25' ' ' PHE . . . -76.9 112.61 13.69 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.179 -0.95 . . . . 0.0 110.514 -179.659 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.481 ' O ' ' CG ' ' A' ' 13' ' ' HIS . 52.5 mt -72.99 -22.32 60.7 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.089 -1.007 . . . . 0.0 109.314 179.262 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.481 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 77.8 m-70 -156.83 151.68 25.92 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.651 -0.656 . . . . 0.0 109.521 179.881 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 34.9 p -65.26 136.83 57.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.899 -1.126 . . . . 0.0 109.895 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.587 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 67.0 t80 -97.78 157.08 16.27 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.085 -1.009 . . . . 0.0 110.119 179.853 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.558 ' O ' ' CE2' ' A' ' 15' ' ' TYR . 3.0 mt-10 -111.74 136.07 21.14 Favored Pre-proline 0 N--CA 1.491 1.582 0 O-C-N 121.336 -0.852 . . . . 0.0 110.295 -179.82 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.457 ' HD3' ' HA3' ' A' ' 24' ' ' GLY . 46.8 Cg_endo -94.32 87.17 0.13 Allowed 'Trans proline' 0 C--N 1.305 -1.747 0 O-C-N 124.065 1.561 . . . . 0.0 110.272 179.842 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 90.1 p -80.51 0.86 31.86 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.286 -0.884 . . . . 0.0 110.242 -179.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . . . . . . . . . 93.9 m-70 -142.12 -177.92 5.47 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.206 -0.934 . . . . 0.0 110.278 -179.963 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -97.72 126.11 42.89 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.208 -0.932 . . . . 0.0 110.169 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 112.33 -9.87 26.55 Favored Glycine 0 N--CA 1.489 2.176 0 N-CA-C 109.521 -1.432 . . . . 0.0 109.521 -179.984 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.516 ' N ' ' OD1' ' A' ' 22' ' ' ASP . 1.1 m-20 -92.12 171.05 9.35 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -1.171 . . . . 0.0 110.129 -179.96 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.506 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 15.5 tp -127.12 132.31 50.62 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.279 -0.888 . . . . 0.0 110.052 -179.931 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.475 ' HA2' ' HB3' ' A' ' 15' ' ' TYR . . . -109.2 60.29 0.33 Allowed Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.76 -1.336 . . . . 0.0 109.76 -179.653 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.794 ' CG ' HD11 ' A' ' 31' ' ' LEU . 39.6 p90 -52.61 175.44 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.156 -1.202 . . . . 0.0 110.92 -179.684 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.493 ' O ' ' CB ' ' A' ' 11' ' ' ALA . 96.3 mt-10 -109.75 -179.5 3.83 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.401 -0.812 . . . . 0.0 110.323 179.991 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.0 tttt -70.87 130.34 41.4 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.093 -1.005 . . . . 0.0 110.187 179.674 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 89.9 -18.47 47.31 Favored Glycine 0 N--CA 1.487 2.037 0 N-CA-C 109.404 -1.479 . . . . 0.0 109.404 -179.991 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.478 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 22.3 mm-40 -61.45 123.91 19.15 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.081 -1.246 . . . . 0.0 110.086 -179.667 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.466 ' NE2' HD23 ' A' ' 8' ' ' LEU . 48.9 tt0 -79.46 134.47 36.54 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.335 -0.853 . . . . 0.0 110.28 -179.76 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.794 HD11 ' CG ' ' A' ' 25' ' ' PHE . 41.8 mt -129.85 150.03 51.32 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.334 -0.854 . . . . 0.0 110.176 -179.895 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.478 ' O ' ' HA ' ' A' ' 43' ' ' ALA . 19.4 ttt180 -94.59 133.35 38.33 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.329 -0.857 . . . . 0.0 110.065 179.809 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.817 HD11 ' CG1' ' A' ' 9' ' ' VAL . 34.8 mt -80.89 121.48 34.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 O-C-N 121.202 -0.936 . . . . 0.0 110.031 179.937 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.44 HD13 ' OE2' ' A' ' 51' ' ' GLU . 4.6 mt -99.49 -33.15 10.78 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.272 -0.892 . . . . 0.0 110.317 -179.777 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.523 ' OE1' ' CE ' ' A' ' 42' ' ' LYS . 79.6 tt0 -150.98 146.97 26.59 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.176 -0.953 . . . . 0.0 110.194 -179.924 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.623 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 98.2 mt-30 -128.82 55.17 1.73 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.269 -0.895 . . . . 0.0 110.195 -179.943 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 21.1 t -111.23 125.99 54.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.238 -0.914 . . . . 0.0 110.249 -179.89 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 82.74 -175.05 53.25 Favored Glycine 0 N--CA 1.491 2.321 0 N-CA-C 109.517 -1.433 . . . . 0.0 109.517 179.983 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 91.4 mt-10 -67.91 -37.08 81.24 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.324 -1.104 . . . . 0.0 110.203 179.97 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.418 ' HZ3' ' CE1' ' A' ' 15' ' ' TYR . 85.7 m95 -91.47 141.31 28.88 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.246 -0.909 . . . . 0.0 110.149 179.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.623 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 50.9 m0 -122.28 153.75 38.49 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.222 -0.924 . . . . 0.0 110.391 -179.97 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.523 ' CE ' ' OE1' ' A' ' 35' ' ' GLU . 50.2 mttt -89.13 146.42 24.81 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.302 -0.874 . . . . 0.0 109.558 179.472 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.771 ' HB2' HG12 ' A' ' 54' ' ' ILE . . . -148.71 170.08 18.98 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.085 -1.01 . . . . 0.0 110.653 -179.61 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 51' ' ' GLU . 42.8 tt0 -137.51 145.25 42.77 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.383 -0.823 . . . . 0.0 109.878 179.807 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.462 ' OG ' HD21 ' A' ' 23' ' ' LEU . 53.4 m -74.2 139.34 44.33 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.226 -0.921 . . . . 0.0 110.256 -179.936 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 9.8 tp -82.34 -26.14 33.24 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.183 -0.948 . . . . 0.0 110.224 -179.942 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 74.3 p -98.96 -28.23 13.52 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.265 -0.897 . . . . 0.0 110.158 -179.987 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.14 -18.94 18.21 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.241 -0.912 . . . . 0.0 110.091 179.836 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 66.95 6.04 35.72 Favored Glycine 0 N--CA 1.492 2.394 0 N-CA-C 110.113 -1.195 . . . . 0.0 110.113 179.634 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 44' ' ' GLN . 29.3 mt-30 -83.13 155.18 23.94 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.04 -1.271 . . . . 0.0 110.485 -179.803 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.44 ' OE2' HD13 ' A' ' 34' ' ' LEU . 69.1 tt0 -114.99 134.81 54.87 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.326 -0.859 . . . . 0.0 109.951 179.813 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.506 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -145.6 -152.14 5.57 Favored Glycine 0 N--CA 1.489 2.196 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.68 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 85.4 m-85 -122.9 134.25 54.37 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.481 -1.011 . . . . 0.0 109.614 179.638 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.771 HG12 ' HB2' ' A' ' 43' ' ' ALA . 1.2 pp -127.46 133.73 25.4 Favored Pre-proline 0 N--CA 1.49 1.526 0 O-C-N 121.116 -0.99 . . . . 0.0 110.631 -179.617 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.574 ' HD3' ' CE1' ' A' ' 15' ' ' TYR . 43.0 Cg_endo -66.08 157.42 59.66 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 O-C-N 124.149 1.605 . . . . 0.0 110.187 179.611 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.474 ' HB2' ' CH2' ' A' ' 41' ' ' TRP . 18.9 p90 -88.19 -1.63 58.13 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.274 -0.891 . . . . 0.0 111.36 -179.06 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.524 ' OD1' ' N ' ' A' ' 58' ' ' PHE . 42.3 p30 -99.43 -25.83 14.33 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.82 -1.175 . . . . 0.0 111.066 -179.451 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.569 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 11.7 m-30 -92.43 -3.97 54.42 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.89 -1.131 . . . . 0.0 110.54 -179.78 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.682 HG21 ' CD1' ' A' ' 54' ' ' ILE . 21.8 m -126.91 144.32 37.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.1 -1.0 . . . . 0.0 110.095 179.919 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . . . . . . . . . . . -137.22 167.19 22.04 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.237 -0.914 . . . . 0.0 110.362 -179.856 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 18.5 tttt -66.49 133.34 50.19 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.336 -0.852 . . . . 0.0 110.194 179.98 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.18 146.77 49.77 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.242 -0.911 . . . . 0.0 110.208 179.981 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 80.6 m-20 . . . . . 0 N--CA 1.492 1.637 0 CA-C-O 118.038 -0.982 . . . . 0.0 110.187 179.993 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 109.534 -1.426 . . . . 0.0 109.534 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 68.4 m -123.22 80.07 52.41 Favored Pre-proline 0 N--CA 1.491 1.59 0 O-C-N 121.262 -1.14 . . . . 0.0 110.173 -179.964 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -59.51 -18.93 49.49 Favored 'Trans proline' 0 C--N 1.305 -1.733 0 O-C-N 124.014 1.534 . . . . 0.0 110.336 -179.991 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.9 tp -56.02 -38.35 70.41 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.242 -0.912 . . . . 0.0 110.256 179.986 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.539 ' HA ' ' CD1' ' A' ' 8' ' ' LEU . 99.0 mt-30 -62.24 -32.73 73.45 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 110.27 -179.932 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 87.1 m-20 -61.7 -26.05 67.8 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.272 -0.893 . . . . 0.0 110.315 -179.937 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 24.4 m120 -86.94 -6.04 58.9 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.162 -0.961 . . . . 0.0 110.256 -179.989 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.539 ' CD1' ' HA ' ' A' ' 5' ' ' GLN . 44.0 mt -79.07 146.97 32.96 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.273 -0.892 . . . . 0.0 110.215 179.973 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.649 HG21 HG11 ' A' ' 59' ' ' VAL . 4.2 m -154.48 172.68 0.64 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.32 -0.862 . . . . 0.0 110.333 -179.962 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 60.0 mt -113.69 141.51 29.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.342 -0.849 . . . . 0.0 109.943 179.783 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.538 ' HB1' ' CE1' ' A' ' 25' ' ' PHE . . . -80.46 111.89 17.3 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.143 -0.973 . . . . 0.0 110.119 -179.894 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.416 ' O ' ' ND1' ' A' ' 13' ' ' HIS . 24.2 tp -66.43 -27.86 68.16 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.099 -1.0 . . . . 0.0 109.543 179.529 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.416 ' ND1' ' O ' ' A' ' 12' ' ' LEU . 89.5 m-70 -150.8 155.73 39.83 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.472 -0.767 . . . . 0.0 109.836 -180.0 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.531 ' CB ' ' HA ' ' A' ' 26' ' ' GLU . 52.5 p -68.15 144.28 55.06 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.14 -0.975 . . . . 0.0 110.019 179.93 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.573 ' CD1' ' HG3' ' A' ' 55' ' ' PRO . 27.4 t80 -94.44 153.71 17.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.042 -1.036 . . . . 0.0 110.323 -179.897 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.446 ' HA ' ' HD2' ' A' ' 17' ' ' PRO . 19.0 tp10 -110.45 77.83 1.34 Allowed Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.291 -0.881 . . . . 0.0 110.216 -179.911 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.508 ' HB3' ' HB2' ' A' ' 22' ' ' ASP . 48.1 Cg_endo -41.52 98.99 0.03 OUTLIER 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.127 1.593 . . . . 0.0 110.422 179.895 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.489 ' OG ' ' CD2' ' A' ' 19' ' ' HIS . 87.5 p -82.31 9.27 9.24 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.206 -0.934 . . . . 0.0 110.25 179.992 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.489 ' CD2' ' OG ' ' A' ' 18' ' ' SER . 87.3 m-70 -148.3 164.23 34.66 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.254 -0.904 . . . . 0.0 110.192 179.967 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 80.7 m-20 -80.93 118.94 22.85 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.244 -0.91 . . . . 0.0 110.304 179.98 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 118.08 14.8 6.4 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.526 -1.43 . . . . 0.0 109.526 179.957 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.508 ' HB2' ' HB3' ' A' ' 17' ' ' PRO . 13.0 m-20 -111.32 168.47 9.5 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.174 -1.192 . . . . 0.0 110.284 179.998 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.506 ' HB2' ' HA3' ' A' ' 52' ' ' GLY . 17.1 tp -110.22 113.38 26.02 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.273 -0.892 . . . . 0.0 109.998 179.872 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.505 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -96.43 53.25 1.54 Allowed Glycine 0 N--CA 1.49 2.267 0 N-CA-C 109.452 -1.459 . . . . 0.0 109.452 179.901 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.551 ' HE2' HG22 ' A' ' 54' ' ' ILE . 35.8 p90 -54.13 174.5 0.06 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.248 -1.148 . . . . 0.0 111.123 -179.557 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.531 ' HA ' ' CB ' ' A' ' 14' ' ' SER . 94.3 mt-10 -109.43 177.23 4.81 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.499 -0.751 . . . . 0.0 109.964 179.78 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 21.0 tttt -66.95 139.59 57.71 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.172 -0.955 . . . . 0.0 110.378 -179.997 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 86.96 -14.02 57.98 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.502 -1.439 . . . . 0.0 109.502 179.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.453 ' HB2' ' O ' ' A' ' 26' ' ' GLU . 3.7 mt-10 -66.6 126.16 28.03 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.135 -1.215 . . . . 0.0 110.308 -179.865 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.975 ' C ' HD12 ' A' ' 31' ' ' LEU . 44.7 tt0 -79.7 137.33 37.02 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.269 -0.894 . . . . 0.0 109.814 179.954 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.975 HD12 ' C ' ' A' ' 30' ' ' GLN . 8.3 mp -136.89 156.99 47.76 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.246 -0.909 . . . . 0.0 110.627 -179.553 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.592 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 38.5 ttt180 -106.26 131.65 53.24 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.412 -0.805 . . . . 0.0 109.24 179.247 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.458 HD11 HG11 ' A' ' 9' ' ' VAL . 87.6 mt -90.8 94.35 4.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 121.109 -0.994 . . . . 0.0 110.713 -179.318 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.93 HD12 ' HA ' ' A' ' 43' ' ' ALA . 1.1 mp -79.85 -32.69 40.55 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.247 -0.908 . . . . 0.0 110.379 179.993 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.495 ' HB3' ' CB ' ' A' ' 42' ' ' LYS . 67.3 tt0 -130.58 135.46 47.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.119 -0.988 . . . . 0.0 110.253 -179.931 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.624 ' HA ' ' CD1' ' A' ' 41' ' ' TRP . 58.8 tt0 -131.41 55.7 1.84 Allowed 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.29 -0.881 . . . . 0.0 110.174 179.984 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.2 m -120.65 145.42 47.45 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.281 -0.887 . . . . 0.0 110.231 179.961 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 73.89 -174.66 48.61 Favored Glycine 0 N--CA 1.489 2.191 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 -179.958 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -71.8 -30.68 65.78 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.236 -1.155 . . . . 0.0 110.128 -179.982 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.555 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 99.3 m95 -99.38 145.71 27.09 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.162 -0.961 . . . . 0.0 110.23 -179.99 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.624 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.6 m0 -121.2 157.04 31.11 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.35 -0.844 . . . . 0.0 110.207 179.896 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.495 ' CB ' ' HB3' ' A' ' 35' ' ' GLU . 43.8 tttp -101.37 138.69 38.06 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.327 -0.858 . . . . 0.0 109.012 179.065 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.93 ' HA ' HD12 ' A' ' 34' ' ' LEU . . . -149.93 177.38 9.9 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.838 -1.164 . . . . 0.0 110.998 -179.419 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . 0.518 ' HG3' ' CG ' ' A' ' 51' ' ' GLU . 39.4 tt0 -140.14 148.42 41.62 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.53 -0.731 . . . . 0.0 109.886 179.81 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 2.0 t -96.4 111.32 23.46 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.121 -0.987 . . . . 0.0 110.283 -179.894 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 66.3 mt -71.19 -2.89 17.45 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.241 -0.912 . . . . 0.0 110.34 -179.949 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.501 ' OG1' HG23 ' A' ' 48' ' ' THR . 31.3 p -85.53 -32.38 22.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.219 -0.926 . . . . 0.0 110.005 179.866 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . 0.501 HG23 ' OG1' ' A' ' 47' ' ' THR . 23.6 p -120.82 -3.74 9.7 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.297 -0.877 . . . . 0.0 110.134 179.88 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 67.05 48.07 61.87 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 109.579 -1.408 . . . . 0.0 109.579 179.84 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.478 ' O ' ' HG3' ' A' ' 44' ' ' GLN . 49.6 mt-30 -129.41 155.67 45.31 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.194 -1.18 . . . . 0.0 110.428 -179.982 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.518 ' CG ' ' HG3' ' A' ' 44' ' ' GLN . 95.4 mt-10 -119.56 160.77 21.8 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.337 -0.852 . . . . 0.0 109.844 179.87 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.506 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -178.32 -157.69 19.52 Favored Glycine 0 N--CA 1.488 2.165 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 179.961 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . . . . . . . . . 60.6 m-85 -120.79 136.09 54.99 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.457 -1.025 . . . . 0.0 109.973 179.833 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.551 HG22 ' HE2' ' A' ' 25' ' ' PHE . 5.2 pt -130.91 149.71 74.49 Favored Pre-proline 0 N--CA 1.491 1.578 0 O-C-N 121.282 -0.886 . . . . 0.0 110.417 -179.773 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.609 ' HG2' ' CD1' ' A' ' 58' ' ' PHE . 44.8 Cg_endo -78.13 143.2 19.98 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 124.023 1.538 . . . . 0.0 109.848 179.702 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.562 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 35.2 p90 -66.86 -8.95 32.69 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.241 -0.912 . . . . 0.0 110.962 -179.311 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . . . . . . . . . 38.6 t-20 -90.81 -26.13 19.58 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.911 -1.118 . . . . 0.0 110.939 -179.355 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.609 ' CD1' ' HG2' ' A' ' 55' ' ' PRO . 7.2 m-85 -84.18 6.67 21.69 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.005 -1.059 . . . . 0.0 110.215 -179.761 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.649 HG11 HG21 ' A' ' 9' ' ' VAL . 15.2 t -147.3 169.11 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.232 -0.918 . . . . 0.0 110.136 -179.983 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.625 ' O ' HG12 ' A' ' 9' ' ' VAL . . . -159.02 166.03 32.66 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.222 -0.924 . . . . 0.0 110.374 -179.968 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . . . . . . . . . 82.9 mttt -76.51 121.37 23.04 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.263 -0.898 . . . . 0.0 110.2 179.935 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -50.31 -34.36 23.33 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.235 -0.916 . . . . 0.0 110.194 179.979 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 41.6 t-20 . . . . . 0 N--CA 1.492 1.627 0 CA-C-O 117.952 -1.023 . . . . 0.0 110.193 -179.961 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.245 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 . . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 58.7 m -124.7 152.03 68.7 Favored Pre-proline 0 N--CA 1.491 1.622 0 O-C-N 121.273 -1.133 . . . . 0.0 110.159 179.93 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . 0.452 ' HG2' HD12 ' A' ' 4' ' ' LEU . 46.6 Cg_endo -55.79 -20.88 30.32 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.032 1.543 . . . . 0.0 110.44 -179.977 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.452 HD12 ' HG2' ' A' ' 3' ' ' PRO . 5.7 mp -94.6 136.87 34.41 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.203 -0.935 . . . . 0.0 110.206 -179.963 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . 0.53 ' O ' HD13 ' A' ' 8' ' ' LEU . 93.2 mt-30 -105.55 148.5 27.2 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.261 -0.899 . . . . 0.0 110.08 179.995 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -104.47 11.13 34.82 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.299 -0.876 . . . . 0.0 110.077 179.863 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -86.71 4.85 38.97 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.302 -0.874 . . . . 0.0 110.175 179.931 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' LEU . . . . . 0.743 HD12 ' N ' ' A' ' 8' ' ' LEU . 6.1 mp -83.63 136.46 34.22 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.229 -0.919 . . . . 0.0 110.267 179.991 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.849 HG21 HD11 ' A' ' 33' ' ' ILE . 25.3 m -140.69 164.34 21.46 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.265 -0.897 . . . . 0.0 110.29 -179.972 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ILE . . . . . . . . . . . . . 24.5 mm -109.39 140.71 27.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 121.361 -0.837 . . . . 0.0 109.75 179.662 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' ALA . . . . . 0.499 ' HB1' ' CE1' ' A' ' 25' ' ' PHE . . . -80.0 107.25 12.64 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.178 -0.951 . . . . 0.0 110.311 -179.828 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.444 HD12 ' N ' ' A' ' 12' ' ' LEU . 7.6 mp -67.63 -23.19 65.32 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.097 -1.002 . . . . 0.0 109.173 179.366 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' HIS . . . . . 0.417 ' CG ' ' O ' ' A' ' 12' ' ' LEU . 90.8 m-70 -153.33 146.45 24.64 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.621 -0.674 . . . . 0.0 109.576 179.75 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.49 ' HA ' ' O ' ' A' ' 25' ' ' PHE . 55.4 p -63.01 147.28 51.12 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.044 -1.035 . . . . 0.0 109.8 179.917 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 25' ' ' PHE . 38.6 t80 -99.08 161.32 13.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.141 -0.974 . . . . 0.0 110.398 -179.865 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.455 ' CG ' ' O ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -118.96 85.17 28.23 Favored Pre-proline 0 N--CA 1.492 1.635 0 O-C-N 121.29 -0.881 . . . . 0.0 110.148 179.92 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.539 ' CB ' ' HB2' ' A' ' 22' ' ' ASP . 47.4 Cg_endo -44.36 96.2 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.714 0 O-C-N 124.02 1.537 . . . . 0.0 110.546 -179.91 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.433 ' N ' ' O ' ' A' ' 16' ' ' GLU . 25.2 p -83.24 3.9 29.21 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.905 . . . . 0.0 109.955 179.783 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' HIS . . . . . 0.442 ' HB3' ' OD2' ' A' ' 22' ' ' ASP . 84.9 t60 -148.2 166.9 26.52 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.342 -0.849 . . . . 0.0 110.116 -179.92 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 60.9 m-20 -75.81 130.72 39.03 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.201 -0.937 . . . . 0.0 110.139 179.965 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 104.45 15.36 21.35 Favored Glycine 0 N--CA 1.489 2.217 0 N-CA-C 109.509 -1.437 . . . . 0.0 109.509 179.995 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.539 ' HB2' ' CB ' ' A' ' 17' ' ' PRO . 27.8 m-20 -111.74 161.04 16.72 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.23 -1.159 . . . . 0.0 110.439 -179.862 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.495 ' HA ' HD12 ' A' ' 23' ' ' LEU . 13.6 tp -116.2 120.03 37.67 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.283 -0.886 . . . . 0.0 109.801 179.927 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.51 ' HA3' ' HD3' ' A' ' 17' ' ' PRO . . . -97.78 50.51 1.38 Allowed Glycine 0 N--CA 1.492 2.412 0 N-CA-C 109.856 -1.298 . . . . 0.0 109.856 -179.792 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 15' ' ' TYR . 30.2 p90 -48.71 172.35 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.227 -1.161 . . . . 0.0 111.19 -179.847 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.434 ' N ' ' OE1' ' A' ' 29' ' ' GLU . 81.0 mt-10 -102.78 173.46 6.31 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.565 -0.71 . . . . 0.0 110.078 179.635 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 pttm -70.11 136.8 50.56 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.134 -0.979 . . . . 0.0 110.159 179.789 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 88.77 -10.23 73.16 Favored Glycine 0 N--CA 1.487 2.054 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 179.981 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' GLU . . . . . 0.465 ' OE1' ' HB2' ' A' ' 25' ' ' PHE . 67.2 tt0 -73.43 128.31 35.12 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.05 -1.264 . . . . 0.0 110.124 -179.907 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' GLN . . . . . 0.834 ' O ' HD23 ' A' ' 31' ' ' LEU . 46.4 tt0 -79.61 141.46 36.52 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.211 -0.93 . . . . 0.0 109.82 179.906 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.834 HD23 ' O ' ' A' ' 30' ' ' GLN . 17.4 mt -140.64 161.97 36.49 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.221 -0.924 . . . . 0.0 110.515 -179.693 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.587 ' O ' ' HB1' ' A' ' 43' ' ' ALA . 7.2 tpt180 -103.67 129.91 51.06 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.414 -0.804 . . . . 0.0 109.617 179.487 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.849 HD11 HG21 ' A' ' 9' ' ' VAL . 25.3 mm -93.67 94.26 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.179 -0.951 . . . . 0.0 110.458 -179.744 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.584 HD12 ' HA ' ' A' ' 43' ' ' ALA . 1.2 mt -79.92 -28.08 39.8 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.279 -0.888 . . . . 0.0 110.775 -179.675 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.465 ' HB2' ' CB ' ' A' ' 42' ' ' LYS . 62.1 mt-10 -131.19 138.38 49.37 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 120.965 -1.084 . . . . 0.0 110.489 -179.83 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.638 HE21 HG21 ' A' ' 33' ' ' ILE . 98.8 mt-30 -135.03 54.28 1.95 Allowed 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 0.0 110.043 179.892 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.6 t -120.49 142.52 49.21 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.273 -0.892 . . . . 0.0 110.205 179.972 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.63 -169.88 54.96 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.389 -1.484 . . . . 0.0 109.389 -179.889 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -76.6 -33.96 58.41 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.296 -1.12 . . . . 0.0 110.146 179.957 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' TRP . . . . . 0.559 ' CZ3' ' HB3' ' A' ' 55' ' ' PRO . 98.7 m95 -96.93 143.37 27.87 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.266 -0.896 . . . . 0.0 110.42 -179.904 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' TRP . . . . . 0.626 ' CD1' ' HA ' ' A' ' 36' ' ' GLN . 45.5 m0 -120.1 156.19 31.5 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.284 -0.885 . . . . 0.0 110.238 179.966 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' LYS . . . . . 0.471 ' HA ' ' HA ' ' A' ' 53' ' ' PHE . 12.6 tttp -100.28 141.78 32.66 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.329 -0.857 . . . . 0.0 109.368 179.372 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.587 ' HB1' ' O ' ' A' ' 32' ' ' ARG . . . -153.69 179.44 8.84 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.053 -1.029 . . . . 0.0 110.94 -179.612 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -142.01 150.61 41.55 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.49 -0.756 . . . . 0.0 109.876 179.834 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.551 ' OG ' HD22 ' A' ' 31' ' ' LEU . 13.3 m -99.02 121.97 41.67 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.118 -0.989 . . . . 0.0 110.356 -179.952 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' LEU . . . . . . . . . . . . . 71.6 mt -79.2 5.04 13.13 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.226 -0.921 . . . . 0.0 110.179 179.888 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.52 -42.07 4.42 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.283 -0.885 . . . . 0.0 110.159 179.871 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' THR . . . . . . . . . . . . . 72.2 p -90.65 -27.41 19.06 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.264 -0.898 . . . . 0.0 110.135 179.979 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 82.8 33.42 24.44 Favored Glycine 0 N--CA 1.49 2.241 0 N-CA-C 109.469 -1.452 . . . . 0.0 109.469 -179.908 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -128.34 153.02 47.48 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.268 -1.136 . . . . 0.0 110.306 -179.96 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.437 ' OE2' ' HE2' ' A' ' 42' ' ' LYS . 84.8 tt0 -120.43 142.57 49.11 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.223 -0.923 . . . . 0.0 110.231 179.85 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' GLY . . . . . 0.423 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -168.55 161.62 35.35 Favored Glycine 0 N--CA 1.49 2.234 0 N-CA-C 109.681 -1.368 . . . . 0.0 109.681 -179.856 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' PHE . . . . . 0.471 ' HA ' ' HA ' ' A' ' 42' ' ' LYS . 95.4 m-85 -71.72 146.92 47.86 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.328 -1.101 . . . . 0.0 109.854 179.591 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' ILE . . . . . 0.736 HD12 HG21 ' A' ' 59' ' ' VAL . 1.1 pt -136.87 136.47 21.4 Favored Pre-proline 0 N--CA 1.489 1.525 0 O-C-N 121.195 -0.941 . . . . 0.0 110.357 -179.715 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.574 ' HD3' ' CD1' ' A' ' 15' ' ' TYR . 45.0 Cg_endo -58.7 147.66 86.68 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.048 1.551 . . . . 0.0 110.045 179.651 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.585 ' HB2' ' CZ3' ' A' ' 41' ' ' TRP . 19.1 p90 -82.89 -5.64 59.11 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.173 -0.954 . . . . 0.0 110.999 -179.419 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' ASN . . . . . 0.56 ' OD1' ' CZ ' ' A' ' 56' ' ' PHE . 83.6 m-20 -89.54 -25.58 21.3 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.927 -1.108 . . . . 0.0 110.632 -179.642 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . 0.542 ' CD2' ' CG ' ' A' ' 55' ' ' PRO . 17.3 m-30 -93.55 2.22 56.47 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.064 -1.023 . . . . 0.0 110.268 179.968 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.736 HG21 HD12 ' A' ' 54' ' ' ILE . 34.1 m -137.2 143.38 34.72 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.215 -0.928 . . . . 0.0 110.12 179.763 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' ALA . . . . . 0.468 ' O ' ' HB ' ' A' ' 9' ' ' VAL . . . -135.09 161.55 34.99 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.215 -0.928 . . . . 0.0 110.411 -179.875 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' LYS . . . . . 0.581 ' HA ' HG12 ' A' ' 9' ' ' VAL . 54.6 mttp -71.45 136.52 47.68 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.188 -0.945 . . . . 0.0 110.161 179.997 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -66.25 -35.61 80.86 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.291 -0.881 . . . . 0.0 110.254 179.925 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ASN . . . . . . . . . . . . . 89.5 m-20 . . . . . 0 N--CA 1.491 1.601 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.228 -179.973 . . . . . . . . 0 0 . 1 stop_ save_